data_2lyh_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lyh _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.9 tm? . . . . . 0 N--CA 1.436 -1.172 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.526 ' O ' HG11 ' A' ' 163' ' ' VAL . 2.0 pt? -58.81 -30.35 67.55 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.455 -179.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -78.78 -26.4 44.45 Favored 'General case' 0 C--N 1.309 -1.166 0 O-C-N 121.837 -0.54 . . . . 0.0 110.563 -179.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 24.9 m -85.84 -28.59 24.34 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.574 0.702 . . . . 0.0 109.637 177.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.526 HG11 ' O ' ' A' ' 160' ' ' LEU . 0.3 OUTLIER -66.3 -25.71 36.15 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 CA-C-O 121.832 0.825 . . . . 0.0 111.072 -176.703 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -84.87 -7.44 59.17 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.37 177.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -96.3 1.86 52.33 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.027 -178.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 70.3 mt -73.96 131.14 81.83 Favored Pre-proline 0 C--N 1.314 -0.975 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.057 -177.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -66.68 128.23 18.62 Favored 'Trans proline' 0 C--O 1.246 0.897 0 C-N-CA 121.934 1.756 . . . . 0.0 110.235 175.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 116.02 -24.23 10.2 Favored Glycine 0 C--N 1.297 -1.59 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 -178.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 65.6 t -75.02 -58.39 4.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 177.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 90.13 107.06 1.27 Allowed Glycine 0 N--CA 1.425 -2.062 0 CA-C-N 115.431 -0.804 . . . . 0.0 113.576 177.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? -68.46 -21.24 64.65 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 121.577 0.703 . . . . 0.0 111.201 178.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 57.9 t -82.53 -30.56 9.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-O 121.712 0.768 . . . . 0.0 109.35 178.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.46 ' O ' HD11 ' A' ' 177' ' ' LEU . 60.0 mtpt -84.79 -10.25 57.38 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.955 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -51.73 -53.79 46.97 Favored Pre-proline 0 C--O 1.201 -1.472 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -178.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -62.3 -26.58 77.3 Favored 'Trans proline' 0 C--N 1.376 1.982 0 C-N-CA 121.856 1.704 . . . . 0.0 113.413 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 61.6 tp -77.38 -45.27 26.49 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 121.741 0.781 . . . . 0.0 109.103 178.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.46 HD11 ' O ' ' A' ' 173' ' ' LYS . 8.2 mp -71.84 -24.35 61.69 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.873 178.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.439 HD11 ' O ' ' A' ' 181' ' ' PHE . 42.5 tp -67.31 -11.68 58.21 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 124.091 0.956 . . . . 0.0 110.401 177.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -76.53 -20.59 56.74 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.514 175.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 7.8 mmmm -105.58 -42.13 5.29 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.918 178.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' PHE . . . . . 0.439 ' O ' HD11 ' A' ' 178' ' ' LEU . 32.5 m-85 -105.64 130.55 22.87 Favored Pre-proline 0 C--N 1.299 -1.611 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.935 -174.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -53.73 -42.4 66.52 Favored 'Trans proline' 0 C--N 1.359 1.128 0 C-N-CA 123.623 2.882 . . . . 0.0 113.7 -175.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 42.6 m -158.5 177.5 11.17 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.414 ' HA ' ' HB3' ' A' ' 187' ' ' LEU . 0.2 OUTLIER -59.52 -27.89 38.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 -175.961 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -69.1 -38.63 79.03 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 120.67 0.272 . . . . 0.0 110.94 -177.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.9 -33.44 39.89 Favored 'General case' 0 C--O 1.195 -1.81 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 176.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.414 ' HB3' ' HA ' ' A' ' 184' ' ' ILE . 62.4 tp -52.63 -67.78 0.22 Allowed 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 125.104 1.362 . . . . 0.0 113.467 -176.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 19.4 m -74.65 -24.75 58.87 Favored 'General case' 0 C--N 1.289 -2.04 0 C-N-CA 120.24 -0.584 . . . . 0.0 111.609 -176.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.463 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 62.4 t30 -89.45 12.0 17.7 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-O 122.095 0.95 . . . . 0.0 110.025 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.51 156.62 31.95 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.606 173.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 6.6 m -63.6 154.38 32.91 Favored 'General case' 0 N--CA 1.425 -1.676 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.082 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 48.9 mm -52.02 -39.73 26.96 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.825 0 C-N-CA 123.477 0.711 . . . . 0.0 110.889 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . 0.489 ' O ' ' HG2' ' A' ' 197' ' ' GLN . . . -59.39 -39.13 94.39 Favored Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 116.18 -0.464 . . . . 0.0 112.631 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . 0.473 ' O ' ' HB2' ' A' ' 197' ' ' GLN . 41.6 mm-40 -77.72 -38.55 46.96 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.43 0.633 . . . . 0.0 109.807 -176.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 96.8 mt -69.88 -32.2 70.42 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.485 178.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -67.37 -29.72 69.32 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -178.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . 0.489 ' HG2' ' O ' ' A' ' 193' ' ' GLY . 15.8 mm100 -59.62 -33.84 72.01 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.737 -1.12 . . . . 0.0 112.441 178.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 23.4 m -103.48 -26.83 3.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -174.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.443 HG21 ' H ' ' A' ' 200' ' ' GLY . 1.4 m -123.15 -82.82 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 175.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . 0.443 ' H ' HG21 ' A' ' 199' ' ' VAL . . . -177.0 167.87 39.42 Favored Glycine 0 N--CA 1.419 -2.449 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 -177.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 19.5 tm0? -64.14 -47.95 77.94 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 123.254 0.622 . . . . 0.0 110.814 -175.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -71.65 -32.34 67.81 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.859 0.361 . . . . 0.0 111.066 -177.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.421 ' O ' ' HG2' ' A' ' 206' ' ' GLN . 2.9 t -69.03 -40.07 80.39 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.649 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 179.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -60.19 -43.18 96.12 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 114.294 -1.321 . . . . 0.0 109.675 177.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -59.72 -45.58 91.75 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.785 179.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' GLN . . . . . 0.421 ' HG2' ' O ' ' A' ' 203' ' ' VAL . 12.0 pt20 -66.26 -34.75 78.72 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 120.145 -0.622 . . . . 0.0 111.084 -179.041 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 87.3 mt -69.43 -51.48 41.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.291 0.567 . . . . 0.0 109.712 178.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' HIS . . . . . 0.55 ' HA ' ' CE2' ' A' ' 211' ' ' PHE . 13.4 t60 -68.0 -36.71 80.46 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.237 -175.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -68.06 -32.79 73.37 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.694 176.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -54.62 -52.21 62.94 Favored 'General case' 0 C--O 1.215 -0.733 0 C-N-CA 124.023 0.929 . . . . 0.0 112.367 -174.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.55 ' CE2' ' HA ' ' A' ' 208' ' ' HIS . 21.5 p90 -80.8 -23.85 38.96 Favored 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 120.36 -0.536 . . . . 0.0 112.097 -178.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 75.2 m . . . . . 0 C--O 1.247 0.932 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.248 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.473 ' O ' HD22 ' A' ' 159' ' ' LEU . 6.2 tt . . . . . 0 C--O 1.215 -0.73 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -59.37 -22.36 61.24 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.045 0.45 . . . . 0.0 111.738 178.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 32.8 ptt180 -73.49 -35.42 65.64 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.459 ' HA ' ' OE1' ' A' ' 165' ' ' GLN . 33.3 m -87.03 -29.11 22.18 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 124.244 1.018 . . . . 0.0 112.163 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 2.8 p -64.56 -27.08 41.76 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-O 121.752 0.787 . . . . 0.0 110.757 -176.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -82.94 -8.67 59.54 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.91 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.459 ' OE1' ' HA ' ' A' ' 162' ' ' THR . 51.0 mt-30 -98.42 0.42 45.26 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.665 -177.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 96.4 mt -68.43 131.54 91.66 Favored Pre-proline 0 C--N 1.312 -1.048 0 N-CA-C 108.876 -0.786 . . . . 0.0 108.876 178.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -61.36 128.72 25.77 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 121.843 1.696 . . . . 0.0 109.632 177.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 115.52 -30.12 6.87 Favored Glycine 0 N--CA 1.429 -1.773 0 C-N-CA 120.267 -0.968 . . . . 0.0 111.279 -178.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 84.5 t -66.2 -62.91 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 103.47 105.19 2.95 Favored Glycine 0 N--CA 1.427 -1.964 0 C-N-CA 120.575 -0.822 . . . . 0.0 112.164 178.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -81.29 -17.11 50.46 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -177.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 42.4 t -85.15 -37.84 12.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 CA-C-O 121.596 0.712 . . . . 0.0 109.3 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.509 ' O ' ' HG ' ' A' ' 177' ' ' LEU . 20.8 ptmt -88.72 -4.75 58.45 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.509 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -54.72 -48.89 94.24 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -178.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . 0.485 ' O ' ' HG2' ' A' ' 179' ' ' GLN . 11.2 Cg_endo -57.27 -35.15 98.85 Favored 'Trans proline' 0 C--N 1.38 2.237 0 C-N-CA 121.715 1.61 . . . . 0.0 112.179 177.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 59.4 tp -69.31 -42.4 75.45 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.274 0.559 . . . . 0.0 109.54 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 173' ' ' LYS . 74.5 mt -69.47 -29.85 67.6 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.795 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 50.9 tp -70.73 -12.57 61.63 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.738 179.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' A' ' 175' ' ' PRO . 24.8 mm-40 -88.22 -13.77 40.2 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 176.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -99.33 -51.52 3.77 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 -179.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' PHE . . . . . 0.564 ' CD2' ' HG ' ' A' ' 187' ' ' LEU . 89.7 m-85 -94.24 148.85 35.8 Favored Pre-proline 0 C--N 1.307 -1.267 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.183 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -68.94 -31.29 24.66 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.053 1.835 . . . . 0.0 113.332 -175.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 66.5 m -158.56 161.84 37.32 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -62.01 -29.41 46.39 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.411 0 O-C-N 123.55 0.531 . . . . 0.0 112.024 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -62.54 -47.7 82.77 Favored 'General case' 0 C--O 1.211 -0.966 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.429 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -74.08 -31.18 62.72 Favored 'General case' 0 C--O 1.2 -1.528 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.564 ' HG ' ' CD2' ' A' ' 181' ' ' PHE . 4.5 tt -57.81 -59.91 4.5 Favored 'General case' 0 C--O 1.204 -1.301 0 C-N-CA 123.811 0.844 . . . . 0.0 109.561 -178.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 22.8 m -73.77 -24.72 59.89 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -178.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -86.98 1.99 50.95 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-O 121.516 0.674 . . . . 0.0 110.724 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.55 156.94 31.07 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 124.023 0.929 . . . . 0.0 111.373 175.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 5.0 m -64.49 159.72 20.91 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.249 -178.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 43.1 mm -52.67 -38.79 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 123.205 0.602 . . . . 0.0 111.449 -179.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . 0.487 ' O ' ' HG2' ' A' ' 197' ' ' GLN . . . -61.48 -43.65 99.04 Favored Glycine 0 C--O 1.214 -1.142 0 C-N-CA 120.853 -0.689 . . . . 0.0 111.908 178.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -67.47 -41.23 84.95 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.635 0.731 . . . . 0.0 109.575 -176.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 94.2 mt -70.47 -31.05 68.03 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.001 -0.999 . . . . 0.0 111.121 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . 0.517 ' HG2' ' N ' ' A' ' 201' ' ' GLN . 4.2 tm-20 -73.42 -41.01 63.81 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . 0.487 ' HG2' ' O ' ' A' ' 193' ' ' GLY . 14.6 mm100 -57.66 -25.32 60.04 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 123.8 0.84 . . . . 0.0 112.369 178.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 14.6 m -103.52 -34.84 3.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.419 HG12 HG13 ' A' ' 203' ' ' VAL . 1.2 t -122.01 -77.43 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 C-N-CA 119.259 -0.976 . . . . 0.0 111.392 178.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -177.22 160.43 27.34 Favored Glycine 0 N--CA 1.435 -1.383 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 -176.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' GLN . . . . . 0.517 ' N ' ' HG2' ' A' ' 196' ' ' GLU . 4.0 pt20 -63.36 -38.05 89.64 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 123.624 0.77 . . . . 0.0 112.34 -176.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -74.86 -34.92 62.34 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 121.837 0.827 . . . . 0.0 109.672 -178.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.446 ' O ' ' HG2' ' A' ' 206' ' ' GLN . 24.8 t -68.53 -45.09 82.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-N 114.373 -1.285 . . . . 0.0 109.57 -179.397 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -53.51 -43.82 68.62 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 114.161 -1.381 . . . . 0.0 109.756 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -66.8 -44.98 79.84 Favored 'General case' 0 N--CA 1.421 -1.904 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.451 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' GLN . . . . . 0.446 ' HG2' ' O ' ' A' ' 203' ' ' VAL . 20.9 pt20 -66.09 -33.67 76.31 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.254 -0.578 . . . . 0.0 111.147 -178.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 84.7 mt -73.59 -50.19 31.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.561 177.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 28.0 t-80 -63.75 -46.99 82.81 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.997 -177.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -72.35 -9.96 59.18 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -178.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -64.13 -47.43 79.98 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 178.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -97.79 -29.44 13.36 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.647 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 33.4 m . . . . . 0 CA--C 1.542 0.668 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -176.883 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 4.2 mm? . . . . . 0 CA--C 1.506 -0.741 0 N-CA-C 111.574 0.213 . . . . 0.0 111.574 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.414 ' O ' HG12 ' A' ' 163' ' ' VAL . 1.7 pt? -60.53 -32.63 71.66 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.281 0.562 . . . . 0.0 111.232 178.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -75.39 -30.14 60.03 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.036 177.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.59 ' O ' ' HG2' ' A' ' 165' ' ' GLN . 12.0 m -81.27 -37.99 27.58 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-O 121.457 0.646 . . . . 0.0 110.015 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.414 HG12 ' O ' ' A' ' 160' ' ' LEU . 1.7 p -63.55 -25.15 37.65 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.049 0 CA-C-O 121.479 0.657 . . . . 0.0 110.952 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . 0.445 HE21 HG13 ' A' ' 184' ' ' ILE . 3.4 pt20 -90.13 -11.64 40.64 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 122.015 -0.428 . . . . 0.0 110.9 178.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.59 ' HG2' ' O ' ' A' ' 162' ' ' THR . 18.9 pt20 -91.77 -6.02 52.54 Favored 'General case' 0 CA--C 1.505 -0.783 0 C-N-CA 119.303 -0.959 . . . . 0.0 111.168 -174.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 66.0 mt -61.19 133.51 92.84 Favored Pre-proline 0 C--N 1.298 -1.654 0 CA-C-N 114.823 -1.08 . . . . 0.0 109.481 -178.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -63.3 127.96 21.4 Favored 'Trans proline' 0 C--O 1.246 0.91 0 C-N-CA 122.022 1.815 . . . . 0.0 110.345 179.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 114.36 -32.82 5.71 Favored Glycine 0 N--CA 1.424 -2.126 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 -177.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 57.9 t -69.02 -53.01 28.27 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 177.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . 0.438 ' HA3' ' HG2' ' A' ' 173' ' ' LYS . . . 88.88 90.93 1.15 Allowed Glycine 0 N--CA 1.414 -2.779 0 CA-C-N 114.77 -1.105 . . . . 0.0 111.818 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -66.3 -23.18 66.33 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 120.776 0.322 . . . . 0.0 111.724 -178.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 47.2 t -86.53 -28.19 5.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-O 121.194 0.521 . . . . 0.0 110.281 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.557 ' O ' ' HG ' ' A' ' 177' ' ' LEU . 21.0 ptmt -91.29 9.26 32.18 Favored 'General case' 0 C--O 1.214 -0.764 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.707 178.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . 0.451 ' O ' ' HG ' ' A' ' 178' ' ' LEU . . . -52.07 -48.66 87.88 Favored Pre-proline 0 CA--C 1.556 1.2 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 177.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -59.99 -23.22 72.22 Favored 'Trans proline' 0 C--N 1.381 2.243 0 C-N-CA 122.401 2.067 . . . . 0.0 112.867 177.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.493 ' HB3' ' O ' ' A' ' 173' ' ' LYS . 51.0 tp -79.23 -21.05 46.77 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 123.683 0.793 . . . . 0.0 109.489 178.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.557 ' HG ' ' O ' ' A' ' 173' ' ' LYS . 39.7 mt -98.32 -34.46 10.68 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -178.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 174' ' ' ALA . 95.2 mt -66.82 -5.66 13.17 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.997 0.919 . . . . 0.0 112.732 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . 0.458 ' HG2' ' O ' ' A' ' 176' ' ' LEU . 16.1 pt20 -74.5 -35.02 63.2 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 172.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm -92.52 -51.43 5.13 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.138 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' PHE . . . . . 0.417 ' CD1' ' HA ' ' A' ' 187' ' ' LEU . 89.9 m-85 -90.27 144.36 30.9 Favored Pre-proline 0 C--N 1.304 -1.401 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.63 -176.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -69.78 -44.56 1.99 Allowed 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 121.851 1.701 . . . . 0.0 112.652 -175.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 45.4 m -152.38 167.84 27.4 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 178.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.445 HG13 HE21 ' A' ' 164' ' ' GLN . 0.2 OUTLIER -60.75 -31.76 50.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 N-CA-C 115.613 1.708 . . . . 0.0 115.613 -173.225 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -68.57 -45.92 70.78 Favored 'General case' 0 C--O 1.207 -1.15 0 C-N-CA 118.81 -1.156 . . . . 0.0 110.425 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -67.49 -32.8 73.87 Favored 'General case' 0 C--O 1.209 -1.059 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.417 ' HA ' ' CD1' ' A' ' 181' ' ' PHE . 3.6 tt -56.76 -62.6 1.62 Allowed 'General case' 0 C--O 1.213 -0.857 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.5 -179.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 29.5 m -70.87 -27.82 64.11 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -178.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.49 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 11.1 t-20 -81.03 -3.25 51.17 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-O 121.222 0.534 . . . . 0.0 110.511 -178.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.56 155.67 32.31 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 123.055 0.542 . . . . 0.0 110.79 177.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 20.6 t -68.09 170.65 8.08 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 121.262 0.553 . . . . 0.0 110.836 -175.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 47.7 mm -59.33 -39.61 79.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.55 -177.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . 0.549 ' O ' ' HG3' ' A' ' 197' ' ' GLN . . . -59.86 -38.62 94.31 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.305 178.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -77.82 -43.12 31.42 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -176.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 96.2 mt -67.6 -25.32 65.7 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.712 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 9.7 tm-20 -73.67 -31.7 63.59 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . 0.549 ' HG3' ' O ' ' A' ' 193' ' ' GLY . 98.4 mt-30 -68.8 -20.29 64.32 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.913 -1.04 . . . . 0.0 111.702 -178.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 16.7 m -105.19 -33.32 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.74 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.023 177.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.401 HG11 HG12 ' A' ' 203' ' ' VAL . 1.7 t -124.64 -84.48 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 C-N-CA 120.338 -0.545 . . . . 0.0 111.504 176.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -177.91 168.95 40.66 Favored Glycine 0 N--CA 1.436 -1.331 0 N-CA-C 109.851 -1.299 . . . . 0.0 109.851 -176.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -59.14 -52.86 63.9 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.911 0.884 . . . . 0.0 112.628 -175.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -68.85 -35.39 76.88 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 121.45 0.643 . . . . 0.0 111.186 -173.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.401 HG12 HG11 ' A' ' 199' ' ' VAL . 2.2 t -72.57 -38.19 58.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -178.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -57.85 -44.11 86.34 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 114.347 -1.297 . . . . 0.0 109.844 178.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -64.42 -42.78 95.86 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.886 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -74.56 -25.02 59.02 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.417 -0.513 . . . . 0.0 112.239 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 98.2 mt -76.4 -49.43 24.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 174.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 53.3 t-80 -63.44 -47.36 82.2 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.003 -178.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -65.74 -20.07 66.13 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -179.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -59.05 -44.13 91.76 Favored 'General case' 0 C--O 1.214 -0.792 0 C-N-CA 122.799 0.439 . . . . 0.0 110.613 -178.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.49 ' CZ ' ' HA ' ' A' ' 189' ' ' ASN . 31.6 p90 -99.4 -25.73 14.37 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.672 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 37.5 m . . . . . 0 C--N 1.313 -1.022 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -178.692 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.4 tm? . . . . . 0 CA--C 1.527 0.086 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.512 ' O ' HG11 ' A' ' 163' ' ' VAL . 1.6 pt? -60.38 -23.79 64.59 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.267 -0.879 . . . . 0.0 112.118 178.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.402 ' O ' ' HG2' ' A' ' 164' ' ' GLN . 14.3 ptm180 -65.87 -29.36 69.79 Favored 'General case' 0 C--O 1.215 -0.744 0 CA-C-O 120.92 0.39 . . . . 0.0 110.115 176.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 37.9 m -86.55 -31.75 21.06 Favored 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 123.025 0.53 . . . . 0.0 111.39 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.512 HG11 ' O ' ' A' ' 160' ' ' LEU . 2.5 p -64.52 -25.66 38.43 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.115 0 CA-C-O 121.418 0.627 . . . . 0.0 111.372 -176.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . 0.402 ' HG2' ' O ' ' A' ' 161' ' ' ARG . 29.5 pt20 -81.32 -13.01 58.87 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 121.161 0.505 . . . . 0.0 110.459 177.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -95.38 -0.05 53.0 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.545 -175.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 81.2 mt -66.14 132.42 94.53 Favored Pre-proline 0 C--N 1.317 -0.837 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.28 128.16 26.54 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.096 1.864 . . . . 0.0 111.006 178.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 112.65 -29.91 7.87 Favored Glycine 0 N--CA 1.425 -2.096 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 -178.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 59.1 t -73.25 -65.74 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 101.97 110.55 3.38 Favored Glycine 0 N--CA 1.43 -1.737 0 C-N-CA 120.314 -0.946 . . . . 0.0 112.799 177.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -82.66 -18.88 39.47 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.4 0.619 . . . . 0.0 111.597 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 62.7 t -84.13 -30.35 7.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 CA-C-O 121.819 0.819 . . . . 0.0 109.27 177.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -90.34 -4.17 57.27 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.372 178.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . 0.493 ' O ' ' HG ' ' A' ' 178' ' ' LEU . . . -55.07 -47.16 99.19 Favored Pre-proline 0 C--O 1.202 -1.403 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -178.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . 0.435 ' O ' ' HG3' ' A' ' 179' ' ' GLN . 36.2 Cg_exo -59.82 -36.99 89.33 Favored 'Trans proline' 0 C--N 1.381 2.243 0 CA-C-N 121.337 1.513 . . . . 0.0 111.234 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 57.2 tp -66.97 -44.64 79.96 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.665 176.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 96.3 mt -65.33 -32.25 73.79 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.027 178.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 174' ' ' ALA . 88.7 mt -72.44 -7.32 49.24 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 123.4 0.68 . . . . 0.0 111.774 178.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . 0.435 ' HG3' ' O ' ' A' ' 175' ' ' PRO . 52.6 mt-30 -95.65 -9.31 32.39 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.386 0.612 . . . . 0.0 109.356 174.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -105.18 -51.42 3.03 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' PHE . . . . . 0.421 ' CD2' ' HG ' ' A' ' 187' ' ' LEU . 86.4 m-85 -99.69 149.46 35.93 Favored Pre-proline 0 C--N 1.294 -1.837 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -66.99 -46.11 3.47 Favored 'Trans proline' 0 C--O 1.24 0.601 0 C-N-CA 121.439 1.426 . . . . 0.0 112.13 -175.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 30.0 m -151.33 167.79 26.81 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -60.67 -29.86 45.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 -174.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 56.8 tp60 -70.82 -39.13 73.23 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 119.731 -0.788 . . . . 0.0 110.384 -176.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -76.06 -32.23 59.18 Favored 'General case' 0 C--O 1.197 -1.66 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 178.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.421 ' HG ' ' CD2' ' A' ' 181' ' ' PHE . 3.8 tt -56.53 -61.26 2.54 Favored 'General case' 0 C--O 1.212 -0.906 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.717 -178.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 19.8 m -70.26 -32.16 69.87 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 120.641 -0.423 . . . . 0.0 111.88 -178.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.402 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 7.9 t30 -83.96 4.72 28.47 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-O 121.566 0.698 . . . . 0.0 110.839 -177.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.46 156.16 33.26 Favored 'General case' 0 C--O 1.248 1.004 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.414 174.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 2.6 m -63.58 159.48 18.74 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.987 -176.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 50.8 mm -53.09 -36.25 24.45 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.963 0 C-N-CA 122.917 0.487 . . . . 0.0 111.537 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -69.47 -28.92 71.9 Favored Glycine 0 C--N 1.314 -0.66 0 C-N-CA 121.222 -0.513 . . . . 0.0 112.903 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . 0.671 ' O ' ' HG2' ' A' ' 197' ' ' GLN . 26.2 mt-10 -81.29 -31.28 33.69 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -178.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 97.3 mt -79.33 -29.45 42.32 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.409 175.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . 0.524 ' HG2' ' N ' ' A' ' 201' ' ' GLN . 2.6 tm-20 -69.59 -35.61 75.48 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -178.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . 0.671 ' HG2' ' O ' ' A' ' 194' ' ' GLU . 20.3 pt20 -67.19 -20.86 65.78 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.412 -176.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 15.7 m -104.6 -31.19 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -127.32 -83.41 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 173.135 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -177.21 164.07 33.14 Favored Glycine 0 CA--C 1.488 -1.602 0 N-CA-C 108.027 -2.029 . . . . 0.0 108.027 -176.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' GLN . . . . . 0.524 ' N ' ' HG2' ' A' ' 196' ' ' GLU . 12.1 pt20 -69.68 -38.59 77.08 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 118.239 1.02 . . . . 0.0 111.778 -176.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -64.25 -28.86 70.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.644 0.735 . . . . 0.0 110.561 -179.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 3.1 t -81.17 -43.09 20.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 178.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -56.44 -46.03 80.51 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.209 -1.36 . . . . 0.0 110.946 -178.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -60.74 -44.82 96.19 Favored 'General case' 0 C--O 1.199 -1.588 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.599 -178.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -73.63 -33.22 64.43 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.528 -178.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 92.5 mt -66.37 -49.56 74.64 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.241 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 175.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' HIS . . . . . 0.523 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 9.9 t60 -68.68 -39.2 80.68 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.829 -176.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -65.44 -29.12 69.77 Favored 'General case' 0 C--O 1.219 -0.523 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 177.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -54.27 -47.69 72.05 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.208 0.603 . . . . 0.0 111.912 -176.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.523 ' CZ ' ' HA ' ' A' ' 208' ' ' HIS . 19.9 p90 -93.6 -22.16 18.96 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.096 -178.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 80.6 m . . . . . 0 C--N 1.317 -0.842 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.198 179.404 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 41.7 tp . . . . . 0 N--CA 1.438 -1.067 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.408 ' O ' HG13 ' A' ' 163' ' ' VAL . 2.4 pt? -60.75 -29.84 69.63 Favored 'General case' 0 C--O 1.225 -0.193 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.789 -178.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -63.07 -37.44 87.22 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.52 177.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 15.0 m -86.32 -31.95 21.29 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.183 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.408 HG13 ' O ' ' A' ' 160' ' ' LEU . 0.7 OUTLIER -62.96 -25.91 39.68 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.928 0 CA-C-O 121.587 0.708 . . . . 0.0 111.556 -176.597 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . 0.455 ' HG3' HE21 ' A' ' 165' ' ' GLN . 28.9 pt20 -85.99 -8.02 58.25 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.15 0.5 . . . . 0.0 110.732 178.008 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.455 HE21 ' HG3' ' A' ' 164' ' ' GLN . 29.0 mm-40 -97.49 -0.16 46.53 Favored 'General case' 0 C--O 1.238 0.476 0 O-C-N 122.249 -0.282 . . . . 0.0 110.873 -177.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 92.1 mt -62.1 129.68 92.23 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -62.71 127.44 20.64 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 121.603 1.535 . . . . 0.0 110.619 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 115.56 -29.95 6.95 Favored Glycine 0 N--CA 1.424 -2.138 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.646 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 93.2 t -58.15 -60.27 2.45 Favored 'Isoleucine or valine' 0 C--O 1.245 0.847 0 CA-C-O 120.954 0.407 . . . . 0.0 110.94 -179.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 93.89 85.87 1.62 Allowed Glycine 0 N--CA 1.431 -1.647 0 C-N-CA 120.331 -0.938 . . . . 0.0 110.983 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -68.62 -12.03 60.82 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.668 0.746 . . . . 0.0 111.916 -176.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 42.1 t -71.73 -28.58 31.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 176.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.602 ' O ' ' HG ' ' A' ' 177' ' ' LEU . 47.1 mtmt -87.37 0.19 55.83 Favored 'General case' 0 C--O 1.208 -1.098 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.308 -179.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . 0.47 ' O ' ' HG ' ' A' ' 178' ' ' LEU . . . -46.73 -53.06 27.82 Favored Pre-proline 0 N--CA 1.483 1.206 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 -174.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . 0.417 ' O ' ' HG2' ' A' ' 179' ' ' GLN . 32.2 Cg_exo -60.07 -43.41 36.31 Favored 'Trans proline' 0 C--N 1.373 1.831 0 C-N-CA 121.569 1.512 . . . . 0.0 111.379 179.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 49.2 tp -60.83 -45.55 94.02 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.918 177.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.602 ' HG ' ' O ' ' A' ' 173' ' ' LYS . 91.6 mt -61.62 -41.72 97.87 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.173 178.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 174' ' ' ALA . 90.8 mt -68.95 -8.39 44.02 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . 0.417 ' HG2' ' O ' ' A' ' 175' ' ' PRO . 29.5 mm-40 -80.6 -21.14 41.86 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.374 0.607 . . . . 0.0 110.011 175.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 8.2 mmmm -106.51 -45.01 4.35 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.801 177.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' PHE . . . . . 0.439 ' O ' ' HA ' ' A' ' 178' ' ' LEU . 32.3 m-85 -103.42 132.31 21.21 Favored Pre-proline 0 N--CA 1.424 -1.769 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -176.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -62.31 -35.76 71.63 Favored 'Trans proline' 0 CA--C 1.51 -0.695 0 C-N-CA 122.839 2.359 . . . . 0.0 112.803 -172.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 59.3 m -153.46 160.21 42.51 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.474 ' O ' ' HB3' ' A' ' 187' ' ' LEU . 0.2 OUTLIER -60.02 -23.14 26.19 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.5 0 O-C-N 123.926 0.766 . . . . 0.0 112.905 -178.335 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -66.23 -47.2 74.59 Favored 'General case' 0 C--O 1.215 -0.715 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -77.33 -29.04 53.34 Favored 'General case' 0 C--O 1.19 -2.051 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -178.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.474 ' HB3' ' O ' ' A' ' 184' ' ' ILE . 41.2 tp -51.57 -64.14 0.91 Allowed 'General case' 0 C--O 1.204 -1.329 0 C-N-CA 124.351 1.06 . . . . 0.0 111.63 177.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 20.0 m -69.23 -24.43 64.01 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.402 0.62 . . . . 0.0 111.454 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -85.97 1.37 50.38 Favored 'General case' 0 C--O 1.244 0.816 0 CA-C-O 122.042 0.925 . . . . 0.0 111.194 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -67.85 157.05 35.75 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.218 177.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 15.0 m -63.3 153.72 33.98 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.568 -179.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 51.1 mm -57.87 -34.32 48.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.117 -176.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . 0.416 ' O ' ' HG3' ' A' ' 197' ' ' GLN . . . -62.19 -36.41 92.95 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 116.095 -0.502 . . . . 0.0 112.477 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . 0.501 ' O ' ' HB2' ' A' ' 197' ' ' GLN . 55.4 mm-40 -77.66 -41.64 37.51 Favored 'General case' 0 CA--C 1.498 -1.043 0 CA-C-O 121.62 0.724 . . . . 0.0 109.915 -178.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.436 HD21 ' O ' ' A' ' 187' ' ' LEU . 97.5 mt -67.64 -32.24 72.79 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.131 -0.941 . . . . 0.0 111.074 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . 0.524 ' HG2' ' N ' ' A' ' 201' ' ' GLN . 4.6 tm-20 -66.44 -30.15 70.45 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -178.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . 0.501 ' HB2' ' O ' ' A' ' 194' ' ' GLU . 69.6 mt-30 -60.16 -37.27 79.62 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.652 -1.158 . . . . 0.0 111.376 178.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 30.0 m -103.66 -31.04 2.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -175.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.508 HG21 ' H ' ' A' ' 200' ' ' GLY . 6.5 m -115.34 -85.67 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 176.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . 0.508 ' H ' HG21 ' A' ' 199' ' ' VAL . . . -178.74 166.25 35.87 Favored Glycine 0 N--CA 1.408 -3.225 0 N-CA-C 108.413 -1.875 . . . . 0.0 108.413 -177.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' GLN . . . . . 0.524 ' N ' ' HG2' ' A' ' 196' ' ' GLU . 0.4 OUTLIER -62.64 -51.38 67.49 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 123.827 0.851 . . . . 0.0 109.122 -179.344 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -72.73 -26.73 61.68 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.066 -176.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 3.4 t -76.44 -42.83 36.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -56.29 -43.54 78.98 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.241 -1.345 . . . . 0.0 109.902 179.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -54.89 -53.79 50.87 Favored 'General case' 0 N--CA 1.436 -1.16 0 C-N-CA 124.218 1.007 . . . . 0.0 111.964 177.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -69.87 -28.87 66.01 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 119.826 -0.749 . . . . 0.0 111.903 -176.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 98.6 mt -71.78 -48.73 49.84 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-N 116.22 -0.446 . . . . 0.0 109.873 177.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 10.4 t60 -70.96 -40.0 72.23 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -176.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -66.51 -25.55 66.74 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 178.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -53.65 -47.52 70.27 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.069 0.948 . . . . 0.0 112.285 -175.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -93.35 -23.59 18.4 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.694 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 62.8 m . . . . . 0 C--N 1.314 -0.963 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.241 -179.821 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.8 tm? . . . . . 0 N--CA 1.44 -0.96 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.6 pp -59.51 -27.51 66.23 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 123.944 0.898 . . . . 0.0 111.917 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 11.4 ptt180 -67.57 -37.8 83.16 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -178.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 25.0 m -86.5 -31.6 21.21 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.21 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.36 -26.23 40.32 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 CA-C-O 121.609 0.719 . . . . 0.0 111.358 -177.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -86.54 -8.01 57.89 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.591 177.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -105.3 21.19 17.59 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 -176.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.438 HG12 ' CD1' ' A' ' 210' ' ' PHE . 75.0 mt -78.93 125.93 83.08 Favored Pre-proline 0 C--N 1.31 -1.116 0 CA-C-N 116.297 -0.411 . . . . 0.0 109.961 -178.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -66.6 130.84 24.47 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.208 1.939 . . . . 0.0 110.073 176.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 120.21 -35.16 3.87 Favored Glycine 0 C--N 1.292 -1.88 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 -177.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 95.5 t -60.45 -52.56 60.0 Favored 'Isoleucine or valine' 0 C--O 1.246 0.875 0 CA-C-O 121.376 0.608 . . . . 0.0 110.052 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 99.68 99.77 2.26 Favored Glycine 0 N--CA 1.425 -2.09 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -177.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -63.32 -29.81 71.06 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 120.969 0.414 . . . . 0.0 111.491 -176.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 60.9 t -83.19 -26.52 7.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-O 121.513 0.673 . . . . 0.0 110.148 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.432 ' HZ2' HG13 ' A' ' 199' ' ' VAL . 37.3 ttpt -92.45 -5.8 51.21 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 120.443 -0.503 . . . . 0.0 109.808 -178.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -53.4 -49.9 85.78 Favored Pre-proline 0 CA--C 1.553 1.085 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -177.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -57.52 -30.1 87.17 Favored 'Trans proline' 0 C--N 1.384 2.399 0 C-N-CA 121.961 1.774 . . . . 0.0 112.562 176.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.417 ' HB3' ' O ' ' A' ' 173' ' ' LYS . 54.0 tp -70.22 -39.8 74.89 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 121.469 0.652 . . . . 0.0 109.604 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 9.5 mp -72.52 -32.68 66.32 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.174 178.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 42.7 tp -68.93 -8.84 48.1 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.005 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -82.96 -23.27 33.49 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 174.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm -93.37 -49.67 5.83 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.497 0.665 . . . . 0.0 109.736 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' PHE . . . . . 0.551 ' CD2' HD23 ' A' ' 187' ' ' LEU . 64.5 m-85 -95.14 143.0 25.38 Favored Pre-proline 0 C--N 1.304 -1.37 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.642 -176.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -66.36 -39.19 17.9 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.37 2.047 . . . . 0.0 113.867 -174.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 58.8 m -157.0 164.51 37.93 Favored 'General case' 0 C--O 1.247 0.938 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.409 ' HA ' ' CB ' ' A' ' 187' ' ' LEU . 0.2 OUTLIER -56.36 -29.66 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 -176.194 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -62.66 -45.83 91.02 Favored 'General case' 0 C--O 1.217 -0.636 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.328 178.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -78.78 -28.84 44.76 Favored 'General case' 0 C--O 1.201 -1.462 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -177.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.551 HD23 ' CD2' ' A' ' 181' ' ' PHE . 0.3 OUTLIER -51.71 -67.65 0.23 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.263 1.425 . . . . 0.0 109.541 -179.629 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 17.0 m -73.09 -27.17 61.55 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.048 -176.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -81.59 1.31 34.39 Favored 'General case' 0 C--O 1.253 1.241 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.32 154.98 36.7 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 121.601 0.715 . . . . 0.0 110.684 174.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 3.5 m -68.95 163.11 25.25 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.702 -177.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.4 mm -53.56 -41.2 45.05 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.184 0 C-N-CA 123.105 0.562 . . . . 0.0 111.056 -178.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . 0.488 ' O ' ' HG3' ' A' ' 197' ' ' GLN . . . -63.84 -38.94 96.86 Favored Glycine 0 CA--C 1.522 0.497 0 O-C-N 123.395 0.434 . . . . 0.0 112.675 179.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . 0.434 ' O ' ' HB2' ' A' ' 197' ' ' GLN . 29.7 mt-10 -73.11 -38.21 66.42 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -177.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 95.8 mt -72.93 -30.4 63.86 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.539 177.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . 0.471 ' HG2' ' N ' ' A' ' 201' ' ' GLN . 5.6 tm-20 -63.88 -37.5 87.63 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . 0.488 ' HG3' ' O ' ' A' ' 193' ' ' GLY . 29.2 mt-30 -54.82 -35.02 63.49 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.571 -1.195 . . . . 0.0 112.123 177.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 10.0 m -102.11 -35.08 3.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -175.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.532 HG21 ' H ' ' A' ' 200' ' ' GLY . 5.1 m -116.14 -83.2 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 176.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . 0.532 ' H ' HG21 ' A' ' 199' ' ' VAL . . . -178.86 162.55 29.66 Favored Glycine 0 N--CA 1.417 -2.593 0 N-CA-C 107.364 -2.295 . . . . 0.0 107.364 -177.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' GLN . . . . . 0.471 ' N ' ' HG2' ' A' ' 196' ' ' GLU . 9.6 pt20 -66.93 -36.29 81.91 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 118.834 1.317 . . . . 0.0 111.587 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -67.31 -41.07 85.93 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.403 0.62 . . . . 0.0 110.52 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 2.7 t -72.56 -39.17 61.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-O 121.864 0.84 . . . . 0.0 109.015 -177.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -54.64 -40.57 69.11 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 113.856 -1.52 . . . . 0.0 110.751 -178.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . 0.432 ' HG3' ' O ' ' A' ' 201' ' ' GLN . 26.6 mt-30 -61.92 -48.46 80.33 Favored 'General case' 0 N--CA 1.422 -1.84 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.674 -179.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 23.1 pt20 -70.6 -32.71 70.16 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 119.112 -1.035 . . . . 0.0 111.224 -178.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' ILE . . . . . 0.412 ' HA ' HG21 ' A' ' 166' ' ' ILE . 91.6 mt -66.44 -50.78 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 O-C-N 123.531 0.519 . . . . 0.0 110.091 178.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 11.7 t60 -69.42 -39.87 77.63 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.787 -177.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -66.28 -25.67 66.97 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 178.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . 0.438 ' CD1' HG12 ' A' ' 166' ' ' ILE . 57.4 t80 -52.33 -57.44 9.77 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.447 0.699 . . . . 0.0 112.282 -176.058 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -79.66 -24.66 41.67 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.508 -177.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 77.3 m . . . . . 0 N--CA 1.441 -0.885 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.046 178.396 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.4 tm? . . . . . 0 N--CA 1.442 -0.86 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.451 ' O ' HG13 ' A' ' 163' ' ' VAL . 1.6 pt? -60.79 -28.68 68.94 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.357 -177.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 -65.07 -34.45 78.45 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-O 121.327 0.584 . . . . 0.0 109.488 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 24.7 m -86.69 -33.45 20.04 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.183 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.451 HG13 ' O ' ' A' ' 160' ' ' LEU . 0.9 OUTLIER -62.22 -26.18 39.55 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 CA-C-O 121.701 0.762 . . . . 0.0 111.68 -174.908 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -81.08 -10.6 59.65 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.805 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -104.74 12.4 32.82 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.265 0.555 . . . . 0.0 110.942 -174.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.406 HG21 ' HA ' ' A' ' 207' ' ' ILE . 83.7 mt -78.51 142.68 62.49 Favored Pre-proline 0 C--N 1.31 -1.145 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.137 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.28 128.39 26.12 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.225 1.95 . . . . 0.0 110.935 174.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 113.71 -31.02 6.82 Favored Glycine 0 N--CA 1.435 -1.43 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 -178.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 60.9 t -72.68 -64.36 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 178.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 98.95 133.23 7.99 Favored Glycine 0 N--CA 1.438 -1.177 0 C-N-CA 120.299 -0.953 . . . . 0.0 113.443 175.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 54.9 pttt -89.07 -25.53 21.87 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.348 0.594 . . . . 0.0 110.926 177.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 61.7 t -84.8 -32.11 7.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 178.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -81.09 -14.26 57.94 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 114.331 -1.304 . . . . 0.0 109.079 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -52.03 -53.93 46.49 Favored Pre-proline 0 N--CA 1.476 0.841 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 -174.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . 0.514 ' O ' ' HG2' ' A' ' 179' ' ' GLN . 19.1 Cg_endo -60.33 -33.75 94.15 Favored 'Trans proline' 0 C--N 1.377 2.077 0 C-N-CA 121.198 1.266 . . . . 0.0 112.232 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 60.9 tp -70.87 -39.32 72.95 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.574 178.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.502 ' CD2' HG11 ' A' ' 198' ' ' VAL . 93.9 mt -64.18 -36.91 85.61 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.085 177.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 97.7 mt -72.35 -9.56 58.66 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.63 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . 0.514 ' HG2' ' O ' ' A' ' 175' ' ' PRO . 11.8 mm-40 -82.57 -19.25 38.86 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 176.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm -104.75 -51.21 3.11 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.687 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -102.68 142.98 25.67 Favored Pre-proline 0 C--N 1.303 -1.449 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -175.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -60.99 -41.81 41.62 Favored 'Trans proline' 0 C--N 1.356 0.959 0 C-N-CA 122.663 2.242 . . . . 0.0 112.321 -172.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 59.6 m -154.45 169.4 23.85 Favored 'General case' 0 N--CA 1.421 -1.92 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 177.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.413 ' HA ' ' HB3' ' A' ' 187' ' ' LEU . 0.2 OUTLIER -63.15 -20.5 26.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 -174.931 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -73.91 -44.31 55.61 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.172 -177.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -78.9 -26.53 43.81 Favored 'General case' 0 C--O 1.2 -1.529 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 178.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.413 ' HB3' ' HA ' ' A' ' 184' ' ' ILE . 54.6 tp -56.21 -56.41 21.34 Favored 'General case' 0 C--O 1.207 -1.156 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.726 177.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 23.2 p -72.76 -31.21 64.74 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.929 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -84.11 6.39 22.51 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 121.521 0.677 . . . . 0.0 111.317 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.3 155.58 34.79 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.029 173.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' SER . . . . . 0.442 ' OG ' ' HG3' ' A' ' 194' ' ' GLU . 10.2 p -63.95 156.83 26.62 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.811 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 48.7 mm -52.29 -36.2 20.84 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.948 0 C-N-CA 123.244 0.618 . . . . 0.0 110.374 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -59.33 -41.33 96.85 Favored Glycine 0 N--CA 1.442 -0.904 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.629 177.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . 0.522 ' O ' ' HG2' ' A' ' 197' ' ' GLN . 30.1 mt-10 -77.62 -35.72 52.38 Favored 'General case' 0 C--O 1.206 -1.217 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -177.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 96.1 mt -74.37 -24.56 59.17 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.803 0.811 . . . . 0.0 110.291 178.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -74.07 -24.15 59.46 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.847 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . 0.522 ' HG2' ' O ' ' A' ' 194' ' ' GLU . 4.9 pt20 -67.03 -29.91 69.85 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -177.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.502 HG11 ' CD2' ' A' ' 177' ' ' LEU . 13.4 m -99.1 -21.2 5.22 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.947 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.687 -174.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -139.23 -84.22 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 173.214 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -178.29 171.94 44.35 Favored Glycine 0 N--CA 1.431 -1.643 0 N-CA-C 108.514 -1.834 . . . . 0.0 108.514 -173.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -69.06 -42.41 76.29 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 117.886 0.843 . . . . 0.0 112.024 -177.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -68.26 -31.54 71.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.629 0.728 . . . . 0.0 110.69 -177.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 2.1 t -77.75 -40.08 27.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -179.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -57.45 -39.72 76.91 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 114.616 -1.175 . . . . 0.0 109.844 177.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -59.69 -46.71 88.24 Favored 'General case' 0 C--O 1.209 -1.049 0 CA-C-N 115.075 -0.966 . . . . 0.0 112.322 177.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -68.52 -28.48 67.03 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 119.901 -0.72 . . . . 0.0 111.477 -178.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' ILE . . . . . 0.406 ' HA ' HG21 ' A' ' 166' ' ' ILE . 76.2 mt -73.96 -52.55 20.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.117 176.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -70.3 -40.78 74.04 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 120.958 0.408 . . . . 0.0 110.981 -175.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -73.84 -10.55 59.78 Favored 'General case' 0 C--N 1.323 -0.587 0 O-C-N 122.106 -0.371 . . . . 0.0 111.875 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -60.07 -47.78 84.45 Favored 'General case' 0 C--O 1.218 -0.563 0 CA-C-O 121.084 0.469 . . . . 0.0 110.257 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -96.39 -26.59 15.28 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.207 -178.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 32.7 m . . . . . 0 CA--C 1.549 0.937 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -178.246 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 37.8 mt . . . . . 0 CA--C 1.491 -1.324 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -59.13 -30.6 68.25 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.385 0.612 . . . . 0.0 110.67 176.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -76.33 -33.5 58.99 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.987 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 24.7 m -85.28 -37.14 20.35 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 120.959 0.409 . . . . 0.0 111.15 -178.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 4.1 p -59.68 -25.92 33.37 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.404 0 CA-C-O 121.266 0.555 . . . . 0.0 112.428 -178.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -87.82 -10.26 51.4 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-O 121.592 0.711 . . . . 0.0 110.368 177.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -101.65 3.01 39.41 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.311 -176.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 88.9 mt -60.91 133.65 92.37 Favored Pre-proline 0 C--O 1.248 1.017 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.268 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -60.88 127.91 23.87 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 121.991 1.794 . . . . 0.0 109.92 176.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 113.65 -36.55 3.98 Favored Glycine 0 N--CA 1.428 -1.885 0 C-N-CA 120.012 -1.09 . . . . 0.0 112.019 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 57.5 t -58.83 -44.2 89.95 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 CA-C-O 121.498 0.666 . . . . 0.0 110.757 -178.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 91.45 80.76 1.41 Allowed Glycine 0 N--CA 1.408 -3.179 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -177.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 55.2 pttt -63.59 -13.87 45.99 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.515 0.674 . . . . 0.0 112.623 -178.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 43.3 t -71.12 -32.11 46.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-O 122.158 0.98 . . . . 0.0 108.421 175.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.402 ' HB3' HD11 ' A' ' 177' ' ' LEU . 89.9 mttt -88.26 -6.21 57.92 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.472 -177.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -54.23 -52.99 64.01 Favored Pre-proline 0 CA--C 1.558 1.254 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -177.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -67.4 -31.26 35.04 Favored 'Trans proline' 0 C--N 1.375 1.931 0 C-N-CA 121.584 1.523 . . . . 0.0 112.325 179.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 55.4 tp -69.96 -44.7 68.98 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.684 0.754 . . . . 0.0 109.601 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.402 HD11 ' HB3' ' A' ' 173' ' ' LYS . 5.4 mp -75.35 -22.28 57.7 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.081 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 44.1 tp -70.55 -11.25 60.81 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 121.637 0.732 . . . . 0.0 109.803 175.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -88.62 -14.35 37.69 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 174.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -105.07 -51.17 3.08 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 122.014 0.911 . . . . 0.0 110.325 -176.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' PHE . . . . . 0.458 ' CD2' ' HA ' ' A' ' 187' ' ' LEU . 90.0 m-85 -88.72 148.92 42.84 Favored Pre-proline 0 N--CA 1.417 -2.116 0 CA-C-N 114.423 -1.262 . . . . 0.0 107.753 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -59.07 -47.5 17.51 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.479 2.119 . . . . 0.0 111.883 -179.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 23.9 m -153.21 165.0 37.05 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.444 HD12 ' H ' ' A' ' 184' ' ' ILE . 0.2 OUTLIER -62.36 -27.25 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -178.202 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 24.8 tp60 -61.57 -41.15 96.97 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 110.348 -0.242 . . . . 0.0 110.348 177.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' GLN . . . . . 0.419 ' NE2' ' HD2' ' A' ' 181' ' ' PHE . 0.7 OUTLIER -79.06 -32.91 45.0 Favored 'General case' 0 C--O 1.196 -1.733 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -179.736 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.458 ' HA ' ' CD2' ' A' ' 181' ' ' PHE . 5.3 tt -53.72 -62.01 1.93 Allowed 'General case' 0 C--O 1.21 -0.991 0 C-N-CA 123.893 0.877 . . . . 0.0 110.471 -176.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 25.4 m -73.99 -23.23 59.43 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -177.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -89.75 4.33 50.01 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.467 0.651 . . . . 0.0 109.372 -179.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.2 154.98 36.47 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-O 121.301 0.572 . . . . 0.0 110.123 175.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 3.0 m -64.26 158.05 24.3 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.48 -176.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 48.8 mm -53.44 -37.86 31.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 C-N-CA 123.279 0.631 . . . . 0.0 111.191 -177.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -63.4 -38.32 96.19 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.642 178.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -74.22 -37.27 63.89 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -176.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 96.2 mt -74.02 -31.36 62.89 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.832 -1.076 . . . . 0.0 110.71 178.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -64.87 -35.54 81.47 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -60.55 -26.36 66.84 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 114.438 -1.255 . . . . 0.0 112.834 178.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 13.1 m -103.59 -37.35 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.305 0 C-N-CA 120.04 -0.664 . . . . 0.0 112.437 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.477 HG22 ' H ' ' A' ' 200' ' ' GLY . 2.5 m -117.87 -80.97 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 177.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . 0.477 ' H ' HG22 ' A' ' 199' ' ' VAL . . . -178.05 166.88 37.28 Favored Glycine 0 N--CA 1.424 -2.16 0 N-CA-C 108.536 -1.826 . . . . 0.0 108.536 -178.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -69.23 -41.94 76.34 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 118.218 1.009 . . . . 0.0 110.296 -178.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -65.55 -35.98 82.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.414 0.626 . . . . 0.0 110.197 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.417 ' O ' HG13 ' A' ' 207' ' ' ILE . 2.7 t -72.66 -43.5 61.65 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.829 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -55.2 -42.47 73.31 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.3 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -58.74 -52.39 65.9 Favored 'General case' 0 N--CA 1.433 -1.315 0 C-N-CA 124.263 1.025 . . . . 0.0 111.507 177.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -69.01 -27.39 65.64 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 -178.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' ILE . . . . . 0.417 HG13 ' O ' ' A' ' 203' ' ' VAL . 98.3 mt -73.45 -51.36 25.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-O 121.311 0.577 . . . . 0.0 109.723 176.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -71.33 -37.94 71.69 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.783 -173.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -75.64 -10.08 59.14 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 178.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -66.12 -46.66 76.78 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.103 0.478 . . . . 0.0 110.86 -179.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -93.11 -25.7 17.77 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.883 -177.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 25.6 m . . . . . 0 CA--C 1.55 0.976 0 CA-C-O 121.387 0.613 . . . . 0.0 111.569 -178.783 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.475 ' O ' HD22 ' A' ' 159' ' ' LEU . 6.4 tt . . . . . 0 C--O 1.211 -0.948 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.468 ' O ' HG12 ' A' ' 163' ' ' VAL . 3.4 pp -53.85 -31.42 49.46 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.98 0.912 . . . . 0.0 111.595 176.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -71.5 -29.38 64.73 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.844 0.831 . . . . 0.0 109.397 -178.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 21.1 m -86.69 -29.56 22.37 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.157 177.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.468 HG12 ' O ' ' A' ' 160' ' ' LEU . 0.3 OUTLIER -65.24 -26.46 39.71 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.643 0 CA-C-O 121.583 0.706 . . . . 0.0 110.916 -176.124 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -82.64 -6.71 59.51 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.481 0.657 . . . . 0.0 110.865 177.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 78.9 mm-40 -101.64 13.26 35.45 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.098 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 80.9 mt -84.35 131.75 49.5 Favored Pre-proline 0 C--N 1.306 -1.297 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -62.89 127.14 19.66 Favored 'Trans proline' 0 C--O 1.245 0.86 0 C-N-CA 121.642 1.561 . . . . 0.0 110.633 177.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 112.33 -18.51 23.12 Favored Glycine 0 N--CA 1.43 -1.765 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.62 -177.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 84.0 t -71.67 -50.41 39.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 178.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 96.58 102.09 2.02 Favored Glycine 0 N--CA 1.43 -1.743 0 C-N-CA 120.236 -0.983 . . . . 0.0 113.159 178.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -67.76 -32.4 72.98 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.219 0.533 . . . . 0.0 110.678 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 48.7 t -85.1 -30.76 6.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-O 121.801 0.81 . . . . 0.0 109.342 -178.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -79.89 -12.74 59.72 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.875 -178.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -50.72 -55.03 29.97 Favored Pre-proline 0 CA--C 1.55 0.974 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -177.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . 0.486 ' O ' ' HG3' ' A' ' 179' ' ' GLN . 21.1 Cg_endo -62.25 -28.68 79.37 Favored 'Trans proline' 0 C--N 1.369 1.642 0 CA-C-N 121.045 1.409 . . . . 0.0 112.899 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 51.7 tp -73.02 -47.98 40.31 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 176.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.401 ' HB3' HD12 ' A' ' 187' ' ' LEU . 97.2 mt -59.27 -39.77 83.92 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.686 177.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.43 ' HA ' ' O ' ' A' ' 181' ' ' PHE . 10.2 mp -68.99 -6.81 30.12 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 179.013 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . 0.486 ' HG3' ' O ' ' A' ' 175' ' ' PRO . 76.7 mt-30 -83.19 -17.35 43.13 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 174.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 7.7 mmmm -103.94 -44.92 4.9 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.09 177.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' PHE . . . . . 0.43 ' O ' ' HA ' ' A' ' 178' ' ' LEU . 27.9 m-85 -111.35 131.51 22.23 Favored Pre-proline 0 N--CA 1.424 -1.753 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 -176.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -48.33 -38.57 34.41 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 124.152 3.235 . . . . 0.0 113.801 -175.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 73.6 p -154.06 173.69 15.69 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -177.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.445 ' HA ' ' HB3' ' A' ' 187' ' ' LEU . 0.2 OUTLIER -66.59 -21.24 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 O-C-N 123.664 0.602 . . . . 0.0 110.78 175.275 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -67.07 -48.49 68.08 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -77.76 -32.73 52.79 Favored 'General case' 0 C--O 1.201 -1.449 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -178.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.445 ' HB3' ' HA ' ' A' ' 184' ' ' ILE . 61.5 tp -52.78 -57.72 9.22 Favored 'General case' 0 C--O 1.207 -1.156 0 C-N-CA 124.589 1.156 . . . . 0.0 111.691 178.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 24.5 p -68.73 -32.79 72.82 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.617 0.723 . . . . 0.0 111.353 -179.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -80.97 -2.67 48.76 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.259 -178.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -66.35 156.51 34.27 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 123.465 0.706 . . . . 0.0 111.015 177.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 5.4 m -63.26 152.31 38.08 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.115 -175.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 50.3 mm -54.21 -35.86 31.05 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.839 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.865 -177.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . 0.405 ' O ' ' HG2' ' A' ' 197' ' ' GLN . . . -61.63 -39.09 96.92 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.322 -0.466 . . . . 0.0 112.56 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -71.42 -45.11 63.54 Favored 'General case' 0 CA--C 1.489 -1.392 0 CA-C-O 121.548 0.69 . . . . 0.0 110.214 -178.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 95.8 mt -66.65 -29.59 69.64 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 114.279 -1.328 . . . . 0.0 110.804 178.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -70.49 -33.11 70.86 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . 0.436 ' HA ' ' OE1' ' A' ' 197' ' ' GLN . 13.6 mm-40 -66.65 -21.51 66.11 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 114.987 -1.006 . . . . 0.0 113.1 -179.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 18.8 m -104.11 -32.85 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.757 177.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -125.17 -85.38 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 173.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -177.22 165.35 35.23 Favored Glycine 0 N--CA 1.43 -1.742 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -176.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -58.39 -49.32 77.69 Favored 'General case' 0 C--O 1.21 -0.996 0 CA-C-N 117.487 0.643 . . . . 0.0 111.626 -177.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -65.01 -32.57 74.35 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.314 0.578 . . . . 0.0 111.095 -175.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.413 ' O ' HG13 ' A' ' 207' ' ' ILE . 3.8 t -75.76 -44.56 39.43 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 -179.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -57.06 -43.75 82.36 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 114.009 -1.45 . . . . 0.0 109.912 179.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -62.94 -44.97 94.61 Favored 'General case' 0 N--CA 1.424 -1.752 0 CA-C-N 114.982 -1.008 . . . . 0.0 112.579 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -69.43 -29.16 66.82 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 119.442 -0.903 . . . . 0.0 111.169 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' ILE . . . . . 0.413 HG13 ' O ' ' A' ' 203' ' ' VAL . 87.4 mt -72.04 -52.15 26.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 176.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 12.2 t60 -69.7 -37.03 76.45 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.614 -174.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -73.36 -22.32 60.32 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 179.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -50.94 -56.74 10.92 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.843 0.857 . . . . 0.0 111.475 -177.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -83.57 -27.64 29.12 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.235 -176.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 38.8 m . . . . . 0 C--N 1.311 -1.081 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.472 -178.304 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.469 ' O ' HD22 ' A' ' 159' ' ' LEU . 5.5 tt . . . . . 0 N--CA 1.471 0.604 0 N-CA-C 111.243 0.09 . . . . 0.0 111.243 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -57.99 -22.28 48.69 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 177.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -68.86 -32.1 71.52 Favored 'General case' 0 C--O 1.218 -0.555 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 177.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 28.4 m -86.51 -34.04 20.13 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.442 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -63.87 -26.53 40.8 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.968 0 CA-C-O 121.516 0.674 . . . . 0.0 110.644 -176.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -82.84 -7.74 59.63 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.371 177.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.531 ' HA ' HE21 ' A' ' 165' ' ' GLN . 0.0 OUTLIER -108.47 13.59 25.32 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.89 0.376 . . . . 0.0 110.605 -176.417 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.437 HG21 ' HA ' ' A' ' 207' ' ' ILE . 81.2 mt -71.82 138.71 82.74 Favored Pre-proline 0 C--N 1.31 -1.12 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.876 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -61.73 128.85 25.69 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.132 1.888 . . . . 0.0 110.637 175.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 114.46 -33.46 5.38 Favored Glycine 0 C--N 1.308 -0.978 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -178.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.465 ' O ' ' HE3' ' A' ' 173' ' ' LYS . 89.1 t -63.14 -57.48 11.78 Favored 'Isoleucine or valine' 0 C--N 1.338 0.109 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 178.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 99.24 126.82 5.76 Favored Glycine 0 N--CA 1.43 -1.748 0 C-N-CA 120.588 -0.815 . . . . 0.0 113.552 175.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -85.51 -25.07 27.05 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 121.313 0.578 . . . . 0.0 111.145 178.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 40.8 t -83.96 -28.26 7.31 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-O 122.082 0.944 . . . . 0.0 108.897 -178.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.465 ' HE3' ' O ' ' A' ' 169' ' ' VAL . 46.6 mtmt -87.28 -1.03 57.62 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.593 178.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -51.77 -49.01 85.79 Favored Pre-proline 0 CA--C 1.546 0.811 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 -178.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . 0.504 ' O ' ' HG2' ' A' ' 179' ' ' GLN . 26.1 Cg_exo -62.86 -42.6 23.91 Favored 'Trans proline' 0 C--N 1.378 2.097 0 CA-C-N 120.69 1.282 . . . . 0.0 111.022 178.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 39.6 tp -58.42 -48.94 79.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.184 177.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 87.5 mt -60.68 -40.48 92.32 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.173 178.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 94.3 mt -71.15 -13.53 61.97 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . 0.504 ' HG2' ' O ' ' A' ' 175' ' ' PRO . 28.6 mm-40 -93.83 -12.38 29.13 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.289 0.566 . . . . 0.0 110.055 174.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -97.74 -50.59 4.4 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 121.792 0.805 . . . . 0.0 109.515 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' PHE . . . . . 0.493 ' CD2' ' HG ' ' A' ' 187' ' ' LEU . 79.9 m-85 -100.26 146.64 32.32 Favored Pre-proline 0 C--N 1.294 -1.846 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.871 -178.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -70.93 -29.45 18.3 Favored 'Trans proline' 0 C--O 1.235 0.366 0 C-N-CA 122.551 2.167 . . . . 0.0 112.594 -178.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' SER . . . . . 0.418 ' O ' ' HB2' ' A' ' 187' ' ' LEU . 64.3 p -153.84 166.58 32.46 Favored 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -178.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -71.05 -22.51 22.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 O-C-N 123.479 0.487 . . . . 0.0 110.138 176.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -61.81 -52.84 62.52 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 114.944 -1.025 . . . . 0.0 108.914 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -76.95 -28.03 55.04 Favored 'General case' 0 C--O 1.207 -1.15 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -179.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.493 ' HG ' ' CD2' ' A' ' 181' ' ' PHE . 3.7 tt -54.78 -64.56 0.8 Allowed 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 124.081 0.952 . . . . 0.0 110.24 -178.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 24.0 m -75.94 -22.93 55.49 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.773 -175.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -84.87 -3.87 58.86 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.32 0.581 . . . . 0.0 110.18 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.7 154.58 38.53 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.687 178.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 1.9 t -73.59 169.23 17.69 Favored 'General case' 0 N--CA 1.423 -1.812 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.984 -176.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 50.1 mm -51.8 -39.37 24.48 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.973 0 C-N-CA 123.99 0.916 . . . . 0.0 111.138 -176.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . 0.429 ' O ' ' HG3' ' A' ' 197' ' ' GLN . . . -59.26 -31.88 70.68 Favored Glycine 0 CA--C 1.527 0.817 0 O-C-N 123.431 0.457 . . . . 0.0 113.899 -179.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . 0.515 ' O ' ' HB2' ' A' ' 197' ' ' GLN . 29.2 mm-40 -83.61 -40.13 19.42 Favored 'General case' 0 C--O 1.215 -0.746 0 CA-C-O 121.696 0.76 . . . . 0.0 109.638 -178.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 77.7 mt -73.39 -23.99 60.24 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-O 121.744 0.783 . . . . 0.0 110.696 -178.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -71.83 -26.54 62.42 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 178.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . 0.515 ' HB2' ' O ' ' A' ' 194' ' ' GLU . 74.6 mt-30 -61.17 -29.67 69.94 Favored 'General case' 0 C--O 1.242 0.71 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.719 178.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 12.0 m -103.27 -37.18 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.295 0 C-N-CA 120.709 -0.397 . . . . 0.0 111.888 -178.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.42 HG23 ' H ' ' A' ' 200' ' ' GLY . 1.7 m -122.47 -83.75 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . 0.42 ' H ' HG23 ' A' ' 199' ' ' VAL . . . -177.6 172.53 45.26 Favored Glycine 0 N--CA 1.429 -1.789 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -175.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -64.55 -46.78 81.31 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 117.421 0.611 . . . . 0.0 111.816 -176.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -70.6 -30.21 66.82 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.311 0.577 . . . . 0.0 110.997 -176.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.597 ' O ' ' HG2' ' A' ' 206' ' ' GLN . 2.2 t -78.62 -33.91 17.28 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.051 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -63.25 -38.45 91.22 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.41 175.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . 0.495 ' HA ' HE21 ' A' ' 205' ' ' GLN . 0.0 OUTLIER -60.24 -42.69 95.81 Favored 'General case' 0 C--O 1.207 -1.134 0 CA-C-N 115.32 -0.855 . . . . 0.0 112.522 179.434 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' GLN . . . . . 0.597 ' HG2' ' O ' ' A' ' 203' ' ' VAL . 20.6 pt20 -66.79 -30.22 70.37 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.894 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' ILE . . . . . 0.437 ' HA ' HG21 ' A' ' 166' ' ' ILE . 71.6 mt -78.19 -52.91 15.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-O 121.47 0.652 . . . . 0.0 109.982 178.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 40.0 t-80 -65.04 -39.56 93.51 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.839 -175.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -80.97 -14.04 58.33 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 120.728 -0.389 . . . . 0.0 112.023 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -55.11 -53.84 50.82 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.323 0.649 . . . . 0.0 111.318 -176.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -84.28 -27.82 27.58 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.896 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 25.5 m . . . . . 0 CA--C 1.55 0.969 0 CA-C-O 121.204 0.526 . . . . 0.0 111.392 -179.341 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 39.5 tp . . . . . 0 N--CA 1.446 -0.662 0 N-CA-C 111.608 0.225 . . . . 0.0 111.608 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -62.57 -26.55 68.64 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.074 0.464 . . . . 0.0 110.24 177.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 23.9 ptt180 -67.35 -35.58 79.67 Favored 'General case' 0 C--O 1.215 -0.731 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 8.4 m -86.14 -33.28 20.91 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.618 -178.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -64.95 -26.09 39.25 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-O 121.515 0.674 . . . . 0.0 110.835 -175.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 30.3 pt20 -85.27 -7.3 59.08 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.307 177.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -99.26 4.7 46.67 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -178.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.409 HG21 ' HA ' ' A' ' 207' ' ' ILE . 85.7 mt -72.18 131.58 85.08 Favored Pre-proline 0 C--N 1.309 -1.162 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -179.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -62.13 131.73 35.89 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.485 2.123 . . . . 0.0 110.586 176.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 113.83 -36.42 4.03 Favored Glycine 0 N--CA 1.424 -2.134 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 -178.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 91.9 t -55.72 -48.09 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-O 120.96 0.409 . . . . 0.0 110.593 -178.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 85.63 95.26 0.77 Allowed Glycine 0 N--CA 1.429 -1.794 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 -179.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -70.24 -18.71 63.16 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -175.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 62.0 t -83.24 -30.75 8.32 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 CA-C-O 121.396 0.617 . . . . 0.0 109.831 179.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.596 ' O ' ' HG ' ' A' ' 177' ' ' LEU . 21.2 ptmt -93.93 -4.0 50.61 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.415 0.626 . . . . 0.0 110.035 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . 0.435 ' N ' ' HD2' ' A' ' 175' ' ' PRO . . . -59.72 -45.99 98.49 Favored Pre-proline 0 CA--C 1.548 0.9 0 CA-C-N 114.906 -1.043 . . . . 0.0 113.417 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' A' ' 174' ' ' ALA . 9.3 Cg_endo -54.88 -35.94 90.27 Favored 'Trans proline' 0 C--N 1.385 2.449 0 C-N-CA 122.176 1.917 . . . . 0.0 112.193 176.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 53.3 tp -68.14 -42.3 80.34 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.437 0.637 . . . . 0.0 109.699 178.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.596 ' HG ' ' O ' ' A' ' 173' ' ' LYS . 59.8 mt -70.1 -31.06 68.43 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.75 -179.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 35.5 tp -72.91 -10.83 60.23 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.528 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . 0.428 ' HG2' ' O ' ' A' ' 175' ' ' PRO . 13.8 mm100 -83.72 -20.17 33.91 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 174.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -103.65 -51.81 3.11 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-O 121.31 0.576 . . . . 0.0 110.354 -174.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -90.73 140.55 26.47 Favored Pre-proline 0 C--N 1.296 -1.751 0 CA-C-N 115.346 -0.843 . . . . 0.0 108.752 178.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -47.0 -47.5 16.51 Favored 'Trans proline' 0 C--N 1.361 1.217 0 C-N-CA 123.96 3.107 . . . . 0.0 112.545 -176.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' SER . . . . . 0.439 ' OG ' HD12 ' A' ' 184' ' ' ILE . 25.8 t -153.71 169.48 23.21 Favored 'General case' 0 N--CA 1.41 -2.437 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.458 HD12 ' H ' ' A' ' 184' ' ' ILE . 0.2 OUTLIER -60.03 -27.93 40.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 O-C-N 124.013 0.821 . . . . 0.0 110.151 177.114 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -56.86 -50.21 73.16 Favored 'General case' 0 C--O 1.212 -0.889 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.033 176.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.1 -34.04 43.85 Favored 'General case' 0 C--O 1.206 -1.217 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -177.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 57.8 tp -50.8 -62.55 1.53 Allowed 'General case' 0 C--O 1.21 -0.976 0 C-N-CA 124.408 1.083 . . . . 0.0 111.278 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 25.3 m -72.07 -22.66 61.33 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.012 0.434 . . . . 0.0 112.07 -178.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -83.59 -4.04 58.21 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 121.488 0.661 . . . . 0.0 110.845 -178.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.74 155.48 35.97 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.019 175.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 4.0 m -65.33 162.27 17.88 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.994 -176.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.2 mm -53.66 -39.98 40.54 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.622 0 C-N-CA 122.751 0.42 . . . . 0.0 111.113 -178.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -62.77 -35.14 91.52 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 121.515 -0.374 . . . . 0.0 112.471 179.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . 0.636 ' O ' ' HG2' ' A' ' 197' ' ' GLN . 25.2 mt-10 -80.7 -29.72 36.46 Favored 'General case' 0 C--O 1.215 -0.76 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -177.135 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 97.4 mt -78.76 -33.33 46.57 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.983 176.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -67.46 -31.71 72.07 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 -177.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . 0.636 ' HG2' ' O ' ' A' ' 194' ' ' GLU . 16.5 pt20 -67.92 -28.39 67.45 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.529 -177.509 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 14.1 m -99.52 -34.58 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.969 -177.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.448 HG22 ' H ' ' A' ' 200' ' ' GLY . 2.5 m -119.81 -82.84 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 175.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . 0.448 ' H ' HG22 ' A' ' 199' ' ' VAL . . . -177.84 166.0 35.96 Favored Glycine 0 N--CA 1.429 -1.794 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 -176.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 8.8 tm0? -62.51 -47.03 85.73 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 117.565 0.682 . . . . 0.0 110.303 -177.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -71.63 -28.8 64.02 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.248 -176.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 3.0 t -76.06 -41.2 38.08 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.706 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -55.94 -45.11 78.88 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 114.224 -1.353 . . . . 0.0 109.651 179.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -59.26 -46.65 87.95 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 114.973 -1.012 . . . . 0.0 112.437 179.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -67.87 -33.09 74.06 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 120.366 -0.533 . . . . 0.0 111.357 -179.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' ILE . . . . . 0.409 ' HA ' HG21 ' A' ' 166' ' ' ILE . 85.8 mt -74.72 -50.44 25.87 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-O 121.141 0.496 . . . . 0.0 110.577 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 15.1 t60 -68.99 -43.88 73.98 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.106 -175.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -72.58 -10.77 60.2 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -62.46 -47.42 84.12 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.169 0.509 . . . . 0.0 110.223 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -98.07 -25.17 15.03 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.857 -178.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 24.1 m . . . . . 0 C--N 1.322 -0.589 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -178.45 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 42.8 tp . . . . . 0 N--CA 1.441 -0.911 0 CA-C-O 120.491 0.186 . . . . 0.0 110.667 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -60.26 -25.67 65.87 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.246 0.546 . . . . 0.0 112.038 -179.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -73.62 -33.58 64.62 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.207 0.527 . . . . 0.0 110.114 177.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 16.9 m -85.76 -33.99 21.28 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 121.243 0.544 . . . . 0.0 110.591 -178.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -64.17 -25.61 38.46 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.131 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.049 -176.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . 0.414 ' NE2' HG13 ' A' ' 184' ' ' ILE . 11.5 pt20 -87.69 -7.59 57.2 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.755 177.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -103.56 12.15 35.36 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.17 0.51 . . . . 0.0 109.996 -178.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 77.7 mt -72.8 125.97 90.88 Favored Pre-proline 0 C--N 1.314 -0.961 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.24 128.5 20.6 Favored 'Trans proline' 0 N--CA 1.445 -1.331 0 C-N-CA 121.562 1.508 . . . . 0.0 109.183 176.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 116.16 -29.24 7.17 Favored Glycine 0 N--CA 1.428 -1.872 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 -177.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 93.1 t -65.32 -52.23 54.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 121.313 0.578 . . . . 0.0 110.426 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 102.33 75.31 1.09 Allowed Glycine 0 N--CA 1.424 -2.102 0 C-N-CA 120.365 -0.921 . . . . 0.0 111.234 -179.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -73.64 -15.63 61.25 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.279 0.562 . . . . 0.0 111.656 -177.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 45.1 t -86.86 -22.86 6.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 CA-C-O 121.96 0.886 . . . . 0.0 108.637 176.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.45 ' O ' ' HG ' ' A' ' 177' ' ' LEU . 38.0 ttpt -96.12 8.36 43.98 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.309 -1.314 . . . . 0.0 108.226 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -56.67 -46.3 99.85 Favored Pre-proline 0 C--O 1.212 -0.901 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 -177.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . 0.556 ' O ' ' HG2' ' A' ' 179' ' ' GLN . 51.7 Cg_exo -56.97 -41.08 79.04 Favored 'Trans proline' 0 C--N 1.377 2.036 0 CA-C-N 121.204 1.466 . . . . 0.0 111.345 178.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 48.5 tp -64.7 -43.36 93.74 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.435 176.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 173' ' ' LYS . 96.3 mt -63.34 -40.27 96.83 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.533 178.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -68.63 -6.91 28.57 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 178.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . 0.556 ' HG2' ' O ' ' A' ' 175' ' ' PRO . 86.9 mm-40 -84.46 -15.64 45.38 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.06 0.457 . . . . 0.0 110.102 174.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -112.17 -51.01 2.87 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 121.434 0.635 . . . . 0.0 110.047 179.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' PHE . . . . . 0.473 ' CD1' ' HA ' ' A' ' 187' ' ' LEU . 80.6 m-85 -88.58 139.05 29.68 Favored Pre-proline 0 C--N 1.299 -1.622 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.433 -177.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -64.07 -48.94 4.31 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.511 2.141 . . . . 0.0 112.289 -177.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 25.2 m -148.11 167.38 25.16 Favored 'General case' 0 N--CA 1.426 -1.646 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 178.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.414 HG13 ' NE2' ' A' ' 164' ' ' GLN . 0.2 OUTLIER -60.66 -25.45 35.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -179.085 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 24.0 tp60 -60.87 -51.91 67.27 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.52 -178.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -79.24 -27.18 42.41 Favored 'General case' 0 C--O 1.189 -2.103 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.473 ' HA ' ' CD1' ' A' ' 181' ' ' PHE . 5.1 tt -52.32 -61.55 2.2 Favored 'General case' 0 C--O 1.214 -0.804 0 C-N-CA 123.332 0.653 . . . . 0.0 110.304 -177.459 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 19.5 m -73.72 -22.97 59.72 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 121.165 0.507 . . . . 0.0 112.035 -177.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -91.0 7.44 40.32 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.858 178.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -66.21 156.89 32.87 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 123.22 0.608 . . . . 0.0 111.533 176.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 4.6 m -62.9 158.27 19.52 Favored 'General case' 0 N--CA 1.427 -1.61 0 CA-C-N 115.153 -0.931 . . . . 0.0 109.761 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 47.9 mm -55.54 -36.06 40.38 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.355 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.491 -177.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -62.58 -36.15 92.81 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 121.045 -0.598 . . . . 0.0 112.434 178.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . 0.448 ' O ' ' HG2' ' A' ' 197' ' ' GLN . 13.1 mm-40 -76.84 -35.88 57.21 Favored 'General case' 0 C--O 1.215 -0.727 0 CA-C-O 121.475 0.655 . . . . 0.0 109.36 -177.271 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 92.0 mt -77.94 -23.33 48.59 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-O 121.616 0.722 . . . . 0.0 110.793 178.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . 0.456 ' HG2' ' N ' ' A' ' 201' ' ' GLN . 4.0 tm-20 -81.95 -37.76 26.22 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -178.174 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . 0.448 ' HG2' ' O ' ' A' ' 194' ' ' GLU . 9.9 pt20 -66.37 -22.79 66.26 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.736 -178.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 194' ' ' GLU . 12.6 m -99.19 -28.83 3.44 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 1.5 t -130.64 -79.74 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.613 176.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -177.51 164.63 33.88 Favored Glycine 0 N--CA 1.438 -1.181 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 -177.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' GLN . . . . . 0.456 ' N ' ' HG2' ' A' ' 196' ' ' GLU . 11.1 pt20 -66.23 -40.13 90.04 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -177.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -68.2 -24.71 64.97 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 122.188 0.994 . . . . 0.0 109.827 -178.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 6.9 t -83.32 -47.56 18.1 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 CA-C-N 114.435 -1.257 . . . . 0.0 108.324 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -52.89 -44.96 67.28 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 114.473 -1.239 . . . . 0.0 110.846 -178.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -63.33 -48.03 79.73 Favored 'General case' 0 N--CA 1.423 -1.783 0 CA-C-N 114.922 -1.035 . . . . 0.0 111.574 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -70.96 -29.82 65.93 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.48 -177.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 90.6 mt -69.53 -51.91 37.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 175.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 7.0 t60 -69.6 -31.15 69.13 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.472 0.653 . . . . 0.0 109.374 -176.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -80.18 -13.69 59.05 Favored 'General case' 0 C--O 1.207 -1.142 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 176.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -62.24 -43.37 98.98 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-O 121.022 0.439 . . . . 0.0 111.782 -176.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -90.91 -23.38 20.51 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.261 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 28.4 m . . . . . 0 CA--C 1.555 1.152 0 CA-C-O 121.059 0.457 . . . . 0.0 111.277 178.644 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.439 HD21 ' O ' ' A' ' 159' ' ' LEU . 6.4 tt . . . . . 0 C--O 1.221 -0.415 0 CA-C-O 120.139 0.019 . . . . 0.0 110.972 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.416 ' O ' HG11 ' A' ' 163' ' ' VAL . 2.4 pt? -59.22 -25.19 63.79 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.821 0.344 . . . . 0.0 111.834 179.122 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 5.5 ptm180 -77.98 -26.05 48.47 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 120.077 -0.649 . . . . 0.0 109.522 -179.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 97.0 m -86.7 -32.1 20.67 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.253 176.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.416 HG11 ' O ' ' A' ' 160' ' ' LEU . 0.8 OUTLIER -65.47 -26.09 38.46 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 CA-C-O 121.654 0.74 . . . . 0.0 110.9 -177.07 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -83.61 -14.62 51.56 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.532 0.682 . . . . 0.0 109.768 176.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -99.52 20.39 13.95 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.455 -176.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 98.4 mt -80.09 129.16 71.06 Favored Pre-proline 0 C--N 1.293 -1.87 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 175.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.65 128.79 23.14 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 122.036 1.824 . . . . 0.0 109.96 177.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 116.21 -29.4 7.07 Favored Glycine 0 N--CA 1.426 -1.975 0 C-N-CA 120.146 -1.026 . . . . 0.0 111.508 -179.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 63.6 t -63.6 -64.85 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.592 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 177.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 113.62 98.95 2.33 Favored Glycine 0 N--CA 1.422 -2.255 0 C-N-CA 120.066 -1.064 . . . . 0.0 112.18 178.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -68.77 -27.39 65.85 Favored 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 122.926 0.49 . . . . 0.0 111.32 -178.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 22.5 t -83.88 -30.9 7.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-O 121.299 0.571 . . . . 0.0 109.748 -175.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.527 ' O ' ' HG ' ' A' ' 177' ' ' LEU . 20.4 ptmt -91.72 1.41 57.18 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.36 178.423 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -56.99 -50.35 88.71 Favored Pre-proline 0 CA--C 1.545 0.785 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.523 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -58.91 -24.05 70.74 Favored 'Trans proline' 0 C--N 1.376 2.021 0 C-N-CA 121.801 1.667 . . . . 0.0 112.764 178.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.403 ' HB3' ' O ' ' A' ' 173' ' ' LYS . 54.5 tp -77.58 -40.05 43.59 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 177.001 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.527 ' HG ' ' O ' ' A' ' 173' ' ' LYS . 84.3 mt -71.53 -33.59 69.31 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.869 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -69.12 -5.87 24.98 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 177.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -93.17 -3.74 53.37 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.266 0.555 . . . . 0.0 109.869 174.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -113.0 -50.53 2.88 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.47 176.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' PHE . . . . . 0.565 ' CD2' ' HG ' ' A' ' 187' ' ' LEU . 66.8 m-85 -96.76 141.16 22.67 Favored Pre-proline 0 C--N 1.309 -1.173 0 CA-C-N 114.769 -1.105 . . . . 0.0 108.55 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -67.76 -35.73 20.8 Favored 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 122.096 1.864 . . . . 0.0 112.82 -177.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 67.7 p -149.3 165.54 31.66 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -178.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -65.67 -26.13 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 O-C-N 123.403 0.439 . . . . 0.0 110.559 177.164 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -63.98 -43.57 95.34 Favored 'General case' 0 C--O 1.202 -1.416 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.977 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' GLN . . . . . 0.41 ' NE2' ' HD1' ' A' ' 181' ' ' PHE . 0.6 OUTLIER -78.84 -34.56 45.05 Favored 'General case' 0 C--O 1.197 -1.703 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.944 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.565 ' HG ' ' CD2' ' A' ' 181' ' ' PHE . 4.8 tt -52.88 -66.61 0.35 Allowed 'General case' 0 C--O 1.21 -1.022 0 C-N-CA 124.205 1.002 . . . . 0.0 111.296 -175.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 23.1 m -75.2 -21.73 58.47 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.243 0.544 . . . . 0.0 112.062 -175.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -86.6 -4.33 59.16 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.032 -178.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.38 155.43 35.42 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 121.498 0.666 . . . . 0.0 111.167 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 12.4 m -65.32 162.17 18.06 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.365 -177.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 41.4 mm -53.57 -40.3 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 123.073 0.549 . . . . 0.0 110.892 -178.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -62.55 -29.03 72.36 Favored Glycine 0 C--O 1.214 -1.133 0 CA-C-N 115.974 -0.557 . . . . 0.0 113.135 -179.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -83.6 -41.88 17.35 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 121.467 0.651 . . . . 0.0 109.275 -178.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 97.4 mt -69.54 -38.42 77.49 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 114.706 -1.134 . . . . 0.0 111.345 -178.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.32 -33.9 77.05 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.311 0.577 . . . . 0.0 109.522 -176.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -60.94 -30.29 70.13 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.619 -1.173 . . . . 0.0 112.923 177.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 16.9 m -103.75 -39.29 5.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -176.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.49 HG21 ' H ' ' A' ' 200' ' ' GLY . 3.5 m -108.09 -84.64 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 177.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . 0.49 ' H ' HG21 ' A' ' 199' ' ' VAL . . . -178.0 167.46 38.24 Favored Glycine 0 N--CA 1.414 -2.819 0 N-CA-C 108.574 -1.81 . . . . 0.0 108.574 -178.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -57.69 -52.7 64.35 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 117.535 0.667 . . . . 0.0 112.357 179.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -67.37 -34.58 77.59 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.313 0.578 . . . . 0.0 110.809 -176.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.45 ' O ' ' HG2' ' A' ' 206' ' ' GLN . 2.6 t -70.57 -42.3 78.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 -179.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -56.36 -46.24 80.11 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.61 178.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -61.68 -47.02 87.23 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 114.972 -1.013 . . . . 0.0 112.615 179.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' GLN . . . . . 0.45 ' HG2' ' O ' ' A' ' 203' ' ' VAL . 3.4 pt20 -65.28 -34.98 79.62 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 118.373 0.533 . . . . 0.0 111.364 -178.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 88.4 mt -72.92 -50.52 32.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.972 178.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -65.01 -45.31 86.07 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.821 -177.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -70.07 -15.79 63.04 Favored 'General case' 0 C--O 1.217 -0.624 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -59.24 -45.54 90.9 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.129 0.572 . . . . 0.0 110.44 -179.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -95.91 -31.18 13.25 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.091 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 52.0 m . . . . . 0 CA--C 1.541 0.605 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.518 -177.396 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 43.0 tp . . . . . 0 N--CA 1.44 -0.956 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.461 ' O ' HG11 ' A' ' 163' ' ' VAL . 2.3 pt? -55.44 -34.54 64.55 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-O 121.223 0.535 . . . . 0.0 111.695 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -66.0 -31.9 73.07 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.198 177.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 15.9 m -86.72 -31.45 20.98 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 120.956 0.408 . . . . 0.0 110.76 178.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.461 HG11 ' O ' ' A' ' 160' ' ' LEU . 0.3 OUTLIER -64.79 -25.85 38.75 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.069 0 CA-C-O 121.719 0.771 . . . . 0.0 110.647 -177.271 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . 0.423 ' OE1' HG23 ' A' ' 184' ' ' ILE . 9.8 pt20 -83.44 -6.69 59.53 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.412 175.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -100.2 7.96 44.15 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.062 0.458 . . . . 0.0 110.307 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 84.5 mt -75.38 128.72 83.8 Favored Pre-proline 0 C--N 1.317 -0.829 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -65.75 128.67 20.42 Favored 'Trans proline' 0 C--O 1.238 0.478 0 C-N-CA 122.145 1.896 . . . . 0.0 111.353 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 117.35 -27.99 7.41 Favored Glycine 0 C--N 1.306 -1.084 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 -179.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 97.7 t -61.86 -62.01 1.34 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.689 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 177.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 110.89 100.81 2.6 Favored Glycine 0 N--CA 1.424 -2.12 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.323 176.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -73.66 -26.51 60.78 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.261 0.553 . . . . 0.0 109.935 177.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 62.1 t -82.88 -24.46 8.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-O 122.08 0.943 . . . . 0.0 108.896 178.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.502 ' HZ3' HG23 ' A' ' 199' ' ' VAL . 44.9 mtpt -86.01 -0.82 56.47 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.497 -1.229 . . . . 0.0 110.305 178.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -47.98 -51.04 50.76 Favored Pre-proline 0 C--O 1.203 -1.377 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -178.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . 0.574 ' O ' ' HG2' ' A' ' 179' ' ' GLN . 12.9 Cg_endo -58.24 -42.57 55.24 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 121.684 1.589 . . . . 0.0 112.132 177.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 55.6 tp -64.46 -45.56 86.89 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.729 0.776 . . . . 0.0 109.639 179.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' A' ' 173' ' ' LYS . 93.2 mt -69.16 -26.41 64.85 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.973 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 57.4 tp -74.06 -30.75 62.54 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 121.132 0.492 . . . . 0.0 109.831 178.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . 0.574 ' HG2' ' O ' ' A' ' 175' ' ' PRO . 12.7 mm-40 -76.09 -30.97 58.5 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 121.167 0.508 . . . . 0.0 109.965 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 22.9 mmmt -83.28 -50.62 8.21 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.979 179.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -111.75 135.66 21.16 Favored Pre-proline 0 N--CA 1.436 -1.134 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.795 -172.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.42 -38.51 82.87 Favored 'Trans proline' 0 N--CA 1.487 1.118 0 C-N-CA 124.367 3.378 . . . . 0.0 114.184 -176.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 24.4 t -158.66 167.83 28.49 Favored 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 179.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.434 ' HA ' ' HB3' ' A' ' 187' ' ' LEU . 0.2 OUTLIER -61.37 -26.98 40.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 O-C-N 124.277 0.985 . . . . 0.0 110.995 178.214 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -64.39 -40.73 96.39 Favored 'General case' 0 C--O 1.21 -1.022 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.692 179.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -80.2 -37.87 32.34 Favored 'General case' 0 C--O 1.191 -2.017 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 177.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.434 ' HB3' ' HA ' ' A' ' 184' ' ' ILE . 66.8 tp -46.67 -65.59 0.54 Allowed 'General case' 0 C--O 1.212 -0.873 0 C-N-CA 126.07 1.748 . . . . 0.0 113.202 -177.045 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 36.9 m -72.96 -20.94 60.95 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -177.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -91.89 3.88 54.19 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.461 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.96 158.23 28.71 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 124.816 1.247 . . . . 0.0 112.737 178.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 14.6 m -62.99 152.06 37.9 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.848 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 48.2 mm -55.15 -35.57 36.09 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.137 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.878 -177.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -61.9 -30.2 74.57 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 121.313 -0.47 . . . . 0.0 112.842 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . 0.446 ' O ' ' HG2' ' A' ' 197' ' ' GLN . 59.4 mm-40 -84.24 -36.99 22.33 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-O 121.529 0.681 . . . . 0.0 109.752 -179.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 96.0 mt -75.97 -24.38 55.4 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.385 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . 0.417 ' HG2' ' N ' ' A' ' 201' ' ' GLN . 3.9 tm-20 -78.91 -37.95 38.64 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -178.041 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . 0.446 ' HG2' ' O ' ' A' ' 194' ' ' GLU . 10.3 pt20 -69.75 -19.6 63.53 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 114.999 -1.0 . . . . 0.0 112.328 -175.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 17.1 m -102.54 -26.33 3.52 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 C-N-CA 120.587 -0.445 . . . . 0.0 111.842 178.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.502 HG23 ' HZ3' ' A' ' 173' ' ' LYS . 0.2 OUTLIER -128.24 -81.8 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 C-N-CA 120.721 -0.392 . . . . 0.0 111.129 175.897 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -176.95 162.78 31.24 Favored Glycine 0 N--CA 1.442 -0.914 0 N-CA-C 108.791 -1.723 . . . . 0.0 108.791 -176.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' GLN . . . . . 0.417 ' N ' ' HG2' ' A' ' 196' ' ' GLU . 8.8 tt0 -67.01 -40.69 87.36 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 117.996 0.898 . . . . 0.0 112.065 -176.117 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -65.7 -37.64 87.01 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.399 0.619 . . . . 0.0 109.936 -179.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.425 HG13 HG12 ' A' ' 199' ' ' VAL . 3.9 t -69.91 -44.05 79.04 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.864 0 CA-C-N 114.986 -1.007 . . . . 0.0 108.755 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -55.31 -46.43 76.27 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 114.356 -1.293 . . . . 0.0 110.2 -179.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -71.12 -31.62 67.99 Favored 'General case' 0 N--CA 1.417 -2.124 0 CA-C-N 114.735 -1.12 . . . . 0.0 112.494 -177.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -78.08 -34.1 50.45 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 119.742 -0.783 . . . . 0.0 110.765 178.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 93.7 mt -66.38 -45.61 88.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 174.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 28.4 t-80 -68.95 -35.77 77.15 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.007 -178.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -72.56 -25.6 61.42 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 121.743 -0.598 . . . . 0.0 112.507 177.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -50.84 -54.13 26.37 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.532 1.133 . . . . 0.0 112.667 -175.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 20.3 p90 -81.76 -24.16 36.21 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -177.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 30.6 m . . . . . 0 C--N 1.31 -1.111 0 CA-C-O 120.975 0.417 . . . . 0.0 111.225 179.953 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.409 HD13 ' O ' ' A' ' 159' ' ' LEU . 3.0 tm? . . . . . 0 N--CA 1.424 -1.747 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.401 ' HA ' ' CG1' ' A' ' 163' ' ' VAL . 2.4 pt? -61.82 -23.52 66.28 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 115.316 -0.856 . . . . 0.0 112.035 -177.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 34.6 ptt180 -70.0 -39.32 75.96 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.345 0.593 . . . . 0.0 110.104 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 74.8 m -86.75 -32.57 20.33 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.937 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.401 ' CG1' ' HA ' ' A' ' 160' ' ' LEU . 0.4 OUTLIER -62.49 -26.2 39.87 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.126 -174.568 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -80.47 -10.22 59.75 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.995 179.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -103.8 11.45 35.75 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 121.143 0.497 . . . . 0.0 110.978 -176.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.402 HG23 ' HA ' ' A' ' 207' ' ' ILE . 73.6 mt -78.74 133.86 61.81 Favored Pre-proline 0 C--N 1.304 -1.404 0 CA-C-N 116.059 -0.518 . . . . 0.0 109.71 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -62.12 128.76 24.94 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.106 1.871 . . . . 0.0 109.869 175.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 116.07 -40.95 2.25 Favored Glycine 0 N--CA 1.429 -1.805 0 N-CA-C 108.668 -1.773 . . . . 0.0 108.668 -176.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.46 ' O ' HD13 ' A' ' 177' ' ' LEU . 57.7 t -70.89 -56.34 11.03 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.174 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 174.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 91.77 147.08 19.58 Favored Glycine 0 N--CA 1.417 -2.596 0 C-N-CA 120.201 -1.0 . . . . 0.0 114.893 172.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 56.7 pttt -89.37 -35.93 15.79 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 114.401 -0.899 . . . . 0.0 110.556 177.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 43.3 t -86.14 -39.03 13.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-O 121.204 0.526 . . . . 0.0 110.729 -175.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.638 ' O ' ' HG ' ' A' ' 177' ' ' LEU . 21.6 ptmt -84.25 2.07 41.73 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.765 -178.321 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -54.59 -52.75 67.17 Favored Pre-proline 0 CA--C 1.563 1.443 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -61.74 -23.16 75.85 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 122.137 1.891 . . . . 0.0 112.22 177.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.503 ' HB3' ' O ' ' A' ' 173' ' ' LYS . 53.5 tp -74.54 -34.86 63.08 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.252 176.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.638 ' HG ' ' O ' ' A' ' 173' ' ' LYS . 61.5 mt -78.69 -29.29 45.48 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.073 -179.07 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 87.3 mt -68.69 -5.58 21.13 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.615 177.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -85.3 -21.42 28.99 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 121.838 0.828 . . . . 0.0 108.941 174.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -101.05 -47.41 4.77 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.567 -178.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' PHE . . . . . 0.57 ' CD2' ' HG ' ' A' ' 187' ' ' LEU . 85.4 m-85 -107.32 149.06 38.27 Favored Pre-proline 0 N--CA 1.427 -1.609 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.623 -175.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -67.46 -50.47 0.94 Allowed 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.774 2.316 . . . . 0.0 112.566 -178.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 66.6 m -150.19 164.48 35.57 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -57.33 -30.49 35.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 115.671 1.73 . . . . 0.0 115.671 -173.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -68.55 -46.9 68.25 Favored 'General case' 0 C--O 1.206 -1.223 0 C-N-CA 119.439 -0.905 . . . . 0.0 108.995 -176.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -73.04 -29.89 63.32 Favored 'General case' 0 C--O 1.194 -1.846 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.57 ' HG ' ' CD2' ' A' ' 181' ' ' PHE . 5.1 tt -56.03 -64.12 0.96 Allowed 'General case' 0 C--O 1.217 -0.607 0 C-N-CA 123.666 0.786 . . . . 0.0 110.27 -178.168 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 17.6 m -74.29 -26.44 60.19 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 123.29 0.369 . . . . 0.0 111.831 -176.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.411 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 8.6 t30 -85.36 -0.03 53.55 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.138 0.494 . . . . 0.0 111.014 -178.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -66.62 155.47 37.77 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.035 0.445 . . . . 0.0 110.704 175.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 12.5 m -63.94 159.72 19.27 Favored 'General case' 0 C--O 1.251 1.14 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.089 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.1 mm -49.09 -39.17 12.06 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.851 0 C-N-CA 123.772 0.829 . . . . 0.0 111.619 -179.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . 0.457 ' O ' ' HG3' ' A' ' 197' ' ' GLN . . . -57.22 -39.05 89.45 Favored Glycine 0 CA--C 1.526 0.767 0 O-C-N 123.129 0.268 . . . . 0.0 113.453 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -77.56 -41.46 38.86 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.551 0.691 . . . . 0.0 109.231 -177.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 96.0 mt -69.72 -26.44 64.33 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.268 -179.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . 0.598 ' HG2' ' N ' ' A' ' 201' ' ' GLN . 1.5 tm-20 -73.39 -34.43 65.54 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 -179.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . 0.457 ' HG3' ' O ' ' A' ' 193' ' ' GLY . 89.9 mt-30 -62.52 -29.92 70.91 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.999 178.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 12.8 m -103.84 -24.44 4.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -176.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -128.4 -85.75 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.779 176.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -178.36 158.3 22.86 Favored Glycine 0 CA--C 1.494 -1.223 0 N-CA-C 108.669 -1.772 . . . . 0.0 108.669 -176.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' GLN . . . . . 0.598 ' N ' ' HG2' ' A' ' 196' ' ' GLU . 10.7 pt20 -57.19 -46.39 82.89 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -177.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -69.93 -34.69 73.8 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.395 0.616 . . . . 0.0 110.55 -175.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.448 ' O ' HG13 ' A' ' 207' ' ' ILE . 2.0 t -75.2 -39.28 42.78 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-N 114.945 -1.025 . . . . 0.0 108.241 -178.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -57.48 -41.59 80.97 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.587 -1.188 . . . . 0.0 109.903 179.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . 0.404 ' HG3' ' O ' ' A' ' 201' ' ' GLN . 27.9 mt-30 -64.56 -39.79 94.38 Favored 'General case' 0 N--CA 1.422 -1.85 0 CA-C-N 114.966 -1.015 . . . . 0.0 112.047 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 27.1 pt20 -73.4 -30.09 63.02 Favored 'General case' 0 C--O 1.218 -0.554 0 C-N-CA 119.367 -0.933 . . . . 0.0 110.438 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 203' ' ' VAL . 82.8 mt -68.03 -53.07 32.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 176.178 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 53.3 t-80 -62.57 -43.73 98.08 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 114.668 -1.151 . . . . 0.0 110.531 -177.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -70.7 -25.3 62.9 Favored 'General case' 0 C--O 1.202 -1.396 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -54.56 -47.84 72.76 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.083 0.553 . . . . 0.0 111.742 -176.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . 0.411 ' CZ ' ' HA ' ' A' ' 189' ' ' ASN . 34.1 p90 -93.69 -26.34 17.07 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.172 -178.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 46.4 m . . . . . 0 CA--C 1.551 1.002 0 CA-C-O 120.895 0.379 . . . . 0.0 111.061 179.994 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 44.6 tp . . . . . 0 C--O 1.236 0.38 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -63.36 -23.94 67.63 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.666 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -72.13 -32.5 66.99 Favored 'General case' 0 C--O 1.22 -0.497 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 10.2 m -86.37 -35.59 19.7 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.937 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -61.66 -25.68 37.57 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 C-N-CA 123.835 0.854 . . . . 0.0 111.571 -177.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -86.11 -8.01 58.18 Favored 'General case' 0 C--N 1.311 -1.103 0 O-C-N 121.941 -0.474 . . . . 0.0 111.561 178.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -97.46 17.99 16.33 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-O 120.606 0.241 . . . . 0.0 110.638 -176.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.407 HG22 ' HA ' ' A' ' 207' ' ' ILE . 65.2 mt -83.09 120.33 75.79 Favored Pre-proline 0 C--N 1.302 -1.463 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.364 -176.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.23 129.12 15.58 Favored 'Trans proline' 0 N--CA 1.445 -1.364 0 C-N-CA 121.82 1.68 . . . . 0.0 108.349 175.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 124.45 -33.14 3.88 Favored Glycine 0 C--N 1.288 -2.126 0 N-CA-C 108.47 -1.852 . . . . 0.0 108.47 -171.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 81.3 t -68.48 -43.5 83.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 174.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 107.55 140.27 9.43 Favored Glycine 0 N--CA 1.424 -2.12 0 CA-C-N 115.267 -0.879 . . . . 0.0 112.492 175.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -89.27 -36.27 15.68 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 121.131 0.491 . . . . 0.0 110.193 178.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 44.0 t -89.19 -31.98 5.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-O 121.735 0.778 . . . . 0.0 109.643 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.429 ' HG2' ' HG ' ' A' ' 177' ' ' LEU . 39.3 ttmt -77.36 -14.39 59.73 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.376 -179.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -52.36 -53.86 48.34 Favored Pre-proline 0 CA--C 1.557 1.222 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -176.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . 0.433 ' O ' ' HG3' ' A' ' 179' ' ' GLN . 18.9 Cg_endo -61.19 -32.36 90.75 Favored 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 121.575 1.517 . . . . 0.0 112.8 178.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 57.4 tp -69.84 -40.59 75.75 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.543 0.687 . . . . 0.0 109.804 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.429 ' HG ' ' HG2' ' A' ' 173' ' ' LYS . 87.6 mt -68.51 -27.99 66.61 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.259 178.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 43.4 tp -74.91 -9.49 58.59 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.179 177.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . 0.433 ' HG3' ' O ' ' A' ' 175' ' ' PRO . 24.6 mt-30 -91.02 -29.74 17.19 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 175.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -84.27 -50.64 7.67 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.825 -179.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -97.7 149.12 35.38 Favored Pre-proline 0 C--N 1.293 -1.857 0 CA-C-N 115.056 -0.974 . . . . 0.0 109.204 -177.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -68.78 -42.21 4.89 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 121.994 1.796 . . . . 0.0 112.705 -177.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 78.2 p -147.72 166.77 26.48 Favored 'General case' 0 N--CA 1.427 -1.58 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -177.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -62.42 -29.28 46.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 O-C-N 123.772 0.67 . . . . 0.0 111.569 177.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -63.23 -45.95 89.25 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.735 -179.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' GLN . . . . . 0.502 HE21 ' C ' ' A' ' 186' ' ' GLN . 0.0 OUTLIER -79.2 -32.59 44.11 Favored 'General case' 0 C--O 1.202 -1.419 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.54 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 4.1 tt -53.81 -64.09 0.94 Allowed 'General case' 0 C--O 1.218 -0.567 0 C-N-CA 124.141 0.976 . . . . 0.0 110.285 -176.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 19.9 m -70.42 -20.71 62.9 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 121.322 0.582 . . . . 0.0 111.793 -178.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -90.34 4.9 49.46 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.408 0.623 . . . . 0.0 111.009 -178.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.49 155.3 36.02 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.781 173.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 5.4 t -72.89 168.69 18.4 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.553 -175.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 50.8 mm -59.62 -37.73 72.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.751 -175.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -60.34 -31.92 75.44 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 116.448 -0.342 . . . . 0.0 112.803 178.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . 0.479 ' O ' ' HG2' ' A' ' 197' ' ' GLN . 24.3 mt-10 -83.77 -36.73 23.38 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 121.556 0.693 . . . . 0.0 109.269 -177.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 88.6 mt -78.44 -23.27 46.69 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-O 121.306 0.574 . . . . 0.0 111.72 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . 0.556 ' HG2' ' N ' ' A' ' 201' ' ' GLN . 2.5 tm-20 -80.49 -37.44 31.72 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' A' ' 194' ' ' GLU . 9.5 pt20 -68.01 -14.69 63.16 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.708 -177.367 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 4.1 m -103.46 -34.66 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 N-CA-C 111.621 0.23 . . . . 0.0 111.621 174.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 1.3 t -128.76 -80.31 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 C-N-CA 119.909 -0.716 . . . . 0.0 111.25 177.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -177.61 166.27 36.52 Favored Glycine 0 N--CA 1.434 -1.458 0 N-CA-C 111.46 -0.656 . . . . 0.0 111.46 -176.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' GLN . . . . . 0.556 ' N ' ' HG2' ' A' ' 196' ' ' GLU . 78.7 mt-30 -56.51 -50.39 71.95 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 124.756 1.222 . . . . 0.0 111.82 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -64.81 -27.87 69.17 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.681 0.753 . . . . 0.0 111.205 -175.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 90.3 t -80.14 -49.44 18.99 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.581 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -52.31 -46.64 66.07 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 124.763 1.225 . . . . 0.0 110.891 -179.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -61.74 -45.75 92.6 Favored 'General case' 0 N--CA 1.419 -2.011 0 CA-C-N 114.433 -1.258 . . . . 0.0 111.529 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -73.86 -28.61 61.67 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.348 -0.541 . . . . 0.0 111.877 -179.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' ILE . . . . . 0.407 ' HA ' HG22 ' A' ' 166' ' ' ILE . 81.9 mt -70.04 -50.34 48.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.182 0.515 . . . . 0.0 109.945 175.189 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 9.7 t60 -72.63 -37.02 68.15 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.248 -175.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -73.85 -16.38 61.13 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 120.22 -0.592 . . . . 0.0 112.164 178.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -54.37 -56.72 15.75 Favored 'General case' 0 C--O 1.215 -0.716 0 C-N-CA 123.386 0.674 . . . . 0.0 111.68 -177.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -81.04 -26.35 36.44 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.59 -178.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 32.3 m . . . . . 0 N--CA 1.443 -0.818 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.585 179.687 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.6 tt . . . . . 0 N--CA 1.485 1.288 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.413 ' HA ' ' CG1' ' A' ' 163' ' ' VAL . 2.3 pt? -58.18 -22.43 51.51 Favored 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 179.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 -68.04 -39.17 83.11 Favored 'General case' 0 C--O 1.223 -0.34 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 176.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 93.7 m -86.51 -31.64 21.18 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.731 -177.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.413 ' CG1' ' HA ' ' A' ' 160' ' ' LEU . 0.5 OUTLIER -65.32 -26.19 38.94 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 CA-C-O 121.664 0.745 . . . . 0.0 111.083 -177.416 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -86.44 -8.01 57.97 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.597 178.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -104.41 16.41 26.2 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.441 -178.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 84.5 mt -77.72 127.01 83.43 Favored Pre-proline 0 C--N 1.302 -1.46 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -66.31 128.55 19.6 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 121.778 1.652 . . . . 0.0 109.522 177.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 120.66 -33.87 4.29 Favored Glycine 0 N--CA 1.427 -1.953 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 -177.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 93.3 t -59.33 -60.27 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 CA-C-O 121.294 0.568 . . . . 0.0 110.447 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 113.87 95.04 2.1 Favored Glycine 0 N--CA 1.428 -1.833 0 C-N-CA 119.965 -1.112 . . . . 0.0 112.248 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -76.68 -20.57 56.47 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 121.274 0.559 . . . . 0.0 110.863 -178.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 57.5 t -83.11 -29.87 8.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-O 121.672 0.749 . . . . 0.0 109.362 178.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -83.44 -7.18 59.6 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.432 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -49.14 -50.12 65.5 Favored Pre-proline 0 CA--C 1.551 0.99 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 -176.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . 0.502 ' O ' ' HG3' ' A' ' 179' ' ' GLN . 10.9 Cg_endo -57.28 -36.84 99.01 Favored 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 121.583 1.522 . . . . 0.0 112.862 177.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 60.4 tp -71.83 -40.47 69.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 97.0 mt -66.05 -34.03 77.16 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.705 179.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 47.9 tp -70.72 -13.94 62.25 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.441 0.639 . . . . 0.0 110.834 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . 0.502 ' HG3' ' O ' ' A' ' 175' ' ' PRO . 21.0 mt-30 -89.43 -35.99 15.7 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 176.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 40.9 mmtm -80.83 -47.43 13.84 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.212 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' PHE . . . . . 0.529 ' CD2' ' HA ' ' A' ' 187' ' ' LEU . 80.1 m-85 -101.78 145.54 30.65 Favored Pre-proline 0 C--N 1.296 -1.753 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -177.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -56.8 -47.57 22.76 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 122.919 2.412 . . . . 0.0 111.673 177.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 78.2 p -153.24 171.58 18.31 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 -178.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -63.32 -25.14 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 121.333 0.587 . . . . 0.0 110.401 176.003 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -65.51 -45.12 84.77 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.359 -178.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -79.49 -36.2 39.01 Favored 'General case' 0 C--O 1.203 -1.381 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 176.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.529 ' HA ' ' CD2' ' A' ' 181' ' ' PHE . 4.7 tt -49.1 -66.29 0.42 Allowed 'General case' 0 C--O 1.213 -0.844 0 C-N-CA 125.482 1.513 . . . . 0.0 111.503 -175.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 35.1 m -70.95 -20.78 62.41 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -175.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -90.89 0.59 57.45 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.58 155.46 35.71 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 122.902 0.481 . . . . 0.0 110.445 175.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' SER . . . . . 0.404 ' OG ' ' HG3' ' A' ' 194' ' ' GLU . 27.9 p -66.98 165.24 15.99 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.125 -178.447 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 50.7 mm -55.91 -37.64 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -58.58 -37.08 88.12 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-N 115.309 -0.86 . . . . 0.0 113.514 178.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . 0.404 ' HG3' ' OG ' ' A' ' 191' ' ' SER . 30.1 mt-10 -83.4 -37.88 22.69 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.336 0.589 . . . . 0.0 109.503 -177.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 95.0 mt -71.65 -31.76 67.19 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.866 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -67.1 -31.37 71.79 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.35 0.595 . . . . 0.0 109.743 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -63.81 -26.27 68.55 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 114.865 -1.061 . . . . 0.0 112.723 179.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 12.2 m -103.88 -38.35 5.02 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.466 HG21 ' H ' ' A' ' 200' ' ' GLY . 2.5 m -117.05 -80.55 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 178.081 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . 0.466 ' H ' HG21 ' A' ' 199' ' ' VAL . . . -177.99 166.41 36.54 Favored Glycine 0 N--CA 1.418 -2.525 0 N-CA-C 108.434 -1.866 . . . . 0.0 108.434 -178.082 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' GLN . . . . . 0.521 ' O ' ' HG3' ' A' ' 205' ' ' GLN . 63.4 tt0 -68.54 -43.37 76.84 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 118.038 0.919 . . . . 0.0 110.837 -178.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -65.46 -32.99 74.9 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.122 0.487 . . . . 0.0 110.866 -179.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 2.4 t -75.53 -40.89 41.74 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.738 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -179.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -57.94 -43.85 86.56 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.355 -179.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . 0.521 ' HG3' ' O ' ' A' ' 201' ' ' GLN . 26.7 mt-30 -61.89 -47.12 86.4 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.684 -178.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -69.53 -33.05 72.24 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.437 -0.505 . . . . 0.0 111.54 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 99.2 mt -69.24 -50.39 52.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.13 0.49 . . . . 0.0 109.82 176.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 59.5 t-80 -67.59 -39.88 84.81 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.253 -177.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -72.01 -18.39 61.97 Favored 'General case' 0 C--O 1.213 -0.826 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -55.12 -51.45 66.4 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.396 0.617 . . . . 0.0 110.459 -178.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -89.37 -27.67 20.31 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.994 -179.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 60.4 m . . . . . 0 C--N 1.318 -0.764 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -177.981 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 48.8 tp . . . . . 0 N--CA 1.438 -1.051 0 N-CA-C 110.579 -0.156 . . . . 0.0 110.579 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -49.59 -40.9 40.4 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.159 0.984 . . . . 0.0 112.542 -178.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -59.89 -47.05 87.32 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.35 178.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 38.0 m -86.18 -29.72 23.0 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 120.988 0.423 . . . . 0.0 112.083 -175.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -67.0 -25.38 34.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 121.701 0.762 . . . . 0.0 111.239 -175.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 24.6 pt20 -82.59 -7.6 59.64 Favored 'General case' 0 C--N 1.315 -0.921 0 O-C-N 121.897 -0.502 . . . . 0.0 111.847 177.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -101.77 21.92 13.74 Favored 'General case' 0 C--O 1.239 0.553 0 CA-C-O 121.459 0.647 . . . . 0.0 110.671 -178.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.442 HG22 ' HA ' ' A' ' 207' ' ' ILE . 74.5 mt -88.51 133.15 36.93 Favored Pre-proline 0 C--N 1.303 -1.425 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.395 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -64.18 128.58 21.98 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 121.708 1.606 . . . . 0.0 109.745 175.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 118.76 -30.97 5.71 Favored Glycine 0 N--CA 1.43 -1.715 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -174.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 97.8 t -74.22 -59.58 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 176.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 104.69 147.16 16.19 Favored Glycine 0 N--CA 1.44 -1.074 0 C-N-CA 120.931 -0.652 . . . . 0.0 113.923 174.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . 0.411 ' HG3' ' N ' ' A' ' 172' ' ' VAL . 57.2 pttt -89.64 -43.36 10.8 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.11 0.481 . . . . 0.0 110.883 176.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.411 ' N ' ' HG3' ' A' ' 171' ' ' LYS . 40.4 t -81.32 -33.17 12.47 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.69 0 CA-C-O 121.679 0.752 . . . . 0.0 109.933 -174.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.486 ' O ' ' HG ' ' A' ' 177' ' ' LEU . 14.4 ptmm? -90.94 5.94 46.66 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.931 -179.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -66.11 -47.39 62.18 Favored Pre-proline 0 CA--C 1.55 0.972 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . 0.471 ' O ' ' HG2' ' A' ' 179' ' ' GLN . 37.0 Cg_exo -61.25 -36.88 77.56 Favored 'Trans proline' 0 C--N 1.384 2.438 0 C-N-CA 121.555 1.503 . . . . 0.0 110.724 178.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 58.9 tp -61.71 -46.79 88.15 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.3 175.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 173' ' ' LYS . 94.1 mt -61.38 -37.69 84.32 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.938 178.307 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 95.7 mt -65.75 -17.92 64.96 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.337 177.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . 0.471 ' HG2' ' O ' ' A' ' 175' ' ' PRO . 15.3 mm100 -92.47 -7.81 46.42 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 120.899 0.381 . . . . 0.0 110.488 177.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . 0.467 ' HZ1' ' HA ' ' A' ' 180' ' ' LYS . 0.3 OUTLIER -102.87 -51.68 3.23 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.644 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' PHE . . . . . 0.471 ' CD2' ' HG ' ' A' ' 187' ' ' LEU . 88.3 m-85 -98.08 149.91 36.21 Favored Pre-proline 0 C--N 1.294 -1.843 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -63.89 -43.42 16.08 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 121.737 1.625 . . . . 0.0 112.063 -175.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 43.1 m -155.05 171.8 19.17 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -65.99 -28.94 45.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -175.015 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 22.4 tp60 -66.88 -35.8 80.85 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.973 -177.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -79.66 -37.44 35.89 Favored 'General case' 0 C--O 1.203 -1.349 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 176.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.471 ' HG ' ' CD2' ' A' ' 181' ' ' PHE . 4.3 tt -49.71 -68.07 0.21 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.065 1.346 . . . . 0.0 112.344 -173.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 20.1 m -72.65 -24.29 61.02 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 121.169 0.509 . . . . 0.0 111.818 -174.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -87.47 1.27 53.95 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.995 -179.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.2 155.76 33.98 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 121.085 0.469 . . . . 0.0 110.582 176.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 4.7 m -63.34 160.96 14.89 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.297 -177.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 46.4 mm -50.16 -41.06 18.13 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.865 0 C-N-CA 123.278 0.631 . . . . 0.0 110.927 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -61.82 -30.05 74.01 Favored Glycine 0 CA--C 1.523 0.549 0 CA-C-N 116.216 -0.447 . . . . 0.0 113.243 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -83.44 -44.67 14.51 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 98.4 mt -65.69 -28.29 68.96 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.857 -179.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -70.43 -35.41 73.37 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -63.5 -24.72 67.94 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.221 -0.9 . . . . 0.0 113.221 -178.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 13.4 m -101.47 -26.42 3.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -178.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.44 HG22 ' H ' ' A' ' 200' ' ' GLY . 2.2 m -131.77 -82.33 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 112.902 0.705 . . . . 0.0 112.902 174.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . 0.44 ' H ' HG22 ' A' ' 199' ' ' VAL . . . -177.37 165.36 35.16 Favored Glycine 0 N--CA 1.422 -2.249 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 -177.023 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -65.3 -39.07 92.05 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 117.596 0.698 . . . . 0.0 112.507 -177.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -66.91 -35.92 81.08 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.164 0.507 . . . . 0.0 110.306 -178.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.414 ' O ' ' HG2' ' A' ' 206' ' ' GLN . 2.0 t -76.62 -39.46 32.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 -179.165 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -57.22 -41.5 79.58 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.033 178.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . 0.493 ' HA ' HE21 ' A' ' 205' ' ' GLN . 0.0 OUTLIER -62.42 -40.82 97.79 Favored 'General case' 0 N--CA 1.424 -1.737 0 CA-C-N 115.133 -0.939 . . . . 0.0 112.341 179.689 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' GLN . . . . . 0.414 ' HG2' ' O ' ' A' ' 203' ' ' VAL . 20.8 pt20 -72.42 -34.59 67.96 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.895 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' ILE . . . . . 0.442 ' HA ' HG22 ' A' ' 166' ' ' ILE . 73.5 mt -65.67 -48.55 82.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.559 0.695 . . . . 0.0 109.417 175.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 46.9 t-80 -67.22 -40.38 86.37 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.071 -178.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -64.29 -25.93 68.26 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 178.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -56.62 -43.73 80.48 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.533 0.733 . . . . 0.0 110.894 -177.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -95.88 -28.46 14.7 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 120.108 -0.637 . . . . 0.0 111.838 178.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 86.7 m . . . . . 0 CA--C 1.547 0.849 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 179.915 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 42.4 mt . . . . . 0 CA--C 1.487 -1.458 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -61.31 -29.58 69.96 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.66 176.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 27.0 ptt180 -78.86 -24.78 44.09 Favored 'General case' 0 C--O 1.216 -0.69 0 C-N-CA 120.485 -0.486 . . . . 0.0 109.703 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 26.5 m -86.19 -41.53 14.59 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-O 121.377 0.608 . . . . 0.0 110.379 178.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -59.78 -26.5 35.48 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 C-N-CA 124.216 1.007 . . . . 0.0 111.553 -177.434 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -83.29 -15.1 51.47 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.81 177.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -106.28 14.2 27.78 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-O 121.329 0.585 . . . . 0.0 110.129 -175.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 94.8 mt -71.56 132.05 85.82 Favored Pre-proline 0 C--O 1.249 1.04 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 176.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -63.15 128.44 22.81 Favored 'Trans proline' 0 C--O 1.246 0.924 0 C-N-CA 122.007 1.805 . . . . 0.0 109.768 176.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 117.1 -32.82 5.29 Favored Glycine 0 N--CA 1.431 -1.65 0 C-N-CA 120.789 -0.72 . . . . 0.0 111.391 -177.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 59.6 t -66.95 -71.43 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.773 0 CA-C-O 121.231 0.538 . . . . 0.0 109.674 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 113.66 109.42 2.88 Favored Glycine 0 N--CA 1.421 -2.302 0 C-N-CA 119.975 -1.107 . . . . 0.0 112.91 177.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt -78.74 -15.05 58.91 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 121.718 0.771 . . . . 0.0 109.69 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 91.0 t -79.81 -36.64 17.38 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.895 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.521 ' O ' ' HG ' ' A' ' 177' ' ' LEU . 9.3 ptpp? -90.43 -5.89 55.56 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.073 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -52.81 -49.67 85.45 Favored Pre-proline 0 CA--C 1.552 1.03 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -177.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -62.56 -23.94 74.99 Favored 'Trans proline' 0 C--N 1.371 1.714 0 C-N-CA 121.283 1.322 . . . . 0.0 112.824 176.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.449 ' HA ' HE21 ' A' ' 179' ' ' GLN . 59.6 tp -77.63 -39.34 45.58 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 175.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 173' ' ' LYS . 87.4 mt -69.17 -33.05 72.79 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.837 -179.228 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 41.1 tp -68.24 -12.73 61.47 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-O 121.824 0.821 . . . . 0.0 110.76 178.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . 0.449 HE21 ' HA ' ' A' ' 176' ' ' LEU . 51.3 mt-30 -94.13 -3.34 51.22 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.829 177.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 37.2 mmtm -117.51 -45.91 2.69 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 121.284 0.564 . . . . 0.0 110.94 177.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -102.4 145.03 29.79 Favored Pre-proline 0 C--N 1.303 -1.451 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 -179.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -67.0 -34.45 29.04 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 121.723 1.615 . . . . 0.0 112.411 -176.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 84.5 p -151.29 166.49 30.79 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -178.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -66.91 -25.02 33.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 O-C-N 123.384 0.428 . . . . 0.0 110.885 175.025 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -64.71 -47.46 78.24 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.45 178.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -73.37 -35.93 66.0 Favored 'General case' 0 C--O 1.195 -1.775 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.418 HD23 HD11 ' A' ' 177' ' ' LEU . 4.4 tt -49.04 -65.96 0.48 Allowed 'General case' 0 C--O 1.217 -0.631 0 C-N-CA 124.697 1.199 . . . . 0.0 110.398 -177.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 19.8 m -68.79 -23.75 64.33 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -177.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 26.6 m-80 -85.11 -2.76 58.37 Favored 'General case' 0 C--O 1.242 0.699 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 178.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -66.34 156.3 34.87 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 122.978 0.511 . . . . 0.0 110.965 178.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 15.8 m -63.05 153.3 34.44 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.832 -178.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 48.9 mm -51.21 -36.67 16.95 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.927 0 C-N-CA 123.84 0.856 . . . . 0.0 111.274 -176.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . 0.557 ' O ' ' HG2' ' A' ' 197' ' ' GLN . . . -58.42 -45.89 93.78 Favored Glycine 0 N--CA 1.443 -0.843 0 O-C-N 123.385 0.428 . . . . 0.0 112.547 178.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . 0.471 ' O ' ' HB2' ' A' ' 197' ' ' GLN . 11.1 mm-40 -67.96 -40.77 83.13 Favored 'General case' 0 CA--C 1.494 -1.208 0 CA-C-O 121.772 0.796 . . . . 0.0 109.705 -177.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 94.3 mt -70.82 -31.09 67.71 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.76 178.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -68.95 -35.71 77.1 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . 0.557 ' HG2' ' O ' ' A' ' 193' ' ' GLY . 15.5 mm100 -57.89 -33.31 68.6 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.638 -1.164 . . . . 0.0 111.465 177.172 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 14.2 m -103.33 -35.04 3.62 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -176.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.402 HG23 ' H ' ' A' ' 200' ' ' GLY . 2.4 m -118.89 -77.66 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 176.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . 0.402 ' H ' HG23 ' A' ' 199' ' ' VAL . . . -178.69 165.33 34.39 Favored Glycine 0 N--CA 1.419 -2.443 0 N-CA-C 107.963 -2.055 . . . . 0.0 107.963 -177.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' GLN . . . . . 0.401 ' O ' ' HG3' ' A' ' 205' ' ' GLN . 35.7 tt0 -66.07 -45.65 80.52 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 117.762 0.781 . . . . 0.0 109.855 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -67.76 -33.59 75.14 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-O 121.161 0.505 . . . . 0.0 110.983 -179.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 2.6 t -73.81 -40.52 53.53 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.686 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 -178.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -56.04 -44.97 79.3 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.545 -1.207 . . . . 0.0 109.882 177.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . 0.401 ' HG3' ' O ' ' A' ' 201' ' ' GLN . 27.4 mt-30 -59.32 -50.9 72.19 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.582 178.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -66.97 -30.63 70.81 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 121.046 -0.261 . . . . 0.0 111.559 -176.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 97.4 mt -75.11 -51.4 21.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.373 177.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 9.7 t60 -69.86 -38.4 76.43 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.368 0.604 . . . . 0.0 110.202 -175.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -77.95 -9.94 59.34 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -60.1 -51.29 70.23 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-O 121.514 0.673 . . . . 0.0 110.395 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -86.82 -26.97 23.79 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.394 -179.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 37.6 m . . . . . 0 C--N 1.316 -0.856 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.595 -179.741 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.1 tm? . . . . . 0 N--CA 1.45 -0.436 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.412 ' O ' HG13 ' A' ' 163' ' ' VAL . 2.1 pt? -60.21 -33.08 71.75 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -178.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -75.79 -26.26 57.15 Favored 'General case' 0 C--O 1.219 -0.536 0 CA-C-O 121.768 0.794 . . . . 0.0 109.75 -178.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 21.5 m -86.24 -35.43 20.01 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-O 121.537 0.685 . . . . 0.0 110.153 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.412 HG13 ' O ' ' A' ' 160' ' ' LEU . 0.4 OUTLIER -64.54 -25.2 37.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.224 -176.507 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -84.57 -10.8 57.06 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.115 0.484 . . . . 0.0 110.787 177.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -102.75 23.38 12.17 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.292 0.568 . . . . 0.0 110.364 -177.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 84.8 mt -84.18 129.57 57.81 Favored Pre-proline 0 C--N 1.308 -1.221 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.98 128.79 18.32 Favored 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 121.778 1.652 . . . . 0.0 110.561 177.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 113.89 -16.72 20.65 Favored Glycine 0 C--N 1.297 -1.635 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.807 179.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 77.9 t -61.69 -43.21 96.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-O 121.028 0.442 . . . . 0.0 110.87 179.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 108.35 88.53 1.98 Allowed Glycine 0 N--CA 1.44 -1.097 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.383 178.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -60.64 -33.67 73.14 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -178.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 38.3 t -83.93 -23.49 7.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.336 0.589 . . . . 0.0 109.927 -176.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.526 ' O ' ' HG ' ' A' ' 177' ' ' LEU . 31.2 mtpt -85.57 -2.17 57.88 Favored 'General case' 0 C--O 1.193 -1.911 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.826 -176.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -42.97 -52.07 12.01 Favored Pre-proline 0 CA--C 1.566 1.587 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 -176.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.72 -38.55 10.23 Favored 'Trans proline' 0 C--N 1.366 1.487 0 C-N-CA 121.653 1.569 . . . . 0.0 111.738 178.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 54.4 tp -64.05 -41.31 97.43 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.116 177.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.526 ' HG ' ' O ' ' A' ' 173' ' ' LYS . 94.5 mt -58.22 -36.79 73.68 Favored 'General case' 0 C--O 1.206 -1.198 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.424 175.21 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.425 ' HA ' ' O ' ' A' ' 181' ' ' PHE . 92.5 mt -70.81 -11.93 61.25 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.299 0.571 . . . . 0.0 112.272 178.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -88.06 -5.42 58.49 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.83 0.824 . . . . 0.0 109.41 174.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . 0.452 ' HZ1' ' HA ' ' A' ' 180' ' ' LYS . 0.3 OUTLIER -113.82 -50.73 2.82 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.359 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' PHE . . . . . 0.52 ' CD2' ' HG ' ' A' ' 187' ' ' LEU . 34.5 m-85 -110.23 140.81 22.78 Favored Pre-proline 0 C--N 1.3 -1.549 0 CA-C-N 114.571 -1.195 . . . . 0.0 108.921 -177.244 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.91 -52.5 5.86 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 123.178 2.585 . . . . 0.0 112.682 178.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 50.7 m -154.64 172.83 17.24 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -179.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -54.05 -32.08 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 114.495 1.294 . . . . 0.0 114.495 -176.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -65.02 -43.06 93.7 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.901 0.381 . . . . 0.0 111.01 -177.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -79.42 -35.9 39.84 Favored 'General case' 0 C--O 1.196 -1.73 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 176.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.52 ' HG ' ' CD2' ' A' ' 181' ' ' PHE . 5.5 tt -51.82 -67.05 0.28 Allowed 'General case' 0 C--O 1.208 -1.126 0 C-N-CA 124.712 1.205 . . . . 0.0 112.208 -173.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 24.3 m -75.83 -18.72 59.36 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-O 121.157 0.503 . . . . 0.0 112.235 -174.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -93.57 -0.06 56.4 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.131 -179.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.93 155.6 36.02 Favored 'General case' 0 CA--C 1.506 -0.721 0 C-N-CA 123.539 0.736 . . . . 0.0 110.375 176.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 20.4 m -64.95 159.51 22.76 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.035 -176.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 48.2 mm -51.72 -39.62 24.56 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.647 0 C-N-CA 123.271 0.628 . . . . 0.0 110.707 -177.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -60.16 -37.92 93.63 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-N 116.003 -0.544 . . . . 0.0 113.482 179.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -75.1 -41.25 59.08 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -177.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 96.1 mt -68.64 -34.66 76.1 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.217 179.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . 0.456 ' HG2' ' N ' ' A' ' 201' ' ' GLN . 5.0 tm-20 -65.92 -33.75 76.53 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -178.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -61.88 -30.5 70.91 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.792 -1.094 . . . . 0.0 113.113 179.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 25.9 m -100.3 -36.27 5.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 C-N-CA 119.592 -0.843 . . . . 0.0 111.411 -179.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.487 HG22 ' H ' ' A' ' 200' ' ' GLY . 2.9 m -116.19 -85.65 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 176.216 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . 0.487 ' H ' HG22 ' A' ' 199' ' ' VAL . . . -176.82 165.67 35.97 Favored Glycine 0 N--CA 1.415 -2.708 0 N-CA-C 108.274 -1.93 . . . . 0.0 108.274 -175.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' GLN . . . . . 0.456 ' N ' ' HG2' ' A' ' 196' ' ' GLU . 52.9 tt0 -67.72 -42.15 82.37 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 117.496 0.648 . . . . 0.0 112.097 -174.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -66.66 -35.78 80.97 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.186 0.517 . . . . 0.0 110.624 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.495 ' O ' ' HG2' ' A' ' 206' ' ' GLN . 2.6 t -71.64 -40.38 70.62 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.747 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -57.06 -43.84 82.44 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 114.366 -1.288 . . . . 0.0 110.098 178.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . 0.407 ' HG3' ' O ' ' A' ' 201' ' ' GLN . 53.9 mt-30 -60.93 -45.59 94.06 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 114.955 -1.021 . . . . 0.0 112.372 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' GLN . . . . . 0.495 ' HG2' ' O ' ' A' ' 203' ' ' VAL . 13.2 pt20 -69.29 -30.86 69.03 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 120.236 -0.585 . . . . 0.0 110.708 -177.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 92.4 mt -73.44 -50.38 30.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.268 178.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 48.1 t-80 -69.1 -41.46 77.4 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.159 -177.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -73.44 -11.51 60.49 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 121.941 -0.474 . . . . 0.0 112.227 179.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -58.82 -51.9 68.02 Favored 'General case' 0 C--O 1.217 -0.646 0 C-N-CA 122.795 0.438 . . . . 0.0 110.743 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -80.51 -24.84 39.09 Favored 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.524 -179.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 27.5 m . . . . . 0 CA--C 1.546 0.815 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.615 175.696 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 36.6 t . . . . . 0 N--CA 1.437 -1.105 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -133.59 164.39 27.28 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -177.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -77.94 124.05 86.2 Favored Pre-proline 0 C--N 1.306 -1.296 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 170.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -58.03 108.48 0.39 Allowed 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.471 2.114 . . . . 0.0 113.283 -175.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 93.7 mt -90.1 -3.68 57.78 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.01 -0.995 . . . . 0.0 108.754 176.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 74.8 mt -81.21 105.22 12.24 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 114.777 -1.102 . . . . 0.0 108.491 178.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 127.27 160.42 10.49 Favored Glycine 0 N--CA 1.431 -1.68 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.548 178.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -88.7 127.11 35.58 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -122.21 128.86 51.69 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.425 -176.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -106.0 128.94 54.17 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 174.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -132.45 101.8 5.48 Favored 'General case' 0 C--N 1.295 -1.761 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.743 -177.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 52.1 tp -78.98 106.66 11.17 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 176.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 85.0 mt -101.18 135.13 43.15 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.277 -172.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 60.6 tp -88.35 85.53 6.9 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 176.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 28.4 m -135.63 107.26 6.96 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.314 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -77.58 115.85 53.17 Favored Pre-proline 0 C--N 1.307 -1.245 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 -179.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -81.8 21.43 0.94 Allowed 'Trans proline' 0 N--CA 1.482 0.827 0 C-N-CA 123.5 2.8 . . . . 0.0 113.536 -174.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.565 ' O ' ' HG2' ' A' ' 161' ' ' ARG . 28.0 m 62.88 59.47 1.37 Allowed 'General case' 0 N--CA 1.436 -1.175 0 CA-C-O 122.531 1.158 . . . . 0.0 109.583 -176.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -76.99 -29.75 55.64 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 114.255 -1.339 . . . . 0.0 108.929 -179.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.526 ' O ' HG11 ' A' ' 163' ' ' VAL . 2.0 pt? -58.81 -30.35 67.55 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.455 -179.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.565 ' HG2' ' O ' ' A' ' 158' ' ' SER . 12.3 ptm180 -78.78 -26.4 44.45 Favored 'General case' 0 C--N 1.309 -1.166 0 O-C-N 121.837 -0.54 . . . . 0.0 110.563 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 24.9 m -85.84 -28.59 24.34 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.574 0.702 . . . . 0.0 109.637 177.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.526 HG11 ' O ' ' A' ' 160' ' ' LEU . 0.3 OUTLIER -66.3 -25.71 36.15 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 CA-C-O 121.832 0.825 . . . . 0.0 111.072 -176.703 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -84.87 -7.44 59.17 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.37 177.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -96.3 1.86 52.33 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.027 -178.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 70.3 mt -73.96 131.14 81.83 Favored Pre-proline 0 C--N 1.314 -0.975 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.057 -177.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -66.68 128.23 18.62 Favored 'Trans proline' 0 C--O 1.246 0.897 0 C-N-CA 121.934 1.756 . . . . 0.0 110.235 175.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 116.02 -24.23 10.2 Favored Glycine 0 C--N 1.297 -1.59 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 -178.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 65.6 t -75.02 -58.39 4.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 177.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 90.13 107.06 1.27 Allowed Glycine 0 N--CA 1.425 -2.062 0 CA-C-N 115.431 -0.804 . . . . 0.0 113.576 177.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? -68.46 -21.24 64.65 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 121.577 0.703 . . . . 0.0 111.201 178.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 57.9 t -82.53 -30.56 9.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-O 121.712 0.768 . . . . 0.0 109.35 178.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.46 ' O ' HD11 ' A' ' 177' ' ' LEU . 60.0 mtpt -84.79 -10.25 57.38 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.955 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -51.73 -53.79 46.97 Favored Pre-proline 0 C--O 1.201 -1.472 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -178.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -62.3 -26.58 77.3 Favored 'Trans proline' 0 C--N 1.376 1.982 0 C-N-CA 121.856 1.704 . . . . 0.0 113.413 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 61.6 tp -77.38 -45.27 26.49 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 121.741 0.781 . . . . 0.0 109.103 178.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.46 HD11 ' O ' ' A' ' 173' ' ' LYS . 8.2 mp -71.84 -24.35 61.69 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.873 178.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.439 HD11 ' O ' ' A' ' 181' ' ' PHE . 42.5 tp -67.31 -11.68 58.21 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 124.091 0.956 . . . . 0.0 110.401 177.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -76.53 -20.59 56.74 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.514 175.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 7.8 mmmm -105.58 -42.13 5.29 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.918 178.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . 0.439 ' O ' HD11 ' A' ' 178' ' ' LEU . 32.5 m-85 -105.64 130.55 22.87 Favored Pre-proline 0 C--N 1.299 -1.611 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.935 -174.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -53.73 -42.4 66.52 Favored 'Trans proline' 0 C--N 1.359 1.128 0 C-N-CA 123.623 2.882 . . . . 0.0 113.7 -175.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 42.6 m -158.5 177.5 11.17 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.414 ' HA ' ' HB3' ' A' ' 187' ' ' LEU . 0.2 OUTLIER -59.52 -27.89 38.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 -175.961 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -69.1 -38.63 79.03 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 120.67 0.272 . . . . 0.0 110.94 -177.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.9 -33.44 39.89 Favored 'General case' 0 C--O 1.195 -1.81 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 176.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.414 ' HB3' ' HA ' ' A' ' 184' ' ' ILE . 62.4 tp -52.63 -67.78 0.22 Allowed 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 125.104 1.362 . . . . 0.0 113.467 -176.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 19.4 m -74.65 -24.75 58.87 Favored 'General case' 0 C--N 1.289 -2.04 0 C-N-CA 120.24 -0.584 . . . . 0.0 111.609 -176.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.463 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 62.4 t30 -89.45 12.0 17.7 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-O 122.095 0.95 . . . . 0.0 110.025 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.51 156.62 31.95 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.606 173.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 6.6 m -63.6 154.38 32.91 Favored 'General case' 0 N--CA 1.425 -1.676 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.082 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 48.9 mm -52.02 -39.73 26.96 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.825 0 C-N-CA 123.477 0.711 . . . . 0.0 110.889 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . 0.489 ' O ' ' HG2' ' A' ' 197' ' ' GLN . . . -59.39 -39.13 94.39 Favored Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 116.18 -0.464 . . . . 0.0 112.631 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . 0.473 ' O ' ' HB2' ' A' ' 197' ' ' GLN . 41.6 mm-40 -77.72 -38.55 46.96 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.43 0.633 . . . . 0.0 109.807 -176.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 96.8 mt -69.88 -32.2 70.42 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.485 178.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -67.37 -29.72 69.32 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -178.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.489 ' HG2' ' O ' ' A' ' 193' ' ' GLY . 15.8 mm100 -59.62 -33.84 72.01 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.737 -1.12 . . . . 0.0 112.441 178.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 23.4 m -103.48 -26.83 3.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -174.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.443 HG21 ' H ' ' A' ' 200' ' ' GLY . 1.4 m -123.15 -82.82 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 175.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . 0.443 ' H ' HG21 ' A' ' 199' ' ' VAL . . . -177.0 167.87 39.42 Favored Glycine 0 N--CA 1.419 -2.449 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 -177.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 19.5 tm0? -64.14 -47.95 77.94 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 123.254 0.622 . . . . 0.0 110.814 -175.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -71.65 -32.34 67.81 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.859 0.361 . . . . 0.0 111.066 -177.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.421 ' O ' ' HG2' ' A' ' 206' ' ' GLN . 2.9 t -69.03 -40.07 80.39 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.649 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 179.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -60.19 -43.18 96.12 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 114.294 -1.321 . . . . 0.0 109.675 177.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -59.72 -45.58 91.75 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.785 179.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . 0.421 ' HG2' ' O ' ' A' ' 203' ' ' VAL . 12.0 pt20 -66.26 -34.75 78.72 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 120.145 -0.622 . . . . 0.0 111.084 -179.041 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 87.3 mt -69.43 -51.48 41.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.291 0.567 . . . . 0.0 109.712 178.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' HIS . . . . . 0.55 ' HA ' ' CE2' ' A' ' 211' ' ' PHE . 13.4 t60 -68.0 -36.71 80.46 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.237 -175.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -68.06 -32.79 73.37 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.694 176.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -54.62 -52.21 62.94 Favored 'General case' 0 C--O 1.215 -0.733 0 C-N-CA 124.023 0.929 . . . . 0.0 112.367 -174.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.55 ' CE2' ' HA ' ' A' ' 208' ' ' HIS . 21.5 p90 -80.8 -23.85 38.96 Favored 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 120.36 -0.536 . . . . 0.0 112.097 -178.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 75.2 m -65.78 -51.53 58.34 Favored 'General case' 0 C--O 1.247 0.932 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -140.88 109.04 6.47 Favored Pre-proline 0 N--CA 1.423 -1.803 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 177.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -108.43 162.61 0.1 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 122.282 1.988 . . . . 0.0 113.743 177.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 13.6 tpp180 . . . . . 0 N--CA 1.422 -1.871 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 174.246 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 50.8 m . . . . . 0 N--CA 1.427 -1.623 0 N-CA-C 110.334 -0.247 . . . . 0.0 110.334 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt 61.19 83.84 0.14 Allowed 'General case' 0 C--O 1.242 0.701 0 C-N-CA 124.272 1.029 . . . . 0.0 111.995 176.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.498 HD22 ' HA ' ' A' ' 146' ' ' LEU . 27.8 p-10 -96.67 157.8 34.67 Favored Pre-proline 0 C--N 1.295 -1.795 0 CA-C-N 114.696 -1.138 . . . . 0.0 108.624 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -39.26 -54.76 1.7 Allowed 'Trans proline' 0 C--N 1.366 1.464 0 C-N-CA 124.131 3.221 . . . . 0.0 114.067 178.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 7.1 tt -156.97 114.17 3.1 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.498 ' HA ' HD22 ' A' ' 143' ' ' ASN . 57.1 tp -69.16 105.88 2.63 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.566 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 132.45 -149.35 19.46 Favored Glycine 0 N--CA 1.41 -3.087 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 178.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -106.8 101.93 11.33 Favored 'General case' 0 C--N 1.284 -2.263 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -76.75 169.09 18.94 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-O 121.104 0.478 . . . . 0.0 110.183 -178.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 9.9 tpt180 -98.96 131.39 45.06 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -74.44 100.68 3.89 Favored 'General case' 0 N--CA 1.425 -1.713 0 N-CA-C 105.085 -2.191 . . . . 0.0 105.085 171.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 62.6 tp -93.89 122.48 36.42 Favored 'General case' 0 N--CA 1.41 -2.438 0 CA-C-N 114.592 -1.186 . . . . 0.0 109.869 -172.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -77.27 83.54 3.73 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.987 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.507 HD13 ' O ' ' A' ' 154' ' ' LEU . 2.9 pp -108.03 119.03 38.3 Favored 'General case' 0 N--CA 1.404 -2.767 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 169.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 8.6 t -80.73 107.26 13.39 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -176.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -73.29 113.66 24.22 Favored Pre-proline 0 C--N 1.291 -1.958 0 CA-C-N 114.129 -1.396 . . . . 0.0 109.65 -176.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.426 ' C ' ' H ' ' A' ' 159' ' ' LEU . 87.2 Cg_endo -81.15 -165.27 0.33 Allowed 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 122.464 2.11 . . . . 0.0 112.012 -178.091 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.43 ' O ' ' HG2' ' A' ' 161' ' ' ARG . 14.7 m -75.45 18.63 0.21 Allowed 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -176.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.473 ' O ' HD22 ' A' ' 159' ' ' LEU . 6.2 tt -60.21 -21.81 62.23 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 124.628 1.171 . . . . 0.0 110.169 -178.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -59.37 -22.36 61.24 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.045 0.45 . . . . 0.0 111.738 178.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.43 ' HG2' ' O ' ' A' ' 158' ' ' SER . 32.8 ptt180 -73.49 -35.42 65.64 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.459 ' HA ' ' OE1' ' A' ' 165' ' ' GLN . 33.3 m -87.03 -29.11 22.18 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 124.244 1.018 . . . . 0.0 112.163 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 2.8 p -64.56 -27.08 41.76 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-O 121.752 0.787 . . . . 0.0 110.757 -176.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -82.94 -8.67 59.54 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.91 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.459 ' OE1' ' HA ' ' A' ' 162' ' ' THR . 51.0 mt-30 -98.42 0.42 45.26 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.665 -177.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 96.4 mt -68.43 131.54 91.66 Favored Pre-proline 0 C--N 1.312 -1.048 0 N-CA-C 108.876 -0.786 . . . . 0.0 108.876 178.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -61.36 128.72 25.77 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 121.843 1.696 . . . . 0.0 109.632 177.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 115.52 -30.12 6.87 Favored Glycine 0 N--CA 1.429 -1.773 0 C-N-CA 120.267 -0.968 . . . . 0.0 111.279 -178.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 84.5 t -66.2 -62.91 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 103.47 105.19 2.95 Favored Glycine 0 N--CA 1.427 -1.964 0 C-N-CA 120.575 -0.822 . . . . 0.0 112.164 178.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -81.29 -17.11 50.46 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -177.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 42.4 t -85.15 -37.84 12.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 CA-C-O 121.596 0.712 . . . . 0.0 109.3 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.509 ' O ' ' HG ' ' A' ' 177' ' ' LEU . 20.8 ptmt -88.72 -4.75 58.45 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.509 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -54.72 -48.89 94.24 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -178.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.485 ' O ' ' HG2' ' A' ' 179' ' ' GLN . 11.2 Cg_endo -57.27 -35.15 98.85 Favored 'Trans proline' 0 C--N 1.38 2.237 0 C-N-CA 121.715 1.61 . . . . 0.0 112.179 177.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 59.4 tp -69.31 -42.4 75.45 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.274 0.559 . . . . 0.0 109.54 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 173' ' ' LYS . 74.5 mt -69.47 -29.85 67.6 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.795 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 50.9 tp -70.73 -12.57 61.63 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.738 179.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' A' ' 175' ' ' PRO . 24.8 mm-40 -88.22 -13.77 40.2 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 176.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -99.33 -51.52 3.77 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 -179.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . 0.564 ' CD2' ' HG ' ' A' ' 187' ' ' LEU . 89.7 m-85 -94.24 148.85 35.8 Favored Pre-proline 0 C--N 1.307 -1.267 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.183 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -68.94 -31.29 24.66 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.053 1.835 . . . . 0.0 113.332 -175.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 66.5 m -158.56 161.84 37.32 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -62.01 -29.41 46.39 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.411 0 O-C-N 123.55 0.531 . . . . 0.0 112.024 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -62.54 -47.7 82.77 Favored 'General case' 0 C--O 1.211 -0.966 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.429 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -74.08 -31.18 62.72 Favored 'General case' 0 C--O 1.2 -1.528 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.564 ' HG ' ' CD2' ' A' ' 181' ' ' PHE . 4.5 tt -57.81 -59.91 4.5 Favored 'General case' 0 C--O 1.204 -1.301 0 C-N-CA 123.811 0.844 . . . . 0.0 109.561 -178.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 22.8 m -73.77 -24.72 59.89 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -178.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -86.98 1.99 50.95 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-O 121.516 0.674 . . . . 0.0 110.724 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.55 156.94 31.07 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 124.023 0.929 . . . . 0.0 111.373 175.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 5.0 m -64.49 159.72 20.91 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.249 -178.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 43.1 mm -52.67 -38.79 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 123.205 0.602 . . . . 0.0 111.449 -179.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . 0.487 ' O ' ' HG2' ' A' ' 197' ' ' GLN . . . -61.48 -43.65 99.04 Favored Glycine 0 C--O 1.214 -1.142 0 C-N-CA 120.853 -0.689 . . . . 0.0 111.908 178.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -67.47 -41.23 84.95 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.635 0.731 . . . . 0.0 109.575 -176.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 94.2 mt -70.47 -31.05 68.03 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.001 -0.999 . . . . 0.0 111.121 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . 0.517 ' HG2' ' N ' ' A' ' 201' ' ' GLN . 4.2 tm-20 -73.42 -41.01 63.81 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.487 ' HG2' ' O ' ' A' ' 193' ' ' GLY . 14.6 mm100 -57.66 -25.32 60.04 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 123.8 0.84 . . . . 0.0 112.369 178.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 14.6 m -103.52 -34.84 3.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.419 HG12 HG13 ' A' ' 203' ' ' VAL . 1.2 t -122.01 -77.43 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 C-N-CA 119.259 -0.976 . . . . 0.0 111.392 178.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -177.22 160.43 27.34 Favored Glycine 0 N--CA 1.435 -1.383 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 -176.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . 0.517 ' N ' ' HG2' ' A' ' 196' ' ' GLU . 4.0 pt20 -63.36 -38.05 89.64 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 123.624 0.77 . . . . 0.0 112.34 -176.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -74.86 -34.92 62.34 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 121.837 0.827 . . . . 0.0 109.672 -178.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.446 ' O ' ' HG2' ' A' ' 206' ' ' GLN . 24.8 t -68.53 -45.09 82.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-N 114.373 -1.285 . . . . 0.0 109.57 -179.397 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -53.51 -43.82 68.62 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 114.161 -1.381 . . . . 0.0 109.756 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -66.8 -44.98 79.84 Favored 'General case' 0 N--CA 1.421 -1.904 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.451 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . 0.446 ' HG2' ' O ' ' A' ' 203' ' ' VAL . 20.9 pt20 -66.09 -33.67 76.31 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.254 -0.578 . . . . 0.0 111.147 -178.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 84.7 mt -73.59 -50.19 31.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.561 177.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 28.0 t-80 -63.75 -46.99 82.81 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.997 -177.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -72.35 -9.96 59.18 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -178.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -64.13 -47.43 79.98 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 178.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -97.79 -29.44 13.36 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.647 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 33.4 m -77.97 -37.37 47.55 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -176.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -93.84 133.74 27.33 Favored Pre-proline 0 C--N 1.311 -1.08 0 C-N-CA 120.376 -0.53 . . . . 0.0 109.627 -176.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -51.16 159.97 2.41 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 123.981 3.121 . . . . 0.0 114.023 177.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 25.3 ptt180 . . . . . 0 C--N 1.296 -1.724 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.059 -176.17 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.9 m . . . . . 0 N--CA 1.422 -1.847 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -167.23 -56.44 0.03 OUTLIER 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.099 -176.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -79.33 131.24 66.16 Favored Pre-proline 0 C--N 1.313 -0.982 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.756 -175.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -65.03 109.55 1.33 Allowed 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.025 1.817 . . . . 0.0 109.711 176.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 58.2 tp -142.32 107.87 5.07 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-O 121.363 0.602 . . . . 0.0 109.952 -176.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 7.8 mp -89.06 104.8 17.32 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 115.058 -0.974 . . . . 0.0 108.47 176.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 147.76 -150.13 22.31 Favored Glycine 0 N--CA 1.424 -2.154 0 N-CA-C 108.425 -1.87 . . . . 0.0 108.425 -177.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -91.58 158.95 16.15 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 117.355 0.577 . . . . 0.0 111.147 179.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -76.03 96.3 3.78 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 121.492 0.663 . . . . 0.0 111.368 -175.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 44.7 ttm180 -125.93 103.92 8.02 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.442 178.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -86.46 101.08 12.83 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 121.286 0.565 . . . . 0.0 109.494 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 61.0 tp -129.86 121.17 26.18 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.45 ' H ' HD21 ' A' ' 153' ' ' LEU . 2.0 pt? -72.83 153.58 41.0 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.998 177.213 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 49.6 mt -105.74 111.72 24.5 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.6 176.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 42.3 p -80.77 101.51 9.38 Favored 'General case' 0 N--CA 1.417 -2.08 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 170.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -107.25 129.36 24.41 Favored Pre-proline 0 C--N 1.285 -2.234 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -89.9 23.44 0.7 Allowed 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 123.044 2.496 . . . . 0.0 108.441 168.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 19.8 m -72.25 103.88 3.51 Favored 'General case' 0 N--CA 1.414 -2.265 0 CA-C-N 114.048 -1.433 . . . . 0.0 110.866 -178.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -90.37 -22.15 21.63 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.574 177.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.414 ' O ' HG12 ' A' ' 163' ' ' VAL . 1.7 pt? -60.53 -32.63 71.66 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.281 0.562 . . . . 0.0 111.232 178.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -75.39 -30.14 60.03 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.036 177.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.59 ' O ' ' HG2' ' A' ' 165' ' ' GLN . 12.0 m -81.27 -37.99 27.58 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-O 121.457 0.646 . . . . 0.0 110.015 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.414 HG12 ' O ' ' A' ' 160' ' ' LEU . 1.7 p -63.55 -25.15 37.65 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.049 0 CA-C-O 121.479 0.657 . . . . 0.0 110.952 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . 0.445 HE21 HG13 ' A' ' 184' ' ' ILE . 3.4 pt20 -90.13 -11.64 40.64 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 122.015 -0.428 . . . . 0.0 110.9 178.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.59 ' HG2' ' O ' ' A' ' 162' ' ' THR . 18.9 pt20 -91.77 -6.02 52.54 Favored 'General case' 0 CA--C 1.505 -0.783 0 C-N-CA 119.303 -0.959 . . . . 0.0 111.168 -174.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 66.0 mt -61.19 133.51 92.84 Favored Pre-proline 0 C--N 1.298 -1.654 0 CA-C-N 114.823 -1.08 . . . . 0.0 109.481 -178.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -63.3 127.96 21.4 Favored 'Trans proline' 0 C--O 1.246 0.91 0 C-N-CA 122.022 1.815 . . . . 0.0 110.345 179.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 114.36 -32.82 5.71 Favored Glycine 0 N--CA 1.424 -2.126 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 -177.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 57.9 t -69.02 -53.01 28.27 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 177.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . 0.438 ' HA3' ' HG2' ' A' ' 173' ' ' LYS . . . 88.88 90.93 1.15 Allowed Glycine 0 N--CA 1.414 -2.779 0 CA-C-N 114.77 -1.105 . . . . 0.0 111.818 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -66.3 -23.18 66.33 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 120.776 0.322 . . . . 0.0 111.724 -178.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 47.2 t -86.53 -28.19 5.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-O 121.194 0.521 . . . . 0.0 110.281 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.557 ' O ' ' HG ' ' A' ' 177' ' ' LEU . 21.0 ptmt -91.29 9.26 32.18 Favored 'General case' 0 C--O 1.214 -0.764 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.707 178.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . 0.451 ' O ' ' HG ' ' A' ' 178' ' ' LEU . . . -52.07 -48.66 87.88 Favored Pre-proline 0 CA--C 1.556 1.2 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 177.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -59.99 -23.22 72.22 Favored 'Trans proline' 0 C--N 1.381 2.243 0 C-N-CA 122.401 2.067 . . . . 0.0 112.867 177.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.493 ' HB3' ' O ' ' A' ' 173' ' ' LYS . 51.0 tp -79.23 -21.05 46.77 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 123.683 0.793 . . . . 0.0 109.489 178.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.557 ' HG ' ' O ' ' A' ' 173' ' ' LYS . 39.7 mt -98.32 -34.46 10.68 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -178.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 174' ' ' ALA . 95.2 mt -66.82 -5.66 13.17 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.997 0.919 . . . . 0.0 112.732 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . 0.458 ' HG2' ' O ' ' A' ' 176' ' ' LEU . 16.1 pt20 -74.5 -35.02 63.2 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 172.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm -92.52 -51.43 5.13 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.138 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . 0.417 ' CD1' ' HA ' ' A' ' 187' ' ' LEU . 89.9 m-85 -90.27 144.36 30.9 Favored Pre-proline 0 C--N 1.304 -1.401 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.63 -176.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -69.78 -44.56 1.99 Allowed 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 121.851 1.701 . . . . 0.0 112.652 -175.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 45.4 m -152.38 167.84 27.4 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 178.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.445 HG13 HE21 ' A' ' 164' ' ' GLN . 0.2 OUTLIER -60.75 -31.76 50.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 N-CA-C 115.613 1.708 . . . . 0.0 115.613 -173.225 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -68.57 -45.92 70.78 Favored 'General case' 0 C--O 1.207 -1.15 0 C-N-CA 118.81 -1.156 . . . . 0.0 110.425 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -67.49 -32.8 73.87 Favored 'General case' 0 C--O 1.209 -1.059 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.417 ' HA ' ' CD1' ' A' ' 181' ' ' PHE . 3.6 tt -56.76 -62.6 1.62 Allowed 'General case' 0 C--O 1.213 -0.857 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.5 -179.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 29.5 m -70.87 -27.82 64.11 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -178.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.49 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 11.1 t-20 -81.03 -3.25 51.17 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-O 121.222 0.534 . . . . 0.0 110.511 -178.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.56 155.67 32.31 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 123.055 0.542 . . . . 0.0 110.79 177.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 20.6 t -68.09 170.65 8.08 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 121.262 0.553 . . . . 0.0 110.836 -175.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 47.7 mm -59.33 -39.61 79.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.55 -177.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . 0.549 ' O ' ' HG3' ' A' ' 197' ' ' GLN . . . -59.86 -38.62 94.31 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.305 178.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -77.82 -43.12 31.42 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -176.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 96.2 mt -67.6 -25.32 65.7 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.712 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 9.7 tm-20 -73.67 -31.7 63.59 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.549 ' HG3' ' O ' ' A' ' 193' ' ' GLY . 98.4 mt-30 -68.8 -20.29 64.32 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.913 -1.04 . . . . 0.0 111.702 -178.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 16.7 m -105.19 -33.32 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.74 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.023 177.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.401 HG11 HG12 ' A' ' 203' ' ' VAL . 1.7 t -124.64 -84.48 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 C-N-CA 120.338 -0.545 . . . . 0.0 111.504 176.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -177.91 168.95 40.66 Favored Glycine 0 N--CA 1.436 -1.331 0 N-CA-C 109.851 -1.299 . . . . 0.0 109.851 -176.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -59.14 -52.86 63.9 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.911 0.884 . . . . 0.0 112.628 -175.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -68.85 -35.39 76.88 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 121.45 0.643 . . . . 0.0 111.186 -173.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.401 HG12 HG11 ' A' ' 199' ' ' VAL . 2.2 t -72.57 -38.19 58.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -178.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -57.85 -44.11 86.34 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 114.347 -1.297 . . . . 0.0 109.844 178.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -64.42 -42.78 95.86 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.886 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -74.56 -25.02 59.02 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.417 -0.513 . . . . 0.0 112.239 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 98.2 mt -76.4 -49.43 24.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 174.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 53.3 t-80 -63.44 -47.36 82.2 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.003 -178.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -65.74 -20.07 66.13 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -179.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -59.05 -44.13 91.76 Favored 'General case' 0 C--O 1.214 -0.792 0 C-N-CA 122.799 0.439 . . . . 0.0 110.613 -178.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.49 ' CZ ' ' HA ' ' A' ' 189' ' ' ASN . 31.6 p90 -99.4 -25.73 14.37 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.672 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 37.5 m -74.63 -35.77 62.9 Favored 'General case' 0 C--N 1.313 -1.022 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -178.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 59.0 tp60 -108.41 119.62 49.0 Favored Pre-proline 0 N--CA 1.434 -1.26 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 -177.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -67.22 170.03 14.09 Favored 'Trans proline' 0 C--O 1.243 0.742 0 C-N-CA 122.604 2.202 . . . . 0.0 113.141 178.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . 0.455 ' N ' ' HD2' ' A' ' 215' ' ' ARG . 2.4 mpt_? . . . . . 0 C--O 1.26 1.609 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.147 -177.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 9.1 p . . . . . 0 N--CA 1.427 -1.614 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -96.32 148.02 23.19 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 178.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -91.09 132.57 33.87 Favored Pre-proline 0 C--N 1.292 -1.9 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -178.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -74.25 93.24 0.9 Allowed 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 121.872 1.715 . . . . 0.0 112.994 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 11.1 mp -86.5 -23.72 25.83 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.244 174.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 60.7 tp -55.03 124.41 16.72 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 123.867 0.867 . . . . 0.0 111.801 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -168.85 -174.46 37.48 Favored Glycine 0 N--CA 1.428 -1.865 0 N-CA-C 108.117 -1.993 . . . . 0.0 108.117 178.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -89.28 93.28 9.49 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 118.232 1.016 . . . . 0.0 110.111 178.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -92.03 111.92 23.65 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 178.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 76.7 mtp180 -72.73 103.81 3.75 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -108.29 101.63 10.82 Favored 'General case' 0 CA--C 1.481 -1.696 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 -176.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 95.7 mt -118.5 101.12 7.91 Favored 'General case' 0 C--N 1.276 -2.628 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.473 -173.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 26.1 tp -94.12 128.99 40.84 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 178.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.541 ' O ' HD11 ' A' ' 154' ' ' LEU . 4.7 pp -84.01 106.24 15.52 Favored 'General case' 0 N--CA 1.432 -1.346 0 C-N-CA 119.083 -1.047 . . . . 0.0 111.089 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 40.0 m -114.5 133.75 55.54 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 175.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -96.99 107.03 35.04 Favored Pre-proline 0 C--N 1.303 -1.454 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -177.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -69.24 -45.04 2.04 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.431 2.087 . . . . 0.0 113.245 -175.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 48.4 t -102.32 108.46 19.82 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-O 120.796 0.331 . . . . 0.0 110.582 -176.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -93.94 -27.37 16.4 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 173.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.512 ' O ' HG11 ' A' ' 163' ' ' VAL . 1.6 pt? -60.38 -23.79 64.59 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.267 -0.879 . . . . 0.0 112.118 178.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.402 ' O ' ' HG2' ' A' ' 164' ' ' GLN . 14.3 ptm180 -65.87 -29.36 69.79 Favored 'General case' 0 C--O 1.215 -0.744 0 CA-C-O 120.92 0.39 . . . . 0.0 110.115 176.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 37.9 m -86.55 -31.75 21.06 Favored 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 123.025 0.53 . . . . 0.0 111.39 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.512 HG11 ' O ' ' A' ' 160' ' ' LEU . 2.5 p -64.52 -25.66 38.43 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.115 0 CA-C-O 121.418 0.627 . . . . 0.0 111.372 -176.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . 0.402 ' HG2' ' O ' ' A' ' 161' ' ' ARG . 29.5 pt20 -81.32 -13.01 58.87 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 121.161 0.505 . . . . 0.0 110.459 177.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -95.38 -0.05 53.0 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.545 -175.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 81.2 mt -66.14 132.42 94.53 Favored Pre-proline 0 C--N 1.317 -0.837 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.28 128.16 26.54 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.096 1.864 . . . . 0.0 111.006 178.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 112.65 -29.91 7.87 Favored Glycine 0 N--CA 1.425 -2.096 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 -178.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 59.1 t -73.25 -65.74 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 101.97 110.55 3.38 Favored Glycine 0 N--CA 1.43 -1.737 0 C-N-CA 120.314 -0.946 . . . . 0.0 112.799 177.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -82.66 -18.88 39.47 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.4 0.619 . . . . 0.0 111.597 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 62.7 t -84.13 -30.35 7.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 CA-C-O 121.819 0.819 . . . . 0.0 109.27 177.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -90.34 -4.17 57.27 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.372 178.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . 0.493 ' O ' ' HG ' ' A' ' 178' ' ' LEU . . . -55.07 -47.16 99.19 Favored Pre-proline 0 C--O 1.202 -1.403 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -178.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.435 ' O ' ' HG3' ' A' ' 179' ' ' GLN . 36.2 Cg_exo -59.82 -36.99 89.33 Favored 'Trans proline' 0 C--N 1.381 2.243 0 CA-C-N 121.337 1.513 . . . . 0.0 111.234 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 57.2 tp -66.97 -44.64 79.96 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.665 176.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 96.3 mt -65.33 -32.25 73.79 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.027 178.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 174' ' ' ALA . 88.7 mt -72.44 -7.32 49.24 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 123.4 0.68 . . . . 0.0 111.774 178.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . 0.435 ' HG3' ' O ' ' A' ' 175' ' ' PRO . 52.6 mt-30 -95.65 -9.31 32.39 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.386 0.612 . . . . 0.0 109.356 174.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -105.18 -51.42 3.03 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . 0.421 ' CD2' ' HG ' ' A' ' 187' ' ' LEU . 86.4 m-85 -99.69 149.46 35.93 Favored Pre-proline 0 C--N 1.294 -1.837 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -66.99 -46.11 3.47 Favored 'Trans proline' 0 C--O 1.24 0.601 0 C-N-CA 121.439 1.426 . . . . 0.0 112.13 -175.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 30.0 m -151.33 167.79 26.81 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -60.67 -29.86 45.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 -174.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 56.8 tp60 -70.82 -39.13 73.23 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 119.731 -0.788 . . . . 0.0 110.384 -176.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -76.06 -32.23 59.18 Favored 'General case' 0 C--O 1.197 -1.66 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 178.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.421 ' HG ' ' CD2' ' A' ' 181' ' ' PHE . 3.8 tt -56.53 -61.26 2.54 Favored 'General case' 0 C--O 1.212 -0.906 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.717 -178.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 19.8 m -70.26 -32.16 69.87 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 120.641 -0.423 . . . . 0.0 111.88 -178.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.402 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 7.9 t30 -83.96 4.72 28.47 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-O 121.566 0.698 . . . . 0.0 110.839 -177.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.46 156.16 33.26 Favored 'General case' 0 C--O 1.248 1.004 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.414 174.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 2.6 m -63.58 159.48 18.74 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.987 -176.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 50.8 mm -53.09 -36.25 24.45 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.963 0 C-N-CA 122.917 0.487 . . . . 0.0 111.537 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -69.47 -28.92 71.9 Favored Glycine 0 C--N 1.314 -0.66 0 C-N-CA 121.222 -0.513 . . . . 0.0 112.903 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . 0.671 ' O ' ' HG2' ' A' ' 197' ' ' GLN . 26.2 mt-10 -81.29 -31.28 33.69 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -178.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 97.3 mt -79.33 -29.45 42.32 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.409 175.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . 0.524 ' HG2' ' N ' ' A' ' 201' ' ' GLN . 2.6 tm-20 -69.59 -35.61 75.48 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -178.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.671 ' HG2' ' O ' ' A' ' 194' ' ' GLU . 20.3 pt20 -67.19 -20.86 65.78 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.412 -176.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 15.7 m -104.6 -31.19 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -127.32 -83.41 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 173.135 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -177.21 164.07 33.14 Favored Glycine 0 CA--C 1.488 -1.602 0 N-CA-C 108.027 -2.029 . . . . 0.0 108.027 -176.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . 0.524 ' N ' ' HG2' ' A' ' 196' ' ' GLU . 12.1 pt20 -69.68 -38.59 77.08 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 118.239 1.02 . . . . 0.0 111.778 -176.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -64.25 -28.86 70.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.644 0.735 . . . . 0.0 110.561 -179.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 3.1 t -81.17 -43.09 20.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 178.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -56.44 -46.03 80.51 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.209 -1.36 . . . . 0.0 110.946 -178.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -60.74 -44.82 96.19 Favored 'General case' 0 C--O 1.199 -1.588 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.599 -178.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -73.63 -33.22 64.43 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.528 -178.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 92.5 mt -66.37 -49.56 74.64 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.241 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 175.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' HIS . . . . . 0.523 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 9.9 t60 -68.68 -39.2 80.68 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.829 -176.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -65.44 -29.12 69.77 Favored 'General case' 0 C--O 1.219 -0.523 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 177.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -54.27 -47.69 72.05 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.208 0.603 . . . . 0.0 111.912 -176.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.523 ' CZ ' ' HA ' ' A' ' 208' ' ' HIS . 19.9 p90 -93.6 -22.16 18.96 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.096 -178.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 80.6 m -75.59 -34.65 60.65 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.198 179.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -81.68 134.28 50.96 Favored Pre-proline 0 C--N 1.313 -1.01 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 174.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_exo -50.15 159.61 1.78 Allowed 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.803 3.002 . . . . 0.0 114.162 -178.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 . . . . . 0 C--N 1.289 -2.04 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.581 179.821 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 25.7 t . . . . . 0 N--CA 1.428 -1.546 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -119.37 13.14 12.66 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.542 0.687 . . . . 0.0 110.586 -179.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -140.14 121.76 9.6 Favored Pre-proline 0 C--N 1.302 -1.467 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 177.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -49.5 111.04 0.43 Allowed 'Trans proline' 0 C--O 1.245 0.854 0 C-N-CA 123.107 2.538 . . . . 0.0 113.16 178.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 61.5 tp -136.92 -53.8 0.71 Allowed 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 177.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.453 ' H ' HD11 ' A' ' 146' ' ' LEU . 0.0 OUTLIER -101.6 172.27 7.06 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.009 -0.996 . . . . 0.0 108.7 174.186 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 169.75 -151.75 17.81 Favored Glycine 0 N--CA 1.433 -1.513 0 C-N-CA 120.031 -1.081 . . . . 0.0 111.662 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -124.51 143.43 50.67 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -178.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -71.26 136.21 47.84 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 120.99 0.424 . . . . 0.0 110.559 178.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 4.1 tpm_? -82.25 94.53 7.33 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 175.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -52.74 113.39 1.06 Allowed 'General case' 0 CA--C 1.501 -0.936 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.138 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 53.5 tp -132.35 96.22 3.81 Favored 'General case' 0 N--CA 1.416 -2.169 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.481 -175.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -140.74 164.6 29.77 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 177.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -70.07 91.64 0.7 Allowed 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 177.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 15.3 m -94.77 103.06 14.96 Favored 'General case' 0 N--CA 1.415 -2.223 0 CA-C-N 114.557 -1.202 . . . . 0.0 111.764 -174.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -109.73 165.76 12.04 Favored Pre-proline 0 C--N 1.288 -2.089 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 170.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -59.25 95.43 0.09 OUTLIER 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 121.818 1.678 . . . . 0.0 109.799 174.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 47.3 t -164.32 89.69 0.54 Allowed 'General case' 0 N--CA 1.419 -2.02 0 C-N-CA 124.058 0.943 . . . . 0.0 108.816 -175.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 41.7 tp -94.08 -19.81 20.49 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 174.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.408 ' O ' HG13 ' A' ' 163' ' ' VAL . 2.4 pt? -60.75 -29.84 69.63 Favored 'General case' 0 C--O 1.225 -0.193 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.789 -178.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -63.07 -37.44 87.22 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.52 177.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 15.0 m -86.32 -31.95 21.29 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.183 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.408 HG13 ' O ' ' A' ' 160' ' ' LEU . 0.7 OUTLIER -62.96 -25.91 39.68 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.928 0 CA-C-O 121.587 0.708 . . . . 0.0 111.556 -176.597 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . 0.455 ' HG3' HE21 ' A' ' 165' ' ' GLN . 28.9 pt20 -85.99 -8.02 58.25 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.15 0.5 . . . . 0.0 110.732 178.008 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.455 HE21 ' HG3' ' A' ' 164' ' ' GLN . 29.0 mm-40 -97.49 -0.16 46.53 Favored 'General case' 0 C--O 1.238 0.476 0 O-C-N 122.249 -0.282 . . . . 0.0 110.873 -177.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 92.1 mt -62.1 129.68 92.23 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -62.71 127.44 20.64 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 121.603 1.535 . . . . 0.0 110.619 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 115.56 -29.95 6.95 Favored Glycine 0 N--CA 1.424 -2.138 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.646 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 93.2 t -58.15 -60.27 2.45 Favored 'Isoleucine or valine' 0 C--O 1.245 0.847 0 CA-C-O 120.954 0.407 . . . . 0.0 110.94 -179.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 93.89 85.87 1.62 Allowed Glycine 0 N--CA 1.431 -1.647 0 C-N-CA 120.331 -0.938 . . . . 0.0 110.983 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -68.62 -12.03 60.82 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.668 0.746 . . . . 0.0 111.916 -176.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 42.1 t -71.73 -28.58 31.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 176.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.602 ' O ' ' HG ' ' A' ' 177' ' ' LEU . 47.1 mtmt -87.37 0.19 55.83 Favored 'General case' 0 C--O 1.208 -1.098 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.308 -179.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . 0.47 ' O ' ' HG ' ' A' ' 178' ' ' LEU . . . -46.73 -53.06 27.82 Favored Pre-proline 0 N--CA 1.483 1.206 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 -174.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.417 ' O ' ' HG2' ' A' ' 179' ' ' GLN . 32.2 Cg_exo -60.07 -43.41 36.31 Favored 'Trans proline' 0 C--N 1.373 1.831 0 C-N-CA 121.569 1.512 . . . . 0.0 111.379 179.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 49.2 tp -60.83 -45.55 94.02 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.918 177.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.602 ' HG ' ' O ' ' A' ' 173' ' ' LYS . 91.6 mt -61.62 -41.72 97.87 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.173 178.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 174' ' ' ALA . 90.8 mt -68.95 -8.39 44.02 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . 0.417 ' HG2' ' O ' ' A' ' 175' ' ' PRO . 29.5 mm-40 -80.6 -21.14 41.86 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.374 0.607 . . . . 0.0 110.011 175.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 8.2 mmmm -106.51 -45.01 4.35 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.801 177.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . 0.439 ' O ' ' HA ' ' A' ' 178' ' ' LEU . 32.3 m-85 -103.42 132.31 21.21 Favored Pre-proline 0 N--CA 1.424 -1.769 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -176.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -62.31 -35.76 71.63 Favored 'Trans proline' 0 CA--C 1.51 -0.695 0 C-N-CA 122.839 2.359 . . . . 0.0 112.803 -172.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 59.3 m -153.46 160.21 42.51 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.474 ' O ' ' HB3' ' A' ' 187' ' ' LEU . 0.2 OUTLIER -60.02 -23.14 26.19 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.5 0 O-C-N 123.926 0.766 . . . . 0.0 112.905 -178.335 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -66.23 -47.2 74.59 Favored 'General case' 0 C--O 1.215 -0.715 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -77.33 -29.04 53.34 Favored 'General case' 0 C--O 1.19 -2.051 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -178.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.474 ' HB3' ' O ' ' A' ' 184' ' ' ILE . 41.2 tp -51.57 -64.14 0.91 Allowed 'General case' 0 C--O 1.204 -1.329 0 C-N-CA 124.351 1.06 . . . . 0.0 111.63 177.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 20.0 m -69.23 -24.43 64.01 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.402 0.62 . . . . 0.0 111.454 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -85.97 1.37 50.38 Favored 'General case' 0 C--O 1.244 0.816 0 CA-C-O 122.042 0.925 . . . . 0.0 111.194 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -67.85 157.05 35.75 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.218 177.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 15.0 m -63.3 153.72 33.98 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.568 -179.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 51.1 mm -57.87 -34.32 48.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.117 -176.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . 0.416 ' O ' ' HG3' ' A' ' 197' ' ' GLN . . . -62.19 -36.41 92.95 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 116.095 -0.502 . . . . 0.0 112.477 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . 0.501 ' O ' ' HB2' ' A' ' 197' ' ' GLN . 55.4 mm-40 -77.66 -41.64 37.51 Favored 'General case' 0 CA--C 1.498 -1.043 0 CA-C-O 121.62 0.724 . . . . 0.0 109.915 -178.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.436 HD21 ' O ' ' A' ' 187' ' ' LEU . 97.5 mt -67.64 -32.24 72.79 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.131 -0.941 . . . . 0.0 111.074 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . 0.524 ' HG2' ' N ' ' A' ' 201' ' ' GLN . 4.6 tm-20 -66.44 -30.15 70.45 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -178.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.501 ' HB2' ' O ' ' A' ' 194' ' ' GLU . 69.6 mt-30 -60.16 -37.27 79.62 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.652 -1.158 . . . . 0.0 111.376 178.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 30.0 m -103.66 -31.04 2.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -175.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.508 HG21 ' H ' ' A' ' 200' ' ' GLY . 6.5 m -115.34 -85.67 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 176.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . 0.508 ' H ' HG21 ' A' ' 199' ' ' VAL . . . -178.74 166.25 35.87 Favored Glycine 0 N--CA 1.408 -3.225 0 N-CA-C 108.413 -1.875 . . . . 0.0 108.413 -177.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . 0.524 ' N ' ' HG2' ' A' ' 196' ' ' GLU . 0.4 OUTLIER -62.64 -51.38 67.49 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 123.827 0.851 . . . . 0.0 109.122 -179.344 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -72.73 -26.73 61.68 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.066 -176.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 3.4 t -76.44 -42.83 36.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -56.29 -43.54 78.98 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.241 -1.345 . . . . 0.0 109.902 179.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -54.89 -53.79 50.87 Favored 'General case' 0 N--CA 1.436 -1.16 0 C-N-CA 124.218 1.007 . . . . 0.0 111.964 177.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -69.87 -28.87 66.01 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 119.826 -0.749 . . . . 0.0 111.903 -176.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 98.6 mt -71.78 -48.73 49.84 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-N 116.22 -0.446 . . . . 0.0 109.873 177.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 10.4 t60 -70.96 -40.0 72.23 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -176.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -66.51 -25.55 66.74 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 178.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -53.65 -47.52 70.27 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.069 0.948 . . . . 0.0 112.285 -175.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -93.35 -23.59 18.4 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.694 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 62.8 m -70.58 -48.15 56.66 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.241 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -82.01 117.5 68.56 Favored Pre-proline 0 C--N 1.316 -0.886 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.304 -178.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_exo -54.38 124.34 15.83 Favored 'Trans proline' 0 C--O 1.246 0.901 0 C-N-CA 123.722 2.948 . . . . 0.0 112.89 178.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 69.9 mtp180 . . . . . 0 C--N 1.278 -2.514 0 CA-C-N 114.316 -1.311 . . . . 0.0 109.061 -178.644 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 16.8 m . . . . . 0 N--CA 1.443 -0.803 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -88.13 -17.76 30.29 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 120.661 -0.416 . . . . 0.0 111.903 -175.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -140.73 151.32 62.8 Favored Pre-proline 0 C--N 1.302 -1.481 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 177.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -80.75 79.71 3.24 Favored 'Trans proline' 0 N--CA 1.429 -2.296 0 C-N-CA 121.507 1.471 . . . . 0.0 110.434 174.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 38.2 tp -86.93 76.11 9.46 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 178.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 82.7 mt -106.99 159.01 16.6 Favored 'General case' 0 N--CA 1.418 -2.072 0 CA-C-N 113.962 -1.472 . . . . 0.0 109.266 -176.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 91.63 146.86 18.91 Favored Glycine 0 N--CA 1.423 -2.189 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -174.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -130.72 97.79 4.45 Favored 'General case' 0 C--N 1.284 -2.278 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -142.08 119.84 11.88 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 120.783 0.325 . . . . 0.0 110.161 178.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 44.9 ttp180 -98.29 104.23 16.24 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 177.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -110.76 101.5 10.12 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 -176.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 94.3 mt -128.43 97.98 4.9 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.593 -176.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -102.85 124.75 48.95 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 177.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 5.5 tt -98.36 92.75 5.84 Favored 'General case' 0 N--CA 1.422 -1.852 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 5.1 p -89.6 144.3 26.12 Favored 'General case' 0 C--N 1.285 -2.197 0 CA-C-N 114.946 -1.025 . . . . 0.0 109.028 174.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.409 ' OE2' ' HD2' ' A' ' 157' ' ' PRO . 11.1 tp10 -84.32 116.24 64.07 Favored Pre-proline 0 C--N 1.305 -1.348 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -177.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.409 ' HD2' ' OE2' ' A' ' 156' ' ' GLU . 75.4 Cg_endo -84.92 171.94 9.06 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.772 2.315 . . . . 0.0 112.983 -177.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 26.4 t 62.37 84.93 0.13 Allowed 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 124.884 1.273 . . . . 0.0 111.879 179.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -77.61 -31.42 52.91 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 177.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.6 pp -59.51 -27.51 66.23 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 123.944 0.898 . . . . 0.0 111.917 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 11.4 ptt180 -67.57 -37.8 83.16 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -178.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 25.0 m -86.5 -31.6 21.21 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.21 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.36 -26.23 40.32 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 CA-C-O 121.609 0.719 . . . . 0.0 111.358 -177.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -86.54 -8.01 57.89 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.591 177.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -105.3 21.19 17.59 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 -176.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.438 HG12 ' CD1' ' A' ' 210' ' ' PHE . 75.0 mt -78.93 125.93 83.08 Favored Pre-proline 0 C--N 1.31 -1.116 0 CA-C-N 116.297 -0.411 . . . . 0.0 109.961 -178.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -66.6 130.84 24.47 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.208 1.939 . . . . 0.0 110.073 176.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 120.21 -35.16 3.87 Favored Glycine 0 C--N 1.292 -1.88 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 -177.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 95.5 t -60.45 -52.56 60.0 Favored 'Isoleucine or valine' 0 C--O 1.246 0.875 0 CA-C-O 121.376 0.608 . . . . 0.0 110.052 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 99.68 99.77 2.26 Favored Glycine 0 N--CA 1.425 -2.09 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -177.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -63.32 -29.81 71.06 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 120.969 0.414 . . . . 0.0 111.491 -176.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 60.9 t -83.19 -26.52 7.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-O 121.513 0.673 . . . . 0.0 110.148 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.432 ' HZ2' HG13 ' A' ' 199' ' ' VAL . 37.3 ttpt -92.45 -5.8 51.21 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 120.443 -0.503 . . . . 0.0 109.808 -178.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -53.4 -49.9 85.78 Favored Pre-proline 0 CA--C 1.553 1.085 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -177.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -57.52 -30.1 87.17 Favored 'Trans proline' 0 C--N 1.384 2.399 0 C-N-CA 121.961 1.774 . . . . 0.0 112.562 176.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.417 ' HB3' ' O ' ' A' ' 173' ' ' LYS . 54.0 tp -70.22 -39.8 74.89 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 121.469 0.652 . . . . 0.0 109.604 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 9.5 mp -72.52 -32.68 66.32 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.174 178.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 42.7 tp -68.93 -8.84 48.1 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.005 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -82.96 -23.27 33.49 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 174.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm -93.37 -49.67 5.83 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.497 0.665 . . . . 0.0 109.736 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . 0.551 ' CD2' HD23 ' A' ' 187' ' ' LEU . 64.5 m-85 -95.14 143.0 25.38 Favored Pre-proline 0 C--N 1.304 -1.37 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.642 -176.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -66.36 -39.19 17.9 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.37 2.047 . . . . 0.0 113.867 -174.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 58.8 m -157.0 164.51 37.93 Favored 'General case' 0 C--O 1.247 0.938 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.409 ' HA ' ' CB ' ' A' ' 187' ' ' LEU . 0.2 OUTLIER -56.36 -29.66 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 -176.194 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -62.66 -45.83 91.02 Favored 'General case' 0 C--O 1.217 -0.636 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.328 178.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -78.78 -28.84 44.76 Favored 'General case' 0 C--O 1.201 -1.462 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -177.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.551 HD23 ' CD2' ' A' ' 181' ' ' PHE . 0.3 OUTLIER -51.71 -67.65 0.23 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.263 1.425 . . . . 0.0 109.541 -179.629 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 17.0 m -73.09 -27.17 61.55 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.048 -176.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -81.59 1.31 34.39 Favored 'General case' 0 C--O 1.253 1.241 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.32 154.98 36.7 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 121.601 0.715 . . . . 0.0 110.684 174.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 3.5 m -68.95 163.11 25.25 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.702 -177.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.4 mm -53.56 -41.2 45.05 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.184 0 C-N-CA 123.105 0.562 . . . . 0.0 111.056 -178.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . 0.488 ' O ' ' HG3' ' A' ' 197' ' ' GLN . . . -63.84 -38.94 96.86 Favored Glycine 0 CA--C 1.522 0.497 0 O-C-N 123.395 0.434 . . . . 0.0 112.675 179.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . 0.434 ' O ' ' HB2' ' A' ' 197' ' ' GLN . 29.7 mt-10 -73.11 -38.21 66.42 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -177.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 95.8 mt -72.93 -30.4 63.86 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.539 177.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . 0.471 ' HG2' ' N ' ' A' ' 201' ' ' GLN . 5.6 tm-20 -63.88 -37.5 87.63 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.488 ' HG3' ' O ' ' A' ' 193' ' ' GLY . 29.2 mt-30 -54.82 -35.02 63.49 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.571 -1.195 . . . . 0.0 112.123 177.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 10.0 m -102.11 -35.08 3.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -175.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.532 HG21 ' H ' ' A' ' 200' ' ' GLY . 5.1 m -116.14 -83.2 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 176.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . 0.532 ' H ' HG21 ' A' ' 199' ' ' VAL . . . -178.86 162.55 29.66 Favored Glycine 0 N--CA 1.417 -2.593 0 N-CA-C 107.364 -2.295 . . . . 0.0 107.364 -177.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . 0.471 ' N ' ' HG2' ' A' ' 196' ' ' GLU . 9.6 pt20 -66.93 -36.29 81.91 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 118.834 1.317 . . . . 0.0 111.587 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -67.31 -41.07 85.93 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.403 0.62 . . . . 0.0 110.52 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 2.7 t -72.56 -39.17 61.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-O 121.864 0.84 . . . . 0.0 109.015 -177.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -54.64 -40.57 69.11 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 113.856 -1.52 . . . . 0.0 110.751 -178.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . 0.432 ' HG3' ' O ' ' A' ' 201' ' ' GLN . 26.6 mt-30 -61.92 -48.46 80.33 Favored 'General case' 0 N--CA 1.422 -1.84 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.674 -179.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 23.1 pt20 -70.6 -32.71 70.16 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 119.112 -1.035 . . . . 0.0 111.224 -178.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' ILE . . . . . 0.412 ' HA ' HG21 ' A' ' 166' ' ' ILE . 91.6 mt -66.44 -50.78 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 O-C-N 123.531 0.519 . . . . 0.0 110.091 178.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 11.7 t60 -69.42 -39.87 77.63 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.787 -177.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -66.28 -25.67 66.97 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 178.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . 0.438 ' CD1' HG12 ' A' ' 166' ' ' ILE . 57.4 t80 -52.33 -57.44 9.77 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.447 0.699 . . . . 0.0 112.282 -176.058 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -79.66 -24.66 41.67 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.508 -177.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 77.3 m -64.49 -38.45 91.05 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.046 178.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -76.85 125.64 86.78 Favored Pre-proline 0 C--N 1.309 -1.193 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 176.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -74.08 157.11 46.94 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 122.192 1.928 . . . . 0.0 110.063 178.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 7.5 tpt180 . . . . . 0 C--N 1.292 -1.893 0 C-N-CA 119.956 -0.697 . . . . 0.0 109.421 -176.62 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 18.5 p . . . . . 0 N--CA 1.429 -1.484 0 CA-C-O 120.548 0.213 . . . . 0.0 110.573 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -97.78 155.14 17.17 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 174.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -82.2 150.9 65.42 Favored Pre-proline 0 C--N 1.308 -1.21 0 CA-C-O 121.015 0.436 . . . . 0.0 112.064 -173.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -75.99 110.8 3.15 Favored 'Trans proline' 0 N--CA 1.445 -1.348 0 C-N-CA 122.687 2.258 . . . . 0.0 111.265 174.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 96.6 mt -77.63 -39.14 46.22 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 115.3 -0.863 . . . . 0.0 108.696 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 7.4 mp -82.96 105.11 13.69 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 115.193 -0.912 . . . . 0.0 108.985 177.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -163.41 167.53 37.68 Favored Glycine 0 N--CA 1.42 -2.415 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -83.22 96.42 8.44 Favored 'General case' 0 C--N 1.289 -2.023 0 C-N-CA 122.71 0.404 . . . . 0.0 111.41 -176.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 43.7 mmtm -88.87 100.51 13.23 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 174.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 10.6 tpp180 -75.46 98.81 4.01 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 121.167 0.508 . . . . 0.0 110.139 -175.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -136.16 102.38 4.99 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 86.4 mt -123.39 125.04 44.25 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.55 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 6.5 tt -132.87 124.53 28.09 Favored 'General case' 0 C--N 1.287 -2.124 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.72 77.13 0.3 Allowed 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 122.567 1.175 . . . . 0.0 112.701 178.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 11.2 p -80.19 124.61 28.95 Favored 'General case' 0 N--CA 1.417 -2.114 0 CA-C-N 114.823 -1.08 . . . . 0.0 111.992 -173.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -73.38 142.25 81.32 Favored Pre-proline 0 N--CA 1.424 -1.734 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 173.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -75.22 45.05 1.31 Allowed 'Trans proline' 0 CA--C 1.532 0.398 0 C-N-CA 123.237 2.625 . . . . 0.0 113.294 -176.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.499 ' O ' ' HG2' ' A' ' 161' ' ' ARG . 6.2 p -103.02 35.14 2.62 Favored 'General case' 0 C--N 1.295 -1.774 0 C-N-CA 123.524 0.73 . . . . 0.0 110.637 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -89.63 -37.28 14.76 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.451 ' O ' HG13 ' A' ' 163' ' ' VAL . 1.6 pt? -60.79 -28.68 68.94 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.357 -177.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.499 ' HG2' ' O ' ' A' ' 158' ' ' SER . 35.9 ptt180 -65.07 -34.45 78.45 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-O 121.327 0.584 . . . . 0.0 109.488 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 24.7 m -86.69 -33.45 20.04 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.183 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.451 HG13 ' O ' ' A' ' 160' ' ' LEU . 0.9 OUTLIER -62.22 -26.18 39.55 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 CA-C-O 121.701 0.762 . . . . 0.0 111.68 -174.908 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -81.08 -10.6 59.65 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.805 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -104.74 12.4 32.82 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.265 0.555 . . . . 0.0 110.942 -174.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.406 HG21 ' HA ' ' A' ' 207' ' ' ILE . 83.7 mt -78.51 142.68 62.49 Favored Pre-proline 0 C--N 1.31 -1.145 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.137 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.28 128.39 26.12 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.225 1.95 . . . . 0.0 110.935 174.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 113.71 -31.02 6.82 Favored Glycine 0 N--CA 1.435 -1.43 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 -178.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 60.9 t -72.68 -64.36 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 178.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 98.95 133.23 7.99 Favored Glycine 0 N--CA 1.438 -1.177 0 C-N-CA 120.299 -0.953 . . . . 0.0 113.443 175.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 54.9 pttt -89.07 -25.53 21.87 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.348 0.594 . . . . 0.0 110.926 177.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 61.7 t -84.8 -32.11 7.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 178.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -81.09 -14.26 57.94 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 114.331 -1.304 . . . . 0.0 109.079 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -52.03 -53.93 46.49 Favored Pre-proline 0 N--CA 1.476 0.841 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 -174.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.514 ' O ' ' HG2' ' A' ' 179' ' ' GLN . 19.1 Cg_endo -60.33 -33.75 94.15 Favored 'Trans proline' 0 C--N 1.377 2.077 0 C-N-CA 121.198 1.266 . . . . 0.0 112.232 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 60.9 tp -70.87 -39.32 72.95 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.574 178.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.502 ' CD2' HG11 ' A' ' 198' ' ' VAL . 93.9 mt -64.18 -36.91 85.61 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.085 177.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 97.7 mt -72.35 -9.56 58.66 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.63 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . 0.514 ' HG2' ' O ' ' A' ' 175' ' ' PRO . 11.8 mm-40 -82.57 -19.25 38.86 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 176.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm -104.75 -51.21 3.11 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.687 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -102.68 142.98 25.67 Favored Pre-proline 0 C--N 1.303 -1.449 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -175.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -60.99 -41.81 41.62 Favored 'Trans proline' 0 C--N 1.356 0.959 0 C-N-CA 122.663 2.242 . . . . 0.0 112.321 -172.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 59.6 m -154.45 169.4 23.85 Favored 'General case' 0 N--CA 1.421 -1.92 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 177.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.413 ' HA ' ' HB3' ' A' ' 187' ' ' LEU . 0.2 OUTLIER -63.15 -20.5 26.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 -174.931 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -73.91 -44.31 55.61 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.172 -177.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -78.9 -26.53 43.81 Favored 'General case' 0 C--O 1.2 -1.529 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 178.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.413 ' HB3' ' HA ' ' A' ' 184' ' ' ILE . 54.6 tp -56.21 -56.41 21.34 Favored 'General case' 0 C--O 1.207 -1.156 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.726 177.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 23.2 p -72.76 -31.21 64.74 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.929 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -84.11 6.39 22.51 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 121.521 0.677 . . . . 0.0 111.317 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.3 155.58 34.79 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.029 173.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' SER . . . . . 0.442 ' OG ' ' HG3' ' A' ' 194' ' ' GLU . 10.2 p -63.95 156.83 26.62 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.811 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 48.7 mm -52.29 -36.2 20.84 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.948 0 C-N-CA 123.244 0.618 . . . . 0.0 110.374 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -59.33 -41.33 96.85 Favored Glycine 0 N--CA 1.442 -0.904 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.629 177.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . 0.522 ' O ' ' HG2' ' A' ' 197' ' ' GLN . 30.1 mt-10 -77.62 -35.72 52.38 Favored 'General case' 0 C--O 1.206 -1.217 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -177.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 96.1 mt -74.37 -24.56 59.17 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.803 0.811 . . . . 0.0 110.291 178.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -74.07 -24.15 59.46 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.847 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.522 ' HG2' ' O ' ' A' ' 194' ' ' GLU . 4.9 pt20 -67.03 -29.91 69.85 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -177.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.502 HG11 ' CD2' ' A' ' 177' ' ' LEU . 13.4 m -99.1 -21.2 5.22 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.947 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.687 -174.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -139.23 -84.22 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 173.214 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -178.29 171.94 44.35 Favored Glycine 0 N--CA 1.431 -1.643 0 N-CA-C 108.514 -1.834 . . . . 0.0 108.514 -173.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -69.06 -42.41 76.29 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 117.886 0.843 . . . . 0.0 112.024 -177.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -68.26 -31.54 71.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.629 0.728 . . . . 0.0 110.69 -177.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 2.1 t -77.75 -40.08 27.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -179.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -57.45 -39.72 76.91 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 114.616 -1.175 . . . . 0.0 109.844 177.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -59.69 -46.71 88.24 Favored 'General case' 0 C--O 1.209 -1.049 0 CA-C-N 115.075 -0.966 . . . . 0.0 112.322 177.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -68.52 -28.48 67.03 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 119.901 -0.72 . . . . 0.0 111.477 -178.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' ILE . . . . . 0.406 ' HA ' HG21 ' A' ' 166' ' ' ILE . 76.2 mt -73.96 -52.55 20.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.117 176.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -70.3 -40.78 74.04 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 120.958 0.408 . . . . 0.0 110.981 -175.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -73.84 -10.55 59.78 Favored 'General case' 0 C--N 1.323 -0.587 0 O-C-N 122.106 -0.371 . . . . 0.0 111.875 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -60.07 -47.78 84.45 Favored 'General case' 0 C--O 1.218 -0.563 0 CA-C-O 121.084 0.469 . . . . 0.0 110.257 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -96.39 -26.59 15.28 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.207 -178.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 32.7 m -74.17 -33.18 63.38 Favored 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -178.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -93.75 135.93 24.49 Favored Pre-proline 0 C--N 1.312 -1.025 0 O-C-N 121.964 -0.46 . . . . 0.0 109.802 -178.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -66.77 157.91 58.86 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 122.782 2.322 . . . . 0.0 112.246 179.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 30.8 ttp-105 . . . . . 0 C--N 1.303 -1.454 0 CA-C-N 115.2 -0.909 . . . . 0.0 108.854 -177.217 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 20.0 m . . . . . 0 N--CA 1.417 -2.123 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -134.29 148.09 50.73 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 108.606 -0.886 . . . . 0.0 108.606 -177.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -133.18 140.93 38.91 Favored Pre-proline 0 C--N 1.294 -1.843 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -82.1 68.16 7.94 Favored 'Trans proline' 0 N--CA 1.439 -1.714 0 C-N-CA 121.833 1.689 . . . . 0.0 111.257 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 5.8 tt -89.95 -68.35 0.79 Allowed 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 178.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -128.14 105.23 8.23 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 176.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -174.42 161.44 31.35 Favored Glycine 0 N--CA 1.421 -2.338 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -112.41 169.09 9.12 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.442 ' HB2' ' HZ3' ' A' ' 149' ' ' LYS . 10.3 mtmp? -86.99 151.58 23.14 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 172.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 37.4 mmt180 -74.28 97.83 3.08 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.557 0.694 . . . . 0.0 111.934 -176.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -160.98 103.17 1.3 Allowed 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 114.372 -1.285 . . . . 0.0 108.202 177.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 60.0 tp -106.15 119.55 39.5 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -93.7 154.66 17.68 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -81.67 76.79 8.57 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 177.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 13.7 m -85.45 103.79 14.66 Favored 'General case' 0 N--CA 1.415 -2.217 0 CA-C-N 114.766 -1.106 . . . . 0.0 108.058 178.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -84.85 143.64 40.72 Favored Pre-proline 0 C--N 1.293 -1.878 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -83.86 19.38 1.36 Allowed 'Trans proline' 0 C--O 1.243 0.754 0 C-N-CA 122.865 2.377 . . . . 0.0 111.704 -177.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.421 ' O ' ' HG2' ' A' ' 161' ' ' ARG . 5.3 m -74.24 91.98 2.2 Favored 'General case' 0 N--CA 1.42 -1.965 0 CA-C-N 115.381 -0.827 . . . . 0.0 108.992 178.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 37.8 mt -93.56 -18.87 21.75 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -59.13 -30.6 68.25 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.385 0.612 . . . . 0.0 110.67 176.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.421 ' HG2' ' O ' ' A' ' 158' ' ' SER . 16.0 ptm180 -76.33 -33.5 58.99 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.987 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 24.7 m -85.28 -37.14 20.35 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 120.959 0.409 . . . . 0.0 111.15 -178.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 4.1 p -59.68 -25.92 33.37 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.404 0 CA-C-O 121.266 0.555 . . . . 0.0 112.428 -178.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -87.82 -10.26 51.4 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-O 121.592 0.711 . . . . 0.0 110.368 177.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -101.65 3.01 39.41 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.311 -176.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 88.9 mt -60.91 133.65 92.37 Favored Pre-proline 0 C--O 1.248 1.017 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.268 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -60.88 127.91 23.87 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 121.991 1.794 . . . . 0.0 109.92 176.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 113.65 -36.55 3.98 Favored Glycine 0 N--CA 1.428 -1.885 0 C-N-CA 120.012 -1.09 . . . . 0.0 112.019 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 57.5 t -58.83 -44.2 89.95 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 CA-C-O 121.498 0.666 . . . . 0.0 110.757 -178.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 91.45 80.76 1.41 Allowed Glycine 0 N--CA 1.408 -3.179 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -177.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 55.2 pttt -63.59 -13.87 45.99 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.515 0.674 . . . . 0.0 112.623 -178.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 43.3 t -71.12 -32.11 46.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-O 122.158 0.98 . . . . 0.0 108.421 175.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.402 ' HB3' HD11 ' A' ' 177' ' ' LEU . 89.9 mttt -88.26 -6.21 57.92 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.472 -177.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -54.23 -52.99 64.01 Favored Pre-proline 0 CA--C 1.558 1.254 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -177.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -67.4 -31.26 35.04 Favored 'Trans proline' 0 C--N 1.375 1.931 0 C-N-CA 121.584 1.523 . . . . 0.0 112.325 179.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 55.4 tp -69.96 -44.7 68.98 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.684 0.754 . . . . 0.0 109.601 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.402 HD11 ' HB3' ' A' ' 173' ' ' LYS . 5.4 mp -75.35 -22.28 57.7 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.081 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 44.1 tp -70.55 -11.25 60.81 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 121.637 0.732 . . . . 0.0 109.803 175.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -88.62 -14.35 37.69 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 174.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -105.07 -51.17 3.08 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 122.014 0.911 . . . . 0.0 110.325 -176.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . 0.458 ' CD2' ' HA ' ' A' ' 187' ' ' LEU . 90.0 m-85 -88.72 148.92 42.84 Favored Pre-proline 0 N--CA 1.417 -2.116 0 CA-C-N 114.423 -1.262 . . . . 0.0 107.753 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -59.07 -47.5 17.51 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.479 2.119 . . . . 0.0 111.883 -179.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 23.9 m -153.21 165.0 37.05 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.444 HD12 ' H ' ' A' ' 184' ' ' ILE . 0.2 OUTLIER -62.36 -27.25 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -178.202 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 24.8 tp60 -61.57 -41.15 96.97 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 110.348 -0.242 . . . . 0.0 110.348 177.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . 0.419 ' NE2' ' HD2' ' A' ' 181' ' ' PHE . 0.7 OUTLIER -79.06 -32.91 45.0 Favored 'General case' 0 C--O 1.196 -1.733 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -179.736 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.458 ' HA ' ' CD2' ' A' ' 181' ' ' PHE . 5.3 tt -53.72 -62.01 1.93 Allowed 'General case' 0 C--O 1.21 -0.991 0 C-N-CA 123.893 0.877 . . . . 0.0 110.471 -176.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 25.4 m -73.99 -23.23 59.43 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -177.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -89.75 4.33 50.01 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.467 0.651 . . . . 0.0 109.372 -179.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.2 154.98 36.47 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-O 121.301 0.572 . . . . 0.0 110.123 175.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 3.0 m -64.26 158.05 24.3 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.48 -176.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 48.8 mm -53.44 -37.86 31.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 C-N-CA 123.279 0.631 . . . . 0.0 111.191 -177.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -63.4 -38.32 96.19 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.642 178.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -74.22 -37.27 63.89 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -176.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 96.2 mt -74.02 -31.36 62.89 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.832 -1.076 . . . . 0.0 110.71 178.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -64.87 -35.54 81.47 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -60.55 -26.36 66.84 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 114.438 -1.255 . . . . 0.0 112.834 178.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 13.1 m -103.59 -37.35 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.305 0 C-N-CA 120.04 -0.664 . . . . 0.0 112.437 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.477 HG22 ' H ' ' A' ' 200' ' ' GLY . 2.5 m -117.87 -80.97 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 177.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . 0.477 ' H ' HG22 ' A' ' 199' ' ' VAL . . . -178.05 166.88 37.28 Favored Glycine 0 N--CA 1.424 -2.16 0 N-CA-C 108.536 -1.826 . . . . 0.0 108.536 -178.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -69.23 -41.94 76.34 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 118.218 1.009 . . . . 0.0 110.296 -178.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -65.55 -35.98 82.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.414 0.626 . . . . 0.0 110.197 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.417 ' O ' HG13 ' A' ' 207' ' ' ILE . 2.7 t -72.66 -43.5 61.65 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.829 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -55.2 -42.47 73.31 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.3 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -58.74 -52.39 65.9 Favored 'General case' 0 N--CA 1.433 -1.315 0 C-N-CA 124.263 1.025 . . . . 0.0 111.507 177.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -69.01 -27.39 65.64 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 -178.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' ILE . . . . . 0.417 HG13 ' O ' ' A' ' 203' ' ' VAL . 98.3 mt -73.45 -51.36 25.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-O 121.311 0.577 . . . . 0.0 109.723 176.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -71.33 -37.94 71.69 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.783 -173.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -75.64 -10.08 59.14 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 178.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -66.12 -46.66 76.78 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.103 0.478 . . . . 0.0 110.86 -179.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -93.11 -25.7 17.77 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.883 -177.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 25.6 m -74.65 -25.8 59.44 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-O 121.387 0.613 . . . . 0.0 111.569 -178.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -110.87 153.56 43.7 Favored Pre-proline 0 C--N 1.314 -0.956 0 O-C-N 121.989 -0.444 . . . . 0.0 110.145 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -84.99 154.91 11.28 Favored 'Trans proline' 0 N--CA 1.443 -1.462 0 C-N-CA 121.918 1.745 . . . . 0.0 111.625 178.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 69.7 mtp180 . . . . . 0 C--N 1.299 -1.629 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 177.471 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 18.1 m . . . . . 0 C--O 1.242 0.682 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -89.89 -23.46 21.61 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.479 0.657 . . . . 0.0 110.428 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -123.15 167.12 15.47 Favored Pre-proline 0 C--N 1.296 -1.742 0 N-CA-C 105.464 -2.05 . . . . 0.0 105.464 177.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -60.59 97.32 0.12 Allowed 'Trans proline' 0 C--O 1.248 0.999 0 C-N-CA 121.831 1.687 . . . . 0.0 110.576 175.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 58.6 tp -83.12 -40.2 20.1 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.491 -177.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -82.19 174.4 11.22 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 168.26 -158.59 31.41 Favored Glycine 0 N--CA 1.412 -2.928 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -89.84 104.0 16.6 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 121.825 0.821 . . . . 0.0 112.382 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -98.12 152.55 19.22 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 174.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 54.0 ttp180 -83.36 93.74 7.81 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 176.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -168.87 101.29 0.39 Allowed 'General case' 0 N--CA 1.426 -1.65 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -85.45 96.41 9.58 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 177.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 61.5 tp -135.76 129.32 32.37 Favored 'General case' 0 N--CA 1.421 -1.894 0 CA-C-N 114.488 -1.233 . . . . 0.0 108.952 -176.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 5.5 tt -77.05 99.74 5.43 Favored 'General case' 0 N--CA 1.421 -1.918 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 175.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 64.0 m -131.02 101.74 5.73 Favored 'General case' 0 N--CA 1.424 -1.734 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 173.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -144.33 119.12 5.95 Favored Pre-proline 0 C--N 1.299 -1.605 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 -176.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.67 -32.43 96.82 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 122.739 2.293 . . . . 0.0 114.138 -176.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.573 ' O ' ' HG2' ' A' ' 161' ' ' ARG . 31.9 m 57.73 32.87 22.51 Favored 'General case' 0 C--O 1.22 -0.452 0 C-N-CA 123.423 0.689 . . . . 0.0 111.168 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.475 ' O ' HD22 ' A' ' 159' ' ' LEU . 6.4 tt -60.44 -22.83 63.88 Favored 'General case' 0 C--O 1.211 -0.948 0 C-N-CA 123.744 0.818 . . . . 0.0 110.322 -175.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.468 ' O ' HG12 ' A' ' 163' ' ' VAL . 3.4 pp -53.85 -31.42 49.46 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.98 0.912 . . . . 0.0 111.595 176.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.573 ' HG2' ' O ' ' A' ' 158' ' ' SER . 13.6 ptm180 -71.5 -29.38 64.73 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.844 0.831 . . . . 0.0 109.397 -178.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 21.1 m -86.69 -29.56 22.37 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.157 177.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.468 HG12 ' O ' ' A' ' 160' ' ' LEU . 0.3 OUTLIER -65.24 -26.46 39.71 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.643 0 CA-C-O 121.583 0.706 . . . . 0.0 110.916 -176.124 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -82.64 -6.71 59.51 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.481 0.657 . . . . 0.0 110.865 177.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 78.9 mm-40 -101.64 13.26 35.45 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.098 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 80.9 mt -84.35 131.75 49.5 Favored Pre-proline 0 C--N 1.306 -1.297 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -62.89 127.14 19.66 Favored 'Trans proline' 0 C--O 1.245 0.86 0 C-N-CA 121.642 1.561 . . . . 0.0 110.633 177.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 112.33 -18.51 23.12 Favored Glycine 0 N--CA 1.43 -1.765 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.62 -177.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 84.0 t -71.67 -50.41 39.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 178.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 96.58 102.09 2.02 Favored Glycine 0 N--CA 1.43 -1.743 0 C-N-CA 120.236 -0.983 . . . . 0.0 113.159 178.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -67.76 -32.4 72.98 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.219 0.533 . . . . 0.0 110.678 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 48.7 t -85.1 -30.76 6.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-O 121.801 0.81 . . . . 0.0 109.342 -178.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -79.89 -12.74 59.72 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.875 -178.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -50.72 -55.03 29.97 Favored Pre-proline 0 CA--C 1.55 0.974 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -177.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.486 ' O ' ' HG3' ' A' ' 179' ' ' GLN . 21.1 Cg_endo -62.25 -28.68 79.37 Favored 'Trans proline' 0 C--N 1.369 1.642 0 CA-C-N 121.045 1.409 . . . . 0.0 112.899 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 51.7 tp -73.02 -47.98 40.31 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 176.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.401 ' HB3' HD12 ' A' ' 187' ' ' LEU . 97.2 mt -59.27 -39.77 83.92 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.686 177.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.43 ' HA ' ' O ' ' A' ' 181' ' ' PHE . 10.2 mp -68.99 -6.81 30.12 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 179.013 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . 0.486 ' HG3' ' O ' ' A' ' 175' ' ' PRO . 76.7 mt-30 -83.19 -17.35 43.13 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 174.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 7.7 mmmm -103.94 -44.92 4.9 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.09 177.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . 0.43 ' O ' ' HA ' ' A' ' 178' ' ' LEU . 27.9 m-85 -111.35 131.51 22.23 Favored Pre-proline 0 N--CA 1.424 -1.753 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 -176.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -48.33 -38.57 34.41 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 124.152 3.235 . . . . 0.0 113.801 -175.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 73.6 p -154.06 173.69 15.69 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -177.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.445 ' HA ' ' HB3' ' A' ' 187' ' ' LEU . 0.2 OUTLIER -66.59 -21.24 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 O-C-N 123.664 0.602 . . . . 0.0 110.78 175.275 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -67.07 -48.49 68.08 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -77.76 -32.73 52.79 Favored 'General case' 0 C--O 1.201 -1.449 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -178.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.445 ' HB3' ' HA ' ' A' ' 184' ' ' ILE . 61.5 tp -52.78 -57.72 9.22 Favored 'General case' 0 C--O 1.207 -1.156 0 C-N-CA 124.589 1.156 . . . . 0.0 111.691 178.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 24.5 p -68.73 -32.79 72.82 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.617 0.723 . . . . 0.0 111.353 -179.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -80.97 -2.67 48.76 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.259 -178.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -66.35 156.51 34.27 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 123.465 0.706 . . . . 0.0 111.015 177.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 5.4 m -63.26 152.31 38.08 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.115 -175.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 50.3 mm -54.21 -35.86 31.05 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.839 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.865 -177.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . 0.405 ' O ' ' HG2' ' A' ' 197' ' ' GLN . . . -61.63 -39.09 96.92 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.322 -0.466 . . . . 0.0 112.56 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -71.42 -45.11 63.54 Favored 'General case' 0 CA--C 1.489 -1.392 0 CA-C-O 121.548 0.69 . . . . 0.0 110.214 -178.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 95.8 mt -66.65 -29.59 69.64 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 114.279 -1.328 . . . . 0.0 110.804 178.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -70.49 -33.11 70.86 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.436 ' HA ' ' OE1' ' A' ' 197' ' ' GLN . 13.6 mm-40 -66.65 -21.51 66.11 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 114.987 -1.006 . . . . 0.0 113.1 -179.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 18.8 m -104.11 -32.85 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.757 177.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -125.17 -85.38 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 173.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -177.22 165.35 35.23 Favored Glycine 0 N--CA 1.43 -1.742 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -176.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -58.39 -49.32 77.69 Favored 'General case' 0 C--O 1.21 -0.996 0 CA-C-N 117.487 0.643 . . . . 0.0 111.626 -177.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -65.01 -32.57 74.35 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.314 0.578 . . . . 0.0 111.095 -175.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.413 ' O ' HG13 ' A' ' 207' ' ' ILE . 3.8 t -75.76 -44.56 39.43 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 -179.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -57.06 -43.75 82.36 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 114.009 -1.45 . . . . 0.0 109.912 179.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -62.94 -44.97 94.61 Favored 'General case' 0 N--CA 1.424 -1.752 0 CA-C-N 114.982 -1.008 . . . . 0.0 112.579 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -69.43 -29.16 66.82 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 119.442 -0.903 . . . . 0.0 111.169 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' ILE . . . . . 0.413 HG13 ' O ' ' A' ' 203' ' ' VAL . 87.4 mt -72.04 -52.15 26.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 176.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 12.2 t60 -69.7 -37.03 76.45 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.614 -174.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -73.36 -22.32 60.32 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 179.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -50.94 -56.74 10.92 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.843 0.857 . . . . 0.0 111.475 -177.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -83.57 -27.64 29.12 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.235 -176.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 38.8 m -69.83 -48.03 60.5 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.472 -178.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -87.27 146.8 40.83 Favored Pre-proline 0 C--N 1.309 -1.188 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 -177.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -85.77 164.93 10.44 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.189 1.926 . . . . 0.0 110.293 173.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . 0.624 ' HD3' ' O ' ' A' ' 215' ' ' ARG 0.262 0.0 OUTLIER . . . . . 0 C--N 1.303 -1.421 0 O-C-N 121.948 -0.47 . . . . 0.0 110.745 177.487 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 37.0 t . . . . . 0 N--CA 1.428 -1.549 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -136.28 147.36 47.46 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 174.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -86.29 151.9 54.53 Favored Pre-proline 0 C--N 1.288 -2.085 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -60.0 159.99 23.74 Favored 'Trans proline' 0 C--O 1.256 1.403 0 C-N-CA 122.471 2.114 . . . . 0.0 111.606 178.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 67.4 tp -56.57 -46.52 80.72 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 6.0 tt -105.45 115.92 31.06 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 175.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -150.7 152.58 24.41 Favored Glycine 0 N--CA 1.423 -2.204 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -115.01 132.05 56.73 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -80.47 96.49 6.77 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-O 121.237 0.541 . . . . 0.0 110.056 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -157.12 108.87 2.39 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 177.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -153.27 160.91 42.84 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -178.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 59.5 tp -134.17 96.93 3.72 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 175.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 7.5 mp -72.17 137.22 46.79 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.363 -176.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -93.15 75.11 4.67 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 -178.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 62.1 m -146.8 102.45 3.54 Favored 'General case' 0 N--CA 1.425 -1.703 0 CA-C-N 114.284 -1.326 . . . . 0.0 108.812 173.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -105.65 160.88 24.56 Favored Pre-proline 0 C--N 1.295 -1.79 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.419 ' O ' ' HD2' ' A' ' 161' ' ' ARG . 33.0 Cg_exo -62.71 111.84 1.46 Allowed 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.181 1.921 . . . . 0.0 110.273 177.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 48.5 m 77.59 84.59 0.08 Allowed 'General case' 0 C--O 1.207 -1.184 0 C-N-CA 125.191 1.396 . . . . 0.0 110.589 -174.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.469 ' O ' HD22 ' A' ' 159' ' ' LEU . 5.5 tt -57.95 -28.63 64.49 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.779 0.831 . . . . 0.0 111.243 -174.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -57.99 -22.28 48.69 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 177.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.419 ' HD2' ' O ' ' A' ' 157' ' ' PRO . 11.1 ptm180 -68.86 -32.1 71.52 Favored 'General case' 0 C--O 1.218 -0.555 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 177.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 28.4 m -86.51 -34.04 20.13 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.442 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -63.87 -26.53 40.8 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.968 0 CA-C-O 121.516 0.674 . . . . 0.0 110.644 -176.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -82.84 -7.74 59.63 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.371 177.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.531 ' HA ' HE21 ' A' ' 165' ' ' GLN . 0.0 OUTLIER -108.47 13.59 25.32 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.89 0.376 . . . . 0.0 110.605 -176.417 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.437 HG21 ' HA ' ' A' ' 207' ' ' ILE . 81.2 mt -71.82 138.71 82.74 Favored Pre-proline 0 C--N 1.31 -1.12 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.876 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -61.73 128.85 25.69 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.132 1.888 . . . . 0.0 110.637 175.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 114.46 -33.46 5.38 Favored Glycine 0 C--N 1.308 -0.978 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -178.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.465 ' O ' ' HE3' ' A' ' 173' ' ' LYS . 89.1 t -63.14 -57.48 11.78 Favored 'Isoleucine or valine' 0 C--N 1.338 0.109 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 178.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 99.24 126.82 5.76 Favored Glycine 0 N--CA 1.43 -1.748 0 C-N-CA 120.588 -0.815 . . . . 0.0 113.552 175.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -85.51 -25.07 27.05 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 121.313 0.578 . . . . 0.0 111.145 178.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 40.8 t -83.96 -28.26 7.31 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-O 122.082 0.944 . . . . 0.0 108.897 -178.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.465 ' HE3' ' O ' ' A' ' 169' ' ' VAL . 46.6 mtmt -87.28 -1.03 57.62 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.593 178.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -51.77 -49.01 85.79 Favored Pre-proline 0 CA--C 1.546 0.811 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 -178.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.504 ' O ' ' HG2' ' A' ' 179' ' ' GLN . 26.1 Cg_exo -62.86 -42.6 23.91 Favored 'Trans proline' 0 C--N 1.378 2.097 0 CA-C-N 120.69 1.282 . . . . 0.0 111.022 178.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 39.6 tp -58.42 -48.94 79.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.184 177.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 87.5 mt -60.68 -40.48 92.32 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.173 178.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 94.3 mt -71.15 -13.53 61.97 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . 0.504 ' HG2' ' O ' ' A' ' 175' ' ' PRO . 28.6 mm-40 -93.83 -12.38 29.13 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.289 0.566 . . . . 0.0 110.055 174.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -97.74 -50.59 4.4 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 121.792 0.805 . . . . 0.0 109.515 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . 0.493 ' CD2' ' HG ' ' A' ' 187' ' ' LEU . 79.9 m-85 -100.26 146.64 32.32 Favored Pre-proline 0 C--N 1.294 -1.846 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.871 -178.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -70.93 -29.45 18.3 Favored 'Trans proline' 0 C--O 1.235 0.366 0 C-N-CA 122.551 2.167 . . . . 0.0 112.594 -178.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' SER . . . . . 0.418 ' O ' ' HB2' ' A' ' 187' ' ' LEU . 64.3 p -153.84 166.58 32.46 Favored 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -178.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -71.05 -22.51 22.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 O-C-N 123.479 0.487 . . . . 0.0 110.138 176.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -61.81 -52.84 62.52 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 114.944 -1.025 . . . . 0.0 108.914 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -76.95 -28.03 55.04 Favored 'General case' 0 C--O 1.207 -1.15 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -179.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.493 ' HG ' ' CD2' ' A' ' 181' ' ' PHE . 3.7 tt -54.78 -64.56 0.8 Allowed 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 124.081 0.952 . . . . 0.0 110.24 -178.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 24.0 m -75.94 -22.93 55.49 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.773 -175.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -84.87 -3.87 58.86 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.32 0.581 . . . . 0.0 110.18 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.7 154.58 38.53 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.687 178.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 1.9 t -73.59 169.23 17.69 Favored 'General case' 0 N--CA 1.423 -1.812 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.984 -176.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 50.1 mm -51.8 -39.37 24.48 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.973 0 C-N-CA 123.99 0.916 . . . . 0.0 111.138 -176.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . 0.429 ' O ' ' HG3' ' A' ' 197' ' ' GLN . . . -59.26 -31.88 70.68 Favored Glycine 0 CA--C 1.527 0.817 0 O-C-N 123.431 0.457 . . . . 0.0 113.899 -179.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . 0.515 ' O ' ' HB2' ' A' ' 197' ' ' GLN . 29.2 mm-40 -83.61 -40.13 19.42 Favored 'General case' 0 C--O 1.215 -0.746 0 CA-C-O 121.696 0.76 . . . . 0.0 109.638 -178.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 77.7 mt -73.39 -23.99 60.24 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-O 121.744 0.783 . . . . 0.0 110.696 -178.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -71.83 -26.54 62.42 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 178.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.515 ' HB2' ' O ' ' A' ' 194' ' ' GLU . 74.6 mt-30 -61.17 -29.67 69.94 Favored 'General case' 0 C--O 1.242 0.71 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.719 178.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 12.0 m -103.27 -37.18 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.295 0 C-N-CA 120.709 -0.397 . . . . 0.0 111.888 -178.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.42 HG23 ' H ' ' A' ' 200' ' ' GLY . 1.7 m -122.47 -83.75 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . 0.42 ' H ' HG23 ' A' ' 199' ' ' VAL . . . -177.6 172.53 45.26 Favored Glycine 0 N--CA 1.429 -1.789 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -175.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -64.55 -46.78 81.31 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 117.421 0.611 . . . . 0.0 111.816 -176.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -70.6 -30.21 66.82 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.311 0.577 . . . . 0.0 110.997 -176.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.597 ' O ' ' HG2' ' A' ' 206' ' ' GLN . 2.2 t -78.62 -33.91 17.28 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.051 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -63.25 -38.45 91.22 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.41 175.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . 0.495 ' HA ' HE21 ' A' ' 205' ' ' GLN . 0.0 OUTLIER -60.24 -42.69 95.81 Favored 'General case' 0 C--O 1.207 -1.134 0 CA-C-N 115.32 -0.855 . . . . 0.0 112.522 179.434 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . 0.597 ' HG2' ' O ' ' A' ' 203' ' ' VAL . 20.6 pt20 -66.79 -30.22 70.37 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.894 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' ILE . . . . . 0.437 ' HA ' HG21 ' A' ' 166' ' ' ILE . 71.6 mt -78.19 -52.91 15.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-O 121.47 0.652 . . . . 0.0 109.982 178.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 40.0 t-80 -65.04 -39.56 93.51 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.839 -175.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -80.97 -14.04 58.33 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 120.728 -0.389 . . . . 0.0 112.023 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -55.11 -53.84 50.82 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.323 0.649 . . . . 0.0 111.318 -176.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -84.28 -27.82 27.58 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.896 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 25.5 m -71.54 -27.29 63.08 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-O 121.204 0.526 . . . . 0.0 111.392 -179.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -88.28 116.18 65.46 Favored Pre-proline 0 C--N 1.305 -1.341 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.85 158.32 42.85 Favored 'Trans proline' 0 N--CA 1.44 -1.656 0 C-N-CA 121.465 1.443 . . . . 0.0 109.143 176.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 35.8 ttm180 . . . . . 0 C--N 1.285 -2.232 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -174.399 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 19.8 m . . . . . 0 N--CA 1.433 -1.299 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 66.3 tttm -145.08 145.53 31.48 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -175.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -78.82 118.71 74.0 Favored Pre-proline 0 C--N 1.304 -1.39 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -179.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_exo -71.12 132.09 20.51 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.075 1.85 . . . . 0.0 110.899 179.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 92.5 mt -98.99 83.2 2.86 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-O 121.555 0.693 . . . . 0.0 109.336 179.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 50.7 tp -123.3 105.32 9.75 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.159 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -148.75 -156.58 7.19 Favored Glycine 0 N--CA 1.414 -2.767 0 C-N-CA 120.366 -0.921 . . . . 0.0 112.155 -178.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 55.9 mttp -87.38 101.58 13.71 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-O 121.266 0.555 . . . . 0.0 110.144 -176.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -111.7 105.61 14.17 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 175.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 60.5 ttt180 -120.22 111.9 18.4 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.946 -177.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -87.9 103.47 15.7 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 178.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 53.9 tp -96.01 93.26 6.89 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-O 121.972 0.891 . . . . 0.0 110.685 -175.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 7.0 tt -111.18 135.55 51.54 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 179.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.11 93.98 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 122.706 1.241 . . . . 0.0 111.908 178.267 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 16.1 m -98.86 109.48 22.23 Favored 'General case' 0 N--CA 1.421 -1.899 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.726 -173.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -105.8 98.2 17.3 Favored Pre-proline 0 C--N 1.295 -1.762 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 171.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -77.76 83.24 2.22 Favored 'Trans proline' 0 N--CA 1.429 -2.302 0 C-N-CA 121.876 1.718 . . . . 0.0 110.777 178.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 2.4 m -87.39 -6.4 58.47 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 175.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 39.5 tp -55.58 -17.83 6.35 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 125.482 1.513 . . . . 0.0 111.608 178.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -62.57 -26.55 68.64 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.074 0.464 . . . . 0.0 110.24 177.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 23.9 ptt180 -67.35 -35.58 79.67 Favored 'General case' 0 C--O 1.215 -0.731 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 8.4 m -86.14 -33.28 20.91 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.618 -178.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -64.95 -26.09 39.25 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-O 121.515 0.674 . . . . 0.0 110.835 -175.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 30.3 pt20 -85.27 -7.3 59.08 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.307 177.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -99.26 4.7 46.67 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -178.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.409 HG21 ' HA ' ' A' ' 207' ' ' ILE . 85.7 mt -72.18 131.58 85.08 Favored Pre-proline 0 C--N 1.309 -1.162 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -179.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -62.13 131.73 35.89 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.485 2.123 . . . . 0.0 110.586 176.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 113.83 -36.42 4.03 Favored Glycine 0 N--CA 1.424 -2.134 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 -178.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 91.9 t -55.72 -48.09 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-O 120.96 0.409 . . . . 0.0 110.593 -178.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 85.63 95.26 0.77 Allowed Glycine 0 N--CA 1.429 -1.794 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 -179.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -70.24 -18.71 63.16 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -175.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 62.0 t -83.24 -30.75 8.32 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 CA-C-O 121.396 0.617 . . . . 0.0 109.831 179.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.596 ' O ' ' HG ' ' A' ' 177' ' ' LEU . 21.2 ptmt -93.93 -4.0 50.61 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.415 0.626 . . . . 0.0 110.035 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . 0.435 ' N ' ' HD2' ' A' ' 175' ' ' PRO . . . -59.72 -45.99 98.49 Favored Pre-proline 0 CA--C 1.548 0.9 0 CA-C-N 114.906 -1.043 . . . . 0.0 113.417 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' A' ' 174' ' ' ALA . 9.3 Cg_endo -54.88 -35.94 90.27 Favored 'Trans proline' 0 C--N 1.385 2.449 0 C-N-CA 122.176 1.917 . . . . 0.0 112.193 176.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 53.3 tp -68.14 -42.3 80.34 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.437 0.637 . . . . 0.0 109.699 178.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.596 ' HG ' ' O ' ' A' ' 173' ' ' LYS . 59.8 mt -70.1 -31.06 68.43 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.75 -179.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 35.5 tp -72.91 -10.83 60.23 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.528 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . 0.428 ' HG2' ' O ' ' A' ' 175' ' ' PRO . 13.8 mm100 -83.72 -20.17 33.91 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 174.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -103.65 -51.81 3.11 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-O 121.31 0.576 . . . . 0.0 110.354 -174.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -90.73 140.55 26.47 Favored Pre-proline 0 C--N 1.296 -1.751 0 CA-C-N 115.346 -0.843 . . . . 0.0 108.752 178.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -47.0 -47.5 16.51 Favored 'Trans proline' 0 C--N 1.361 1.217 0 C-N-CA 123.96 3.107 . . . . 0.0 112.545 -176.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' SER . . . . . 0.439 ' OG ' HD12 ' A' ' 184' ' ' ILE . 25.8 t -153.71 169.48 23.21 Favored 'General case' 0 N--CA 1.41 -2.437 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.458 HD12 ' H ' ' A' ' 184' ' ' ILE . 0.2 OUTLIER -60.03 -27.93 40.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 O-C-N 124.013 0.821 . . . . 0.0 110.151 177.114 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -56.86 -50.21 73.16 Favored 'General case' 0 C--O 1.212 -0.889 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.033 176.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.1 -34.04 43.85 Favored 'General case' 0 C--O 1.206 -1.217 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -177.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 57.8 tp -50.8 -62.55 1.53 Allowed 'General case' 0 C--O 1.21 -0.976 0 C-N-CA 124.408 1.083 . . . . 0.0 111.278 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 25.3 m -72.07 -22.66 61.33 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.012 0.434 . . . . 0.0 112.07 -178.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -83.59 -4.04 58.21 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 121.488 0.661 . . . . 0.0 110.845 -178.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.74 155.48 35.97 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.019 175.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 4.0 m -65.33 162.27 17.88 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.994 -176.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.2 mm -53.66 -39.98 40.54 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.622 0 C-N-CA 122.751 0.42 . . . . 0.0 111.113 -178.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -62.77 -35.14 91.52 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 121.515 -0.374 . . . . 0.0 112.471 179.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . 0.636 ' O ' ' HG2' ' A' ' 197' ' ' GLN . 25.2 mt-10 -80.7 -29.72 36.46 Favored 'General case' 0 C--O 1.215 -0.76 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -177.135 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 97.4 mt -78.76 -33.33 46.57 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.983 176.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -67.46 -31.71 72.07 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 -177.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.636 ' HG2' ' O ' ' A' ' 194' ' ' GLU . 16.5 pt20 -67.92 -28.39 67.45 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.529 -177.509 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 14.1 m -99.52 -34.58 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.969 -177.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.448 HG22 ' H ' ' A' ' 200' ' ' GLY . 2.5 m -119.81 -82.84 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 175.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . 0.448 ' H ' HG22 ' A' ' 199' ' ' VAL . . . -177.84 166.0 35.96 Favored Glycine 0 N--CA 1.429 -1.794 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 -176.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 8.8 tm0? -62.51 -47.03 85.73 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 117.565 0.682 . . . . 0.0 110.303 -177.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -71.63 -28.8 64.02 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.248 -176.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 3.0 t -76.06 -41.2 38.08 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.706 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -55.94 -45.11 78.88 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 114.224 -1.353 . . . . 0.0 109.651 179.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -59.26 -46.65 87.95 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 114.973 -1.012 . . . . 0.0 112.437 179.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -67.87 -33.09 74.06 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 120.366 -0.533 . . . . 0.0 111.357 -179.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' ILE . . . . . 0.409 ' HA ' HG21 ' A' ' 166' ' ' ILE . 85.8 mt -74.72 -50.44 25.87 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-O 121.141 0.496 . . . . 0.0 110.577 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 15.1 t60 -68.99 -43.88 73.98 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.106 -175.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -72.58 -10.77 60.2 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -62.46 -47.42 84.12 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.169 0.509 . . . . 0.0 110.223 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -98.07 -25.17 15.03 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.857 -178.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 24.1 m -77.13 -38.84 51.26 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -178.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -108.11 115.54 58.29 Favored Pre-proline 0 N--CA 1.435 -1.218 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -176.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.9 167.53 26.38 Favored 'Trans proline' 0 C--O 1.243 0.759 0 C-N-CA 122.406 2.071 . . . . 0.0 112.275 -179.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 48.4 mtm180 . . . . . 0 C--N 1.298 -1.671 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.365 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 13.2 t . . . . . 0 N--CA 1.424 -1.746 0 N-CA-C 106.387 -1.709 . . . . 0.0 106.387 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 51.9 pttt -115.41 -31.17 6.01 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -173.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -139.67 130.95 14.63 Favored Pre-proline 0 C--N 1.31 -1.149 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.104 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -77.39 85.99 1.7 Allowed 'Trans proline' 0 N--CA 1.445 -1.344 0 C-N-CA 121.991 1.794 . . . . 0.0 109.894 173.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 61.5 tp -98.72 -35.16 10.26 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.483 -178.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.6 mp -98.79 114.48 27.05 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -179.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -148.43 -161.55 9.67 Favored Glycine 0 N--CA 1.425 -2.085 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 -177.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -123.21 137.58 54.85 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 178.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.77 142.3 37.1 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 177.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -81.28 149.94 28.75 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 176.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -83.91 101.67 11.85 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.6 tt -113.32 112.74 24.2 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 -179.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 45.2 tp -94.07 137.58 33.11 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.363 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -65.1 108.04 1.72 Allowed 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.626 0.727 . . . . 0.0 109.192 176.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 15.2 m -105.96 110.72 23.1 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.457 179.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -78.14 140.82 61.85 Favored Pre-proline 0 C--N 1.317 -0.834 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 176.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -85.45 66.86 5.79 Favored 'Trans proline' 0 N--CA 1.443 -1.451 0 C-N-CA 122.285 1.99 . . . . 0.0 109.477 172.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 34.6 m -84.92 110.53 18.94 Favored 'General case' 0 N--CA 1.427 -1.595 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.619 -178.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 42.8 tp -93.61 -29.47 15.45 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.667 -178.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -60.26 -25.67 65.87 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.246 0.546 . . . . 0.0 112.038 -179.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -73.62 -33.58 64.62 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.207 0.527 . . . . 0.0 110.114 177.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 16.9 m -85.76 -33.99 21.28 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 121.243 0.544 . . . . 0.0 110.591 -178.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -64.17 -25.61 38.46 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.131 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.049 -176.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . 0.414 ' NE2' HG13 ' A' ' 184' ' ' ILE . 11.5 pt20 -87.69 -7.59 57.2 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.755 177.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -103.56 12.15 35.36 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.17 0.51 . . . . 0.0 109.996 -178.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 77.7 mt -72.8 125.97 90.88 Favored Pre-proline 0 C--N 1.314 -0.961 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.24 128.5 20.6 Favored 'Trans proline' 0 N--CA 1.445 -1.331 0 C-N-CA 121.562 1.508 . . . . 0.0 109.183 176.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 116.16 -29.24 7.17 Favored Glycine 0 N--CA 1.428 -1.872 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 -177.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 93.1 t -65.32 -52.23 54.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 121.313 0.578 . . . . 0.0 110.426 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 102.33 75.31 1.09 Allowed Glycine 0 N--CA 1.424 -2.102 0 C-N-CA 120.365 -0.921 . . . . 0.0 111.234 -179.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -73.64 -15.63 61.25 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.279 0.562 . . . . 0.0 111.656 -177.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 45.1 t -86.86 -22.86 6.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 CA-C-O 121.96 0.886 . . . . 0.0 108.637 176.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.45 ' O ' ' HG ' ' A' ' 177' ' ' LEU . 38.0 ttpt -96.12 8.36 43.98 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.309 -1.314 . . . . 0.0 108.226 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -56.67 -46.3 99.85 Favored Pre-proline 0 C--O 1.212 -0.901 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 -177.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.556 ' O ' ' HG2' ' A' ' 179' ' ' GLN . 51.7 Cg_exo -56.97 -41.08 79.04 Favored 'Trans proline' 0 C--N 1.377 2.036 0 CA-C-N 121.204 1.466 . . . . 0.0 111.345 178.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 48.5 tp -64.7 -43.36 93.74 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.435 176.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 173' ' ' LYS . 96.3 mt -63.34 -40.27 96.83 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.533 178.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -68.63 -6.91 28.57 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 178.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . 0.556 ' HG2' ' O ' ' A' ' 175' ' ' PRO . 86.9 mm-40 -84.46 -15.64 45.38 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.06 0.457 . . . . 0.0 110.102 174.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -112.17 -51.01 2.87 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 121.434 0.635 . . . . 0.0 110.047 179.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . 0.473 ' CD1' ' HA ' ' A' ' 187' ' ' LEU . 80.6 m-85 -88.58 139.05 29.68 Favored Pre-proline 0 C--N 1.299 -1.622 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.433 -177.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -64.07 -48.94 4.31 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.511 2.141 . . . . 0.0 112.289 -177.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 25.2 m -148.11 167.38 25.16 Favored 'General case' 0 N--CA 1.426 -1.646 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 178.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.414 HG13 ' NE2' ' A' ' 164' ' ' GLN . 0.2 OUTLIER -60.66 -25.45 35.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -179.085 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 24.0 tp60 -60.87 -51.91 67.27 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.52 -178.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -79.24 -27.18 42.41 Favored 'General case' 0 C--O 1.189 -2.103 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.473 ' HA ' ' CD1' ' A' ' 181' ' ' PHE . 5.1 tt -52.32 -61.55 2.2 Favored 'General case' 0 C--O 1.214 -0.804 0 C-N-CA 123.332 0.653 . . . . 0.0 110.304 -177.459 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 19.5 m -73.72 -22.97 59.72 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 121.165 0.507 . . . . 0.0 112.035 -177.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -91.0 7.44 40.32 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.858 178.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -66.21 156.89 32.87 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 123.22 0.608 . . . . 0.0 111.533 176.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 4.6 m -62.9 158.27 19.52 Favored 'General case' 0 N--CA 1.427 -1.61 0 CA-C-N 115.153 -0.931 . . . . 0.0 109.761 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 47.9 mm -55.54 -36.06 40.38 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.355 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.491 -177.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -62.58 -36.15 92.81 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 121.045 -0.598 . . . . 0.0 112.434 178.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . 0.448 ' O ' ' HG2' ' A' ' 197' ' ' GLN . 13.1 mm-40 -76.84 -35.88 57.21 Favored 'General case' 0 C--O 1.215 -0.727 0 CA-C-O 121.475 0.655 . . . . 0.0 109.36 -177.271 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 92.0 mt -77.94 -23.33 48.59 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-O 121.616 0.722 . . . . 0.0 110.793 178.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . 0.456 ' HG2' ' N ' ' A' ' 201' ' ' GLN . 4.0 tm-20 -81.95 -37.76 26.22 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -178.174 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.448 ' HG2' ' O ' ' A' ' 194' ' ' GLU . 9.9 pt20 -66.37 -22.79 66.26 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.736 -178.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 194' ' ' GLU . 12.6 m -99.19 -28.83 3.44 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 1.5 t -130.64 -79.74 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.613 176.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -177.51 164.63 33.88 Favored Glycine 0 N--CA 1.438 -1.181 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 -177.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . 0.456 ' N ' ' HG2' ' A' ' 196' ' ' GLU . 11.1 pt20 -66.23 -40.13 90.04 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -177.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -68.2 -24.71 64.97 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 122.188 0.994 . . . . 0.0 109.827 -178.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 6.9 t -83.32 -47.56 18.1 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 CA-C-N 114.435 -1.257 . . . . 0.0 108.324 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -52.89 -44.96 67.28 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 114.473 -1.239 . . . . 0.0 110.846 -178.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -63.33 -48.03 79.73 Favored 'General case' 0 N--CA 1.423 -1.783 0 CA-C-N 114.922 -1.035 . . . . 0.0 111.574 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -70.96 -29.82 65.93 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.48 -177.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 90.6 mt -69.53 -51.91 37.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 175.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 7.0 t60 -69.6 -31.15 69.13 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.472 0.653 . . . . 0.0 109.374 -176.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -80.18 -13.69 59.05 Favored 'General case' 0 C--O 1.207 -1.142 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 176.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -62.24 -43.37 98.98 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-O 121.022 0.439 . . . . 0.0 111.782 -176.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -90.91 -23.38 20.51 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.261 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 28.4 m -76.2 -40.9 51.17 Favored 'General case' 0 CA--C 1.555 1.152 0 CA-C-O 121.059 0.457 . . . . 0.0 111.277 178.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -91.51 126.55 53.94 Favored Pre-proline 0 C--N 1.31 -1.146 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 178.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -48.64 141.66 19.92 Favored 'Trans proline' 0 C--O 1.243 0.751 0 C-N-CA 123.278 2.652 . . . . 0.0 112.995 176.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 . . . . . 0 N--CA 1.415 -2.177 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -177.108 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 43.4 m . . . . . 0 N--CA 1.426 -1.667 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -142.03 -28.24 0.62 Allowed 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.697 -175.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -140.96 148.56 52.67 Favored Pre-proline 0 C--N 1.317 -0.836 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 -176.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -88.35 -174.21 1.06 Allowed 'Trans proline' 0 N--CA 1.439 -1.7 0 C-N-CA 122.137 1.891 . . . . 0.0 109.301 172.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 3.3 tt -98.58 -67.29 0.85 Allowed 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 179.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -128.72 174.8 9.12 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.12 176.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -177.67 174.28 46.77 Favored Glycine 0 N--CA 1.417 -2.593 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 178.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -81.47 109.19 15.7 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 177.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -88.77 145.05 25.84 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -178.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -87.32 116.88 25.71 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 178.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -148.16 105.82 3.68 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.648 179.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 64.4 tp -125.71 109.04 12.12 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 -178.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -105.71 144.38 32.53 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 2.9 tt -89.39 77.38 7.37 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -178.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 20.0 m -82.24 103.46 11.85 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.497 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -79.21 139.82 56.56 Favored Pre-proline 0 C--N 1.309 -1.179 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.159 -177.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -60.47 101.97 0.18 Allowed 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.96 2.44 . . . . 0.0 111.152 176.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.418 ' HB2' ' HD2' ' A' ' 161' ' ' ARG . 16.8 m -97.89 89.06 4.45 Favored 'General case' 0 N--CA 1.416 -2.149 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.439 HD21 ' O ' ' A' ' 159' ' ' LEU . 6.4 tt -64.83 -28.88 69.86 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.972 -173.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.416 ' O ' HG11 ' A' ' 163' ' ' VAL . 2.4 pt? -59.22 -25.19 63.79 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.821 0.344 . . . . 0.0 111.834 179.122 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.418 ' HD2' ' HB2' ' A' ' 158' ' ' SER . 5.5 ptm180 -77.98 -26.05 48.47 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 120.077 -0.649 . . . . 0.0 109.522 -179.099 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 97.0 m -86.7 -32.1 20.67 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.253 176.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.416 HG11 ' O ' ' A' ' 160' ' ' LEU . 0.8 OUTLIER -65.47 -26.09 38.46 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 CA-C-O 121.654 0.74 . . . . 0.0 110.9 -177.07 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -83.61 -14.62 51.56 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.532 0.682 . . . . 0.0 109.768 176.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -99.52 20.39 13.95 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.455 -176.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 98.4 mt -80.09 129.16 71.06 Favored Pre-proline 0 C--N 1.293 -1.87 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 175.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.65 128.79 23.14 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 122.036 1.824 . . . . 0.0 109.96 177.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 116.21 -29.4 7.07 Favored Glycine 0 N--CA 1.426 -1.975 0 C-N-CA 120.146 -1.026 . . . . 0.0 111.508 -179.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 63.6 t -63.6 -64.85 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.592 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 177.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 113.62 98.95 2.33 Favored Glycine 0 N--CA 1.422 -2.255 0 C-N-CA 120.066 -1.064 . . . . 0.0 112.18 178.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -68.77 -27.39 65.85 Favored 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 122.926 0.49 . . . . 0.0 111.32 -178.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 22.5 t -83.88 -30.9 7.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-O 121.299 0.571 . . . . 0.0 109.748 -175.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.527 ' O ' ' HG ' ' A' ' 177' ' ' LEU . 20.4 ptmt -91.72 1.41 57.18 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.36 178.423 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -56.99 -50.35 88.71 Favored Pre-proline 0 CA--C 1.545 0.785 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.523 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -58.91 -24.05 70.74 Favored 'Trans proline' 0 C--N 1.376 2.021 0 C-N-CA 121.801 1.667 . . . . 0.0 112.764 178.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.403 ' HB3' ' O ' ' A' ' 173' ' ' LYS . 54.5 tp -77.58 -40.05 43.59 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 177.001 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.527 ' HG ' ' O ' ' A' ' 173' ' ' LYS . 84.3 mt -71.53 -33.59 69.31 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.869 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -69.12 -5.87 24.98 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 177.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -93.17 -3.74 53.37 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.266 0.555 . . . . 0.0 109.869 174.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -113.0 -50.53 2.88 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.47 176.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . 0.565 ' CD2' ' HG ' ' A' ' 187' ' ' LEU . 66.8 m-85 -96.76 141.16 22.67 Favored Pre-proline 0 C--N 1.309 -1.173 0 CA-C-N 114.769 -1.105 . . . . 0.0 108.55 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -67.76 -35.73 20.8 Favored 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 122.096 1.864 . . . . 0.0 112.82 -177.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 67.7 p -149.3 165.54 31.66 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -178.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -65.67 -26.13 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 O-C-N 123.403 0.439 . . . . 0.0 110.559 177.164 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -63.98 -43.57 95.34 Favored 'General case' 0 C--O 1.202 -1.416 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.977 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . 0.41 ' NE2' ' HD1' ' A' ' 181' ' ' PHE . 0.6 OUTLIER -78.84 -34.56 45.05 Favored 'General case' 0 C--O 1.197 -1.703 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.944 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.565 ' HG ' ' CD2' ' A' ' 181' ' ' PHE . 4.8 tt -52.88 -66.61 0.35 Allowed 'General case' 0 C--O 1.21 -1.022 0 C-N-CA 124.205 1.002 . . . . 0.0 111.296 -175.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 23.1 m -75.2 -21.73 58.47 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.243 0.544 . . . . 0.0 112.062 -175.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -86.6 -4.33 59.16 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.032 -178.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.38 155.43 35.42 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 121.498 0.666 . . . . 0.0 111.167 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 12.4 m -65.32 162.17 18.06 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.365 -177.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 41.4 mm -53.57 -40.3 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 123.073 0.549 . . . . 0.0 110.892 -178.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -62.55 -29.03 72.36 Favored Glycine 0 C--O 1.214 -1.133 0 CA-C-N 115.974 -0.557 . . . . 0.0 113.135 -179.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -83.6 -41.88 17.35 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 121.467 0.651 . . . . 0.0 109.275 -178.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 97.4 mt -69.54 -38.42 77.49 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 114.706 -1.134 . . . . 0.0 111.345 -178.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.32 -33.9 77.05 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.311 0.577 . . . . 0.0 109.522 -176.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -60.94 -30.29 70.13 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.619 -1.173 . . . . 0.0 112.923 177.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 16.9 m -103.75 -39.29 5.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -176.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.49 HG21 ' H ' ' A' ' 200' ' ' GLY . 3.5 m -108.09 -84.64 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 177.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . 0.49 ' H ' HG21 ' A' ' 199' ' ' VAL . . . -178.0 167.46 38.24 Favored Glycine 0 N--CA 1.414 -2.819 0 N-CA-C 108.574 -1.81 . . . . 0.0 108.574 -178.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -57.69 -52.7 64.35 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 117.535 0.667 . . . . 0.0 112.357 179.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -67.37 -34.58 77.59 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.313 0.578 . . . . 0.0 110.809 -176.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.45 ' O ' ' HG2' ' A' ' 206' ' ' GLN . 2.6 t -70.57 -42.3 78.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 -179.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -56.36 -46.24 80.11 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.61 178.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -61.68 -47.02 87.23 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 114.972 -1.013 . . . . 0.0 112.615 179.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . 0.45 ' HG2' ' O ' ' A' ' 203' ' ' VAL . 3.4 pt20 -65.28 -34.98 79.62 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 118.373 0.533 . . . . 0.0 111.364 -178.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 88.4 mt -72.92 -50.52 32.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.972 178.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -65.01 -45.31 86.07 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.821 -177.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -70.07 -15.79 63.04 Favored 'General case' 0 C--O 1.217 -0.624 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -59.24 -45.54 90.9 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.129 0.572 . . . . 0.0 110.44 -179.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -95.91 -31.18 13.25 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.091 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 52.0 m -67.98 -40.07 83.19 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.518 -177.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -93.76 112.16 55.72 Favored Pre-proline 0 N--CA 1.44 -0.93 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -92.37 167.97 2.83 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 122.879 2.386 . . . . 0.0 112.659 -178.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? . . . . . 0 N--CA 1.404 -2.762 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 176.626 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.4 p . . . . . 0 N--CA 1.42 -1.955 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -161.19 135.92 7.34 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 -177.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -140.44 137.69 17.98 Favored Pre-proline 0 C--N 1.306 -1.314 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 173.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.47 -50.81 10.77 Favored 'Trans proline' 0 C--O 1.243 0.749 0 C-N-CA 122.695 2.264 . . . . 0.0 112.665 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 55.9 tp 67.23 -71.23 0.1 Allowed 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 125.114 1.365 . . . . 0.0 111.995 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -128.41 159.41 35.46 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -178.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 153.0 147.92 4.74 Favored Glycine 0 N--CA 1.429 -1.833 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.658 177.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.413 ' H ' ' HD3' ' A' ' 148' ' ' LYS . 0.1 OUTLIER -130.13 146.86 51.81 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 179.646 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -159.54 99.63 1.44 Allowed 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.161 0.505 . . . . 0.0 111.41 178.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 42.2 ttt180 -141.01 93.78 2.63 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 173.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -95.77 101.66 13.37 Favored 'General case' 0 N--CA 1.427 -1.618 0 CA-C-N 115.393 -0.822 . . . . 0.0 109.209 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -132.35 159.45 39.18 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 70.0 mt -124.39 118.27 26.32 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 172.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 5.9 tt -106.91 90.2 3.24 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 -177.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 47.3 m -144.47 103.63 3.98 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -93.86 154.81 40.8 Favored Pre-proline 0 C--N 1.287 -2.114 0 CA-C-N 115.129 -0.942 . . . . 0.0 109.283 -178.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -60.26 -30.63 91.58 Favored 'Trans proline' 0 C--O 1.242 0.682 0 C-N-CA 122.325 2.017 . . . . 0.0 111.577 178.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -75.78 83.86 2.75 Favored 'General case' 0 N--CA 1.415 -2.176 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.222 177.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 43.0 tp -94.06 -25.39 17.21 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.118 178.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.461 ' O ' HG11 ' A' ' 163' ' ' VAL . 2.3 pt? -55.44 -34.54 64.55 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-O 121.223 0.535 . . . . 0.0 111.695 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -66.0 -31.9 73.07 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.198 177.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 15.9 m -86.72 -31.45 20.98 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 120.956 0.408 . . . . 0.0 110.76 178.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.461 HG11 ' O ' ' A' ' 160' ' ' LEU . 0.3 OUTLIER -64.79 -25.85 38.75 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.069 0 CA-C-O 121.719 0.771 . . . . 0.0 110.647 -177.271 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . 0.423 ' OE1' HG23 ' A' ' 184' ' ' ILE . 9.8 pt20 -83.44 -6.69 59.53 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.412 175.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -100.2 7.96 44.15 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.062 0.458 . . . . 0.0 110.307 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 84.5 mt -75.38 128.72 83.8 Favored Pre-proline 0 C--N 1.317 -0.829 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -65.75 128.67 20.42 Favored 'Trans proline' 0 C--O 1.238 0.478 0 C-N-CA 122.145 1.896 . . . . 0.0 111.353 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 117.35 -27.99 7.41 Favored Glycine 0 C--N 1.306 -1.084 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 -179.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 97.7 t -61.86 -62.01 1.34 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.689 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 177.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 110.89 100.81 2.6 Favored Glycine 0 N--CA 1.424 -2.12 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.323 176.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -73.66 -26.51 60.78 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.261 0.553 . . . . 0.0 109.935 177.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 62.1 t -82.88 -24.46 8.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-O 122.08 0.943 . . . . 0.0 108.896 178.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.502 ' HZ3' HG23 ' A' ' 199' ' ' VAL . 44.9 mtpt -86.01 -0.82 56.47 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.497 -1.229 . . . . 0.0 110.305 178.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -47.98 -51.04 50.76 Favored Pre-proline 0 C--O 1.203 -1.377 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -178.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.574 ' O ' ' HG2' ' A' ' 179' ' ' GLN . 12.9 Cg_endo -58.24 -42.57 55.24 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 121.684 1.589 . . . . 0.0 112.132 177.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 55.6 tp -64.46 -45.56 86.89 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.729 0.776 . . . . 0.0 109.639 179.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' A' ' 173' ' ' LYS . 93.2 mt -69.16 -26.41 64.85 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.973 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 57.4 tp -74.06 -30.75 62.54 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 121.132 0.492 . . . . 0.0 109.831 178.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . 0.574 ' HG2' ' O ' ' A' ' 175' ' ' PRO . 12.7 mm-40 -76.09 -30.97 58.5 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 121.167 0.508 . . . . 0.0 109.965 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 22.9 mmmt -83.28 -50.62 8.21 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.979 179.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -111.75 135.66 21.16 Favored Pre-proline 0 N--CA 1.436 -1.134 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.795 -172.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.42 -38.51 82.87 Favored 'Trans proline' 0 N--CA 1.487 1.118 0 C-N-CA 124.367 3.378 . . . . 0.0 114.184 -176.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 24.4 t -158.66 167.83 28.49 Favored 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 179.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.434 ' HA ' ' HB3' ' A' ' 187' ' ' LEU . 0.2 OUTLIER -61.37 -26.98 40.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 O-C-N 124.277 0.985 . . . . 0.0 110.995 178.214 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -64.39 -40.73 96.39 Favored 'General case' 0 C--O 1.21 -1.022 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.692 179.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -80.2 -37.87 32.34 Favored 'General case' 0 C--O 1.191 -2.017 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 177.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.434 ' HB3' ' HA ' ' A' ' 184' ' ' ILE . 66.8 tp -46.67 -65.59 0.54 Allowed 'General case' 0 C--O 1.212 -0.873 0 C-N-CA 126.07 1.748 . . . . 0.0 113.202 -177.045 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 36.9 m -72.96 -20.94 60.95 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -177.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -91.89 3.88 54.19 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.461 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.96 158.23 28.71 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 124.816 1.247 . . . . 0.0 112.737 178.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 14.6 m -62.99 152.06 37.9 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.848 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 48.2 mm -55.15 -35.57 36.09 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.137 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.878 -177.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -61.9 -30.2 74.57 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 121.313 -0.47 . . . . 0.0 112.842 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . 0.446 ' O ' ' HG2' ' A' ' 197' ' ' GLN . 59.4 mm-40 -84.24 -36.99 22.33 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-O 121.529 0.681 . . . . 0.0 109.752 -179.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 96.0 mt -75.97 -24.38 55.4 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.385 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . 0.417 ' HG2' ' N ' ' A' ' 201' ' ' GLN . 3.9 tm-20 -78.91 -37.95 38.64 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -178.041 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.446 ' HG2' ' O ' ' A' ' 194' ' ' GLU . 10.3 pt20 -69.75 -19.6 63.53 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 114.999 -1.0 . . . . 0.0 112.328 -175.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 17.1 m -102.54 -26.33 3.52 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 C-N-CA 120.587 -0.445 . . . . 0.0 111.842 178.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.502 HG23 ' HZ3' ' A' ' 173' ' ' LYS . 0.2 OUTLIER -128.24 -81.8 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 C-N-CA 120.721 -0.392 . . . . 0.0 111.129 175.897 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -176.95 162.78 31.24 Favored Glycine 0 N--CA 1.442 -0.914 0 N-CA-C 108.791 -1.723 . . . . 0.0 108.791 -176.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . 0.417 ' N ' ' HG2' ' A' ' 196' ' ' GLU . 8.8 tt0 -67.01 -40.69 87.36 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 117.996 0.898 . . . . 0.0 112.065 -176.117 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -65.7 -37.64 87.01 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.399 0.619 . . . . 0.0 109.936 -179.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.425 HG13 HG12 ' A' ' 199' ' ' VAL . 3.9 t -69.91 -44.05 79.04 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.864 0 CA-C-N 114.986 -1.007 . . . . 0.0 108.755 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -55.31 -46.43 76.27 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 114.356 -1.293 . . . . 0.0 110.2 -179.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -71.12 -31.62 67.99 Favored 'General case' 0 N--CA 1.417 -2.124 0 CA-C-N 114.735 -1.12 . . . . 0.0 112.494 -177.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -78.08 -34.1 50.45 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 119.742 -0.783 . . . . 0.0 110.765 178.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 93.7 mt -66.38 -45.61 88.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 174.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 28.4 t-80 -68.95 -35.77 77.15 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.007 -178.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -72.56 -25.6 61.42 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 121.743 -0.598 . . . . 0.0 112.507 177.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -50.84 -54.13 26.37 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.532 1.133 . . . . 0.0 112.667 -175.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 20.3 p90 -81.76 -24.16 36.21 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -177.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 30.6 m -76.53 -38.27 55.36 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 120.975 0.417 . . . . 0.0 111.225 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -96.47 117.71 65.87 Favored Pre-proline 0 C--N 1.312 -1.031 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -178.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -74.38 177.87 7.76 Favored 'Trans proline' 0 C--O 1.245 0.859 0 C-N-CA 122.711 2.274 . . . . 0.0 112.137 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 58.2 mtt85 . . . . . 0 C--N 1.298 -1.672 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -179.199 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 35.9 m . . . . . 0 N--CA 1.436 -1.164 0 CA-C-O 121.267 0.556 . . . . 0.0 110.96 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -112.59 -26.9 8.42 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 176.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -104.12 111.29 65.12 Favored Pre-proline 0 C--N 1.305 -1.342 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 171.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.412 ' HB2' ' O ' ' A' ' 146' ' ' LEU . 50.6 Cg_endo -71.28 128.29 14.47 Favored 'Trans proline' 0 N--CA 1.445 -1.342 0 C-N-CA 121.505 1.47 . . . . 0.0 111.799 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 92.0 mt -64.37 -40.88 96.7 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.697 177.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.412 ' O ' ' HB2' ' A' ' 144' ' ' PRO . 7.2 mp -107.18 148.06 29.34 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.044 177.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 137.18 -149.81 20.42 Favored Glycine 0 N--CA 1.417 -2.617 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 -178.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -69.25 168.9 13.21 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 123.493 0.717 . . . . 0.0 110.429 -178.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -61.68 101.76 0.21 Allowed 'General case' 0 C--O 1.24 0.603 0 O-C-N 123.737 0.648 . . . . 0.0 109.849 174.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.419 ' HD2' ' O ' ' A' ' 150' ' ' ARG . 3.4 ppt_? -102.72 100.19 10.21 Favored 'General case' 0 N--CA 1.425 -1.704 0 CA-C-O 122.24 1.019 . . . . 0.0 112.535 -178.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -77.54 108.65 10.87 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.946 178.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 62.9 tp -146.97 142.32 27.4 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 106.201 -1.778 . . . . 0.0 106.201 176.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -70.11 132.38 45.74 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.442 0.639 . . . . 0.0 109.55 178.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.468 ' O ' HD22 ' A' ' 154' ' ' LEU 0.382 0.0 OUTLIER -85.0 81.18 9.01 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-O 123.501 1.62 . . . . 0.0 111.292 179.589 . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 66.3 m -133.16 102.28 5.52 Favored 'General case' 0 N--CA 1.395 -3.21 0 CA-C-N 113.913 -1.494 . . . . 0.0 108.821 178.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.451 ' OE1' ' HD2' ' A' ' 157' ' ' PRO . 7.0 tp10 -95.66 138.42 21.79 Favored Pre-proline 0 C--N 1.291 -1.956 0 N-CA-C 104.521 -2.4 . . . . 0.0 104.521 174.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.46 ' C ' ' H ' ' A' ' 159' ' ' LEU . 6.2 Cg_endo -49.72 128.54 21.55 Favored 'Trans proline' 0 C--O 1.246 0.922 0 C-N-CA 122.617 2.211 . . . . 0.0 110.832 177.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.492 ' O ' ' HG2' ' A' ' 161' ' ' ARG . 3.3 p -66.35 33.4 0.02 OUTLIER 'General case' 0 C--O 1.207 -1.132 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 -176.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.46 ' H ' ' C ' ' A' ' 157' ' ' PRO . 3.0 tm? -90.8 -23.77 20.51 Favored 'General case' 0 C--N 1.277 -2.551 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 175.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.401 ' HA ' ' CG1' ' A' ' 163' ' ' VAL . 2.4 pt? -61.82 -23.52 66.28 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 115.316 -0.856 . . . . 0.0 112.035 -177.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.492 ' HG2' ' O ' ' A' ' 158' ' ' SER . 34.6 ptt180 -70.0 -39.32 75.96 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.345 0.593 . . . . 0.0 110.104 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 74.8 m -86.75 -32.57 20.33 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.937 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.401 ' CG1' ' HA ' ' A' ' 160' ' ' LEU . 0.4 OUTLIER -62.49 -26.2 39.87 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.126 -174.568 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -80.47 -10.22 59.75 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.995 179.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -103.8 11.45 35.75 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 121.143 0.497 . . . . 0.0 110.978 -176.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.402 HG23 ' HA ' ' A' ' 207' ' ' ILE . 73.6 mt -78.74 133.86 61.81 Favored Pre-proline 0 C--N 1.304 -1.404 0 CA-C-N 116.059 -0.518 . . . . 0.0 109.71 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -62.12 128.76 24.94 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.106 1.871 . . . . 0.0 109.869 175.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 116.07 -40.95 2.25 Favored Glycine 0 N--CA 1.429 -1.805 0 N-CA-C 108.668 -1.773 . . . . 0.0 108.668 -176.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.46 ' O ' HD13 ' A' ' 177' ' ' LEU . 57.7 t -70.89 -56.34 11.03 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.174 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 174.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 91.77 147.08 19.58 Favored Glycine 0 N--CA 1.417 -2.596 0 C-N-CA 120.201 -1.0 . . . . 0.0 114.893 172.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 56.7 pttt -89.37 -35.93 15.79 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 114.401 -0.899 . . . . 0.0 110.556 177.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 43.3 t -86.14 -39.03 13.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-O 121.204 0.526 . . . . 0.0 110.729 -175.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.638 ' O ' ' HG ' ' A' ' 177' ' ' LEU . 21.6 ptmt -84.25 2.07 41.73 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.765 -178.321 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -54.59 -52.75 67.17 Favored Pre-proline 0 CA--C 1.563 1.443 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -61.74 -23.16 75.85 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 122.137 1.891 . . . . 0.0 112.22 177.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.503 ' HB3' ' O ' ' A' ' 173' ' ' LYS . 53.5 tp -74.54 -34.86 63.08 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.252 176.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.638 ' HG ' ' O ' ' A' ' 173' ' ' LYS . 61.5 mt -78.69 -29.29 45.48 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.073 -179.07 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 87.3 mt -68.69 -5.58 21.13 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.615 177.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -85.3 -21.42 28.99 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 121.838 0.828 . . . . 0.0 108.941 174.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -101.05 -47.41 4.77 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.567 -178.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . 0.57 ' CD2' ' HG ' ' A' ' 187' ' ' LEU . 85.4 m-85 -107.32 149.06 38.27 Favored Pre-proline 0 N--CA 1.427 -1.609 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.623 -175.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -67.46 -50.47 0.94 Allowed 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.774 2.316 . . . . 0.0 112.566 -178.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 66.6 m -150.19 164.48 35.57 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -57.33 -30.49 35.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 115.671 1.73 . . . . 0.0 115.671 -173.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -68.55 -46.9 68.25 Favored 'General case' 0 C--O 1.206 -1.223 0 C-N-CA 119.439 -0.905 . . . . 0.0 108.995 -176.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -73.04 -29.89 63.32 Favored 'General case' 0 C--O 1.194 -1.846 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.57 ' HG ' ' CD2' ' A' ' 181' ' ' PHE . 5.1 tt -56.03 -64.12 0.96 Allowed 'General case' 0 C--O 1.217 -0.607 0 C-N-CA 123.666 0.786 . . . . 0.0 110.27 -178.168 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 17.6 m -74.29 -26.44 60.19 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 123.29 0.369 . . . . 0.0 111.831 -176.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.411 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 8.6 t30 -85.36 -0.03 53.55 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.138 0.494 . . . . 0.0 111.014 -178.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -66.62 155.47 37.77 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.035 0.445 . . . . 0.0 110.704 175.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 12.5 m -63.94 159.72 19.27 Favored 'General case' 0 C--O 1.251 1.14 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.089 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.1 mm -49.09 -39.17 12.06 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.851 0 C-N-CA 123.772 0.829 . . . . 0.0 111.619 -179.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . 0.457 ' O ' ' HG3' ' A' ' 197' ' ' GLN . . . -57.22 -39.05 89.45 Favored Glycine 0 CA--C 1.526 0.767 0 O-C-N 123.129 0.268 . . . . 0.0 113.453 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -77.56 -41.46 38.86 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.551 0.691 . . . . 0.0 109.231 -177.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 96.0 mt -69.72 -26.44 64.33 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.268 -179.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . 0.598 ' HG2' ' N ' ' A' ' 201' ' ' GLN . 1.5 tm-20 -73.39 -34.43 65.54 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 -179.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.457 ' HG3' ' O ' ' A' ' 193' ' ' GLY . 89.9 mt-30 -62.52 -29.92 70.91 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.999 178.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 12.8 m -103.84 -24.44 4.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -176.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -128.4 -85.75 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.779 176.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -178.36 158.3 22.86 Favored Glycine 0 CA--C 1.494 -1.223 0 N-CA-C 108.669 -1.772 . . . . 0.0 108.669 -176.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . 0.598 ' N ' ' HG2' ' A' ' 196' ' ' GLU . 10.7 pt20 -57.19 -46.39 82.89 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -177.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -69.93 -34.69 73.8 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.395 0.616 . . . . 0.0 110.55 -175.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.448 ' O ' HG13 ' A' ' 207' ' ' ILE . 2.0 t -75.2 -39.28 42.78 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-N 114.945 -1.025 . . . . 0.0 108.241 -178.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -57.48 -41.59 80.97 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.587 -1.188 . . . . 0.0 109.903 179.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . 0.404 ' HG3' ' O ' ' A' ' 201' ' ' GLN . 27.9 mt-30 -64.56 -39.79 94.38 Favored 'General case' 0 N--CA 1.422 -1.85 0 CA-C-N 114.966 -1.015 . . . . 0.0 112.047 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 27.1 pt20 -73.4 -30.09 63.02 Favored 'General case' 0 C--O 1.218 -0.554 0 C-N-CA 119.367 -0.933 . . . . 0.0 110.438 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 203' ' ' VAL . 82.8 mt -68.03 -53.07 32.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 176.178 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 53.3 t-80 -62.57 -43.73 98.08 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 114.668 -1.151 . . . . 0.0 110.531 -177.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -70.7 -25.3 62.9 Favored 'General case' 0 C--O 1.202 -1.396 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -54.56 -47.84 72.76 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.083 0.553 . . . . 0.0 111.742 -176.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . 0.411 ' CZ ' ' HA ' ' A' ' 189' ' ' ASN . 34.1 p90 -93.69 -26.34 17.07 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.172 -178.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 46.4 m -75.67 -37.89 59.19 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-O 120.895 0.379 . . . . 0.0 111.061 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -94.0 120.53 65.63 Favored Pre-proline 0 C--N 1.31 -1.144 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 177.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.07 159.01 51.14 Favored 'Trans proline' 0 C--O 1.244 0.798 0 C-N-CA 122.464 2.109 . . . . 0.0 112.854 -177.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 29.0 ttp180 . . . . . 0 C--N 1.3 -1.555 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 177.865 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.6 t . . . . . 0 N--CA 1.43 -1.471 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -112.05 -59.72 1.96 Allowed 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.35 0.595 . . . . 0.0 110.338 -179.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -72.75 127.71 89.33 Favored Pre-proline 0 C--N 1.305 -1.366 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.742 -175.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -73.29 97.85 0.97 Allowed 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 121.975 1.784 . . . . 0.0 109.068 173.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 40.7 tp -121.66 -17.92 7.31 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.396 -176.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 93.4 mt -117.29 156.06 28.44 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 115.59 -150.26 18.7 Favored Glycine 0 N--CA 1.412 -2.935 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 178.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -110.63 147.45 34.24 Favored 'General case' 0 C--N 1.276 -2.595 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -115.4 126.14 54.02 Favored 'General case' 0 C--N 1.287 -2.12 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 174.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 17.9 tpt180 -47.6 105.37 0.07 Allowed 'General case' 0 C--O 1.245 0.84 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 -167.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -154.84 156.68 36.63 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 105.722 -1.955 . . . . 0.0 105.722 177.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.418 HD23 ' H ' ' A' ' 152' ' ' LEU . 1.8 pt? -116.21 143.93 44.87 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.293 -177.111 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 68.1 tp -148.16 132.12 17.17 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 179.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 62.3 tp -80.76 105.66 12.16 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 177.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 12.9 t -86.47 115.73 24.16 Favored 'General case' 0 N--CA 1.411 -2.401 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -109.44 137.18 20.22 Favored Pre-proline 0 C--N 1.284 -2.258 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 -175.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.84 9.98 0.55 Allowed 'Trans proline' 0 N--CA 1.49 1.271 0 C-N-CA 123.725 2.95 . . . . 0.0 114.799 -177.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.428 ' O ' ' HG2' ' A' ' 161' ' ' ARG . 18.9 m 63.72 34.73 11.89 Favored 'General case' 0 C--O 1.216 -0.696 0 C-N-CA 124.553 1.141 . . . . 0.0 109.94 178.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 44.6 tp -57.26 -26.87 61.47 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 124.701 1.2 . . . . 0.0 112.641 -174.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -63.36 -23.94 67.63 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.666 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.428 ' HG2' ' O ' ' A' ' 158' ' ' SER . 30.4 ptt180 -72.13 -32.5 66.99 Favored 'General case' 0 C--O 1.22 -0.497 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 10.2 m -86.37 -35.59 19.7 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.937 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -61.66 -25.68 37.57 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 C-N-CA 123.835 0.854 . . . . 0.0 111.571 -177.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -86.11 -8.01 58.18 Favored 'General case' 0 C--N 1.311 -1.103 0 O-C-N 121.941 -0.474 . . . . 0.0 111.561 178.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -97.46 17.99 16.33 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-O 120.606 0.241 . . . . 0.0 110.638 -176.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.407 HG22 ' HA ' ' A' ' 207' ' ' ILE . 65.2 mt -83.09 120.33 75.79 Favored Pre-proline 0 C--N 1.302 -1.463 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.364 -176.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.23 129.12 15.58 Favored 'Trans proline' 0 N--CA 1.445 -1.364 0 C-N-CA 121.82 1.68 . . . . 0.0 108.349 175.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 124.45 -33.14 3.88 Favored Glycine 0 C--N 1.288 -2.126 0 N-CA-C 108.47 -1.852 . . . . 0.0 108.47 -171.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 81.3 t -68.48 -43.5 83.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 174.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 107.55 140.27 9.43 Favored Glycine 0 N--CA 1.424 -2.12 0 CA-C-N 115.267 -0.879 . . . . 0.0 112.492 175.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -89.27 -36.27 15.68 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 121.131 0.491 . . . . 0.0 110.193 178.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 44.0 t -89.19 -31.98 5.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-O 121.735 0.778 . . . . 0.0 109.643 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.429 ' HG2' ' HG ' ' A' ' 177' ' ' LEU . 39.3 ttmt -77.36 -14.39 59.73 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.376 -179.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -52.36 -53.86 48.34 Favored Pre-proline 0 CA--C 1.557 1.222 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -176.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.433 ' O ' ' HG3' ' A' ' 179' ' ' GLN . 18.9 Cg_endo -61.19 -32.36 90.75 Favored 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 121.575 1.517 . . . . 0.0 112.8 178.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 57.4 tp -69.84 -40.59 75.75 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.543 0.687 . . . . 0.0 109.804 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.429 ' HG ' ' HG2' ' A' ' 173' ' ' LYS . 87.6 mt -68.51 -27.99 66.61 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.259 178.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 43.4 tp -74.91 -9.49 58.59 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.179 177.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . 0.433 ' HG3' ' O ' ' A' ' 175' ' ' PRO . 24.6 mt-30 -91.02 -29.74 17.19 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 175.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -84.27 -50.64 7.67 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.825 -179.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -97.7 149.12 35.38 Favored Pre-proline 0 C--N 1.293 -1.857 0 CA-C-N 115.056 -0.974 . . . . 0.0 109.204 -177.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -68.78 -42.21 4.89 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 121.994 1.796 . . . . 0.0 112.705 -177.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 78.2 p -147.72 166.77 26.48 Favored 'General case' 0 N--CA 1.427 -1.58 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -177.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -62.42 -29.28 46.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 O-C-N 123.772 0.67 . . . . 0.0 111.569 177.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -63.23 -45.95 89.25 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.735 -179.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . 0.502 HE21 ' C ' ' A' ' 186' ' ' GLN . 0.0 OUTLIER -79.2 -32.59 44.11 Favored 'General case' 0 C--O 1.202 -1.419 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.54 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 4.1 tt -53.81 -64.09 0.94 Allowed 'General case' 0 C--O 1.218 -0.567 0 C-N-CA 124.141 0.976 . . . . 0.0 110.285 -176.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 19.9 m -70.42 -20.71 62.9 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 121.322 0.582 . . . . 0.0 111.793 -178.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -90.34 4.9 49.46 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.408 0.623 . . . . 0.0 111.009 -178.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.49 155.3 36.02 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.781 173.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 5.4 t -72.89 168.69 18.4 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.553 -175.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 50.8 mm -59.62 -37.73 72.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.751 -175.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -60.34 -31.92 75.44 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 116.448 -0.342 . . . . 0.0 112.803 178.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . 0.479 ' O ' ' HG2' ' A' ' 197' ' ' GLN . 24.3 mt-10 -83.77 -36.73 23.38 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 121.556 0.693 . . . . 0.0 109.269 -177.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 88.6 mt -78.44 -23.27 46.69 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-O 121.306 0.574 . . . . 0.0 111.72 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . 0.556 ' HG2' ' N ' ' A' ' 201' ' ' GLN . 2.5 tm-20 -80.49 -37.44 31.72 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' A' ' 194' ' ' GLU . 9.5 pt20 -68.01 -14.69 63.16 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.708 -177.367 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 4.1 m -103.46 -34.66 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 N-CA-C 111.621 0.23 . . . . 0.0 111.621 174.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 1.3 t -128.76 -80.31 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 C-N-CA 119.909 -0.716 . . . . 0.0 111.25 177.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -177.61 166.27 36.52 Favored Glycine 0 N--CA 1.434 -1.458 0 N-CA-C 111.46 -0.656 . . . . 0.0 111.46 -176.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . 0.556 ' N ' ' HG2' ' A' ' 196' ' ' GLU . 78.7 mt-30 -56.51 -50.39 71.95 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 124.756 1.222 . . . . 0.0 111.82 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -64.81 -27.87 69.17 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.681 0.753 . . . . 0.0 111.205 -175.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 90.3 t -80.14 -49.44 18.99 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.581 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -52.31 -46.64 66.07 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 124.763 1.225 . . . . 0.0 110.891 -179.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -61.74 -45.75 92.6 Favored 'General case' 0 N--CA 1.419 -2.011 0 CA-C-N 114.433 -1.258 . . . . 0.0 111.529 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -73.86 -28.61 61.67 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.348 -0.541 . . . . 0.0 111.877 -179.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' ILE . . . . . 0.407 ' HA ' HG22 ' A' ' 166' ' ' ILE . 81.9 mt -70.04 -50.34 48.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.182 0.515 . . . . 0.0 109.945 175.189 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 9.7 t60 -72.63 -37.02 68.15 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.248 -175.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -73.85 -16.38 61.13 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 120.22 -0.592 . . . . 0.0 112.164 178.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -54.37 -56.72 15.75 Favored 'General case' 0 C--O 1.215 -0.716 0 C-N-CA 123.386 0.674 . . . . 0.0 111.68 -177.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -81.04 -26.35 36.44 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.59 -178.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 32.3 m -64.73 -38.5 91.2 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.585 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -108.89 110.26 61.01 Favored Pre-proline 0 C--N 1.315 -0.909 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 175.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -89.94 156.67 4.93 Favored 'Trans proline' 0 N--CA 1.44 -1.623 0 C-N-CA 122.243 1.962 . . . . 0.0 112.888 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 62.8 ttp180 . . . . . 0 C--N 1.301 -1.535 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 179.271 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 49.1 m . . . . . 0 N--CA 1.433 -1.299 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 20.7 pttm -119.63 13.93 12.57 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -175.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -127.32 150.64 73.06 Favored Pre-proline 0 C--N 1.301 -1.52 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 178.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -63.74 115.43 3.06 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.085 1.856 . . . . 0.0 109.854 176.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.498 HD21 ' H ' ' A' ' 145' ' ' LEU . 2.0 pt? -75.39 -6.86 52.14 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.511 -1.222 . . . . 0.0 113.144 -173.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 62.0 tp -82.96 104.02 12.86 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 170.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 89.22 -172.82 40.27 Favored Glycine 0 N--CA 1.401 -3.644 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 -173.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 59.2 mttm -112.22 168.01 9.96 Favored 'General case' 0 C--N 1.27 -2.876 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 178.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -74.33 113.2 11.27 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 176.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 8.4 tpm_? -77.03 93.34 3.83 Favored 'General case' 0 N--CA 1.427 -1.59 0 CA-C-O 121.71 0.767 . . . . 0.0 110.657 -178.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -93.65 108.23 19.99 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 171.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 59.8 tp -128.06 121.14 28.97 Favored 'General case' 0 C--N 1.292 -1.894 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.8 -174.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -113.76 129.01 56.64 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 175.651 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -120.7 96.59 5.18 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.439 ' O ' ' HD3' ' A' ' 157' ' ' PRO . 8.1 p -101.16 103.56 14.61 Favored 'General case' 0 N--CA 1.423 -1.807 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.345 -175.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -104.54 96.54 10.42 Favored Pre-proline 0 C--N 1.308 -1.212 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.647 174.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.439 ' HD3' ' O ' ' A' ' 155' ' ' SER . 9.2 Cg_exo -75.88 -24.93 11.03 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 121.903 1.735 . . . . 0.0 109.65 175.411 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.485 ' O ' ' HG2' ' A' ' 161' ' ' ARG . 3.4 p -105.92 33.94 3.55 Favored 'General case' 0 N--CA 1.425 -1.68 0 C-N-CA 125.312 1.445 . . . . 0.0 109.441 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.6 tt -43.22 -35.36 1.39 Allowed 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 126.387 1.875 . . . . 0.0 113.246 -173.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.413 ' HA ' ' CG1' ' A' ' 163' ' ' VAL . 2.3 pt? -58.18 -22.43 51.51 Favored 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 179.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.485 ' HG2' ' O ' ' A' ' 158' ' ' SER . 37.7 ptt180 -68.04 -39.17 83.11 Favored 'General case' 0 C--O 1.223 -0.34 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 176.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 93.7 m -86.51 -31.64 21.18 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.731 -177.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.413 ' CG1' ' HA ' ' A' ' 160' ' ' LEU . 0.5 OUTLIER -65.32 -26.19 38.94 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 CA-C-O 121.664 0.745 . . . . 0.0 111.083 -177.416 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -86.44 -8.01 57.97 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.597 178.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -104.41 16.41 26.2 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.441 -178.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 84.5 mt -77.72 127.01 83.43 Favored Pre-proline 0 C--N 1.302 -1.46 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -66.31 128.55 19.6 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 121.778 1.652 . . . . 0.0 109.522 177.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 120.66 -33.87 4.29 Favored Glycine 0 N--CA 1.427 -1.953 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 -177.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 93.3 t -59.33 -60.27 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 CA-C-O 121.294 0.568 . . . . 0.0 110.447 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 113.87 95.04 2.1 Favored Glycine 0 N--CA 1.428 -1.833 0 C-N-CA 119.965 -1.112 . . . . 0.0 112.248 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -76.68 -20.57 56.47 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 121.274 0.559 . . . . 0.0 110.863 -178.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 57.5 t -83.11 -29.87 8.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-O 121.672 0.749 . . . . 0.0 109.362 178.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -83.44 -7.18 59.6 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.432 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -49.14 -50.12 65.5 Favored Pre-proline 0 CA--C 1.551 0.99 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 -176.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.502 ' O ' ' HG3' ' A' ' 179' ' ' GLN . 10.9 Cg_endo -57.28 -36.84 99.01 Favored 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 121.583 1.522 . . . . 0.0 112.862 177.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 60.4 tp -71.83 -40.47 69.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 97.0 mt -66.05 -34.03 77.16 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.705 179.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 47.9 tp -70.72 -13.94 62.25 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.441 0.639 . . . . 0.0 110.834 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . 0.502 ' HG3' ' O ' ' A' ' 175' ' ' PRO . 21.0 mt-30 -89.43 -35.99 15.7 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 176.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 40.9 mmtm -80.83 -47.43 13.84 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.212 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . 0.529 ' CD2' ' HA ' ' A' ' 187' ' ' LEU . 80.1 m-85 -101.78 145.54 30.65 Favored Pre-proline 0 C--N 1.296 -1.753 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -177.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -56.8 -47.57 22.76 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 122.919 2.412 . . . . 0.0 111.673 177.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 78.2 p -153.24 171.58 18.31 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 -178.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -63.32 -25.14 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 121.333 0.587 . . . . 0.0 110.401 176.003 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -65.51 -45.12 84.77 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.359 -178.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -79.49 -36.2 39.01 Favored 'General case' 0 C--O 1.203 -1.381 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 176.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.529 ' HA ' ' CD2' ' A' ' 181' ' ' PHE . 4.7 tt -49.1 -66.29 0.42 Allowed 'General case' 0 C--O 1.213 -0.844 0 C-N-CA 125.482 1.513 . . . . 0.0 111.503 -175.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 35.1 m -70.95 -20.78 62.41 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -175.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -90.89 0.59 57.45 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.58 155.46 35.71 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 122.902 0.481 . . . . 0.0 110.445 175.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' SER . . . . . 0.404 ' OG ' ' HG3' ' A' ' 194' ' ' GLU . 27.9 p -66.98 165.24 15.99 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.125 -178.447 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 50.7 mm -55.91 -37.64 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -58.58 -37.08 88.12 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-N 115.309 -0.86 . . . . 0.0 113.514 178.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . 0.404 ' HG3' ' OG ' ' A' ' 191' ' ' SER . 30.1 mt-10 -83.4 -37.88 22.69 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.336 0.589 . . . . 0.0 109.503 -177.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 95.0 mt -71.65 -31.76 67.19 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.866 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -67.1 -31.37 71.79 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.35 0.595 . . . . 0.0 109.743 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -63.81 -26.27 68.55 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 114.865 -1.061 . . . . 0.0 112.723 179.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 12.2 m -103.88 -38.35 5.02 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.466 HG21 ' H ' ' A' ' 200' ' ' GLY . 2.5 m -117.05 -80.55 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 178.081 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . 0.466 ' H ' HG21 ' A' ' 199' ' ' VAL . . . -177.99 166.41 36.54 Favored Glycine 0 N--CA 1.418 -2.525 0 N-CA-C 108.434 -1.866 . . . . 0.0 108.434 -178.082 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . 0.521 ' O ' ' HG3' ' A' ' 205' ' ' GLN . 63.4 tt0 -68.54 -43.37 76.84 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 118.038 0.919 . . . . 0.0 110.837 -178.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -65.46 -32.99 74.9 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.122 0.487 . . . . 0.0 110.866 -179.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 2.4 t -75.53 -40.89 41.74 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.738 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -179.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -57.94 -43.85 86.56 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.355 -179.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . 0.521 ' HG3' ' O ' ' A' ' 201' ' ' GLN . 26.7 mt-30 -61.89 -47.12 86.4 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.684 -178.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -69.53 -33.05 72.24 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.437 -0.505 . . . . 0.0 111.54 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 99.2 mt -69.24 -50.39 52.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.13 0.49 . . . . 0.0 109.82 176.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 59.5 t-80 -67.59 -39.88 84.81 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.253 -177.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -72.01 -18.39 61.97 Favored 'General case' 0 C--O 1.213 -0.826 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -55.12 -51.45 66.4 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.396 0.617 . . . . 0.0 110.459 -178.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -89.37 -27.67 20.31 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.994 -179.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 60.4 m -73.97 -46.81 41.63 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -177.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -84.16 136.56 40.67 Favored Pre-proline 0 C--N 1.304 -1.377 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -176.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo -51.6 144.06 34.51 Favored 'Trans proline' 0 C--O 1.249 1.035 0 C-N-CA 123.218 2.612 . . . . 0.0 112.586 176.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 28.4 mmm180 . . . . . 0 C--N 1.289 -2.024 0 CA-C-N 114.825 -1.08 . . . . 0.0 108.482 -175.993 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 2.9 p . . . . . 0 N--CA 1.427 -1.588 0 CA-C-O 121.391 0.615 . . . . 0.0 110.893 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -104.78 160.02 15.32 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 115.401 -0.818 . . . . 0.0 108.988 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -115.93 167.44 10.24 Favored Pre-proline 0 C--N 1.286 -2.194 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -66.62 96.08 0.35 Allowed 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 121.459 1.439 . . . . 0.0 109.839 172.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 45.2 tp -68.97 -38.29 79.28 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 92.3 mt -94.42 111.73 23.48 Favored 'General case' 0 N--CA 1.424 -1.731 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 174.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 165.97 -149.66 16.07 Favored Glycine 0 N--CA 1.428 -1.892 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -176.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 15.3 ptmm? -119.48 114.2 21.92 Favored 'General case' 0 C--N 1.293 -1.853 0 C-N-CA 119.363 -0.935 . . . . 0.0 111.965 179.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.53 96.32 2.89 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 106.071 -1.825 . . . . 0.0 106.071 173.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 2.3 tpp180 -92.35 109.42 20.81 Favored 'General case' 0 C--N 1.285 -2.207 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.412 -174.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -89.58 102.7 15.38 Favored 'General case' 0 N--CA 1.426 -1.639 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 175.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 55.8 tp -100.11 118.65 36.91 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.499 -176.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.467 HD13 ' H ' ' A' ' 154' ' ' LEU . 0.2 OUTLIER -151.99 166.84 30.32 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 103.955 -2.609 . . . . 0.0 103.955 -177.964 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.481 ' O ' HD11 ' A' ' 154' ' ' LEU . 2.5 pp -61.55 99.17 0.1 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 122.572 1.177 . . . . 0.0 112.726 179.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 19.2 m -84.77 107.88 17.18 Favored 'General case' 0 N--CA 1.417 -2.089 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.616 178.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -113.83 134.21 22.14 Favored Pre-proline 0 N--CA 1.413 -2.288 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 177.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -66.68 -14.99 46.12 Favored 'Trans proline' 0 C--O 1.235 0.366 0 C-N-CA 122.382 2.054 . . . . 0.0 110.995 177.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 3.8 m -77.08 79.89 3.61 Favored 'General case' 0 N--CA 1.415 -2.178 0 CA-C-N 115.354 -0.839 . . . . 0.0 108.967 177.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 48.8 tp -90.62 -33.63 15.78 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.579 -178.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -49.59 -40.9 40.4 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.159 0.984 . . . . 0.0 112.542 -178.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -59.89 -47.05 87.32 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.35 178.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 38.0 m -86.18 -29.72 23.0 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 120.988 0.423 . . . . 0.0 112.083 -175.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -67.0 -25.38 34.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 121.701 0.762 . . . . 0.0 111.239 -175.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 24.6 pt20 -82.59 -7.6 59.64 Favored 'General case' 0 C--N 1.315 -0.921 0 O-C-N 121.897 -0.502 . . . . 0.0 111.847 177.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -101.77 21.92 13.74 Favored 'General case' 0 C--O 1.239 0.553 0 CA-C-O 121.459 0.647 . . . . 0.0 110.671 -178.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.442 HG22 ' HA ' ' A' ' 207' ' ' ILE . 74.5 mt -88.51 133.15 36.93 Favored Pre-proline 0 C--N 1.303 -1.425 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.395 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -64.18 128.58 21.98 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 121.708 1.606 . . . . 0.0 109.745 175.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 118.76 -30.97 5.71 Favored Glycine 0 N--CA 1.43 -1.715 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -174.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 97.8 t -74.22 -59.58 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 176.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 104.69 147.16 16.19 Favored Glycine 0 N--CA 1.44 -1.074 0 C-N-CA 120.931 -0.652 . . . . 0.0 113.923 174.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . 0.411 ' HG3' ' N ' ' A' ' 172' ' ' VAL . 57.2 pttt -89.64 -43.36 10.8 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.11 0.481 . . . . 0.0 110.883 176.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.411 ' N ' ' HG3' ' A' ' 171' ' ' LYS . 40.4 t -81.32 -33.17 12.47 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.69 0 CA-C-O 121.679 0.752 . . . . 0.0 109.933 -174.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.486 ' O ' ' HG ' ' A' ' 177' ' ' LEU . 14.4 ptmm? -90.94 5.94 46.66 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.931 -179.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -66.11 -47.39 62.18 Favored Pre-proline 0 CA--C 1.55 0.972 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.471 ' O ' ' HG2' ' A' ' 179' ' ' GLN . 37.0 Cg_exo -61.25 -36.88 77.56 Favored 'Trans proline' 0 C--N 1.384 2.438 0 C-N-CA 121.555 1.503 . . . . 0.0 110.724 178.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 58.9 tp -61.71 -46.79 88.15 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.3 175.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 173' ' ' LYS . 94.1 mt -61.38 -37.69 84.32 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.938 178.307 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 95.7 mt -65.75 -17.92 64.96 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.337 177.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . 0.471 ' HG2' ' O ' ' A' ' 175' ' ' PRO . 15.3 mm100 -92.47 -7.81 46.42 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 120.899 0.381 . . . . 0.0 110.488 177.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.467 ' HZ1' ' HA ' ' A' ' 180' ' ' LYS . 0.3 OUTLIER -102.87 -51.68 3.23 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.644 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . 0.471 ' CD2' ' HG ' ' A' ' 187' ' ' LEU . 88.3 m-85 -98.08 149.91 36.21 Favored Pre-proline 0 C--N 1.294 -1.843 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -63.89 -43.42 16.08 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 121.737 1.625 . . . . 0.0 112.063 -175.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 43.1 m -155.05 171.8 19.17 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -65.99 -28.94 45.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -175.015 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 22.4 tp60 -66.88 -35.8 80.85 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.973 -177.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -79.66 -37.44 35.89 Favored 'General case' 0 C--O 1.203 -1.349 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 176.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.471 ' HG ' ' CD2' ' A' ' 181' ' ' PHE . 4.3 tt -49.71 -68.07 0.21 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.065 1.346 . . . . 0.0 112.344 -173.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 20.1 m -72.65 -24.29 61.02 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 121.169 0.509 . . . . 0.0 111.818 -174.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -87.47 1.27 53.95 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.995 -179.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.2 155.76 33.98 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 121.085 0.469 . . . . 0.0 110.582 176.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 4.7 m -63.34 160.96 14.89 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.297 -177.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 46.4 mm -50.16 -41.06 18.13 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.865 0 C-N-CA 123.278 0.631 . . . . 0.0 110.927 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -61.82 -30.05 74.01 Favored Glycine 0 CA--C 1.523 0.549 0 CA-C-N 116.216 -0.447 . . . . 0.0 113.243 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -83.44 -44.67 14.51 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 98.4 mt -65.69 -28.29 68.96 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.857 -179.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -70.43 -35.41 73.37 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -63.5 -24.72 67.94 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.221 -0.9 . . . . 0.0 113.221 -178.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 13.4 m -101.47 -26.42 3.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -178.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.44 HG22 ' H ' ' A' ' 200' ' ' GLY . 2.2 m -131.77 -82.33 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 112.902 0.705 . . . . 0.0 112.902 174.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . 0.44 ' H ' HG22 ' A' ' 199' ' ' VAL . . . -177.37 165.36 35.16 Favored Glycine 0 N--CA 1.422 -2.249 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 -177.023 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -65.3 -39.07 92.05 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 117.596 0.698 . . . . 0.0 112.507 -177.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -66.91 -35.92 81.08 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.164 0.507 . . . . 0.0 110.306 -178.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.414 ' O ' ' HG2' ' A' ' 206' ' ' GLN . 2.0 t -76.62 -39.46 32.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 -179.165 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -57.22 -41.5 79.58 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.033 178.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . 0.493 ' HA ' HE21 ' A' ' 205' ' ' GLN . 0.0 OUTLIER -62.42 -40.82 97.79 Favored 'General case' 0 N--CA 1.424 -1.737 0 CA-C-N 115.133 -0.939 . . . . 0.0 112.341 179.689 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . 0.414 ' HG2' ' O ' ' A' ' 203' ' ' VAL . 20.8 pt20 -72.42 -34.59 67.96 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.895 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' ILE . . . . . 0.442 ' HA ' HG22 ' A' ' 166' ' ' ILE . 73.5 mt -65.67 -48.55 82.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.559 0.695 . . . . 0.0 109.417 175.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 46.9 t-80 -67.22 -40.38 86.37 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.071 -178.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -64.29 -25.93 68.26 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 178.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -56.62 -43.73 80.48 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.533 0.733 . . . . 0.0 110.894 -177.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -95.88 -28.46 14.7 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 120.108 -0.637 . . . . 0.0 111.838 178.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 86.7 m -64.24 -41.12 97.13 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -103.98 125.8 33.53 Favored Pre-proline 0 C--N 1.306 -1.311 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -81.69 157.46 18.75 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 121.957 1.771 . . . . 0.0 110.184 174.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 40.7 mtm180 . . . . . 0 C--N 1.294 -1.823 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.018 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 14.0 m . . . . . 0 N--CA 1.437 -1.116 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -103.91 124.71 49.48 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 178.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -91.77 124.98 58.94 Favored Pre-proline 0 C--N 1.306 -1.312 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -174.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -88.78 28.99 0.45 Allowed 'Trans proline' 0 CA--C 1.505 -0.966 0 C-N-CA 123.98 3.12 . . . . 0.0 112.09 179.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 61.4 tp -150.31 102.96 3.11 Favored 'General case' 0 N--CA 1.409 -2.482 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.93 -176.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 74.9 mt -106.63 109.04 20.84 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -160.41 145.67 11.48 Favored Glycine 0 N--CA 1.422 -2.261 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.286 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -99.47 168.67 9.83 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.76 150.38 49.48 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 177.201 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 23.3 ttt180 -111.99 97.41 6.65 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -96.62 101.25 12.83 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 45.6 tp -100.16 108.72 20.91 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 178.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -79.56 158.81 27.07 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.134 -175.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.496 HD21 ' O ' ' A' ' 154' ' ' LEU 0.303 0.0 OUTLIER -76.72 84.06 3.35 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 122.552 1.168 . . . . 0.0 112.104 178.75 . . . . . . . . 4 4 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 19.6 m -86.88 106.33 17.68 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 173.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -73.3 112.59 16.42 Favored Pre-proline 0 C--N 1.297 -1.697 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.206 -175.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -76.06 103.61 1.77 Allowed 'Trans proline' 0 N--CA 1.427 -2.412 0 C-N-CA 121.76 1.64 . . . . 0.0 108.522 176.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.582 ' O ' ' HG2' ' A' ' 161' ' ' ARG . 28.0 m -74.85 77.12 2.12 Favored 'General case' 0 N--CA 1.419 -2.008 0 CA-C-O 121.841 0.829 . . . . 0.0 109.099 178.237 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 42.4 mt -62.67 -21.82 66.01 Favored 'General case' 0 CA--C 1.487 -1.458 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -175.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -61.31 -29.58 69.96 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.66 176.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.582 ' HG2' ' O ' ' A' ' 158' ' ' SER . 27.0 ptt180 -78.86 -24.78 44.09 Favored 'General case' 0 C--O 1.216 -0.69 0 C-N-CA 120.485 -0.486 . . . . 0.0 109.703 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 26.5 m -86.19 -41.53 14.59 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-O 121.377 0.608 . . . . 0.0 110.379 178.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -59.78 -26.5 35.48 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 C-N-CA 124.216 1.007 . . . . 0.0 111.553 -177.434 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -83.29 -15.1 51.47 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.81 177.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -106.28 14.2 27.78 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-O 121.329 0.585 . . . . 0.0 110.129 -175.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 94.8 mt -71.56 132.05 85.82 Favored Pre-proline 0 C--O 1.249 1.04 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 176.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -63.15 128.44 22.81 Favored 'Trans proline' 0 C--O 1.246 0.924 0 C-N-CA 122.007 1.805 . . . . 0.0 109.768 176.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 117.1 -32.82 5.29 Favored Glycine 0 N--CA 1.431 -1.65 0 C-N-CA 120.789 -0.72 . . . . 0.0 111.391 -177.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 59.6 t -66.95 -71.43 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.773 0 CA-C-O 121.231 0.538 . . . . 0.0 109.674 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 113.66 109.42 2.88 Favored Glycine 0 N--CA 1.421 -2.302 0 C-N-CA 119.975 -1.107 . . . . 0.0 112.91 177.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt -78.74 -15.05 58.91 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 121.718 0.771 . . . . 0.0 109.69 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 91.0 t -79.81 -36.64 17.38 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.895 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.521 ' O ' ' HG ' ' A' ' 177' ' ' LEU . 9.3 ptpp? -90.43 -5.89 55.56 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.073 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -52.81 -49.67 85.45 Favored Pre-proline 0 CA--C 1.552 1.03 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -177.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -62.56 -23.94 74.99 Favored 'Trans proline' 0 C--N 1.371 1.714 0 C-N-CA 121.283 1.322 . . . . 0.0 112.824 176.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.449 ' HA ' HE21 ' A' ' 179' ' ' GLN . 59.6 tp -77.63 -39.34 45.58 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 175.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 173' ' ' LYS . 87.4 mt -69.17 -33.05 72.79 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.837 -179.228 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 41.1 tp -68.24 -12.73 61.47 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-O 121.824 0.821 . . . . 0.0 110.76 178.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . 0.449 HE21 ' HA ' ' A' ' 176' ' ' LEU . 51.3 mt-30 -94.13 -3.34 51.22 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.829 177.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 37.2 mmtm -117.51 -45.91 2.69 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 121.284 0.564 . . . . 0.0 110.94 177.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -102.4 145.03 29.79 Favored Pre-proline 0 C--N 1.303 -1.451 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 -179.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -67.0 -34.45 29.04 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 121.723 1.615 . . . . 0.0 112.411 -176.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 84.5 p -151.29 166.49 30.79 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -178.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -66.91 -25.02 33.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 O-C-N 123.384 0.428 . . . . 0.0 110.885 175.025 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -64.71 -47.46 78.24 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.45 178.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -73.37 -35.93 66.0 Favored 'General case' 0 C--O 1.195 -1.775 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.418 HD23 HD11 ' A' ' 177' ' ' LEU . 4.4 tt -49.04 -65.96 0.48 Allowed 'General case' 0 C--O 1.217 -0.631 0 C-N-CA 124.697 1.199 . . . . 0.0 110.398 -177.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 19.8 m -68.79 -23.75 64.33 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -177.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 26.6 m-80 -85.11 -2.76 58.37 Favored 'General case' 0 C--O 1.242 0.699 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 178.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -66.34 156.3 34.87 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 122.978 0.511 . . . . 0.0 110.965 178.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 15.8 m -63.05 153.3 34.44 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.832 -178.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 48.9 mm -51.21 -36.67 16.95 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.927 0 C-N-CA 123.84 0.856 . . . . 0.0 111.274 -176.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . 0.557 ' O ' ' HG2' ' A' ' 197' ' ' GLN . . . -58.42 -45.89 93.78 Favored Glycine 0 N--CA 1.443 -0.843 0 O-C-N 123.385 0.428 . . . . 0.0 112.547 178.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . 0.471 ' O ' ' HB2' ' A' ' 197' ' ' GLN . 11.1 mm-40 -67.96 -40.77 83.13 Favored 'General case' 0 CA--C 1.494 -1.208 0 CA-C-O 121.772 0.796 . . . . 0.0 109.705 -177.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 94.3 mt -70.82 -31.09 67.71 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.76 178.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -68.95 -35.71 77.1 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.557 ' HG2' ' O ' ' A' ' 193' ' ' GLY . 15.5 mm100 -57.89 -33.31 68.6 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.638 -1.164 . . . . 0.0 111.465 177.172 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 14.2 m -103.33 -35.04 3.62 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -176.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.402 HG23 ' H ' ' A' ' 200' ' ' GLY . 2.4 m -118.89 -77.66 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 176.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . 0.402 ' H ' HG23 ' A' ' 199' ' ' VAL . . . -178.69 165.33 34.39 Favored Glycine 0 N--CA 1.419 -2.443 0 N-CA-C 107.963 -2.055 . . . . 0.0 107.963 -177.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . 0.401 ' O ' ' HG3' ' A' ' 205' ' ' GLN . 35.7 tt0 -66.07 -45.65 80.52 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 117.762 0.781 . . . . 0.0 109.855 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -67.76 -33.59 75.14 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-O 121.161 0.505 . . . . 0.0 110.983 -179.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 2.6 t -73.81 -40.52 53.53 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.686 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 -178.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -56.04 -44.97 79.3 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.545 -1.207 . . . . 0.0 109.882 177.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . 0.401 ' HG3' ' O ' ' A' ' 201' ' ' GLN . 27.4 mt-30 -59.32 -50.9 72.19 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.582 178.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -66.97 -30.63 70.81 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 121.046 -0.261 . . . . 0.0 111.559 -176.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 97.4 mt -75.11 -51.4 21.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.373 177.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 9.7 t60 -69.86 -38.4 76.43 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.368 0.604 . . . . 0.0 110.202 -175.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -77.95 -9.94 59.34 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -60.1 -51.29 70.23 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-O 121.514 0.673 . . . . 0.0 110.395 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -86.82 -26.97 23.79 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.394 -179.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 37.6 m -72.77 -43.97 62.18 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.595 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -114.21 119.16 40.98 Favored Pre-proline 0 C--N 1.303 -1.443 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -44.84 128.38 8.89 Favored 'Trans proline' 0 C--O 1.251 1.146 0 C-N-CA 123.93 3.087 . . . . 0.0 113.981 177.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 35.8 ttm180 . . . . . 0 C--N 1.295 -1.799 0 CA-C-N 113.955 -1.475 . . . . 0.0 108.773 -178.5 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 61.0 m . . . . . 0 C--O 1.243 0.75 0 N-CA-C 111.509 0.189 . . . . 0.0 111.509 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp 70.12 -62.11 0.44 Allowed 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 125.095 1.358 . . . . 0.0 112.168 177.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -98.64 148.68 34.88 Favored Pre-proline 0 C--N 1.299 -1.622 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -179.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -79.95 3.8 7.29 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.355 2.037 . . . . 0.0 112.04 178.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 55.1 tp 62.06 102.45 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 125.398 1.479 . . . . 0.0 111.272 -177.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 83.7 mt -77.79 109.52 11.88 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.557 0.694 . . . . 0.0 110.288 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -153.56 -150.18 5.38 Favored Glycine 0 N--CA 1.431 -1.673 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 -178.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.46 ' HB2' ' HZ3' ' A' ' 148' ' ' LYS . 0.1 OUTLIER -85.46 145.19 27.55 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.601 -179.914 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 66.1 pttt -150.03 153.97 37.39 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 177.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 17.9 ptt180 -120.62 104.4 9.9 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 121.872 0.844 . . . . 0.0 111.934 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -137.16 148.54 46.67 Favored 'General case' 0 N--CA 1.431 -1.388 0 CA-C-N 114.293 -1.322 . . . . 0.0 107.669 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 58.4 tp -121.01 116.76 25.69 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 91.7 mt -88.58 157.76 18.5 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 178.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 53.4 tp -86.71 77.24 9.37 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 121.585 0.707 . . . . 0.0 109.72 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 20.5 m -96.03 115.9 28.13 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.203 178.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -131.28 156.64 79.85 Favored Pre-proline 0 C--N 1.304 -1.403 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -49.33 -61.92 0.5 Allowed 'Trans proline' 0 CA--C 1.553 1.453 0 C-N-CA 124.077 3.184 . . . . 0.0 116.885 -176.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.519 ' O ' ' HG2' ' A' ' 161' ' ' ARG . 13.7 p -173.26 27.94 0.01 OUTLIER 'General case' 0 C--O 1.245 0.861 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -170.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -73.42 -43.75 59.79 Favored 'General case' 0 C--N 1.291 -1.963 0 O-C-N 121.546 -0.721 . . . . 0.0 109.166 -177.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.412 ' O ' HG13 ' A' ' 163' ' ' VAL . 2.1 pt? -60.21 -33.08 71.75 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -178.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.519 ' HG2' ' O ' ' A' ' 158' ' ' SER . 4.1 ptm180 -75.79 -26.26 57.15 Favored 'General case' 0 C--O 1.219 -0.536 0 CA-C-O 121.768 0.794 . . . . 0.0 109.75 -178.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 21.5 m -86.24 -35.43 20.01 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-O 121.537 0.685 . . . . 0.0 110.153 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.412 HG13 ' O ' ' A' ' 160' ' ' LEU . 0.4 OUTLIER -64.54 -25.2 37.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.224 -176.507 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -84.57 -10.8 57.06 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.115 0.484 . . . . 0.0 110.787 177.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -102.75 23.38 12.17 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.292 0.568 . . . . 0.0 110.364 -177.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 84.8 mt -84.18 129.57 57.81 Favored Pre-proline 0 C--N 1.308 -1.221 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.98 128.79 18.32 Favored 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 121.778 1.652 . . . . 0.0 110.561 177.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 113.89 -16.72 20.65 Favored Glycine 0 C--N 1.297 -1.635 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.807 179.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 77.9 t -61.69 -43.21 96.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-O 121.028 0.442 . . . . 0.0 110.87 179.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 108.35 88.53 1.98 Allowed Glycine 0 N--CA 1.44 -1.097 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.383 178.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -60.64 -33.67 73.14 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -178.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 38.3 t -83.93 -23.49 7.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.336 0.589 . . . . 0.0 109.927 -176.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.526 ' O ' ' HG ' ' A' ' 177' ' ' LEU . 31.2 mtpt -85.57 -2.17 57.88 Favored 'General case' 0 C--O 1.193 -1.911 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.826 -176.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -42.97 -52.07 12.01 Favored Pre-proline 0 CA--C 1.566 1.587 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 -176.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.72 -38.55 10.23 Favored 'Trans proline' 0 C--N 1.366 1.487 0 C-N-CA 121.653 1.569 . . . . 0.0 111.738 178.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 54.4 tp -64.05 -41.31 97.43 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.116 177.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.526 ' HG ' ' O ' ' A' ' 173' ' ' LYS . 94.5 mt -58.22 -36.79 73.68 Favored 'General case' 0 C--O 1.206 -1.198 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.424 175.21 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.425 ' HA ' ' O ' ' A' ' 181' ' ' PHE . 92.5 mt -70.81 -11.93 61.25 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.299 0.571 . . . . 0.0 112.272 178.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -88.06 -5.42 58.49 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.83 0.824 . . . . 0.0 109.41 174.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.452 ' HZ1' ' HA ' ' A' ' 180' ' ' LYS . 0.3 OUTLIER -113.82 -50.73 2.82 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.359 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . 0.52 ' CD2' ' HG ' ' A' ' 187' ' ' LEU . 34.5 m-85 -110.23 140.81 22.78 Favored Pre-proline 0 C--N 1.3 -1.549 0 CA-C-N 114.571 -1.195 . . . . 0.0 108.921 -177.244 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.91 -52.5 5.86 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 123.178 2.585 . . . . 0.0 112.682 178.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 50.7 m -154.64 172.83 17.24 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -179.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -54.05 -32.08 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 114.495 1.294 . . . . 0.0 114.495 -176.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -65.02 -43.06 93.7 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.901 0.381 . . . . 0.0 111.01 -177.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -79.42 -35.9 39.84 Favored 'General case' 0 C--O 1.196 -1.73 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 176.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.52 ' HG ' ' CD2' ' A' ' 181' ' ' PHE . 5.5 tt -51.82 -67.05 0.28 Allowed 'General case' 0 C--O 1.208 -1.126 0 C-N-CA 124.712 1.205 . . . . 0.0 112.208 -173.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 24.3 m -75.83 -18.72 59.36 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-O 121.157 0.503 . . . . 0.0 112.235 -174.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -93.57 -0.06 56.4 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.131 -179.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.93 155.6 36.02 Favored 'General case' 0 CA--C 1.506 -0.721 0 C-N-CA 123.539 0.736 . . . . 0.0 110.375 176.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 20.4 m -64.95 159.51 22.76 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.035 -176.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 48.2 mm -51.72 -39.62 24.56 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.647 0 C-N-CA 123.271 0.628 . . . . 0.0 110.707 -177.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -60.16 -37.92 93.63 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-N 116.003 -0.544 . . . . 0.0 113.482 179.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -75.1 -41.25 59.08 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -177.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 96.1 mt -68.64 -34.66 76.1 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.217 179.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . 0.456 ' HG2' ' N ' ' A' ' 201' ' ' GLN . 5.0 tm-20 -65.92 -33.75 76.53 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -178.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -61.88 -30.5 70.91 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.792 -1.094 . . . . 0.0 113.113 179.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 25.9 m -100.3 -36.27 5.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 C-N-CA 119.592 -0.843 . . . . 0.0 111.411 -179.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.487 HG22 ' H ' ' A' ' 200' ' ' GLY . 2.9 m -116.19 -85.65 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 176.216 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . 0.487 ' H ' HG22 ' A' ' 199' ' ' VAL . . . -176.82 165.67 35.97 Favored Glycine 0 N--CA 1.415 -2.708 0 N-CA-C 108.274 -1.93 . . . . 0.0 108.274 -175.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . 0.456 ' N ' ' HG2' ' A' ' 196' ' ' GLU . 52.9 tt0 -67.72 -42.15 82.37 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 117.496 0.648 . . . . 0.0 112.097 -174.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -66.66 -35.78 80.97 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.186 0.517 . . . . 0.0 110.624 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.495 ' O ' ' HG2' ' A' ' 206' ' ' GLN . 2.6 t -71.64 -40.38 70.62 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.747 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -57.06 -43.84 82.44 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 114.366 -1.288 . . . . 0.0 110.098 178.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . 0.407 ' HG3' ' O ' ' A' ' 201' ' ' GLN . 53.9 mt-30 -60.93 -45.59 94.06 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 114.955 -1.021 . . . . 0.0 112.372 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' GLN . . . . . 0.495 ' HG2' ' O ' ' A' ' 203' ' ' VAL . 13.2 pt20 -69.29 -30.86 69.03 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 120.236 -0.585 . . . . 0.0 110.708 -177.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 92.4 mt -73.44 -50.38 30.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.268 178.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 48.1 t-80 -69.1 -41.46 77.4 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.159 -177.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -73.44 -11.51 60.49 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 121.941 -0.474 . . . . 0.0 112.227 179.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -58.82 -51.9 68.02 Favored 'General case' 0 C--O 1.217 -0.646 0 C-N-CA 122.795 0.438 . . . . 0.0 110.743 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -80.51 -24.84 39.09 Favored 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.524 -179.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 27.5 m -61.84 -47.7 83.91 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.615 175.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -74.17 121.33 84.94 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.484 -178.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -80.48 147.59 17.91 Favored 'Trans proline' 0 C--O 1.253 1.256 0 C-N-CA 122.199 1.932 . . . . 0.0 112.181 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? . . . . . 0 N--CA 1.414 -2.242 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 179.806 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.9 tm? . . . . . 0 N--CA 1.436 -1.172 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.535 ' O ' HG12 ' A' ' 163' ' ' VAL . 2.0 pt? -58.81 -30.35 67.55 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.455 -179.155 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -78.78 -26.4 44.45 Favored 'General case' 0 C--N 1.309 -1.166 0 O-C-N 121.837 -0.54 . . . . 0.0 110.563 -179.532 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 24.9 m -85.84 -28.59 24.34 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.574 0.702 . . . . 0.0 109.637 177.262 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.535 HG12 ' O ' ' A' ' 160' ' ' LEU . 0.3 OUTLIER -66.3 -25.71 36.15 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 CA-C-O 121.832 0.825 . . . . 0.0 111.072 -176.703 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -84.87 -7.44 59.17 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.37 177.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -96.3 1.86 52.33 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.027 -178.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.404 HG21 ' HA ' ' A' ' 207' ' ' ILE . 70.3 mt -73.96 131.14 81.83 Favored Pre-proline 0 C--N 1.314 -0.975 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.057 -177.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -66.68 128.23 18.62 Favored 'Trans proline' 0 C--O 1.246 0.897 0 C-N-CA 121.934 1.756 . . . . 0.0 110.235 175.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 116.02 -24.23 10.2 Favored Glycine 0 C--N 1.297 -1.59 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 -178.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 65.6 t -75.02 -58.39 4.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 177.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 90.13 107.06 1.27 Allowed Glycine 0 N--CA 1.425 -2.062 0 CA-C-N 115.431 -0.804 . . . . 0.0 113.576 177.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? -68.46 -21.24 64.65 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 121.577 0.703 . . . . 0.0 111.201 178.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 57.9 t -82.53 -30.56 9.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-O 121.712 0.768 . . . . 0.0 109.35 178.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.429 ' O ' HD13 ' A' ' 177' ' ' LEU . 60.0 mtpt -84.79 -10.25 57.38 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.955 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -51.73 -53.79 46.97 Favored Pre-proline 0 C--O 1.201 -1.472 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -178.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -62.3 -26.58 77.3 Favored 'Trans proline' 0 C--N 1.376 1.982 0 C-N-CA 121.856 1.704 . . . . 0.0 113.413 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 61.6 tp -77.38 -45.27 26.49 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 121.741 0.781 . . . . 0.0 109.103 178.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.429 HD13 ' O ' ' A' ' 173' ' ' LYS . 8.2 mp -71.84 -24.35 61.69 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.873 178.257 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.449 HD12 ' O ' ' A' ' 181' ' ' PHE . 42.5 tp -67.31 -11.68 58.21 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 124.091 0.956 . . . . 0.0 110.401 177.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -76.53 -20.59 56.74 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.514 175.043 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 7.8 mmmm -105.58 -42.13 5.29 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.918 178.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' PHE . . . . . 0.449 ' O ' HD12 ' A' ' 178' ' ' LEU . 32.5 m-85 -105.64 130.55 22.87 Favored Pre-proline 0 C--N 1.299 -1.611 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.935 -174.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -53.73 -42.4 66.52 Favored 'Trans proline' 0 C--N 1.359 1.128 0 C-N-CA 123.623 2.882 . . . . 0.0 113.7 -175.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 42.6 m -158.5 177.5 11.17 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.482 ' HA ' ' HB3' ' A' ' 187' ' ' LEU . 0.2 OUTLIER -59.52 -27.89 38.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 -175.961 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -69.1 -38.63 79.03 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 120.67 0.272 . . . . 0.0 110.94 -177.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -79.9 -33.44 39.89 Favored 'General case' 0 C--O 1.195 -1.81 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 176.296 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.482 ' HB3' ' HA ' ' A' ' 184' ' ' ILE . 62.4 tp -52.63 -67.78 0.22 Allowed 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 125.104 1.362 . . . . 0.0 113.467 -176.258 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 188' ' ' SER . . . . . 0.438 ' HB2' HG22 ' A' ' 163' ' ' VAL . 19.4 m -74.65 -24.75 58.87 Favored 'General case' 0 C--N 1.289 -2.04 0 C-N-CA 120.24 -0.584 . . . . 0.0 111.609 -176.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.473 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 62.4 t30 -89.45 12.0 17.7 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-O 122.095 0.95 . . . . 0.0 110.025 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.51 156.62 31.95 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.606 173.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 6.6 m -63.6 154.38 32.91 Favored 'General case' 0 N--CA 1.425 -1.676 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.082 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 48.9 mm -52.02 -39.73 26.96 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.825 0 C-N-CA 123.477 0.711 . . . . 0.0 110.889 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' GLY . . . . . 0.502 ' O ' ' HG2' ' A' ' 197' ' ' GLN . . . -59.39 -39.13 94.39 Favored Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 116.18 -0.464 . . . . 0.0 112.631 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 194' ' ' GLU . . . . . 0.441 ' O ' ' HB2' ' A' ' 197' ' ' GLN . 41.6 mm-40 -77.72 -38.55 46.96 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.43 0.633 . . . . 0.0 109.807 -176.533 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 96.8 mt -69.88 -32.2 70.42 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.485 178.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -67.37 -29.72 69.32 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -178.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' GLN . . . . . 0.502 ' HG2' ' O ' ' A' ' 193' ' ' GLY . 15.8 mm100 -59.62 -33.84 72.01 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.737 -1.12 . . . . 0.0 112.441 178.671 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 23.4 m -103.48 -26.83 3.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -174.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.484 HG23 ' H ' ' A' ' 200' ' ' GLY . 1.4 m -123.15 -82.82 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 175.531 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 200' ' ' GLY . . . . . 0.484 ' H ' HG23 ' A' ' 199' ' ' VAL . . . -177.0 167.87 39.42 Favored Glycine 0 N--CA 1.419 -2.449 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 -177.209 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 19.5 tm0? -64.14 -47.95 77.94 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 123.254 0.622 . . . . 0.0 110.814 -175.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -71.65 -32.34 67.81 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.859 0.361 . . . . 0.0 111.066 -177.075 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.442 ' O ' ' HG2' ' A' ' 206' ' ' GLN . 2.9 t -69.03 -40.07 80.39 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.649 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 179.047 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -60.19 -43.18 96.12 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 114.294 -1.321 . . . . 0.0 109.675 177.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -59.72 -45.58 91.75 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.785 179.069 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' GLN . . . . . 0.442 ' HG2' ' O ' ' A' ' 203' ' ' VAL . 12.0 pt20 -66.26 -34.75 78.72 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 120.145 -0.622 . . . . 0.0 111.084 -179.041 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 207' ' ' ILE . . . . . 0.404 ' HA ' HG21 ' A' ' 166' ' ' ILE . 87.3 mt -69.43 -51.48 41.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.291 0.567 . . . . 0.0 109.712 178.342 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 208' ' ' HIS . . . . . 0.553 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 13.4 t60 -68.0 -36.71 80.46 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.237 -175.49 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -68.06 -32.79 73.37 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.694 176.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -54.62 -52.21 62.94 Favored 'General case' 0 C--O 1.215 -0.733 0 C-N-CA 124.023 0.929 . . . . 0.0 112.367 -174.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.553 ' CZ ' ' HA ' ' A' ' 208' ' ' HIS . 21.5 p90 -80.8 -23.85 38.96 Favored 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 120.36 -0.536 . . . . 0.0 112.097 -178.664 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 75.2 m . . . . . 0 C--O 1.247 0.932 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.248 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.483 ' O ' HD23 ' A' ' 159' ' ' LEU . 6.2 tt . . . . . 0 C--O 1.215 -0.73 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -59.37 -22.36 61.24 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.045 0.45 . . . . 0.0 111.738 178.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 32.8 ptt180 -73.49 -35.42 65.64 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.275 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.451 ' HA ' ' OE1' ' A' ' 165' ' ' GLN . 33.3 m -87.03 -29.11 22.18 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 124.244 1.018 . . . . 0.0 112.163 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 2.8 p -64.56 -27.08 41.76 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-O 121.752 0.787 . . . . 0.0 110.757 -176.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -82.94 -8.67 59.54 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.91 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.451 ' OE1' ' HA ' ' A' ' 162' ' ' THR . 51.0 mt-30 -98.42 0.42 45.26 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.665 -177.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 96.4 mt -68.43 131.54 91.66 Favored Pre-proline 0 C--N 1.312 -1.048 0 N-CA-C 108.876 -0.786 . . . . 0.0 108.876 178.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -61.36 128.72 25.77 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 121.843 1.696 . . . . 0.0 109.632 177.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 115.52 -30.12 6.87 Favored Glycine 0 N--CA 1.429 -1.773 0 C-N-CA 120.267 -0.968 . . . . 0.0 111.279 -178.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 84.5 t -66.2 -62.91 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 103.47 105.19 2.95 Favored Glycine 0 N--CA 1.427 -1.964 0 C-N-CA 120.575 -0.822 . . . . 0.0 112.164 178.204 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -81.29 -17.11 50.46 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -177.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 42.4 t -85.15 -37.84 12.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 CA-C-O 121.596 0.712 . . . . 0.0 109.3 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.518 ' O ' ' HG ' ' A' ' 177' ' ' LEU . 20.8 ptmt -88.72 -4.75 58.45 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.509 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -54.72 -48.89 94.24 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -178.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.489 ' O ' ' HG2' ' A' ' 179' ' ' GLN . 11.2 Cg_endo -57.27 -35.15 98.85 Favored 'Trans proline' 0 C--N 1.38 2.237 0 C-N-CA 121.715 1.61 . . . . 0.0 112.179 177.483 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 59.4 tp -69.31 -42.4 75.45 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.274 0.559 . . . . 0.0 109.54 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.518 ' HG ' ' O ' ' A' ' 173' ' ' LYS . 74.5 mt -69.47 -29.85 67.6 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.795 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 50.9 tp -70.73 -12.57 61.63 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.738 179.234 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' GLN . . . . . 0.489 ' HG2' ' O ' ' A' ' 175' ' ' PRO . 24.8 mm-40 -88.22 -13.77 40.2 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 176.515 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -99.33 -51.52 3.77 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 -179.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' PHE . . . . . 0.581 ' CD2' ' HG ' ' A' ' 187' ' ' LEU . 89.7 m-85 -94.24 148.85 35.8 Favored Pre-proline 0 C--N 1.307 -1.267 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.183 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -68.94 -31.29 24.66 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.053 1.835 . . . . 0.0 113.332 -175.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 66.5 m -158.56 161.84 37.32 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -62.01 -29.41 46.39 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.411 0 O-C-N 123.55 0.531 . . . . 0.0 112.024 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -62.54 -47.7 82.77 Favored 'General case' 0 C--O 1.211 -0.966 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.429 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 14.0 tm0? -74.08 -31.18 62.72 Favored 'General case' 0 C--O 1.2 -1.528 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -179.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.581 ' HG ' ' CD2' ' A' ' 181' ' ' PHE . 4.5 tt -57.81 -59.91 4.5 Favored 'General case' 0 C--O 1.204 -1.301 0 C-N-CA 123.811 0.844 . . . . 0.0 109.561 -178.297 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 22.8 m -73.77 -24.72 59.89 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -178.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -86.98 1.99 50.95 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-O 121.516 0.674 . . . . 0.0 110.724 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.55 156.94 31.07 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 124.023 0.929 . . . . 0.0 111.373 175.267 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 5.0 m -64.49 159.72 20.91 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.249 -178.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 43.1 mm -52.67 -38.79 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 123.205 0.602 . . . . 0.0 111.449 -179.077 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' GLY . . . . . 0.506 ' O ' ' HG2' ' A' ' 197' ' ' GLN . . . -61.48 -43.65 99.04 Favored Glycine 0 C--O 1.214 -1.142 0 C-N-CA 120.853 -0.689 . . . . 0.0 111.908 178.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -67.47 -41.23 84.95 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.635 0.731 . . . . 0.0 109.575 -176.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 94.2 mt -70.47 -31.05 68.03 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.001 -0.999 . . . . 0.0 111.121 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 196' ' ' GLU . . . . . 0.543 ' HG2' ' N ' ' A' ' 201' ' ' GLN . 4.2 tm-20 -73.42 -41.01 63.81 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 197' ' ' GLN . . . . . 0.506 ' HG2' ' O ' ' A' ' 193' ' ' GLY . 85.5 mm-40 -57.66 -25.32 60.04 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 123.8 0.84 . . . . 0.0 112.369 178.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.405 HG23 HG23 ' A' ' 199' ' ' VAL . 14.6 m -103.52 -34.84 3.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.539 HG11 HG11 ' A' ' 203' ' ' VAL . 1.2 t -122.01 -77.43 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 C-N-CA 119.259 -0.976 . . . . 0.0 111.392 178.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -177.22 160.43 27.34 Favored Glycine 0 N--CA 1.435 -1.383 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 -176.044 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' GLN . . . . . 0.543 ' N ' ' HG2' ' A' ' 196' ' ' GLU . 13.9 pt20 -63.36 -38.05 89.64 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 123.624 0.77 . . . . 0.0 112.34 -176.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -74.86 -34.92 62.34 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 121.837 0.827 . . . . 0.0 109.672 -178.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.539 HG11 HG11 ' A' ' 199' ' ' VAL . 24.8 t -68.53 -45.09 82.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-N 114.373 -1.285 . . . . 0.0 109.57 -179.397 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -53.51 -43.82 68.62 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 114.161 -1.381 . . . . 0.0 109.756 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -66.8 -44.98 79.84 Favored 'General case' 0 N--CA 1.421 -1.904 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.451 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 206' ' ' GLN . . . . . 0.467 ' HG2' ' O ' ' A' ' 203' ' ' VAL . 20.9 pt20 -66.09 -33.67 76.31 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.254 -0.578 . . . . 0.0 111.147 -178.618 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 84.7 mt -73.59 -50.19 31.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.561 177.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 28.0 t-80 -63.75 -46.99 82.81 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.997 -177.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -72.35 -9.96 59.18 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -178.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -64.13 -47.43 79.98 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 178.325 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -97.79 -29.44 13.36 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.647 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 33.4 m . . . . . 0 CA--C 1.542 0.668 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -176.883 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 4.2 mm? . . . . . 0 CA--C 1.506 -0.741 0 N-CA-C 111.574 0.213 . . . . 0.0 111.574 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.521 HD23 ' H ' ' A' ' 160' ' ' LEU . 1.7 pt? -60.53 -32.63 71.66 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.281 0.562 . . . . 0.0 111.232 178.22 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.413 ' O ' ' HG2' ' A' ' 164' ' ' GLN . 14.8 ptm180 -75.39 -30.14 60.03 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.036 177.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.601 ' O ' ' HG2' ' A' ' 165' ' ' GLN . 12.0 m -81.27 -37.99 27.58 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-O 121.457 0.646 . . . . 0.0 110.015 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.402 HG12 ' O ' ' A' ' 160' ' ' LEU . 1.7 p -63.55 -25.15 37.65 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.049 0 CA-C-O 121.479 0.657 . . . . 0.0 110.952 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' GLN . . . . . 0.413 ' HG2' ' O ' ' A' ' 161' ' ' ARG . 12.1 pt20 -90.13 -11.64 40.64 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 122.015 -0.428 . . . . 0.0 110.9 178.139 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.601 ' HG2' ' O ' ' A' ' 162' ' ' THR . 18.9 pt20 -91.77 -6.02 52.54 Favored 'General case' 0 CA--C 1.505 -0.783 0 C-N-CA 119.303 -0.959 . . . . 0.0 111.168 -174.194 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 66.0 mt -61.19 133.51 92.84 Favored Pre-proline 0 C--N 1.298 -1.654 0 CA-C-N 114.823 -1.08 . . . . 0.0 109.481 -178.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -63.3 127.96 21.4 Favored 'Trans proline' 0 C--O 1.246 0.91 0 C-N-CA 122.022 1.815 . . . . 0.0 110.345 179.24 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 114.36 -32.82 5.71 Favored Glycine 0 N--CA 1.424 -2.126 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 -177.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 57.9 t -69.02 -53.01 28.27 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 177.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' GLY . . . . . 0.483 ' HA3' ' HG2' ' A' ' 173' ' ' LYS . . . 88.88 90.93 1.15 Allowed Glycine 0 N--CA 1.414 -2.779 0 CA-C-N 114.77 -1.105 . . . . 0.0 111.818 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -66.3 -23.18 66.33 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 120.776 0.322 . . . . 0.0 111.724 -178.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 47.2 t -86.53 -28.19 5.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-O 121.194 0.521 . . . . 0.0 110.281 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.564 ' O ' ' HG ' ' A' ' 177' ' ' LEU . 21.0 ptmt -91.29 9.26 32.18 Favored 'General case' 0 C--O 1.214 -0.764 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.707 178.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' ALA . . . . . 0.464 ' O ' ' HG ' ' A' ' 178' ' ' LEU . . . -52.07 -48.66 87.88 Favored Pre-proline 0 CA--C 1.556 1.2 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 177.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -59.99 -23.22 72.22 Favored 'Trans proline' 0 C--N 1.381 2.243 0 C-N-CA 122.401 2.067 . . . . 0.0 112.867 177.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.497 ' HB3' ' O ' ' A' ' 173' ' ' LYS . 51.0 tp -79.23 -21.05 46.77 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 123.683 0.793 . . . . 0.0 109.489 178.426 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.564 ' HG ' ' O ' ' A' ' 173' ' ' LYS . 39.7 mt -98.32 -34.46 10.68 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -178.472 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 174' ' ' ALA . 95.2 mt -66.82 -5.66 13.17 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.997 0.919 . . . . 0.0 112.732 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' GLN . . . . . 0.473 ' HG2' ' O ' ' A' ' 176' ' ' LEU . 16.1 pt20 -74.5 -35.02 63.2 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 172.622 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm -92.52 -51.43 5.13 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.138 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' PHE . . . . . 0.426 ' CD1' ' HA ' ' A' ' 187' ' ' LEU . 89.9 m-85 -90.27 144.36 30.9 Favored Pre-proline 0 C--N 1.304 -1.401 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.63 -176.369 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -69.78 -44.56 1.99 Allowed 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 121.851 1.701 . . . . 0.0 112.652 -175.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 45.4 m -152.38 167.84 27.4 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 178.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.489 HD13 ' H ' ' A' ' 184' ' ' ILE . 0.2 OUTLIER -60.75 -31.76 50.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 N-CA-C 115.613 1.708 . . . . 0.0 115.613 -173.225 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -68.57 -45.92 70.78 Favored 'General case' 0 C--O 1.207 -1.15 0 C-N-CA 118.81 -1.156 . . . . 0.0 110.425 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 11.1 tm0? -67.49 -32.8 73.87 Favored 'General case' 0 C--O 1.209 -1.059 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.426 ' HA ' ' CD1' ' A' ' 181' ' ' PHE . 3.6 tt -56.76 -62.6 1.62 Allowed 'General case' 0 C--O 1.213 -0.857 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.5 -179.181 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 29.5 m -70.87 -27.82 64.11 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -178.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.498 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 11.1 t-20 -81.03 -3.25 51.17 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-O 121.222 0.534 . . . . 0.0 110.511 -178.062 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.412 ' HB1' ' HB2' ' A' ' 194' ' ' GLU . . . -64.56 155.67 32.31 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 123.055 0.542 . . . . 0.0 110.79 177.043 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 20.6 t -68.09 170.65 8.08 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 121.262 0.553 . . . . 0.0 110.836 -175.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 47.7 mm -59.33 -39.61 79.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.55 -177.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' GLY . . . . . 0.548 ' O ' ' HG3' ' A' ' 197' ' ' GLN . . . -59.86 -38.62 94.31 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.305 178.267 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 194' ' ' GLU . . . . . 0.412 ' HB2' ' HB1' ' A' ' 190' ' ' ALA . 29.2 mt-10 -77.82 -43.12 31.42 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -176.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 96.2 mt -67.6 -25.32 65.7 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.712 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 196' ' ' GLU . . . . . 0.415 ' HG2' ' N ' ' A' ' 201' ' ' GLN . 9.7 tm-20 -73.67 -31.7 63.59 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 197' ' ' GLN . . . . . 0.548 ' HG3' ' O ' ' A' ' 193' ' ' GLY . 98.4 mt-30 -68.8 -20.29 64.32 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.913 -1.04 . . . . 0.0 111.702 -178.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.434 HG23 HG23 ' A' ' 199' ' ' VAL . 16.7 m -105.19 -33.32 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.74 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.023 177.444 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.512 HG11 HG11 ' A' ' 203' ' ' VAL . 1.7 t -124.64 -84.48 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 C-N-CA 120.338 -0.545 . . . . 0.0 111.504 176.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -177.91 168.95 40.66 Favored Glycine 0 N--CA 1.436 -1.331 0 N-CA-C 109.851 -1.299 . . . . 0.0 109.851 -176.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' GLN . . . . . 0.415 ' N ' ' HG2' ' A' ' 196' ' ' GLU . 51.5 mt-30 -59.14 -52.86 63.9 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.911 0.884 . . . . 0.0 112.628 -175.456 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -68.85 -35.39 76.88 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 121.45 0.643 . . . . 0.0 111.186 -173.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.512 HG11 HG11 ' A' ' 199' ' ' VAL . 2.2 t -72.57 -38.19 58.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -178.241 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -57.85 -44.11 86.34 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 114.347 -1.297 . . . . 0.0 109.844 178.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -64.42 -42.78 95.86 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.886 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -74.56 -25.02 59.02 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.417 -0.513 . . . . 0.0 112.239 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 98.2 mt -76.4 -49.43 24.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 174.319 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 53.3 t-80 -63.44 -47.36 82.2 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.003 -178.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -65.74 -20.07 66.13 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -179.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -59.05 -44.13 91.76 Favored 'General case' 0 C--O 1.214 -0.792 0 C-N-CA 122.799 0.439 . . . . 0.0 110.613 -178.205 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.498 ' CZ ' ' HA ' ' A' ' 189' ' ' ASN . 31.6 p90 -99.4 -25.73 14.37 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.672 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 37.5 m . . . . . 0 C--N 1.313 -1.022 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -178.692 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.4 tm? . . . . . 0 CA--C 1.527 0.086 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.654 ' H ' HD23 ' A' ' 160' ' ' LEU . 1.6 pt? -60.38 -23.79 64.59 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.267 -0.879 . . . . 0.0 112.118 178.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.412 ' O ' ' HG2' ' A' ' 164' ' ' GLN . 14.3 ptm180 -65.87 -29.36 69.79 Favored 'General case' 0 C--O 1.215 -0.744 0 CA-C-O 120.92 0.39 . . . . 0.0 110.115 176.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 37.9 m -86.55 -31.75 21.06 Favored 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 123.025 0.53 . . . . 0.0 111.39 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.51 HG12 ' O ' ' A' ' 160' ' ' LEU . 2.5 p -64.52 -25.66 38.43 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.115 0 CA-C-O 121.418 0.627 . . . . 0.0 111.372 -176.429 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' GLN . . . . . 0.412 ' HG2' ' O ' ' A' ' 161' ' ' ARG . 29.5 pt20 -81.32 -13.01 58.87 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 121.161 0.505 . . . . 0.0 110.459 177.767 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -95.38 -0.05 53.0 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.545 -175.234 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 81.2 mt -66.14 132.42 94.53 Favored Pre-proline 0 C--N 1.317 -0.837 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.28 128.16 26.54 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.096 1.864 . . . . 0.0 111.006 178.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 112.65 -29.91 7.87 Favored Glycine 0 N--CA 1.425 -2.096 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 -178.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 59.1 t -73.25 -65.74 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.062 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 101.97 110.55 3.38 Favored Glycine 0 N--CA 1.43 -1.737 0 C-N-CA 120.314 -0.946 . . . . 0.0 112.799 177.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -82.66 -18.88 39.47 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.4 0.619 . . . . 0.0 111.597 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 62.7 t -84.13 -30.35 7.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 CA-C-O 121.819 0.819 . . . . 0.0 109.27 177.005 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -90.34 -4.17 57.27 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.372 178.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' ALA . . . . . 0.507 ' O ' ' HG ' ' A' ' 178' ' ' LEU . . . -55.07 -47.16 99.19 Favored Pre-proline 0 C--O 1.202 -1.403 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -178.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.443 ' O ' ' HG3' ' A' ' 179' ' ' GLN . 36.2 Cg_exo -59.82 -36.99 89.33 Favored 'Trans proline' 0 C--N 1.381 2.243 0 CA-C-N 121.337 1.513 . . . . 0.0 111.234 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 57.2 tp -66.97 -44.64 79.96 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.665 176.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 96.3 mt -65.33 -32.25 73.79 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.027 178.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.507 ' HG ' ' O ' ' A' ' 174' ' ' ALA . 88.7 mt -72.44 -7.32 49.24 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 123.4 0.68 . . . . 0.0 111.774 178.074 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' GLN . . . . . 0.443 ' HG3' ' O ' ' A' ' 175' ' ' PRO . 52.6 mt-30 -95.65 -9.31 32.39 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.386 0.612 . . . . 0.0 109.356 174.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -105.18 -51.42 3.03 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.19 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' PHE . . . . . 0.448 ' CD2' ' HG ' ' A' ' 187' ' ' LEU . 86.4 m-85 -99.69 149.46 35.93 Favored Pre-proline 0 C--N 1.294 -1.837 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -66.99 -46.11 3.47 Favored 'Trans proline' 0 C--O 1.24 0.601 0 C-N-CA 121.439 1.426 . . . . 0.0 112.13 -175.184 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 30.0 m -151.33 167.79 26.81 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.241 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.432 HD13 ' H ' ' A' ' 184' ' ' ILE . 0.2 OUTLIER -60.67 -29.86 45.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 -174.274 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 56.8 tp60 -70.82 -39.13 73.23 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 119.731 -0.788 . . . . 0.0 110.384 -176.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 14.1 tm0? -76.06 -32.23 59.18 Favored 'General case' 0 C--O 1.197 -1.66 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 178.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.448 ' HG ' ' CD2' ' A' ' 181' ' ' PHE . 3.8 tt -56.53 -61.26 2.54 Favored 'General case' 0 C--O 1.212 -0.906 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.717 -178.447 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 19.8 m -70.26 -32.16 69.87 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 120.641 -0.423 . . . . 0.0 111.88 -178.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.405 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 7.9 t30 -83.96 4.72 28.47 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-O 121.566 0.698 . . . . 0.0 110.839 -177.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.414 ' HB1' ' HB2' ' A' ' 194' ' ' GLU . . . -65.46 156.16 33.26 Favored 'General case' 0 C--O 1.248 1.004 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.414 174.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 2.6 m -63.58 159.48 18.74 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.987 -176.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 50.8 mm -53.09 -36.25 24.45 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.963 0 C-N-CA 122.917 0.487 . . . . 0.0 111.537 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -69.47 -28.92 71.9 Favored Glycine 0 C--N 1.314 -0.66 0 C-N-CA 121.222 -0.513 . . . . 0.0 112.903 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' GLU . . . . . 0.678 ' O ' ' HG2' ' A' ' 197' ' ' GLN . 26.2 mt-10 -81.29 -31.28 33.69 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -178.516 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 97.3 mt -79.33 -29.45 42.32 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.409 175.053 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' GLU . . . . . 0.549 ' HG2' ' N ' ' A' ' 201' ' ' GLN . 2.6 tm-20 -69.59 -35.61 75.48 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -178.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 197' ' ' GLN . . . . . 0.678 ' HG2' ' O ' ' A' ' 194' ' ' GLU . 20.3 pt20 -67.19 -20.86 65.78 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.412 -176.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 15.7 m -104.6 -31.19 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -127.32 -83.41 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 173.135 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -177.21 164.07 33.14 Favored Glycine 0 CA--C 1.488 -1.602 0 N-CA-C 108.027 -2.029 . . . . 0.0 108.027 -176.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' GLN . . . . . 0.549 ' N ' ' HG2' ' A' ' 196' ' ' GLU . 12.1 pt20 -69.68 -38.59 77.08 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 118.239 1.02 . . . . 0.0 111.778 -176.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -64.25 -28.86 70.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.644 0.735 . . . . 0.0 110.561 -179.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 3.1 t -81.17 -43.09 20.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 178.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -56.44 -46.03 80.51 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.209 -1.36 . . . . 0.0 110.946 -178.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -60.74 -44.82 96.19 Favored 'General case' 0 C--O 1.199 -1.588 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.599 -178.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -73.63 -33.22 64.43 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.528 -178.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 92.5 mt -66.37 -49.56 74.64 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.241 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 175.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' HIS . . . . . 0.545 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 9.9 t60 -68.68 -39.2 80.68 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.829 -176.48 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -65.44 -29.12 69.77 Favored 'General case' 0 C--O 1.219 -0.523 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 177.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -54.27 -47.69 72.05 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.208 0.603 . . . . 0.0 111.912 -176.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.545 ' CZ ' ' HA ' ' A' ' 208' ' ' HIS . 19.9 p90 -93.6 -22.16 18.96 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.096 -178.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 80.6 m . . . . . 0 C--N 1.317 -0.842 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.198 179.404 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 41.7 tp . . . . . 0 N--CA 1.438 -1.067 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.421 ' O ' HG12 ' A' ' 163' ' ' VAL . 2.4 pt? -60.75 -29.84 69.63 Favored 'General case' 0 C--O 1.225 -0.193 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.789 -178.723 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -63.07 -37.44 87.22 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.52 177.329 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 15.0 m -86.32 -31.95 21.29 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.183 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.421 HG12 ' O ' ' A' ' 160' ' ' LEU . 0.7 OUTLIER -62.96 -25.91 39.68 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.928 0 CA-C-O 121.587 0.708 . . . . 0.0 111.556 -176.597 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 28.9 pt20 -85.99 -8.02 58.25 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.15 0.5 . . . . 0.0 110.732 178.008 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -97.49 -0.16 46.53 Favored 'General case' 0 C--O 1.238 0.476 0 O-C-N 122.249 -0.282 . . . . 0.0 110.873 -177.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 92.1 mt -62.1 129.68 92.23 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -62.71 127.44 20.64 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 121.603 1.535 . . . . 0.0 110.619 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 115.56 -29.95 6.95 Favored Glycine 0 N--CA 1.424 -2.138 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.646 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 93.2 t -58.15 -60.27 2.45 Favored 'Isoleucine or valine' 0 C--O 1.245 0.847 0 CA-C-O 120.954 0.407 . . . . 0.0 110.94 -179.133 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 93.89 85.87 1.62 Allowed Glycine 0 N--CA 1.431 -1.647 0 C-N-CA 120.331 -0.938 . . . . 0.0 110.983 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -68.62 -12.03 60.82 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.668 0.746 . . . . 0.0 111.916 -176.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 42.1 t -71.73 -28.58 31.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 176.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.62 ' O ' ' HG ' ' A' ' 177' ' ' LEU . 47.1 mtmt -87.37 0.19 55.83 Favored 'General case' 0 C--O 1.208 -1.098 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.308 -179.156 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' ALA . . . . . 0.479 ' O ' ' HG ' ' A' ' 178' ' ' LEU . . . -46.73 -53.06 27.82 Favored Pre-proline 0 N--CA 1.483 1.206 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 -174.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.415 ' O ' ' HG2' ' A' ' 179' ' ' GLN . 32.2 Cg_exo -60.07 -43.41 36.31 Favored 'Trans proline' 0 C--N 1.373 1.831 0 C-N-CA 121.569 1.512 . . . . 0.0 111.379 179.214 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 49.2 tp -60.83 -45.55 94.02 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.918 177.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.62 ' HG ' ' O ' ' A' ' 173' ' ' LYS . 91.6 mt -61.62 -41.72 97.87 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.173 178.283 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 174' ' ' ALA . 90.8 mt -68.95 -8.39 44.02 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' GLN . . . . . 0.415 ' HG2' ' O ' ' A' ' 175' ' ' PRO . 29.5 mm-40 -80.6 -21.14 41.86 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.374 0.607 . . . . 0.0 110.011 175.195 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 8.2 mmmm -106.51 -45.01 4.35 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.801 177.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' PHE . . . . . 0.45 ' O ' ' HA ' ' A' ' 178' ' ' LEU . 32.3 m-85 -103.42 132.31 21.21 Favored Pre-proline 0 N--CA 1.424 -1.769 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -176.645 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -62.31 -35.76 71.63 Favored 'Trans proline' 0 CA--C 1.51 -0.695 0 C-N-CA 122.839 2.359 . . . . 0.0 112.803 -172.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 59.3 m -153.46 160.21 42.51 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.473 ' O ' ' HB3' ' A' ' 187' ' ' LEU . 0.2 OUTLIER -60.02 -23.14 26.19 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.5 0 O-C-N 123.926 0.766 . . . . 0.0 112.905 -178.335 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -66.23 -47.2 74.59 Favored 'General case' 0 C--O 1.215 -0.715 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.36 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 9.3 tm0? -77.33 -29.04 53.34 Favored 'General case' 0 C--O 1.19 -2.051 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -178.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.474 HD13 ' HB3' ' A' ' 177' ' ' LEU . 41.2 tp -51.57 -64.14 0.91 Allowed 'General case' 0 C--O 1.204 -1.329 0 C-N-CA 124.351 1.06 . . . . 0.0 111.63 177.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 20.0 m -69.23 -24.43 64.01 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.402 0.62 . . . . 0.0 111.454 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -85.97 1.37 50.38 Favored 'General case' 0 C--O 1.244 0.816 0 CA-C-O 122.042 0.925 . . . . 0.0 111.194 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -67.85 157.05 35.75 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.218 177.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 15.0 m -63.3 153.72 33.98 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.568 -179.069 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 51.1 mm -57.87 -34.32 48.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.117 -176.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' GLY . . . . . 0.416 ' O ' ' HG3' ' A' ' 197' ' ' GLN . . . -62.19 -36.41 92.95 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 116.095 -0.502 . . . . 0.0 112.477 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 194' ' ' GLU . . . . . 0.463 ' O ' ' HB2' ' A' ' 197' ' ' GLN . 55.4 mm-40 -77.66 -41.64 37.51 Favored 'General case' 0 CA--C 1.498 -1.043 0 CA-C-O 121.62 0.724 . . . . 0.0 109.915 -178.504 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.459 HD21 ' O ' ' A' ' 187' ' ' LEU . 97.5 mt -67.64 -32.24 72.79 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.131 -0.941 . . . . 0.0 111.074 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 196' ' ' GLU . . . . . 0.554 ' HG2' ' N ' ' A' ' 201' ' ' GLN . 4.6 tm-20 -66.44 -30.15 70.45 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -178.133 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 197' ' ' GLN . . . . . 0.463 ' HB2' ' O ' ' A' ' 194' ' ' GLU . 69.6 mt-30 -60.16 -37.27 79.62 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.652 -1.158 . . . . 0.0 111.376 178.327 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 30.0 m -103.66 -31.04 2.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -175.301 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.6 HG23 ' H ' ' A' ' 200' ' ' GLY . 6.5 m -115.34 -85.67 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 176.074 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 200' ' ' GLY . . . . . 0.6 ' H ' HG23 ' A' ' 199' ' ' VAL . . . -178.74 166.25 35.87 Favored Glycine 0 N--CA 1.408 -3.225 0 N-CA-C 108.413 -1.875 . . . . 0.0 108.413 -177.567 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 201' ' ' GLN . . . . . 0.554 ' N ' ' HG2' ' A' ' 196' ' ' GLU . 0.4 OUTLIER -62.64 -51.38 67.49 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 123.827 0.851 . . . . 0.0 109.122 -179.344 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -72.73 -26.73 61.68 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.066 -176.005 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 3.4 t -76.44 -42.83 36.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -56.29 -43.54 78.98 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.241 -1.345 . . . . 0.0 109.902 179.094 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -54.89 -53.79 50.87 Favored 'General case' 0 N--CA 1.436 -1.16 0 C-N-CA 124.218 1.007 . . . . 0.0 111.964 177.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 28.4 pt20 -69.87 -28.87 66.01 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 119.826 -0.749 . . . . 0.0 111.903 -176.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 98.6 mt -71.78 -48.73 49.84 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-N 116.22 -0.446 . . . . 0.0 109.873 177.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 10.4 t60 -70.96 -40.0 72.23 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -176.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -66.51 -25.55 66.74 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 178.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -53.65 -47.52 70.27 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.069 0.948 . . . . 0.0 112.285 -175.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -93.35 -23.59 18.4 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.694 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 62.8 m . . . . . 0 C--N 1.314 -0.963 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.241 -179.821 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.8 tm? . . . . . 0 N--CA 1.44 -0.96 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.434 ' HA ' HG12 ' A' ' 163' ' ' VAL . 3.6 pp -59.51 -27.51 66.23 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 123.944 0.898 . . . . 0.0 111.917 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 11.4 ptt180 -67.57 -37.8 83.16 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -178.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 25.0 m -86.5 -31.6 21.21 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.21 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.442 HG22 ' HB2' ' A' ' 188' ' ' SER . 0.3 OUTLIER -63.36 -26.23 40.32 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 CA-C-O 121.609 0.719 . . . . 0.0 111.358 -177.231 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -86.54 -8.01 57.89 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.591 177.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -105.3 21.19 17.59 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 -176.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.456 HG21 ' HA ' ' A' ' 207' ' ' ILE . 75.0 mt -78.93 125.93 83.08 Favored Pre-proline 0 C--N 1.31 -1.116 0 CA-C-N 116.297 -0.411 . . . . 0.0 109.961 -178.074 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -66.6 130.84 24.47 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.208 1.939 . . . . 0.0 110.073 176.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 120.21 -35.16 3.87 Favored Glycine 0 C--N 1.292 -1.88 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 -177.133 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 95.5 t -60.45 -52.56 60.0 Favored 'Isoleucine or valine' 0 C--O 1.246 0.875 0 CA-C-O 121.376 0.608 . . . . 0.0 110.052 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 99.68 99.77 2.26 Favored Glycine 0 N--CA 1.425 -2.09 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -177.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -63.32 -29.81 71.06 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 120.969 0.414 . . . . 0.0 111.491 -176.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 60.9 t -83.19 -26.52 7.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-O 121.513 0.673 . . . . 0.0 110.148 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.426 ' O ' ' HB3' ' A' ' 176' ' ' LEU . 37.3 ttpt -92.45 -5.8 51.21 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 120.443 -0.503 . . . . 0.0 109.808 -178.503 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -53.4 -49.9 85.78 Favored Pre-proline 0 CA--C 1.553 1.085 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -177.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -57.52 -30.1 87.17 Favored 'Trans proline' 0 C--N 1.384 2.399 0 C-N-CA 121.961 1.774 . . . . 0.0 112.562 176.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.426 ' HB3' ' O ' ' A' ' 173' ' ' LYS . 54.0 tp -70.22 -39.8 74.89 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 121.469 0.652 . . . . 0.0 109.604 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.419 ' HB3' HD21 ' A' ' 187' ' ' LEU . 9.5 mp -72.52 -32.68 66.32 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.174 178.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 42.7 tp -68.93 -8.84 48.1 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.005 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -82.96 -23.27 33.49 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 174.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm -93.37 -49.67 5.83 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.497 0.665 . . . . 0.0 109.736 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' PHE . . . . . 0.548 ' CD2' HD22 ' A' ' 187' ' ' LEU . 64.5 m-85 -95.14 143.0 25.38 Favored Pre-proline 0 C--N 1.304 -1.37 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.642 -176.649 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -66.36 -39.19 17.9 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.37 2.047 . . . . 0.0 113.867 -174.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 58.8 m -157.0 164.51 37.93 Favored 'General case' 0 C--O 1.247 0.938 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.409 ' HA ' ' HB2' ' A' ' 187' ' ' LEU . 0.2 OUTLIER -56.36 -29.66 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 -176.194 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -62.66 -45.83 91.02 Favored 'General case' 0 C--O 1.217 -0.636 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.328 178.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 10.5 tm0? -78.78 -28.84 44.76 Favored 'General case' 0 C--O 1.201 -1.462 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -177.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.548 HD22 ' CD2' ' A' ' 181' ' ' PHE . 0.3 OUTLIER -51.71 -67.65 0.23 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.263 1.425 . . . . 0.0 109.541 -179.629 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 188' ' ' SER . . . . . 0.442 ' HB2' HG22 ' A' ' 163' ' ' VAL . 17.0 m -73.09 -27.17 61.55 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.048 -176.325 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -81.59 1.31 34.39 Favored 'General case' 0 C--O 1.253 1.241 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.521 ' HB1' ' HB2' ' A' ' 194' ' ' GLU . . . -65.32 154.98 36.7 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 121.601 0.715 . . . . 0.0 110.684 174.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 3.5 m -68.95 163.11 25.25 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.702 -177.252 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.4 mm -53.56 -41.2 45.05 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.184 0 C-N-CA 123.105 0.562 . . . . 0.0 111.056 -178.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' GLY . . . . . 0.494 ' O ' ' HG3' ' A' ' 197' ' ' GLN . . . -63.84 -38.94 96.86 Favored Glycine 0 CA--C 1.522 0.497 0 O-C-N 123.395 0.434 . . . . 0.0 112.675 179.301 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 194' ' ' GLU . . . . . 0.521 ' HB2' ' HB1' ' A' ' 190' ' ' ALA . 29.7 mt-10 -73.11 -38.21 66.42 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -177.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 95.8 mt -72.93 -30.4 63.86 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.539 177.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 196' ' ' GLU . . . . . 0.495 ' HG2' ' N ' ' A' ' 201' ' ' GLN . 5.6 tm-20 -63.88 -37.5 87.63 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 197' ' ' GLN . . . . . 0.494 ' HG3' ' O ' ' A' ' 193' ' ' GLY . 29.2 mt-30 -54.82 -35.02 63.49 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.571 -1.195 . . . . 0.0 112.123 177.653 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 10.0 m -102.11 -35.08 3.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -175.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.614 HG23 ' H ' ' A' ' 200' ' ' GLY . 5.1 m -116.14 -83.2 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 176.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 200' ' ' GLY . . . . . 0.614 ' H ' HG23 ' A' ' 199' ' ' VAL . . . -178.86 162.55 29.66 Favored Glycine 0 N--CA 1.417 -2.593 0 N-CA-C 107.364 -2.295 . . . . 0.0 107.364 -177.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 201' ' ' GLN . . . . . 0.495 ' N ' ' HG2' ' A' ' 196' ' ' GLU . 9.6 pt20 -66.93 -36.29 81.91 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 118.834 1.317 . . . . 0.0 111.587 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -67.31 -41.07 85.93 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.403 0.62 . . . . 0.0 110.52 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 2.7 t -72.56 -39.17 61.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-O 121.864 0.84 . . . . 0.0 109.015 -177.281 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -54.64 -40.57 69.11 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 113.856 -1.52 . . . . 0.0 110.751 -178.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' GLN . . . . . 0.43 ' HG3' ' O ' ' A' ' 201' ' ' GLN . 98.7 mt-30 -61.92 -48.46 80.33 Favored 'General case' 0 N--CA 1.422 -1.84 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.674 -179.106 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 23.1 pt20 -70.6 -32.71 70.16 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 119.112 -1.035 . . . . 0.0 111.224 -178.437 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 207' ' ' ILE . . . . . 0.456 ' HA ' HG21 ' A' ' 166' ' ' ILE . 91.6 mt -66.44 -50.78 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 O-C-N 123.531 0.519 . . . . 0.0 110.091 178.069 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 11.7 t60 -69.42 -39.87 77.63 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.787 -177.248 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -66.28 -25.67 66.97 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 178.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' PHE . . . . . 0.433 ' CD1' HG12 ' A' ' 166' ' ' ILE . 57.4 t80 -52.33 -57.44 9.77 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.447 0.699 . . . . 0.0 112.282 -176.058 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -79.66 -24.66 41.67 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.508 -177.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 77.3 m . . . . . 0 N--CA 1.441 -0.885 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.046 178.396 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.4 tm? . . . . . 0 N--CA 1.442 -0.86 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.465 ' O ' HG12 ' A' ' 163' ' ' VAL . 1.6 pt? -60.79 -28.68 68.94 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.357 -177.485 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 -65.07 -34.45 78.45 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-O 121.327 0.584 . . . . 0.0 109.488 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 24.7 m -86.69 -33.45 20.04 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.183 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.465 HG12 ' O ' ' A' ' 160' ' ' LEU . 0.9 OUTLIER -62.22 -26.18 39.55 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 CA-C-O 121.701 0.762 . . . . 0.0 111.68 -174.908 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -81.08 -10.6 59.65 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.805 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -104.74 12.4 32.82 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.265 0.555 . . . . 0.0 110.942 -174.193 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.436 HG21 ' HA ' ' A' ' 207' ' ' ILE . 83.7 mt -78.51 142.68 62.49 Favored Pre-proline 0 C--N 1.31 -1.145 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.137 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.28 128.39 26.12 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.225 1.95 . . . . 0.0 110.935 174.328 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 113.71 -31.02 6.82 Favored Glycine 0 N--CA 1.435 -1.43 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 -178.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 60.9 t -72.68 -64.36 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 178.102 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 98.95 133.23 7.99 Favored Glycine 0 N--CA 1.438 -1.177 0 C-N-CA 120.299 -0.953 . . . . 0.0 113.443 175.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 54.9 pttt -89.07 -25.53 21.87 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.348 0.594 . . . . 0.0 110.926 177.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 61.7 t -84.8 -32.11 7.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 178.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -81.09 -14.26 57.94 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 114.331 -1.304 . . . . 0.0 109.079 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -52.03 -53.93 46.49 Favored Pre-proline 0 N--CA 1.476 0.841 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 -174.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.516 ' O ' ' HG2' ' A' ' 179' ' ' GLN . 19.1 Cg_endo -60.33 -33.75 94.15 Favored 'Trans proline' 0 C--N 1.377 2.077 0 C-N-CA 121.198 1.266 . . . . 0.0 112.232 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 60.9 tp -70.87 -39.32 72.95 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.574 178.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.515 ' CD2' HG11 ' A' ' 198' ' ' VAL . 93.9 mt -64.18 -36.91 85.61 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.085 177.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 97.7 mt -72.35 -9.56 58.66 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.63 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' GLN . . . . . 0.516 ' HG2' ' O ' ' A' ' 175' ' ' PRO . 11.8 mm-40 -82.57 -19.25 38.86 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 176.26 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm -104.75 -51.21 3.11 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.687 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -102.68 142.98 25.67 Favored Pre-proline 0 C--N 1.303 -1.449 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -175.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -60.99 -41.81 41.62 Favored 'Trans proline' 0 C--N 1.356 0.959 0 C-N-CA 122.663 2.242 . . . . 0.0 112.321 -172.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 59.6 m -154.45 169.4 23.85 Favored 'General case' 0 N--CA 1.421 -1.92 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 177.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.502 ' HA ' ' HB3' ' A' ' 187' ' ' LEU . 0.2 OUTLIER -63.15 -20.5 26.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 -174.931 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -73.91 -44.31 55.61 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.172 -177.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 12.5 tm0? -78.9 -26.53 43.81 Favored 'General case' 0 C--O 1.2 -1.529 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 178.126 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.502 ' HB3' ' HA ' ' A' ' 184' ' ' ILE . 54.6 tp -56.21 -56.41 21.34 Favored 'General case' 0 C--O 1.207 -1.156 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.726 177.397 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 23.2 p -72.76 -31.21 64.74 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.929 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -84.11 6.39 22.51 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 121.521 0.677 . . . . 0.0 111.317 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.425 ' HB1' ' HB2' ' A' ' 194' ' ' GLU . . . -65.3 155.58 34.79 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.029 173.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 191' ' ' SER . . . . . 0.421 ' OG ' ' HG3' ' A' ' 194' ' ' GLU . 10.2 p -63.95 156.83 26.62 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.811 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 48.7 mm -52.29 -36.2 20.84 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.948 0 C-N-CA 123.244 0.618 . . . . 0.0 110.374 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -59.33 -41.33 96.85 Favored Glycine 0 N--CA 1.442 -0.904 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.629 177.04 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' GLU . . . . . 0.516 ' O ' ' HG2' ' A' ' 197' ' ' GLN . 30.1 mt-10 -77.62 -35.72 52.38 Favored 'General case' 0 C--O 1.206 -1.217 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -177.12 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 96.1 mt -74.37 -24.56 59.17 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.803 0.811 . . . . 0.0 110.291 178.345 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -74.07 -24.15 59.46 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.847 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' GLN . . . . . 0.516 ' HG2' ' O ' ' A' ' 194' ' ' GLU . 4.9 pt20 -67.03 -29.91 69.85 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -177.565 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.515 HG11 ' CD2' ' A' ' 177' ' ' LEU . 13.4 m -99.1 -21.2 5.22 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.947 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.687 -174.59 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.402 HG23 ' H ' ' A' ' 200' ' ' GLY . 0.2 OUTLIER -139.23 -84.22 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 173.214 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 200' ' ' GLY . . . . . 0.402 ' H ' HG23 ' A' ' 199' ' ' VAL . . . -178.29 171.94 44.35 Favored Glycine 0 N--CA 1.431 -1.643 0 N-CA-C 108.514 -1.834 . . . . 0.0 108.514 -173.319 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -69.06 -42.41 76.29 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 117.886 0.843 . . . . 0.0 112.024 -177.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -68.26 -31.54 71.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.629 0.728 . . . . 0.0 110.69 -177.009 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 2.1 t -77.75 -40.08 27.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -179.164 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -57.45 -39.72 76.91 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 114.616 -1.175 . . . . 0.0 109.844 177.34 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -59.69 -46.71 88.24 Favored 'General case' 0 C--O 1.209 -1.049 0 CA-C-N 115.075 -0.966 . . . . 0.0 112.322 177.136 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 206' ' ' GLN . . . . . 0.406 ' O ' ' HB2' ' A' ' 210' ' ' PHE . 4.3 pt20 -68.52 -28.48 67.03 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 119.901 -0.72 . . . . 0.0 111.477 -178.242 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 207' ' ' ILE . . . . . 0.436 ' HA ' HG21 ' A' ' 166' ' ' ILE . 76.2 mt -73.96 -52.55 20.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.117 176.375 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -70.3 -40.78 74.04 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 120.958 0.408 . . . . 0.0 110.981 -175.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -73.84 -10.55 59.78 Favored 'General case' 0 C--N 1.323 -0.587 0 O-C-N 122.106 -0.371 . . . . 0.0 111.875 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' PHE . . . . . 0.406 ' HB2' ' O ' ' A' ' 206' ' ' GLN . 40.8 t80 -60.07 -47.78 84.45 Favored 'General case' 0 C--O 1.218 -0.563 0 CA-C-O 121.084 0.469 . . . . 0.0 110.257 179.672 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -96.39 -26.59 15.28 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.207 -178.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 32.7 m . . . . . 0 CA--C 1.549 0.937 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -178.246 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 37.8 mt . . . . . 0 CA--C 1.491 -1.324 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.461 ' H ' HD23 ' A' ' 160' ' ' LEU . 2.2 pt? -59.13 -30.6 68.25 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.385 0.612 . . . . 0.0 110.67 176.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -76.33 -33.5 58.99 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.987 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 24.7 m -85.28 -37.14 20.35 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 120.959 0.409 . . . . 0.0 111.15 -178.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.423 HG22 ' CB ' ' A' ' 188' ' ' SER . 4.1 p -59.68 -25.92 33.37 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.404 0 CA-C-O 121.266 0.555 . . . . 0.0 112.428 -178.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -87.82 -10.26 51.4 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-O 121.592 0.711 . . . . 0.0 110.368 177.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -101.65 3.01 39.41 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.311 -176.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.414 ' HB ' ' CG2' ' A' ' 169' ' ' VAL . 88.9 mt -60.91 133.65 92.37 Favored Pre-proline 0 C--O 1.248 1.017 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.268 178.639 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -60.88 127.91 23.87 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 121.991 1.794 . . . . 0.0 109.92 176.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 113.65 -36.55 3.98 Favored Glycine 0 N--CA 1.428 -1.885 0 C-N-CA 120.012 -1.09 . . . . 0.0 112.019 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.414 ' CG2' ' HB ' ' A' ' 166' ' ' ILE . 57.5 t -58.83 -44.2 89.95 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 CA-C-O 121.498 0.666 . . . . 0.0 110.757 -178.199 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 91.45 80.76 1.41 Allowed Glycine 0 N--CA 1.408 -3.179 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -177.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 55.2 pttt -63.59 -13.87 45.99 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.515 0.674 . . . . 0.0 112.623 -178.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 43.3 t -71.12 -32.11 46.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-O 122.158 0.98 . . . . 0.0 108.421 175.176 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.533 ' HB3' HD13 ' A' ' 177' ' ' LEU . 89.9 mttt -88.26 -6.21 57.92 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.472 -177.787 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -54.23 -52.99 64.01 Favored Pre-proline 0 CA--C 1.558 1.254 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -177.103 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -67.4 -31.26 35.04 Favored 'Trans proline' 0 C--N 1.375 1.931 0 C-N-CA 121.584 1.523 . . . . 0.0 112.325 179.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 55.4 tp -69.96 -44.7 68.98 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.684 0.754 . . . . 0.0 109.601 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.533 HD13 ' HB3' ' A' ' 173' ' ' LYS . 5.4 mp -75.35 -22.28 57.7 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.081 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 44.1 tp -70.55 -11.25 60.81 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 121.637 0.732 . . . . 0.0 109.803 175.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -88.62 -14.35 37.69 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 174.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -105.07 -51.17 3.08 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 122.014 0.911 . . . . 0.0 110.325 -176.305 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' PHE . . . . . 0.465 ' CD2' ' HA ' ' A' ' 187' ' ' LEU . 90.0 m-85 -88.72 148.92 42.84 Favored Pre-proline 0 N--CA 1.417 -2.116 0 CA-C-N 114.423 -1.262 . . . . 0.0 107.753 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -59.07 -47.5 17.51 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.479 2.119 . . . . 0.0 111.883 -179.056 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 23.9 m -153.21 165.0 37.05 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.554 HD13 ' H ' ' A' ' 184' ' ' ILE . 0.2 OUTLIER -62.36 -27.25 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -178.202 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 24.8 tp60 -61.57 -41.15 96.97 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 110.348 -0.242 . . . . 0.0 110.348 177.113 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 14.8 tm0? -79.06 -32.91 45.0 Favored 'General case' 0 C--O 1.196 -1.733 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.465 ' HA ' ' CD2' ' A' ' 181' ' ' PHE . 5.3 tt -53.72 -62.01 1.93 Allowed 'General case' 0 C--O 1.21 -0.991 0 C-N-CA 123.893 0.877 . . . . 0.0 110.471 -176.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 188' ' ' SER . . . . . 0.423 ' CB ' HG22 ' A' ' 163' ' ' VAL . 25.4 m -73.99 -23.23 59.43 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -177.633 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -89.75 4.33 50.01 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.467 0.651 . . . . 0.0 109.372 -179.188 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.401 ' HB1' ' HB2' ' A' ' 194' ' ' GLU . . . -65.2 154.98 36.47 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-O 121.301 0.572 . . . . 0.0 110.123 175.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 3.0 m -64.26 158.05 24.3 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.48 -176.121 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 48.8 mm -53.44 -37.86 31.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 C-N-CA 123.279 0.631 . . . . 0.0 111.191 -177.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -63.4 -38.32 96.19 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.642 178.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' GLU . . . . . 0.401 ' HB2' ' HB1' ' A' ' 190' ' ' ALA . 26.7 mt-10 -74.22 -37.27 63.89 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -176.452 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 96.2 mt -74.02 -31.36 62.89 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.832 -1.076 . . . . 0.0 110.71 178.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -64.87 -35.54 81.47 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -60.55 -26.36 66.84 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 114.438 -1.255 . . . . 0.0 112.834 178.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 13.1 m -103.59 -37.35 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.305 0 C-N-CA 120.04 -0.664 . . . . 0.0 112.437 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.519 HG23 ' H ' ' A' ' 200' ' ' GLY . 2.5 m -117.87 -80.97 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 177.482 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 200' ' ' GLY . . . . . 0.519 ' H ' HG23 ' A' ' 199' ' ' VAL . . . -178.05 166.88 37.28 Favored Glycine 0 N--CA 1.424 -2.16 0 N-CA-C 108.536 -1.826 . . . . 0.0 108.536 -178.597 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -69.23 -41.94 76.34 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 118.218 1.009 . . . . 0.0 110.296 -178.048 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -65.55 -35.98 82.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.414 0.626 . . . . 0.0 110.197 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.412 ' O ' HG13 ' A' ' 207' ' ' ILE . 2.7 t -72.66 -43.5 61.65 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.829 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -55.2 -42.47 73.31 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.3 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -58.74 -52.39 65.9 Favored 'General case' 0 N--CA 1.433 -1.315 0 C-N-CA 124.263 1.025 . . . . 0.0 111.507 177.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -69.01 -27.39 65.64 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 -178.006 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 207' ' ' ILE . . . . . 0.412 HG13 ' O ' ' A' ' 203' ' ' VAL . 98.3 mt -73.45 -51.36 25.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-O 121.311 0.577 . . . . 0.0 109.723 176.005 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -71.33 -37.94 71.69 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.783 -173.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -75.64 -10.08 59.14 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 178.227 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -66.12 -46.66 76.78 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.103 0.478 . . . . 0.0 110.86 -179.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -93.11 -25.7 17.77 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.883 -177.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 25.6 m . . . . . 0 CA--C 1.55 0.976 0 CA-C-O 121.387 0.613 . . . . 0.0 111.569 -178.783 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.49 ' O ' HD23 ' A' ' 159' ' ' LEU . 6.4 tt . . . . . 0 C--O 1.211 -0.948 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.48 ' O ' HG12 ' A' ' 163' ' ' VAL . 3.4 pp -53.85 -31.42 49.46 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.98 0.912 . . . . 0.0 111.595 176.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -71.5 -29.38 64.73 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.844 0.831 . . . . 0.0 109.397 -178.198 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 21.1 m -86.69 -29.56 22.37 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.157 177.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 160' ' ' LEU . 0.3 OUTLIER -65.24 -26.46 39.71 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.643 0 CA-C-O 121.583 0.706 . . . . 0.0 110.916 -176.124 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -82.64 -6.71 59.51 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.481 0.657 . . . . 0.0 110.865 177.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 78.9 mm-40 -101.64 13.26 35.45 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.098 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 80.9 mt -84.35 131.75 49.5 Favored Pre-proline 0 C--N 1.306 -1.297 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -62.89 127.14 19.66 Favored 'Trans proline' 0 C--O 1.245 0.86 0 C-N-CA 121.642 1.561 . . . . 0.0 110.633 177.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 112.33 -18.51 23.12 Favored Glycine 0 N--CA 1.43 -1.765 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.62 -177.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 84.0 t -71.67 -50.41 39.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 178.472 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 96.58 102.09 2.02 Favored Glycine 0 N--CA 1.43 -1.743 0 C-N-CA 120.236 -0.983 . . . . 0.0 113.159 178.298 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -67.76 -32.4 72.98 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.219 0.533 . . . . 0.0 110.678 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 48.7 t -85.1 -30.76 6.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-O 121.801 0.81 . . . . 0.0 109.342 -178.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -79.89 -12.74 59.72 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.875 -178.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -50.72 -55.03 29.97 Favored Pre-proline 0 CA--C 1.55 0.974 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -177.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.494 ' O ' ' HG3' ' A' ' 179' ' ' GLN . 21.1 Cg_endo -62.25 -28.68 79.37 Favored 'Trans proline' 0 C--N 1.369 1.642 0 CA-C-N 121.045 1.409 . . . . 0.0 112.899 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 51.7 tp -73.02 -47.98 40.31 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 176.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.456 ' HB3' HD13 ' A' ' 187' ' ' LEU . 97.2 mt -59.27 -39.77 83.92 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.686 177.528 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.438 ' HA ' ' O ' ' A' ' 181' ' ' PHE . 10.2 mp -68.99 -6.81 30.12 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 179.013 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' GLN . . . . . 0.494 ' HG3' ' O ' ' A' ' 175' ' ' PRO . 76.7 mt-30 -83.19 -17.35 43.13 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 174.372 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 7.7 mmmm -103.94 -44.92 4.9 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.09 177.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' PHE . . . . . 0.438 ' O ' ' HA ' ' A' ' 178' ' ' LEU . 27.9 m-85 -111.35 131.51 22.23 Favored Pre-proline 0 N--CA 1.424 -1.753 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 -176.631 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 182' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 181' ' ' PHE . 78.4 Cg_exo -48.33 -38.57 34.41 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 124.152 3.235 . . . . 0.0 113.801 -175.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 73.6 p -154.06 173.69 15.69 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -177.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.521 HD13 ' H ' ' A' ' 184' ' ' ILE . 0.2 OUTLIER -66.59 -21.24 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 O-C-N 123.664 0.602 . . . . 0.0 110.78 175.275 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -67.07 -48.49 68.08 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 9.5 tm0? -77.76 -32.73 52.79 Favored 'General case' 0 C--O 1.201 -1.449 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -178.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.498 ' HB3' ' HA ' ' A' ' 184' ' ' ILE . 61.5 tp -52.78 -57.72 9.22 Favored 'General case' 0 C--O 1.207 -1.156 0 C-N-CA 124.589 1.156 . . . . 0.0 111.691 178.253 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 24.5 p -68.73 -32.79 72.82 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.617 0.723 . . . . 0.0 111.353 -179.017 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -80.97 -2.67 48.76 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.259 -178.148 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -66.35 156.51 34.27 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 123.465 0.706 . . . . 0.0 111.015 177.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 5.4 m -63.26 152.31 38.08 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.115 -175.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 50.3 mm -54.21 -35.86 31.05 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.839 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.865 -177.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' GLY . . . . . 0.422 ' O ' ' HG2' ' A' ' 197' ' ' GLN . . . -61.63 -39.09 96.92 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.322 -0.466 . . . . 0.0 112.56 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -71.42 -45.11 63.54 Favored 'General case' 0 CA--C 1.489 -1.392 0 CA-C-O 121.548 0.69 . . . . 0.0 110.214 -178.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 95.8 mt -66.65 -29.59 69.64 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 114.279 -1.328 . . . . 0.0 110.804 178.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -70.49 -33.11 70.86 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' GLN . . . . . 0.441 ' HA ' ' OE1' ' A' ' 197' ' ' GLN . 13.6 mm-40 -66.65 -21.51 66.11 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 114.987 -1.006 . . . . 0.0 113.1 -179.285 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 18.8 m -104.11 -32.85 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.757 177.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.424 HG23 ' H ' ' A' ' 200' ' ' GLY . 0.7 OUTLIER -125.17 -85.38 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 173.76 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 200' ' ' GLY . . . . . 0.424 ' H ' HG23 ' A' ' 199' ' ' VAL . . . -177.22 165.35 35.23 Favored Glycine 0 N--CA 1.43 -1.742 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -176.206 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -58.39 -49.32 77.69 Favored 'General case' 0 C--O 1.21 -0.996 0 CA-C-N 117.487 0.643 . . . . 0.0 111.626 -177.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -65.01 -32.57 74.35 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.314 0.578 . . . . 0.0 111.095 -175.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.412 ' O ' HG13 ' A' ' 207' ' ' ILE . 3.8 t -75.76 -44.56 39.43 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 -179.317 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -57.06 -43.75 82.36 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 114.009 -1.45 . . . . 0.0 109.912 179.016 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -62.94 -44.97 94.61 Favored 'General case' 0 N--CA 1.424 -1.752 0 CA-C-N 114.982 -1.008 . . . . 0.0 112.579 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -69.43 -29.16 66.82 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 119.442 -0.903 . . . . 0.0 111.169 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' ILE . . . . . 0.412 HG13 ' O ' ' A' ' 203' ' ' VAL . 87.4 mt -72.04 -52.15 26.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 176.522 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 12.2 t60 -69.7 -37.03 76.45 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.614 -174.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -73.36 -22.32 60.32 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 179.086 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -50.94 -56.74 10.92 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.843 0.857 . . . . 0.0 111.475 -177.426 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -83.57 -27.64 29.12 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.235 -176.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 38.8 m . . . . . 0 C--N 1.311 -1.081 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.472 -178.304 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.479 ' O ' HD23 ' A' ' 159' ' ' LEU . 5.5 tt . . . . . 0 N--CA 1.471 0.604 0 N-CA-C 111.243 0.09 . . . . 0.0 111.243 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.492 ' H ' HD23 ' A' ' 160' ' ' LEU . 2.1 pt? -57.99 -22.28 48.69 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 177.548 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -68.86 -32.1 71.52 Favored 'General case' 0 C--O 1.218 -0.555 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 177.559 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 28.4 m -86.51 -34.04 20.13 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.442 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -63.87 -26.53 40.8 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.968 0 CA-C-O 121.516 0.674 . . . . 0.0 110.644 -176.243 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -82.84 -7.74 59.63 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.371 177.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -108.47 13.59 25.32 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.89 0.376 . . . . 0.0 110.605 -176.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.477 HG21 ' HA ' ' A' ' 207' ' ' ILE . 81.2 mt -71.82 138.71 82.74 Favored Pre-proline 0 C--N 1.31 -1.12 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.876 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -61.73 128.85 25.69 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.132 1.888 . . . . 0.0 110.637 175.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 114.46 -33.46 5.38 Favored Glycine 0 C--N 1.308 -0.978 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -178.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.498 ' O ' ' HE3' ' A' ' 173' ' ' LYS . 89.1 t -63.14 -57.48 11.78 Favored 'Isoleucine or valine' 0 C--N 1.338 0.109 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 178.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 99.24 126.82 5.76 Favored Glycine 0 N--CA 1.43 -1.748 0 C-N-CA 120.588 -0.815 . . . . 0.0 113.552 175.291 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -85.51 -25.07 27.05 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 121.313 0.578 . . . . 0.0 111.145 178.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 40.8 t -83.96 -28.26 7.31 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-O 122.082 0.944 . . . . 0.0 108.897 -178.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.498 ' HE3' ' O ' ' A' ' 169' ' ' VAL . 46.6 mtmt -87.28 -1.03 57.62 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.593 178.166 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -51.77 -49.01 85.79 Favored Pre-proline 0 CA--C 1.546 0.811 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 -178.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.516 ' O ' ' HG2' ' A' ' 179' ' ' GLN . 26.1 Cg_exo -62.86 -42.6 23.91 Favored 'Trans proline' 0 C--N 1.378 2.097 0 CA-C-N 120.69 1.282 . . . . 0.0 111.022 178.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 39.6 tp -58.42 -48.94 79.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.184 177.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.456 ' HB3' HD11 ' A' ' 187' ' ' LEU . 87.5 mt -60.68 -40.48 92.32 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.173 178.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 94.3 mt -71.15 -13.53 61.97 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' GLN . . . . . 0.516 ' HG2' ' O ' ' A' ' 175' ' ' PRO . 28.6 mm-40 -93.83 -12.38 29.13 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.289 0.566 . . . . 0.0 110.055 174.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -97.74 -50.59 4.4 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 121.792 0.805 . . . . 0.0 109.515 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' PHE . . . . . 0.518 ' CD2' ' HG ' ' A' ' 187' ' ' LEU . 79.9 m-85 -100.26 146.64 32.32 Favored Pre-proline 0 C--N 1.294 -1.846 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.871 -178.746 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -70.93 -29.45 18.3 Favored 'Trans proline' 0 C--O 1.235 0.366 0 C-N-CA 122.551 2.167 . . . . 0.0 112.594 -178.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' SER . . . . . 0.431 ' O ' ' HB2' ' A' ' 187' ' ' LEU . 64.3 p -153.84 166.58 32.46 Favored 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -178.173 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.436 HD13 ' H ' ' A' ' 184' ' ' ILE . 0.2 OUTLIER -71.05 -22.51 22.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 O-C-N 123.479 0.487 . . . . 0.0 110.138 176.574 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 26.6 tp60 -61.81 -52.84 62.52 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 114.944 -1.025 . . . . 0.0 108.914 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -76.95 -28.03 55.04 Favored 'General case' 0 C--O 1.207 -1.15 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -179.194 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.518 ' HG ' ' CD2' ' A' ' 181' ' ' PHE . 3.7 tt -54.78 -64.56 0.8 Allowed 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 124.081 0.952 . . . . 0.0 110.24 -178.32 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 24.0 m -75.94 -22.93 55.49 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.773 -175.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -84.87 -3.87 58.86 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.32 0.581 . . . . 0.0 110.18 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.7 154.58 38.53 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.687 178.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 1.9 t -73.59 169.23 17.69 Favored 'General case' 0 N--CA 1.423 -1.812 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.984 -176.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 50.1 mm -51.8 -39.37 24.48 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.973 0 C-N-CA 123.99 0.916 . . . . 0.0 111.138 -176.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' GLY . . . . . 0.433 ' O ' ' HG3' ' A' ' 197' ' ' GLN . . . -59.26 -31.88 70.68 Favored Glycine 0 CA--C 1.527 0.817 0 O-C-N 123.431 0.457 . . . . 0.0 113.899 -179.116 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 194' ' ' GLU . . . . . 0.47 ' O ' ' HB2' ' A' ' 197' ' ' GLN . 29.2 mm-40 -83.61 -40.13 19.42 Favored 'General case' 0 C--O 1.215 -0.746 0 CA-C-O 121.696 0.76 . . . . 0.0 109.638 -178.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.414 ' HB2' ' HB1' ' A' ' 204' ' ' ALA . 77.7 mt -73.39 -23.99 60.24 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-O 121.744 0.783 . . . . 0.0 110.696 -178.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -71.83 -26.54 62.42 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 178.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' GLN . . . . . 0.47 ' HB2' ' O ' ' A' ' 194' ' ' GLU . 28.1 mt-30 -61.17 -29.67 69.94 Favored 'General case' 0 C--O 1.242 0.71 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.719 178.587 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.402 HG11 ' CD2' ' A' ' 177' ' ' LEU . 12.0 m -103.27 -37.18 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.295 0 C-N-CA 120.709 -0.397 . . . . 0.0 111.888 -178.078 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.459 HG23 ' H ' ' A' ' 200' ' ' GLY . 1.7 m -122.47 -83.75 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 200' ' ' GLY . . . . . 0.459 ' H ' HG23 ' A' ' 199' ' ' VAL . . . -177.6 172.53 45.26 Favored Glycine 0 N--CA 1.429 -1.789 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -175.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -64.55 -46.78 81.31 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 117.421 0.611 . . . . 0.0 111.816 -176.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -70.6 -30.21 66.82 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.311 0.577 . . . . 0.0 110.997 -176.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.62 ' O ' ' HG2' ' A' ' 206' ' ' GLN . 2.2 t -78.62 -33.91 17.28 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.051 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 204' ' ' ALA . . . . . 0.414 ' HB1' ' HB2' ' A' ' 195' ' ' LEU . . . -63.25 -38.45 91.22 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.41 175.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 23.1 mm-40 -60.24 -42.69 95.81 Favored 'General case' 0 C--O 1.207 -1.134 0 CA-C-N 115.32 -0.855 . . . . 0.0 112.522 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 206' ' ' GLN . . . . . 0.62 ' HG2' ' O ' ' A' ' 203' ' ' VAL . 20.6 pt20 -66.79 -30.22 70.37 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.894 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 207' ' ' ILE . . . . . 0.477 ' HA ' HG21 ' A' ' 166' ' ' ILE . 71.6 mt -78.19 -52.91 15.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-O 121.47 0.652 . . . . 0.0 109.982 178.432 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 40.0 t-80 -65.04 -39.56 93.51 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.839 -175.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -80.97 -14.04 58.33 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 120.728 -0.389 . . . . 0.0 112.023 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -55.11 -53.84 50.82 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.323 0.649 . . . . 0.0 111.318 -176.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -84.28 -27.82 27.58 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.896 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 25.5 m . . . . . 0 CA--C 1.55 0.969 0 CA-C-O 121.204 0.526 . . . . 0.0 111.392 -179.341 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 39.5 tp . . . . . 0 N--CA 1.446 -0.662 0 N-CA-C 111.608 0.225 . . . . 0.0 111.608 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -62.57 -26.55 68.64 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.074 0.464 . . . . 0.0 110.24 177.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 23.9 ptt180 -67.35 -35.58 79.67 Favored 'General case' 0 C--O 1.215 -0.731 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 8.4 m -86.14 -33.28 20.91 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.618 -178.506 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -64.95 -26.09 39.25 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-O 121.515 0.674 . . . . 0.0 110.835 -175.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 30.3 pt20 -85.27 -7.3 59.08 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.307 177.52 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -99.26 4.7 46.67 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -178.725 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.442 HG21 ' HA ' ' A' ' 207' ' ' ILE . 85.7 mt -72.18 131.58 85.08 Favored Pre-proline 0 C--N 1.309 -1.162 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -179.469 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -62.13 131.73 35.89 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.485 2.123 . . . . 0.0 110.586 176.187 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 113.83 -36.42 4.03 Favored Glycine 0 N--CA 1.424 -2.134 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 -178.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 91.9 t -55.72 -48.09 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-O 120.96 0.409 . . . . 0.0 110.593 -178.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 85.63 95.26 0.77 Allowed Glycine 0 N--CA 1.429 -1.794 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 -179.233 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -70.24 -18.71 63.16 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -175.401 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 62.0 t -83.24 -30.75 8.32 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 CA-C-O 121.396 0.617 . . . . 0.0 109.831 179.058 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.604 ' O ' ' HG ' ' A' ' 177' ' ' LEU . 21.2 ptmt -93.93 -4.0 50.61 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.415 0.626 . . . . 0.0 110.035 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' ALA . . . . . 0.443 ' N ' ' HD2' ' A' ' 175' ' ' PRO . . . -59.72 -45.99 98.49 Favored Pre-proline 0 CA--C 1.548 0.9 0 CA-C-N 114.906 -1.043 . . . . 0.0 113.417 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.443 ' HD2' ' N ' ' A' ' 174' ' ' ALA . 9.3 Cg_endo -54.88 -35.94 90.27 Favored 'Trans proline' 0 C--N 1.385 2.449 0 C-N-CA 122.176 1.917 . . . . 0.0 112.193 176.465 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 53.3 tp -68.14 -42.3 80.34 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.437 0.637 . . . . 0.0 109.699 178.385 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.604 ' HG ' ' O ' ' A' ' 173' ' ' LYS . 59.8 mt -70.1 -31.06 68.43 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.75 -179.604 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 35.5 tp -72.91 -10.83 60.23 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.528 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' GLN . . . . . 0.438 ' HG2' ' O ' ' A' ' 175' ' ' PRO . 85.6 mm-40 -83.72 -20.17 33.91 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 174.779 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -103.65 -51.81 3.11 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-O 121.31 0.576 . . . . 0.0 110.354 -174.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -90.73 140.55 26.47 Favored Pre-proline 0 C--N 1.296 -1.751 0 CA-C-N 115.346 -0.843 . . . . 0.0 108.752 178.584 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -47.0 -47.5 16.51 Favored 'Trans proline' 0 C--N 1.361 1.217 0 C-N-CA 123.96 3.107 . . . . 0.0 112.545 -176.272 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' SER . . . . . 0.435 ' OG ' HD13 ' A' ' 184' ' ' ILE . 25.8 t -153.71 169.48 23.21 Favored 'General case' 0 N--CA 1.41 -2.437 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.589 HD13 ' H ' ' A' ' 184' ' ' ILE . 0.2 OUTLIER -60.03 -27.93 40.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 O-C-N 124.013 0.821 . . . . 0.0 110.151 177.114 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -56.86 -50.21 73.16 Favored 'General case' 0 C--O 1.212 -0.889 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.033 176.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 7.1 tm0? -79.1 -34.04 43.85 Favored 'General case' 0 C--O 1.206 -1.217 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -177.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.451 ' HB3' ' HA ' ' A' ' 184' ' ' ILE . 57.8 tp -50.8 -62.55 1.53 Allowed 'General case' 0 C--O 1.21 -0.976 0 C-N-CA 124.408 1.083 . . . . 0.0 111.278 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 25.3 m -72.07 -22.66 61.33 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.012 0.434 . . . . 0.0 112.07 -178.581 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -83.59 -4.04 58.21 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 121.488 0.661 . . . . 0.0 110.845 -178.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.513 ' HB1' ' HB2' ' A' ' 194' ' ' GLU . . . -65.74 155.48 35.97 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.019 175.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 4.0 m -65.33 162.27 17.88 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.994 -176.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.2 mm -53.66 -39.98 40.54 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.622 0 C-N-CA 122.751 0.42 . . . . 0.0 111.113 -178.673 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -62.77 -35.14 91.52 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 121.515 -0.374 . . . . 0.0 112.471 179.112 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 194' ' ' GLU . . . . . 0.644 ' O ' ' HG2' ' A' ' 197' ' ' GLN . 25.2 mt-10 -80.7 -29.72 36.46 Favored 'General case' 0 C--O 1.215 -0.76 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -177.135 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 97.4 mt -78.76 -33.33 46.57 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.983 176.304 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 196' ' ' GLU . . . . . 0.422 ' HG2' ' N ' ' A' ' 201' ' ' GLN . 6.5 tm-20 -67.46 -31.71 72.07 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 -177.699 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 197' ' ' GLN . . . . . 0.644 ' HG2' ' O ' ' A' ' 194' ' ' GLU . 16.5 pt20 -67.92 -28.39 67.45 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.529 -177.509 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 14.1 m -99.52 -34.58 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.969 -177.31 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.481 HG23 ' H ' ' A' ' 200' ' ' GLY . 2.5 m -119.81 -82.84 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 175.797 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 200' ' ' GLY . . . . . 0.481 ' H ' HG23 ' A' ' 199' ' ' VAL . . . -177.84 166.0 35.96 Favored Glycine 0 N--CA 1.429 -1.794 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 -176.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 201' ' ' GLN . . . . . 0.422 ' N ' ' HG2' ' A' ' 196' ' ' GLU . 8.8 tm0? -62.51 -47.03 85.73 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 117.565 0.682 . . . . 0.0 110.303 -177.242 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -71.63 -28.8 64.02 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.248 -176.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 3.0 t -76.06 -41.2 38.08 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.706 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -55.94 -45.11 78.88 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 114.224 -1.353 . . . . 0.0 109.651 179.033 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -59.26 -46.65 87.95 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 114.973 -1.012 . . . . 0.0 112.437 179.031 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -67.87 -33.09 74.06 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 120.366 -0.533 . . . . 0.0 111.357 -179.046 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 207' ' ' ILE . . . . . 0.442 ' HA ' HG21 ' A' ' 166' ' ' ILE . 85.8 mt -74.72 -50.44 25.87 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-O 121.141 0.496 . . . . 0.0 110.577 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 15.1 t60 -68.99 -43.88 73.98 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.106 -175.376 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -72.58 -10.77 60.2 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -62.46 -47.42 84.12 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.169 0.509 . . . . 0.0 110.223 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -98.07 -25.17 15.03 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.857 -178.593 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 24.1 m . . . . . 0 C--N 1.322 -0.589 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -178.45 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 42.8 tp . . . . . 0 N--CA 1.441 -0.911 0 CA-C-O 120.491 0.186 . . . . 0.0 110.667 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -60.26 -25.67 65.87 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.246 0.546 . . . . 0.0 112.038 -179.239 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -73.62 -33.58 64.62 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.207 0.527 . . . . 0.0 110.114 177.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 16.9 m -85.76 -33.99 21.28 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 121.243 0.544 . . . . 0.0 110.591 -178.463 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.438 HG22 ' CB ' ' A' ' 188' ' ' SER . 0.8 OUTLIER -64.17 -25.61 38.46 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.131 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.049 -176.555 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -87.69 -7.59 57.2 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.755 177.547 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -103.56 12.15 35.36 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.17 0.51 . . . . 0.0 109.996 -178.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 77.7 mt -72.8 125.97 90.88 Favored Pre-proline 0 C--N 1.314 -0.961 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.24 128.5 20.6 Favored 'Trans proline' 0 N--CA 1.445 -1.331 0 C-N-CA 121.562 1.508 . . . . 0.0 109.183 176.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 116.16 -29.24 7.17 Favored Glycine 0 N--CA 1.428 -1.872 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 -177.17 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 93.1 t -65.32 -52.23 54.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 121.313 0.578 . . . . 0.0 110.426 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 102.33 75.31 1.09 Allowed Glycine 0 N--CA 1.424 -2.102 0 C-N-CA 120.365 -0.921 . . . . 0.0 111.234 -179.314 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -73.64 -15.63 61.25 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.279 0.562 . . . . 0.0 111.656 -177.184 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 45.1 t -86.86 -22.86 6.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 CA-C-O 121.96 0.886 . . . . 0.0 108.637 176.276 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.464 ' O ' ' HG ' ' A' ' 177' ' ' LEU . 38.0 ttpt -96.12 8.36 43.98 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.309 -1.314 . . . . 0.0 108.226 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -56.67 -46.3 99.85 Favored Pre-proline 0 C--O 1.212 -0.901 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 -177.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.567 ' O ' ' HG2' ' A' ' 179' ' ' GLN . 51.7 Cg_exo -56.97 -41.08 79.04 Favored 'Trans proline' 0 C--N 1.377 2.036 0 CA-C-N 121.204 1.466 . . . . 0.0 111.345 178.554 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 48.5 tp -64.7 -43.36 93.74 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.435 176.381 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 173' ' ' LYS . 96.3 mt -63.34 -40.27 96.83 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.533 178.391 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -68.63 -6.91 28.57 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 178.503 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' GLN . . . . . 0.567 ' HG2' ' O ' ' A' ' 175' ' ' PRO . 86.9 mm-40 -84.46 -15.64 45.38 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.06 0.457 . . . . 0.0 110.102 174.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -112.17 -51.01 2.87 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 121.434 0.635 . . . . 0.0 110.047 179.437 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' PHE . . . . . 0.485 ' CD1' ' HA ' ' A' ' 187' ' ' LEU . 80.6 m-85 -88.58 139.05 29.68 Favored Pre-proline 0 C--N 1.299 -1.622 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.433 -177.602 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -64.07 -48.94 4.31 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.511 2.141 . . . . 0.0 112.289 -177.142 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 25.2 m -148.11 167.38 25.16 Favored 'General case' 0 N--CA 1.426 -1.646 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 178.285 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -60.66 -25.45 35.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -179.085 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 24.0 tp60 -60.87 -51.91 67.27 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.52 -178.402 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 22.1 tm0? -79.24 -27.18 42.41 Favored 'General case' 0 C--O 1.189 -2.103 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.745 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.485 ' HA ' ' CD1' ' A' ' 181' ' ' PHE . 5.1 tt -52.32 -61.55 2.2 Favored 'General case' 0 C--O 1.214 -0.804 0 C-N-CA 123.332 0.653 . . . . 0.0 110.304 -177.459 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 188' ' ' SER . . . . . 0.438 ' CB ' HG22 ' A' ' 163' ' ' VAL . 19.5 m -73.72 -22.97 59.72 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 121.165 0.507 . . . . 0.0 112.035 -177.445 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -91.0 7.44 40.32 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.858 178.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -66.21 156.89 32.87 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 123.22 0.608 . . . . 0.0 111.533 176.126 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 4.6 m -62.9 158.27 19.52 Favored 'General case' 0 N--CA 1.427 -1.61 0 CA-C-N 115.153 -0.931 . . . . 0.0 109.761 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 47.9 mm -55.54 -36.06 40.38 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.355 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.491 -177.219 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -62.58 -36.15 92.81 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 121.045 -0.598 . . . . 0.0 112.434 178.211 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 194' ' ' GLU . . . . . 0.463 ' O ' ' HG2' ' A' ' 197' ' ' GLN . 13.1 mm-40 -76.84 -35.88 57.21 Favored 'General case' 0 C--O 1.215 -0.727 0 CA-C-O 121.475 0.655 . . . . 0.0 109.36 -177.271 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 92.0 mt -77.94 -23.33 48.59 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-O 121.616 0.722 . . . . 0.0 110.793 178.564 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 196' ' ' GLU . . . . . 0.477 ' HG2' ' N ' ' A' ' 201' ' ' GLN . 4.0 tm-20 -81.95 -37.76 26.22 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -178.174 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 197' ' ' GLN . . . . . 0.463 ' HG2' ' O ' ' A' ' 194' ' ' GLU . 20.5 pt20 -66.37 -22.79 66.26 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.736 -178.506 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.429 HG22 ' O ' ' A' ' 194' ' ' GLU . 12.6 m -99.19 -28.83 3.44 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.422 HG23 HG23 ' A' ' 198' ' ' VAL . 1.5 t -130.64 -79.74 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.613 176.221 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -177.51 164.63 33.88 Favored Glycine 0 N--CA 1.438 -1.181 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 -177.199 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 201' ' ' GLN . . . . . 0.477 ' N ' ' HG2' ' A' ' 196' ' ' GLU . 11.1 pt20 -66.23 -40.13 90.04 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -177.538 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -68.2 -24.71 64.97 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 122.188 0.994 . . . . 0.0 109.827 -178.437 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.416 HG11 HG11 ' A' ' 199' ' ' VAL . 6.9 t -83.32 -47.56 18.1 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 CA-C-N 114.435 -1.257 . . . . 0.0 108.324 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -52.89 -44.96 67.28 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 114.473 -1.239 . . . . 0.0 110.846 -178.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -63.33 -48.03 79.73 Favored 'General case' 0 N--CA 1.423 -1.783 0 CA-C-N 114.922 -1.035 . . . . 0.0 111.574 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -70.96 -29.82 65.93 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.48 -177.407 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 90.6 mt -69.53 -51.91 37.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 175.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 7.0 t60 -69.6 -31.15 69.13 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.472 0.653 . . . . 0.0 109.374 -176.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -80.18 -13.69 59.05 Favored 'General case' 0 C--O 1.207 -1.142 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 176.175 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -62.24 -43.37 98.98 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-O 121.022 0.439 . . . . 0.0 111.782 -176.397 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -90.91 -23.38 20.51 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.261 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 28.4 m . . . . . 0 CA--C 1.555 1.152 0 CA-C-O 121.059 0.457 . . . . 0.0 111.277 178.644 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.443 ' O ' HD23 ' A' ' 159' ' ' LEU . 6.4 tt . . . . . 0 C--O 1.221 -0.415 0 CA-C-O 120.139 0.019 . . . . 0.0 110.972 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.423 ' O ' HG12 ' A' ' 163' ' ' VAL . 2.4 pt? -59.22 -25.19 63.79 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.821 0.344 . . . . 0.0 111.834 179.122 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 5.5 ptm180 -77.98 -26.05 48.47 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 120.077 -0.649 . . . . 0.0 109.522 -179.099 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 97.0 m -86.7 -32.1 20.67 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.253 176.523 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.423 HG12 ' O ' ' A' ' 160' ' ' LEU . 0.8 OUTLIER -65.47 -26.09 38.46 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 CA-C-O 121.654 0.74 . . . . 0.0 110.9 -177.07 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -83.61 -14.62 51.56 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.532 0.682 . . . . 0.0 109.768 176.636 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -99.52 20.39 13.95 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.455 -176.3 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 98.4 mt -80.09 129.16 71.06 Favored Pre-proline 0 C--N 1.293 -1.87 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 175.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.65 128.79 23.14 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 122.036 1.824 . . . . 0.0 109.96 177.744 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 116.21 -29.4 7.07 Favored Glycine 0 N--CA 1.426 -1.975 0 C-N-CA 120.146 -1.026 . . . . 0.0 111.508 -179.038 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 63.6 t -63.6 -64.85 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.592 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 177.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 113.62 98.95 2.33 Favored Glycine 0 N--CA 1.422 -2.255 0 C-N-CA 120.066 -1.064 . . . . 0.0 112.18 178.215 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -68.77 -27.39 65.85 Favored 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 122.926 0.49 . . . . 0.0 111.32 -178.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 22.5 t -83.88 -30.9 7.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-O 121.299 0.571 . . . . 0.0 109.748 -175.358 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.536 ' O ' ' HG ' ' A' ' 177' ' ' LEU . 20.4 ptmt -91.72 1.41 57.18 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.36 178.423 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -56.99 -50.35 88.71 Favored Pre-proline 0 CA--C 1.545 0.785 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.523 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.412 ' O ' ' HG2' ' A' ' 179' ' ' GLN . 15.9 Cg_endo -58.91 -24.05 70.74 Favored 'Trans proline' 0 C--N 1.376 2.021 0 C-N-CA 121.801 1.667 . . . . 0.0 112.764 178.163 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.409 ' HB3' ' O ' ' A' ' 173' ' ' LYS . 54.5 tp -77.58 -40.05 43.59 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 177.001 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.536 ' HG ' ' O ' ' A' ' 173' ' ' LYS . 84.3 mt -71.53 -33.59 69.31 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.869 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -69.12 -5.87 24.98 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 177.235 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 179' ' ' GLN . . . . . 0.412 ' HG2' ' O ' ' A' ' 175' ' ' PRO . 29.8 mm-40 -93.17 -3.74 53.37 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.266 0.555 . . . . 0.0 109.869 174.549 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -113.0 -50.53 2.88 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.47 176.088 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' PHE . . . . . 0.579 ' CD2' ' HG ' ' A' ' 187' ' ' LEU . 66.8 m-85 -96.76 141.16 22.67 Favored Pre-proline 0 C--N 1.309 -1.173 0 CA-C-N 114.769 -1.105 . . . . 0.0 108.55 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -67.76 -35.73 20.8 Favored 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 122.096 1.864 . . . . 0.0 112.82 -177.271 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 67.7 p -149.3 165.54 31.66 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -178.314 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -65.67 -26.13 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 O-C-N 123.403 0.439 . . . . 0.0 110.559 177.164 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -63.98 -43.57 95.34 Favored 'General case' 0 C--O 1.202 -1.416 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.977 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 13.0 tm0? -78.84 -34.56 45.05 Favored 'General case' 0 C--O 1.197 -1.703 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.579 ' HG ' ' CD2' ' A' ' 181' ' ' PHE . 4.8 tt -52.88 -66.61 0.35 Allowed 'General case' 0 C--O 1.21 -1.022 0 C-N-CA 124.205 1.002 . . . . 0.0 111.296 -175.775 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 23.1 m -75.2 -21.73 58.47 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.243 0.544 . . . . 0.0 112.062 -175.632 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -86.6 -4.33 59.16 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.032 -178.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.38 155.43 35.42 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 121.498 0.666 . . . . 0.0 111.167 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 12.4 m -65.32 162.17 18.06 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.365 -177.137 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 41.4 mm -53.57 -40.3 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 123.073 0.549 . . . . 0.0 110.892 -178.477 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -62.55 -29.03 72.36 Favored Glycine 0 C--O 1.214 -1.133 0 CA-C-N 115.974 -0.557 . . . . 0.0 113.135 -179.471 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -83.6 -41.88 17.35 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 121.467 0.651 . . . . 0.0 109.275 -178.071 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 97.4 mt -69.54 -38.42 77.49 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 114.706 -1.134 . . . . 0.0 111.345 -178.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.32 -33.9 77.05 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.311 0.577 . . . . 0.0 109.522 -176.571 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -60.94 -30.29 70.13 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.619 -1.173 . . . . 0.0 112.923 177.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 16.9 m -103.75 -39.29 5.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -176.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.555 HG23 ' H ' ' A' ' 200' ' ' GLY . 3.5 m -108.09 -84.64 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 177.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 200' ' ' GLY . . . . . 0.555 ' H ' HG23 ' A' ' 199' ' ' VAL . . . -178.0 167.46 38.24 Favored Glycine 0 N--CA 1.414 -2.819 0 N-CA-C 108.574 -1.81 . . . . 0.0 108.574 -178.466 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -57.69 -52.7 64.35 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 117.535 0.667 . . . . 0.0 112.357 179.403 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -67.37 -34.58 77.59 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.313 0.578 . . . . 0.0 110.809 -176.207 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.463 ' O ' ' HG2' ' A' ' 206' ' ' GLN . 2.6 t -70.57 -42.3 78.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 -179.562 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -56.36 -46.24 80.11 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.61 178.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -61.68 -47.02 87.23 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 114.972 -1.013 . . . . 0.0 112.615 179.124 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 206' ' ' GLN . . . . . 0.463 ' HG2' ' O ' ' A' ' 203' ' ' VAL . 3.4 pt20 -65.28 -34.98 79.62 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 118.373 0.533 . . . . 0.0 111.364 -178.303 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 88.4 mt -72.92 -50.52 32.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.972 178.172 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -65.01 -45.31 86.07 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.821 -177.045 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -70.07 -15.79 63.04 Favored 'General case' 0 C--O 1.217 -0.624 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -59.24 -45.54 90.9 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.129 0.572 . . . . 0.0 110.44 -179.148 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -95.91 -31.18 13.25 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.091 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 52.0 m . . . . . 0 CA--C 1.541 0.605 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.518 -177.396 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 43.0 tp . . . . . 0 N--CA 1.44 -0.956 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.468 ' O ' HG12 ' A' ' 163' ' ' VAL . 2.3 pt? -55.44 -34.54 64.55 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-O 121.223 0.535 . . . . 0.0 111.695 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -66.0 -31.9 73.07 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.198 177.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 15.9 m -86.72 -31.45 20.98 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 120.956 0.408 . . . . 0.0 110.76 178.054 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.468 HG12 ' O ' ' A' ' 160' ' ' LEU . 0.3 OUTLIER -64.79 -25.85 38.75 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.069 0 CA-C-O 121.719 0.771 . . . . 0.0 110.647 -177.271 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 164' ' ' GLN . . . . . 0.438 ' OE1' HG21 ' A' ' 184' ' ' ILE . 9.8 pt20 -83.44 -6.69 59.53 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.412 175.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -100.2 7.96 44.15 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.062 0.458 . . . . 0.0 110.307 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 84.5 mt -75.38 128.72 83.8 Favored Pre-proline 0 C--N 1.317 -0.829 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -65.75 128.67 20.42 Favored 'Trans proline' 0 C--O 1.238 0.478 0 C-N-CA 122.145 1.896 . . . . 0.0 111.353 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 117.35 -27.99 7.41 Favored Glycine 0 C--N 1.306 -1.084 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 -179.27 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 97.7 t -61.86 -62.01 1.34 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.689 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 177.69 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 110.89 100.81 2.6 Favored Glycine 0 N--CA 1.424 -2.12 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.323 176.3 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -73.66 -26.51 60.78 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.261 0.553 . . . . 0.0 109.935 177.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 62.1 t -82.88 -24.46 8.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-O 122.08 0.943 . . . . 0.0 108.896 178.294 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.438 ' O ' ' HG ' ' A' ' 177' ' ' LEU . 44.9 mtpt -86.01 -0.82 56.47 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.497 -1.229 . . . . 0.0 110.305 178.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -47.98 -51.04 50.76 Favored Pre-proline 0 C--O 1.203 -1.377 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -178.306 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.585 ' O ' ' HG2' ' A' ' 179' ' ' GLN . 12.9 Cg_endo -58.24 -42.57 55.24 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 121.684 1.589 . . . . 0.0 112.132 177.487 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 55.6 tp -64.46 -45.56 86.89 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.729 0.776 . . . . 0.0 109.639 179.496 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' A' ' 173' ' ' LYS . 93.2 mt -69.16 -26.41 64.85 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.973 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 57.4 tp -74.06 -30.75 62.54 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 121.132 0.492 . . . . 0.0 109.831 178.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' GLN . . . . . 0.585 ' HG2' ' O ' ' A' ' 175' ' ' PRO . 12.7 mm-40 -76.09 -30.97 58.5 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 121.167 0.508 . . . . 0.0 109.965 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 22.9 mmmt -83.28 -50.62 8.21 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.979 179.123 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' PHE . . . . . 0.427 ' HA ' ' HD3' ' A' ' 182' ' ' PRO . 28.8 m-85 -111.75 135.66 21.16 Favored Pre-proline 0 N--CA 1.436 -1.134 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.795 -172.388 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 182' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 181' ' ' PHE . 51.2 Cg_exo -53.42 -38.51 82.87 Favored 'Trans proline' 0 N--CA 1.487 1.118 0 C-N-CA 124.367 3.378 . . . . 0.0 114.184 -176.6 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 24.4 t -158.66 167.83 28.49 Favored 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 179.689 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.514 ' HA ' ' HB3' ' A' ' 187' ' ' LEU . 0.2 OUTLIER -61.37 -26.98 40.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 O-C-N 124.277 0.985 . . . . 0.0 110.995 178.214 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -64.39 -40.73 96.39 Favored 'General case' 0 C--O 1.21 -1.022 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.692 179.4 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 9.5 tm0? -80.2 -37.87 32.34 Favored 'General case' 0 C--O 1.191 -2.017 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 177.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.514 ' HB3' ' HA ' ' A' ' 184' ' ' ILE . 66.8 tp -46.67 -65.59 0.54 Allowed 'General case' 0 C--O 1.212 -0.873 0 C-N-CA 126.07 1.748 . . . . 0.0 113.202 -177.045 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 36.9 m -72.96 -20.94 60.95 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -177.303 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -91.89 3.88 54.19 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.461 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.96 158.23 28.71 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 124.816 1.247 . . . . 0.0 112.737 178.622 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 14.6 m -62.99 152.06 37.9 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.848 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 48.2 mm -55.15 -35.57 36.09 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.137 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.878 -177.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -61.9 -30.2 74.57 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 121.313 -0.47 . . . . 0.0 112.842 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 194' ' ' GLU . . . . . 0.461 ' O ' ' HG2' ' A' ' 197' ' ' GLN . 59.4 mm-40 -84.24 -36.99 22.33 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-O 121.529 0.681 . . . . 0.0 109.752 -179.573 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.404 HD21 ' O ' ' A' ' 187' ' ' LEU . 96.0 mt -75.97 -24.38 55.4 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.385 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 196' ' ' GLU . . . . . 0.442 ' HG2' ' N ' ' A' ' 201' ' ' GLN . 3.9 tm-20 -78.91 -37.95 38.64 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -178.041 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 197' ' ' GLN . . . . . 0.461 ' HG2' ' O ' ' A' ' 194' ' ' GLU . 10.3 pt20 -69.75 -19.6 63.53 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 114.999 -1.0 . . . . 0.0 112.328 -175.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 17.1 m -102.54 -26.33 3.52 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 C-N-CA 120.587 -0.445 . . . . 0.0 111.842 178.107 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.531 HG11 HG11 ' A' ' 203' ' ' VAL . 0.2 OUTLIER -128.24 -81.8 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 C-N-CA 120.721 -0.392 . . . . 0.0 111.129 175.897 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -176.95 162.78 31.24 Favored Glycine 0 N--CA 1.442 -0.914 0 N-CA-C 108.791 -1.723 . . . . 0.0 108.791 -176.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 201' ' ' GLN . . . . . 0.442 ' N ' ' HG2' ' A' ' 196' ' ' GLU . 51.6 tt0 -67.01 -40.69 87.36 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 117.996 0.898 . . . . 0.0 112.065 -176.117 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -65.7 -37.64 87.01 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.399 0.619 . . . . 0.0 109.936 -179.186 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.531 HG11 HG11 ' A' ' 199' ' ' VAL . 3.9 t -69.91 -44.05 79.04 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.864 0 CA-C-N 114.986 -1.007 . . . . 0.0 108.755 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -55.31 -46.43 76.27 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 114.356 -1.293 . . . . 0.0 110.2 -179.247 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -71.12 -31.62 67.99 Favored 'General case' 0 N--CA 1.417 -2.124 0 CA-C-N 114.735 -1.12 . . . . 0.0 112.494 -177.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 206' ' ' GLN . . . . . 0.42 ' HG2' ' O ' ' A' ' 203' ' ' VAL . 14.2 pt20 -78.08 -34.1 50.45 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 119.742 -0.783 . . . . 0.0 110.765 178.244 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 93.7 mt -66.38 -45.61 88.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 174.464 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 28.4 t-80 -68.95 -35.77 77.15 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.007 -178.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -72.56 -25.6 61.42 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 121.743 -0.598 . . . . 0.0 112.507 177.794 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -50.84 -54.13 26.37 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.532 1.133 . . . . 0.0 112.667 -175.452 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 20.3 p90 -81.76 -24.16 36.21 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -177.136 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 30.6 m . . . . . 0 C--N 1.31 -1.111 0 CA-C-O 120.975 0.417 . . . . 0.0 111.225 179.953 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.414 HD13 ' O ' ' A' ' 159' ' ' LEU . 3.0 tm? . . . . . 0 N--CA 1.424 -1.747 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.405 ' HA ' HG12 ' A' ' 163' ' ' VAL . 2.4 pt? -61.82 -23.52 66.28 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 115.316 -0.856 . . . . 0.0 112.035 -177.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 34.6 ptt180 -70.0 -39.32 75.96 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.345 0.593 . . . . 0.0 110.104 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 74.8 m -86.75 -32.57 20.33 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.937 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.436 HG22 ' CB ' ' A' ' 188' ' ' SER . 0.4 OUTLIER -62.49 -26.2 39.87 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.126 -174.568 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -80.47 -10.22 59.75 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.995 179.436 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -103.8 11.45 35.75 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 121.143 0.497 . . . . 0.0 110.978 -176.033 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.444 HG21 ' HA ' ' A' ' 207' ' ' ILE . 73.6 mt -78.74 133.86 61.81 Favored Pre-proline 0 C--N 1.304 -1.404 0 CA-C-N 116.059 -0.518 . . . . 0.0 109.71 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -62.12 128.76 24.94 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.106 1.871 . . . . 0.0 109.869 175.026 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 116.07 -40.95 2.25 Favored Glycine 0 N--CA 1.429 -1.805 0 N-CA-C 108.668 -1.773 . . . . 0.0 108.668 -176.201 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.455 ' O ' HD11 ' A' ' 177' ' ' LEU . 57.7 t -70.89 -56.34 11.03 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.174 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 174.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 91.77 147.08 19.58 Favored Glycine 0 N--CA 1.417 -2.596 0 C-N-CA 120.201 -1.0 . . . . 0.0 114.893 172.128 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' LYS . . . . . 0.449 ' HG3' HG23 ' A' ' 172' ' ' VAL . 56.7 pttt -89.37 -35.93 15.79 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 114.401 -0.899 . . . . 0.0 110.556 177.863 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.449 HG23 ' HG3' ' A' ' 171' ' ' LYS . 43.3 t -86.14 -39.03 13.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-O 121.204 0.526 . . . . 0.0 110.729 -175.008 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.652 ' O ' ' HG ' ' A' ' 177' ' ' LEU . 21.6 ptmt -84.25 2.07 41.73 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.765 -178.321 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 174' ' ' ALA . . . . . 0.412 ' O ' ' HG ' ' A' ' 178' ' ' LEU . . . -54.59 -52.75 67.17 Favored Pre-proline 0 CA--C 1.563 1.443 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -61.74 -23.16 75.85 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 122.137 1.891 . . . . 0.0 112.22 177.407 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.509 ' HB3' ' O ' ' A' ' 173' ' ' LYS . 53.5 tp -74.54 -34.86 63.08 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.252 176.649 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.652 ' HG ' ' O ' ' A' ' 173' ' ' LYS . 61.5 mt -78.69 -29.29 45.48 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.073 -179.07 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 174' ' ' ALA . 87.3 mt -68.69 -5.58 21.13 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.615 177.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -85.3 -21.42 28.99 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 121.838 0.828 . . . . 0.0 108.941 174.254 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -101.05 -47.41 4.77 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.567 -178.319 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' PHE . . . . . 0.588 ' CD2' ' HG ' ' A' ' 187' ' ' LEU . 85.4 m-85 -107.32 149.06 38.27 Favored Pre-proline 0 N--CA 1.427 -1.609 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.623 -175.458 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 182' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 181' ' ' PHE . 2.8 Cg_exo -67.46 -50.47 0.94 Allowed 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.774 2.316 . . . . 0.0 112.566 -178.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 66.6 m -150.19 164.48 35.57 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -57.33 -30.49 35.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 115.671 1.73 . . . . 0.0 115.671 -173.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 14.3 tm0? -68.55 -46.9 68.25 Favored 'General case' 0 C--O 1.206 -1.223 0 C-N-CA 119.439 -0.905 . . . . 0.0 108.995 -176.261 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 13.9 tm0? -73.04 -29.89 63.32 Favored 'General case' 0 C--O 1.194 -1.846 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.588 ' HG ' ' CD2' ' A' ' 181' ' ' PHE . 5.1 tt -56.03 -64.12 0.96 Allowed 'General case' 0 C--O 1.217 -0.607 0 C-N-CA 123.666 0.786 . . . . 0.0 110.27 -178.168 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 188' ' ' SER . . . . . 0.436 ' CB ' HG22 ' A' ' 163' ' ' VAL . 17.6 m -74.29 -26.44 60.19 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 123.29 0.369 . . . . 0.0 111.831 -176.64 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.416 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 8.6 t30 -85.36 -0.03 53.55 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.138 0.494 . . . . 0.0 111.014 -178.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -66.62 155.47 37.77 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.035 0.445 . . . . 0.0 110.704 175.4 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 12.5 m -63.94 159.72 19.27 Favored 'General case' 0 C--O 1.251 1.14 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.089 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.1 mm -49.09 -39.17 12.06 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.851 0 C-N-CA 123.772 0.829 . . . . 0.0 111.619 -179.296 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 193' ' ' GLY . . . . . 0.462 ' O ' ' HG3' ' A' ' 197' ' ' GLN . . . -57.22 -39.05 89.45 Favored Glycine 0 CA--C 1.526 0.767 0 O-C-N 123.129 0.268 . . . . 0.0 113.453 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -77.56 -41.46 38.86 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.551 0.691 . . . . 0.0 109.231 -177.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 96.0 mt -69.72 -26.44 64.33 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.268 -179.253 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 196' ' ' GLU . . . . . 0.624 ' HG2' ' N ' ' A' ' 201' ' ' GLN . 1.5 tm-20 -73.39 -34.43 65.54 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 -179.575 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 197' ' ' GLN . . . . . 0.462 ' HG3' ' O ' ' A' ' 193' ' ' GLY . 89.9 mt-30 -62.52 -29.92 70.91 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.999 178.474 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.416 HG23 HG23 ' A' ' 199' ' ' VAL . 12.8 m -103.84 -24.44 4.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -176.568 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.436 HG11 HG11 ' A' ' 203' ' ' VAL . 1.0 OUTLIER -128.4 -85.75 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.779 176.58 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -178.36 158.3 22.86 Favored Glycine 0 CA--C 1.494 -1.223 0 N-CA-C 108.669 -1.772 . . . . 0.0 108.669 -176.133 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 201' ' ' GLN . . . . . 0.624 ' N ' ' HG2' ' A' ' 196' ' ' GLU . 10.7 pt20 -57.19 -46.39 82.89 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -177.805 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -69.93 -34.69 73.8 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.395 0.616 . . . . 0.0 110.55 -175.535 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.445 ' O ' HG13 ' A' ' 207' ' ' ILE . 2.0 t -75.2 -39.28 42.78 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-N 114.945 -1.025 . . . . 0.0 108.241 -178.291 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -57.48 -41.59 80.97 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.587 -1.188 . . . . 0.0 109.903 179.319 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -64.56 -39.79 94.38 Favored 'General case' 0 N--CA 1.422 -1.85 0 CA-C-N 114.966 -1.015 . . . . 0.0 112.047 -179.586 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -73.4 -30.09 63.02 Favored 'General case' 0 C--O 1.218 -0.554 0 C-N-CA 119.367 -0.933 . . . . 0.0 110.438 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 207' ' ' ILE . . . . . 0.445 HG13 ' O ' ' A' ' 203' ' ' VAL . 82.8 mt -68.03 -53.07 32.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 176.178 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 53.3 t-80 -62.57 -43.73 98.08 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 114.668 -1.151 . . . . 0.0 110.531 -177.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -70.7 -25.3 62.9 Favored 'General case' 0 C--O 1.202 -1.396 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -54.56 -47.84 72.76 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.083 0.553 . . . . 0.0 111.742 -176.5 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 211' ' ' PHE . . . . . 0.416 ' CZ ' ' HA ' ' A' ' 189' ' ' ASN . 34.1 p90 -93.69 -26.34 17.07 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.172 -178.607 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 46.4 m . . . . . 0 CA--C 1.551 1.002 0 CA-C-O 120.895 0.379 . . . . 0.0 111.061 179.994 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 44.6 tp . . . . . 0 C--O 1.236 0.38 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -63.36 -23.94 67.63 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.666 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -72.13 -32.5 66.99 Favored 'General case' 0 C--O 1.22 -0.497 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 10.2 m -86.37 -35.59 19.7 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.937 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.435 HG22 ' HB2' ' A' ' 188' ' ' SER . 0.4 OUTLIER -61.66 -25.68 37.57 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 C-N-CA 123.835 0.854 . . . . 0.0 111.571 -177.259 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -86.11 -8.01 58.18 Favored 'General case' 0 C--N 1.311 -1.103 0 O-C-N 121.941 -0.474 . . . . 0.0 111.561 178.297 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -97.46 17.99 16.33 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-O 120.606 0.241 . . . . 0.0 110.638 -176.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.438 HG21 ' HA ' ' A' ' 207' ' ' ILE . 65.2 mt -83.09 120.33 75.79 Favored Pre-proline 0 C--N 1.302 -1.463 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.364 -176.81 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.23 129.12 15.58 Favored 'Trans proline' 0 N--CA 1.445 -1.364 0 C-N-CA 121.82 1.68 . . . . 0.0 108.349 175.523 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 124.45 -33.14 3.88 Favored Glycine 0 C--N 1.288 -2.126 0 N-CA-C 108.47 -1.852 . . . . 0.0 108.47 -171.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 81.3 t -68.48 -43.5 83.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 174.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 107.55 140.27 9.43 Favored Glycine 0 N--CA 1.424 -2.12 0 CA-C-N 115.267 -0.879 . . . . 0.0 112.492 175.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -89.27 -36.27 15.68 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 121.131 0.491 . . . . 0.0 110.193 178.673 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 44.0 t -89.19 -31.98 5.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-O 121.735 0.778 . . . . 0.0 109.643 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.45 ' HG2' ' HG ' ' A' ' 177' ' ' LEU . 39.3 ttmt -77.36 -14.39 59.73 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.376 -179.592 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -52.36 -53.86 48.34 Favored Pre-proline 0 CA--C 1.557 1.222 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -176.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.444 ' O ' ' HG3' ' A' ' 179' ' ' GLN . 18.9 Cg_endo -61.19 -32.36 90.75 Favored 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 121.575 1.517 . . . . 0.0 112.8 178.596 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 57.4 tp -69.84 -40.59 75.75 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.543 0.687 . . . . 0.0 109.804 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.45 ' HG ' ' HG2' ' A' ' 173' ' ' LYS . 87.6 mt -68.51 -27.99 66.61 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.259 178.596 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 43.4 tp -74.91 -9.49 58.59 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.179 177.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 179' ' ' GLN . . . . . 0.444 ' HG3' ' O ' ' A' ' 175' ' ' PRO . 72.3 mt-30 -91.02 -29.74 17.19 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 175.343 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -84.27 -50.64 7.67 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.825 -179.398 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 181' ' ' PHE . . . . . 0.421 ' CD2' ' HG ' ' A' ' 187' ' ' LEU . 71.9 m-85 -97.7 149.12 35.38 Favored Pre-proline 0 C--N 1.293 -1.857 0 CA-C-N 115.056 -0.974 . . . . 0.0 109.204 -177.321 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -68.78 -42.21 4.89 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 121.994 1.796 . . . . 0.0 112.705 -177.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 78.2 p -147.72 166.77 26.48 Favored 'General case' 0 N--CA 1.427 -1.58 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -177.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.451 HD13 ' H ' ' A' ' 184' ' ' ILE . 0.2 OUTLIER -62.42 -29.28 46.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 O-C-N 123.772 0.67 . . . . 0.0 111.569 177.971 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -63.23 -45.95 89.25 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.735 -179.541 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -79.2 -32.59 44.11 Favored 'General case' 0 C--O 1.202 -1.419 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.421 ' HG ' ' CD2' ' A' ' 181' ' ' PHE . 4.1 tt -53.81 -64.09 0.94 Allowed 'General case' 0 C--O 1.218 -0.567 0 C-N-CA 124.141 0.976 . . . . 0.0 110.285 -176.228 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 188' ' ' SER . . . . . 0.435 ' HB2' HG22 ' A' ' 163' ' ' VAL . 19.9 m -70.42 -20.71 62.9 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 121.322 0.582 . . . . 0.0 111.793 -178.073 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -90.34 4.9 49.46 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.408 0.623 . . . . 0.0 111.009 -178.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.49 155.3 36.02 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.781 173.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 5.4 t -72.89 168.69 18.4 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.553 -175.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 50.8 mm -59.62 -37.73 72.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.751 -175.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -60.34 -31.92 75.44 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 116.448 -0.342 . . . . 0.0 112.803 178.503 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 194' ' ' GLU . . . . . 0.495 ' O ' ' HG2' ' A' ' 197' ' ' GLN . 24.3 mt-10 -83.77 -36.73 23.38 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 121.556 0.693 . . . . 0.0 109.269 -177.765 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 88.6 mt -78.44 -23.27 46.69 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-O 121.306 0.574 . . . . 0.0 111.72 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 196' ' ' GLU . . . . . 0.572 ' HG2' ' N ' ' A' ' 201' ' ' GLN . 2.5 tm-20 -80.49 -37.44 31.72 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 197' ' ' GLN . . . . . 0.495 ' HG2' ' O ' ' A' ' 194' ' ' GLU . 19.8 pt20 -68.01 -14.69 63.16 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.708 -177.367 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 4.1 m -103.46 -34.66 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 N-CA-C 111.621 0.23 . . . . 0.0 111.621 174.639 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 1.3 t -128.76 -80.31 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 C-N-CA 119.909 -0.716 . . . . 0.0 111.25 177.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -177.61 166.27 36.52 Favored Glycine 0 N--CA 1.434 -1.458 0 N-CA-C 111.46 -0.656 . . . . 0.0 111.46 -176.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 201' ' ' GLN . . . . . 0.572 ' N ' ' HG2' ' A' ' 196' ' ' GLU . 78.7 mt-30 -56.51 -50.39 71.95 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 124.756 1.222 . . . . 0.0 111.82 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -64.81 -27.87 69.17 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.681 0.753 . . . . 0.0 111.205 -175.357 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 90.3 t -80.14 -49.44 18.99 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.581 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -52.31 -46.64 66.07 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 124.763 1.225 . . . . 0.0 110.891 -179.446 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -61.74 -45.75 92.6 Favored 'General case' 0 N--CA 1.419 -2.011 0 CA-C-N 114.433 -1.258 . . . . 0.0 111.529 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -73.86 -28.61 61.67 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.348 -0.541 . . . . 0.0 111.877 -179.286 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 207' ' ' ILE . . . . . 0.438 ' HA ' HG21 ' A' ' 166' ' ' ILE . 81.9 mt -70.04 -50.34 48.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.182 0.515 . . . . 0.0 109.945 175.189 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 9.7 t60 -72.63 -37.02 68.15 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.248 -175.463 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -73.85 -16.38 61.13 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 120.22 -0.592 . . . . 0.0 112.164 178.233 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -54.37 -56.72 15.75 Favored 'General case' 0 C--O 1.215 -0.716 0 C-N-CA 123.386 0.674 . . . . 0.0 111.68 -177.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -81.04 -26.35 36.44 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.59 -178.018 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 32.3 m . . . . . 0 N--CA 1.443 -0.818 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.585 179.687 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.6 tt . . . . . 0 N--CA 1.485 1.288 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.5 ' HA ' HG12 ' A' ' 163' ' ' VAL . 2.3 pt? -58.18 -22.43 51.51 Favored 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 179.669 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 -68.04 -39.17 83.11 Favored 'General case' 0 C--O 1.223 -0.34 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 176.479 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 93.7 m -86.51 -31.64 21.18 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.731 -177.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.5 HG12 ' HA ' ' A' ' 160' ' ' LEU . 0.5 OUTLIER -65.32 -26.19 38.94 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 CA-C-O 121.664 0.745 . . . . 0.0 111.083 -177.416 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -86.44 -8.01 57.97 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.597 178.007 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -104.41 16.41 26.2 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.441 -178.354 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 84.5 mt -77.72 127.01 83.43 Favored Pre-proline 0 C--N 1.302 -1.46 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.289 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -66.31 128.55 19.6 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 121.778 1.652 . . . . 0.0 109.522 177.766 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 120.66 -33.87 4.29 Favored Glycine 0 N--CA 1.427 -1.953 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 -177.276 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 93.3 t -59.33 -60.27 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 CA-C-O 121.294 0.568 . . . . 0.0 110.447 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 113.87 95.04 2.1 Favored Glycine 0 N--CA 1.428 -1.833 0 C-N-CA 119.965 -1.112 . . . . 0.0 112.248 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -76.68 -20.57 56.47 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 121.274 0.559 . . . . 0.0 110.863 -178.109 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 57.5 t -83.11 -29.87 8.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-O 121.672 0.749 . . . . 0.0 109.362 178.237 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -83.44 -7.18 59.6 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.432 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -49.14 -50.12 65.5 Favored Pre-proline 0 CA--C 1.551 0.99 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 -176.315 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.512 ' O ' ' HG3' ' A' ' 179' ' ' GLN . 10.9 Cg_endo -57.28 -36.84 99.01 Favored 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 121.583 1.522 . . . . 0.0 112.862 177.818 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 60.4 tp -71.83 -40.47 69.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.372 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.419 ' HB3' HD11 ' A' ' 187' ' ' LEU . 97.0 mt -66.05 -34.03 77.16 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.705 179.331 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 47.9 tp -70.72 -13.94 62.25 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.441 0.639 . . . . 0.0 110.834 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' GLN . . . . . 0.512 ' HG3' ' O ' ' A' ' 175' ' ' PRO . 90.5 mt-30 -89.43 -35.99 15.7 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 176.824 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 40.9 mmtm -80.83 -47.43 13.84 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.212 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 181' ' ' PHE . . . . . 0.531 ' CD2' ' HA ' ' A' ' 187' ' ' LEU . 80.1 m-85 -101.78 145.54 30.65 Favored Pre-proline 0 C--N 1.296 -1.753 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -177.42 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -56.8 -47.57 22.76 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 122.919 2.412 . . . . 0.0 111.673 177.285 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 183' ' ' SER . . . . . 0.411 ' O ' ' HB2' ' A' ' 187' ' ' LEU . 78.2 p -153.24 171.58 18.31 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 -178.557 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -63.32 -25.14 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 121.333 0.587 . . . . 0.0 110.401 176.003 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -65.51 -45.12 84.77 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.359 -178.676 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 16.3 tm0? -79.49 -36.2 39.01 Favored 'General case' 0 C--O 1.203 -1.381 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 176.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.531 ' HA ' ' CD2' ' A' ' 181' ' ' PHE . 4.7 tt -49.1 -66.29 0.42 Allowed 'General case' 0 C--O 1.213 -0.844 0 C-N-CA 125.482 1.513 . . . . 0.0 111.503 -175.221 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 35.1 m -70.95 -20.78 62.41 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -175.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -90.89 0.59 57.45 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.472 ' HB1' ' HB2' ' A' ' 194' ' ' GLU . . . -65.58 155.46 35.71 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 122.902 0.481 . . . . 0.0 110.445 175.748 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 27.9 p -66.98 165.24 15.99 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.125 -178.447 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 50.7 mm -55.91 -37.64 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.292 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -58.58 -37.08 88.12 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-N 115.309 -0.86 . . . . 0.0 113.514 178.258 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 194' ' ' GLU . . . . . 0.472 ' HB2' ' HB1' ' A' ' 190' ' ' ALA . 30.1 mt-10 -83.4 -37.88 22.69 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.336 0.589 . . . . 0.0 109.503 -177.708 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 95.0 mt -71.65 -31.76 67.19 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.866 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -67.1 -31.37 71.79 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.35 0.595 . . . . 0.0 109.743 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -63.81 -26.27 68.55 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 114.865 -1.061 . . . . 0.0 112.723 179.163 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 12.2 m -103.88 -38.35 5.02 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.517 HG23 ' H ' ' A' ' 200' ' ' GLY . 2.5 m -117.05 -80.55 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 178.081 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 200' ' ' GLY . . . . . 0.517 ' H ' HG23 ' A' ' 199' ' ' VAL . . . -177.99 166.41 36.54 Favored Glycine 0 N--CA 1.418 -2.525 0 N-CA-C 108.434 -1.866 . . . . 0.0 108.434 -178.082 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 201' ' ' GLN . . . . . 0.519 ' O ' ' HG3' ' A' ' 205' ' ' GLN . 63.4 tt0 -68.54 -43.37 76.84 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 118.038 0.919 . . . . 0.0 110.837 -178.78 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -65.46 -32.99 74.9 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.122 0.487 . . . . 0.0 110.866 -179.156 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 2.4 t -75.53 -40.89 41.74 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.738 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -179.452 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -57.94 -43.85 86.56 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.355 -179.001 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 205' ' ' GLN . . . . . 0.519 ' HG3' ' O ' ' A' ' 201' ' ' GLN . 98.4 mt-30 -61.89 -47.12 86.4 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.684 -178.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -69.53 -33.05 72.24 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.437 -0.505 . . . . 0.0 111.54 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 99.2 mt -69.24 -50.39 52.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.13 0.49 . . . . 0.0 109.82 176.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 59.5 t-80 -67.59 -39.88 84.81 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.253 -177.386 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -72.01 -18.39 61.97 Favored 'General case' 0 C--O 1.213 -0.826 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -55.12 -51.45 66.4 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.396 0.617 . . . . 0.0 110.459 -178.814 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -89.37 -27.67 20.31 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.994 -179.241 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 60.4 m . . . . . 0 C--N 1.318 -0.764 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -177.981 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 48.8 tp . . . . . 0 N--CA 1.438 -1.051 0 N-CA-C 110.579 -0.156 . . . . 0.0 110.579 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.413 ' HA ' HG12 ' A' ' 163' ' ' VAL . 2.0 pt? -49.59 -40.9 40.4 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.159 0.984 . . . . 0.0 112.542 -178.002 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.434 HH11 ' HD3' ' A' ' 161' ' ' ARG . 1.7 ptm180 -59.89 -47.05 87.32 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.35 178.323 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 38.0 m -86.18 -29.72 23.0 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 120.988 0.423 . . . . 0.0 112.083 -175.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.413 HG12 ' HA ' ' A' ' 160' ' ' LEU . 0.6 OUTLIER -67.0 -25.38 34.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 121.701 0.762 . . . . 0.0 111.239 -175.771 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 24.6 pt20 -82.59 -7.6 59.64 Favored 'General case' 0 C--N 1.315 -0.921 0 O-C-N 121.897 -0.502 . . . . 0.0 111.847 177.001 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -101.77 21.92 13.74 Favored 'General case' 0 C--O 1.239 0.553 0 CA-C-O 121.459 0.647 . . . . 0.0 110.671 -178.224 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.496 HG21 ' HA ' ' A' ' 207' ' ' ILE . 74.5 mt -88.51 133.15 36.93 Favored Pre-proline 0 C--N 1.303 -1.425 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.395 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -64.18 128.58 21.98 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 121.708 1.606 . . . . 0.0 109.745 175.252 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 118.76 -30.97 5.71 Favored Glycine 0 N--CA 1.43 -1.715 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -174.716 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 97.8 t -74.22 -59.58 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 176.42 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 104.69 147.16 16.19 Favored Glycine 0 N--CA 1.44 -1.074 0 C-N-CA 120.931 -0.652 . . . . 0.0 113.923 174.299 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' LYS . . . . . 0.541 ' HG3' HG23 ' A' ' 172' ' ' VAL . 57.2 pttt -89.64 -43.36 10.8 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.11 0.481 . . . . 0.0 110.883 176.737 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.541 HG23 ' HG3' ' A' ' 171' ' ' LYS . 40.4 t -81.32 -33.17 12.47 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.69 0 CA-C-O 121.679 0.752 . . . . 0.0 109.933 -174.628 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.501 ' O ' ' HG ' ' A' ' 177' ' ' LEU . 14.4 ptmm? -90.94 5.94 46.66 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.931 -179.354 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -66.11 -47.39 62.18 Favored Pre-proline 0 CA--C 1.55 0.972 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.488 ' O ' ' HG2' ' A' ' 179' ' ' GLN . 37.0 Cg_exo -61.25 -36.88 77.56 Favored 'Trans proline' 0 C--N 1.384 2.438 0 C-N-CA 121.555 1.503 . . . . 0.0 110.724 178.68 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 58.9 tp -61.71 -46.79 88.15 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.3 175.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.501 ' HG ' ' O ' ' A' ' 173' ' ' LYS . 94.1 mt -61.38 -37.69 84.32 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.938 178.307 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 95.7 mt -65.75 -17.92 64.96 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.337 177.588 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 179' ' ' GLN . . . . . 0.488 ' HG2' ' O ' ' A' ' 175' ' ' PRO . 15.3 mm100 -92.47 -7.81 46.42 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 120.899 0.381 . . . . 0.0 110.488 177.558 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.462 ' HA ' ' NZ ' ' A' ' 180' ' ' LYS . 0.3 OUTLIER -102.87 -51.68 3.23 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.644 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 181' ' ' PHE . . . . . 0.496 ' CD2' ' HG ' ' A' ' 187' ' ' LEU . 88.3 m-85 -98.08 149.91 36.21 Favored Pre-proline 0 C--N 1.294 -1.843 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -63.89 -43.42 16.08 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 121.737 1.625 . . . . 0.0 112.063 -175.091 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 43.1 m -155.05 171.8 19.17 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.506 HD13 ' H ' ' A' ' 184' ' ' ILE . 0.2 OUTLIER -65.99 -28.94 45.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -175.015 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 22.4 tp60 -66.88 -35.8 80.85 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.973 -177.215 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 11.6 tm0? -79.66 -37.44 35.89 Favored 'General case' 0 C--O 1.203 -1.349 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 176.49 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.496 ' HG ' ' CD2' ' A' ' 181' ' ' PHE . 4.3 tt -49.71 -68.07 0.21 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.065 1.346 . . . . 0.0 112.344 -173.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 20.1 m -72.65 -24.29 61.02 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 121.169 0.509 . . . . 0.0 111.818 -174.298 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -87.47 1.27 53.95 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.995 -179.32 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.2 155.76 33.98 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 121.085 0.469 . . . . 0.0 110.582 176.52 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 4.7 m -63.34 160.96 14.89 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.297 -177.49 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 46.4 mm -50.16 -41.06 18.13 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.865 0 C-N-CA 123.278 0.631 . . . . 0.0 110.927 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -61.82 -30.05 74.01 Favored Glycine 0 CA--C 1.523 0.549 0 CA-C-N 116.216 -0.447 . . . . 0.0 113.243 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -83.44 -44.67 14.51 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 98.4 mt -65.69 -28.29 68.96 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.857 -179.323 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -70.43 -35.41 73.37 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -63.5 -24.72 67.94 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.221 -0.9 . . . . 0.0 113.221 -178.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 13.4 m -101.47 -26.42 3.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -178.474 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.478 HG23 ' H ' ' A' ' 200' ' ' GLY . 2.2 m -131.77 -82.33 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 112.902 0.705 . . . . 0.0 112.902 174.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 200' ' ' GLY . . . . . 0.478 ' H ' HG23 ' A' ' 199' ' ' VAL . . . -177.37 165.36 35.16 Favored Glycine 0 N--CA 1.422 -2.249 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 -177.023 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 23.1 pt20 -65.3 -39.07 92.05 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 117.596 0.698 . . . . 0.0 112.507 -177.637 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -66.91 -35.92 81.08 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.164 0.507 . . . . 0.0 110.306 -178.534 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.435 ' O ' ' HG2' ' A' ' 206' ' ' GLN . 2.0 t -76.62 -39.46 32.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 -179.165 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -57.22 -41.5 79.58 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.033 178.291 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 -62.42 -40.82 97.79 Favored 'General case' 0 N--CA 1.424 -1.737 0 CA-C-N 115.133 -0.939 . . . . 0.0 112.341 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 206' ' ' GLN . . . . . 0.435 ' HG2' ' O ' ' A' ' 203' ' ' VAL . 20.8 pt20 -72.42 -34.59 67.96 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.895 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 207' ' ' ILE . . . . . 0.496 ' HA ' HG21 ' A' ' 166' ' ' ILE . 73.5 mt -65.67 -48.55 82.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.559 0.695 . . . . 0.0 109.417 175.61 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 46.9 t-80 -67.22 -40.38 86.37 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.071 -178.517 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -64.29 -25.93 68.26 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 178.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -56.62 -43.73 80.48 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.533 0.733 . . . . 0.0 110.894 -177.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -95.88 -28.46 14.7 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 120.108 -0.637 . . . . 0.0 111.838 178.219 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 86.7 m . . . . . 0 CA--C 1.547 0.849 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 179.915 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 42.4 mt . . . . . 0 CA--C 1.487 -1.458 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.538 ' H ' HD23 ' A' ' 160' ' ' LEU . 2.0 pt? -61.31 -29.58 69.96 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.66 176.583 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 27.0 ptt180 -78.86 -24.78 44.09 Favored 'General case' 0 C--O 1.216 -0.69 0 C-N-CA 120.485 -0.486 . . . . 0.0 109.703 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 26.5 m -86.19 -41.53 14.59 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-O 121.377 0.608 . . . . 0.0 110.379 178.304 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -59.78 -26.5 35.48 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 C-N-CA 124.216 1.007 . . . . 0.0 111.553 -177.434 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -83.29 -15.1 51.47 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.81 177.746 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -106.28 14.2 27.78 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-O 121.329 0.585 . . . . 0.0 110.129 -175.317 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 94.8 mt -71.56 132.05 85.82 Favored Pre-proline 0 C--O 1.249 1.04 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 176.66 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -63.15 128.44 22.81 Favored 'Trans proline' 0 C--O 1.246 0.924 0 C-N-CA 122.007 1.805 . . . . 0.0 109.768 176.18 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 117.1 -32.82 5.29 Favored Glycine 0 N--CA 1.431 -1.65 0 C-N-CA 120.789 -0.72 . . . . 0.0 111.391 -177.245 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 59.6 t -66.95 -71.43 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.773 0 CA-C-O 121.231 0.538 . . . . 0.0 109.674 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 113.66 109.42 2.88 Favored Glycine 0 N--CA 1.421 -2.302 0 C-N-CA 119.975 -1.107 . . . . 0.0 112.91 177.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt -78.74 -15.05 58.91 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 121.718 0.771 . . . . 0.0 109.69 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 91.0 t -79.81 -36.64 17.38 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.895 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.538 ' O ' ' HG ' ' A' ' 177' ' ' LEU . 9.3 ptpp? -90.43 -5.89 55.56 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.073 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -52.81 -49.67 85.45 Favored Pre-proline 0 CA--C 1.552 1.03 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -177.528 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -62.56 -23.94 74.99 Favored 'Trans proline' 0 C--N 1.371 1.714 0 C-N-CA 121.283 1.322 . . . . 0.0 112.824 176.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 59.6 tp -77.63 -39.34 45.58 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 175.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 173' ' ' LYS . 87.4 mt -69.17 -33.05 72.79 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.837 -179.228 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 41.1 tp -68.24 -12.73 61.47 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-O 121.824 0.821 . . . . 0.0 110.76 178.694 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -94.13 -3.34 51.22 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.829 177.418 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 37.2 mmtm -117.51 -45.91 2.69 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 121.284 0.564 . . . . 0.0 110.94 177.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -102.4 145.03 29.79 Favored Pre-proline 0 C--N 1.303 -1.451 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 -179.022 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -67.0 -34.45 29.04 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 121.723 1.615 . . . . 0.0 112.411 -176.158 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 84.5 p -151.29 166.49 30.79 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -178.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.467 HD13 ' H ' ' A' ' 184' ' ' ILE . 0.2 OUTLIER -66.91 -25.02 33.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 O-C-N 123.384 0.428 . . . . 0.0 110.885 175.025 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -64.71 -47.46 78.24 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.45 178.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 12.4 tm0? -73.37 -35.93 66.0 Favored 'General case' 0 C--O 1.195 -1.775 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.466 HD21 HD13 ' A' ' 177' ' ' LEU . 4.4 tt -49.04 -65.96 0.48 Allowed 'General case' 0 C--O 1.217 -0.631 0 C-N-CA 124.697 1.199 . . . . 0.0 110.398 -177.565 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 19.8 m -68.79 -23.75 64.33 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -177.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 26.6 m-80 -85.11 -2.76 58.37 Favored 'General case' 0 C--O 1.242 0.699 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 178.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -66.34 156.3 34.87 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 122.978 0.511 . . . . 0.0 110.965 178.32 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 15.8 m -63.05 153.3 34.44 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.832 -178.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 48.9 mm -51.21 -36.67 16.95 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.927 0 C-N-CA 123.84 0.856 . . . . 0.0 111.274 -176.659 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 193' ' ' GLY . . . . . 0.57 ' O ' ' HG2' ' A' ' 197' ' ' GLN . . . -58.42 -45.89 93.78 Favored Glycine 0 N--CA 1.443 -0.843 0 O-C-N 123.385 0.428 . . . . 0.0 112.547 178.634 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 194' ' ' GLU . . . . . 0.447 ' O ' ' HB2' ' A' ' 197' ' ' GLN . 11.1 mm-40 -67.96 -40.77 83.13 Favored 'General case' 0 CA--C 1.494 -1.208 0 CA-C-O 121.772 0.796 . . . . 0.0 109.705 -177.696 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 94.3 mt -70.82 -31.09 67.71 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.76 178.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -68.95 -35.71 77.1 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.433 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 197' ' ' GLN . . . . . 0.57 ' HG2' ' O ' ' A' ' 193' ' ' GLY . 15.5 mm100 -57.89 -33.31 68.6 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.638 -1.164 . . . . 0.0 111.465 177.172 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 14.2 m -103.33 -35.04 3.62 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -176.066 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.467 HG23 ' H ' ' A' ' 200' ' ' GLY . 2.4 m -118.89 -77.66 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 176.476 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 200' ' ' GLY . . . . . 0.467 ' H ' HG23 ' A' ' 199' ' ' VAL . . . -178.69 165.33 34.39 Favored Glycine 0 N--CA 1.419 -2.443 0 N-CA-C 107.963 -2.055 . . . . 0.0 107.963 -177.799 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -66.07 -45.65 80.52 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 117.762 0.781 . . . . 0.0 109.855 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -67.76 -33.59 75.14 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-O 121.161 0.505 . . . . 0.0 110.983 -179.116 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.412 HG23 ' H ' ' A' ' 203' ' ' VAL . 2.6 t -73.81 -40.52 53.53 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.686 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 -178.531 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -56.04 -44.97 79.3 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.545 -1.207 . . . . 0.0 109.882 177.657 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -59.32 -50.9 72.19 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.582 178.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -66.97 -30.63 70.81 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 121.046 -0.261 . . . . 0.0 111.559 -176.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 97.4 mt -75.11 -51.4 21.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.373 177.369 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 9.7 t60 -69.86 -38.4 76.43 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.368 0.604 . . . . 0.0 110.202 -175.224 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -77.95 -9.94 59.34 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -60.1 -51.29 70.23 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-O 121.514 0.673 . . . . 0.0 110.395 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -86.82 -26.97 23.79 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.394 -179.18 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 37.6 m . . . . . 0 C--N 1.316 -0.856 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.595 -179.741 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.1 tm? . . . . . 0 N--CA 1.45 -0.436 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.422 ' O ' HG12 ' A' ' 163' ' ' VAL . 2.1 pt? -60.21 -33.08 71.75 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -178.57 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -75.79 -26.26 57.15 Favored 'General case' 0 C--O 1.219 -0.536 0 CA-C-O 121.768 0.794 . . . . 0.0 109.75 -178.145 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 21.5 m -86.24 -35.43 20.01 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-O 121.537 0.685 . . . . 0.0 110.153 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.422 HG12 ' O ' ' A' ' 160' ' ' LEU . 0.4 OUTLIER -64.54 -25.2 37.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.224 -176.507 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -84.57 -10.8 57.06 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.115 0.484 . . . . 0.0 110.787 177.348 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -102.75 23.38 12.17 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.292 0.568 . . . . 0.0 110.364 -177.123 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.416 HG21 ' HA ' ' A' ' 207' ' ' ILE . 84.8 mt -84.18 129.57 57.81 Favored Pre-proline 0 C--N 1.308 -1.221 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.048 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.98 128.79 18.32 Favored 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 121.778 1.652 . . . . 0.0 110.561 177.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 113.89 -16.72 20.65 Favored Glycine 0 C--N 1.297 -1.635 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.807 179.016 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 77.9 t -61.69 -43.21 96.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-O 121.028 0.442 . . . . 0.0 110.87 179.351 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 108.35 88.53 1.98 Allowed Glycine 0 N--CA 1.44 -1.097 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.383 178.246 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -60.64 -33.67 73.14 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -178.432 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 38.3 t -83.93 -23.49 7.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.336 0.589 . . . . 0.0 109.927 -176.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.54 ' O ' ' HG ' ' A' ' 177' ' ' LEU . 31.2 mtpt -85.57 -2.17 57.88 Favored 'General case' 0 C--O 1.193 -1.911 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.826 -176.669 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -42.97 -52.07 12.01 Favored Pre-proline 0 CA--C 1.566 1.587 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 -176.596 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.72 -38.55 10.23 Favored 'Trans proline' 0 C--N 1.366 1.487 0 C-N-CA 121.653 1.569 . . . . 0.0 111.738 178.003 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 54.4 tp -64.05 -41.31 97.43 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.116 177.232 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.54 ' HG ' ' O ' ' A' ' 173' ' ' LYS . 94.5 mt -58.22 -36.79 73.68 Favored 'General case' 0 C--O 1.206 -1.198 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.424 175.21 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.431 ' HA ' ' O ' ' A' ' 181' ' ' PHE . 92.5 mt -70.81 -11.93 61.25 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.299 0.571 . . . . 0.0 112.272 178.785 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -88.06 -5.42 58.49 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.83 0.824 . . . . 0.0 109.41 174.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.409 ' HA ' ' NZ ' ' A' ' 180' ' ' LYS . 0.3 OUTLIER -113.82 -50.73 2.82 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.359 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 181' ' ' PHE . . . . . 0.537 ' CD2' ' HG ' ' A' ' 187' ' ' LEU . 34.5 m-85 -110.23 140.81 22.78 Favored Pre-proline 0 C--N 1.3 -1.549 0 CA-C-N 114.571 -1.195 . . . . 0.0 108.921 -177.244 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.91 -52.5 5.86 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 123.178 2.585 . . . . 0.0 112.682 178.345 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 50.7 m -154.64 172.83 17.24 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -179.35 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -54.05 -32.08 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 114.495 1.294 . . . . 0.0 114.495 -176.749 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -65.02 -43.06 93.7 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.901 0.381 . . . . 0.0 111.01 -177.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 13.5 tm0? -79.42 -35.9 39.84 Favored 'General case' 0 C--O 1.196 -1.73 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 176.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.537 ' HG ' ' CD2' ' A' ' 181' ' ' PHE . 5.5 tt -51.82 -67.05 0.28 Allowed 'General case' 0 C--O 1.208 -1.126 0 C-N-CA 124.712 1.205 . . . . 0.0 112.208 -173.795 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 188' ' ' SER . . . . . 0.417 ' CB ' HG22 ' A' ' 163' ' ' VAL . 24.3 m -75.83 -18.72 59.36 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-O 121.157 0.503 . . . . 0.0 112.235 -174.409 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -93.57 -0.06 56.4 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.131 -179.076 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.93 155.6 36.02 Favored 'General case' 0 CA--C 1.506 -0.721 0 C-N-CA 123.539 0.736 . . . . 0.0 110.375 176.206 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 20.4 m -64.95 159.51 22.76 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.035 -176.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 48.2 mm -51.72 -39.62 24.56 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.647 0 C-N-CA 123.271 0.628 . . . . 0.0 110.707 -177.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -60.16 -37.92 93.63 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-N 116.003 -0.544 . . . . 0.0 113.482 179.305 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -75.1 -41.25 59.08 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -177.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 96.1 mt -68.64 -34.66 76.1 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.217 179.178 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 196' ' ' GLU . . . . . 0.476 ' HG2' ' N ' ' A' ' 201' ' ' GLN . 5.0 tm-20 -65.92 -33.75 76.53 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -178.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -61.88 -30.5 70.91 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.792 -1.094 . . . . 0.0 113.113 179.376 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 25.9 m -100.3 -36.27 5.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 C-N-CA 119.592 -0.843 . . . . 0.0 111.411 -179.057 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.544 HG23 ' H ' ' A' ' 200' ' ' GLY . 2.9 m -116.19 -85.65 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 176.216 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 200' ' ' GLY . . . . . 0.544 ' H ' HG23 ' A' ' 199' ' ' VAL . . . -176.82 165.67 35.97 Favored Glycine 0 N--CA 1.415 -2.708 0 N-CA-C 108.274 -1.93 . . . . 0.0 108.274 -175.676 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 201' ' ' GLN . . . . . 0.476 ' N ' ' HG2' ' A' ' 196' ' ' GLU . 52.9 tt0 -67.72 -42.15 82.37 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 117.496 0.648 . . . . 0.0 112.097 -174.596 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -66.66 -35.78 80.97 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.186 0.517 . . . . 0.0 110.624 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.519 ' O ' ' HG2' ' A' ' 206' ' ' GLN . 2.6 t -71.64 -40.38 70.62 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.747 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -57.06 -43.84 82.44 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 114.366 -1.288 . . . . 0.0 110.098 178.513 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 205' ' ' GLN . . . . . 0.403 ' HG3' ' O ' ' A' ' 201' ' ' GLN . 53.9 mt-30 -60.93 -45.59 94.06 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 114.955 -1.021 . . . . 0.0 112.372 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 206' ' ' GLN . . . . . 0.519 ' HG2' ' O ' ' A' ' 203' ' ' VAL . 13.2 pt20 -69.29 -30.86 69.03 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 120.236 -0.585 . . . . 0.0 110.708 -177.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 207' ' ' ILE . . . . . 0.416 ' HA ' HG21 ' A' ' 166' ' ' ILE . 92.4 mt -73.44 -50.38 30.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.268 178.107 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 48.1 t-80 -69.1 -41.46 77.4 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.159 -177.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -73.44 -11.51 60.49 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 121.941 -0.474 . . . . 0.0 112.227 179.334 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -58.82 -51.9 68.02 Favored 'General case' 0 C--O 1.217 -0.646 0 C-N-CA 122.795 0.438 . . . . 0.0 110.743 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -80.51 -24.84 39.09 Favored 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.524 -179.427 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 27.5 m . . . . . 0 CA--C 1.546 0.815 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.615 175.696 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 36.6 t . . . . . 0 N--CA 1.437 -1.105 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -133.59 164.39 27.28 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -177.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -77.94 124.05 86.2 Favored Pre-proline 0 C--N 1.306 -1.296 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 170.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -58.03 108.48 0.39 Allowed 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.471 2.114 . . . . 0.0 113.283 -175.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 93.7 mt -90.1 -3.68 57.78 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.01 -0.995 . . . . 0.0 108.754 176.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 74.8 mt -81.21 105.22 12.24 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 114.777 -1.102 . . . . 0.0 108.491 178.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 127.27 160.42 10.49 Favored Glycine 0 N--CA 1.431 -1.68 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.548 178.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -88.7 127.11 35.58 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -122.21 128.86 51.69 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.425 -176.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -106.0 128.94 54.17 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 174.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -132.45 101.8 5.48 Favored 'General case' 0 C--N 1.295 -1.761 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.743 -177.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 52.1 tp -78.98 106.66 11.17 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 176.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 85.0 mt -101.18 135.13 43.15 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.277 -172.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 60.6 tp -88.35 85.53 6.9 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 176.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 28.4 m -135.63 107.26 6.96 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.314 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -77.58 115.85 53.17 Favored Pre-proline 0 C--N 1.307 -1.245 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 -179.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -81.8 21.43 0.94 Allowed 'Trans proline' 0 N--CA 1.482 0.827 0 C-N-CA 123.5 2.8 . . . . 0.0 113.536 -174.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.578 ' O ' ' HG2' ' A' ' 161' ' ' ARG . 28.0 m 62.88 59.47 1.37 Allowed 'General case' 0 N--CA 1.436 -1.175 0 CA-C-O 122.531 1.158 . . . . 0.0 109.583 -176.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -76.99 -29.75 55.64 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 114.255 -1.339 . . . . 0.0 108.929 -179.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.535 ' O ' HG12 ' A' ' 163' ' ' VAL . 2.0 pt? -58.81 -30.35 67.55 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.455 -179.155 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.578 ' HG2' ' O ' ' A' ' 158' ' ' SER . 12.3 ptm180 -78.78 -26.4 44.45 Favored 'General case' 0 C--N 1.309 -1.166 0 O-C-N 121.837 -0.54 . . . . 0.0 110.563 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 24.9 m -85.84 -28.59 24.34 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.574 0.702 . . . . 0.0 109.637 177.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.535 HG12 ' O ' ' A' ' 160' ' ' LEU . 0.3 OUTLIER -66.3 -25.71 36.15 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 CA-C-O 121.832 0.825 . . . . 0.0 111.072 -176.703 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -84.87 -7.44 59.17 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.37 177.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -96.3 1.86 52.33 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.027 -178.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.404 HG21 ' HA ' ' A' ' 207' ' ' ILE . 70.3 mt -73.96 131.14 81.83 Favored Pre-proline 0 C--N 1.314 -0.975 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.057 -177.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -66.68 128.23 18.62 Favored 'Trans proline' 0 C--O 1.246 0.897 0 C-N-CA 121.934 1.756 . . . . 0.0 110.235 175.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 116.02 -24.23 10.2 Favored Glycine 0 C--N 1.297 -1.59 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 -178.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 65.6 t -75.02 -58.39 4.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 177.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 90.13 107.06 1.27 Allowed Glycine 0 N--CA 1.425 -2.062 0 CA-C-N 115.431 -0.804 . . . . 0.0 113.576 177.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? -68.46 -21.24 64.65 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 121.577 0.703 . . . . 0.0 111.201 178.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 57.9 t -82.53 -30.56 9.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-O 121.712 0.768 . . . . 0.0 109.35 178.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.429 ' O ' HD13 ' A' ' 177' ' ' LEU . 60.0 mtpt -84.79 -10.25 57.38 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.955 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -51.73 -53.79 46.97 Favored Pre-proline 0 C--O 1.201 -1.472 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -178.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -62.3 -26.58 77.3 Favored 'Trans proline' 0 C--N 1.376 1.982 0 C-N-CA 121.856 1.704 . . . . 0.0 113.413 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 61.6 tp -77.38 -45.27 26.49 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 121.741 0.781 . . . . 0.0 109.103 178.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.429 HD13 ' O ' ' A' ' 173' ' ' LYS . 8.2 mp -71.84 -24.35 61.69 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.873 178.257 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.449 HD12 ' O ' ' A' ' 181' ' ' PHE . 42.5 tp -67.31 -11.68 58.21 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 124.091 0.956 . . . . 0.0 110.401 177.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -76.53 -20.59 56.74 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.514 175.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 7.8 mmmm -105.58 -42.13 5.29 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.918 178.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' PHE . . . . . 0.449 ' O ' HD12 ' A' ' 178' ' ' LEU . 32.5 m-85 -105.64 130.55 22.87 Favored Pre-proline 0 C--N 1.299 -1.611 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.935 -174.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -53.73 -42.4 66.52 Favored 'Trans proline' 0 C--N 1.359 1.128 0 C-N-CA 123.623 2.882 . . . . 0.0 113.7 -175.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 42.6 m -158.5 177.5 11.17 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.482 ' HA ' ' HB3' ' A' ' 187' ' ' LEU . 0.2 OUTLIER -59.52 -27.89 38.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 -175.961 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -69.1 -38.63 79.03 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 120.67 0.272 . . . . 0.0 110.94 -177.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -79.9 -33.44 39.89 Favored 'General case' 0 C--O 1.195 -1.81 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 176.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.482 ' HB3' ' HA ' ' A' ' 184' ' ' ILE . 62.4 tp -52.63 -67.78 0.22 Allowed 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 125.104 1.362 . . . . 0.0 113.467 -176.258 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.438 ' HB2' HG22 ' A' ' 163' ' ' VAL . 19.4 m -74.65 -24.75 58.87 Favored 'General case' 0 C--N 1.289 -2.04 0 C-N-CA 120.24 -0.584 . . . . 0.0 111.609 -176.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.473 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 62.4 t30 -89.45 12.0 17.7 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-O 122.095 0.95 . . . . 0.0 110.025 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.51 156.62 31.95 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.606 173.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 6.6 m -63.6 154.38 32.91 Favored 'General case' 0 N--CA 1.425 -1.676 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.082 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 48.9 mm -52.02 -39.73 26.96 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.825 0 C-N-CA 123.477 0.711 . . . . 0.0 110.889 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.502 ' O ' ' HG2' ' A' ' 197' ' ' GLN . . . -59.39 -39.13 94.39 Favored Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 116.18 -0.464 . . . . 0.0 112.631 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 0.441 ' O ' ' HB2' ' A' ' 197' ' ' GLN . 41.6 mm-40 -77.72 -38.55 46.96 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.43 0.633 . . . . 0.0 109.807 -176.533 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 96.8 mt -69.88 -32.2 70.42 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.485 178.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -67.37 -29.72 69.32 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -178.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.502 ' HG2' ' O ' ' A' ' 193' ' ' GLY . 15.8 mm100 -59.62 -33.84 72.01 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.737 -1.12 . . . . 0.0 112.441 178.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 23.4 m -103.48 -26.83 3.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -174.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.484 HG23 ' H ' ' A' ' 200' ' ' GLY . 1.4 m -123.15 -82.82 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 175.531 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' GLY . . . . . 0.484 ' H ' HG23 ' A' ' 199' ' ' VAL . . . -177.0 167.87 39.42 Favored Glycine 0 N--CA 1.419 -2.449 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 -177.209 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 19.5 tm0? -64.14 -47.95 77.94 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 123.254 0.622 . . . . 0.0 110.814 -175.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -71.65 -32.34 67.81 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.859 0.361 . . . . 0.0 111.066 -177.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.442 ' O ' ' HG2' ' A' ' 206' ' ' GLN . 2.9 t -69.03 -40.07 80.39 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.649 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 179.047 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -60.19 -43.18 96.12 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 114.294 -1.321 . . . . 0.0 109.675 177.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -59.72 -45.58 91.75 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.785 179.069 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' GLN . . . . . 0.442 ' HG2' ' O ' ' A' ' 203' ' ' VAL . 12.0 pt20 -66.26 -34.75 78.72 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 120.145 -0.622 . . . . 0.0 111.084 -179.041 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' ILE . . . . . 0.404 ' HA ' HG21 ' A' ' 166' ' ' ILE . 87.3 mt -69.43 -51.48 41.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.291 0.567 . . . . 0.0 109.712 178.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' HIS . . . . . 0.553 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 13.4 t60 -68.0 -36.71 80.46 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.237 -175.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -68.06 -32.79 73.37 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.694 176.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -54.62 -52.21 62.94 Favored 'General case' 0 C--O 1.215 -0.733 0 C-N-CA 124.023 0.929 . . . . 0.0 112.367 -174.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.553 ' CZ ' ' HA ' ' A' ' 208' ' ' HIS . 21.5 p90 -80.8 -23.85 38.96 Favored 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 120.36 -0.536 . . . . 0.0 112.097 -178.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 75.2 m -65.78 -51.53 58.34 Favored 'General case' 0 C--O 1.247 0.932 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -140.88 109.04 6.47 Favored Pre-proline 0 N--CA 1.423 -1.803 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 177.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -108.43 162.61 0.1 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 122.282 1.988 . . . . 0.0 113.743 177.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 13.6 tpp180 . . . . . 0 N--CA 1.422 -1.871 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 174.246 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 50.8 m . . . . . 0 N--CA 1.427 -1.623 0 N-CA-C 110.334 -0.247 . . . . 0.0 110.334 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt 61.19 83.84 0.14 Allowed 'General case' 0 C--O 1.242 0.701 0 C-N-CA 124.272 1.029 . . . . 0.0 111.995 176.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.55 HD21 ' HA ' ' A' ' 146' ' ' LEU . 27.8 p-10 -96.67 157.8 34.67 Favored Pre-proline 0 C--N 1.295 -1.795 0 CA-C-N 114.696 -1.138 . . . . 0.0 108.624 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -39.26 -54.76 1.7 Allowed 'Trans proline' 0 C--N 1.366 1.464 0 C-N-CA 124.131 3.221 . . . . 0.0 114.067 178.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 7.1 tt -156.97 114.17 3.1 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.55 ' HA ' HD21 ' A' ' 143' ' ' ASN . 57.1 tp -69.16 105.88 2.63 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.566 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 132.45 -149.35 19.46 Favored Glycine 0 N--CA 1.41 -3.087 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 178.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -106.8 101.93 11.33 Favored 'General case' 0 C--N 1.284 -2.263 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -76.75 169.09 18.94 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-O 121.104 0.478 . . . . 0.0 110.183 -178.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 9.9 tpt180 -98.96 131.39 45.06 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -74.44 100.68 3.89 Favored 'General case' 0 N--CA 1.425 -1.713 0 N-CA-C 105.085 -2.191 . . . . 0.0 105.085 171.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 62.6 tp -93.89 122.48 36.42 Favored 'General case' 0 N--CA 1.41 -2.438 0 CA-C-N 114.592 -1.186 . . . . 0.0 109.869 -172.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -77.27 83.54 3.73 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.987 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.511 HD12 ' O ' ' A' ' 154' ' ' LEU . 2.9 pp -108.03 119.03 38.3 Favored 'General case' 0 N--CA 1.404 -2.767 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 169.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 8.6 t -80.73 107.26 13.39 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -176.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -73.29 113.66 24.22 Favored Pre-proline 0 C--N 1.291 -1.958 0 CA-C-N 114.129 -1.396 . . . . 0.0 109.65 -176.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -81.15 -165.27 0.33 Allowed 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 122.464 2.11 . . . . 0.0 112.012 -178.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.414 ' O ' ' HG2' ' A' ' 161' ' ' ARG . 14.7 m -75.45 18.63 0.21 Allowed 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -176.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.483 ' O ' HD23 ' A' ' 159' ' ' LEU . 6.2 tt -60.21 -21.81 62.23 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 124.628 1.171 . . . . 0.0 110.169 -178.628 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -59.37 -22.36 61.24 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.045 0.45 . . . . 0.0 111.738 178.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.414 ' HG2' ' O ' ' A' ' 158' ' ' SER . 32.8 ptt180 -73.49 -35.42 65.64 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.275 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.451 ' HA ' ' OE1' ' A' ' 165' ' ' GLN . 33.3 m -87.03 -29.11 22.18 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 124.244 1.018 . . . . 0.0 112.163 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 2.8 p -64.56 -27.08 41.76 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-O 121.752 0.787 . . . . 0.0 110.757 -176.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -82.94 -8.67 59.54 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.91 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.451 ' OE1' ' HA ' ' A' ' 162' ' ' THR . 51.0 mt-30 -98.42 0.42 45.26 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.665 -177.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 96.4 mt -68.43 131.54 91.66 Favored Pre-proline 0 C--N 1.312 -1.048 0 N-CA-C 108.876 -0.786 . . . . 0.0 108.876 178.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -61.36 128.72 25.77 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 121.843 1.696 . . . . 0.0 109.632 177.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 115.52 -30.12 6.87 Favored Glycine 0 N--CA 1.429 -1.773 0 C-N-CA 120.267 -0.968 . . . . 0.0 111.279 -178.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 84.5 t -66.2 -62.91 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 103.47 105.19 2.95 Favored Glycine 0 N--CA 1.427 -1.964 0 C-N-CA 120.575 -0.822 . . . . 0.0 112.164 178.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -81.29 -17.11 50.46 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -177.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 42.4 t -85.15 -37.84 12.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 CA-C-O 121.596 0.712 . . . . 0.0 109.3 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.518 ' O ' ' HG ' ' A' ' 177' ' ' LEU . 20.8 ptmt -88.72 -4.75 58.45 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.509 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -54.72 -48.89 94.24 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -178.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.489 ' O ' ' HG2' ' A' ' 179' ' ' GLN . 11.2 Cg_endo -57.27 -35.15 98.85 Favored 'Trans proline' 0 C--N 1.38 2.237 0 C-N-CA 121.715 1.61 . . . . 0.0 112.179 177.483 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 59.4 tp -69.31 -42.4 75.45 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.274 0.559 . . . . 0.0 109.54 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.518 ' HG ' ' O ' ' A' ' 173' ' ' LYS . 74.5 mt -69.47 -29.85 67.6 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.795 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 50.9 tp -70.73 -12.57 61.63 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.738 179.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' GLN . . . . . 0.489 ' HG2' ' O ' ' A' ' 175' ' ' PRO . 24.8 mm-40 -88.22 -13.77 40.2 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 176.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -99.33 -51.52 3.77 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 -179.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' PHE . . . . . 0.581 ' CD2' ' HG ' ' A' ' 187' ' ' LEU . 89.7 m-85 -94.24 148.85 35.8 Favored Pre-proline 0 C--N 1.307 -1.267 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.183 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -68.94 -31.29 24.66 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.053 1.835 . . . . 0.0 113.332 -175.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 66.5 m -158.56 161.84 37.32 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -62.01 -29.41 46.39 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.411 0 O-C-N 123.55 0.531 . . . . 0.0 112.024 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -62.54 -47.7 82.77 Favored 'General case' 0 C--O 1.211 -0.966 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.429 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 14.0 tm0? -74.08 -31.18 62.72 Favored 'General case' 0 C--O 1.2 -1.528 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -179.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.581 ' HG ' ' CD2' ' A' ' 181' ' ' PHE . 4.5 tt -57.81 -59.91 4.5 Favored 'General case' 0 C--O 1.204 -1.301 0 C-N-CA 123.811 0.844 . . . . 0.0 109.561 -178.297 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 22.8 m -73.77 -24.72 59.89 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -178.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -86.98 1.99 50.95 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-O 121.516 0.674 . . . . 0.0 110.724 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.55 156.94 31.07 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 124.023 0.929 . . . . 0.0 111.373 175.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 5.0 m -64.49 159.72 20.91 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.249 -178.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 43.1 mm -52.67 -38.79 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 123.205 0.602 . . . . 0.0 111.449 -179.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.506 ' O ' ' HG2' ' A' ' 197' ' ' GLN . . . -61.48 -43.65 99.04 Favored Glycine 0 C--O 1.214 -1.142 0 C-N-CA 120.853 -0.689 . . . . 0.0 111.908 178.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -67.47 -41.23 84.95 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.635 0.731 . . . . 0.0 109.575 -176.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 94.2 mt -70.47 -31.05 68.03 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.001 -0.999 . . . . 0.0 111.121 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' GLU . . . . . 0.543 ' HG2' ' N ' ' A' ' 201' ' ' GLN . 4.2 tm-20 -73.42 -41.01 63.81 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.506 ' HG2' ' O ' ' A' ' 193' ' ' GLY . 85.5 mm-40 -57.66 -25.32 60.04 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 123.8 0.84 . . . . 0.0 112.369 178.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.405 HG23 HG23 ' A' ' 199' ' ' VAL . 14.6 m -103.52 -34.84 3.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.539 HG11 HG11 ' A' ' 203' ' ' VAL . 1.2 t -122.01 -77.43 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 C-N-CA 119.259 -0.976 . . . . 0.0 111.392 178.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -177.22 160.43 27.34 Favored Glycine 0 N--CA 1.435 -1.383 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 -176.044 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' GLN . . . . . 0.543 ' N ' ' HG2' ' A' ' 196' ' ' GLU . 13.9 pt20 -63.36 -38.05 89.64 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 123.624 0.77 . . . . 0.0 112.34 -176.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -74.86 -34.92 62.34 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 121.837 0.827 . . . . 0.0 109.672 -178.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.539 HG11 HG11 ' A' ' 199' ' ' VAL . 24.8 t -68.53 -45.09 82.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-N 114.373 -1.285 . . . . 0.0 109.57 -179.397 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -53.51 -43.82 68.62 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 114.161 -1.381 . . . . 0.0 109.756 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -66.8 -44.98 79.84 Favored 'General case' 0 N--CA 1.421 -1.904 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.451 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' GLN . . . . . 0.467 ' HG2' ' O ' ' A' ' 203' ' ' VAL . 20.9 pt20 -66.09 -33.67 76.31 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.254 -0.578 . . . . 0.0 111.147 -178.618 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 84.7 mt -73.59 -50.19 31.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.561 177.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 28.0 t-80 -63.75 -46.99 82.81 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.997 -177.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -72.35 -9.96 59.18 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -178.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -64.13 -47.43 79.98 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 178.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -97.79 -29.44 13.36 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.647 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 33.4 m -77.97 -37.37 47.55 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -176.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -93.84 133.74 27.33 Favored Pre-proline 0 C--N 1.311 -1.08 0 C-N-CA 120.376 -0.53 . . . . 0.0 109.627 -176.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -51.16 159.97 2.41 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 123.981 3.121 . . . . 0.0 114.023 177.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 25.3 ptt180 . . . . . 0 C--N 1.296 -1.724 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.059 -176.17 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.9 m . . . . . 0 N--CA 1.422 -1.847 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -167.23 -56.44 0.03 OUTLIER 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.099 -176.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.407 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . 95.2 m-20 -79.33 131.24 66.16 Favored Pre-proline 0 C--N 1.313 -0.982 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.756 -175.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 143' ' ' ASN . 21.0 Cg_exo -65.03 109.55 1.33 Allowed 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.025 1.817 . . . . 0.0 109.711 176.278 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 58.2 tp -142.32 107.87 5.07 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-O 121.363 0.602 . . . . 0.0 109.952 -176.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 7.8 mp -89.06 104.8 17.32 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 115.058 -0.974 . . . . 0.0 108.47 176.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 147.76 -150.13 22.31 Favored Glycine 0 N--CA 1.424 -2.154 0 N-CA-C 108.425 -1.87 . . . . 0.0 108.425 -177.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -91.58 158.95 16.15 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 117.355 0.577 . . . . 0.0 111.147 179.171 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -76.03 96.3 3.78 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 121.492 0.663 . . . . 0.0 111.368 -175.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 44.7 ttm180 -125.93 103.92 8.02 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.442 178.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -86.46 101.08 12.83 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 121.286 0.565 . . . . 0.0 109.494 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 61.0 tp -129.86 121.17 26.18 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.601 HD23 ' H ' ' A' ' 153' ' ' LEU . 2.0 pt? -72.83 153.58 41.0 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.998 177.213 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 49.6 mt -105.74 111.72 24.5 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.6 176.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 42.3 p -80.77 101.51 9.38 Favored 'General case' 0 N--CA 1.417 -2.08 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 170.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.401 ' HB3' ' OG ' ' A' ' 158' ' ' SER . 42.0 mt-10 -107.25 129.36 24.41 Favored Pre-proline 0 C--N 1.285 -2.234 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -89.9 23.44 0.7 Allowed 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 123.044 2.496 . . . . 0.0 108.441 168.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.401 ' OG ' ' HB3' ' A' ' 156' ' ' GLU . 19.8 m -72.25 103.88 3.51 Favored 'General case' 0 N--CA 1.414 -2.265 0 CA-C-N 114.048 -1.433 . . . . 0.0 110.866 -178.329 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -90.37 -22.15 21.63 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.574 177.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.521 HD23 ' H ' ' A' ' 160' ' ' LEU . 1.7 pt? -60.53 -32.63 71.66 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.281 0.562 . . . . 0.0 111.232 178.22 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.413 ' O ' ' HG2' ' A' ' 164' ' ' GLN . 14.8 ptm180 -75.39 -30.14 60.03 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.036 177.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.601 ' O ' ' HG2' ' A' ' 165' ' ' GLN . 12.0 m -81.27 -37.99 27.58 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-O 121.457 0.646 . . . . 0.0 110.015 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.402 HG12 ' O ' ' A' ' 160' ' ' LEU . 1.7 p -63.55 -25.15 37.65 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.049 0 CA-C-O 121.479 0.657 . . . . 0.0 110.952 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' GLN . . . . . 0.413 ' HG2' ' O ' ' A' ' 161' ' ' ARG . 12.1 pt20 -90.13 -11.64 40.64 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 122.015 -0.428 . . . . 0.0 110.9 178.139 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.601 ' HG2' ' O ' ' A' ' 162' ' ' THR . 18.9 pt20 -91.77 -6.02 52.54 Favored 'General case' 0 CA--C 1.505 -0.783 0 C-N-CA 119.303 -0.959 . . . . 0.0 111.168 -174.194 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 66.0 mt -61.19 133.51 92.84 Favored Pre-proline 0 C--N 1.298 -1.654 0 CA-C-N 114.823 -1.08 . . . . 0.0 109.481 -178.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -63.3 127.96 21.4 Favored 'Trans proline' 0 C--O 1.246 0.91 0 C-N-CA 122.022 1.815 . . . . 0.0 110.345 179.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 114.36 -32.82 5.71 Favored Glycine 0 N--CA 1.424 -2.126 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 -177.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 57.9 t -69.02 -53.01 28.27 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 177.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' GLY . . . . . 0.483 ' HA3' ' HG2' ' A' ' 173' ' ' LYS . . . 88.88 90.93 1.15 Allowed Glycine 0 N--CA 1.414 -2.779 0 CA-C-N 114.77 -1.105 . . . . 0.0 111.818 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -66.3 -23.18 66.33 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 120.776 0.322 . . . . 0.0 111.724 -178.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 47.2 t -86.53 -28.19 5.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-O 121.194 0.521 . . . . 0.0 110.281 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.564 ' O ' ' HG ' ' A' ' 177' ' ' LEU . 21.0 ptmt -91.29 9.26 32.18 Favored 'General case' 0 C--O 1.214 -0.764 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.707 178.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.464 ' O ' ' HG ' ' A' ' 178' ' ' LEU . . . -52.07 -48.66 87.88 Favored Pre-proline 0 CA--C 1.556 1.2 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 177.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -59.99 -23.22 72.22 Favored 'Trans proline' 0 C--N 1.381 2.243 0 C-N-CA 122.401 2.067 . . . . 0.0 112.867 177.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.497 ' HB3' ' O ' ' A' ' 173' ' ' LYS . 51.0 tp -79.23 -21.05 46.77 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 123.683 0.793 . . . . 0.0 109.489 178.426 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.564 ' HG ' ' O ' ' A' ' 173' ' ' LYS . 39.7 mt -98.32 -34.46 10.68 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -178.472 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 174' ' ' ALA . 95.2 mt -66.82 -5.66 13.17 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.997 0.919 . . . . 0.0 112.732 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' GLN . . . . . 0.473 ' HG2' ' O ' ' A' ' 176' ' ' LEU . 16.1 pt20 -74.5 -35.02 63.2 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 172.622 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm -92.52 -51.43 5.13 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.138 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' PHE . . . . . 0.426 ' CD1' ' HA ' ' A' ' 187' ' ' LEU . 89.9 m-85 -90.27 144.36 30.9 Favored Pre-proline 0 C--N 1.304 -1.401 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.63 -176.369 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -69.78 -44.56 1.99 Allowed 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 121.851 1.701 . . . . 0.0 112.652 -175.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 45.4 m -152.38 167.84 27.4 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 178.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.489 HD13 ' H ' ' A' ' 184' ' ' ILE . 0.2 OUTLIER -60.75 -31.76 50.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 N-CA-C 115.613 1.708 . . . . 0.0 115.613 -173.225 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -68.57 -45.92 70.78 Favored 'General case' 0 C--O 1.207 -1.15 0 C-N-CA 118.81 -1.156 . . . . 0.0 110.425 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 11.1 tm0? -67.49 -32.8 73.87 Favored 'General case' 0 C--O 1.209 -1.059 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.426 ' HA ' ' CD1' ' A' ' 181' ' ' PHE . 3.6 tt -56.76 -62.6 1.62 Allowed 'General case' 0 C--O 1.213 -0.857 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.5 -179.181 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 29.5 m -70.87 -27.82 64.11 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -178.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.498 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 11.1 t-20 -81.03 -3.25 51.17 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-O 121.222 0.534 . . . . 0.0 110.511 -178.062 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.412 ' HB1' ' HB2' ' A' ' 194' ' ' GLU . . . -64.56 155.67 32.31 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 123.055 0.542 . . . . 0.0 110.79 177.043 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 20.6 t -68.09 170.65 8.08 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 121.262 0.553 . . . . 0.0 110.836 -175.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 47.7 mm -59.33 -39.61 79.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.55 -177.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.548 ' O ' ' HG3' ' A' ' 197' ' ' GLN . . . -59.86 -38.62 94.31 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.305 178.267 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 0.412 ' HB2' ' HB1' ' A' ' 190' ' ' ALA . 29.2 mt-10 -77.82 -43.12 31.42 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -176.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 96.2 mt -67.6 -25.32 65.7 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.712 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' GLU . . . . . 0.415 ' HG2' ' N ' ' A' ' 201' ' ' GLN . 9.7 tm-20 -73.67 -31.7 63.59 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.548 ' HG3' ' O ' ' A' ' 193' ' ' GLY . 98.4 mt-30 -68.8 -20.29 64.32 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.913 -1.04 . . . . 0.0 111.702 -178.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.434 HG23 HG23 ' A' ' 199' ' ' VAL . 16.7 m -105.19 -33.32 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.74 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.023 177.444 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.512 HG11 HG11 ' A' ' 203' ' ' VAL . 1.7 t -124.64 -84.48 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 C-N-CA 120.338 -0.545 . . . . 0.0 111.504 176.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -177.91 168.95 40.66 Favored Glycine 0 N--CA 1.436 -1.331 0 N-CA-C 109.851 -1.299 . . . . 0.0 109.851 -176.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' GLN . . . . . 0.415 ' N ' ' HG2' ' A' ' 196' ' ' GLU . 51.5 mt-30 -59.14 -52.86 63.9 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.911 0.884 . . . . 0.0 112.628 -175.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -68.85 -35.39 76.88 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 121.45 0.643 . . . . 0.0 111.186 -173.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.512 HG11 HG11 ' A' ' 199' ' ' VAL . 2.2 t -72.57 -38.19 58.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -178.241 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -57.85 -44.11 86.34 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 114.347 -1.297 . . . . 0.0 109.844 178.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -64.42 -42.78 95.86 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.886 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -74.56 -25.02 59.02 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.417 -0.513 . . . . 0.0 112.239 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 98.2 mt -76.4 -49.43 24.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 174.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 53.3 t-80 -63.44 -47.36 82.2 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.003 -178.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -65.74 -20.07 66.13 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -179.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -59.05 -44.13 91.76 Favored 'General case' 0 C--O 1.214 -0.792 0 C-N-CA 122.799 0.439 . . . . 0.0 110.613 -178.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.498 ' CZ ' ' HA ' ' A' ' 189' ' ' ASN . 31.6 p90 -99.4 -25.73 14.37 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.672 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 37.5 m -74.63 -35.77 62.9 Favored 'General case' 0 C--N 1.313 -1.022 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -178.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' GLN . . . . . 0.401 ' HA ' ' HD3' ' A' ' 214' ' ' PRO . 59.0 tp60 -108.41 119.62 49.0 Favored Pre-proline 0 N--CA 1.434 -1.26 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 -177.287 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 213' ' ' GLN . 23.4 Cg_exo -67.22 170.03 14.09 Favored 'Trans proline' 0 C--O 1.243 0.742 0 C-N-CA 122.604 2.202 . . . . 0.0 113.141 178.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 215' ' ' ARG . . . . . 0.456 ' HD2' ' N ' ' A' ' 215' ' ' ARG . 2.4 mpt_? . . . . . 0 C--O 1.26 1.609 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.147 -177.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 9.1 p . . . . . 0 N--CA 1.427 -1.614 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -96.32 148.02 23.19 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 178.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.421 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . 18.3 m120 -91.09 132.57 33.87 Favored Pre-proline 0 C--N 1.292 -1.9 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -178.496 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 143' ' ' ASN . 4.2 Cg_exo -74.25 93.24 0.9 Allowed 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 121.872 1.715 . . . . 0.0 112.994 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 11.1 mp -86.5 -23.72 25.83 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.244 174.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 60.7 tp -55.03 124.41 16.72 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 123.867 0.867 . . . . 0.0 111.801 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -168.85 -174.46 37.48 Favored Glycine 0 N--CA 1.428 -1.865 0 N-CA-C 108.117 -1.993 . . . . 0.0 108.117 178.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -89.28 93.28 9.49 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 118.232 1.016 . . . . 0.0 110.111 178.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -92.03 111.92 23.65 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 178.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 76.7 mtp180 -72.73 103.81 3.75 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -108.29 101.63 10.82 Favored 'General case' 0 CA--C 1.481 -1.696 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 -176.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 95.7 mt -118.5 101.12 7.91 Favored 'General case' 0 C--N 1.276 -2.628 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.473 -173.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 26.1 tp -94.12 128.99 40.84 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 178.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.545 HD12 ' O ' ' A' ' 154' ' ' LEU . 4.7 pp -84.01 106.24 15.52 Favored 'General case' 0 N--CA 1.432 -1.346 0 C-N-CA 119.083 -1.047 . . . . 0.0 111.089 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 40.0 m -114.5 133.75 55.54 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 175.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -96.99 107.03 35.04 Favored Pre-proline 0 C--N 1.303 -1.454 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -177.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -69.24 -45.04 2.04 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.431 2.087 . . . . 0.0 113.245 -175.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 48.4 t -102.32 108.46 19.82 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-O 120.796 0.331 . . . . 0.0 110.582 -176.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -93.94 -27.37 16.4 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 173.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.654 ' H ' HD23 ' A' ' 160' ' ' LEU . 1.6 pt? -60.38 -23.79 64.59 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.267 -0.879 . . . . 0.0 112.118 178.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.412 ' O ' ' HG2' ' A' ' 164' ' ' GLN . 14.3 ptm180 -65.87 -29.36 69.79 Favored 'General case' 0 C--O 1.215 -0.744 0 CA-C-O 120.92 0.39 . . . . 0.0 110.115 176.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 37.9 m -86.55 -31.75 21.06 Favored 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 123.025 0.53 . . . . 0.0 111.39 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.51 HG12 ' O ' ' A' ' 160' ' ' LEU . 2.5 p -64.52 -25.66 38.43 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.115 0 CA-C-O 121.418 0.627 . . . . 0.0 111.372 -176.429 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' GLN . . . . . 0.412 ' HG2' ' O ' ' A' ' 161' ' ' ARG . 29.5 pt20 -81.32 -13.01 58.87 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 121.161 0.505 . . . . 0.0 110.459 177.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -95.38 -0.05 53.0 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.545 -175.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 81.2 mt -66.14 132.42 94.53 Favored Pre-proline 0 C--N 1.317 -0.837 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.28 128.16 26.54 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.096 1.864 . . . . 0.0 111.006 178.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 112.65 -29.91 7.87 Favored Glycine 0 N--CA 1.425 -2.096 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 -178.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 59.1 t -73.25 -65.74 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.062 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 101.97 110.55 3.38 Favored Glycine 0 N--CA 1.43 -1.737 0 C-N-CA 120.314 -0.946 . . . . 0.0 112.799 177.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -82.66 -18.88 39.47 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.4 0.619 . . . . 0.0 111.597 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 62.7 t -84.13 -30.35 7.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 CA-C-O 121.819 0.819 . . . . 0.0 109.27 177.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -90.34 -4.17 57.27 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.372 178.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.507 ' O ' ' HG ' ' A' ' 178' ' ' LEU . . . -55.07 -47.16 99.19 Favored Pre-proline 0 C--O 1.202 -1.403 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -178.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.443 ' O ' ' HG3' ' A' ' 179' ' ' GLN . 36.2 Cg_exo -59.82 -36.99 89.33 Favored 'Trans proline' 0 C--N 1.381 2.243 0 CA-C-N 121.337 1.513 . . . . 0.0 111.234 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 57.2 tp -66.97 -44.64 79.96 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.665 176.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 96.3 mt -65.33 -32.25 73.79 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.027 178.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.507 ' HG ' ' O ' ' A' ' 174' ' ' ALA . 88.7 mt -72.44 -7.32 49.24 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 123.4 0.68 . . . . 0.0 111.774 178.074 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' GLN . . . . . 0.443 ' HG3' ' O ' ' A' ' 175' ' ' PRO . 52.6 mt-30 -95.65 -9.31 32.39 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.386 0.612 . . . . 0.0 109.356 174.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -105.18 -51.42 3.03 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' PHE . . . . . 0.448 ' CD2' ' HG ' ' A' ' 187' ' ' LEU . 86.4 m-85 -99.69 149.46 35.93 Favored Pre-proline 0 C--N 1.294 -1.837 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -66.99 -46.11 3.47 Favored 'Trans proline' 0 C--O 1.24 0.601 0 C-N-CA 121.439 1.426 . . . . 0.0 112.13 -175.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 30.0 m -151.33 167.79 26.81 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.432 HD13 ' H ' ' A' ' 184' ' ' ILE . 0.2 OUTLIER -60.67 -29.86 45.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 -174.274 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 56.8 tp60 -70.82 -39.13 73.23 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 119.731 -0.788 . . . . 0.0 110.384 -176.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 14.1 tm0? -76.06 -32.23 59.18 Favored 'General case' 0 C--O 1.197 -1.66 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 178.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.448 ' HG ' ' CD2' ' A' ' 181' ' ' PHE . 3.8 tt -56.53 -61.26 2.54 Favored 'General case' 0 C--O 1.212 -0.906 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.717 -178.447 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 19.8 m -70.26 -32.16 69.87 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 120.641 -0.423 . . . . 0.0 111.88 -178.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.405 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 7.9 t30 -83.96 4.72 28.47 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-O 121.566 0.698 . . . . 0.0 110.839 -177.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.414 ' HB1' ' HB2' ' A' ' 194' ' ' GLU . . . -65.46 156.16 33.26 Favored 'General case' 0 C--O 1.248 1.004 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.414 174.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 2.6 m -63.58 159.48 18.74 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.987 -176.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 50.8 mm -53.09 -36.25 24.45 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.963 0 C-N-CA 122.917 0.487 . . . . 0.0 111.537 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -69.47 -28.92 71.9 Favored Glycine 0 C--N 1.314 -0.66 0 C-N-CA 121.222 -0.513 . . . . 0.0 112.903 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 0.678 ' O ' ' HG2' ' A' ' 197' ' ' GLN . 26.2 mt-10 -81.29 -31.28 33.69 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -178.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 97.3 mt -79.33 -29.45 42.32 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.409 175.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' GLU . . . . . 0.549 ' HG2' ' N ' ' A' ' 201' ' ' GLN . 2.6 tm-20 -69.59 -35.61 75.48 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -178.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.678 ' HG2' ' O ' ' A' ' 194' ' ' GLU . 20.3 pt20 -67.19 -20.86 65.78 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.412 -176.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 15.7 m -104.6 -31.19 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -127.32 -83.41 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 173.135 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -177.21 164.07 33.14 Favored Glycine 0 CA--C 1.488 -1.602 0 N-CA-C 108.027 -2.029 . . . . 0.0 108.027 -176.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' GLN . . . . . 0.549 ' N ' ' HG2' ' A' ' 196' ' ' GLU . 12.1 pt20 -69.68 -38.59 77.08 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 118.239 1.02 . . . . 0.0 111.778 -176.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -64.25 -28.86 70.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.644 0.735 . . . . 0.0 110.561 -179.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 3.1 t -81.17 -43.09 20.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 178.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -56.44 -46.03 80.51 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.209 -1.36 . . . . 0.0 110.946 -178.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -60.74 -44.82 96.19 Favored 'General case' 0 C--O 1.199 -1.588 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.599 -178.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -73.63 -33.22 64.43 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.528 -178.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 92.5 mt -66.37 -49.56 74.64 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.241 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 175.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' HIS . . . . . 0.545 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 9.9 t60 -68.68 -39.2 80.68 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.829 -176.48 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -65.44 -29.12 69.77 Favored 'General case' 0 C--O 1.219 -0.523 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 177.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -54.27 -47.69 72.05 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.208 0.603 . . . . 0.0 111.912 -176.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.545 ' CZ ' ' HA ' ' A' ' 208' ' ' HIS . 19.9 p90 -93.6 -22.16 18.96 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.096 -178.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 80.6 m -75.59 -34.65 60.65 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.198 179.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -81.68 134.28 50.96 Favored Pre-proline 0 C--N 1.313 -1.01 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 174.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_exo -50.15 159.61 1.78 Allowed 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.803 3.002 . . . . 0.0 114.162 -178.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 . . . . . 0 C--N 1.289 -2.04 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.581 179.821 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 25.7 t . . . . . 0 N--CA 1.428 -1.546 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -119.37 13.14 12.66 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.542 0.687 . . . . 0.0 110.586 -179.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -140.14 121.76 9.6 Favored Pre-proline 0 C--N 1.302 -1.467 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 177.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -49.5 111.04 0.43 Allowed 'Trans proline' 0 C--O 1.245 0.854 0 C-N-CA 123.107 2.538 . . . . 0.0 113.16 178.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 61.5 tp -136.92 -53.8 0.71 Allowed 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 177.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.619 HD13 ' H ' ' A' ' 146' ' ' LEU . 0.0 OUTLIER -101.6 172.27 7.06 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.009 -0.996 . . . . 0.0 108.7 174.186 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 169.75 -151.75 17.81 Favored Glycine 0 N--CA 1.433 -1.513 0 C-N-CA 120.031 -1.081 . . . . 0.0 111.662 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -124.51 143.43 50.67 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -178.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -71.26 136.21 47.84 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 120.99 0.424 . . . . 0.0 110.559 178.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 4.1 tpm_? -82.25 94.53 7.33 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 175.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -52.74 113.39 1.06 Allowed 'General case' 0 CA--C 1.501 -0.936 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.138 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 53.5 tp -132.35 96.22 3.81 Favored 'General case' 0 N--CA 1.416 -2.169 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.481 -175.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -140.74 164.6 29.77 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 177.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -70.07 91.64 0.7 Allowed 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 177.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 15.3 m -94.77 103.06 14.96 Favored 'General case' 0 N--CA 1.415 -2.223 0 CA-C-N 114.557 -1.202 . . . . 0.0 111.764 -174.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -109.73 165.76 12.04 Favored Pre-proline 0 C--N 1.288 -2.089 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 170.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -59.25 95.43 0.09 OUTLIER 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 121.818 1.678 . . . . 0.0 109.799 174.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 47.3 t -164.32 89.69 0.54 Allowed 'General case' 0 N--CA 1.419 -2.02 0 C-N-CA 124.058 0.943 . . . . 0.0 108.816 -175.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 41.7 tp -94.08 -19.81 20.49 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 174.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.421 ' O ' HG12 ' A' ' 163' ' ' VAL . 2.4 pt? -60.75 -29.84 69.63 Favored 'General case' 0 C--O 1.225 -0.193 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.789 -178.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -63.07 -37.44 87.22 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.52 177.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 15.0 m -86.32 -31.95 21.29 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.183 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.421 HG12 ' O ' ' A' ' 160' ' ' LEU . 0.7 OUTLIER -62.96 -25.91 39.68 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.928 0 CA-C-O 121.587 0.708 . . . . 0.0 111.556 -176.597 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 28.9 pt20 -85.99 -8.02 58.25 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.15 0.5 . . . . 0.0 110.732 178.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -97.49 -0.16 46.53 Favored 'General case' 0 C--O 1.238 0.476 0 O-C-N 122.249 -0.282 . . . . 0.0 110.873 -177.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 92.1 mt -62.1 129.68 92.23 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -62.71 127.44 20.64 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 121.603 1.535 . . . . 0.0 110.619 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 115.56 -29.95 6.95 Favored Glycine 0 N--CA 1.424 -2.138 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.646 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 93.2 t -58.15 -60.27 2.45 Favored 'Isoleucine or valine' 0 C--O 1.245 0.847 0 CA-C-O 120.954 0.407 . . . . 0.0 110.94 -179.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 93.89 85.87 1.62 Allowed Glycine 0 N--CA 1.431 -1.647 0 C-N-CA 120.331 -0.938 . . . . 0.0 110.983 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -68.62 -12.03 60.82 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.668 0.746 . . . . 0.0 111.916 -176.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 42.1 t -71.73 -28.58 31.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 176.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.62 ' O ' ' HG ' ' A' ' 177' ' ' LEU . 47.1 mtmt -87.37 0.19 55.83 Favored 'General case' 0 C--O 1.208 -1.098 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.308 -179.156 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.479 ' O ' ' HG ' ' A' ' 178' ' ' LEU . . . -46.73 -53.06 27.82 Favored Pre-proline 0 N--CA 1.483 1.206 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 -174.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.415 ' O ' ' HG2' ' A' ' 179' ' ' GLN . 32.2 Cg_exo -60.07 -43.41 36.31 Favored 'Trans proline' 0 C--N 1.373 1.831 0 C-N-CA 121.569 1.512 . . . . 0.0 111.379 179.214 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 49.2 tp -60.83 -45.55 94.02 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.918 177.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.62 ' HG ' ' O ' ' A' ' 173' ' ' LYS . 91.6 mt -61.62 -41.72 97.87 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.173 178.283 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 174' ' ' ALA . 90.8 mt -68.95 -8.39 44.02 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' GLN . . . . . 0.415 ' HG2' ' O ' ' A' ' 175' ' ' PRO . 29.5 mm-40 -80.6 -21.14 41.86 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.374 0.607 . . . . 0.0 110.011 175.195 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 8.2 mmmm -106.51 -45.01 4.35 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.801 177.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' PHE . . . . . 0.45 ' O ' ' HA ' ' A' ' 178' ' ' LEU . 32.3 m-85 -103.42 132.31 21.21 Favored Pre-proline 0 N--CA 1.424 -1.769 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -176.645 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -62.31 -35.76 71.63 Favored 'Trans proline' 0 CA--C 1.51 -0.695 0 C-N-CA 122.839 2.359 . . . . 0.0 112.803 -172.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 59.3 m -153.46 160.21 42.51 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.473 ' O ' ' HB3' ' A' ' 187' ' ' LEU . 0.2 OUTLIER -60.02 -23.14 26.19 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.5 0 O-C-N 123.926 0.766 . . . . 0.0 112.905 -178.335 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -66.23 -47.2 74.59 Favored 'General case' 0 C--O 1.215 -0.715 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 9.3 tm0? -77.33 -29.04 53.34 Favored 'General case' 0 C--O 1.19 -2.051 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -178.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.474 HD13 ' HB3' ' A' ' 177' ' ' LEU . 41.2 tp -51.57 -64.14 0.91 Allowed 'General case' 0 C--O 1.204 -1.329 0 C-N-CA 124.351 1.06 . . . . 0.0 111.63 177.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 20.0 m -69.23 -24.43 64.01 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.402 0.62 . . . . 0.0 111.454 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -85.97 1.37 50.38 Favored 'General case' 0 C--O 1.244 0.816 0 CA-C-O 122.042 0.925 . . . . 0.0 111.194 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -67.85 157.05 35.75 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.218 177.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 15.0 m -63.3 153.72 33.98 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.568 -179.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 51.1 mm -57.87 -34.32 48.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.117 -176.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.416 ' O ' ' HG3' ' A' ' 197' ' ' GLN . . . -62.19 -36.41 92.95 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 116.095 -0.502 . . . . 0.0 112.477 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 0.463 ' O ' ' HB2' ' A' ' 197' ' ' GLN . 55.4 mm-40 -77.66 -41.64 37.51 Favored 'General case' 0 CA--C 1.498 -1.043 0 CA-C-O 121.62 0.724 . . . . 0.0 109.915 -178.504 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.459 HD21 ' O ' ' A' ' 187' ' ' LEU . 97.5 mt -67.64 -32.24 72.79 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.131 -0.941 . . . . 0.0 111.074 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' GLU . . . . . 0.554 ' HG2' ' N ' ' A' ' 201' ' ' GLN . 4.6 tm-20 -66.44 -30.15 70.45 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -178.133 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.463 ' HB2' ' O ' ' A' ' 194' ' ' GLU . 69.6 mt-30 -60.16 -37.27 79.62 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.652 -1.158 . . . . 0.0 111.376 178.327 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 30.0 m -103.66 -31.04 2.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -175.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.6 HG23 ' H ' ' A' ' 200' ' ' GLY . 6.5 m -115.34 -85.67 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 176.074 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 200' ' ' GLY . . . . . 0.6 ' H ' HG23 ' A' ' 199' ' ' VAL . . . -178.74 166.25 35.87 Favored Glycine 0 N--CA 1.408 -3.225 0 N-CA-C 108.413 -1.875 . . . . 0.0 108.413 -177.567 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 201' ' ' GLN . . . . . 0.554 ' N ' ' HG2' ' A' ' 196' ' ' GLU . 0.4 OUTLIER -62.64 -51.38 67.49 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 123.827 0.851 . . . . 0.0 109.122 -179.344 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -72.73 -26.73 61.68 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.066 -176.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 3.4 t -76.44 -42.83 36.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -56.29 -43.54 78.98 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.241 -1.345 . . . . 0.0 109.902 179.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -54.89 -53.79 50.87 Favored 'General case' 0 N--CA 1.436 -1.16 0 C-N-CA 124.218 1.007 . . . . 0.0 111.964 177.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 28.4 pt20 -69.87 -28.87 66.01 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 119.826 -0.749 . . . . 0.0 111.903 -176.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 98.6 mt -71.78 -48.73 49.84 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-N 116.22 -0.446 . . . . 0.0 109.873 177.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 10.4 t60 -70.96 -40.0 72.23 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -176.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -66.51 -25.55 66.74 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 178.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -53.65 -47.52 70.27 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.069 0.948 . . . . 0.0 112.285 -175.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -93.35 -23.59 18.4 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.694 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 62.8 m -70.58 -48.15 56.66 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.241 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -82.01 117.5 68.56 Favored Pre-proline 0 C--N 1.316 -0.886 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.304 -178.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_exo -54.38 124.34 15.83 Favored 'Trans proline' 0 C--O 1.246 0.901 0 C-N-CA 123.722 2.948 . . . . 0.0 112.89 178.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 69.9 mtp180 . . . . . 0 C--N 1.278 -2.514 0 CA-C-N 114.316 -1.311 . . . . 0.0 109.061 -178.644 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 16.8 m . . . . . 0 N--CA 1.443 -0.803 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -88.13 -17.76 30.29 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 120.661 -0.416 . . . . 0.0 111.903 -175.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -140.73 151.32 62.8 Favored Pre-proline 0 C--N 1.302 -1.481 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 177.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -80.75 79.71 3.24 Favored 'Trans proline' 0 N--CA 1.429 -2.296 0 C-N-CA 121.507 1.471 . . . . 0.0 110.434 174.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 38.2 tp -86.93 76.11 9.46 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 178.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 82.7 mt -106.99 159.01 16.6 Favored 'General case' 0 N--CA 1.418 -2.072 0 CA-C-N 113.962 -1.472 . . . . 0.0 109.266 -176.065 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 91.63 146.86 18.91 Favored Glycine 0 N--CA 1.423 -2.189 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -174.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -130.72 97.79 4.45 Favored 'General case' 0 C--N 1.284 -2.278 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -142.08 119.84 11.88 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 120.783 0.325 . . . . 0.0 110.161 178.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 44.9 ttp180 -98.29 104.23 16.24 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 177.048 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -110.76 101.5 10.12 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 -176.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 94.3 mt -128.43 97.98 4.9 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.593 -176.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -102.85 124.75 48.95 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 177.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 5.5 tt -98.36 92.75 5.84 Favored 'General case' 0 N--CA 1.422 -1.852 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 5.1 p -89.6 144.3 26.12 Favored 'General case' 0 C--N 1.285 -2.197 0 CA-C-N 114.946 -1.025 . . . . 0.0 109.028 174.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.42 ' OE2' ' HD2' ' A' ' 157' ' ' PRO . 11.1 tp10 -84.32 116.24 64.07 Favored Pre-proline 0 C--N 1.305 -1.348 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -177.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.42 ' HD2' ' OE2' ' A' ' 156' ' ' GLU . 75.4 Cg_endo -84.92 171.94 9.06 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.772 2.315 . . . . 0.0 112.983 -177.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.404 ' OG ' ' HB3' ' A' ' 161' ' ' ARG . 26.4 t 62.37 84.93 0.13 Allowed 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 124.884 1.273 . . . . 0.0 111.879 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -77.61 -31.42 52.91 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 177.069 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.434 ' HA ' HG12 ' A' ' 163' ' ' VAL . 3.6 pp -59.51 -27.51 66.23 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 123.944 0.898 . . . . 0.0 111.917 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.404 ' HB3' ' OG ' ' A' ' 158' ' ' SER . 11.4 ptt180 -67.57 -37.8 83.16 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -178.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 25.0 m -86.5 -31.6 21.21 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.21 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.442 HG22 ' HB2' ' A' ' 188' ' ' SER . 0.3 OUTLIER -63.36 -26.23 40.32 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 CA-C-O 121.609 0.719 . . . . 0.0 111.358 -177.231 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -86.54 -8.01 57.89 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.591 177.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -105.3 21.19 17.59 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 -176.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.456 HG21 ' HA ' ' A' ' 207' ' ' ILE . 75.0 mt -78.93 125.93 83.08 Favored Pre-proline 0 C--N 1.31 -1.116 0 CA-C-N 116.297 -0.411 . . . . 0.0 109.961 -178.074 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -66.6 130.84 24.47 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.208 1.939 . . . . 0.0 110.073 176.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 120.21 -35.16 3.87 Favored Glycine 0 C--N 1.292 -1.88 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 -177.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 95.5 t -60.45 -52.56 60.0 Favored 'Isoleucine or valine' 0 C--O 1.246 0.875 0 CA-C-O 121.376 0.608 . . . . 0.0 110.052 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 99.68 99.77 2.26 Favored Glycine 0 N--CA 1.425 -2.09 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -177.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -63.32 -29.81 71.06 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 120.969 0.414 . . . . 0.0 111.491 -176.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 60.9 t -83.19 -26.52 7.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-O 121.513 0.673 . . . . 0.0 110.148 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.426 ' O ' ' HB3' ' A' ' 176' ' ' LEU . 37.3 ttpt -92.45 -5.8 51.21 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 120.443 -0.503 . . . . 0.0 109.808 -178.503 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -53.4 -49.9 85.78 Favored Pre-proline 0 CA--C 1.553 1.085 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -177.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -57.52 -30.1 87.17 Favored 'Trans proline' 0 C--N 1.384 2.399 0 C-N-CA 121.961 1.774 . . . . 0.0 112.562 176.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.426 ' HB3' ' O ' ' A' ' 173' ' ' LYS . 54.0 tp -70.22 -39.8 74.89 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 121.469 0.652 . . . . 0.0 109.604 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.419 ' HB3' HD21 ' A' ' 187' ' ' LEU . 9.5 mp -72.52 -32.68 66.32 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.174 178.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 42.7 tp -68.93 -8.84 48.1 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.005 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -82.96 -23.27 33.49 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 174.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm -93.37 -49.67 5.83 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.497 0.665 . . . . 0.0 109.736 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' PHE . . . . . 0.548 ' CD2' HD22 ' A' ' 187' ' ' LEU . 64.5 m-85 -95.14 143.0 25.38 Favored Pre-proline 0 C--N 1.304 -1.37 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.642 -176.649 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -66.36 -39.19 17.9 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.37 2.047 . . . . 0.0 113.867 -174.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 58.8 m -157.0 164.51 37.93 Favored 'General case' 0 C--O 1.247 0.938 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.409 ' HA ' ' HB2' ' A' ' 187' ' ' LEU . 0.2 OUTLIER -56.36 -29.66 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 -176.194 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -62.66 -45.83 91.02 Favored 'General case' 0 C--O 1.217 -0.636 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.328 178.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 10.5 tm0? -78.78 -28.84 44.76 Favored 'General case' 0 C--O 1.201 -1.462 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -177.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.548 HD22 ' CD2' ' A' ' 181' ' ' PHE . 0.3 OUTLIER -51.71 -67.65 0.23 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.263 1.425 . . . . 0.0 109.541 -179.629 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.442 ' HB2' HG22 ' A' ' 163' ' ' VAL . 17.0 m -73.09 -27.17 61.55 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.048 -176.325 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -81.59 1.31 34.39 Favored 'General case' 0 C--O 1.253 1.241 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.521 ' HB1' ' HB2' ' A' ' 194' ' ' GLU . . . -65.32 154.98 36.7 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 121.601 0.715 . . . . 0.0 110.684 174.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 3.5 m -68.95 163.11 25.25 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.702 -177.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.4 mm -53.56 -41.2 45.05 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.184 0 C-N-CA 123.105 0.562 . . . . 0.0 111.056 -178.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.494 ' O ' ' HG3' ' A' ' 197' ' ' GLN . . . -63.84 -38.94 96.86 Favored Glycine 0 CA--C 1.522 0.497 0 O-C-N 123.395 0.434 . . . . 0.0 112.675 179.301 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 0.521 ' HB2' ' HB1' ' A' ' 190' ' ' ALA . 29.7 mt-10 -73.11 -38.21 66.42 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -177.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 95.8 mt -72.93 -30.4 63.86 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.539 177.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' GLU . . . . . 0.495 ' HG2' ' N ' ' A' ' 201' ' ' GLN . 5.6 tm-20 -63.88 -37.5 87.63 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.494 ' HG3' ' O ' ' A' ' 193' ' ' GLY . 29.2 mt-30 -54.82 -35.02 63.49 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.571 -1.195 . . . . 0.0 112.123 177.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 10.0 m -102.11 -35.08 3.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -175.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.614 HG23 ' H ' ' A' ' 200' ' ' GLY . 5.1 m -116.14 -83.2 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 176.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' GLY . . . . . 0.614 ' H ' HG23 ' A' ' 199' ' ' VAL . . . -178.86 162.55 29.66 Favored Glycine 0 N--CA 1.417 -2.593 0 N-CA-C 107.364 -2.295 . . . . 0.0 107.364 -177.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 201' ' ' GLN . . . . . 0.495 ' N ' ' HG2' ' A' ' 196' ' ' GLU . 9.6 pt20 -66.93 -36.29 81.91 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 118.834 1.317 . . . . 0.0 111.587 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -67.31 -41.07 85.93 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.403 0.62 . . . . 0.0 110.52 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 2.7 t -72.56 -39.17 61.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-O 121.864 0.84 . . . . 0.0 109.015 -177.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -54.64 -40.57 69.11 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 113.856 -1.52 . . . . 0.0 110.751 -178.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' GLN . . . . . 0.43 ' HG3' ' O ' ' A' ' 201' ' ' GLN . 98.7 mt-30 -61.92 -48.46 80.33 Favored 'General case' 0 N--CA 1.422 -1.84 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.674 -179.106 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 23.1 pt20 -70.6 -32.71 70.16 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 119.112 -1.035 . . . . 0.0 111.224 -178.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' ILE . . . . . 0.456 ' HA ' HG21 ' A' ' 166' ' ' ILE . 91.6 mt -66.44 -50.78 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 O-C-N 123.531 0.519 . . . . 0.0 110.091 178.069 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 11.7 t60 -69.42 -39.87 77.63 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.787 -177.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -66.28 -25.67 66.97 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 178.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' PHE . . . . . 0.433 ' CD1' HG12 ' A' ' 166' ' ' ILE . 57.4 t80 -52.33 -57.44 9.77 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.447 0.699 . . . . 0.0 112.282 -176.058 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -79.66 -24.66 41.67 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.508 -177.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 77.3 m -64.49 -38.45 91.05 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.046 178.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -76.85 125.64 86.78 Favored Pre-proline 0 C--N 1.309 -1.193 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 176.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -74.08 157.11 46.94 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 122.192 1.928 . . . . 0.0 110.063 178.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 7.5 tpt180 . . . . . 0 C--N 1.292 -1.893 0 C-N-CA 119.956 -0.697 . . . . 0.0 109.421 -176.62 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 18.5 p . . . . . 0 N--CA 1.429 -1.484 0 CA-C-O 120.548 0.213 . . . . 0.0 110.573 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -97.78 155.14 17.17 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 174.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -82.2 150.9 65.42 Favored Pre-proline 0 C--N 1.308 -1.21 0 CA-C-O 121.015 0.436 . . . . 0.0 112.064 -173.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -75.99 110.8 3.15 Favored 'Trans proline' 0 N--CA 1.445 -1.348 0 C-N-CA 122.687 2.258 . . . . 0.0 111.265 174.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 96.6 mt -77.63 -39.14 46.22 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 115.3 -0.863 . . . . 0.0 108.696 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 7.4 mp -82.96 105.11 13.69 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 115.193 -0.912 . . . . 0.0 108.985 177.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -163.41 167.53 37.68 Favored Glycine 0 N--CA 1.42 -2.415 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -83.22 96.42 8.44 Favored 'General case' 0 C--N 1.289 -2.023 0 C-N-CA 122.71 0.404 . . . . 0.0 111.41 -176.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 43.7 mmtm -88.87 100.51 13.23 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 174.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 10.6 tpp180 -75.46 98.81 4.01 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 121.167 0.508 . . . . 0.0 110.139 -175.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -136.16 102.38 4.99 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 86.4 mt -123.39 125.04 44.25 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.55 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 6.5 tt -132.87 124.53 28.09 Favored 'General case' 0 C--N 1.287 -2.124 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.72 77.13 0.3 Allowed 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 122.567 1.175 . . . . 0.0 112.701 178.023 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 11.2 p -80.19 124.61 28.95 Favored 'General case' 0 N--CA 1.417 -2.114 0 CA-C-N 114.823 -1.08 . . . . 0.0 111.992 -173.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.426 ' HA ' ' HD3' ' A' ' 157' ' ' PRO . 28.5 mm-40 -73.38 142.25 81.32 Favored Pre-proline 0 N--CA 1.424 -1.734 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 173.071 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 156' ' ' GLU . 8.0 Cg_exo -75.22 45.05 1.31 Allowed 'Trans proline' 0 CA--C 1.532 0.398 0 C-N-CA 123.237 2.625 . . . . 0.0 113.294 -176.215 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.51 ' O ' ' HG2' ' A' ' 161' ' ' ARG . 6.2 p -103.02 35.14 2.62 Favored 'General case' 0 C--N 1.295 -1.774 0 C-N-CA 123.524 0.73 . . . . 0.0 110.637 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -89.63 -37.28 14.76 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.465 ' O ' HG12 ' A' ' 163' ' ' VAL . 1.6 pt? -60.79 -28.68 68.94 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.357 -177.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.51 ' HG2' ' O ' ' A' ' 158' ' ' SER . 35.9 ptt180 -65.07 -34.45 78.45 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-O 121.327 0.584 . . . . 0.0 109.488 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 24.7 m -86.69 -33.45 20.04 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.183 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.465 HG12 ' O ' ' A' ' 160' ' ' LEU . 0.9 OUTLIER -62.22 -26.18 39.55 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 CA-C-O 121.701 0.762 . . . . 0.0 111.68 -174.908 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -81.08 -10.6 59.65 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.805 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -104.74 12.4 32.82 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.265 0.555 . . . . 0.0 110.942 -174.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.436 HG21 ' HA ' ' A' ' 207' ' ' ILE . 83.7 mt -78.51 142.68 62.49 Favored Pre-proline 0 C--N 1.31 -1.145 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.137 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.28 128.39 26.12 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.225 1.95 . . . . 0.0 110.935 174.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 113.71 -31.02 6.82 Favored Glycine 0 N--CA 1.435 -1.43 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 -178.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 60.9 t -72.68 -64.36 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 178.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 98.95 133.23 7.99 Favored Glycine 0 N--CA 1.438 -1.177 0 C-N-CA 120.299 -0.953 . . . . 0.0 113.443 175.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 54.9 pttt -89.07 -25.53 21.87 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.348 0.594 . . . . 0.0 110.926 177.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 61.7 t -84.8 -32.11 7.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 178.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -81.09 -14.26 57.94 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 114.331 -1.304 . . . . 0.0 109.079 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -52.03 -53.93 46.49 Favored Pre-proline 0 N--CA 1.476 0.841 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 -174.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.516 ' O ' ' HG2' ' A' ' 179' ' ' GLN . 19.1 Cg_endo -60.33 -33.75 94.15 Favored 'Trans proline' 0 C--N 1.377 2.077 0 C-N-CA 121.198 1.266 . . . . 0.0 112.232 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 60.9 tp -70.87 -39.32 72.95 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.574 178.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.515 ' CD2' HG11 ' A' ' 198' ' ' VAL . 93.9 mt -64.18 -36.91 85.61 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.085 177.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 97.7 mt -72.35 -9.56 58.66 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.63 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' GLN . . . . . 0.516 ' HG2' ' O ' ' A' ' 175' ' ' PRO . 11.8 mm-40 -82.57 -19.25 38.86 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 176.26 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm -104.75 -51.21 3.11 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.687 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -102.68 142.98 25.67 Favored Pre-proline 0 C--N 1.303 -1.449 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -175.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -60.99 -41.81 41.62 Favored 'Trans proline' 0 C--N 1.356 0.959 0 C-N-CA 122.663 2.242 . . . . 0.0 112.321 -172.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 59.6 m -154.45 169.4 23.85 Favored 'General case' 0 N--CA 1.421 -1.92 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 177.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.502 ' HA ' ' HB3' ' A' ' 187' ' ' LEU . 0.2 OUTLIER -63.15 -20.5 26.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 -174.931 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -73.91 -44.31 55.61 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.172 -177.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 12.5 tm0? -78.9 -26.53 43.81 Favored 'General case' 0 C--O 1.2 -1.529 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 178.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.502 ' HB3' ' HA ' ' A' ' 184' ' ' ILE . 54.6 tp -56.21 -56.41 21.34 Favored 'General case' 0 C--O 1.207 -1.156 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.726 177.397 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 23.2 p -72.76 -31.21 64.74 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.929 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -84.11 6.39 22.51 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 121.521 0.677 . . . . 0.0 111.317 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.425 ' HB1' ' HB2' ' A' ' 194' ' ' GLU . . . -65.3 155.58 34.79 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.029 173.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' SER . . . . . 0.421 ' OG ' ' HG3' ' A' ' 194' ' ' GLU . 10.2 p -63.95 156.83 26.62 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.811 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 48.7 mm -52.29 -36.2 20.84 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.948 0 C-N-CA 123.244 0.618 . . . . 0.0 110.374 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -59.33 -41.33 96.85 Favored Glycine 0 N--CA 1.442 -0.904 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.629 177.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 0.516 ' O ' ' HG2' ' A' ' 197' ' ' GLN . 30.1 mt-10 -77.62 -35.72 52.38 Favored 'General case' 0 C--O 1.206 -1.217 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -177.12 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 96.1 mt -74.37 -24.56 59.17 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.803 0.811 . . . . 0.0 110.291 178.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -74.07 -24.15 59.46 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.847 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.516 ' HG2' ' O ' ' A' ' 194' ' ' GLU . 4.9 pt20 -67.03 -29.91 69.85 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -177.565 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.515 HG11 ' CD2' ' A' ' 177' ' ' LEU . 13.4 m -99.1 -21.2 5.22 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.947 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.687 -174.59 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.402 HG23 ' H ' ' A' ' 200' ' ' GLY . 0.2 OUTLIER -139.23 -84.22 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 173.214 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 200' ' ' GLY . . . . . 0.402 ' H ' HG23 ' A' ' 199' ' ' VAL . . . -178.29 171.94 44.35 Favored Glycine 0 N--CA 1.431 -1.643 0 N-CA-C 108.514 -1.834 . . . . 0.0 108.514 -173.319 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -69.06 -42.41 76.29 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 117.886 0.843 . . . . 0.0 112.024 -177.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -68.26 -31.54 71.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.629 0.728 . . . . 0.0 110.69 -177.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 2.1 t -77.75 -40.08 27.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -179.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -57.45 -39.72 76.91 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 114.616 -1.175 . . . . 0.0 109.844 177.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -59.69 -46.71 88.24 Favored 'General case' 0 C--O 1.209 -1.049 0 CA-C-N 115.075 -0.966 . . . . 0.0 112.322 177.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' GLN . . . . . 0.406 ' O ' ' HB2' ' A' ' 210' ' ' PHE . 4.3 pt20 -68.52 -28.48 67.03 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 119.901 -0.72 . . . . 0.0 111.477 -178.242 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 207' ' ' ILE . . . . . 0.436 ' HA ' HG21 ' A' ' 166' ' ' ILE . 76.2 mt -73.96 -52.55 20.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.117 176.375 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -70.3 -40.78 74.04 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 120.958 0.408 . . . . 0.0 110.981 -175.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -73.84 -10.55 59.78 Favored 'General case' 0 C--N 1.323 -0.587 0 O-C-N 122.106 -0.371 . . . . 0.0 111.875 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' PHE . . . . . 0.406 ' HB2' ' O ' ' A' ' 206' ' ' GLN . 40.8 t80 -60.07 -47.78 84.45 Favored 'General case' 0 C--O 1.218 -0.563 0 CA-C-O 121.084 0.469 . . . . 0.0 110.257 179.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -96.39 -26.59 15.28 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.207 -178.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 32.7 m -74.17 -33.18 63.38 Favored 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -178.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -93.75 135.93 24.49 Favored Pre-proline 0 C--N 1.312 -1.025 0 O-C-N 121.964 -0.46 . . . . 0.0 109.802 -178.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -66.77 157.91 58.86 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 122.782 2.322 . . . . 0.0 112.246 179.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 30.8 ttp-105 . . . . . 0 C--N 1.303 -1.454 0 CA-C-N 115.2 -0.909 . . . . 0.0 108.854 -177.217 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 20.0 m . . . . . 0 N--CA 1.417 -2.123 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -134.29 148.09 50.73 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 108.606 -0.886 . . . . 0.0 108.606 -177.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -133.18 140.93 38.91 Favored Pre-proline 0 C--N 1.294 -1.843 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -82.1 68.16 7.94 Favored 'Trans proline' 0 N--CA 1.439 -1.714 0 C-N-CA 121.833 1.689 . . . . 0.0 111.257 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 5.8 tt -89.95 -68.35 0.79 Allowed 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 178.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -128.14 105.23 8.23 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 176.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -174.42 161.44 31.35 Favored Glycine 0 N--CA 1.421 -2.338 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -112.41 169.09 9.12 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 10.3 mtmp? -86.99 151.58 23.14 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 172.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 37.4 mmt180 -74.28 97.83 3.08 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.557 0.694 . . . . 0.0 111.934 -176.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -160.98 103.17 1.3 Allowed 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 114.372 -1.285 . . . . 0.0 108.202 177.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 60.0 tp -106.15 119.55 39.5 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.37 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -93.7 154.66 17.68 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -81.67 76.79 8.57 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 177.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 13.7 m -85.45 103.79 14.66 Favored 'General case' 0 N--CA 1.415 -2.217 0 CA-C-N 114.766 -1.106 . . . . 0.0 108.058 178.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -84.85 143.64 40.72 Favored Pre-proline 0 C--N 1.293 -1.878 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -83.86 19.38 1.36 Allowed 'Trans proline' 0 C--O 1.243 0.754 0 C-N-CA 122.865 2.377 . . . . 0.0 111.704 -177.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.439 ' O ' ' HG2' ' A' ' 161' ' ' ARG . 5.3 m -74.24 91.98 2.2 Favored 'General case' 0 N--CA 1.42 -1.965 0 CA-C-N 115.381 -0.827 . . . . 0.0 108.992 178.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 37.8 mt -93.56 -18.87 21.75 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.461 ' H ' HD23 ' A' ' 160' ' ' LEU . 2.2 pt? -59.13 -30.6 68.25 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.385 0.612 . . . . 0.0 110.67 176.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.439 ' HG2' ' O ' ' A' ' 158' ' ' SER . 16.0 ptm180 -76.33 -33.5 58.99 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.987 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 24.7 m -85.28 -37.14 20.35 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 120.959 0.409 . . . . 0.0 111.15 -178.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.423 HG22 ' CB ' ' A' ' 188' ' ' SER . 4.1 p -59.68 -25.92 33.37 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.404 0 CA-C-O 121.266 0.555 . . . . 0.0 112.428 -178.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -87.82 -10.26 51.4 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-O 121.592 0.711 . . . . 0.0 110.368 177.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -101.65 3.01 39.41 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.311 -176.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.414 ' HB ' ' CG2' ' A' ' 169' ' ' VAL . 88.9 mt -60.91 133.65 92.37 Favored Pre-proline 0 C--O 1.248 1.017 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.268 178.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -60.88 127.91 23.87 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 121.991 1.794 . . . . 0.0 109.92 176.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 113.65 -36.55 3.98 Favored Glycine 0 N--CA 1.428 -1.885 0 C-N-CA 120.012 -1.09 . . . . 0.0 112.019 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.414 ' CG2' ' HB ' ' A' ' 166' ' ' ILE . 57.5 t -58.83 -44.2 89.95 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 CA-C-O 121.498 0.666 . . . . 0.0 110.757 -178.199 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 91.45 80.76 1.41 Allowed Glycine 0 N--CA 1.408 -3.179 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -177.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 55.2 pttt -63.59 -13.87 45.99 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.515 0.674 . . . . 0.0 112.623 -178.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 43.3 t -71.12 -32.11 46.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-O 122.158 0.98 . . . . 0.0 108.421 175.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.533 ' HB3' HD13 ' A' ' 177' ' ' LEU . 89.9 mttt -88.26 -6.21 57.92 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.472 -177.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -54.23 -52.99 64.01 Favored Pre-proline 0 CA--C 1.558 1.254 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -177.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -67.4 -31.26 35.04 Favored 'Trans proline' 0 C--N 1.375 1.931 0 C-N-CA 121.584 1.523 . . . . 0.0 112.325 179.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 55.4 tp -69.96 -44.7 68.98 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.684 0.754 . . . . 0.0 109.601 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.533 HD13 ' HB3' ' A' ' 173' ' ' LYS . 5.4 mp -75.35 -22.28 57.7 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.081 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 44.1 tp -70.55 -11.25 60.81 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 121.637 0.732 . . . . 0.0 109.803 175.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -88.62 -14.35 37.69 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 174.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -105.07 -51.17 3.08 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 122.014 0.911 . . . . 0.0 110.325 -176.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' PHE . . . . . 0.465 ' CD2' ' HA ' ' A' ' 187' ' ' LEU . 90.0 m-85 -88.72 148.92 42.84 Favored Pre-proline 0 N--CA 1.417 -2.116 0 CA-C-N 114.423 -1.262 . . . . 0.0 107.753 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -59.07 -47.5 17.51 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.479 2.119 . . . . 0.0 111.883 -179.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 23.9 m -153.21 165.0 37.05 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.554 HD13 ' H ' ' A' ' 184' ' ' ILE . 0.2 OUTLIER -62.36 -27.25 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -178.202 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 24.8 tp60 -61.57 -41.15 96.97 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 110.348 -0.242 . . . . 0.0 110.348 177.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 14.8 tm0? -79.06 -32.91 45.0 Favored 'General case' 0 C--O 1.196 -1.733 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.465 ' HA ' ' CD2' ' A' ' 181' ' ' PHE . 5.3 tt -53.72 -62.01 1.93 Allowed 'General case' 0 C--O 1.21 -0.991 0 C-N-CA 123.893 0.877 . . . . 0.0 110.471 -176.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.423 ' CB ' HG22 ' A' ' 163' ' ' VAL . 25.4 m -73.99 -23.23 59.43 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -177.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -89.75 4.33 50.01 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.467 0.651 . . . . 0.0 109.372 -179.188 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.401 ' HB1' ' HB2' ' A' ' 194' ' ' GLU . . . -65.2 154.98 36.47 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-O 121.301 0.572 . . . . 0.0 110.123 175.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 3.0 m -64.26 158.05 24.3 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.48 -176.121 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 48.8 mm -53.44 -37.86 31.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 C-N-CA 123.279 0.631 . . . . 0.0 111.191 -177.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -63.4 -38.32 96.19 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.642 178.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 0.401 ' HB2' ' HB1' ' A' ' 190' ' ' ALA . 26.7 mt-10 -74.22 -37.27 63.89 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -176.452 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 96.2 mt -74.02 -31.36 62.89 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.832 -1.076 . . . . 0.0 110.71 178.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -64.87 -35.54 81.47 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -60.55 -26.36 66.84 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 114.438 -1.255 . . . . 0.0 112.834 178.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 13.1 m -103.59 -37.35 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.305 0 C-N-CA 120.04 -0.664 . . . . 0.0 112.437 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.519 HG23 ' H ' ' A' ' 200' ' ' GLY . 2.5 m -117.87 -80.97 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 177.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' GLY . . . . . 0.519 ' H ' HG23 ' A' ' 199' ' ' VAL . . . -178.05 166.88 37.28 Favored Glycine 0 N--CA 1.424 -2.16 0 N-CA-C 108.536 -1.826 . . . . 0.0 108.536 -178.597 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -69.23 -41.94 76.34 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 118.218 1.009 . . . . 0.0 110.296 -178.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -65.55 -35.98 82.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.414 0.626 . . . . 0.0 110.197 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.412 ' O ' HG13 ' A' ' 207' ' ' ILE . 2.7 t -72.66 -43.5 61.65 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.829 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -55.2 -42.47 73.31 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.3 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -58.74 -52.39 65.9 Favored 'General case' 0 N--CA 1.433 -1.315 0 C-N-CA 124.263 1.025 . . . . 0.0 111.507 177.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -69.01 -27.39 65.64 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 -178.006 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' ILE . . . . . 0.412 HG13 ' O ' ' A' ' 203' ' ' VAL . 98.3 mt -73.45 -51.36 25.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-O 121.311 0.577 . . . . 0.0 109.723 176.005 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -71.33 -37.94 71.69 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.783 -173.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -75.64 -10.08 59.14 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 178.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -66.12 -46.66 76.78 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.103 0.478 . . . . 0.0 110.86 -179.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -93.11 -25.7 17.77 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.883 -177.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 25.6 m -74.65 -25.8 59.44 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-O 121.387 0.613 . . . . 0.0 111.569 -178.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -110.87 153.56 43.7 Favored Pre-proline 0 C--N 1.314 -0.956 0 O-C-N 121.989 -0.444 . . . . 0.0 110.145 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -84.99 154.91 11.28 Favored 'Trans proline' 0 N--CA 1.443 -1.462 0 C-N-CA 121.918 1.745 . . . . 0.0 111.625 178.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 69.7 mtp180 . . . . . 0 C--N 1.299 -1.629 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 177.471 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 18.1 m . . . . . 0 C--O 1.242 0.682 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -89.89 -23.46 21.61 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.479 0.657 . . . . 0.0 110.428 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -123.15 167.12 15.47 Favored Pre-proline 0 C--N 1.296 -1.742 0 N-CA-C 105.464 -2.05 . . . . 0.0 105.464 177.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -60.59 97.32 0.12 Allowed 'Trans proline' 0 C--O 1.248 0.999 0 C-N-CA 121.831 1.687 . . . . 0.0 110.576 175.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 58.6 tp -83.12 -40.2 20.1 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.491 -177.007 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.449 ' H ' HD23 ' A' ' 146' ' ' LEU . 2.5 pt? -82.19 174.4 11.22 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.422 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 168.26 -158.59 31.41 Favored Glycine 0 N--CA 1.412 -2.928 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -89.84 104.0 16.6 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 121.825 0.821 . . . . 0.0 112.382 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -98.12 152.55 19.22 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 174.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 54.0 ttp180 -83.36 93.74 7.81 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 176.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -168.87 101.29 0.39 Allowed 'General case' 0 N--CA 1.426 -1.65 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -85.45 96.41 9.58 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 177.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 61.5 tp -135.76 129.32 32.37 Favored 'General case' 0 N--CA 1.421 -1.894 0 CA-C-N 114.488 -1.233 . . . . 0.0 108.952 -176.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 5.5 tt -77.05 99.74 5.43 Favored 'General case' 0 N--CA 1.421 -1.918 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 175.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 64.0 m -131.02 101.74 5.73 Favored 'General case' 0 N--CA 1.424 -1.734 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 173.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -144.33 119.12 5.95 Favored Pre-proline 0 C--N 1.299 -1.605 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 -176.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.67 -32.43 96.82 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 122.739 2.293 . . . . 0.0 114.138 -176.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.565 ' O ' ' HG2' ' A' ' 161' ' ' ARG . 31.9 m 57.73 32.87 22.51 Favored 'General case' 0 C--O 1.22 -0.452 0 C-N-CA 123.423 0.689 . . . . 0.0 111.168 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.49 ' O ' HD23 ' A' ' 159' ' ' LEU . 6.4 tt -60.44 -22.83 63.88 Favored 'General case' 0 C--O 1.211 -0.948 0 C-N-CA 123.744 0.818 . . . . 0.0 110.322 -175.45 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.48 ' O ' HG12 ' A' ' 163' ' ' VAL . 3.4 pp -53.85 -31.42 49.46 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.98 0.912 . . . . 0.0 111.595 176.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.565 ' HG2' ' O ' ' A' ' 158' ' ' SER . 13.6 ptm180 -71.5 -29.38 64.73 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.844 0.831 . . . . 0.0 109.397 -178.198 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 21.1 m -86.69 -29.56 22.37 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.157 177.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 160' ' ' LEU . 0.3 OUTLIER -65.24 -26.46 39.71 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.643 0 CA-C-O 121.583 0.706 . . . . 0.0 110.916 -176.124 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -82.64 -6.71 59.51 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.481 0.657 . . . . 0.0 110.865 177.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 78.9 mm-40 -101.64 13.26 35.45 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.098 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 80.9 mt -84.35 131.75 49.5 Favored Pre-proline 0 C--N 1.306 -1.297 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -62.89 127.14 19.66 Favored 'Trans proline' 0 C--O 1.245 0.86 0 C-N-CA 121.642 1.561 . . . . 0.0 110.633 177.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 112.33 -18.51 23.12 Favored Glycine 0 N--CA 1.43 -1.765 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.62 -177.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 84.0 t -71.67 -50.41 39.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 178.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 96.58 102.09 2.02 Favored Glycine 0 N--CA 1.43 -1.743 0 C-N-CA 120.236 -0.983 . . . . 0.0 113.159 178.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -67.76 -32.4 72.98 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.219 0.533 . . . . 0.0 110.678 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 48.7 t -85.1 -30.76 6.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-O 121.801 0.81 . . . . 0.0 109.342 -178.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -79.89 -12.74 59.72 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.875 -178.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -50.72 -55.03 29.97 Favored Pre-proline 0 CA--C 1.55 0.974 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -177.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.494 ' O ' ' HG3' ' A' ' 179' ' ' GLN . 21.1 Cg_endo -62.25 -28.68 79.37 Favored 'Trans proline' 0 C--N 1.369 1.642 0 CA-C-N 121.045 1.409 . . . . 0.0 112.899 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 51.7 tp -73.02 -47.98 40.31 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 176.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.456 ' HB3' HD13 ' A' ' 187' ' ' LEU . 97.2 mt -59.27 -39.77 83.92 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.686 177.528 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.438 ' HA ' ' O ' ' A' ' 181' ' ' PHE . 10.2 mp -68.99 -6.81 30.12 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 179.013 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' GLN . . . . . 0.494 ' HG3' ' O ' ' A' ' 175' ' ' PRO . 76.7 mt-30 -83.19 -17.35 43.13 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 174.372 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 7.7 mmmm -103.94 -44.92 4.9 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.09 177.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' PHE . . . . . 0.438 ' O ' ' HA ' ' A' ' 178' ' ' LEU . 27.9 m-85 -111.35 131.51 22.23 Favored Pre-proline 0 N--CA 1.424 -1.753 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 -176.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 181' ' ' PHE . 78.4 Cg_exo -48.33 -38.57 34.41 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 124.152 3.235 . . . . 0.0 113.801 -175.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 73.6 p -154.06 173.69 15.69 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -177.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.521 HD13 ' H ' ' A' ' 184' ' ' ILE . 0.2 OUTLIER -66.59 -21.24 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 O-C-N 123.664 0.602 . . . . 0.0 110.78 175.275 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -67.07 -48.49 68.08 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 9.5 tm0? -77.76 -32.73 52.79 Favored 'General case' 0 C--O 1.201 -1.449 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -178.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.498 ' HB3' ' HA ' ' A' ' 184' ' ' ILE . 61.5 tp -52.78 -57.72 9.22 Favored 'General case' 0 C--O 1.207 -1.156 0 C-N-CA 124.589 1.156 . . . . 0.0 111.691 178.253 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 24.5 p -68.73 -32.79 72.82 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.617 0.723 . . . . 0.0 111.353 -179.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -80.97 -2.67 48.76 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.259 -178.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -66.35 156.51 34.27 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 123.465 0.706 . . . . 0.0 111.015 177.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 5.4 m -63.26 152.31 38.08 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.115 -175.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 50.3 mm -54.21 -35.86 31.05 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.839 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.865 -177.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.422 ' O ' ' HG2' ' A' ' 197' ' ' GLN . . . -61.63 -39.09 96.92 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.322 -0.466 . . . . 0.0 112.56 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -71.42 -45.11 63.54 Favored 'General case' 0 CA--C 1.489 -1.392 0 CA-C-O 121.548 0.69 . . . . 0.0 110.214 -178.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 95.8 mt -66.65 -29.59 69.64 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 114.279 -1.328 . . . . 0.0 110.804 178.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -70.49 -33.11 70.86 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.441 ' HA ' ' OE1' ' A' ' 197' ' ' GLN . 13.6 mm-40 -66.65 -21.51 66.11 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 114.987 -1.006 . . . . 0.0 113.1 -179.285 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 18.8 m -104.11 -32.85 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.757 177.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.424 HG23 ' H ' ' A' ' 200' ' ' GLY . 0.7 OUTLIER -125.17 -85.38 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 173.76 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 200' ' ' GLY . . . . . 0.424 ' H ' HG23 ' A' ' 199' ' ' VAL . . . -177.22 165.35 35.23 Favored Glycine 0 N--CA 1.43 -1.742 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -176.206 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -58.39 -49.32 77.69 Favored 'General case' 0 C--O 1.21 -0.996 0 CA-C-N 117.487 0.643 . . . . 0.0 111.626 -177.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -65.01 -32.57 74.35 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.314 0.578 . . . . 0.0 111.095 -175.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.412 ' O ' HG13 ' A' ' 207' ' ' ILE . 3.8 t -75.76 -44.56 39.43 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 -179.317 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -57.06 -43.75 82.36 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 114.009 -1.45 . . . . 0.0 109.912 179.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -62.94 -44.97 94.61 Favored 'General case' 0 N--CA 1.424 -1.752 0 CA-C-N 114.982 -1.008 . . . . 0.0 112.579 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -69.43 -29.16 66.82 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 119.442 -0.903 . . . . 0.0 111.169 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' ILE . . . . . 0.412 HG13 ' O ' ' A' ' 203' ' ' VAL . 87.4 mt -72.04 -52.15 26.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 176.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 12.2 t60 -69.7 -37.03 76.45 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.614 -174.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -73.36 -22.32 60.32 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 179.086 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -50.94 -56.74 10.92 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.843 0.857 . . . . 0.0 111.475 -177.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -83.57 -27.64 29.12 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.235 -176.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 38.8 m -69.83 -48.03 60.5 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.472 -178.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -87.27 146.8 40.83 Favored Pre-proline 0 C--N 1.309 -1.188 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 -177.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -85.77 164.93 10.44 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.189 1.926 . . . . 0.0 110.293 173.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' ARG . . . . . 0.627 ' HD3' ' O ' ' A' ' 215' ' ' ARG 0.262 0.0 OUTLIER . . . . . 0 C--N 1.303 -1.421 0 O-C-N 121.948 -0.47 . . . . 0.0 110.745 177.487 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 37.0 t . . . . . 0 N--CA 1.428 -1.549 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -136.28 147.36 47.46 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 174.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -86.29 151.9 54.53 Favored Pre-proline 0 C--N 1.288 -2.085 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -60.0 159.99 23.74 Favored 'Trans proline' 0 C--O 1.256 1.403 0 C-N-CA 122.471 2.114 . . . . 0.0 111.606 178.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 67.4 tp -56.57 -46.52 80.72 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 6.0 tt -105.45 115.92 31.06 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 175.016 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -150.7 152.58 24.41 Favored Glycine 0 N--CA 1.423 -2.204 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -115.01 132.05 56.73 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -80.47 96.49 6.77 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-O 121.237 0.541 . . . . 0.0 110.056 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -157.12 108.87 2.39 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 177.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -153.27 160.91 42.84 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -178.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 59.5 tp -134.17 96.93 3.72 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 175.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 7.5 mp -72.17 137.22 46.79 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.363 -176.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -93.15 75.11 4.67 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 -178.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 62.1 m -146.8 102.45 3.54 Favored 'General case' 0 N--CA 1.425 -1.703 0 CA-C-N 114.284 -1.326 . . . . 0.0 108.812 173.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -105.65 160.88 24.56 Favored Pre-proline 0 C--N 1.295 -1.79 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.448 ' O ' ' HD2' ' A' ' 161' ' ' ARG . 33.0 Cg_exo -62.71 111.84 1.46 Allowed 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.181 1.921 . . . . 0.0 110.273 177.426 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 48.5 m 77.59 84.59 0.08 Allowed 'General case' 0 C--O 1.207 -1.184 0 C-N-CA 125.191 1.396 . . . . 0.0 110.589 -174.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.479 ' O ' HD23 ' A' ' 159' ' ' LEU . 5.5 tt -57.95 -28.63 64.49 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.779 0.831 . . . . 0.0 111.243 -174.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.492 ' H ' HD23 ' A' ' 160' ' ' LEU . 2.1 pt? -57.99 -22.28 48.69 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 177.548 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.448 ' HD2' ' O ' ' A' ' 157' ' ' PRO . 11.1 ptm180 -68.86 -32.1 71.52 Favored 'General case' 0 C--O 1.218 -0.555 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 177.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 28.4 m -86.51 -34.04 20.13 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.442 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -63.87 -26.53 40.8 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.968 0 CA-C-O 121.516 0.674 . . . . 0.0 110.644 -176.243 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -82.84 -7.74 59.63 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.371 177.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -108.47 13.59 25.32 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.89 0.376 . . . . 0.0 110.605 -176.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.477 HG21 ' HA ' ' A' ' 207' ' ' ILE . 81.2 mt -71.82 138.71 82.74 Favored Pre-proline 0 C--N 1.31 -1.12 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.876 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -61.73 128.85 25.69 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.132 1.888 . . . . 0.0 110.637 175.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 114.46 -33.46 5.38 Favored Glycine 0 C--N 1.308 -0.978 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -178.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.498 ' O ' ' HE3' ' A' ' 173' ' ' LYS . 89.1 t -63.14 -57.48 11.78 Favored 'Isoleucine or valine' 0 C--N 1.338 0.109 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 178.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 99.24 126.82 5.76 Favored Glycine 0 N--CA 1.43 -1.748 0 C-N-CA 120.588 -0.815 . . . . 0.0 113.552 175.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -85.51 -25.07 27.05 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 121.313 0.578 . . . . 0.0 111.145 178.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 40.8 t -83.96 -28.26 7.31 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-O 122.082 0.944 . . . . 0.0 108.897 -178.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.498 ' HE3' ' O ' ' A' ' 169' ' ' VAL . 46.6 mtmt -87.28 -1.03 57.62 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.593 178.166 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -51.77 -49.01 85.79 Favored Pre-proline 0 CA--C 1.546 0.811 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 -178.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.516 ' O ' ' HG2' ' A' ' 179' ' ' GLN . 26.1 Cg_exo -62.86 -42.6 23.91 Favored 'Trans proline' 0 C--N 1.378 2.097 0 CA-C-N 120.69 1.282 . . . . 0.0 111.022 178.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 39.6 tp -58.42 -48.94 79.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.184 177.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.456 ' HB3' HD11 ' A' ' 187' ' ' LEU . 87.5 mt -60.68 -40.48 92.32 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.173 178.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 94.3 mt -71.15 -13.53 61.97 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' GLN . . . . . 0.516 ' HG2' ' O ' ' A' ' 175' ' ' PRO . 28.6 mm-40 -93.83 -12.38 29.13 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.289 0.566 . . . . 0.0 110.055 174.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -97.74 -50.59 4.4 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 121.792 0.805 . . . . 0.0 109.515 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' PHE . . . . . 0.518 ' CD2' ' HG ' ' A' ' 187' ' ' LEU . 79.9 m-85 -100.26 146.64 32.32 Favored Pre-proline 0 C--N 1.294 -1.846 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.871 -178.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -70.93 -29.45 18.3 Favored 'Trans proline' 0 C--O 1.235 0.366 0 C-N-CA 122.551 2.167 . . . . 0.0 112.594 -178.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' SER . . . . . 0.431 ' O ' ' HB2' ' A' ' 187' ' ' LEU . 64.3 p -153.84 166.58 32.46 Favored 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -178.173 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.436 HD13 ' H ' ' A' ' 184' ' ' ILE . 0.2 OUTLIER -71.05 -22.51 22.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 O-C-N 123.479 0.487 . . . . 0.0 110.138 176.574 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 26.6 tp60 -61.81 -52.84 62.52 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 114.944 -1.025 . . . . 0.0 108.914 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -76.95 -28.03 55.04 Favored 'General case' 0 C--O 1.207 -1.15 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -179.194 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.518 ' HG ' ' CD2' ' A' ' 181' ' ' PHE . 3.7 tt -54.78 -64.56 0.8 Allowed 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 124.081 0.952 . . . . 0.0 110.24 -178.32 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 24.0 m -75.94 -22.93 55.49 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.773 -175.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -84.87 -3.87 58.86 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.32 0.581 . . . . 0.0 110.18 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.7 154.58 38.53 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.687 178.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 1.9 t -73.59 169.23 17.69 Favored 'General case' 0 N--CA 1.423 -1.812 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.984 -176.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 50.1 mm -51.8 -39.37 24.48 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.973 0 C-N-CA 123.99 0.916 . . . . 0.0 111.138 -176.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.433 ' O ' ' HG3' ' A' ' 197' ' ' GLN . . . -59.26 -31.88 70.68 Favored Glycine 0 CA--C 1.527 0.817 0 O-C-N 123.431 0.457 . . . . 0.0 113.899 -179.116 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 0.47 ' O ' ' HB2' ' A' ' 197' ' ' GLN . 29.2 mm-40 -83.61 -40.13 19.42 Favored 'General case' 0 C--O 1.215 -0.746 0 CA-C-O 121.696 0.76 . . . . 0.0 109.638 -178.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.414 ' HB2' ' HB1' ' A' ' 204' ' ' ALA . 77.7 mt -73.39 -23.99 60.24 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-O 121.744 0.783 . . . . 0.0 110.696 -178.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -71.83 -26.54 62.42 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 178.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.47 ' HB2' ' O ' ' A' ' 194' ' ' GLU . 28.1 mt-30 -61.17 -29.67 69.94 Favored 'General case' 0 C--O 1.242 0.71 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.719 178.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.402 HG11 ' CD2' ' A' ' 177' ' ' LEU . 12.0 m -103.27 -37.18 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.295 0 C-N-CA 120.709 -0.397 . . . . 0.0 111.888 -178.078 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.459 HG23 ' H ' ' A' ' 200' ' ' GLY . 1.7 m -122.47 -83.75 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 200' ' ' GLY . . . . . 0.459 ' H ' HG23 ' A' ' 199' ' ' VAL . . . -177.6 172.53 45.26 Favored Glycine 0 N--CA 1.429 -1.789 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -175.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -64.55 -46.78 81.31 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 117.421 0.611 . . . . 0.0 111.816 -176.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -70.6 -30.21 66.82 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.311 0.577 . . . . 0.0 110.997 -176.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.62 ' O ' ' HG2' ' A' ' 206' ' ' GLN . 2.2 t -78.62 -33.91 17.28 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.051 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 204' ' ' ALA . . . . . 0.414 ' HB1' ' HB2' ' A' ' 195' ' ' LEU . . . -63.25 -38.45 91.22 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.41 175.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 23.1 mm-40 -60.24 -42.69 95.81 Favored 'General case' 0 C--O 1.207 -1.134 0 CA-C-N 115.32 -0.855 . . . . 0.0 112.522 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' GLN . . . . . 0.62 ' HG2' ' O ' ' A' ' 203' ' ' VAL . 20.6 pt20 -66.79 -30.22 70.37 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.894 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 207' ' ' ILE . . . . . 0.477 ' HA ' HG21 ' A' ' 166' ' ' ILE . 71.6 mt -78.19 -52.91 15.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-O 121.47 0.652 . . . . 0.0 109.982 178.432 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 40.0 t-80 -65.04 -39.56 93.51 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.839 -175.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -80.97 -14.04 58.33 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 120.728 -0.389 . . . . 0.0 112.023 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -55.11 -53.84 50.82 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.323 0.649 . . . . 0.0 111.318 -176.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -84.28 -27.82 27.58 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.896 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 25.5 m -71.54 -27.29 63.08 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-O 121.204 0.526 . . . . 0.0 111.392 -179.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -88.28 116.18 65.46 Favored Pre-proline 0 C--N 1.305 -1.341 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.85 158.32 42.85 Favored 'Trans proline' 0 N--CA 1.44 -1.656 0 C-N-CA 121.465 1.443 . . . . 0.0 109.143 176.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 35.8 ttm180 . . . . . 0 C--N 1.285 -2.232 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -174.399 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 19.8 m . . . . . 0 N--CA 1.433 -1.299 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 66.3 tttm -145.08 145.53 31.48 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -175.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -78.82 118.71 74.0 Favored Pre-proline 0 C--N 1.304 -1.39 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -179.31 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_exo -71.12 132.09 20.51 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.075 1.85 . . . . 0.0 110.899 179.011 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 92.5 mt -98.99 83.2 2.86 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-O 121.555 0.693 . . . . 0.0 109.336 179.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 50.7 tp -123.3 105.32 9.75 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.159 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -148.75 -156.58 7.19 Favored Glycine 0 N--CA 1.414 -2.767 0 C-N-CA 120.366 -0.921 . . . . 0.0 112.155 -178.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 55.9 mttp -87.38 101.58 13.71 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-O 121.266 0.555 . . . . 0.0 110.144 -176.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -111.7 105.61 14.17 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 175.193 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 60.5 ttt180 -120.22 111.9 18.4 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.946 -177.295 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -87.9 103.47 15.7 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 178.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 53.9 tp -96.01 93.26 6.89 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-O 121.972 0.891 . . . . 0.0 110.685 -175.263 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 7.0 tt -111.18 135.55 51.54 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 179.188 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.11 93.98 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 122.706 1.241 . . . . 0.0 111.908 178.267 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 16.1 m -98.86 109.48 22.23 Favored 'General case' 0 N--CA 1.421 -1.899 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.726 -173.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -105.8 98.2 17.3 Favored Pre-proline 0 C--N 1.295 -1.762 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 171.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -77.76 83.24 2.22 Favored 'Trans proline' 0 N--CA 1.429 -2.302 0 C-N-CA 121.876 1.718 . . . . 0.0 110.777 178.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 2.4 m -87.39 -6.4 58.47 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 175.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 39.5 tp -55.58 -17.83 6.35 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 125.482 1.513 . . . . 0.0 111.608 178.131 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -62.57 -26.55 68.64 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.074 0.464 . . . . 0.0 110.24 177.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 23.9 ptt180 -67.35 -35.58 79.67 Favored 'General case' 0 C--O 1.215 -0.731 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 8.4 m -86.14 -33.28 20.91 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.618 -178.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -64.95 -26.09 39.25 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-O 121.515 0.674 . . . . 0.0 110.835 -175.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 30.3 pt20 -85.27 -7.3 59.08 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.307 177.52 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -99.26 4.7 46.67 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -178.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.442 HG21 ' HA ' ' A' ' 207' ' ' ILE . 85.7 mt -72.18 131.58 85.08 Favored Pre-proline 0 C--N 1.309 -1.162 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -179.469 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -62.13 131.73 35.89 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.485 2.123 . . . . 0.0 110.586 176.187 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 113.83 -36.42 4.03 Favored Glycine 0 N--CA 1.424 -2.134 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 -178.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 91.9 t -55.72 -48.09 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-O 120.96 0.409 . . . . 0.0 110.593 -178.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 85.63 95.26 0.77 Allowed Glycine 0 N--CA 1.429 -1.794 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 -179.233 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -70.24 -18.71 63.16 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -175.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 62.0 t -83.24 -30.75 8.32 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 CA-C-O 121.396 0.617 . . . . 0.0 109.831 179.058 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.604 ' O ' ' HG ' ' A' ' 177' ' ' LEU . 21.2 ptmt -93.93 -4.0 50.61 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.415 0.626 . . . . 0.0 110.035 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.443 ' N ' ' HD2' ' A' ' 175' ' ' PRO . . . -59.72 -45.99 98.49 Favored Pre-proline 0 CA--C 1.548 0.9 0 CA-C-N 114.906 -1.043 . . . . 0.0 113.417 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.443 ' HD2' ' N ' ' A' ' 174' ' ' ALA . 9.3 Cg_endo -54.88 -35.94 90.27 Favored 'Trans proline' 0 C--N 1.385 2.449 0 C-N-CA 122.176 1.917 . . . . 0.0 112.193 176.465 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 53.3 tp -68.14 -42.3 80.34 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.437 0.637 . . . . 0.0 109.699 178.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.604 ' HG ' ' O ' ' A' ' 173' ' ' LYS . 59.8 mt -70.1 -31.06 68.43 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.75 -179.604 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 35.5 tp -72.91 -10.83 60.23 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.528 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' GLN . . . . . 0.438 ' HG2' ' O ' ' A' ' 175' ' ' PRO . 85.6 mm-40 -83.72 -20.17 33.91 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 174.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -103.65 -51.81 3.11 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-O 121.31 0.576 . . . . 0.0 110.354 -174.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -90.73 140.55 26.47 Favored Pre-proline 0 C--N 1.296 -1.751 0 CA-C-N 115.346 -0.843 . . . . 0.0 108.752 178.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -47.0 -47.5 16.51 Favored 'Trans proline' 0 C--N 1.361 1.217 0 C-N-CA 123.96 3.107 . . . . 0.0 112.545 -176.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' SER . . . . . 0.435 ' OG ' HD13 ' A' ' 184' ' ' ILE . 25.8 t -153.71 169.48 23.21 Favored 'General case' 0 N--CA 1.41 -2.437 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.589 HD13 ' H ' ' A' ' 184' ' ' ILE . 0.2 OUTLIER -60.03 -27.93 40.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 O-C-N 124.013 0.821 . . . . 0.0 110.151 177.114 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -56.86 -50.21 73.16 Favored 'General case' 0 C--O 1.212 -0.889 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.033 176.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 7.1 tm0? -79.1 -34.04 43.85 Favored 'General case' 0 C--O 1.206 -1.217 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -177.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.451 ' HB3' ' HA ' ' A' ' 184' ' ' ILE . 57.8 tp -50.8 -62.55 1.53 Allowed 'General case' 0 C--O 1.21 -0.976 0 C-N-CA 124.408 1.083 . . . . 0.0 111.278 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 25.3 m -72.07 -22.66 61.33 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.012 0.434 . . . . 0.0 112.07 -178.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -83.59 -4.04 58.21 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 121.488 0.661 . . . . 0.0 110.845 -178.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.513 ' HB1' ' HB2' ' A' ' 194' ' ' GLU . . . -65.74 155.48 35.97 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.019 175.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 4.0 m -65.33 162.27 17.88 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.994 -176.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.2 mm -53.66 -39.98 40.54 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.622 0 C-N-CA 122.751 0.42 . . . . 0.0 111.113 -178.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -62.77 -35.14 91.52 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 121.515 -0.374 . . . . 0.0 112.471 179.112 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 0.644 ' O ' ' HG2' ' A' ' 197' ' ' GLN . 25.2 mt-10 -80.7 -29.72 36.46 Favored 'General case' 0 C--O 1.215 -0.76 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -177.135 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 97.4 mt -78.76 -33.33 46.57 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.983 176.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 196' ' ' GLU . . . . . 0.422 ' HG2' ' N ' ' A' ' 201' ' ' GLN . 6.5 tm-20 -67.46 -31.71 72.07 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 -177.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.644 ' HG2' ' O ' ' A' ' 194' ' ' GLU . 16.5 pt20 -67.92 -28.39 67.45 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.529 -177.509 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 14.1 m -99.52 -34.58 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.969 -177.31 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.481 HG23 ' H ' ' A' ' 200' ' ' GLY . 2.5 m -119.81 -82.84 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 175.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 200' ' ' GLY . . . . . 0.481 ' H ' HG23 ' A' ' 199' ' ' VAL . . . -177.84 166.0 35.96 Favored Glycine 0 N--CA 1.429 -1.794 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 -176.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 201' ' ' GLN . . . . . 0.422 ' N ' ' HG2' ' A' ' 196' ' ' GLU . 8.8 tm0? -62.51 -47.03 85.73 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 117.565 0.682 . . . . 0.0 110.303 -177.242 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -71.63 -28.8 64.02 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.248 -176.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 3.0 t -76.06 -41.2 38.08 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.706 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -55.94 -45.11 78.88 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 114.224 -1.353 . . . . 0.0 109.651 179.033 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -59.26 -46.65 87.95 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 114.973 -1.012 . . . . 0.0 112.437 179.031 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -67.87 -33.09 74.06 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 120.366 -0.533 . . . . 0.0 111.357 -179.046 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 207' ' ' ILE . . . . . 0.442 ' HA ' HG21 ' A' ' 166' ' ' ILE . 85.8 mt -74.72 -50.44 25.87 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-O 121.141 0.496 . . . . 0.0 110.577 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 15.1 t60 -68.99 -43.88 73.98 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.106 -175.376 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -72.58 -10.77 60.2 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -62.46 -47.42 84.12 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.169 0.509 . . . . 0.0 110.223 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -98.07 -25.17 15.03 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.857 -178.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 24.1 m -77.13 -38.84 51.26 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -178.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -108.11 115.54 58.29 Favored Pre-proline 0 N--CA 1.435 -1.218 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -176.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.9 167.53 26.38 Favored 'Trans proline' 0 C--O 1.243 0.759 0 C-N-CA 122.406 2.071 . . . . 0.0 112.275 -179.108 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 48.4 mtm180 . . . . . 0 C--N 1.298 -1.671 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.365 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 13.2 t . . . . . 0 N--CA 1.424 -1.746 0 N-CA-C 106.387 -1.709 . . . . 0.0 106.387 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 51.9 pttt -115.41 -31.17 6.01 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -173.367 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.407 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . 11.3 m120 -139.67 130.95 14.63 Favored Pre-proline 0 C--N 1.31 -1.149 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.104 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 143' ' ' ASN . 5.9 Cg_exo -77.39 85.99 1.7 Allowed 'Trans proline' 0 N--CA 1.445 -1.344 0 C-N-CA 121.991 1.794 . . . . 0.0 109.894 173.724 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 61.5 tp -98.72 -35.16 10.26 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.483 -178.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.6 mp -98.79 114.48 27.05 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -179.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -148.43 -161.55 9.67 Favored Glycine 0 N--CA 1.425 -2.085 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 -177.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -123.21 137.58 54.85 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 178.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.77 142.3 37.1 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 177.432 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -81.28 149.94 28.75 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 176.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -83.91 101.67 11.85 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.6 tt -113.32 112.74 24.2 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 -179.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 45.2 tp -94.07 137.58 33.11 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.363 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -65.1 108.04 1.72 Allowed 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.626 0.727 . . . . 0.0 109.192 176.405 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 15.2 m -105.96 110.72 23.1 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.457 179.254 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -78.14 140.82 61.85 Favored Pre-proline 0 C--N 1.317 -0.834 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 176.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -85.45 66.86 5.79 Favored 'Trans proline' 0 N--CA 1.443 -1.451 0 C-N-CA 122.285 1.99 . . . . 0.0 109.477 172.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.408 ' O ' ' HG2' ' A' ' 161' ' ' ARG . 34.6 m -84.92 110.53 18.94 Favored 'General case' 0 N--CA 1.427 -1.595 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.619 -178.161 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 42.8 tp -93.61 -29.47 15.45 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.667 -178.18 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -60.26 -25.67 65.87 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.246 0.546 . . . . 0.0 112.038 -179.239 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.408 ' HG2' ' O ' ' A' ' 158' ' ' SER . 40.1 ptt180 -73.62 -33.58 64.62 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.207 0.527 . . . . 0.0 110.114 177.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 16.9 m -85.76 -33.99 21.28 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 121.243 0.544 . . . . 0.0 110.591 -178.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.438 HG22 ' CB ' ' A' ' 188' ' ' SER . 0.8 OUTLIER -64.17 -25.61 38.46 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.131 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.049 -176.555 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -87.69 -7.59 57.2 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.755 177.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -103.56 12.15 35.36 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.17 0.51 . . . . 0.0 109.996 -178.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 77.7 mt -72.8 125.97 90.88 Favored Pre-proline 0 C--N 1.314 -0.961 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.24 128.5 20.6 Favored 'Trans proline' 0 N--CA 1.445 -1.331 0 C-N-CA 121.562 1.508 . . . . 0.0 109.183 176.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 116.16 -29.24 7.17 Favored Glycine 0 N--CA 1.428 -1.872 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 -177.17 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 93.1 t -65.32 -52.23 54.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 121.313 0.578 . . . . 0.0 110.426 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 102.33 75.31 1.09 Allowed Glycine 0 N--CA 1.424 -2.102 0 C-N-CA 120.365 -0.921 . . . . 0.0 111.234 -179.314 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -73.64 -15.63 61.25 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.279 0.562 . . . . 0.0 111.656 -177.184 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 45.1 t -86.86 -22.86 6.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 CA-C-O 121.96 0.886 . . . . 0.0 108.637 176.276 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.464 ' O ' ' HG ' ' A' ' 177' ' ' LEU . 38.0 ttpt -96.12 8.36 43.98 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.309 -1.314 . . . . 0.0 108.226 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -56.67 -46.3 99.85 Favored Pre-proline 0 C--O 1.212 -0.901 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 -177.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.567 ' O ' ' HG2' ' A' ' 179' ' ' GLN . 51.7 Cg_exo -56.97 -41.08 79.04 Favored 'Trans proline' 0 C--N 1.377 2.036 0 CA-C-N 121.204 1.466 . . . . 0.0 111.345 178.554 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 48.5 tp -64.7 -43.36 93.74 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.435 176.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 173' ' ' LYS . 96.3 mt -63.34 -40.27 96.83 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.533 178.391 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -68.63 -6.91 28.57 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 178.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' GLN . . . . . 0.567 ' HG2' ' O ' ' A' ' 175' ' ' PRO . 86.9 mm-40 -84.46 -15.64 45.38 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.06 0.457 . . . . 0.0 110.102 174.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -112.17 -51.01 2.87 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 121.434 0.635 . . . . 0.0 110.047 179.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' PHE . . . . . 0.485 ' CD1' ' HA ' ' A' ' 187' ' ' LEU . 80.6 m-85 -88.58 139.05 29.68 Favored Pre-proline 0 C--N 1.299 -1.622 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.433 -177.602 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -64.07 -48.94 4.31 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.511 2.141 . . . . 0.0 112.289 -177.142 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 25.2 m -148.11 167.38 25.16 Favored 'General case' 0 N--CA 1.426 -1.646 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 178.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -60.66 -25.45 35.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -179.085 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 24.0 tp60 -60.87 -51.91 67.27 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.52 -178.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 22.1 tm0? -79.24 -27.18 42.41 Favored 'General case' 0 C--O 1.189 -2.103 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.485 ' HA ' ' CD1' ' A' ' 181' ' ' PHE . 5.1 tt -52.32 -61.55 2.2 Favored 'General case' 0 C--O 1.214 -0.804 0 C-N-CA 123.332 0.653 . . . . 0.0 110.304 -177.459 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.438 ' CB ' HG22 ' A' ' 163' ' ' VAL . 19.5 m -73.72 -22.97 59.72 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 121.165 0.507 . . . . 0.0 112.035 -177.445 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -91.0 7.44 40.32 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.858 178.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -66.21 156.89 32.87 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 123.22 0.608 . . . . 0.0 111.533 176.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 4.6 m -62.9 158.27 19.52 Favored 'General case' 0 N--CA 1.427 -1.61 0 CA-C-N 115.153 -0.931 . . . . 0.0 109.761 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 47.9 mm -55.54 -36.06 40.38 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.355 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.491 -177.219 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -62.58 -36.15 92.81 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 121.045 -0.598 . . . . 0.0 112.434 178.211 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 0.463 ' O ' ' HG2' ' A' ' 197' ' ' GLN . 13.1 mm-40 -76.84 -35.88 57.21 Favored 'General case' 0 C--O 1.215 -0.727 0 CA-C-O 121.475 0.655 . . . . 0.0 109.36 -177.271 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 92.0 mt -77.94 -23.33 48.59 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-O 121.616 0.722 . . . . 0.0 110.793 178.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' GLU . . . . . 0.477 ' HG2' ' N ' ' A' ' 201' ' ' GLN . 4.0 tm-20 -81.95 -37.76 26.22 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -178.174 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.463 ' HG2' ' O ' ' A' ' 194' ' ' GLU . 20.5 pt20 -66.37 -22.79 66.26 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.736 -178.506 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.429 HG22 ' O ' ' A' ' 194' ' ' GLU . 12.6 m -99.19 -28.83 3.44 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.422 HG23 HG23 ' A' ' 198' ' ' VAL . 1.5 t -130.64 -79.74 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.613 176.221 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -177.51 164.63 33.88 Favored Glycine 0 N--CA 1.438 -1.181 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 -177.199 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' GLN . . . . . 0.477 ' N ' ' HG2' ' A' ' 196' ' ' GLU . 11.1 pt20 -66.23 -40.13 90.04 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -177.538 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -68.2 -24.71 64.97 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 122.188 0.994 . . . . 0.0 109.827 -178.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.416 HG11 HG11 ' A' ' 199' ' ' VAL . 6.9 t -83.32 -47.56 18.1 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 CA-C-N 114.435 -1.257 . . . . 0.0 108.324 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -52.89 -44.96 67.28 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 114.473 -1.239 . . . . 0.0 110.846 -178.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -63.33 -48.03 79.73 Favored 'General case' 0 N--CA 1.423 -1.783 0 CA-C-N 114.922 -1.035 . . . . 0.0 111.574 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -70.96 -29.82 65.93 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.48 -177.407 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 90.6 mt -69.53 -51.91 37.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 175.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 7.0 t60 -69.6 -31.15 69.13 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.472 0.653 . . . . 0.0 109.374 -176.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -80.18 -13.69 59.05 Favored 'General case' 0 C--O 1.207 -1.142 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 176.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -62.24 -43.37 98.98 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-O 121.022 0.439 . . . . 0.0 111.782 -176.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -90.91 -23.38 20.51 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.261 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 28.4 m -76.2 -40.9 51.17 Favored 'General case' 0 CA--C 1.555 1.152 0 CA-C-O 121.059 0.457 . . . . 0.0 111.277 178.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -91.51 126.55 53.94 Favored Pre-proline 0 C--N 1.31 -1.146 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 178.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -48.64 141.66 19.92 Favored 'Trans proline' 0 C--O 1.243 0.751 0 C-N-CA 123.278 2.652 . . . . 0.0 112.995 176.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 . . . . . 0 N--CA 1.415 -2.177 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -177.108 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 43.4 m . . . . . 0 N--CA 1.426 -1.667 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -142.03 -28.24 0.62 Allowed 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.697 -175.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.41 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . 3.7 p-10 -140.96 148.56 52.67 Favored Pre-proline 0 C--N 1.317 -0.836 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 -176.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 143' ' ' ASN . 7.0 Cg_endo -88.35 -174.21 1.06 Allowed 'Trans proline' 0 N--CA 1.439 -1.7 0 C-N-CA 122.137 1.891 . . . . 0.0 109.301 172.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 3.3 tt -98.58 -67.29 0.85 Allowed 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 179.354 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -128.72 174.8 9.12 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.12 176.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -177.67 174.28 46.77 Favored Glycine 0 N--CA 1.417 -2.593 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 178.351 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -81.47 109.19 15.7 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 177.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -88.77 145.05 25.84 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -178.184 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.407 ' HA ' ' HD3' ' A' ' 150' ' ' ARG . 37.3 mmt180 -87.32 116.88 25.71 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 178.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -148.16 105.82 3.68 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.648 179.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 64.4 tp -125.71 109.04 12.12 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 -178.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -105.71 144.38 32.53 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.351 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 2.9 tt -89.39 77.38 7.37 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -178.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 20.0 m -82.24 103.46 11.85 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.497 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.412 ' HA ' ' HD3' ' A' ' 157' ' ' PRO . 36.5 mt-10 -79.21 139.82 56.56 Favored Pre-proline 0 C--N 1.309 -1.179 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.159 -177.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 156' ' ' GLU . 37.7 Cg_exo -60.47 101.97 0.18 Allowed 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.96 2.44 . . . . 0.0 111.152 176.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.447 ' HB2' ' HD2' ' A' ' 161' ' ' ARG . 16.8 m -97.89 89.06 4.45 Favored 'General case' 0 N--CA 1.416 -2.149 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.443 ' O ' HD23 ' A' ' 159' ' ' LEU . 6.4 tt -64.83 -28.88 69.86 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.972 -173.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.423 ' O ' HG12 ' A' ' 163' ' ' VAL . 2.4 pt? -59.22 -25.19 63.79 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.821 0.344 . . . . 0.0 111.834 179.122 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.447 ' HD2' ' HB2' ' A' ' 158' ' ' SER . 5.5 ptm180 -77.98 -26.05 48.47 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 120.077 -0.649 . . . . 0.0 109.522 -179.099 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 97.0 m -86.7 -32.1 20.67 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.253 176.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.423 HG12 ' O ' ' A' ' 160' ' ' LEU . 0.8 OUTLIER -65.47 -26.09 38.46 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 CA-C-O 121.654 0.74 . . . . 0.0 110.9 -177.07 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -83.61 -14.62 51.56 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.532 0.682 . . . . 0.0 109.768 176.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -99.52 20.39 13.95 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.455 -176.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 98.4 mt -80.09 129.16 71.06 Favored Pre-proline 0 C--N 1.293 -1.87 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 175.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.65 128.79 23.14 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 122.036 1.824 . . . . 0.0 109.96 177.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 116.21 -29.4 7.07 Favored Glycine 0 N--CA 1.426 -1.975 0 C-N-CA 120.146 -1.026 . . . . 0.0 111.508 -179.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 63.6 t -63.6 -64.85 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.592 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 177.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 113.62 98.95 2.33 Favored Glycine 0 N--CA 1.422 -2.255 0 C-N-CA 120.066 -1.064 . . . . 0.0 112.18 178.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -68.77 -27.39 65.85 Favored 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 122.926 0.49 . . . . 0.0 111.32 -178.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 22.5 t -83.88 -30.9 7.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-O 121.299 0.571 . . . . 0.0 109.748 -175.358 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.536 ' O ' ' HG ' ' A' ' 177' ' ' LEU . 20.4 ptmt -91.72 1.41 57.18 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.36 178.423 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -56.99 -50.35 88.71 Favored Pre-proline 0 CA--C 1.545 0.785 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.523 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.412 ' O ' ' HG2' ' A' ' 179' ' ' GLN . 15.9 Cg_endo -58.91 -24.05 70.74 Favored 'Trans proline' 0 C--N 1.376 2.021 0 C-N-CA 121.801 1.667 . . . . 0.0 112.764 178.163 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.409 ' HB3' ' O ' ' A' ' 173' ' ' LYS . 54.5 tp -77.58 -40.05 43.59 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 177.001 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.536 ' HG ' ' O ' ' A' ' 173' ' ' LYS . 84.3 mt -71.53 -33.59 69.31 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.869 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -69.12 -5.87 24.98 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 177.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' GLN . . . . . 0.412 ' HG2' ' O ' ' A' ' 175' ' ' PRO . 29.8 mm-40 -93.17 -3.74 53.37 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.266 0.555 . . . . 0.0 109.869 174.549 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -113.0 -50.53 2.88 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.47 176.088 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' PHE . . . . . 0.579 ' CD2' ' HG ' ' A' ' 187' ' ' LEU . 66.8 m-85 -96.76 141.16 22.67 Favored Pre-proline 0 C--N 1.309 -1.173 0 CA-C-N 114.769 -1.105 . . . . 0.0 108.55 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -67.76 -35.73 20.8 Favored 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 122.096 1.864 . . . . 0.0 112.82 -177.271 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 67.7 p -149.3 165.54 31.66 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -178.314 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -65.67 -26.13 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 O-C-N 123.403 0.439 . . . . 0.0 110.559 177.164 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -63.98 -43.57 95.34 Favored 'General case' 0 C--O 1.202 -1.416 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.977 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 13.0 tm0? -78.84 -34.56 45.05 Favored 'General case' 0 C--O 1.197 -1.703 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.579 ' HG ' ' CD2' ' A' ' 181' ' ' PHE . 4.8 tt -52.88 -66.61 0.35 Allowed 'General case' 0 C--O 1.21 -1.022 0 C-N-CA 124.205 1.002 . . . . 0.0 111.296 -175.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 23.1 m -75.2 -21.73 58.47 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.243 0.544 . . . . 0.0 112.062 -175.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -86.6 -4.33 59.16 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.032 -178.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.38 155.43 35.42 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 121.498 0.666 . . . . 0.0 111.167 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 12.4 m -65.32 162.17 18.06 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.365 -177.137 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 41.4 mm -53.57 -40.3 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 123.073 0.549 . . . . 0.0 110.892 -178.477 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -62.55 -29.03 72.36 Favored Glycine 0 C--O 1.214 -1.133 0 CA-C-N 115.974 -0.557 . . . . 0.0 113.135 -179.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -83.6 -41.88 17.35 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 121.467 0.651 . . . . 0.0 109.275 -178.071 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 97.4 mt -69.54 -38.42 77.49 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 114.706 -1.134 . . . . 0.0 111.345 -178.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.32 -33.9 77.05 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.311 0.577 . . . . 0.0 109.522 -176.571 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -60.94 -30.29 70.13 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.619 -1.173 . . . . 0.0 112.923 177.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 16.9 m -103.75 -39.29 5.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -176.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.555 HG23 ' H ' ' A' ' 200' ' ' GLY . 3.5 m -108.09 -84.64 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 177.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 200' ' ' GLY . . . . . 0.555 ' H ' HG23 ' A' ' 199' ' ' VAL . . . -178.0 167.46 38.24 Favored Glycine 0 N--CA 1.414 -2.819 0 N-CA-C 108.574 -1.81 . . . . 0.0 108.574 -178.466 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -57.69 -52.7 64.35 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 117.535 0.667 . . . . 0.0 112.357 179.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -67.37 -34.58 77.59 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.313 0.578 . . . . 0.0 110.809 -176.207 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.463 ' O ' ' HG2' ' A' ' 206' ' ' GLN . 2.6 t -70.57 -42.3 78.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 -179.562 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -56.36 -46.24 80.11 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.61 178.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -61.68 -47.02 87.23 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 114.972 -1.013 . . . . 0.0 112.615 179.124 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 206' ' ' GLN . . . . . 0.463 ' HG2' ' O ' ' A' ' 203' ' ' VAL . 3.4 pt20 -65.28 -34.98 79.62 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 118.373 0.533 . . . . 0.0 111.364 -178.303 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 88.4 mt -72.92 -50.52 32.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.972 178.172 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -65.01 -45.31 86.07 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.821 -177.045 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -70.07 -15.79 63.04 Favored 'General case' 0 C--O 1.217 -0.624 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -59.24 -45.54 90.9 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.129 0.572 . . . . 0.0 110.44 -179.148 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -95.91 -31.18 13.25 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.091 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 52.0 m -67.98 -40.07 83.19 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.518 -177.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -93.76 112.16 55.72 Favored Pre-proline 0 N--CA 1.44 -0.93 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -92.37 167.97 2.83 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 122.879 2.386 . . . . 0.0 112.659 -178.271 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? . . . . . 0 N--CA 1.404 -2.762 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 176.626 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.4 p . . . . . 0 N--CA 1.42 -1.955 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -161.19 135.92 7.34 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 -177.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -140.44 137.69 17.98 Favored Pre-proline 0 C--N 1.306 -1.314 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 173.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.47 -50.81 10.77 Favored 'Trans proline' 0 C--O 1.243 0.749 0 C-N-CA 122.695 2.264 . . . . 0.0 112.665 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 55.9 tp 67.23 -71.23 0.1 Allowed 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 125.114 1.365 . . . . 0.0 111.995 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.469 ' H ' HD23 ' A' ' 146' ' ' LEU . 2.4 pt? -128.41 159.41 35.46 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -178.532 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 153.0 147.92 4.74 Favored Glycine 0 N--CA 1.429 -1.833 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.658 177.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.517 ' H ' ' HD3' ' A' ' 148' ' ' LYS . 0.1 OUTLIER -130.13 146.86 51.81 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 179.646 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -159.54 99.63 1.44 Allowed 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.161 0.505 . . . . 0.0 111.41 178.293 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 42.2 ttt180 -141.01 93.78 2.63 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 173.338 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -95.77 101.66 13.37 Favored 'General case' 0 N--CA 1.427 -1.618 0 CA-C-N 115.393 -0.822 . . . . 0.0 109.209 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -132.35 159.45 39.18 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 70.0 mt -124.39 118.27 26.32 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 172.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 5.9 tt -106.91 90.2 3.24 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 -177.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 47.3 m -144.47 103.63 3.98 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -93.86 154.81 40.8 Favored Pre-proline 0 C--N 1.287 -2.114 0 CA-C-N 115.129 -0.942 . . . . 0.0 109.283 -178.287 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -60.26 -30.63 91.58 Favored 'Trans proline' 0 C--O 1.242 0.682 0 C-N-CA 122.325 2.017 . . . . 0.0 111.577 178.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -75.78 83.86 2.75 Favored 'General case' 0 N--CA 1.415 -2.176 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.222 177.278 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 43.0 tp -94.06 -25.39 17.21 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.118 178.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.468 ' O ' HG12 ' A' ' 163' ' ' VAL . 2.3 pt? -55.44 -34.54 64.55 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-O 121.223 0.535 . . . . 0.0 111.695 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -66.0 -31.9 73.07 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.198 177.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 15.9 m -86.72 -31.45 20.98 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 120.956 0.408 . . . . 0.0 110.76 178.054 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.468 HG12 ' O ' ' A' ' 160' ' ' LEU . 0.3 OUTLIER -64.79 -25.85 38.75 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.069 0 CA-C-O 121.719 0.771 . . . . 0.0 110.647 -177.271 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 164' ' ' GLN . . . . . 0.438 ' OE1' HG21 ' A' ' 184' ' ' ILE . 9.8 pt20 -83.44 -6.69 59.53 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.412 175.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -100.2 7.96 44.15 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.062 0.458 . . . . 0.0 110.307 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 84.5 mt -75.38 128.72 83.8 Favored Pre-proline 0 C--N 1.317 -0.829 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -65.75 128.67 20.42 Favored 'Trans proline' 0 C--O 1.238 0.478 0 C-N-CA 122.145 1.896 . . . . 0.0 111.353 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 117.35 -27.99 7.41 Favored Glycine 0 C--N 1.306 -1.084 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 -179.27 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 97.7 t -61.86 -62.01 1.34 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.689 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 177.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 110.89 100.81 2.6 Favored Glycine 0 N--CA 1.424 -2.12 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.323 176.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -73.66 -26.51 60.78 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.261 0.553 . . . . 0.0 109.935 177.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 62.1 t -82.88 -24.46 8.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-O 122.08 0.943 . . . . 0.0 108.896 178.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.438 ' O ' ' HG ' ' A' ' 177' ' ' LEU . 44.9 mtpt -86.01 -0.82 56.47 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.497 -1.229 . . . . 0.0 110.305 178.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -47.98 -51.04 50.76 Favored Pre-proline 0 C--O 1.203 -1.377 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -178.306 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.585 ' O ' ' HG2' ' A' ' 179' ' ' GLN . 12.9 Cg_endo -58.24 -42.57 55.24 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 121.684 1.589 . . . . 0.0 112.132 177.487 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 55.6 tp -64.46 -45.56 86.89 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.729 0.776 . . . . 0.0 109.639 179.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' A' ' 173' ' ' LYS . 93.2 mt -69.16 -26.41 64.85 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.973 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 57.4 tp -74.06 -30.75 62.54 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 121.132 0.492 . . . . 0.0 109.831 178.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' GLN . . . . . 0.585 ' HG2' ' O ' ' A' ' 175' ' ' PRO . 12.7 mm-40 -76.09 -30.97 58.5 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 121.167 0.508 . . . . 0.0 109.965 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 22.9 mmmt -83.28 -50.62 8.21 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.979 179.123 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' PHE . . . . . 0.427 ' HA ' ' HD3' ' A' ' 182' ' ' PRO . 28.8 m-85 -111.75 135.66 21.16 Favored Pre-proline 0 N--CA 1.436 -1.134 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.795 -172.388 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 181' ' ' PHE . 51.2 Cg_exo -53.42 -38.51 82.87 Favored 'Trans proline' 0 N--CA 1.487 1.118 0 C-N-CA 124.367 3.378 . . . . 0.0 114.184 -176.6 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 24.4 t -158.66 167.83 28.49 Favored 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 179.689 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.514 ' HA ' ' HB3' ' A' ' 187' ' ' LEU . 0.2 OUTLIER -61.37 -26.98 40.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 O-C-N 124.277 0.985 . . . . 0.0 110.995 178.214 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -64.39 -40.73 96.39 Favored 'General case' 0 C--O 1.21 -1.022 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.692 179.4 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 9.5 tm0? -80.2 -37.87 32.34 Favored 'General case' 0 C--O 1.191 -2.017 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 177.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.514 ' HB3' ' HA ' ' A' ' 184' ' ' ILE . 66.8 tp -46.67 -65.59 0.54 Allowed 'General case' 0 C--O 1.212 -0.873 0 C-N-CA 126.07 1.748 . . . . 0.0 113.202 -177.045 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 36.9 m -72.96 -20.94 60.95 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -177.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -91.89 3.88 54.19 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.461 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.96 158.23 28.71 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 124.816 1.247 . . . . 0.0 112.737 178.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 14.6 m -62.99 152.06 37.9 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.848 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 48.2 mm -55.15 -35.57 36.09 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.137 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.878 -177.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -61.9 -30.2 74.57 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 121.313 -0.47 . . . . 0.0 112.842 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 0.461 ' O ' ' HG2' ' A' ' 197' ' ' GLN . 59.4 mm-40 -84.24 -36.99 22.33 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-O 121.529 0.681 . . . . 0.0 109.752 -179.573 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.404 HD21 ' O ' ' A' ' 187' ' ' LEU . 96.0 mt -75.97 -24.38 55.4 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.385 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 196' ' ' GLU . . . . . 0.442 ' HG2' ' N ' ' A' ' 201' ' ' GLN . 3.9 tm-20 -78.91 -37.95 38.64 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -178.041 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.461 ' HG2' ' O ' ' A' ' 194' ' ' GLU . 10.3 pt20 -69.75 -19.6 63.53 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 114.999 -1.0 . . . . 0.0 112.328 -175.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 17.1 m -102.54 -26.33 3.52 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 C-N-CA 120.587 -0.445 . . . . 0.0 111.842 178.107 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.531 HG11 HG11 ' A' ' 203' ' ' VAL . 0.2 OUTLIER -128.24 -81.8 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 C-N-CA 120.721 -0.392 . . . . 0.0 111.129 175.897 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -176.95 162.78 31.24 Favored Glycine 0 N--CA 1.442 -0.914 0 N-CA-C 108.791 -1.723 . . . . 0.0 108.791 -176.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' GLN . . . . . 0.442 ' N ' ' HG2' ' A' ' 196' ' ' GLU . 51.6 tt0 -67.01 -40.69 87.36 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 117.996 0.898 . . . . 0.0 112.065 -176.117 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -65.7 -37.64 87.01 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.399 0.619 . . . . 0.0 109.936 -179.186 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.531 HG11 HG11 ' A' ' 199' ' ' VAL . 3.9 t -69.91 -44.05 79.04 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.864 0 CA-C-N 114.986 -1.007 . . . . 0.0 108.755 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -55.31 -46.43 76.27 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 114.356 -1.293 . . . . 0.0 110.2 -179.247 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -71.12 -31.62 67.99 Favored 'General case' 0 N--CA 1.417 -2.124 0 CA-C-N 114.735 -1.12 . . . . 0.0 112.494 -177.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 206' ' ' GLN . . . . . 0.42 ' HG2' ' O ' ' A' ' 203' ' ' VAL . 14.2 pt20 -78.08 -34.1 50.45 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 119.742 -0.783 . . . . 0.0 110.765 178.244 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 93.7 mt -66.38 -45.61 88.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 174.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 28.4 t-80 -68.95 -35.77 77.15 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.007 -178.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -72.56 -25.6 61.42 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 121.743 -0.598 . . . . 0.0 112.507 177.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -50.84 -54.13 26.37 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.532 1.133 . . . . 0.0 112.667 -175.452 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 20.3 p90 -81.76 -24.16 36.21 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -177.136 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 30.6 m -76.53 -38.27 55.36 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 120.975 0.417 . . . . 0.0 111.225 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -96.47 117.71 65.87 Favored Pre-proline 0 C--N 1.312 -1.031 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -178.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -74.38 177.87 7.76 Favored 'Trans proline' 0 C--O 1.245 0.859 0 C-N-CA 122.711 2.274 . . . . 0.0 112.137 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 58.2 mtt85 . . . . . 0 C--N 1.298 -1.672 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -179.199 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 35.9 m . . . . . 0 N--CA 1.436 -1.164 0 CA-C-O 121.267 0.556 . . . . 0.0 110.96 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -112.59 -26.9 8.42 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 176.123 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -104.12 111.29 65.12 Favored Pre-proline 0 C--N 1.305 -1.342 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 171.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.42 ' HB2' ' O ' ' A' ' 146' ' ' LEU . 50.6 Cg_endo -71.28 128.29 14.47 Favored 'Trans proline' 0 N--CA 1.445 -1.342 0 C-N-CA 121.505 1.47 . . . . 0.0 111.799 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 92.0 mt -64.37 -40.88 96.7 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.697 177.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.42 ' O ' ' HB2' ' A' ' 144' ' ' PRO . 7.2 mp -107.18 148.06 29.34 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.044 177.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 137.18 -149.81 20.42 Favored Glycine 0 N--CA 1.417 -2.617 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 -178.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -69.25 168.9 13.21 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 123.493 0.717 . . . . 0.0 110.429 -178.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -61.68 101.76 0.21 Allowed 'General case' 0 C--O 1.24 0.603 0 O-C-N 123.737 0.648 . . . . 0.0 109.849 174.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.436 ' HD2' ' O ' ' A' ' 150' ' ' ARG . 3.4 ppt_? -102.72 100.19 10.21 Favored 'General case' 0 N--CA 1.425 -1.704 0 CA-C-O 122.24 1.019 . . . . 0.0 112.535 -178.716 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -77.54 108.65 10.87 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.946 178.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 62.9 tp -146.97 142.32 27.4 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 106.201 -1.778 . . . . 0.0 106.201 176.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.448 HD23 ' H ' ' A' ' 153' ' ' LEU . 2.7 pt? -70.11 132.38 45.74 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.442 0.639 . . . . 0.0 109.55 178.174 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.577 ' H ' HD13 ' A' ' 154' ' ' LEU 0.382 0.0 OUTLIER -85.0 81.18 9.01 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-O 123.501 1.62 . . . . 0.0 111.292 179.589 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 66.3 m -133.16 102.28 5.52 Favored 'General case' 0 N--CA 1.395 -3.21 0 CA-C-N 113.913 -1.494 . . . . 0.0 108.821 178.258 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.453 ' OE1' ' HD2' ' A' ' 157' ' ' PRO . 7.0 tp10 -95.66 138.42 21.79 Favored Pre-proline 0 C--N 1.291 -1.956 0 N-CA-C 104.521 -2.4 . . . . 0.0 104.521 174.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.453 ' HD2' ' OE1' ' A' ' 156' ' ' GLU . 6.2 Cg_endo -49.72 128.54 21.55 Favored 'Trans proline' 0 C--O 1.246 0.922 0 C-N-CA 122.617 2.211 . . . . 0.0 110.832 177.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.498 ' O ' ' HG2' ' A' ' 161' ' ' ARG . 3.3 p -66.35 33.4 0.02 OUTLIER 'General case' 0 C--O 1.207 -1.132 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 -176.253 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.418 ' H ' ' C ' ' A' ' 157' ' ' PRO . 3.0 tm? -90.8 -23.77 20.51 Favored 'General case' 0 C--N 1.277 -2.551 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 175.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.405 ' HA ' HG12 ' A' ' 163' ' ' VAL . 2.4 pt? -61.82 -23.52 66.28 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 115.316 -0.856 . . . . 0.0 112.035 -177.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.498 ' HG2' ' O ' ' A' ' 158' ' ' SER . 34.6 ptt180 -70.0 -39.32 75.96 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.345 0.593 . . . . 0.0 110.104 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 74.8 m -86.75 -32.57 20.33 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.937 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.436 HG22 ' CB ' ' A' ' 188' ' ' SER . 0.4 OUTLIER -62.49 -26.2 39.87 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.126 -174.568 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -80.47 -10.22 59.75 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.995 179.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -103.8 11.45 35.75 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 121.143 0.497 . . . . 0.0 110.978 -176.033 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.444 HG21 ' HA ' ' A' ' 207' ' ' ILE . 73.6 mt -78.74 133.86 61.81 Favored Pre-proline 0 C--N 1.304 -1.404 0 CA-C-N 116.059 -0.518 . . . . 0.0 109.71 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -62.12 128.76 24.94 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.106 1.871 . . . . 0.0 109.869 175.026 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 116.07 -40.95 2.25 Favored Glycine 0 N--CA 1.429 -1.805 0 N-CA-C 108.668 -1.773 . . . . 0.0 108.668 -176.201 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.455 ' O ' HD11 ' A' ' 177' ' ' LEU . 57.7 t -70.89 -56.34 11.03 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.174 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 174.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 91.77 147.08 19.58 Favored Glycine 0 N--CA 1.417 -2.596 0 C-N-CA 120.201 -1.0 . . . . 0.0 114.893 172.128 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.449 ' HG3' HG23 ' A' ' 172' ' ' VAL . 56.7 pttt -89.37 -35.93 15.79 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 114.401 -0.899 . . . . 0.0 110.556 177.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.449 HG23 ' HG3' ' A' ' 171' ' ' LYS . 43.3 t -86.14 -39.03 13.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-O 121.204 0.526 . . . . 0.0 110.729 -175.008 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.652 ' O ' ' HG ' ' A' ' 177' ' ' LEU . 21.6 ptmt -84.25 2.07 41.73 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.765 -178.321 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.412 ' O ' ' HG ' ' A' ' 178' ' ' LEU . . . -54.59 -52.75 67.17 Favored Pre-proline 0 CA--C 1.563 1.443 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -61.74 -23.16 75.85 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 122.137 1.891 . . . . 0.0 112.22 177.407 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.509 ' HB3' ' O ' ' A' ' 173' ' ' LYS . 53.5 tp -74.54 -34.86 63.08 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.252 176.649 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.652 ' HG ' ' O ' ' A' ' 173' ' ' LYS . 61.5 mt -78.69 -29.29 45.48 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.073 -179.07 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 174' ' ' ALA . 87.3 mt -68.69 -5.58 21.13 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.615 177.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -85.3 -21.42 28.99 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 121.838 0.828 . . . . 0.0 108.941 174.254 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -101.05 -47.41 4.77 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.567 -178.319 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' PHE . . . . . 0.588 ' CD2' ' HG ' ' A' ' 187' ' ' LEU . 85.4 m-85 -107.32 149.06 38.27 Favored Pre-proline 0 N--CA 1.427 -1.609 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.623 -175.458 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 182' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 181' ' ' PHE . 2.8 Cg_exo -67.46 -50.47 0.94 Allowed 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.774 2.316 . . . . 0.0 112.566 -178.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 66.6 m -150.19 164.48 35.57 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -57.33 -30.49 35.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 115.671 1.73 . . . . 0.0 115.671 -173.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 14.3 tm0? -68.55 -46.9 68.25 Favored 'General case' 0 C--O 1.206 -1.223 0 C-N-CA 119.439 -0.905 . . . . 0.0 108.995 -176.261 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 13.9 tm0? -73.04 -29.89 63.32 Favored 'General case' 0 C--O 1.194 -1.846 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.588 ' HG ' ' CD2' ' A' ' 181' ' ' PHE . 5.1 tt -56.03 -64.12 0.96 Allowed 'General case' 0 C--O 1.217 -0.607 0 C-N-CA 123.666 0.786 . . . . 0.0 110.27 -178.168 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.436 ' CB ' HG22 ' A' ' 163' ' ' VAL . 17.6 m -74.29 -26.44 60.19 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 123.29 0.369 . . . . 0.0 111.831 -176.64 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.416 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 8.6 t30 -85.36 -0.03 53.55 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.138 0.494 . . . . 0.0 111.014 -178.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -66.62 155.47 37.77 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.035 0.445 . . . . 0.0 110.704 175.4 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 12.5 m -63.94 159.72 19.27 Favored 'General case' 0 C--O 1.251 1.14 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.089 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.1 mm -49.09 -39.17 12.06 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.851 0 C-N-CA 123.772 0.829 . . . . 0.0 111.619 -179.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.462 ' O ' ' HG3' ' A' ' 197' ' ' GLN . . . -57.22 -39.05 89.45 Favored Glycine 0 CA--C 1.526 0.767 0 O-C-N 123.129 0.268 . . . . 0.0 113.453 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -77.56 -41.46 38.86 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.551 0.691 . . . . 0.0 109.231 -177.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 96.0 mt -69.72 -26.44 64.33 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.268 -179.253 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' GLU . . . . . 0.624 ' HG2' ' N ' ' A' ' 201' ' ' GLN . 1.5 tm-20 -73.39 -34.43 65.54 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 -179.575 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.462 ' HG3' ' O ' ' A' ' 193' ' ' GLY . 89.9 mt-30 -62.52 -29.92 70.91 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.999 178.474 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.416 HG23 HG23 ' A' ' 199' ' ' VAL . 12.8 m -103.84 -24.44 4.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -176.568 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.436 HG11 HG11 ' A' ' 203' ' ' VAL . 1.0 OUTLIER -128.4 -85.75 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.779 176.58 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -178.36 158.3 22.86 Favored Glycine 0 CA--C 1.494 -1.223 0 N-CA-C 108.669 -1.772 . . . . 0.0 108.669 -176.133 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' GLN . . . . . 0.624 ' N ' ' HG2' ' A' ' 196' ' ' GLU . 10.7 pt20 -57.19 -46.39 82.89 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -177.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -69.93 -34.69 73.8 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.395 0.616 . . . . 0.0 110.55 -175.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.445 ' O ' HG13 ' A' ' 207' ' ' ILE . 2.0 t -75.2 -39.28 42.78 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-N 114.945 -1.025 . . . . 0.0 108.241 -178.291 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -57.48 -41.59 80.97 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.587 -1.188 . . . . 0.0 109.903 179.319 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -64.56 -39.79 94.38 Favored 'General case' 0 N--CA 1.422 -1.85 0 CA-C-N 114.966 -1.015 . . . . 0.0 112.047 -179.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -73.4 -30.09 63.02 Favored 'General case' 0 C--O 1.218 -0.554 0 C-N-CA 119.367 -0.933 . . . . 0.0 110.438 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 207' ' ' ILE . . . . . 0.445 HG13 ' O ' ' A' ' 203' ' ' VAL . 82.8 mt -68.03 -53.07 32.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 176.178 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 53.3 t-80 -62.57 -43.73 98.08 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 114.668 -1.151 . . . . 0.0 110.531 -177.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -70.7 -25.3 62.9 Favored 'General case' 0 C--O 1.202 -1.396 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -54.56 -47.84 72.76 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.083 0.553 . . . . 0.0 111.742 -176.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 211' ' ' PHE . . . . . 0.416 ' CZ ' ' HA ' ' A' ' 189' ' ' ASN . 34.1 p90 -93.69 -26.34 17.07 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.172 -178.607 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 46.4 m -75.67 -37.89 59.19 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-O 120.895 0.379 . . . . 0.0 111.061 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -94.0 120.53 65.63 Favored Pre-proline 0 C--N 1.31 -1.144 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 177.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.07 159.01 51.14 Favored 'Trans proline' 0 C--O 1.244 0.798 0 C-N-CA 122.464 2.109 . . . . 0.0 112.854 -177.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 29.0 ttp180 . . . . . 0 C--N 1.3 -1.555 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 177.865 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.6 t . . . . . 0 N--CA 1.43 -1.471 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -112.05 -59.72 1.96 Allowed 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.35 0.595 . . . . 0.0 110.338 -179.131 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.412 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . 38.3 m-80 -72.75 127.71 89.33 Favored Pre-proline 0 C--N 1.305 -1.366 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.742 -175.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 143' ' ' ASN . 6.6 Cg_exo -73.29 97.85 0.97 Allowed 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 121.975 1.784 . . . . 0.0 109.068 173.624 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 40.7 tp -121.66 -17.92 7.31 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.396 -176.19 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 93.4 mt -117.29 156.06 28.44 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.504 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 115.59 -150.26 18.7 Favored Glycine 0 N--CA 1.412 -2.935 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 178.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -110.63 147.45 34.24 Favored 'General case' 0 C--N 1.276 -2.595 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -115.4 126.14 54.02 Favored 'General case' 0 C--N 1.287 -2.12 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 174.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 17.9 tpt180 -47.6 105.37 0.07 Allowed 'General case' 0 C--O 1.245 0.84 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 -167.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -154.84 156.68 36.63 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 105.722 -1.955 . . . . 0.0 105.722 177.412 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.498 HD23 ' H ' ' A' ' 152' ' ' LEU . 1.8 pt? -116.21 143.93 44.87 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.293 -177.111 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 68.1 tp -148.16 132.12 17.17 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 179.449 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 62.3 tp -80.76 105.66 12.16 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 177.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 12.9 t -86.47 115.73 24.16 Favored 'General case' 0 N--CA 1.411 -2.401 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -109.44 137.18 20.22 Favored Pre-proline 0 C--N 1.284 -2.258 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 -175.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.84 9.98 0.55 Allowed 'Trans proline' 0 N--CA 1.49 1.271 0 C-N-CA 123.725 2.95 . . . . 0.0 114.799 -177.032 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.421 ' O ' ' HG2' ' A' ' 161' ' ' ARG . 18.9 m 63.72 34.73 11.89 Favored 'General case' 0 C--O 1.216 -0.696 0 C-N-CA 124.553 1.141 . . . . 0.0 109.94 178.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 44.6 tp -57.26 -26.87 61.47 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 124.701 1.2 . . . . 0.0 112.641 -174.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -63.36 -23.94 67.63 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.666 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.421 ' HG2' ' O ' ' A' ' 158' ' ' SER . 30.4 ptt180 -72.13 -32.5 66.99 Favored 'General case' 0 C--O 1.22 -0.497 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 10.2 m -86.37 -35.59 19.7 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.937 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.435 HG22 ' HB2' ' A' ' 188' ' ' SER . 0.4 OUTLIER -61.66 -25.68 37.57 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 C-N-CA 123.835 0.854 . . . . 0.0 111.571 -177.259 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -86.11 -8.01 58.18 Favored 'General case' 0 C--N 1.311 -1.103 0 O-C-N 121.941 -0.474 . . . . 0.0 111.561 178.297 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -97.46 17.99 16.33 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-O 120.606 0.241 . . . . 0.0 110.638 -176.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.438 HG21 ' HA ' ' A' ' 207' ' ' ILE . 65.2 mt -83.09 120.33 75.79 Favored Pre-proline 0 C--N 1.302 -1.463 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.364 -176.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.23 129.12 15.58 Favored 'Trans proline' 0 N--CA 1.445 -1.364 0 C-N-CA 121.82 1.68 . . . . 0.0 108.349 175.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 124.45 -33.14 3.88 Favored Glycine 0 C--N 1.288 -2.126 0 N-CA-C 108.47 -1.852 . . . . 0.0 108.47 -171.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 81.3 t -68.48 -43.5 83.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 174.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 107.55 140.27 9.43 Favored Glycine 0 N--CA 1.424 -2.12 0 CA-C-N 115.267 -0.879 . . . . 0.0 112.492 175.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -89.27 -36.27 15.68 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 121.131 0.491 . . . . 0.0 110.193 178.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 44.0 t -89.19 -31.98 5.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-O 121.735 0.778 . . . . 0.0 109.643 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.45 ' HG2' ' HG ' ' A' ' 177' ' ' LEU . 39.3 ttmt -77.36 -14.39 59.73 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.376 -179.592 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -52.36 -53.86 48.34 Favored Pre-proline 0 CA--C 1.557 1.222 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -176.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.444 ' O ' ' HG3' ' A' ' 179' ' ' GLN . 18.9 Cg_endo -61.19 -32.36 90.75 Favored 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 121.575 1.517 . . . . 0.0 112.8 178.596 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 57.4 tp -69.84 -40.59 75.75 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.543 0.687 . . . . 0.0 109.804 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.45 ' HG ' ' HG2' ' A' ' 173' ' ' LYS . 87.6 mt -68.51 -27.99 66.61 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.259 178.596 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 43.4 tp -74.91 -9.49 58.59 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.179 177.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' GLN . . . . . 0.444 ' HG3' ' O ' ' A' ' 175' ' ' PRO . 72.3 mt-30 -91.02 -29.74 17.19 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 175.343 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -84.27 -50.64 7.67 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.825 -179.398 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' PHE . . . . . 0.421 ' CD2' ' HG ' ' A' ' 187' ' ' LEU . 71.9 m-85 -97.7 149.12 35.38 Favored Pre-proline 0 C--N 1.293 -1.857 0 CA-C-N 115.056 -0.974 . . . . 0.0 109.204 -177.321 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -68.78 -42.21 4.89 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 121.994 1.796 . . . . 0.0 112.705 -177.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 78.2 p -147.72 166.77 26.48 Favored 'General case' 0 N--CA 1.427 -1.58 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -177.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.451 HD13 ' H ' ' A' ' 184' ' ' ILE . 0.2 OUTLIER -62.42 -29.28 46.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 O-C-N 123.772 0.67 . . . . 0.0 111.569 177.971 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -63.23 -45.95 89.25 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.735 -179.541 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -79.2 -32.59 44.11 Favored 'General case' 0 C--O 1.202 -1.419 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.421 ' HG ' ' CD2' ' A' ' 181' ' ' PHE . 4.1 tt -53.81 -64.09 0.94 Allowed 'General case' 0 C--O 1.218 -0.567 0 C-N-CA 124.141 0.976 . . . . 0.0 110.285 -176.228 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.435 ' HB2' HG22 ' A' ' 163' ' ' VAL . 19.9 m -70.42 -20.71 62.9 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 121.322 0.582 . . . . 0.0 111.793 -178.073 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -90.34 4.9 49.46 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.408 0.623 . . . . 0.0 111.009 -178.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.49 155.3 36.02 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.781 173.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 5.4 t -72.89 168.69 18.4 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.553 -175.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 50.8 mm -59.62 -37.73 72.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.751 -175.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -60.34 -31.92 75.44 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 116.448 -0.342 . . . . 0.0 112.803 178.503 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 0.495 ' O ' ' HG2' ' A' ' 197' ' ' GLN . 24.3 mt-10 -83.77 -36.73 23.38 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 121.556 0.693 . . . . 0.0 109.269 -177.765 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 88.6 mt -78.44 -23.27 46.69 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-O 121.306 0.574 . . . . 0.0 111.72 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' GLU . . . . . 0.572 ' HG2' ' N ' ' A' ' 201' ' ' GLN . 2.5 tm-20 -80.49 -37.44 31.72 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.495 ' HG2' ' O ' ' A' ' 194' ' ' GLU . 19.8 pt20 -68.01 -14.69 63.16 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.708 -177.367 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 4.1 m -103.46 -34.66 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 N-CA-C 111.621 0.23 . . . . 0.0 111.621 174.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 1.3 t -128.76 -80.31 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 C-N-CA 119.909 -0.716 . . . . 0.0 111.25 177.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -177.61 166.27 36.52 Favored Glycine 0 N--CA 1.434 -1.458 0 N-CA-C 111.46 -0.656 . . . . 0.0 111.46 -176.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 201' ' ' GLN . . . . . 0.572 ' N ' ' HG2' ' A' ' 196' ' ' GLU . 78.7 mt-30 -56.51 -50.39 71.95 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 124.756 1.222 . . . . 0.0 111.82 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -64.81 -27.87 69.17 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.681 0.753 . . . . 0.0 111.205 -175.357 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 90.3 t -80.14 -49.44 18.99 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.581 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -52.31 -46.64 66.07 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 124.763 1.225 . . . . 0.0 110.891 -179.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -61.74 -45.75 92.6 Favored 'General case' 0 N--CA 1.419 -2.011 0 CA-C-N 114.433 -1.258 . . . . 0.0 111.529 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -73.86 -28.61 61.67 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.348 -0.541 . . . . 0.0 111.877 -179.286 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 207' ' ' ILE . . . . . 0.438 ' HA ' HG21 ' A' ' 166' ' ' ILE . 81.9 mt -70.04 -50.34 48.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.182 0.515 . . . . 0.0 109.945 175.189 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 9.7 t60 -72.63 -37.02 68.15 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.248 -175.463 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -73.85 -16.38 61.13 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 120.22 -0.592 . . . . 0.0 112.164 178.233 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -54.37 -56.72 15.75 Favored 'General case' 0 C--O 1.215 -0.716 0 C-N-CA 123.386 0.674 . . . . 0.0 111.68 -177.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -81.04 -26.35 36.44 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.59 -178.018 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 32.3 m -64.73 -38.5 91.2 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.585 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -108.89 110.26 61.01 Favored Pre-proline 0 C--N 1.315 -0.909 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 175.412 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -89.94 156.67 4.93 Favored 'Trans proline' 0 N--CA 1.44 -1.623 0 C-N-CA 122.243 1.962 . . . . 0.0 112.888 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 62.8 ttp180 . . . . . 0 C--N 1.301 -1.535 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 179.271 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 49.1 m . . . . . 0 N--CA 1.433 -1.299 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 20.7 pttm -119.63 13.93 12.57 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -175.613 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -127.32 150.64 73.06 Favored Pre-proline 0 C--N 1.301 -1.52 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 178.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -63.74 115.43 3.06 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.085 1.856 . . . . 0.0 109.854 176.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.706 ' H ' HD23 ' A' ' 145' ' ' LEU . 2.0 pt? -75.39 -6.86 52.14 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.511 -1.222 . . . . 0.0 113.144 -173.687 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 62.0 tp -82.96 104.02 12.86 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 170.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 89.22 -172.82 40.27 Favored Glycine 0 N--CA 1.401 -3.644 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 -173.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 59.2 mttm -112.22 168.01 9.96 Favored 'General case' 0 C--N 1.27 -2.876 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 178.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -74.33 113.2 11.27 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 176.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 8.4 tpm_? -77.03 93.34 3.83 Favored 'General case' 0 N--CA 1.427 -1.59 0 CA-C-O 121.71 0.767 . . . . 0.0 110.657 -178.245 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -93.65 108.23 19.99 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 171.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 59.8 tp -128.06 121.14 28.97 Favored 'General case' 0 C--N 1.292 -1.894 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.8 -174.246 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.473 HD13 ' H ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -113.76 129.01 56.64 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 175.651 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -120.7 96.59 5.18 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.452 ' O ' ' HD3' ' A' ' 157' ' ' PRO . 8.1 p -101.16 103.56 14.61 Favored 'General case' 0 N--CA 1.423 -1.807 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.345 -175.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.407 ' HB3' ' HA ' ' A' ' 159' ' ' LEU . 33.2 mm-40 -104.54 96.54 10.42 Favored Pre-proline 0 C--N 1.308 -1.212 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.647 174.624 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.452 ' HD3' ' O ' ' A' ' 155' ' ' SER . 9.2 Cg_exo -75.88 -24.93 11.03 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 121.903 1.735 . . . . 0.0 109.65 175.411 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.476 ' O ' ' HG2' ' A' ' 161' ' ' ARG . 3.4 p -105.92 33.94 3.55 Favored 'General case' 0 N--CA 1.425 -1.68 0 C-N-CA 125.312 1.445 . . . . 0.0 109.441 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.407 ' HA ' ' HB3' ' A' ' 156' ' ' GLU . 2.6 tt -43.22 -35.36 1.39 Allowed 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 126.387 1.875 . . . . 0.0 113.246 -173.531 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.5 ' HA ' HG12 ' A' ' 163' ' ' VAL . 2.3 pt? -58.18 -22.43 51.51 Favored 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 179.669 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.476 ' HG2' ' O ' ' A' ' 158' ' ' SER . 37.7 ptt180 -68.04 -39.17 83.11 Favored 'General case' 0 C--O 1.223 -0.34 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 176.479 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 93.7 m -86.51 -31.64 21.18 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.731 -177.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.5 HG12 ' HA ' ' A' ' 160' ' ' LEU . 0.5 OUTLIER -65.32 -26.19 38.94 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 CA-C-O 121.664 0.745 . . . . 0.0 111.083 -177.416 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -86.44 -8.01 57.97 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.597 178.007 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -104.41 16.41 26.2 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.441 -178.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 84.5 mt -77.72 127.01 83.43 Favored Pre-proline 0 C--N 1.302 -1.46 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.289 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -66.31 128.55 19.6 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 121.778 1.652 . . . . 0.0 109.522 177.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 120.66 -33.87 4.29 Favored Glycine 0 N--CA 1.427 -1.953 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 -177.276 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 93.3 t -59.33 -60.27 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 CA-C-O 121.294 0.568 . . . . 0.0 110.447 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 113.87 95.04 2.1 Favored Glycine 0 N--CA 1.428 -1.833 0 C-N-CA 119.965 -1.112 . . . . 0.0 112.248 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -76.68 -20.57 56.47 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 121.274 0.559 . . . . 0.0 110.863 -178.109 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 57.5 t -83.11 -29.87 8.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-O 121.672 0.749 . . . . 0.0 109.362 178.237 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -83.44 -7.18 59.6 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.432 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -49.14 -50.12 65.5 Favored Pre-proline 0 CA--C 1.551 0.99 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 -176.315 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.512 ' O ' ' HG3' ' A' ' 179' ' ' GLN . 10.9 Cg_endo -57.28 -36.84 99.01 Favored 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 121.583 1.522 . . . . 0.0 112.862 177.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 60.4 tp -71.83 -40.47 69.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.372 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.419 ' HB3' HD11 ' A' ' 187' ' ' LEU . 97.0 mt -66.05 -34.03 77.16 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.705 179.331 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 47.9 tp -70.72 -13.94 62.25 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.441 0.639 . . . . 0.0 110.834 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' GLN . . . . . 0.512 ' HG3' ' O ' ' A' ' 175' ' ' PRO . 90.5 mt-30 -89.43 -35.99 15.7 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 176.824 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 40.9 mmtm -80.83 -47.43 13.84 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.212 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' PHE . . . . . 0.531 ' CD2' ' HA ' ' A' ' 187' ' ' LEU . 80.1 m-85 -101.78 145.54 30.65 Favored Pre-proline 0 C--N 1.296 -1.753 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -177.42 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -56.8 -47.57 22.76 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 122.919 2.412 . . . . 0.0 111.673 177.285 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' SER . . . . . 0.411 ' O ' ' HB2' ' A' ' 187' ' ' LEU . 78.2 p -153.24 171.58 18.31 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 -178.557 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -63.32 -25.14 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 121.333 0.587 . . . . 0.0 110.401 176.003 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -65.51 -45.12 84.77 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.359 -178.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 16.3 tm0? -79.49 -36.2 39.01 Favored 'General case' 0 C--O 1.203 -1.381 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 176.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.531 ' HA ' ' CD2' ' A' ' 181' ' ' PHE . 4.7 tt -49.1 -66.29 0.42 Allowed 'General case' 0 C--O 1.213 -0.844 0 C-N-CA 125.482 1.513 . . . . 0.0 111.503 -175.221 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 35.1 m -70.95 -20.78 62.41 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -175.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -90.89 0.59 57.45 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.472 ' HB1' ' HB2' ' A' ' 194' ' ' GLU . . . -65.58 155.46 35.71 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 122.902 0.481 . . . . 0.0 110.445 175.748 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 27.9 p -66.98 165.24 15.99 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.125 -178.447 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 50.7 mm -55.91 -37.64 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.292 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -58.58 -37.08 88.12 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-N 115.309 -0.86 . . . . 0.0 113.514 178.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 0.472 ' HB2' ' HB1' ' A' ' 190' ' ' ALA . 30.1 mt-10 -83.4 -37.88 22.69 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.336 0.589 . . . . 0.0 109.503 -177.708 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 95.0 mt -71.65 -31.76 67.19 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.866 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -67.1 -31.37 71.79 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.35 0.595 . . . . 0.0 109.743 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -63.81 -26.27 68.55 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 114.865 -1.061 . . . . 0.0 112.723 179.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 12.2 m -103.88 -38.35 5.02 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.517 HG23 ' H ' ' A' ' 200' ' ' GLY . 2.5 m -117.05 -80.55 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 178.081 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 200' ' ' GLY . . . . . 0.517 ' H ' HG23 ' A' ' 199' ' ' VAL . . . -177.99 166.41 36.54 Favored Glycine 0 N--CA 1.418 -2.525 0 N-CA-C 108.434 -1.866 . . . . 0.0 108.434 -178.082 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 201' ' ' GLN . . . . . 0.519 ' O ' ' HG3' ' A' ' 205' ' ' GLN . 63.4 tt0 -68.54 -43.37 76.84 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 118.038 0.919 . . . . 0.0 110.837 -178.78 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -65.46 -32.99 74.9 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.122 0.487 . . . . 0.0 110.866 -179.156 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 2.4 t -75.53 -40.89 41.74 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.738 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -179.452 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -57.94 -43.85 86.56 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.355 -179.001 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 205' ' ' GLN . . . . . 0.519 ' HG3' ' O ' ' A' ' 201' ' ' GLN . 98.4 mt-30 -61.89 -47.12 86.4 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.684 -178.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -69.53 -33.05 72.24 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.437 -0.505 . . . . 0.0 111.54 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 99.2 mt -69.24 -50.39 52.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.13 0.49 . . . . 0.0 109.82 176.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 59.5 t-80 -67.59 -39.88 84.81 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.253 -177.386 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -72.01 -18.39 61.97 Favored 'General case' 0 C--O 1.213 -0.826 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -55.12 -51.45 66.4 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.396 0.617 . . . . 0.0 110.459 -178.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -89.37 -27.67 20.31 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.994 -179.241 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 60.4 m -73.97 -46.81 41.63 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -177.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -84.16 136.56 40.67 Favored Pre-proline 0 C--N 1.304 -1.377 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -176.069 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo -51.6 144.06 34.51 Favored 'Trans proline' 0 C--O 1.249 1.035 0 C-N-CA 123.218 2.612 . . . . 0.0 112.586 176.504 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 28.4 mmm180 . . . . . 0 C--N 1.289 -2.024 0 CA-C-N 114.825 -1.08 . . . . 0.0 108.482 -175.993 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 2.9 p . . . . . 0 N--CA 1.427 -1.588 0 CA-C-O 121.391 0.615 . . . . 0.0 110.893 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -104.78 160.02 15.32 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 115.401 -0.818 . . . . 0.0 108.988 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -115.93 167.44 10.24 Favored Pre-proline 0 C--N 1.286 -2.194 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -66.62 96.08 0.35 Allowed 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 121.459 1.439 . . . . 0.0 109.839 172.286 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 45.2 tp -68.97 -38.29 79.28 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 92.3 mt -94.42 111.73 23.48 Favored 'General case' 0 N--CA 1.424 -1.731 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 174.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 165.97 -149.66 16.07 Favored Glycine 0 N--CA 1.428 -1.892 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -176.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 15.3 ptmm? -119.48 114.2 21.92 Favored 'General case' 0 C--N 1.293 -1.853 0 C-N-CA 119.363 -0.935 . . . . 0.0 111.965 179.073 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.53 96.32 2.89 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 106.071 -1.825 . . . . 0.0 106.071 173.66 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 2.3 tpp180 -92.35 109.42 20.81 Favored 'General case' 0 C--N 1.285 -2.207 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.412 -174.01 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -89.58 102.7 15.38 Favored 'General case' 0 N--CA 1.426 -1.639 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 175.139 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 55.8 tp -100.11 118.65 36.91 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.499 -176.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.58 HD13 ' H ' ' A' ' 154' ' ' LEU . 0.2 OUTLIER -151.99 166.84 30.32 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 103.955 -2.609 . . . . 0.0 103.955 -177.964 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.58 ' H ' HD13 ' A' ' 153' ' ' LEU . 2.5 pp -61.55 99.17 0.1 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 122.572 1.177 . . . . 0.0 112.726 179.419 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 19.2 m -84.77 107.88 17.18 Favored 'General case' 0 N--CA 1.417 -2.089 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.616 178.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -113.83 134.21 22.14 Favored Pre-proline 0 N--CA 1.413 -2.288 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 177.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -66.68 -14.99 46.12 Favored 'Trans proline' 0 C--O 1.235 0.366 0 C-N-CA 122.382 2.054 . . . . 0.0 110.995 177.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 3.8 m -77.08 79.89 3.61 Favored 'General case' 0 N--CA 1.415 -2.178 0 CA-C-N 115.354 -0.839 . . . . 0.0 108.967 177.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 48.8 tp -90.62 -33.63 15.78 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.579 -178.499 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.413 ' HA ' HG12 ' A' ' 163' ' ' VAL . 2.0 pt? -49.59 -40.9 40.4 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.159 0.984 . . . . 0.0 112.542 -178.002 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.434 HH11 ' HD3' ' A' ' 161' ' ' ARG . 1.7 ptm180 -59.89 -47.05 87.32 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.35 178.323 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 38.0 m -86.18 -29.72 23.0 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 120.988 0.423 . . . . 0.0 112.083 -175.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.413 HG12 ' HA ' ' A' ' 160' ' ' LEU . 0.6 OUTLIER -67.0 -25.38 34.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 121.701 0.762 . . . . 0.0 111.239 -175.771 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 24.6 pt20 -82.59 -7.6 59.64 Favored 'General case' 0 C--N 1.315 -0.921 0 O-C-N 121.897 -0.502 . . . . 0.0 111.847 177.001 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -101.77 21.92 13.74 Favored 'General case' 0 C--O 1.239 0.553 0 CA-C-O 121.459 0.647 . . . . 0.0 110.671 -178.224 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.496 HG21 ' HA ' ' A' ' 207' ' ' ILE . 74.5 mt -88.51 133.15 36.93 Favored Pre-proline 0 C--N 1.303 -1.425 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.395 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -64.18 128.58 21.98 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 121.708 1.606 . . . . 0.0 109.745 175.252 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 118.76 -30.97 5.71 Favored Glycine 0 N--CA 1.43 -1.715 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -174.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 97.8 t -74.22 -59.58 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 176.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 104.69 147.16 16.19 Favored Glycine 0 N--CA 1.44 -1.074 0 C-N-CA 120.931 -0.652 . . . . 0.0 113.923 174.299 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.541 ' HG3' HG23 ' A' ' 172' ' ' VAL . 57.2 pttt -89.64 -43.36 10.8 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.11 0.481 . . . . 0.0 110.883 176.737 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.541 HG23 ' HG3' ' A' ' 171' ' ' LYS . 40.4 t -81.32 -33.17 12.47 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.69 0 CA-C-O 121.679 0.752 . . . . 0.0 109.933 -174.628 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.501 ' O ' ' HG ' ' A' ' 177' ' ' LEU . 14.4 ptmm? -90.94 5.94 46.66 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.931 -179.354 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -66.11 -47.39 62.18 Favored Pre-proline 0 CA--C 1.55 0.972 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.488 ' O ' ' HG2' ' A' ' 179' ' ' GLN . 37.0 Cg_exo -61.25 -36.88 77.56 Favored 'Trans proline' 0 C--N 1.384 2.438 0 C-N-CA 121.555 1.503 . . . . 0.0 110.724 178.68 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 58.9 tp -61.71 -46.79 88.15 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.3 175.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.501 ' HG ' ' O ' ' A' ' 173' ' ' LYS . 94.1 mt -61.38 -37.69 84.32 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.938 178.307 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 95.7 mt -65.75 -17.92 64.96 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.337 177.588 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' GLN . . . . . 0.488 ' HG2' ' O ' ' A' ' 175' ' ' PRO . 15.3 mm100 -92.47 -7.81 46.42 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 120.899 0.381 . . . . 0.0 110.488 177.558 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.462 ' HA ' ' NZ ' ' A' ' 180' ' ' LYS . 0.3 OUTLIER -102.87 -51.68 3.23 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.644 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 181' ' ' PHE . . . . . 0.496 ' CD2' ' HG ' ' A' ' 187' ' ' LEU . 88.3 m-85 -98.08 149.91 36.21 Favored Pre-proline 0 C--N 1.294 -1.843 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -63.89 -43.42 16.08 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 121.737 1.625 . . . . 0.0 112.063 -175.091 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 43.1 m -155.05 171.8 19.17 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.506 HD13 ' H ' ' A' ' 184' ' ' ILE . 0.2 OUTLIER -65.99 -28.94 45.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -175.015 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 22.4 tp60 -66.88 -35.8 80.85 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.973 -177.215 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 11.6 tm0? -79.66 -37.44 35.89 Favored 'General case' 0 C--O 1.203 -1.349 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 176.49 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.496 ' HG ' ' CD2' ' A' ' 181' ' ' PHE . 4.3 tt -49.71 -68.07 0.21 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.065 1.346 . . . . 0.0 112.344 -173.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 20.1 m -72.65 -24.29 61.02 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 121.169 0.509 . . . . 0.0 111.818 -174.298 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -87.47 1.27 53.95 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.995 -179.32 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.2 155.76 33.98 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 121.085 0.469 . . . . 0.0 110.582 176.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 4.7 m -63.34 160.96 14.89 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.297 -177.49 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 46.4 mm -50.16 -41.06 18.13 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.865 0 C-N-CA 123.278 0.631 . . . . 0.0 110.927 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -61.82 -30.05 74.01 Favored Glycine 0 CA--C 1.523 0.549 0 CA-C-N 116.216 -0.447 . . . . 0.0 113.243 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -83.44 -44.67 14.51 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 98.4 mt -65.69 -28.29 68.96 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.857 -179.323 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -70.43 -35.41 73.37 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -63.5 -24.72 67.94 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.221 -0.9 . . . . 0.0 113.221 -178.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 13.4 m -101.47 -26.42 3.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -178.474 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.478 HG23 ' H ' ' A' ' 200' ' ' GLY . 2.2 m -131.77 -82.33 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 112.902 0.705 . . . . 0.0 112.902 174.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 200' ' ' GLY . . . . . 0.478 ' H ' HG23 ' A' ' 199' ' ' VAL . . . -177.37 165.36 35.16 Favored Glycine 0 N--CA 1.422 -2.249 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 -177.023 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 23.1 pt20 -65.3 -39.07 92.05 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 117.596 0.698 . . . . 0.0 112.507 -177.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -66.91 -35.92 81.08 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.164 0.507 . . . . 0.0 110.306 -178.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.435 ' O ' ' HG2' ' A' ' 206' ' ' GLN . 2.0 t -76.62 -39.46 32.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 -179.165 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -57.22 -41.5 79.58 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.033 178.291 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 -62.42 -40.82 97.79 Favored 'General case' 0 N--CA 1.424 -1.737 0 CA-C-N 115.133 -0.939 . . . . 0.0 112.341 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 206' ' ' GLN . . . . . 0.435 ' HG2' ' O ' ' A' ' 203' ' ' VAL . 20.8 pt20 -72.42 -34.59 67.96 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.895 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 207' ' ' ILE . . . . . 0.496 ' HA ' HG21 ' A' ' 166' ' ' ILE . 73.5 mt -65.67 -48.55 82.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.559 0.695 . . . . 0.0 109.417 175.61 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 46.9 t-80 -67.22 -40.38 86.37 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.071 -178.517 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -64.29 -25.93 68.26 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 178.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -56.62 -43.73 80.48 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.533 0.733 . . . . 0.0 110.894 -177.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -95.88 -28.46 14.7 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 120.108 -0.637 . . . . 0.0 111.838 178.219 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 86.7 m -64.24 -41.12 97.13 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -103.98 125.8 33.53 Favored Pre-proline 0 C--N 1.306 -1.311 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.352 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -81.69 157.46 18.75 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 121.957 1.771 . . . . 0.0 110.184 174.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 40.7 mtm180 . . . . . 0 C--N 1.294 -1.823 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.018 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 14.0 m . . . . . 0 N--CA 1.437 -1.116 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -103.91 124.71 49.48 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 178.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -91.77 124.98 58.94 Favored Pre-proline 0 C--N 1.306 -1.312 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -174.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -88.78 28.99 0.45 Allowed 'Trans proline' 0 CA--C 1.505 -0.966 0 C-N-CA 123.98 3.12 . . . . 0.0 112.09 179.349 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 61.4 tp -150.31 102.96 3.11 Favored 'General case' 0 N--CA 1.409 -2.482 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.93 -176.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 74.9 mt -106.63 109.04 20.84 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -160.41 145.67 11.48 Favored Glycine 0 N--CA 1.422 -2.261 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.286 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -99.47 168.67 9.83 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.76 150.38 49.48 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 177.201 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 23.3 ttt180 -111.99 97.41 6.65 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.074 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -96.62 101.25 12.83 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 45.6 tp -100.16 108.72 20.91 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 178.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -79.56 158.81 27.07 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.134 -175.21 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.526 ' O ' HD22 ' A' ' 154' ' ' LEU 0.303 0.0 OUTLIER -76.72 84.06 3.35 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 122.552 1.168 . . . . 0.0 112.104 178.75 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 19.6 m -86.88 106.33 17.68 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 173.379 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.424 ' HA ' ' HD3' ' A' ' 157' ' ' PRO . 6.5 mm-40 -73.3 112.59 16.42 Favored Pre-proline 0 C--N 1.297 -1.697 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.206 -175.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 156' ' ' GLU . 4.6 Cg_exo -76.06 103.61 1.77 Allowed 'Trans proline' 0 N--CA 1.427 -2.412 0 C-N-CA 121.76 1.64 . . . . 0.0 108.522 176.644 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.574 ' O ' ' HG2' ' A' ' 161' ' ' ARG . 28.0 m -74.85 77.12 2.12 Favored 'General case' 0 N--CA 1.419 -2.008 0 CA-C-O 121.841 0.829 . . . . 0.0 109.099 178.237 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 42.4 mt -62.67 -21.82 66.01 Favored 'General case' 0 CA--C 1.487 -1.458 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -175.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.538 ' H ' HD23 ' A' ' 160' ' ' LEU . 2.0 pt? -61.31 -29.58 69.96 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.66 176.583 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.574 ' HG2' ' O ' ' A' ' 158' ' ' SER . 27.0 ptt180 -78.86 -24.78 44.09 Favored 'General case' 0 C--O 1.216 -0.69 0 C-N-CA 120.485 -0.486 . . . . 0.0 109.703 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 26.5 m -86.19 -41.53 14.59 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-O 121.377 0.608 . . . . 0.0 110.379 178.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -59.78 -26.5 35.48 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 C-N-CA 124.216 1.007 . . . . 0.0 111.553 -177.434 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -83.29 -15.1 51.47 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.81 177.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -106.28 14.2 27.78 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-O 121.329 0.585 . . . . 0.0 110.129 -175.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 94.8 mt -71.56 132.05 85.82 Favored Pre-proline 0 C--O 1.249 1.04 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 176.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -63.15 128.44 22.81 Favored 'Trans proline' 0 C--O 1.246 0.924 0 C-N-CA 122.007 1.805 . . . . 0.0 109.768 176.18 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 117.1 -32.82 5.29 Favored Glycine 0 N--CA 1.431 -1.65 0 C-N-CA 120.789 -0.72 . . . . 0.0 111.391 -177.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 59.6 t -66.95 -71.43 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.773 0 CA-C-O 121.231 0.538 . . . . 0.0 109.674 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 113.66 109.42 2.88 Favored Glycine 0 N--CA 1.421 -2.302 0 C-N-CA 119.975 -1.107 . . . . 0.0 112.91 177.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt -78.74 -15.05 58.91 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 121.718 0.771 . . . . 0.0 109.69 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 91.0 t -79.81 -36.64 17.38 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.895 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.538 ' O ' ' HG ' ' A' ' 177' ' ' LEU . 9.3 ptpp? -90.43 -5.89 55.56 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.073 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -52.81 -49.67 85.45 Favored Pre-proline 0 CA--C 1.552 1.03 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -177.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -62.56 -23.94 74.99 Favored 'Trans proline' 0 C--N 1.371 1.714 0 C-N-CA 121.283 1.322 . . . . 0.0 112.824 176.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 59.6 tp -77.63 -39.34 45.58 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 175.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 173' ' ' LYS . 87.4 mt -69.17 -33.05 72.79 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.837 -179.228 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 41.1 tp -68.24 -12.73 61.47 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-O 121.824 0.821 . . . . 0.0 110.76 178.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -94.13 -3.34 51.22 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.829 177.418 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 37.2 mmtm -117.51 -45.91 2.69 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 121.284 0.564 . . . . 0.0 110.94 177.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -102.4 145.03 29.79 Favored Pre-proline 0 C--N 1.303 -1.451 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 -179.022 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -67.0 -34.45 29.04 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 121.723 1.615 . . . . 0.0 112.411 -176.158 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 84.5 p -151.29 166.49 30.79 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -178.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.467 HD13 ' H ' ' A' ' 184' ' ' ILE . 0.2 OUTLIER -66.91 -25.02 33.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 O-C-N 123.384 0.428 . . . . 0.0 110.885 175.025 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -64.71 -47.46 78.24 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.45 178.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 12.4 tm0? -73.37 -35.93 66.0 Favored 'General case' 0 C--O 1.195 -1.775 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.466 HD21 HD13 ' A' ' 177' ' ' LEU . 4.4 tt -49.04 -65.96 0.48 Allowed 'General case' 0 C--O 1.217 -0.631 0 C-N-CA 124.697 1.199 . . . . 0.0 110.398 -177.565 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 19.8 m -68.79 -23.75 64.33 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -177.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 26.6 m-80 -85.11 -2.76 58.37 Favored 'General case' 0 C--O 1.242 0.699 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 178.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -66.34 156.3 34.87 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 122.978 0.511 . . . . 0.0 110.965 178.32 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 15.8 m -63.05 153.3 34.44 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.832 -178.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 48.9 mm -51.21 -36.67 16.95 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.927 0 C-N-CA 123.84 0.856 . . . . 0.0 111.274 -176.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.57 ' O ' ' HG2' ' A' ' 197' ' ' GLN . . . -58.42 -45.89 93.78 Favored Glycine 0 N--CA 1.443 -0.843 0 O-C-N 123.385 0.428 . . . . 0.0 112.547 178.634 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 0.447 ' O ' ' HB2' ' A' ' 197' ' ' GLN . 11.1 mm-40 -67.96 -40.77 83.13 Favored 'General case' 0 CA--C 1.494 -1.208 0 CA-C-O 121.772 0.796 . . . . 0.0 109.705 -177.696 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 94.3 mt -70.82 -31.09 67.71 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.76 178.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -68.95 -35.71 77.1 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.433 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.57 ' HG2' ' O ' ' A' ' 193' ' ' GLY . 15.5 mm100 -57.89 -33.31 68.6 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.638 -1.164 . . . . 0.0 111.465 177.172 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 14.2 m -103.33 -35.04 3.62 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -176.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.467 HG23 ' H ' ' A' ' 200' ' ' GLY . 2.4 m -118.89 -77.66 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 176.476 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 200' ' ' GLY . . . . . 0.467 ' H ' HG23 ' A' ' 199' ' ' VAL . . . -178.69 165.33 34.39 Favored Glycine 0 N--CA 1.419 -2.443 0 N-CA-C 107.963 -2.055 . . . . 0.0 107.963 -177.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -66.07 -45.65 80.52 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 117.762 0.781 . . . . 0.0 109.855 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -67.76 -33.59 75.14 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-O 121.161 0.505 . . . . 0.0 110.983 -179.116 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.412 HG23 ' H ' ' A' ' 203' ' ' VAL . 2.6 t -73.81 -40.52 53.53 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.686 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 -178.531 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -56.04 -44.97 79.3 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.545 -1.207 . . . . 0.0 109.882 177.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -59.32 -50.9 72.19 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.582 178.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -66.97 -30.63 70.81 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 121.046 -0.261 . . . . 0.0 111.559 -176.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 97.4 mt -75.11 -51.4 21.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.373 177.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 9.7 t60 -69.86 -38.4 76.43 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.368 0.604 . . . . 0.0 110.202 -175.224 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -77.95 -9.94 59.34 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -60.1 -51.29 70.23 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-O 121.514 0.673 . . . . 0.0 110.395 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -86.82 -26.97 23.79 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.394 -179.18 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 37.6 m -72.77 -43.97 62.18 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.595 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -114.21 119.16 40.98 Favored Pre-proline 0 C--N 1.303 -1.443 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.206 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -44.84 128.38 8.89 Favored 'Trans proline' 0 C--O 1.251 1.146 0 C-N-CA 123.93 3.087 . . . . 0.0 113.981 177.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 35.8 ttm180 . . . . . 0 C--N 1.295 -1.799 0 CA-C-N 113.955 -1.475 . . . . 0.0 108.773 -178.5 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 61.0 m . . . . . 0 C--O 1.243 0.75 0 N-CA-C 111.509 0.189 . . . . 0.0 111.509 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp 70.12 -62.11 0.44 Allowed 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 125.095 1.358 . . . . 0.0 112.168 177.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -98.64 148.68 34.88 Favored Pre-proline 0 C--N 1.299 -1.622 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -179.034 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -79.95 3.8 7.29 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.355 2.037 . . . . 0.0 112.04 178.5 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 55.1 tp 62.06 102.45 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 125.398 1.479 . . . . 0.0 111.272 -177.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 83.7 mt -77.79 109.52 11.88 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.557 0.694 . . . . 0.0 110.288 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -153.56 -150.18 5.38 Favored Glycine 0 N--CA 1.431 -1.673 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 -178.535 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.46 145.19 27.55 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.601 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 66.1 pttt -150.03 153.97 37.39 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 177.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 17.9 ptt180 -120.62 104.4 9.9 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 121.872 0.844 . . . . 0.0 111.934 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -137.16 148.54 46.67 Favored 'General case' 0 N--CA 1.431 -1.388 0 CA-C-N 114.293 -1.322 . . . . 0.0 107.669 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 58.4 tp -121.01 116.76 25.69 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 91.7 mt -88.58 157.76 18.5 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 178.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 53.4 tp -86.71 77.24 9.37 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 121.585 0.707 . . . . 0.0 109.72 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 20.5 m -96.03 115.9 28.13 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.203 178.508 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -131.28 156.64 79.85 Favored Pre-proline 0 C--N 1.304 -1.403 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -49.33 -61.92 0.5 Allowed 'Trans proline' 0 CA--C 1.553 1.453 0 C-N-CA 124.077 3.184 . . . . 0.0 116.885 -176.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.534 ' O ' ' HG2' ' A' ' 161' ' ' ARG . 13.7 p -173.26 27.94 0.01 OUTLIER 'General case' 0 C--O 1.245 0.861 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -170.655 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -73.42 -43.75 59.79 Favored 'General case' 0 C--N 1.291 -1.963 0 O-C-N 121.546 -0.721 . . . . 0.0 109.166 -177.085 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.422 ' O ' HG12 ' A' ' 163' ' ' VAL . 2.1 pt? -60.21 -33.08 71.75 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -178.57 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.534 ' HG2' ' O ' ' A' ' 158' ' ' SER . 4.1 ptm180 -75.79 -26.26 57.15 Favored 'General case' 0 C--O 1.219 -0.536 0 CA-C-O 121.768 0.794 . . . . 0.0 109.75 -178.145 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 21.5 m -86.24 -35.43 20.01 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-O 121.537 0.685 . . . . 0.0 110.153 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.422 HG12 ' O ' ' A' ' 160' ' ' LEU . 0.4 OUTLIER -64.54 -25.2 37.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.224 -176.507 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -84.57 -10.8 57.06 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.115 0.484 . . . . 0.0 110.787 177.348 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -102.75 23.38 12.17 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.292 0.568 . . . . 0.0 110.364 -177.123 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.416 HG21 ' HA ' ' A' ' 207' ' ' ILE . 84.8 mt -84.18 129.57 57.81 Favored Pre-proline 0 C--N 1.308 -1.221 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.048 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.98 128.79 18.32 Favored 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 121.778 1.652 . . . . 0.0 110.561 177.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 113.89 -16.72 20.65 Favored Glycine 0 C--N 1.297 -1.635 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.807 179.016 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 77.9 t -61.69 -43.21 96.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-O 121.028 0.442 . . . . 0.0 110.87 179.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 108.35 88.53 1.98 Allowed Glycine 0 N--CA 1.44 -1.097 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.383 178.246 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -60.64 -33.67 73.14 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -178.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 38.3 t -83.93 -23.49 7.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.336 0.589 . . . . 0.0 109.927 -176.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.54 ' O ' ' HG ' ' A' ' 177' ' ' LEU . 31.2 mtpt -85.57 -2.17 57.88 Favored 'General case' 0 C--O 1.193 -1.911 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.826 -176.669 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -42.97 -52.07 12.01 Favored Pre-proline 0 CA--C 1.566 1.587 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 -176.596 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.72 -38.55 10.23 Favored 'Trans proline' 0 C--N 1.366 1.487 0 C-N-CA 121.653 1.569 . . . . 0.0 111.738 178.003 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 54.4 tp -64.05 -41.31 97.43 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.116 177.232 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.54 ' HG ' ' O ' ' A' ' 173' ' ' LYS . 94.5 mt -58.22 -36.79 73.68 Favored 'General case' 0 C--O 1.206 -1.198 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.424 175.21 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.431 ' HA ' ' O ' ' A' ' 181' ' ' PHE . 92.5 mt -70.81 -11.93 61.25 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.299 0.571 . . . . 0.0 112.272 178.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -88.06 -5.42 58.49 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.83 0.824 . . . . 0.0 109.41 174.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.409 ' HA ' ' NZ ' ' A' ' 180' ' ' LYS . 0.3 OUTLIER -113.82 -50.73 2.82 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.359 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 181' ' ' PHE . . . . . 0.537 ' CD2' ' HG ' ' A' ' 187' ' ' LEU . 34.5 m-85 -110.23 140.81 22.78 Favored Pre-proline 0 C--N 1.3 -1.549 0 CA-C-N 114.571 -1.195 . . . . 0.0 108.921 -177.244 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.91 -52.5 5.86 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 123.178 2.585 . . . . 0.0 112.682 178.345 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 50.7 m -154.64 172.83 17.24 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -179.35 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -54.05 -32.08 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 114.495 1.294 . . . . 0.0 114.495 -176.749 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -65.02 -43.06 93.7 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.901 0.381 . . . . 0.0 111.01 -177.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 13.5 tm0? -79.42 -35.9 39.84 Favored 'General case' 0 C--O 1.196 -1.73 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 176.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.537 ' HG ' ' CD2' ' A' ' 181' ' ' PHE . 5.5 tt -51.82 -67.05 0.28 Allowed 'General case' 0 C--O 1.208 -1.126 0 C-N-CA 124.712 1.205 . . . . 0.0 112.208 -173.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.417 ' CB ' HG22 ' A' ' 163' ' ' VAL . 24.3 m -75.83 -18.72 59.36 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-O 121.157 0.503 . . . . 0.0 112.235 -174.409 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -93.57 -0.06 56.4 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.131 -179.076 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.93 155.6 36.02 Favored 'General case' 0 CA--C 1.506 -0.721 0 C-N-CA 123.539 0.736 . . . . 0.0 110.375 176.206 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 20.4 m -64.95 159.51 22.76 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.035 -176.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 48.2 mm -51.72 -39.62 24.56 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.647 0 C-N-CA 123.271 0.628 . . . . 0.0 110.707 -177.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -60.16 -37.92 93.63 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-N 116.003 -0.544 . . . . 0.0 113.482 179.305 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -75.1 -41.25 59.08 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -177.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 96.1 mt -68.64 -34.66 76.1 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.217 179.178 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 196' ' ' GLU . . . . . 0.476 ' HG2' ' N ' ' A' ' 201' ' ' GLN . 5.0 tm-20 -65.92 -33.75 76.53 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -178.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -61.88 -30.5 70.91 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.792 -1.094 . . . . 0.0 113.113 179.376 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 25.9 m -100.3 -36.27 5.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 C-N-CA 119.592 -0.843 . . . . 0.0 111.411 -179.057 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.544 HG23 ' H ' ' A' ' 200' ' ' GLY . 2.9 m -116.19 -85.65 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 176.216 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 200' ' ' GLY . . . . . 0.544 ' H ' HG23 ' A' ' 199' ' ' VAL . . . -176.82 165.67 35.97 Favored Glycine 0 N--CA 1.415 -2.708 0 N-CA-C 108.274 -1.93 . . . . 0.0 108.274 -175.676 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 201' ' ' GLN . . . . . 0.476 ' N ' ' HG2' ' A' ' 196' ' ' GLU . 52.9 tt0 -67.72 -42.15 82.37 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 117.496 0.648 . . . . 0.0 112.097 -174.596 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -66.66 -35.78 80.97 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.186 0.517 . . . . 0.0 110.624 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.519 ' O ' ' HG2' ' A' ' 206' ' ' GLN . 2.6 t -71.64 -40.38 70.62 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.747 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -57.06 -43.84 82.44 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 114.366 -1.288 . . . . 0.0 110.098 178.513 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 205' ' ' GLN . . . . . 0.403 ' HG3' ' O ' ' A' ' 201' ' ' GLN . 53.9 mt-30 -60.93 -45.59 94.06 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 114.955 -1.021 . . . . 0.0 112.372 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 206' ' ' GLN . . . . . 0.519 ' HG2' ' O ' ' A' ' 203' ' ' VAL . 13.2 pt20 -69.29 -30.86 69.03 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 120.236 -0.585 . . . . 0.0 110.708 -177.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 207' ' ' ILE . . . . . 0.416 ' HA ' HG21 ' A' ' 166' ' ' ILE . 92.4 mt -73.44 -50.38 30.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.268 178.107 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 48.1 t-80 -69.1 -41.46 77.4 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.159 -177.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -73.44 -11.51 60.49 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 121.941 -0.474 . . . . 0.0 112.227 179.334 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -58.82 -51.9 68.02 Favored 'General case' 0 C--O 1.217 -0.646 0 C-N-CA 122.795 0.438 . . . . 0.0 110.743 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -80.51 -24.84 39.09 Favored 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.524 -179.427 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 27.5 m -61.84 -47.7 83.91 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.615 175.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -74.17 121.33 84.94 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.484 -178.707 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -80.48 147.59 17.91 Favored 'Trans proline' 0 C--O 1.253 1.256 0 C-N-CA 122.199 1.932 . . . . 0.0 112.181 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? . . . . . 0 N--CA 1.414 -2.242 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 179.806 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.9 tm? . . . . . 0 N--CA 1.436 -1.172 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.535 ' O ' HG12 ' A' ' 163' ' ' VAL . 2.0 pt? -58.81 -30.35 67.55 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.455 -179.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -78.78 -26.4 44.45 Favored 'General case' 0 C--N 1.309 -1.166 0 O-C-N 121.837 -0.54 . . . . 0.0 110.563 -179.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 24.9 m -85.84 -28.59 24.34 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.574 0.702 . . . . 0.0 109.637 177.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.535 HG12 ' O ' ' A' ' 160' ' ' LEU . 0.3 OUTLIER -66.3 -25.71 36.15 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 CA-C-O 121.832 0.825 . . . . 0.0 111.072 -176.703 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . 0.4 HE21 HG21 ' A' ' 184' ' ' ILE . 3.8 pt20 -84.87 -7.44 59.17 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.37 177.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -96.3 1.86 52.33 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.027 -178.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.404 HG21 ' HA ' ' A' ' 207' ' ' ILE . 70.3 mt -73.96 131.14 81.83 Favored Pre-proline 0 C--N 1.314 -0.975 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.057 -177.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -66.68 128.23 18.62 Favored 'Trans proline' 0 C--O 1.246 0.897 0 C-N-CA 121.934 1.756 . . . . 0.0 110.235 175.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 116.02 -24.23 10.2 Favored Glycine 0 C--N 1.297 -1.59 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 -178.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 65.6 t -75.02 -58.39 4.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 177.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 90.13 107.06 1.27 Allowed Glycine 0 N--CA 1.425 -2.062 0 CA-C-N 115.431 -0.804 . . . . 0.0 113.576 177.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? -68.46 -21.24 64.65 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 121.577 0.703 . . . . 0.0 111.201 178.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 57.9 t -82.53 -30.56 9.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-O 121.712 0.768 . . . . 0.0 109.35 178.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.429 ' O ' HD13 ' A' ' 177' ' ' LEU . 60.0 mtpt -84.79 -10.25 57.38 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.955 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -51.73 -53.79 46.97 Favored Pre-proline 0 C--O 1.201 -1.472 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -178.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -62.3 -26.58 77.3 Favored 'Trans proline' 0 C--N 1.376 1.982 0 C-N-CA 121.856 1.704 . . . . 0.0 113.413 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 61.6 tp -77.38 -45.27 26.49 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 121.741 0.781 . . . . 0.0 109.103 178.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.429 HD13 ' O ' ' A' ' 173' ' ' LYS . 8.2 mp -71.84 -24.35 61.69 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.873 178.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.449 HD12 ' O ' ' A' ' 181' ' ' PHE . 42.5 tp -67.31 -11.68 58.21 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 124.091 0.956 . . . . 0.0 110.401 177.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -76.53 -20.59 56.74 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.514 175.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 7.8 mmmm -105.58 -42.13 5.29 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.918 178.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' PHE . . . . . 0.449 ' O ' HD12 ' A' ' 178' ' ' LEU . 32.5 m-85 -105.64 130.55 22.87 Favored Pre-proline 0 C--N 1.299 -1.611 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.935 -174.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -53.73 -42.4 66.52 Favored 'Trans proline' 0 C--N 1.359 1.128 0 C-N-CA 123.623 2.882 . . . . 0.0 113.7 -175.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 42.6 m -158.5 177.5 11.17 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.482 ' HA ' ' HB3' ' A' ' 187' ' ' LEU . 0.2 OUTLIER -59.52 -27.89 38.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 -175.961 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -69.1 -38.63 79.03 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 120.67 0.272 . . . . 0.0 110.94 -177.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' GLN . . . . . 0.433 HE21 ' C ' ' A' ' 186' ' ' GLN . 0.0 OUTLIER -79.9 -33.44 39.89 Favored 'General case' 0 C--O 1.195 -1.81 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 176.296 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.482 ' HB3' ' HA ' ' A' ' 184' ' ' ILE . 62.4 tp -52.63 -67.78 0.22 Allowed 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 125.104 1.362 . . . . 0.0 113.467 -176.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . 0.438 ' HB2' HG22 ' A' ' 163' ' ' VAL . 19.4 m -74.65 -24.75 58.87 Favored 'General case' 0 C--N 1.289 -2.04 0 C-N-CA 120.24 -0.584 . . . . 0.0 111.609 -176.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.473 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 62.4 t30 -89.45 12.0 17.7 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-O 122.095 0.95 . . . . 0.0 110.025 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.51 156.62 31.95 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.606 173.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 6.6 m -63.6 154.38 32.91 Favored 'General case' 0 N--CA 1.425 -1.676 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.082 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 48.9 mm -52.02 -39.73 26.96 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.825 0 C-N-CA 123.477 0.711 . . . . 0.0 110.889 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . 0.502 ' O ' ' HG2' ' A' ' 197' ' ' GLN . . . -59.39 -39.13 94.39 Favored Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 116.18 -0.464 . . . . 0.0 112.631 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . 0.441 ' O ' ' HB2' ' A' ' 197' ' ' GLN . 41.6 mm-40 -77.72 -38.55 46.96 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.43 0.633 . . . . 0.0 109.807 -176.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 96.8 mt -69.88 -32.2 70.42 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.485 178.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -67.37 -29.72 69.32 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -178.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . 0.502 ' HG2' ' O ' ' A' ' 193' ' ' GLY . 15.8 mm100 -59.62 -33.84 72.01 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.737 -1.12 . . . . 0.0 112.441 178.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 23.4 m -103.48 -26.83 3.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -174.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.484 HG23 ' H ' ' A' ' 200' ' ' GLY . 1.4 m -123.15 -82.82 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 175.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . 0.484 ' H ' HG23 ' A' ' 199' ' ' VAL . . . -177.0 167.87 39.42 Favored Glycine 0 N--CA 1.419 -2.449 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 -177.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 19.5 tm0? -64.14 -47.95 77.94 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 123.254 0.622 . . . . 0.0 110.814 -175.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -71.65 -32.34 67.81 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.859 0.361 . . . . 0.0 111.066 -177.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.442 ' O ' ' HG2' ' A' ' 206' ' ' GLN . 2.9 t -69.03 -40.07 80.39 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.649 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 179.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -60.19 -43.18 96.12 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 114.294 -1.321 . . . . 0.0 109.675 177.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -59.72 -45.58 91.75 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.785 179.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' GLN . . . . . 0.442 ' HG2' ' O ' ' A' ' 203' ' ' VAL . 12.0 pt20 -66.26 -34.75 78.72 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 120.145 -0.622 . . . . 0.0 111.084 -179.041 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' ILE . . . . . 0.404 ' HA ' HG21 ' A' ' 166' ' ' ILE . 87.3 mt -69.43 -51.48 41.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.291 0.567 . . . . 0.0 109.712 178.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' HIS . . . . . 0.553 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 13.4 t60 -68.0 -36.71 80.46 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.237 -175.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -68.06 -32.79 73.37 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.694 176.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -54.62 -52.21 62.94 Favored 'General case' 0 C--O 1.215 -0.733 0 C-N-CA 124.023 0.929 . . . . 0.0 112.367 -174.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.553 ' CZ ' ' HA ' ' A' ' 208' ' ' HIS . 21.5 p90 -80.8 -23.85 38.96 Favored 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 120.36 -0.536 . . . . 0.0 112.097 -178.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 75.2 m . . . . . 0 C--O 1.247 0.932 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.248 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.483 ' O ' HD23 ' A' ' 159' ' ' LEU . 6.2 tt . . . . . 0 C--O 1.215 -0.73 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -59.37 -22.36 61.24 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.045 0.45 . . . . 0.0 111.738 178.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 32.8 ptt180 -73.49 -35.42 65.64 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.451 ' HA ' ' OE1' ' A' ' 165' ' ' GLN . 33.3 m -87.03 -29.11 22.18 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 124.244 1.018 . . . . 0.0 112.163 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 2.8 p -64.56 -27.08 41.76 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-O 121.752 0.787 . . . . 0.0 110.757 -176.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -82.94 -8.67 59.54 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.91 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.451 ' OE1' ' HA ' ' A' ' 162' ' ' THR . 51.0 mt-30 -98.42 0.42 45.26 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.665 -177.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 96.4 mt -68.43 131.54 91.66 Favored Pre-proline 0 C--N 1.312 -1.048 0 N-CA-C 108.876 -0.786 . . . . 0.0 108.876 178.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -61.36 128.72 25.77 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 121.843 1.696 . . . . 0.0 109.632 177.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 115.52 -30.12 6.87 Favored Glycine 0 N--CA 1.429 -1.773 0 C-N-CA 120.267 -0.968 . . . . 0.0 111.279 -178.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 84.5 t -66.2 -62.91 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 103.47 105.19 2.95 Favored Glycine 0 N--CA 1.427 -1.964 0 C-N-CA 120.575 -0.822 . . . . 0.0 112.164 178.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -81.29 -17.11 50.46 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -177.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 42.4 t -85.15 -37.84 12.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 CA-C-O 121.596 0.712 . . . . 0.0 109.3 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.518 ' O ' ' HG ' ' A' ' 177' ' ' LEU . 20.8 ptmt -88.72 -4.75 58.45 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.509 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -54.72 -48.89 94.24 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -178.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.489 ' O ' ' HG2' ' A' ' 179' ' ' GLN . 11.2 Cg_endo -57.27 -35.15 98.85 Favored 'Trans proline' 0 C--N 1.38 2.237 0 C-N-CA 121.715 1.61 . . . . 0.0 112.179 177.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 59.4 tp -69.31 -42.4 75.45 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.274 0.559 . . . . 0.0 109.54 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.518 ' HG ' ' O ' ' A' ' 173' ' ' LYS . 74.5 mt -69.47 -29.85 67.6 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.795 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 50.9 tp -70.73 -12.57 61.63 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.738 179.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . 0.489 ' HG2' ' O ' ' A' ' 175' ' ' PRO . 24.8 mm-40 -88.22 -13.77 40.2 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 176.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -99.33 -51.52 3.77 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 -179.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' PHE . . . . . 0.581 ' CD2' ' HG ' ' A' ' 187' ' ' LEU . 89.7 m-85 -94.24 148.85 35.8 Favored Pre-proline 0 C--N 1.307 -1.267 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.183 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -68.94 -31.29 24.66 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.053 1.835 . . . . 0.0 113.332 -175.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 66.5 m -158.56 161.84 37.32 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -62.01 -29.41 46.39 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.411 0 O-C-N 123.55 0.531 . . . . 0.0 112.024 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -62.54 -47.7 82.77 Favored 'General case' 0 C--O 1.211 -0.966 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.429 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -74.08 -31.18 62.72 Favored 'General case' 0 C--O 1.2 -1.528 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.581 ' HG ' ' CD2' ' A' ' 181' ' ' PHE . 4.5 tt -57.81 -59.91 4.5 Favored 'General case' 0 C--O 1.204 -1.301 0 C-N-CA 123.811 0.844 . . . . 0.0 109.561 -178.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 22.8 m -73.77 -24.72 59.89 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -178.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -86.98 1.99 50.95 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-O 121.516 0.674 . . . . 0.0 110.724 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.55 156.94 31.07 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 124.023 0.929 . . . . 0.0 111.373 175.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 5.0 m -64.49 159.72 20.91 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.249 -178.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 43.1 mm -52.67 -38.79 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 123.205 0.602 . . . . 0.0 111.449 -179.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . 0.506 ' O ' ' HG2' ' A' ' 197' ' ' GLN . . . -61.48 -43.65 99.04 Favored Glycine 0 C--O 1.214 -1.142 0 C-N-CA 120.853 -0.689 . . . . 0.0 111.908 178.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -67.47 -41.23 84.95 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.635 0.731 . . . . 0.0 109.575 -176.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 94.2 mt -70.47 -31.05 68.03 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.001 -0.999 . . . . 0.0 111.121 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . 0.543 ' HG2' ' N ' ' A' ' 201' ' ' GLN . 4.2 tm-20 -73.42 -41.01 63.81 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . 0.506 ' HG2' ' O ' ' A' ' 193' ' ' GLY . 14.6 mm100 -57.66 -25.32 60.04 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 123.8 0.84 . . . . 0.0 112.369 178.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.405 HG23 HG23 ' A' ' 199' ' ' VAL . 14.6 m -103.52 -34.84 3.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.539 HG11 HG11 ' A' ' 203' ' ' VAL . 1.2 t -122.01 -77.43 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 C-N-CA 119.259 -0.976 . . . . 0.0 111.392 178.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -177.22 160.43 27.34 Favored Glycine 0 N--CA 1.435 -1.383 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 -176.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' GLN . . . . . 0.543 ' N ' ' HG2' ' A' ' 196' ' ' GLU . 4.0 pt20 -63.36 -38.05 89.64 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 123.624 0.77 . . . . 0.0 112.34 -176.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -74.86 -34.92 62.34 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 121.837 0.827 . . . . 0.0 109.672 -178.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.539 HG11 HG11 ' A' ' 199' ' ' VAL . 24.8 t -68.53 -45.09 82.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-N 114.373 -1.285 . . . . 0.0 109.57 -179.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -53.51 -43.82 68.62 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 114.161 -1.381 . . . . 0.0 109.756 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -66.8 -44.98 79.84 Favored 'General case' 0 N--CA 1.421 -1.904 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.451 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' GLN . . . . . 0.467 ' HG2' ' O ' ' A' ' 203' ' ' VAL . 20.9 pt20 -66.09 -33.67 76.31 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.254 -0.578 . . . . 0.0 111.147 -178.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 84.7 mt -73.59 -50.19 31.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.561 177.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 28.0 t-80 -63.75 -46.99 82.81 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.997 -177.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -72.35 -9.96 59.18 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -178.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -64.13 -47.43 79.98 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 178.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -97.79 -29.44 13.36 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.647 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 33.4 m . . . . . 0 CA--C 1.542 0.668 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -176.883 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 4.2 mm? . . . . . 0 CA--C 1.506 -0.741 0 N-CA-C 111.574 0.213 . . . . 0.0 111.574 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.521 ' H ' HD23 ' A' ' 160' ' ' LEU . 1.7 pt? -60.53 -32.63 71.66 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.281 0.562 . . . . 0.0 111.232 178.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.413 ' O ' ' HG2' ' A' ' 164' ' ' GLN . 14.8 ptm180 -75.39 -30.14 60.03 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.036 177.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.601 ' O ' ' HG2' ' A' ' 165' ' ' GLN . 12.0 m -81.27 -37.99 27.58 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-O 121.457 0.646 . . . . 0.0 110.015 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.402 HG12 ' O ' ' A' ' 160' ' ' LEU . 1.7 p -63.55 -25.15 37.65 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.049 0 CA-C-O 121.479 0.657 . . . . 0.0 110.952 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . 0.516 HE21 HG13 ' A' ' 184' ' ' ILE . 3.4 pt20 -90.13 -11.64 40.64 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 122.015 -0.428 . . . . 0.0 110.9 178.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.601 ' HG2' ' O ' ' A' ' 162' ' ' THR . 18.9 pt20 -91.77 -6.02 52.54 Favored 'General case' 0 CA--C 1.505 -0.783 0 C-N-CA 119.303 -0.959 . . . . 0.0 111.168 -174.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 66.0 mt -61.19 133.51 92.84 Favored Pre-proline 0 C--N 1.298 -1.654 0 CA-C-N 114.823 -1.08 . . . . 0.0 109.481 -178.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -63.3 127.96 21.4 Favored 'Trans proline' 0 C--O 1.246 0.91 0 C-N-CA 122.022 1.815 . . . . 0.0 110.345 179.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 114.36 -32.82 5.71 Favored Glycine 0 N--CA 1.424 -2.126 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 -177.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 57.9 t -69.02 -53.01 28.27 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 177.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . 0.483 ' HA3' ' HG2' ' A' ' 173' ' ' LYS . . . 88.88 90.93 1.15 Allowed Glycine 0 N--CA 1.414 -2.779 0 CA-C-N 114.77 -1.105 . . . . 0.0 111.818 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -66.3 -23.18 66.33 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 120.776 0.322 . . . . 0.0 111.724 -178.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 47.2 t -86.53 -28.19 5.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-O 121.194 0.521 . . . . 0.0 110.281 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.564 ' O ' ' HG ' ' A' ' 177' ' ' LEU . 21.0 ptmt -91.29 9.26 32.18 Favored 'General case' 0 C--O 1.214 -0.764 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.707 178.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . 0.464 ' O ' ' HG ' ' A' ' 178' ' ' LEU . . . -52.07 -48.66 87.88 Favored Pre-proline 0 CA--C 1.556 1.2 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 177.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -59.99 -23.22 72.22 Favored 'Trans proline' 0 C--N 1.381 2.243 0 C-N-CA 122.401 2.067 . . . . 0.0 112.867 177.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.497 ' HB3' ' O ' ' A' ' 173' ' ' LYS . 51.0 tp -79.23 -21.05 46.77 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 123.683 0.793 . . . . 0.0 109.489 178.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.564 ' HG ' ' O ' ' A' ' 173' ' ' LYS . 39.7 mt -98.32 -34.46 10.68 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -178.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 174' ' ' ALA . 95.2 mt -66.82 -5.66 13.17 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.997 0.919 . . . . 0.0 112.732 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . 0.473 ' HG2' ' O ' ' A' ' 176' ' ' LEU . 16.1 pt20 -74.5 -35.02 63.2 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 172.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm -92.52 -51.43 5.13 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.138 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' PHE . . . . . 0.426 ' CD1' ' HA ' ' A' ' 187' ' ' LEU . 89.9 m-85 -90.27 144.36 30.9 Favored Pre-proline 0 C--N 1.304 -1.401 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.63 -176.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -69.78 -44.56 1.99 Allowed 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 121.851 1.701 . . . . 0.0 112.652 -175.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 45.4 m -152.38 167.84 27.4 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 178.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.516 HG13 HE21 ' A' ' 164' ' ' GLN . 0.2 OUTLIER -60.75 -31.76 50.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 N-CA-C 115.613 1.708 . . . . 0.0 115.613 -173.225 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -68.57 -45.92 70.78 Favored 'General case' 0 C--O 1.207 -1.15 0 C-N-CA 118.81 -1.156 . . . . 0.0 110.425 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -67.49 -32.8 73.87 Favored 'General case' 0 C--O 1.209 -1.059 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.426 ' HA ' ' CD1' ' A' ' 181' ' ' PHE . 3.6 tt -56.76 -62.6 1.62 Allowed 'General case' 0 C--O 1.213 -0.857 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.5 -179.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 29.5 m -70.87 -27.82 64.11 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -178.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.498 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 11.1 t-20 -81.03 -3.25 51.17 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-O 121.222 0.534 . . . . 0.0 110.511 -178.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.412 ' HB1' ' HB2' ' A' ' 194' ' ' GLU . . . -64.56 155.67 32.31 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 123.055 0.542 . . . . 0.0 110.79 177.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 20.6 t -68.09 170.65 8.08 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 121.262 0.553 . . . . 0.0 110.836 -175.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 47.7 mm -59.33 -39.61 79.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.55 -177.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . 0.548 ' O ' ' HG3' ' A' ' 197' ' ' GLN . . . -59.86 -38.62 94.31 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.305 178.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . 0.412 ' HB2' ' HB1' ' A' ' 190' ' ' ALA . 29.2 mt-10 -77.82 -43.12 31.42 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -176.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 96.2 mt -67.6 -25.32 65.7 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.712 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . 0.415 ' HG2' ' N ' ' A' ' 201' ' ' GLN . 9.7 tm-20 -73.67 -31.7 63.59 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . 0.548 ' HG3' ' O ' ' A' ' 193' ' ' GLY . 98.4 mt-30 -68.8 -20.29 64.32 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.913 -1.04 . . . . 0.0 111.702 -178.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.434 HG23 HG23 ' A' ' 199' ' ' VAL . 16.7 m -105.19 -33.32 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.74 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.023 177.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.512 HG11 HG11 ' A' ' 203' ' ' VAL . 1.7 t -124.64 -84.48 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 C-N-CA 120.338 -0.545 . . . . 0.0 111.504 176.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -177.91 168.95 40.66 Favored Glycine 0 N--CA 1.436 -1.331 0 N-CA-C 109.851 -1.299 . . . . 0.0 109.851 -176.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' GLN . . . . . 0.415 ' N ' ' HG2' ' A' ' 196' ' ' GLU . 51.5 mt-30 -59.14 -52.86 63.9 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.911 0.884 . . . . 0.0 112.628 -175.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -68.85 -35.39 76.88 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 121.45 0.643 . . . . 0.0 111.186 -173.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.512 HG11 HG11 ' A' ' 199' ' ' VAL . 2.2 t -72.57 -38.19 58.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -178.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -57.85 -44.11 86.34 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 114.347 -1.297 . . . . 0.0 109.844 178.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -64.42 -42.78 95.86 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.886 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -74.56 -25.02 59.02 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.417 -0.513 . . . . 0.0 112.239 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 98.2 mt -76.4 -49.43 24.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 174.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 53.3 t-80 -63.44 -47.36 82.2 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.003 -178.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -65.74 -20.07 66.13 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -179.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -59.05 -44.13 91.76 Favored 'General case' 0 C--O 1.214 -0.792 0 C-N-CA 122.799 0.439 . . . . 0.0 110.613 -178.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.498 ' CZ ' ' HA ' ' A' ' 189' ' ' ASN . 31.6 p90 -99.4 -25.73 14.37 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.672 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 37.5 m . . . . . 0 C--N 1.313 -1.022 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -178.692 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.4 tm? . . . . . 0 CA--C 1.527 0.086 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.654 HD23 ' H ' ' A' ' 160' ' ' LEU . 1.6 pt? -60.38 -23.79 64.59 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.267 -0.879 . . . . 0.0 112.118 178.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.412 ' O ' ' HG2' ' A' ' 164' ' ' GLN . 14.3 ptm180 -65.87 -29.36 69.79 Favored 'General case' 0 C--O 1.215 -0.744 0 CA-C-O 120.92 0.39 . . . . 0.0 110.115 176.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 37.9 m -86.55 -31.75 21.06 Favored 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 123.025 0.53 . . . . 0.0 111.39 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.51 HG12 ' O ' ' A' ' 160' ' ' LEU . 2.5 p -64.52 -25.66 38.43 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.115 0 CA-C-O 121.418 0.627 . . . . 0.0 111.372 -176.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . 0.412 ' HG2' ' O ' ' A' ' 161' ' ' ARG . 29.5 pt20 -81.32 -13.01 58.87 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 121.161 0.505 . . . . 0.0 110.459 177.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -95.38 -0.05 53.0 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.545 -175.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 81.2 mt -66.14 132.42 94.53 Favored Pre-proline 0 C--N 1.317 -0.837 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.28 128.16 26.54 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.096 1.864 . . . . 0.0 111.006 178.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 112.65 -29.91 7.87 Favored Glycine 0 N--CA 1.425 -2.096 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 -178.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 59.1 t -73.25 -65.74 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 101.97 110.55 3.38 Favored Glycine 0 N--CA 1.43 -1.737 0 C-N-CA 120.314 -0.946 . . . . 0.0 112.799 177.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -82.66 -18.88 39.47 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.4 0.619 . . . . 0.0 111.597 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 62.7 t -84.13 -30.35 7.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 CA-C-O 121.819 0.819 . . . . 0.0 109.27 177.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -90.34 -4.17 57.27 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.372 178.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . 0.507 ' O ' ' HG ' ' A' ' 178' ' ' LEU . . . -55.07 -47.16 99.19 Favored Pre-proline 0 C--O 1.202 -1.403 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -178.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.443 ' O ' ' HG3' ' A' ' 179' ' ' GLN . 36.2 Cg_exo -59.82 -36.99 89.33 Favored 'Trans proline' 0 C--N 1.381 2.243 0 CA-C-N 121.337 1.513 . . . . 0.0 111.234 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 57.2 tp -66.97 -44.64 79.96 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.665 176.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 96.3 mt -65.33 -32.25 73.79 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.027 178.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.507 ' HG ' ' O ' ' A' ' 174' ' ' ALA . 88.7 mt -72.44 -7.32 49.24 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 123.4 0.68 . . . . 0.0 111.774 178.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . 0.443 ' HG3' ' O ' ' A' ' 175' ' ' PRO . 52.6 mt-30 -95.65 -9.31 32.39 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.386 0.612 . . . . 0.0 109.356 174.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -105.18 -51.42 3.03 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' PHE . . . . . 0.448 ' CD2' ' HG ' ' A' ' 187' ' ' LEU . 86.4 m-85 -99.69 149.46 35.93 Favored Pre-proline 0 C--N 1.294 -1.837 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -66.99 -46.11 3.47 Favored 'Trans proline' 0 C--O 1.24 0.601 0 C-N-CA 121.439 1.426 . . . . 0.0 112.13 -175.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 30.0 m -151.33 167.79 26.81 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.432 ' H ' HD13 ' A' ' 184' ' ' ILE . 0.2 OUTLIER -60.67 -29.86 45.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 -174.274 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 56.8 tp60 -70.82 -39.13 73.23 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 119.731 -0.788 . . . . 0.0 110.384 -176.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -76.06 -32.23 59.18 Favored 'General case' 0 C--O 1.197 -1.66 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 178.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.448 ' HG ' ' CD2' ' A' ' 181' ' ' PHE . 3.8 tt -56.53 -61.26 2.54 Favored 'General case' 0 C--O 1.212 -0.906 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.717 -178.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 19.8 m -70.26 -32.16 69.87 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 120.641 -0.423 . . . . 0.0 111.88 -178.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.405 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 7.9 t30 -83.96 4.72 28.47 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-O 121.566 0.698 . . . . 0.0 110.839 -177.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.414 ' HB1' ' HB2' ' A' ' 194' ' ' GLU . . . -65.46 156.16 33.26 Favored 'General case' 0 C--O 1.248 1.004 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.414 174.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 2.6 m -63.58 159.48 18.74 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.987 -176.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 50.8 mm -53.09 -36.25 24.45 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.963 0 C-N-CA 122.917 0.487 . . . . 0.0 111.537 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -69.47 -28.92 71.9 Favored Glycine 0 C--N 1.314 -0.66 0 C-N-CA 121.222 -0.513 . . . . 0.0 112.903 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . 0.678 ' O ' ' HG2' ' A' ' 197' ' ' GLN . 26.2 mt-10 -81.29 -31.28 33.69 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -178.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 97.3 mt -79.33 -29.45 42.32 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.409 175.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . 0.549 ' HG2' ' N ' ' A' ' 201' ' ' GLN . 2.6 tm-20 -69.59 -35.61 75.48 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -178.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . 0.678 ' HG2' ' O ' ' A' ' 194' ' ' GLU . 20.3 pt20 -67.19 -20.86 65.78 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.412 -176.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 15.7 m -104.6 -31.19 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -127.32 -83.41 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 173.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -177.21 164.07 33.14 Favored Glycine 0 CA--C 1.488 -1.602 0 N-CA-C 108.027 -2.029 . . . . 0.0 108.027 -176.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' GLN . . . . . 0.549 ' N ' ' HG2' ' A' ' 196' ' ' GLU . 12.1 pt20 -69.68 -38.59 77.08 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 118.239 1.02 . . . . 0.0 111.778 -176.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -64.25 -28.86 70.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.644 0.735 . . . . 0.0 110.561 -179.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 3.1 t -81.17 -43.09 20.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 178.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -56.44 -46.03 80.51 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.209 -1.36 . . . . 0.0 110.946 -178.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -60.74 -44.82 96.19 Favored 'General case' 0 C--O 1.199 -1.588 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.599 -178.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -73.63 -33.22 64.43 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.528 -178.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 92.5 mt -66.37 -49.56 74.64 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.241 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 175.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' HIS . . . . . 0.545 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 9.9 t60 -68.68 -39.2 80.68 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.829 -176.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -65.44 -29.12 69.77 Favored 'General case' 0 C--O 1.219 -0.523 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 177.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -54.27 -47.69 72.05 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.208 0.603 . . . . 0.0 111.912 -176.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.545 ' CZ ' ' HA ' ' A' ' 208' ' ' HIS . 19.9 p90 -93.6 -22.16 18.96 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.096 -178.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 80.6 m . . . . . 0 C--N 1.317 -0.842 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.198 179.404 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 41.7 tp . . . . . 0 N--CA 1.438 -1.067 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.421 ' O ' HG12 ' A' ' 163' ' ' VAL . 2.4 pt? -60.75 -29.84 69.63 Favored 'General case' 0 C--O 1.225 -0.193 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.789 -178.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -63.07 -37.44 87.22 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.52 177.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 15.0 m -86.32 -31.95 21.29 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.183 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.421 HG12 ' O ' ' A' ' 160' ' ' LEU . 0.7 OUTLIER -62.96 -25.91 39.68 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.928 0 CA-C-O 121.587 0.708 . . . . 0.0 111.556 -176.597 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . 0.501 ' HG3' HE21 ' A' ' 165' ' ' GLN . 28.9 pt20 -85.99 -8.02 58.25 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.15 0.5 . . . . 0.0 110.732 178.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.501 HE21 ' HG3' ' A' ' 164' ' ' GLN . 29.0 mm-40 -97.49 -0.16 46.53 Favored 'General case' 0 C--O 1.238 0.476 0 O-C-N 122.249 -0.282 . . . . 0.0 110.873 -177.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 92.1 mt -62.1 129.68 92.23 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -62.71 127.44 20.64 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 121.603 1.535 . . . . 0.0 110.619 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 115.56 -29.95 6.95 Favored Glycine 0 N--CA 1.424 -2.138 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.646 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 93.2 t -58.15 -60.27 2.45 Favored 'Isoleucine or valine' 0 C--O 1.245 0.847 0 CA-C-O 120.954 0.407 . . . . 0.0 110.94 -179.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 93.89 85.87 1.62 Allowed Glycine 0 N--CA 1.431 -1.647 0 C-N-CA 120.331 -0.938 . . . . 0.0 110.983 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -68.62 -12.03 60.82 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.668 0.746 . . . . 0.0 111.916 -176.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 42.1 t -71.73 -28.58 31.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 176.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.62 ' O ' ' HG ' ' A' ' 177' ' ' LEU . 47.1 mtmt -87.37 0.19 55.83 Favored 'General case' 0 C--O 1.208 -1.098 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.308 -179.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . 0.479 ' O ' ' HG ' ' A' ' 178' ' ' LEU . . . -46.73 -53.06 27.82 Favored Pre-proline 0 N--CA 1.483 1.206 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 -174.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.415 ' O ' ' HG2' ' A' ' 179' ' ' GLN . 32.2 Cg_exo -60.07 -43.41 36.31 Favored 'Trans proline' 0 C--N 1.373 1.831 0 C-N-CA 121.569 1.512 . . . . 0.0 111.379 179.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 49.2 tp -60.83 -45.55 94.02 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.918 177.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.62 ' HG ' ' O ' ' A' ' 173' ' ' LYS . 91.6 mt -61.62 -41.72 97.87 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.173 178.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 174' ' ' ALA . 90.8 mt -68.95 -8.39 44.02 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . 0.415 ' HG2' ' O ' ' A' ' 175' ' ' PRO . 29.5 mm-40 -80.6 -21.14 41.86 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.374 0.607 . . . . 0.0 110.011 175.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 8.2 mmmm -106.51 -45.01 4.35 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.801 177.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' PHE . . . . . 0.45 ' O ' ' HA ' ' A' ' 178' ' ' LEU . 32.3 m-85 -103.42 132.31 21.21 Favored Pre-proline 0 N--CA 1.424 -1.769 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -176.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -62.31 -35.76 71.63 Favored 'Trans proline' 0 CA--C 1.51 -0.695 0 C-N-CA 122.839 2.359 . . . . 0.0 112.803 -172.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 59.3 m -153.46 160.21 42.51 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.473 ' O ' ' HB3' ' A' ' 187' ' ' LEU . 0.2 OUTLIER -60.02 -23.14 26.19 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.5 0 O-C-N 123.926 0.766 . . . . 0.0 112.905 -178.335 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -66.23 -47.2 74.59 Favored 'General case' 0 C--O 1.215 -0.715 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -77.33 -29.04 53.34 Favored 'General case' 0 C--O 1.19 -2.051 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -178.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.474 HD13 ' HB3' ' A' ' 177' ' ' LEU . 41.2 tp -51.57 -64.14 0.91 Allowed 'General case' 0 C--O 1.204 -1.329 0 C-N-CA 124.351 1.06 . . . . 0.0 111.63 177.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 20.0 m -69.23 -24.43 64.01 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.402 0.62 . . . . 0.0 111.454 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -85.97 1.37 50.38 Favored 'General case' 0 C--O 1.244 0.816 0 CA-C-O 122.042 0.925 . . . . 0.0 111.194 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -67.85 157.05 35.75 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.218 177.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 15.0 m -63.3 153.72 33.98 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.568 -179.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 51.1 mm -57.87 -34.32 48.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.117 -176.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . 0.416 ' O ' ' HG3' ' A' ' 197' ' ' GLN . . . -62.19 -36.41 92.95 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 116.095 -0.502 . . . . 0.0 112.477 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . 0.463 ' O ' ' HB2' ' A' ' 197' ' ' GLN . 55.4 mm-40 -77.66 -41.64 37.51 Favored 'General case' 0 CA--C 1.498 -1.043 0 CA-C-O 121.62 0.724 . . . . 0.0 109.915 -178.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.459 HD21 ' O ' ' A' ' 187' ' ' LEU . 97.5 mt -67.64 -32.24 72.79 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.131 -0.941 . . . . 0.0 111.074 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . 0.554 ' HG2' ' N ' ' A' ' 201' ' ' GLN . 4.6 tm-20 -66.44 -30.15 70.45 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -178.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . 0.463 ' HB2' ' O ' ' A' ' 194' ' ' GLU . 69.6 mt-30 -60.16 -37.27 79.62 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.652 -1.158 . . . . 0.0 111.376 178.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 30.0 m -103.66 -31.04 2.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -175.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.6 HG23 ' H ' ' A' ' 200' ' ' GLY . 6.5 m -115.34 -85.67 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 176.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . 0.6 ' H ' HG23 ' A' ' 199' ' ' VAL . . . -178.74 166.25 35.87 Favored Glycine 0 N--CA 1.408 -3.225 0 N-CA-C 108.413 -1.875 . . . . 0.0 108.413 -177.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' GLN . . . . . 0.554 ' N ' ' HG2' ' A' ' 196' ' ' GLU . 0.4 OUTLIER -62.64 -51.38 67.49 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 123.827 0.851 . . . . 0.0 109.122 -179.344 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -72.73 -26.73 61.68 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.066 -176.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 3.4 t -76.44 -42.83 36.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -56.29 -43.54 78.98 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.241 -1.345 . . . . 0.0 109.902 179.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -54.89 -53.79 50.87 Favored 'General case' 0 N--CA 1.436 -1.16 0 C-N-CA 124.218 1.007 . . . . 0.0 111.964 177.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -69.87 -28.87 66.01 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 119.826 -0.749 . . . . 0.0 111.903 -176.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 98.6 mt -71.78 -48.73 49.84 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-N 116.22 -0.446 . . . . 0.0 109.873 177.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 10.4 t60 -70.96 -40.0 72.23 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -176.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -66.51 -25.55 66.74 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 178.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -53.65 -47.52 70.27 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.069 0.948 . . . . 0.0 112.285 -175.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -93.35 -23.59 18.4 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.694 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 62.8 m . . . . . 0 C--N 1.314 -0.963 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.241 -179.821 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.8 tm? . . . . . 0 N--CA 1.44 -0.96 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.434 ' HA ' HG12 ' A' ' 163' ' ' VAL . 3.6 pp -59.51 -27.51 66.23 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 123.944 0.898 . . . . 0.0 111.917 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 11.4 ptt180 -67.57 -37.8 83.16 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -178.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 25.0 m -86.5 -31.6 21.21 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.21 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.442 HG22 ' HB2' ' A' ' 188' ' ' SER . 0.3 OUTLIER -63.36 -26.23 40.32 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 CA-C-O 121.609 0.719 . . . . 0.0 111.358 -177.231 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -86.54 -8.01 57.89 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.591 177.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -105.3 21.19 17.59 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 -176.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.456 HG21 ' HA ' ' A' ' 207' ' ' ILE . 75.0 mt -78.93 125.93 83.08 Favored Pre-proline 0 C--N 1.31 -1.116 0 CA-C-N 116.297 -0.411 . . . . 0.0 109.961 -178.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -66.6 130.84 24.47 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.208 1.939 . . . . 0.0 110.073 176.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 120.21 -35.16 3.87 Favored Glycine 0 C--N 1.292 -1.88 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 -177.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 95.5 t -60.45 -52.56 60.0 Favored 'Isoleucine or valine' 0 C--O 1.246 0.875 0 CA-C-O 121.376 0.608 . . . . 0.0 110.052 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 99.68 99.77 2.26 Favored Glycine 0 N--CA 1.425 -2.09 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -177.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -63.32 -29.81 71.06 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 120.969 0.414 . . . . 0.0 111.491 -176.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 60.9 t -83.19 -26.52 7.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-O 121.513 0.673 . . . . 0.0 110.148 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.426 ' O ' ' HB3' ' A' ' 176' ' ' LEU . 37.3 ttpt -92.45 -5.8 51.21 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 120.443 -0.503 . . . . 0.0 109.808 -178.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -53.4 -49.9 85.78 Favored Pre-proline 0 CA--C 1.553 1.085 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -177.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -57.52 -30.1 87.17 Favored 'Trans proline' 0 C--N 1.384 2.399 0 C-N-CA 121.961 1.774 . . . . 0.0 112.562 176.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.426 ' HB3' ' O ' ' A' ' 173' ' ' LYS . 54.0 tp -70.22 -39.8 74.89 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 121.469 0.652 . . . . 0.0 109.604 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.419 ' HB3' HD21 ' A' ' 187' ' ' LEU . 9.5 mp -72.52 -32.68 66.32 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.174 178.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 42.7 tp -68.93 -8.84 48.1 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.005 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -82.96 -23.27 33.49 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 174.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm -93.37 -49.67 5.83 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.497 0.665 . . . . 0.0 109.736 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' PHE . . . . . 0.548 ' CD2' HD22 ' A' ' 187' ' ' LEU . 64.5 m-85 -95.14 143.0 25.38 Favored Pre-proline 0 C--N 1.304 -1.37 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.642 -176.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -66.36 -39.19 17.9 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.37 2.047 . . . . 0.0 113.867 -174.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 58.8 m -157.0 164.51 37.93 Favored 'General case' 0 C--O 1.247 0.938 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.409 ' HA ' ' HB2' ' A' ' 187' ' ' LEU . 0.2 OUTLIER -56.36 -29.66 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 -176.194 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -62.66 -45.83 91.02 Favored 'General case' 0 C--O 1.217 -0.636 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.328 178.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -78.78 -28.84 44.76 Favored 'General case' 0 C--O 1.201 -1.462 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -177.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.548 HD22 ' CD2' ' A' ' 181' ' ' PHE . 0.3 OUTLIER -51.71 -67.65 0.23 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.263 1.425 . . . . 0.0 109.541 -179.629 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . 0.442 ' HB2' HG22 ' A' ' 163' ' ' VAL . 17.0 m -73.09 -27.17 61.55 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.048 -176.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -81.59 1.31 34.39 Favored 'General case' 0 C--O 1.253 1.241 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.521 ' HB1' ' HB2' ' A' ' 194' ' ' GLU . . . -65.32 154.98 36.7 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 121.601 0.715 . . . . 0.0 110.684 174.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 3.5 m -68.95 163.11 25.25 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.702 -177.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.4 mm -53.56 -41.2 45.05 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.184 0 C-N-CA 123.105 0.562 . . . . 0.0 111.056 -178.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . 0.494 ' O ' ' HG3' ' A' ' 197' ' ' GLN . . . -63.84 -38.94 96.86 Favored Glycine 0 CA--C 1.522 0.497 0 O-C-N 123.395 0.434 . . . . 0.0 112.675 179.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . 0.521 ' HB2' ' HB1' ' A' ' 190' ' ' ALA . 29.7 mt-10 -73.11 -38.21 66.42 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -177.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 95.8 mt -72.93 -30.4 63.86 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.539 177.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . 0.495 ' HG2' ' N ' ' A' ' 201' ' ' GLN . 5.6 tm-20 -63.88 -37.5 87.63 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . 0.494 ' HG3' ' O ' ' A' ' 193' ' ' GLY . 29.2 mt-30 -54.82 -35.02 63.49 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.571 -1.195 . . . . 0.0 112.123 177.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 10.0 m -102.11 -35.08 3.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -175.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.614 HG23 ' H ' ' A' ' 200' ' ' GLY . 5.1 m -116.14 -83.2 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 176.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . 0.614 ' H ' HG23 ' A' ' 199' ' ' VAL . . . -178.86 162.55 29.66 Favored Glycine 0 N--CA 1.417 -2.593 0 N-CA-C 107.364 -2.295 . . . . 0.0 107.364 -177.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' GLN . . . . . 0.495 ' N ' ' HG2' ' A' ' 196' ' ' GLU . 9.6 pt20 -66.93 -36.29 81.91 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 118.834 1.317 . . . . 0.0 111.587 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -67.31 -41.07 85.93 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.403 0.62 . . . . 0.0 110.52 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 2.7 t -72.56 -39.17 61.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-O 121.864 0.84 . . . . 0.0 109.015 -177.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -54.64 -40.57 69.11 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 113.856 -1.52 . . . . 0.0 110.751 -178.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . 0.43 ' HG3' ' O ' ' A' ' 201' ' ' GLN . 26.6 mt-30 -61.92 -48.46 80.33 Favored 'General case' 0 N--CA 1.422 -1.84 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.674 -179.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 23.1 pt20 -70.6 -32.71 70.16 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 119.112 -1.035 . . . . 0.0 111.224 -178.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' ILE . . . . . 0.456 ' HA ' HG21 ' A' ' 166' ' ' ILE . 91.6 mt -66.44 -50.78 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 O-C-N 123.531 0.519 . . . . 0.0 110.091 178.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 11.7 t60 -69.42 -39.87 77.63 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.787 -177.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -66.28 -25.67 66.97 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 178.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . 0.433 ' CD1' HG12 ' A' ' 166' ' ' ILE . 57.4 t80 -52.33 -57.44 9.77 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.447 0.699 . . . . 0.0 112.282 -176.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -79.66 -24.66 41.67 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.508 -177.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 77.3 m . . . . . 0 N--CA 1.441 -0.885 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.046 178.396 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.4 tm? . . . . . 0 N--CA 1.442 -0.86 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.465 ' O ' HG12 ' A' ' 163' ' ' VAL . 1.6 pt? -60.79 -28.68 68.94 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.357 -177.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 -65.07 -34.45 78.45 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-O 121.327 0.584 . . . . 0.0 109.488 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 24.7 m -86.69 -33.45 20.04 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.183 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.465 HG12 ' O ' ' A' ' 160' ' ' LEU . 0.9 OUTLIER -62.22 -26.18 39.55 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 CA-C-O 121.701 0.762 . . . . 0.0 111.68 -174.908 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -81.08 -10.6 59.65 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.805 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -104.74 12.4 32.82 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.265 0.555 . . . . 0.0 110.942 -174.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.436 HG21 ' HA ' ' A' ' 207' ' ' ILE . 83.7 mt -78.51 142.68 62.49 Favored Pre-proline 0 C--N 1.31 -1.145 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.137 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.28 128.39 26.12 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.225 1.95 . . . . 0.0 110.935 174.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 113.71 -31.02 6.82 Favored Glycine 0 N--CA 1.435 -1.43 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 -178.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 60.9 t -72.68 -64.36 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 178.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 98.95 133.23 7.99 Favored Glycine 0 N--CA 1.438 -1.177 0 C-N-CA 120.299 -0.953 . . . . 0.0 113.443 175.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 54.9 pttt -89.07 -25.53 21.87 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.348 0.594 . . . . 0.0 110.926 177.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 61.7 t -84.8 -32.11 7.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 178.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -81.09 -14.26 57.94 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 114.331 -1.304 . . . . 0.0 109.079 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -52.03 -53.93 46.49 Favored Pre-proline 0 N--CA 1.476 0.841 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 -174.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.516 ' O ' ' HG2' ' A' ' 179' ' ' GLN . 19.1 Cg_endo -60.33 -33.75 94.15 Favored 'Trans proline' 0 C--N 1.377 2.077 0 C-N-CA 121.198 1.266 . . . . 0.0 112.232 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 60.9 tp -70.87 -39.32 72.95 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.574 178.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.515 ' CD2' HG11 ' A' ' 198' ' ' VAL . 93.9 mt -64.18 -36.91 85.61 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.085 177.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 97.7 mt -72.35 -9.56 58.66 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.63 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . 0.516 ' HG2' ' O ' ' A' ' 175' ' ' PRO . 11.8 mm-40 -82.57 -19.25 38.86 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 176.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm -104.75 -51.21 3.11 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.687 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -102.68 142.98 25.67 Favored Pre-proline 0 C--N 1.303 -1.449 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -175.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -60.99 -41.81 41.62 Favored 'Trans proline' 0 C--N 1.356 0.959 0 C-N-CA 122.663 2.242 . . . . 0.0 112.321 -172.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 59.6 m -154.45 169.4 23.85 Favored 'General case' 0 N--CA 1.421 -1.92 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 177.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.502 ' HA ' ' HB3' ' A' ' 187' ' ' LEU . 0.2 OUTLIER -63.15 -20.5 26.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 -174.931 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -73.91 -44.31 55.61 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.172 -177.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -78.9 -26.53 43.81 Favored 'General case' 0 C--O 1.2 -1.529 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 178.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.502 ' HB3' ' HA ' ' A' ' 184' ' ' ILE . 54.6 tp -56.21 -56.41 21.34 Favored 'General case' 0 C--O 1.207 -1.156 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.726 177.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 23.2 p -72.76 -31.21 64.74 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.929 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -84.11 6.39 22.51 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 121.521 0.677 . . . . 0.0 111.317 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.425 ' HB1' ' HB2' ' A' ' 194' ' ' GLU . . . -65.3 155.58 34.79 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.029 173.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . 0.421 ' OG ' ' HG3' ' A' ' 194' ' ' GLU . 10.2 p -63.95 156.83 26.62 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.811 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 48.7 mm -52.29 -36.2 20.84 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.948 0 C-N-CA 123.244 0.618 . . . . 0.0 110.374 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -59.33 -41.33 96.85 Favored Glycine 0 N--CA 1.442 -0.904 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.629 177.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . 0.516 ' O ' ' HG2' ' A' ' 197' ' ' GLN . 30.1 mt-10 -77.62 -35.72 52.38 Favored 'General case' 0 C--O 1.206 -1.217 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -177.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 96.1 mt -74.37 -24.56 59.17 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.803 0.811 . . . . 0.0 110.291 178.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -74.07 -24.15 59.46 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.847 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . 0.516 ' HG2' ' O ' ' A' ' 194' ' ' GLU . 4.9 pt20 -67.03 -29.91 69.85 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -177.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.515 HG11 ' CD2' ' A' ' 177' ' ' LEU . 13.4 m -99.1 -21.2 5.22 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.947 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.687 -174.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.402 HG23 ' H ' ' A' ' 200' ' ' GLY . 0.2 OUTLIER -139.23 -84.22 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 173.214 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . 0.402 ' H ' HG23 ' A' ' 199' ' ' VAL . . . -178.29 171.94 44.35 Favored Glycine 0 N--CA 1.431 -1.643 0 N-CA-C 108.514 -1.834 . . . . 0.0 108.514 -173.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -69.06 -42.41 76.29 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 117.886 0.843 . . . . 0.0 112.024 -177.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -68.26 -31.54 71.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.629 0.728 . . . . 0.0 110.69 -177.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 2.1 t -77.75 -40.08 27.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -179.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -57.45 -39.72 76.91 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 114.616 -1.175 . . . . 0.0 109.844 177.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -59.69 -46.71 88.24 Favored 'General case' 0 C--O 1.209 -1.049 0 CA-C-N 115.075 -0.966 . . . . 0.0 112.322 177.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' GLN . . . . . 0.406 ' O ' ' HB2' ' A' ' 210' ' ' PHE . 4.3 pt20 -68.52 -28.48 67.03 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 119.901 -0.72 . . . . 0.0 111.477 -178.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' ILE . . . . . 0.436 ' HA ' HG21 ' A' ' 166' ' ' ILE . 76.2 mt -73.96 -52.55 20.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.117 176.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -70.3 -40.78 74.04 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 120.958 0.408 . . . . 0.0 110.981 -175.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -73.84 -10.55 59.78 Favored 'General case' 0 C--N 1.323 -0.587 0 O-C-N 122.106 -0.371 . . . . 0.0 111.875 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . 0.406 ' HB2' ' O ' ' A' ' 206' ' ' GLN . 40.8 t80 -60.07 -47.78 84.45 Favored 'General case' 0 C--O 1.218 -0.563 0 CA-C-O 121.084 0.469 . . . . 0.0 110.257 179.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -96.39 -26.59 15.28 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.207 -178.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 32.7 m . . . . . 0 CA--C 1.549 0.937 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -178.246 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 37.8 mt . . . . . 0 CA--C 1.491 -1.324 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.461 HD23 ' H ' ' A' ' 160' ' ' LEU . 2.2 pt? -59.13 -30.6 68.25 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.385 0.612 . . . . 0.0 110.67 176.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -76.33 -33.5 58.99 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.987 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 24.7 m -85.28 -37.14 20.35 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 120.959 0.409 . . . . 0.0 111.15 -178.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.423 HG22 ' CB ' ' A' ' 188' ' ' SER . 4.1 p -59.68 -25.92 33.37 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.404 0 CA-C-O 121.266 0.555 . . . . 0.0 112.428 -178.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -87.82 -10.26 51.4 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-O 121.592 0.711 . . . . 0.0 110.368 177.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -101.65 3.01 39.41 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.311 -176.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.414 ' HB ' ' CG2' ' A' ' 169' ' ' VAL . 88.9 mt -60.91 133.65 92.37 Favored Pre-proline 0 C--O 1.248 1.017 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.268 178.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -60.88 127.91 23.87 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 121.991 1.794 . . . . 0.0 109.92 176.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 113.65 -36.55 3.98 Favored Glycine 0 N--CA 1.428 -1.885 0 C-N-CA 120.012 -1.09 . . . . 0.0 112.019 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.414 ' CG2' ' HB ' ' A' ' 166' ' ' ILE . 57.5 t -58.83 -44.2 89.95 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 CA-C-O 121.498 0.666 . . . . 0.0 110.757 -178.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 91.45 80.76 1.41 Allowed Glycine 0 N--CA 1.408 -3.179 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -177.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 55.2 pttt -63.59 -13.87 45.99 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.515 0.674 . . . . 0.0 112.623 -178.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 43.3 t -71.12 -32.11 46.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-O 122.158 0.98 . . . . 0.0 108.421 175.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.533 ' HB3' HD13 ' A' ' 177' ' ' LEU . 89.9 mttt -88.26 -6.21 57.92 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.472 -177.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -54.23 -52.99 64.01 Favored Pre-proline 0 CA--C 1.558 1.254 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -177.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -67.4 -31.26 35.04 Favored 'Trans proline' 0 C--N 1.375 1.931 0 C-N-CA 121.584 1.523 . . . . 0.0 112.325 179.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 55.4 tp -69.96 -44.7 68.98 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.684 0.754 . . . . 0.0 109.601 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.533 HD13 ' HB3' ' A' ' 173' ' ' LYS . 5.4 mp -75.35 -22.28 57.7 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.081 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 44.1 tp -70.55 -11.25 60.81 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 121.637 0.732 . . . . 0.0 109.803 175.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -88.62 -14.35 37.69 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 174.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -105.07 -51.17 3.08 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 122.014 0.911 . . . . 0.0 110.325 -176.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' PHE . . . . . 0.465 ' CD2' ' HA ' ' A' ' 187' ' ' LEU . 90.0 m-85 -88.72 148.92 42.84 Favored Pre-proline 0 N--CA 1.417 -2.116 0 CA-C-N 114.423 -1.262 . . . . 0.0 107.753 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -59.07 -47.5 17.51 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.479 2.119 . . . . 0.0 111.883 -179.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 23.9 m -153.21 165.0 37.05 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.554 ' H ' HD13 ' A' ' 184' ' ' ILE . 0.2 OUTLIER -62.36 -27.25 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -178.202 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 24.8 tp60 -61.57 -41.15 96.97 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 110.348 -0.242 . . . . 0.0 110.348 177.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' GLN . . . . . 0.422 ' NE2' ' HD2' ' A' ' 181' ' ' PHE . 0.7 OUTLIER -79.06 -32.91 45.0 Favored 'General case' 0 C--O 1.196 -1.733 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -179.736 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.465 ' HA ' ' CD2' ' A' ' 181' ' ' PHE . 5.3 tt -53.72 -62.01 1.93 Allowed 'General case' 0 C--O 1.21 -0.991 0 C-N-CA 123.893 0.877 . . . . 0.0 110.471 -176.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . 0.423 ' CB ' HG22 ' A' ' 163' ' ' VAL . 25.4 m -73.99 -23.23 59.43 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -177.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -89.75 4.33 50.01 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.467 0.651 . . . . 0.0 109.372 -179.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.401 ' HB1' ' HB2' ' A' ' 194' ' ' GLU . . . -65.2 154.98 36.47 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-O 121.301 0.572 . . . . 0.0 110.123 175.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 3.0 m -64.26 158.05 24.3 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.48 -176.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 48.8 mm -53.44 -37.86 31.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 C-N-CA 123.279 0.631 . . . . 0.0 111.191 -177.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -63.4 -38.32 96.19 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.642 178.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . 0.401 ' HB2' ' HB1' ' A' ' 190' ' ' ALA . 26.7 mt-10 -74.22 -37.27 63.89 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -176.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 96.2 mt -74.02 -31.36 62.89 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.832 -1.076 . . . . 0.0 110.71 178.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -64.87 -35.54 81.47 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -60.55 -26.36 66.84 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 114.438 -1.255 . . . . 0.0 112.834 178.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 13.1 m -103.59 -37.35 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.305 0 C-N-CA 120.04 -0.664 . . . . 0.0 112.437 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.519 HG23 ' H ' ' A' ' 200' ' ' GLY . 2.5 m -117.87 -80.97 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 177.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . 0.519 ' H ' HG23 ' A' ' 199' ' ' VAL . . . -178.05 166.88 37.28 Favored Glycine 0 N--CA 1.424 -2.16 0 N-CA-C 108.536 -1.826 . . . . 0.0 108.536 -178.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -69.23 -41.94 76.34 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 118.218 1.009 . . . . 0.0 110.296 -178.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -65.55 -35.98 82.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.414 0.626 . . . . 0.0 110.197 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.412 ' O ' HG13 ' A' ' 207' ' ' ILE . 2.7 t -72.66 -43.5 61.65 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.829 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -55.2 -42.47 73.31 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.3 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -58.74 -52.39 65.9 Favored 'General case' 0 N--CA 1.433 -1.315 0 C-N-CA 124.263 1.025 . . . . 0.0 111.507 177.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -69.01 -27.39 65.64 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 -178.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' ILE . . . . . 0.412 HG13 ' O ' ' A' ' 203' ' ' VAL . 98.3 mt -73.45 -51.36 25.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-O 121.311 0.577 . . . . 0.0 109.723 176.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -71.33 -37.94 71.69 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.783 -173.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -75.64 -10.08 59.14 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 178.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -66.12 -46.66 76.78 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.103 0.478 . . . . 0.0 110.86 -179.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -93.11 -25.7 17.77 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.883 -177.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 25.6 m . . . . . 0 CA--C 1.55 0.976 0 CA-C-O 121.387 0.613 . . . . 0.0 111.569 -178.783 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.49 ' O ' HD23 ' A' ' 159' ' ' LEU . 6.4 tt . . . . . 0 C--O 1.211 -0.948 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.48 ' O ' HG12 ' A' ' 163' ' ' VAL . 3.4 pp -53.85 -31.42 49.46 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.98 0.912 . . . . 0.0 111.595 176.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -71.5 -29.38 64.73 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.844 0.831 . . . . 0.0 109.397 -178.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 21.1 m -86.69 -29.56 22.37 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.157 177.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 160' ' ' LEU . 0.3 OUTLIER -65.24 -26.46 39.71 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.643 0 CA-C-O 121.583 0.706 . . . . 0.0 110.916 -176.124 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -82.64 -6.71 59.51 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.481 0.657 . . . . 0.0 110.865 177.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 78.9 mm-40 -101.64 13.26 35.45 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.098 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 80.9 mt -84.35 131.75 49.5 Favored Pre-proline 0 C--N 1.306 -1.297 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -62.89 127.14 19.66 Favored 'Trans proline' 0 C--O 1.245 0.86 0 C-N-CA 121.642 1.561 . . . . 0.0 110.633 177.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 112.33 -18.51 23.12 Favored Glycine 0 N--CA 1.43 -1.765 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.62 -177.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 84.0 t -71.67 -50.41 39.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 178.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 96.58 102.09 2.02 Favored Glycine 0 N--CA 1.43 -1.743 0 C-N-CA 120.236 -0.983 . . . . 0.0 113.159 178.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -67.76 -32.4 72.98 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.219 0.533 . . . . 0.0 110.678 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 48.7 t -85.1 -30.76 6.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-O 121.801 0.81 . . . . 0.0 109.342 -178.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -79.89 -12.74 59.72 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.875 -178.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -50.72 -55.03 29.97 Favored Pre-proline 0 CA--C 1.55 0.974 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -177.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.494 ' O ' ' HG3' ' A' ' 179' ' ' GLN . 21.1 Cg_endo -62.25 -28.68 79.37 Favored 'Trans proline' 0 C--N 1.369 1.642 0 CA-C-N 121.045 1.409 . . . . 0.0 112.899 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 51.7 tp -73.02 -47.98 40.31 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 176.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.456 ' HB3' HD13 ' A' ' 187' ' ' LEU . 97.2 mt -59.27 -39.77 83.92 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.686 177.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.438 ' HA ' ' O ' ' A' ' 181' ' ' PHE . 10.2 mp -68.99 -6.81 30.12 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 179.013 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . 0.494 ' HG3' ' O ' ' A' ' 175' ' ' PRO . 76.7 mt-30 -83.19 -17.35 43.13 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 174.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 7.7 mmmm -103.94 -44.92 4.9 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.09 177.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' PHE . . . . . 0.438 ' O ' ' HA ' ' A' ' 178' ' ' LEU . 27.9 m-85 -111.35 131.51 22.23 Favored Pre-proline 0 N--CA 1.424 -1.753 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 -176.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 181' ' ' PHE . 78.4 Cg_exo -48.33 -38.57 34.41 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 124.152 3.235 . . . . 0.0 113.801 -175.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 73.6 p -154.06 173.69 15.69 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -177.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.521 ' H ' HD13 ' A' ' 184' ' ' ILE . 0.2 OUTLIER -66.59 -21.24 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 O-C-N 123.664 0.602 . . . . 0.0 110.78 175.275 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -67.07 -48.49 68.08 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -77.76 -32.73 52.79 Favored 'General case' 0 C--O 1.201 -1.449 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -178.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.498 ' HB3' ' HA ' ' A' ' 184' ' ' ILE . 61.5 tp -52.78 -57.72 9.22 Favored 'General case' 0 C--O 1.207 -1.156 0 C-N-CA 124.589 1.156 . . . . 0.0 111.691 178.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 24.5 p -68.73 -32.79 72.82 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.617 0.723 . . . . 0.0 111.353 -179.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -80.97 -2.67 48.76 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.259 -178.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -66.35 156.51 34.27 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 123.465 0.706 . . . . 0.0 111.015 177.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 5.4 m -63.26 152.31 38.08 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.115 -175.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 50.3 mm -54.21 -35.86 31.05 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.839 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.865 -177.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . 0.422 ' O ' ' HG2' ' A' ' 197' ' ' GLN . . . -61.63 -39.09 96.92 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.322 -0.466 . . . . 0.0 112.56 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -71.42 -45.11 63.54 Favored 'General case' 0 CA--C 1.489 -1.392 0 CA-C-O 121.548 0.69 . . . . 0.0 110.214 -178.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 95.8 mt -66.65 -29.59 69.64 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 114.279 -1.328 . . . . 0.0 110.804 178.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -70.49 -33.11 70.86 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . 0.441 ' HA ' ' OE1' ' A' ' 197' ' ' GLN . 13.6 mm-40 -66.65 -21.51 66.11 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 114.987 -1.006 . . . . 0.0 113.1 -179.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 18.8 m -104.11 -32.85 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.757 177.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.424 HG23 ' H ' ' A' ' 200' ' ' GLY . 0.7 OUTLIER -125.17 -85.38 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 173.76 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . 0.424 ' H ' HG23 ' A' ' 199' ' ' VAL . . . -177.22 165.35 35.23 Favored Glycine 0 N--CA 1.43 -1.742 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -176.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -58.39 -49.32 77.69 Favored 'General case' 0 C--O 1.21 -0.996 0 CA-C-N 117.487 0.643 . . . . 0.0 111.626 -177.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -65.01 -32.57 74.35 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.314 0.578 . . . . 0.0 111.095 -175.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.412 ' O ' HG13 ' A' ' 207' ' ' ILE . 3.8 t -75.76 -44.56 39.43 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 -179.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -57.06 -43.75 82.36 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 114.009 -1.45 . . . . 0.0 109.912 179.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -62.94 -44.97 94.61 Favored 'General case' 0 N--CA 1.424 -1.752 0 CA-C-N 114.982 -1.008 . . . . 0.0 112.579 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -69.43 -29.16 66.82 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 119.442 -0.903 . . . . 0.0 111.169 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' ILE . . . . . 0.412 HG13 ' O ' ' A' ' 203' ' ' VAL . 87.4 mt -72.04 -52.15 26.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 176.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 12.2 t60 -69.7 -37.03 76.45 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.614 -174.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -73.36 -22.32 60.32 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 179.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -50.94 -56.74 10.92 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.843 0.857 . . . . 0.0 111.475 -177.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -83.57 -27.64 29.12 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.235 -176.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 38.8 m . . . . . 0 C--N 1.311 -1.081 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.472 -178.304 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.479 ' O ' HD23 ' A' ' 159' ' ' LEU . 5.5 tt . . . . . 0 N--CA 1.471 0.604 0 N-CA-C 111.243 0.09 . . . . 0.0 111.243 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.492 HD23 ' H ' ' A' ' 160' ' ' LEU . 2.1 pt? -57.99 -22.28 48.69 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 177.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -68.86 -32.1 71.52 Favored 'General case' 0 C--O 1.218 -0.555 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 177.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 28.4 m -86.51 -34.04 20.13 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.442 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -63.87 -26.53 40.8 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.968 0 CA-C-O 121.516 0.674 . . . . 0.0 110.644 -176.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -82.84 -7.74 59.63 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.371 177.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.592 HE21 ' HA ' ' A' ' 165' ' ' GLN . 0.0 OUTLIER -108.47 13.59 25.32 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.89 0.376 . . . . 0.0 110.605 -176.417 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.477 HG21 ' HA ' ' A' ' 207' ' ' ILE . 81.2 mt -71.82 138.71 82.74 Favored Pre-proline 0 C--N 1.31 -1.12 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.876 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -61.73 128.85 25.69 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.132 1.888 . . . . 0.0 110.637 175.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 114.46 -33.46 5.38 Favored Glycine 0 C--N 1.308 -0.978 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -178.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.498 ' O ' ' HE3' ' A' ' 173' ' ' LYS . 89.1 t -63.14 -57.48 11.78 Favored 'Isoleucine or valine' 0 C--N 1.338 0.109 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 178.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 99.24 126.82 5.76 Favored Glycine 0 N--CA 1.43 -1.748 0 C-N-CA 120.588 -0.815 . . . . 0.0 113.552 175.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -85.51 -25.07 27.05 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 121.313 0.578 . . . . 0.0 111.145 178.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 40.8 t -83.96 -28.26 7.31 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-O 122.082 0.944 . . . . 0.0 108.897 -178.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.498 ' HE3' ' O ' ' A' ' 169' ' ' VAL . 46.6 mtmt -87.28 -1.03 57.62 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.593 178.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -51.77 -49.01 85.79 Favored Pre-proline 0 CA--C 1.546 0.811 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 -178.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.516 ' O ' ' HG2' ' A' ' 179' ' ' GLN . 26.1 Cg_exo -62.86 -42.6 23.91 Favored 'Trans proline' 0 C--N 1.378 2.097 0 CA-C-N 120.69 1.282 . . . . 0.0 111.022 178.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 39.6 tp -58.42 -48.94 79.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.184 177.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.456 ' HB3' HD11 ' A' ' 187' ' ' LEU . 87.5 mt -60.68 -40.48 92.32 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.173 178.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 94.3 mt -71.15 -13.53 61.97 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . 0.516 ' HG2' ' O ' ' A' ' 175' ' ' PRO . 28.6 mm-40 -93.83 -12.38 29.13 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.289 0.566 . . . . 0.0 110.055 174.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -97.74 -50.59 4.4 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 121.792 0.805 . . . . 0.0 109.515 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' PHE . . . . . 0.518 ' CD2' ' HG ' ' A' ' 187' ' ' LEU . 79.9 m-85 -100.26 146.64 32.32 Favored Pre-proline 0 C--N 1.294 -1.846 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.871 -178.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -70.93 -29.45 18.3 Favored 'Trans proline' 0 C--O 1.235 0.366 0 C-N-CA 122.551 2.167 . . . . 0.0 112.594 -178.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . 0.431 ' O ' ' HB2' ' A' ' 187' ' ' LEU . 64.3 p -153.84 166.58 32.46 Favored 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -178.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.436 ' H ' HD13 ' A' ' 184' ' ' ILE . 0.2 OUTLIER -71.05 -22.51 22.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 O-C-N 123.479 0.487 . . . . 0.0 110.138 176.574 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -61.81 -52.84 62.52 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 114.944 -1.025 . . . . 0.0 108.914 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -76.95 -28.03 55.04 Favored 'General case' 0 C--O 1.207 -1.15 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -179.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.518 ' HG ' ' CD2' ' A' ' 181' ' ' PHE . 3.7 tt -54.78 -64.56 0.8 Allowed 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 124.081 0.952 . . . . 0.0 110.24 -178.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 24.0 m -75.94 -22.93 55.49 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.773 -175.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -84.87 -3.87 58.86 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.32 0.581 . . . . 0.0 110.18 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.7 154.58 38.53 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.687 178.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 1.9 t -73.59 169.23 17.69 Favored 'General case' 0 N--CA 1.423 -1.812 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.984 -176.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 50.1 mm -51.8 -39.37 24.48 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.973 0 C-N-CA 123.99 0.916 . . . . 0.0 111.138 -176.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . 0.433 ' O ' ' HG3' ' A' ' 197' ' ' GLN . . . -59.26 -31.88 70.68 Favored Glycine 0 CA--C 1.527 0.817 0 O-C-N 123.431 0.457 . . . . 0.0 113.899 -179.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . 0.47 ' O ' ' HB2' ' A' ' 197' ' ' GLN . 29.2 mm-40 -83.61 -40.13 19.42 Favored 'General case' 0 C--O 1.215 -0.746 0 CA-C-O 121.696 0.76 . . . . 0.0 109.638 -178.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.414 ' HB2' ' HB1' ' A' ' 204' ' ' ALA . 77.7 mt -73.39 -23.99 60.24 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-O 121.744 0.783 . . . . 0.0 110.696 -178.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -71.83 -26.54 62.42 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 178.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . 0.47 ' HB2' ' O ' ' A' ' 194' ' ' GLU . 74.6 mt-30 -61.17 -29.67 69.94 Favored 'General case' 0 C--O 1.242 0.71 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.719 178.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.402 HG11 ' CD2' ' A' ' 177' ' ' LEU . 12.0 m -103.27 -37.18 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.295 0 C-N-CA 120.709 -0.397 . . . . 0.0 111.888 -178.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.459 HG23 ' H ' ' A' ' 200' ' ' GLY . 1.7 m -122.47 -83.75 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . 0.459 ' H ' HG23 ' A' ' 199' ' ' VAL . . . -177.6 172.53 45.26 Favored Glycine 0 N--CA 1.429 -1.789 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -175.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -64.55 -46.78 81.31 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 117.421 0.611 . . . . 0.0 111.816 -176.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -70.6 -30.21 66.82 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.311 0.577 . . . . 0.0 110.997 -176.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.62 ' O ' ' HG2' ' A' ' 206' ' ' GLN . 2.2 t -78.62 -33.91 17.28 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.051 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . 0.414 ' HB1' ' HB2' ' A' ' 195' ' ' LEU . . . -63.25 -38.45 91.22 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.41 175.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . 0.562 HE21 ' HA ' ' A' ' 205' ' ' GLN . 0.0 OUTLIER -60.24 -42.69 95.81 Favored 'General case' 0 C--O 1.207 -1.134 0 CA-C-N 115.32 -0.855 . . . . 0.0 112.522 179.434 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' GLN . . . . . 0.62 ' HG2' ' O ' ' A' ' 203' ' ' VAL . 20.6 pt20 -66.79 -30.22 70.37 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.894 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' ILE . . . . . 0.477 ' HA ' HG21 ' A' ' 166' ' ' ILE . 71.6 mt -78.19 -52.91 15.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-O 121.47 0.652 . . . . 0.0 109.982 178.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 40.0 t-80 -65.04 -39.56 93.51 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.839 -175.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -80.97 -14.04 58.33 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 120.728 -0.389 . . . . 0.0 112.023 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -55.11 -53.84 50.82 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.323 0.649 . . . . 0.0 111.318 -176.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -84.28 -27.82 27.58 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.896 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 25.5 m . . . . . 0 CA--C 1.55 0.969 0 CA-C-O 121.204 0.526 . . . . 0.0 111.392 -179.341 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 39.5 tp . . . . . 0 N--CA 1.446 -0.662 0 N-CA-C 111.608 0.225 . . . . 0.0 111.608 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -62.57 -26.55 68.64 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.074 0.464 . . . . 0.0 110.24 177.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 23.9 ptt180 -67.35 -35.58 79.67 Favored 'General case' 0 C--O 1.215 -0.731 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 8.4 m -86.14 -33.28 20.91 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.618 -178.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -64.95 -26.09 39.25 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-O 121.515 0.674 . . . . 0.0 110.835 -175.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 30.3 pt20 -85.27 -7.3 59.08 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.307 177.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -99.26 4.7 46.67 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -178.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.442 HG21 ' HA ' ' A' ' 207' ' ' ILE . 85.7 mt -72.18 131.58 85.08 Favored Pre-proline 0 C--N 1.309 -1.162 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -179.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -62.13 131.73 35.89 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.485 2.123 . . . . 0.0 110.586 176.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 113.83 -36.42 4.03 Favored Glycine 0 N--CA 1.424 -2.134 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 -178.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 91.9 t -55.72 -48.09 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-O 120.96 0.409 . . . . 0.0 110.593 -178.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 85.63 95.26 0.77 Allowed Glycine 0 N--CA 1.429 -1.794 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 -179.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -70.24 -18.71 63.16 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -175.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 62.0 t -83.24 -30.75 8.32 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 CA-C-O 121.396 0.617 . . . . 0.0 109.831 179.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.604 ' O ' ' HG ' ' A' ' 177' ' ' LEU . 21.2 ptmt -93.93 -4.0 50.61 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.415 0.626 . . . . 0.0 110.035 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . 0.443 ' N ' ' HD2' ' A' ' 175' ' ' PRO . . . -59.72 -45.99 98.49 Favored Pre-proline 0 CA--C 1.548 0.9 0 CA-C-N 114.906 -1.043 . . . . 0.0 113.417 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.443 ' HD2' ' N ' ' A' ' 174' ' ' ALA . 9.3 Cg_endo -54.88 -35.94 90.27 Favored 'Trans proline' 0 C--N 1.385 2.449 0 C-N-CA 122.176 1.917 . . . . 0.0 112.193 176.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 53.3 tp -68.14 -42.3 80.34 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.437 0.637 . . . . 0.0 109.699 178.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.604 ' HG ' ' O ' ' A' ' 173' ' ' LYS . 59.8 mt -70.1 -31.06 68.43 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.75 -179.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 35.5 tp -72.91 -10.83 60.23 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.528 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . 0.438 ' HG2' ' O ' ' A' ' 175' ' ' PRO . 13.8 mm100 -83.72 -20.17 33.91 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 174.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -103.65 -51.81 3.11 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-O 121.31 0.576 . . . . 0.0 110.354 -174.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -90.73 140.55 26.47 Favored Pre-proline 0 C--N 1.296 -1.751 0 CA-C-N 115.346 -0.843 . . . . 0.0 108.752 178.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -47.0 -47.5 16.51 Favored 'Trans proline' 0 C--N 1.361 1.217 0 C-N-CA 123.96 3.107 . . . . 0.0 112.545 -176.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . 0.435 ' OG ' HD13 ' A' ' 184' ' ' ILE . 25.8 t -153.71 169.48 23.21 Favored 'General case' 0 N--CA 1.41 -2.437 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.589 ' H ' HD13 ' A' ' 184' ' ' ILE . 0.2 OUTLIER -60.03 -27.93 40.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 O-C-N 124.013 0.821 . . . . 0.0 110.151 177.114 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -56.86 -50.21 73.16 Favored 'General case' 0 C--O 1.212 -0.889 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.033 176.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.1 -34.04 43.85 Favored 'General case' 0 C--O 1.206 -1.217 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -177.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.451 ' HB3' ' HA ' ' A' ' 184' ' ' ILE . 57.8 tp -50.8 -62.55 1.53 Allowed 'General case' 0 C--O 1.21 -0.976 0 C-N-CA 124.408 1.083 . . . . 0.0 111.278 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 25.3 m -72.07 -22.66 61.33 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.012 0.434 . . . . 0.0 112.07 -178.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -83.59 -4.04 58.21 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 121.488 0.661 . . . . 0.0 110.845 -178.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.513 ' HB1' ' HB2' ' A' ' 194' ' ' GLU . . . -65.74 155.48 35.97 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.019 175.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 4.0 m -65.33 162.27 17.88 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.994 -176.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.2 mm -53.66 -39.98 40.54 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.622 0 C-N-CA 122.751 0.42 . . . . 0.0 111.113 -178.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -62.77 -35.14 91.52 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 121.515 -0.374 . . . . 0.0 112.471 179.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . 0.644 ' O ' ' HG2' ' A' ' 197' ' ' GLN . 25.2 mt-10 -80.7 -29.72 36.46 Favored 'General case' 0 C--O 1.215 -0.76 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -177.135 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 97.4 mt -78.76 -33.33 46.57 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.983 176.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . 0.422 ' HG2' ' N ' ' A' ' 201' ' ' GLN . 6.5 tm-20 -67.46 -31.71 72.07 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 -177.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . 0.644 ' HG2' ' O ' ' A' ' 194' ' ' GLU . 16.5 pt20 -67.92 -28.39 67.45 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.529 -177.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 14.1 m -99.52 -34.58 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.969 -177.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.481 HG23 ' H ' ' A' ' 200' ' ' GLY . 2.5 m -119.81 -82.84 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 175.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . 0.481 ' H ' HG23 ' A' ' 199' ' ' VAL . . . -177.84 166.0 35.96 Favored Glycine 0 N--CA 1.429 -1.794 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 -176.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' GLN . . . . . 0.422 ' N ' ' HG2' ' A' ' 196' ' ' GLU . 8.8 tm0? -62.51 -47.03 85.73 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 117.565 0.682 . . . . 0.0 110.303 -177.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -71.63 -28.8 64.02 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.248 -176.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 3.0 t -76.06 -41.2 38.08 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.706 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -55.94 -45.11 78.88 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 114.224 -1.353 . . . . 0.0 109.651 179.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -59.26 -46.65 87.95 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 114.973 -1.012 . . . . 0.0 112.437 179.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -67.87 -33.09 74.06 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 120.366 -0.533 . . . . 0.0 111.357 -179.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' ILE . . . . . 0.442 ' HA ' HG21 ' A' ' 166' ' ' ILE . 85.8 mt -74.72 -50.44 25.87 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-O 121.141 0.496 . . . . 0.0 110.577 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 15.1 t60 -68.99 -43.88 73.98 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.106 -175.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -72.58 -10.77 60.2 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -62.46 -47.42 84.12 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.169 0.509 . . . . 0.0 110.223 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -98.07 -25.17 15.03 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.857 -178.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 24.1 m . . . . . 0 C--N 1.322 -0.589 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -178.45 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 42.8 tp . . . . . 0 N--CA 1.441 -0.911 0 CA-C-O 120.491 0.186 . . . . 0.0 110.667 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -60.26 -25.67 65.87 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.246 0.546 . . . . 0.0 112.038 -179.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -73.62 -33.58 64.62 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.207 0.527 . . . . 0.0 110.114 177.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 16.9 m -85.76 -33.99 21.28 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 121.243 0.544 . . . . 0.0 110.591 -178.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.438 HG22 ' CB ' ' A' ' 188' ' ' SER . 0.8 OUTLIER -64.17 -25.61 38.46 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.131 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.049 -176.555 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . 0.422 ' NE2' HG13 ' A' ' 184' ' ' ILE . 11.5 pt20 -87.69 -7.59 57.2 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.755 177.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -103.56 12.15 35.36 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.17 0.51 . . . . 0.0 109.996 -178.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 77.7 mt -72.8 125.97 90.88 Favored Pre-proline 0 C--N 1.314 -0.961 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.24 128.5 20.6 Favored 'Trans proline' 0 N--CA 1.445 -1.331 0 C-N-CA 121.562 1.508 . . . . 0.0 109.183 176.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 116.16 -29.24 7.17 Favored Glycine 0 N--CA 1.428 -1.872 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 -177.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 93.1 t -65.32 -52.23 54.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 121.313 0.578 . . . . 0.0 110.426 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 102.33 75.31 1.09 Allowed Glycine 0 N--CA 1.424 -2.102 0 C-N-CA 120.365 -0.921 . . . . 0.0 111.234 -179.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -73.64 -15.63 61.25 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.279 0.562 . . . . 0.0 111.656 -177.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 45.1 t -86.86 -22.86 6.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 CA-C-O 121.96 0.886 . . . . 0.0 108.637 176.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.464 ' O ' ' HG ' ' A' ' 177' ' ' LEU . 38.0 ttpt -96.12 8.36 43.98 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.309 -1.314 . . . . 0.0 108.226 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -56.67 -46.3 99.85 Favored Pre-proline 0 C--O 1.212 -0.901 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 -177.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.567 ' O ' ' HG2' ' A' ' 179' ' ' GLN . 51.7 Cg_exo -56.97 -41.08 79.04 Favored 'Trans proline' 0 C--N 1.377 2.036 0 CA-C-N 121.204 1.466 . . . . 0.0 111.345 178.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 48.5 tp -64.7 -43.36 93.74 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.435 176.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 173' ' ' LYS . 96.3 mt -63.34 -40.27 96.83 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.533 178.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -68.63 -6.91 28.57 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 178.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . 0.567 ' HG2' ' O ' ' A' ' 175' ' ' PRO . 86.9 mm-40 -84.46 -15.64 45.38 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.06 0.457 . . . . 0.0 110.102 174.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -112.17 -51.01 2.87 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 121.434 0.635 . . . . 0.0 110.047 179.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' PHE . . . . . 0.485 ' CD1' ' HA ' ' A' ' 187' ' ' LEU . 80.6 m-85 -88.58 139.05 29.68 Favored Pre-proline 0 C--N 1.299 -1.622 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.433 -177.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -64.07 -48.94 4.31 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.511 2.141 . . . . 0.0 112.289 -177.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 25.2 m -148.11 167.38 25.16 Favored 'General case' 0 N--CA 1.426 -1.646 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 178.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.422 HG13 ' NE2' ' A' ' 164' ' ' GLN . 0.2 OUTLIER -60.66 -25.45 35.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -179.085 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 24.0 tp60 -60.87 -51.91 67.27 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.52 -178.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -79.24 -27.18 42.41 Favored 'General case' 0 C--O 1.189 -2.103 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.485 ' HA ' ' CD1' ' A' ' 181' ' ' PHE . 5.1 tt -52.32 -61.55 2.2 Favored 'General case' 0 C--O 1.214 -0.804 0 C-N-CA 123.332 0.653 . . . . 0.0 110.304 -177.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . 0.438 ' CB ' HG22 ' A' ' 163' ' ' VAL . 19.5 m -73.72 -22.97 59.72 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 121.165 0.507 . . . . 0.0 112.035 -177.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -91.0 7.44 40.32 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.858 178.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -66.21 156.89 32.87 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 123.22 0.608 . . . . 0.0 111.533 176.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 4.6 m -62.9 158.27 19.52 Favored 'General case' 0 N--CA 1.427 -1.61 0 CA-C-N 115.153 -0.931 . . . . 0.0 109.761 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 47.9 mm -55.54 -36.06 40.38 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.355 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.491 -177.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -62.58 -36.15 92.81 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 121.045 -0.598 . . . . 0.0 112.434 178.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . 0.463 ' O ' ' HG2' ' A' ' 197' ' ' GLN . 13.1 mm-40 -76.84 -35.88 57.21 Favored 'General case' 0 C--O 1.215 -0.727 0 CA-C-O 121.475 0.655 . . . . 0.0 109.36 -177.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 92.0 mt -77.94 -23.33 48.59 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-O 121.616 0.722 . . . . 0.0 110.793 178.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . 0.477 ' HG2' ' N ' ' A' ' 201' ' ' GLN . 4.0 tm-20 -81.95 -37.76 26.22 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -178.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . 0.463 ' HG2' ' O ' ' A' ' 194' ' ' GLU . 9.9 pt20 -66.37 -22.79 66.26 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.736 -178.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.429 HG22 ' O ' ' A' ' 194' ' ' GLU . 12.6 m -99.19 -28.83 3.44 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.422 HG23 HG23 ' A' ' 198' ' ' VAL . 1.5 t -130.64 -79.74 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.613 176.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -177.51 164.63 33.88 Favored Glycine 0 N--CA 1.438 -1.181 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 -177.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' GLN . . . . . 0.477 ' N ' ' HG2' ' A' ' 196' ' ' GLU . 11.1 pt20 -66.23 -40.13 90.04 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -177.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -68.2 -24.71 64.97 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 122.188 0.994 . . . . 0.0 109.827 -178.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.416 HG11 HG11 ' A' ' 199' ' ' VAL . 6.9 t -83.32 -47.56 18.1 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 CA-C-N 114.435 -1.257 . . . . 0.0 108.324 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -52.89 -44.96 67.28 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 114.473 -1.239 . . . . 0.0 110.846 -178.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -63.33 -48.03 79.73 Favored 'General case' 0 N--CA 1.423 -1.783 0 CA-C-N 114.922 -1.035 . . . . 0.0 111.574 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -70.96 -29.82 65.93 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.48 -177.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 90.6 mt -69.53 -51.91 37.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 175.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 7.0 t60 -69.6 -31.15 69.13 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.472 0.653 . . . . 0.0 109.374 -176.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -80.18 -13.69 59.05 Favored 'General case' 0 C--O 1.207 -1.142 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 176.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -62.24 -43.37 98.98 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-O 121.022 0.439 . . . . 0.0 111.782 -176.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -90.91 -23.38 20.51 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.261 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 28.4 m . . . . . 0 CA--C 1.555 1.152 0 CA-C-O 121.059 0.457 . . . . 0.0 111.277 178.644 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.443 ' O ' HD23 ' A' ' 159' ' ' LEU . 6.4 tt . . . . . 0 C--O 1.221 -0.415 0 CA-C-O 120.139 0.019 . . . . 0.0 110.972 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.423 ' O ' HG12 ' A' ' 163' ' ' VAL . 2.4 pt? -59.22 -25.19 63.79 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.821 0.344 . . . . 0.0 111.834 179.122 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 5.5 ptm180 -77.98 -26.05 48.47 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 120.077 -0.649 . . . . 0.0 109.522 -179.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 97.0 m -86.7 -32.1 20.67 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.253 176.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.423 HG12 ' O ' ' A' ' 160' ' ' LEU . 0.8 OUTLIER -65.47 -26.09 38.46 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 CA-C-O 121.654 0.74 . . . . 0.0 110.9 -177.07 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -83.61 -14.62 51.56 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.532 0.682 . . . . 0.0 109.768 176.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -99.52 20.39 13.95 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.455 -176.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 98.4 mt -80.09 129.16 71.06 Favored Pre-proline 0 C--N 1.293 -1.87 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 175.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.65 128.79 23.14 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 122.036 1.824 . . . . 0.0 109.96 177.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 116.21 -29.4 7.07 Favored Glycine 0 N--CA 1.426 -1.975 0 C-N-CA 120.146 -1.026 . . . . 0.0 111.508 -179.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 63.6 t -63.6 -64.85 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.592 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 177.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 113.62 98.95 2.33 Favored Glycine 0 N--CA 1.422 -2.255 0 C-N-CA 120.066 -1.064 . . . . 0.0 112.18 178.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -68.77 -27.39 65.85 Favored 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 122.926 0.49 . . . . 0.0 111.32 -178.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 22.5 t -83.88 -30.9 7.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-O 121.299 0.571 . . . . 0.0 109.748 -175.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.536 ' O ' ' HG ' ' A' ' 177' ' ' LEU . 20.4 ptmt -91.72 1.41 57.18 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.36 178.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -56.99 -50.35 88.71 Favored Pre-proline 0 CA--C 1.545 0.785 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.523 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.412 ' O ' ' HG2' ' A' ' 179' ' ' GLN . 15.9 Cg_endo -58.91 -24.05 70.74 Favored 'Trans proline' 0 C--N 1.376 2.021 0 C-N-CA 121.801 1.667 . . . . 0.0 112.764 178.163 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.409 ' HB3' ' O ' ' A' ' 173' ' ' LYS . 54.5 tp -77.58 -40.05 43.59 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 177.001 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.536 ' HG ' ' O ' ' A' ' 173' ' ' LYS . 84.3 mt -71.53 -33.59 69.31 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.869 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -69.12 -5.87 24.98 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 177.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . 0.412 ' HG2' ' O ' ' A' ' 175' ' ' PRO . 29.8 mm-40 -93.17 -3.74 53.37 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.266 0.555 . . . . 0.0 109.869 174.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -113.0 -50.53 2.88 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.47 176.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' PHE . . . . . 0.579 ' CD2' ' HG ' ' A' ' 187' ' ' LEU . 66.8 m-85 -96.76 141.16 22.67 Favored Pre-proline 0 C--N 1.309 -1.173 0 CA-C-N 114.769 -1.105 . . . . 0.0 108.55 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -67.76 -35.73 20.8 Favored 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 122.096 1.864 . . . . 0.0 112.82 -177.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 67.7 p -149.3 165.54 31.66 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -178.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -65.67 -26.13 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 O-C-N 123.403 0.439 . . . . 0.0 110.559 177.164 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -63.98 -43.57 95.34 Favored 'General case' 0 C--O 1.202 -1.416 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.977 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' GLN . . . . . 0.415 ' NE2' ' HD1' ' A' ' 181' ' ' PHE . 0.6 OUTLIER -78.84 -34.56 45.05 Favored 'General case' 0 C--O 1.197 -1.703 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.944 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.579 ' HG ' ' CD2' ' A' ' 181' ' ' PHE . 4.8 tt -52.88 -66.61 0.35 Allowed 'General case' 0 C--O 1.21 -1.022 0 C-N-CA 124.205 1.002 . . . . 0.0 111.296 -175.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 23.1 m -75.2 -21.73 58.47 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.243 0.544 . . . . 0.0 112.062 -175.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -86.6 -4.33 59.16 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.032 -178.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.38 155.43 35.42 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 121.498 0.666 . . . . 0.0 111.167 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 12.4 m -65.32 162.17 18.06 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.365 -177.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 41.4 mm -53.57 -40.3 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 123.073 0.549 . . . . 0.0 110.892 -178.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -62.55 -29.03 72.36 Favored Glycine 0 C--O 1.214 -1.133 0 CA-C-N 115.974 -0.557 . . . . 0.0 113.135 -179.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -83.6 -41.88 17.35 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 121.467 0.651 . . . . 0.0 109.275 -178.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 97.4 mt -69.54 -38.42 77.49 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 114.706 -1.134 . . . . 0.0 111.345 -178.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.32 -33.9 77.05 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.311 0.577 . . . . 0.0 109.522 -176.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -60.94 -30.29 70.13 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.619 -1.173 . . . . 0.0 112.923 177.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 16.9 m -103.75 -39.29 5.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -176.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.555 HG23 ' H ' ' A' ' 200' ' ' GLY . 3.5 m -108.09 -84.64 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 177.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . 0.555 ' H ' HG23 ' A' ' 199' ' ' VAL . . . -178.0 167.46 38.24 Favored Glycine 0 N--CA 1.414 -2.819 0 N-CA-C 108.574 -1.81 . . . . 0.0 108.574 -178.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -57.69 -52.7 64.35 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 117.535 0.667 . . . . 0.0 112.357 179.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -67.37 -34.58 77.59 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.313 0.578 . . . . 0.0 110.809 -176.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.463 ' O ' ' HG2' ' A' ' 206' ' ' GLN . 2.6 t -70.57 -42.3 78.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 -179.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -56.36 -46.24 80.11 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.61 178.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -61.68 -47.02 87.23 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 114.972 -1.013 . . . . 0.0 112.615 179.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' GLN . . . . . 0.463 ' HG2' ' O ' ' A' ' 203' ' ' VAL . 3.4 pt20 -65.28 -34.98 79.62 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 118.373 0.533 . . . . 0.0 111.364 -178.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 88.4 mt -72.92 -50.52 32.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.972 178.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -65.01 -45.31 86.07 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.821 -177.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -70.07 -15.79 63.04 Favored 'General case' 0 C--O 1.217 -0.624 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -59.24 -45.54 90.9 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.129 0.572 . . . . 0.0 110.44 -179.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -95.91 -31.18 13.25 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.091 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 52.0 m . . . . . 0 CA--C 1.541 0.605 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.518 -177.396 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 43.0 tp . . . . . 0 N--CA 1.44 -0.956 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.468 ' O ' HG12 ' A' ' 163' ' ' VAL . 2.3 pt? -55.44 -34.54 64.55 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-O 121.223 0.535 . . . . 0.0 111.695 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -66.0 -31.9 73.07 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.198 177.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 15.9 m -86.72 -31.45 20.98 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 120.956 0.408 . . . . 0.0 110.76 178.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.468 HG12 ' O ' ' A' ' 160' ' ' LEU . 0.3 OUTLIER -64.79 -25.85 38.75 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.069 0 CA-C-O 121.719 0.771 . . . . 0.0 110.647 -177.271 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . 0.438 ' OE1' HG21 ' A' ' 184' ' ' ILE . 9.8 pt20 -83.44 -6.69 59.53 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.412 175.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -100.2 7.96 44.15 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.062 0.458 . . . . 0.0 110.307 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 84.5 mt -75.38 128.72 83.8 Favored Pre-proline 0 C--N 1.317 -0.829 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -65.75 128.67 20.42 Favored 'Trans proline' 0 C--O 1.238 0.478 0 C-N-CA 122.145 1.896 . . . . 0.0 111.353 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 117.35 -27.99 7.41 Favored Glycine 0 C--N 1.306 -1.084 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 -179.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 97.7 t -61.86 -62.01 1.34 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.689 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 177.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 110.89 100.81 2.6 Favored Glycine 0 N--CA 1.424 -2.12 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.323 176.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -73.66 -26.51 60.78 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.261 0.553 . . . . 0.0 109.935 177.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 62.1 t -82.88 -24.46 8.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-O 122.08 0.943 . . . . 0.0 108.896 178.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.438 ' O ' ' HG ' ' A' ' 177' ' ' LEU . 44.9 mtpt -86.01 -0.82 56.47 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.497 -1.229 . . . . 0.0 110.305 178.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -47.98 -51.04 50.76 Favored Pre-proline 0 C--O 1.203 -1.377 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -178.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.585 ' O ' ' HG2' ' A' ' 179' ' ' GLN . 12.9 Cg_endo -58.24 -42.57 55.24 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 121.684 1.589 . . . . 0.0 112.132 177.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 55.6 tp -64.46 -45.56 86.89 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.729 0.776 . . . . 0.0 109.639 179.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' A' ' 173' ' ' LYS . 93.2 mt -69.16 -26.41 64.85 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.973 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 57.4 tp -74.06 -30.75 62.54 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 121.132 0.492 . . . . 0.0 109.831 178.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . 0.585 ' HG2' ' O ' ' A' ' 175' ' ' PRO . 12.7 mm-40 -76.09 -30.97 58.5 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 121.167 0.508 . . . . 0.0 109.965 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 22.9 mmmt -83.28 -50.62 8.21 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.979 179.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' PHE . . . . . 0.427 ' HA ' ' HD3' ' A' ' 182' ' ' PRO . 28.8 m-85 -111.75 135.66 21.16 Favored Pre-proline 0 N--CA 1.436 -1.134 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.795 -172.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 181' ' ' PHE . 51.2 Cg_exo -53.42 -38.51 82.87 Favored 'Trans proline' 0 N--CA 1.487 1.118 0 C-N-CA 124.367 3.378 . . . . 0.0 114.184 -176.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 24.4 t -158.66 167.83 28.49 Favored 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 179.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.514 ' HA ' ' HB3' ' A' ' 187' ' ' LEU . 0.2 OUTLIER -61.37 -26.98 40.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 O-C-N 124.277 0.985 . . . . 0.0 110.995 178.214 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -64.39 -40.73 96.39 Favored 'General case' 0 C--O 1.21 -1.022 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.692 179.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -80.2 -37.87 32.34 Favored 'General case' 0 C--O 1.191 -2.017 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 177.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.514 ' HB3' ' HA ' ' A' ' 184' ' ' ILE . 66.8 tp -46.67 -65.59 0.54 Allowed 'General case' 0 C--O 1.212 -0.873 0 C-N-CA 126.07 1.748 . . . . 0.0 113.202 -177.045 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 36.9 m -72.96 -20.94 60.95 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -177.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -91.89 3.88 54.19 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.461 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.96 158.23 28.71 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 124.816 1.247 . . . . 0.0 112.737 178.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 14.6 m -62.99 152.06 37.9 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.848 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 48.2 mm -55.15 -35.57 36.09 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.137 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.878 -177.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -61.9 -30.2 74.57 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 121.313 -0.47 . . . . 0.0 112.842 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . 0.461 ' O ' ' HG2' ' A' ' 197' ' ' GLN . 59.4 mm-40 -84.24 -36.99 22.33 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-O 121.529 0.681 . . . . 0.0 109.752 -179.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.404 HD21 ' O ' ' A' ' 187' ' ' LEU . 96.0 mt -75.97 -24.38 55.4 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.385 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . 0.442 ' HG2' ' N ' ' A' ' 201' ' ' GLN . 3.9 tm-20 -78.91 -37.95 38.64 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -178.041 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . 0.461 ' HG2' ' O ' ' A' ' 194' ' ' GLU . 10.3 pt20 -69.75 -19.6 63.53 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 114.999 -1.0 . . . . 0.0 112.328 -175.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 17.1 m -102.54 -26.33 3.52 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 C-N-CA 120.587 -0.445 . . . . 0.0 111.842 178.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.531 HG11 HG11 ' A' ' 203' ' ' VAL . 0.2 OUTLIER -128.24 -81.8 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 C-N-CA 120.721 -0.392 . . . . 0.0 111.129 175.897 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -176.95 162.78 31.24 Favored Glycine 0 N--CA 1.442 -0.914 0 N-CA-C 108.791 -1.723 . . . . 0.0 108.791 -176.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' GLN . . . . . 0.442 ' N ' ' HG2' ' A' ' 196' ' ' GLU . 8.8 tt0 -67.01 -40.69 87.36 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 117.996 0.898 . . . . 0.0 112.065 -176.117 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -65.7 -37.64 87.01 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.399 0.619 . . . . 0.0 109.936 -179.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.531 HG11 HG11 ' A' ' 199' ' ' VAL . 3.9 t -69.91 -44.05 79.04 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.864 0 CA-C-N 114.986 -1.007 . . . . 0.0 108.755 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -55.31 -46.43 76.27 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 114.356 -1.293 . . . . 0.0 110.2 -179.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -71.12 -31.62 67.99 Favored 'General case' 0 N--CA 1.417 -2.124 0 CA-C-N 114.735 -1.12 . . . . 0.0 112.494 -177.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' GLN . . . . . 0.42 ' HG2' ' O ' ' A' ' 203' ' ' VAL . 3.4 pt20 -78.08 -34.1 50.45 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 119.742 -0.783 . . . . 0.0 110.765 178.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 93.7 mt -66.38 -45.61 88.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 174.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 28.4 t-80 -68.95 -35.77 77.15 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.007 -178.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -72.56 -25.6 61.42 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 121.743 -0.598 . . . . 0.0 112.507 177.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -50.84 -54.13 26.37 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.532 1.133 . . . . 0.0 112.667 -175.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 20.3 p90 -81.76 -24.16 36.21 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -177.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 30.6 m . . . . . 0 C--N 1.31 -1.111 0 CA-C-O 120.975 0.417 . . . . 0.0 111.225 179.953 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.414 HD13 ' O ' ' A' ' 159' ' ' LEU . 3.0 tm? . . . . . 0 N--CA 1.424 -1.747 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.405 ' HA ' HG12 ' A' ' 163' ' ' VAL . 2.4 pt? -61.82 -23.52 66.28 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 115.316 -0.856 . . . . 0.0 112.035 -177.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 34.6 ptt180 -70.0 -39.32 75.96 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.345 0.593 . . . . 0.0 110.104 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 74.8 m -86.75 -32.57 20.33 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.937 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.436 HG22 ' CB ' ' A' ' 188' ' ' SER . 0.4 OUTLIER -62.49 -26.2 39.87 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.126 -174.568 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -80.47 -10.22 59.75 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.995 179.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -103.8 11.45 35.75 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 121.143 0.497 . . . . 0.0 110.978 -176.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.444 HG21 ' HA ' ' A' ' 207' ' ' ILE . 73.6 mt -78.74 133.86 61.81 Favored Pre-proline 0 C--N 1.304 -1.404 0 CA-C-N 116.059 -0.518 . . . . 0.0 109.71 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -62.12 128.76 24.94 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.106 1.871 . . . . 0.0 109.869 175.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 116.07 -40.95 2.25 Favored Glycine 0 N--CA 1.429 -1.805 0 N-CA-C 108.668 -1.773 . . . . 0.0 108.668 -176.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.455 ' O ' HD11 ' A' ' 177' ' ' LEU . 57.7 t -70.89 -56.34 11.03 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.174 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 174.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 91.77 147.08 19.58 Favored Glycine 0 N--CA 1.417 -2.596 0 C-N-CA 120.201 -1.0 . . . . 0.0 114.893 172.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . 0.449 ' HG3' HG23 ' A' ' 172' ' ' VAL . 56.7 pttt -89.37 -35.93 15.79 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 114.401 -0.899 . . . . 0.0 110.556 177.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.449 HG23 ' HG3' ' A' ' 171' ' ' LYS . 43.3 t -86.14 -39.03 13.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-O 121.204 0.526 . . . . 0.0 110.729 -175.008 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.652 ' O ' ' HG ' ' A' ' 177' ' ' LEU . 21.6 ptmt -84.25 2.07 41.73 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.765 -178.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . 0.412 ' O ' ' HG ' ' A' ' 178' ' ' LEU . . . -54.59 -52.75 67.17 Favored Pre-proline 0 CA--C 1.563 1.443 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -61.74 -23.16 75.85 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 122.137 1.891 . . . . 0.0 112.22 177.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.509 ' HB3' ' O ' ' A' ' 173' ' ' LYS . 53.5 tp -74.54 -34.86 63.08 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.252 176.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.652 ' HG ' ' O ' ' A' ' 173' ' ' LYS . 61.5 mt -78.69 -29.29 45.48 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.073 -179.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 174' ' ' ALA . 87.3 mt -68.69 -5.58 21.13 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.615 177.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -85.3 -21.42 28.99 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 121.838 0.828 . . . . 0.0 108.941 174.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -101.05 -47.41 4.77 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.567 -178.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' PHE . . . . . 0.588 ' CD2' ' HG ' ' A' ' 187' ' ' LEU . 85.4 m-85 -107.32 149.06 38.27 Favored Pre-proline 0 N--CA 1.427 -1.609 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.623 -175.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 181' ' ' PHE . 2.8 Cg_exo -67.46 -50.47 0.94 Allowed 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.774 2.316 . . . . 0.0 112.566 -178.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 66.6 m -150.19 164.48 35.57 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -57.33 -30.49 35.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 115.671 1.73 . . . . 0.0 115.671 -173.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -68.55 -46.9 68.25 Favored 'General case' 0 C--O 1.206 -1.223 0 C-N-CA 119.439 -0.905 . . . . 0.0 108.995 -176.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -73.04 -29.89 63.32 Favored 'General case' 0 C--O 1.194 -1.846 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.588 ' HG ' ' CD2' ' A' ' 181' ' ' PHE . 5.1 tt -56.03 -64.12 0.96 Allowed 'General case' 0 C--O 1.217 -0.607 0 C-N-CA 123.666 0.786 . . . . 0.0 110.27 -178.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . 0.436 ' CB ' HG22 ' A' ' 163' ' ' VAL . 17.6 m -74.29 -26.44 60.19 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 123.29 0.369 . . . . 0.0 111.831 -176.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.416 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 8.6 t30 -85.36 -0.03 53.55 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.138 0.494 . . . . 0.0 111.014 -178.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -66.62 155.47 37.77 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.035 0.445 . . . . 0.0 110.704 175.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 12.5 m -63.94 159.72 19.27 Favored 'General case' 0 C--O 1.251 1.14 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.089 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.1 mm -49.09 -39.17 12.06 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.851 0 C-N-CA 123.772 0.829 . . . . 0.0 111.619 -179.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . 0.462 ' O ' ' HG3' ' A' ' 197' ' ' GLN . . . -57.22 -39.05 89.45 Favored Glycine 0 CA--C 1.526 0.767 0 O-C-N 123.129 0.268 . . . . 0.0 113.453 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -77.56 -41.46 38.86 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.551 0.691 . . . . 0.0 109.231 -177.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 96.0 mt -69.72 -26.44 64.33 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.268 -179.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . 0.624 ' HG2' ' N ' ' A' ' 201' ' ' GLN . 1.5 tm-20 -73.39 -34.43 65.54 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 -179.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . 0.462 ' HG3' ' O ' ' A' ' 193' ' ' GLY . 89.9 mt-30 -62.52 -29.92 70.91 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.999 178.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.416 HG23 HG23 ' A' ' 199' ' ' VAL . 12.8 m -103.84 -24.44 4.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -176.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.436 HG11 HG11 ' A' ' 203' ' ' VAL . 1.0 OUTLIER -128.4 -85.75 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.779 176.58 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -178.36 158.3 22.86 Favored Glycine 0 CA--C 1.494 -1.223 0 N-CA-C 108.669 -1.772 . . . . 0.0 108.669 -176.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' GLN . . . . . 0.624 ' N ' ' HG2' ' A' ' 196' ' ' GLU . 10.7 pt20 -57.19 -46.39 82.89 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -177.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -69.93 -34.69 73.8 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.395 0.616 . . . . 0.0 110.55 -175.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.445 ' O ' HG13 ' A' ' 207' ' ' ILE . 2.0 t -75.2 -39.28 42.78 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-N 114.945 -1.025 . . . . 0.0 108.241 -178.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -57.48 -41.59 80.97 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.587 -1.188 . . . . 0.0 109.903 179.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -64.56 -39.79 94.38 Favored 'General case' 0 N--CA 1.422 -1.85 0 CA-C-N 114.966 -1.015 . . . . 0.0 112.047 -179.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' GLN . . . . . 0.436 HE21 HG13 ' A' ' 203' ' ' VAL . 27.1 pt20 -73.4 -30.09 63.02 Favored 'General case' 0 C--O 1.218 -0.554 0 C-N-CA 119.367 -0.933 . . . . 0.0 110.438 179.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' ILE . . . . . 0.445 HG13 ' O ' ' A' ' 203' ' ' VAL . 82.8 mt -68.03 -53.07 32.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 176.178 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 53.3 t-80 -62.57 -43.73 98.08 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 114.668 -1.151 . . . . 0.0 110.531 -177.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -70.7 -25.3 62.9 Favored 'General case' 0 C--O 1.202 -1.396 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -54.56 -47.84 72.76 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.083 0.553 . . . . 0.0 111.742 -176.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . 0.416 ' CZ ' ' HA ' ' A' ' 189' ' ' ASN . 34.1 p90 -93.69 -26.34 17.07 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.172 -178.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 46.4 m . . . . . 0 CA--C 1.551 1.002 0 CA-C-O 120.895 0.379 . . . . 0.0 111.061 179.994 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 44.6 tp . . . . . 0 C--O 1.236 0.38 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -63.36 -23.94 67.63 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.666 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -72.13 -32.5 66.99 Favored 'General case' 0 C--O 1.22 -0.497 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 10.2 m -86.37 -35.59 19.7 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.937 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.435 HG22 ' HB2' ' A' ' 188' ' ' SER . 0.4 OUTLIER -61.66 -25.68 37.57 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 C-N-CA 123.835 0.854 . . . . 0.0 111.571 -177.259 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -86.11 -8.01 58.18 Favored 'General case' 0 C--N 1.311 -1.103 0 O-C-N 121.941 -0.474 . . . . 0.0 111.561 178.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -97.46 17.99 16.33 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-O 120.606 0.241 . . . . 0.0 110.638 -176.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.438 HG21 ' HA ' ' A' ' 207' ' ' ILE . 65.2 mt -83.09 120.33 75.79 Favored Pre-proline 0 C--N 1.302 -1.463 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.364 -176.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.23 129.12 15.58 Favored 'Trans proline' 0 N--CA 1.445 -1.364 0 C-N-CA 121.82 1.68 . . . . 0.0 108.349 175.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 124.45 -33.14 3.88 Favored Glycine 0 C--N 1.288 -2.126 0 N-CA-C 108.47 -1.852 . . . . 0.0 108.47 -171.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 81.3 t -68.48 -43.5 83.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 174.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 107.55 140.27 9.43 Favored Glycine 0 N--CA 1.424 -2.12 0 CA-C-N 115.267 -0.879 . . . . 0.0 112.492 175.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -89.27 -36.27 15.68 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 121.131 0.491 . . . . 0.0 110.193 178.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 44.0 t -89.19 -31.98 5.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-O 121.735 0.778 . . . . 0.0 109.643 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.45 ' HG2' ' HG ' ' A' ' 177' ' ' LEU . 39.3 ttmt -77.36 -14.39 59.73 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.376 -179.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -52.36 -53.86 48.34 Favored Pre-proline 0 CA--C 1.557 1.222 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -176.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.444 ' O ' ' HG3' ' A' ' 179' ' ' GLN . 18.9 Cg_endo -61.19 -32.36 90.75 Favored 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 121.575 1.517 . . . . 0.0 112.8 178.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 57.4 tp -69.84 -40.59 75.75 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.543 0.687 . . . . 0.0 109.804 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.45 ' HG ' ' HG2' ' A' ' 173' ' ' LYS . 87.6 mt -68.51 -27.99 66.61 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.259 178.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 43.4 tp -74.91 -9.49 58.59 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.179 177.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . 0.444 ' HG3' ' O ' ' A' ' 175' ' ' PRO . 24.6 mt-30 -91.02 -29.74 17.19 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 175.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -84.27 -50.64 7.67 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.825 -179.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' PHE . . . . . 0.421 ' CD2' ' HG ' ' A' ' 187' ' ' LEU . 71.9 m-85 -97.7 149.12 35.38 Favored Pre-proline 0 C--N 1.293 -1.857 0 CA-C-N 115.056 -0.974 . . . . 0.0 109.204 -177.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -68.78 -42.21 4.89 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 121.994 1.796 . . . . 0.0 112.705 -177.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 78.2 p -147.72 166.77 26.48 Favored 'General case' 0 N--CA 1.427 -1.58 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -177.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.451 ' H ' HD13 ' A' ' 184' ' ' ILE . 0.2 OUTLIER -62.42 -29.28 46.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 O-C-N 123.772 0.67 . . . . 0.0 111.569 177.971 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -63.23 -45.95 89.25 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.735 -179.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' GLN . . . . . 0.543 HE21 ' C ' ' A' ' 186' ' ' GLN . 0.0 OUTLIER -79.2 -32.59 44.11 Favored 'General case' 0 C--O 1.202 -1.419 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.54 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.421 ' HG ' ' CD2' ' A' ' 181' ' ' PHE . 4.1 tt -53.81 -64.09 0.94 Allowed 'General case' 0 C--O 1.218 -0.567 0 C-N-CA 124.141 0.976 . . . . 0.0 110.285 -176.228 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . 0.435 ' HB2' HG22 ' A' ' 163' ' ' VAL . 19.9 m -70.42 -20.71 62.9 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 121.322 0.582 . . . . 0.0 111.793 -178.073 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -90.34 4.9 49.46 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.408 0.623 . . . . 0.0 111.009 -178.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.49 155.3 36.02 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.781 173.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 5.4 t -72.89 168.69 18.4 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.553 -175.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 50.8 mm -59.62 -37.73 72.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.751 -175.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -60.34 -31.92 75.44 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 116.448 -0.342 . . . . 0.0 112.803 178.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . 0.495 ' O ' ' HG2' ' A' ' 197' ' ' GLN . 24.3 mt-10 -83.77 -36.73 23.38 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 121.556 0.693 . . . . 0.0 109.269 -177.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 88.6 mt -78.44 -23.27 46.69 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-O 121.306 0.574 . . . . 0.0 111.72 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . 0.572 ' HG2' ' N ' ' A' ' 201' ' ' GLN . 2.5 tm-20 -80.49 -37.44 31.72 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . 0.495 ' HG2' ' O ' ' A' ' 194' ' ' GLU . 9.5 pt20 -68.01 -14.69 63.16 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.708 -177.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 4.1 m -103.46 -34.66 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 N-CA-C 111.621 0.23 . . . . 0.0 111.621 174.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 1.3 t -128.76 -80.31 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 C-N-CA 119.909 -0.716 . . . . 0.0 111.25 177.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -177.61 166.27 36.52 Favored Glycine 0 N--CA 1.434 -1.458 0 N-CA-C 111.46 -0.656 . . . . 0.0 111.46 -176.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' GLN . . . . . 0.572 ' N ' ' HG2' ' A' ' 196' ' ' GLU . 78.7 mt-30 -56.51 -50.39 71.95 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 124.756 1.222 . . . . 0.0 111.82 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -64.81 -27.87 69.17 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.681 0.753 . . . . 0.0 111.205 -175.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 90.3 t -80.14 -49.44 18.99 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.581 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -52.31 -46.64 66.07 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 124.763 1.225 . . . . 0.0 110.891 -179.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -61.74 -45.75 92.6 Favored 'General case' 0 N--CA 1.419 -2.011 0 CA-C-N 114.433 -1.258 . . . . 0.0 111.529 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -73.86 -28.61 61.67 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.348 -0.541 . . . . 0.0 111.877 -179.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' ILE . . . . . 0.438 ' HA ' HG21 ' A' ' 166' ' ' ILE . 81.9 mt -70.04 -50.34 48.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.182 0.515 . . . . 0.0 109.945 175.189 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 9.7 t60 -72.63 -37.02 68.15 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.248 -175.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -73.85 -16.38 61.13 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 120.22 -0.592 . . . . 0.0 112.164 178.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -54.37 -56.72 15.75 Favored 'General case' 0 C--O 1.215 -0.716 0 C-N-CA 123.386 0.674 . . . . 0.0 111.68 -177.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -81.04 -26.35 36.44 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.59 -178.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 32.3 m . . . . . 0 N--CA 1.443 -0.818 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.585 179.687 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.6 tt . . . . . 0 N--CA 1.485 1.288 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.5 ' HA ' HG12 ' A' ' 163' ' ' VAL . 2.3 pt? -58.18 -22.43 51.51 Favored 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 179.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 -68.04 -39.17 83.11 Favored 'General case' 0 C--O 1.223 -0.34 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 176.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 93.7 m -86.51 -31.64 21.18 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.731 -177.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.5 HG12 ' HA ' ' A' ' 160' ' ' LEU . 0.5 OUTLIER -65.32 -26.19 38.94 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 CA-C-O 121.664 0.745 . . . . 0.0 111.083 -177.416 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -86.44 -8.01 57.97 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.597 178.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -104.41 16.41 26.2 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.441 -178.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 84.5 mt -77.72 127.01 83.43 Favored Pre-proline 0 C--N 1.302 -1.46 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -66.31 128.55 19.6 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 121.778 1.652 . . . . 0.0 109.522 177.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 120.66 -33.87 4.29 Favored Glycine 0 N--CA 1.427 -1.953 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 -177.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 93.3 t -59.33 -60.27 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 CA-C-O 121.294 0.568 . . . . 0.0 110.447 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 113.87 95.04 2.1 Favored Glycine 0 N--CA 1.428 -1.833 0 C-N-CA 119.965 -1.112 . . . . 0.0 112.248 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -76.68 -20.57 56.47 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 121.274 0.559 . . . . 0.0 110.863 -178.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 57.5 t -83.11 -29.87 8.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-O 121.672 0.749 . . . . 0.0 109.362 178.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -83.44 -7.18 59.6 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.432 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -49.14 -50.12 65.5 Favored Pre-proline 0 CA--C 1.551 0.99 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 -176.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.512 ' O ' ' HG3' ' A' ' 179' ' ' GLN . 10.9 Cg_endo -57.28 -36.84 99.01 Favored 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 121.583 1.522 . . . . 0.0 112.862 177.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 60.4 tp -71.83 -40.47 69.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.419 ' HB3' HD11 ' A' ' 187' ' ' LEU . 97.0 mt -66.05 -34.03 77.16 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.705 179.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 47.9 tp -70.72 -13.94 62.25 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.441 0.639 . . . . 0.0 110.834 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . 0.512 ' HG3' ' O ' ' A' ' 175' ' ' PRO . 21.0 mt-30 -89.43 -35.99 15.7 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 176.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 40.9 mmtm -80.83 -47.43 13.84 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.212 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' PHE . . . . . 0.531 ' CD2' ' HA ' ' A' ' 187' ' ' LEU . 80.1 m-85 -101.78 145.54 30.65 Favored Pre-proline 0 C--N 1.296 -1.753 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -177.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -56.8 -47.57 22.76 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 122.919 2.412 . . . . 0.0 111.673 177.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . 0.411 ' O ' ' HB2' ' A' ' 187' ' ' LEU . 78.2 p -153.24 171.58 18.31 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 -178.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -63.32 -25.14 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 121.333 0.587 . . . . 0.0 110.401 176.003 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -65.51 -45.12 84.77 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.359 -178.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -79.49 -36.2 39.01 Favored 'General case' 0 C--O 1.203 -1.381 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 176.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.531 ' HA ' ' CD2' ' A' ' 181' ' ' PHE . 4.7 tt -49.1 -66.29 0.42 Allowed 'General case' 0 C--O 1.213 -0.844 0 C-N-CA 125.482 1.513 . . . . 0.0 111.503 -175.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 35.1 m -70.95 -20.78 62.41 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -175.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -90.89 0.59 57.45 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.472 ' HB1' ' HB2' ' A' ' 194' ' ' GLU . . . -65.58 155.46 35.71 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 122.902 0.481 . . . . 0.0 110.445 175.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 27.9 p -66.98 165.24 15.99 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.125 -178.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 50.7 mm -55.91 -37.64 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -58.58 -37.08 88.12 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-N 115.309 -0.86 . . . . 0.0 113.514 178.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . 0.472 ' HB2' ' HB1' ' A' ' 190' ' ' ALA . 30.1 mt-10 -83.4 -37.88 22.69 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.336 0.589 . . . . 0.0 109.503 -177.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 95.0 mt -71.65 -31.76 67.19 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.866 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -67.1 -31.37 71.79 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.35 0.595 . . . . 0.0 109.743 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -63.81 -26.27 68.55 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 114.865 -1.061 . . . . 0.0 112.723 179.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 12.2 m -103.88 -38.35 5.02 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.517 HG23 ' H ' ' A' ' 200' ' ' GLY . 2.5 m -117.05 -80.55 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 178.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . 0.517 ' H ' HG23 ' A' ' 199' ' ' VAL . . . -177.99 166.41 36.54 Favored Glycine 0 N--CA 1.418 -2.525 0 N-CA-C 108.434 -1.866 . . . . 0.0 108.434 -178.082 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' GLN . . . . . 0.519 ' O ' ' HG3' ' A' ' 205' ' ' GLN . 63.4 tt0 -68.54 -43.37 76.84 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 118.038 0.919 . . . . 0.0 110.837 -178.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -65.46 -32.99 74.9 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.122 0.487 . . . . 0.0 110.866 -179.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 2.4 t -75.53 -40.89 41.74 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.738 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -179.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -57.94 -43.85 86.56 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.355 -179.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . 0.519 ' HG3' ' O ' ' A' ' 201' ' ' GLN . 26.7 mt-30 -61.89 -47.12 86.4 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.684 -178.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -69.53 -33.05 72.24 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.437 -0.505 . . . . 0.0 111.54 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 99.2 mt -69.24 -50.39 52.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.13 0.49 . . . . 0.0 109.82 176.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 59.5 t-80 -67.59 -39.88 84.81 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.253 -177.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -72.01 -18.39 61.97 Favored 'General case' 0 C--O 1.213 -0.826 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -55.12 -51.45 66.4 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.396 0.617 . . . . 0.0 110.459 -178.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -89.37 -27.67 20.31 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.994 -179.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 60.4 m . . . . . 0 C--N 1.318 -0.764 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -177.981 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 48.8 tp . . . . . 0 N--CA 1.438 -1.051 0 N-CA-C 110.579 -0.156 . . . . 0.0 110.579 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.413 ' HA ' HG12 ' A' ' 163' ' ' VAL . 2.0 pt? -49.59 -40.9 40.4 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.159 0.984 . . . . 0.0 112.542 -178.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.434 HH11 ' HD3' ' A' ' 161' ' ' ARG . 1.7 ptm180 -59.89 -47.05 87.32 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.35 178.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 38.0 m -86.18 -29.72 23.0 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 120.988 0.423 . . . . 0.0 112.083 -175.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.413 HG12 ' HA ' ' A' ' 160' ' ' LEU . 0.6 OUTLIER -67.0 -25.38 34.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 121.701 0.762 . . . . 0.0 111.239 -175.771 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 24.6 pt20 -82.59 -7.6 59.64 Favored 'General case' 0 C--N 1.315 -0.921 0 O-C-N 121.897 -0.502 . . . . 0.0 111.847 177.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -101.77 21.92 13.74 Favored 'General case' 0 C--O 1.239 0.553 0 CA-C-O 121.459 0.647 . . . . 0.0 110.671 -178.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.496 HG21 ' HA ' ' A' ' 207' ' ' ILE . 74.5 mt -88.51 133.15 36.93 Favored Pre-proline 0 C--N 1.303 -1.425 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.395 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -64.18 128.58 21.98 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 121.708 1.606 . . . . 0.0 109.745 175.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 118.76 -30.97 5.71 Favored Glycine 0 N--CA 1.43 -1.715 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -174.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 97.8 t -74.22 -59.58 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 176.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 104.69 147.16 16.19 Favored Glycine 0 N--CA 1.44 -1.074 0 C-N-CA 120.931 -0.652 . . . . 0.0 113.923 174.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . 0.541 ' HG3' HG23 ' A' ' 172' ' ' VAL . 57.2 pttt -89.64 -43.36 10.8 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.11 0.481 . . . . 0.0 110.883 176.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.541 HG23 ' HG3' ' A' ' 171' ' ' LYS . 40.4 t -81.32 -33.17 12.47 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.69 0 CA-C-O 121.679 0.752 . . . . 0.0 109.933 -174.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.501 ' O ' ' HG ' ' A' ' 177' ' ' LEU . 14.4 ptmm? -90.94 5.94 46.66 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.931 -179.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -66.11 -47.39 62.18 Favored Pre-proline 0 CA--C 1.55 0.972 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.488 ' O ' ' HG2' ' A' ' 179' ' ' GLN . 37.0 Cg_exo -61.25 -36.88 77.56 Favored 'Trans proline' 0 C--N 1.384 2.438 0 C-N-CA 121.555 1.503 . . . . 0.0 110.724 178.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 58.9 tp -61.71 -46.79 88.15 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.3 175.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.501 ' HG ' ' O ' ' A' ' 173' ' ' LYS . 94.1 mt -61.38 -37.69 84.32 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.938 178.307 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 95.7 mt -65.75 -17.92 64.96 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.337 177.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . 0.488 ' HG2' ' O ' ' A' ' 175' ' ' PRO . 15.3 mm100 -92.47 -7.81 46.42 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 120.899 0.381 . . . . 0.0 110.488 177.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.462 ' NZ ' ' HA ' ' A' ' 180' ' ' LYS . 0.3 OUTLIER -102.87 -51.68 3.23 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.644 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' PHE . . . . . 0.496 ' CD2' ' HG ' ' A' ' 187' ' ' LEU . 88.3 m-85 -98.08 149.91 36.21 Favored Pre-proline 0 C--N 1.294 -1.843 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -63.89 -43.42 16.08 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 121.737 1.625 . . . . 0.0 112.063 -175.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 43.1 m -155.05 171.8 19.17 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.506 ' H ' HD13 ' A' ' 184' ' ' ILE . 0.2 OUTLIER -65.99 -28.94 45.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -175.015 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 22.4 tp60 -66.88 -35.8 80.85 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.973 -177.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -79.66 -37.44 35.89 Favored 'General case' 0 C--O 1.203 -1.349 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 176.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.496 ' HG ' ' CD2' ' A' ' 181' ' ' PHE . 4.3 tt -49.71 -68.07 0.21 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.065 1.346 . . . . 0.0 112.344 -173.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 20.1 m -72.65 -24.29 61.02 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 121.169 0.509 . . . . 0.0 111.818 -174.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -87.47 1.27 53.95 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.995 -179.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.2 155.76 33.98 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 121.085 0.469 . . . . 0.0 110.582 176.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 4.7 m -63.34 160.96 14.89 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.297 -177.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 46.4 mm -50.16 -41.06 18.13 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.865 0 C-N-CA 123.278 0.631 . . . . 0.0 110.927 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -61.82 -30.05 74.01 Favored Glycine 0 CA--C 1.523 0.549 0 CA-C-N 116.216 -0.447 . . . . 0.0 113.243 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -83.44 -44.67 14.51 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 98.4 mt -65.69 -28.29 68.96 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.857 -179.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -70.43 -35.41 73.37 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -63.5 -24.72 67.94 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.221 -0.9 . . . . 0.0 113.221 -178.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 13.4 m -101.47 -26.42 3.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -178.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.478 HG23 ' H ' ' A' ' 200' ' ' GLY . 2.2 m -131.77 -82.33 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 112.902 0.705 . . . . 0.0 112.902 174.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . 0.478 ' H ' HG23 ' A' ' 199' ' ' VAL . . . -177.37 165.36 35.16 Favored Glycine 0 N--CA 1.422 -2.249 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 -177.023 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -65.3 -39.07 92.05 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 117.596 0.698 . . . . 0.0 112.507 -177.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -66.91 -35.92 81.08 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.164 0.507 . . . . 0.0 110.306 -178.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.435 ' O ' ' HG2' ' A' ' 206' ' ' GLN . 2.0 t -76.62 -39.46 32.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 -179.165 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -57.22 -41.5 79.58 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.033 178.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . 0.548 HE21 ' HA ' ' A' ' 205' ' ' GLN . 0.0 OUTLIER -62.42 -40.82 97.79 Favored 'General case' 0 N--CA 1.424 -1.737 0 CA-C-N 115.133 -0.939 . . . . 0.0 112.341 179.689 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' GLN . . . . . 0.435 ' HG2' ' O ' ' A' ' 203' ' ' VAL . 20.8 pt20 -72.42 -34.59 67.96 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.895 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' ILE . . . . . 0.496 ' HA ' HG21 ' A' ' 166' ' ' ILE . 73.5 mt -65.67 -48.55 82.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.559 0.695 . . . . 0.0 109.417 175.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 46.9 t-80 -67.22 -40.38 86.37 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.071 -178.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -64.29 -25.93 68.26 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 178.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -56.62 -43.73 80.48 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.533 0.733 . . . . 0.0 110.894 -177.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -95.88 -28.46 14.7 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 120.108 -0.637 . . . . 0.0 111.838 178.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 86.7 m . . . . . 0 CA--C 1.547 0.849 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 179.915 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 42.4 mt . . . . . 0 CA--C 1.487 -1.458 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.538 HD23 ' H ' ' A' ' 160' ' ' LEU . 2.0 pt? -61.31 -29.58 69.96 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.66 176.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 27.0 ptt180 -78.86 -24.78 44.09 Favored 'General case' 0 C--O 1.216 -0.69 0 C-N-CA 120.485 -0.486 . . . . 0.0 109.703 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 26.5 m -86.19 -41.53 14.59 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-O 121.377 0.608 . . . . 0.0 110.379 178.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -59.78 -26.5 35.48 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 C-N-CA 124.216 1.007 . . . . 0.0 111.553 -177.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -83.29 -15.1 51.47 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.81 177.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -106.28 14.2 27.78 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-O 121.329 0.585 . . . . 0.0 110.129 -175.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 94.8 mt -71.56 132.05 85.82 Favored Pre-proline 0 C--O 1.249 1.04 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 176.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -63.15 128.44 22.81 Favored 'Trans proline' 0 C--O 1.246 0.924 0 C-N-CA 122.007 1.805 . . . . 0.0 109.768 176.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 117.1 -32.82 5.29 Favored Glycine 0 N--CA 1.431 -1.65 0 C-N-CA 120.789 -0.72 . . . . 0.0 111.391 -177.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 59.6 t -66.95 -71.43 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.773 0 CA-C-O 121.231 0.538 . . . . 0.0 109.674 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 113.66 109.42 2.88 Favored Glycine 0 N--CA 1.421 -2.302 0 C-N-CA 119.975 -1.107 . . . . 0.0 112.91 177.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt -78.74 -15.05 58.91 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 121.718 0.771 . . . . 0.0 109.69 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 91.0 t -79.81 -36.64 17.38 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.895 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.538 ' O ' ' HG ' ' A' ' 177' ' ' LEU . 9.3 ptpp? -90.43 -5.89 55.56 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.073 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -52.81 -49.67 85.45 Favored Pre-proline 0 CA--C 1.552 1.03 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -177.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -62.56 -23.94 74.99 Favored 'Trans proline' 0 C--N 1.371 1.714 0 C-N-CA 121.283 1.322 . . . . 0.0 112.824 176.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.52 ' HA ' HE21 ' A' ' 179' ' ' GLN . 59.6 tp -77.63 -39.34 45.58 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 175.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 173' ' ' LYS . 87.4 mt -69.17 -33.05 72.79 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.837 -179.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 41.1 tp -68.24 -12.73 61.47 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-O 121.824 0.821 . . . . 0.0 110.76 178.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . 0.52 HE21 ' HA ' ' A' ' 176' ' ' LEU . 51.3 mt-30 -94.13 -3.34 51.22 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.829 177.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 37.2 mmtm -117.51 -45.91 2.69 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 121.284 0.564 . . . . 0.0 110.94 177.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -102.4 145.03 29.79 Favored Pre-proline 0 C--N 1.303 -1.451 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 -179.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -67.0 -34.45 29.04 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 121.723 1.615 . . . . 0.0 112.411 -176.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 84.5 p -151.29 166.49 30.79 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -178.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.467 ' H ' HD13 ' A' ' 184' ' ' ILE . 0.2 OUTLIER -66.91 -25.02 33.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 O-C-N 123.384 0.428 . . . . 0.0 110.885 175.025 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -64.71 -47.46 78.24 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.45 178.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -73.37 -35.93 66.0 Favored 'General case' 0 C--O 1.195 -1.775 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.466 HD21 HD13 ' A' ' 177' ' ' LEU . 4.4 tt -49.04 -65.96 0.48 Allowed 'General case' 0 C--O 1.217 -0.631 0 C-N-CA 124.697 1.199 . . . . 0.0 110.398 -177.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 19.8 m -68.79 -23.75 64.33 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -177.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 26.6 m-80 -85.11 -2.76 58.37 Favored 'General case' 0 C--O 1.242 0.699 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 178.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -66.34 156.3 34.87 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 122.978 0.511 . . . . 0.0 110.965 178.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 15.8 m -63.05 153.3 34.44 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.832 -178.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 48.9 mm -51.21 -36.67 16.95 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.927 0 C-N-CA 123.84 0.856 . . . . 0.0 111.274 -176.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . 0.57 ' O ' ' HG2' ' A' ' 197' ' ' GLN . . . -58.42 -45.89 93.78 Favored Glycine 0 N--CA 1.443 -0.843 0 O-C-N 123.385 0.428 . . . . 0.0 112.547 178.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . 0.447 ' O ' ' HB2' ' A' ' 197' ' ' GLN . 11.1 mm-40 -67.96 -40.77 83.13 Favored 'General case' 0 CA--C 1.494 -1.208 0 CA-C-O 121.772 0.796 . . . . 0.0 109.705 -177.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 94.3 mt -70.82 -31.09 67.71 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.76 178.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -68.95 -35.71 77.1 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . 0.57 ' HG2' ' O ' ' A' ' 193' ' ' GLY . 15.5 mm100 -57.89 -33.31 68.6 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.638 -1.164 . . . . 0.0 111.465 177.172 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 14.2 m -103.33 -35.04 3.62 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -176.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.467 HG23 ' H ' ' A' ' 200' ' ' GLY . 2.4 m -118.89 -77.66 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 176.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . 0.467 ' H ' HG23 ' A' ' 199' ' ' VAL . . . -178.69 165.33 34.39 Favored Glycine 0 N--CA 1.419 -2.443 0 N-CA-C 107.963 -2.055 . . . . 0.0 107.963 -177.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -66.07 -45.65 80.52 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 117.762 0.781 . . . . 0.0 109.855 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -67.76 -33.59 75.14 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-O 121.161 0.505 . . . . 0.0 110.983 -179.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.412 HG23 ' H ' ' A' ' 203' ' ' VAL . 2.6 t -73.81 -40.52 53.53 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.686 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 -178.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -56.04 -44.97 79.3 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.545 -1.207 . . . . 0.0 109.882 177.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -59.32 -50.9 72.19 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.582 178.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -66.97 -30.63 70.81 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 121.046 -0.261 . . . . 0.0 111.559 -176.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 97.4 mt -75.11 -51.4 21.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.373 177.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 9.7 t60 -69.86 -38.4 76.43 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.368 0.604 . . . . 0.0 110.202 -175.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -77.95 -9.94 59.34 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -60.1 -51.29 70.23 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-O 121.514 0.673 . . . . 0.0 110.395 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -86.82 -26.97 23.79 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.394 -179.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 37.6 m . . . . . 0 C--N 1.316 -0.856 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.595 -179.741 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.1 tm? . . . . . 0 N--CA 1.45 -0.436 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.422 ' O ' HG12 ' A' ' 163' ' ' VAL . 2.1 pt? -60.21 -33.08 71.75 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -178.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -75.79 -26.26 57.15 Favored 'General case' 0 C--O 1.219 -0.536 0 CA-C-O 121.768 0.794 . . . . 0.0 109.75 -178.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 21.5 m -86.24 -35.43 20.01 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-O 121.537 0.685 . . . . 0.0 110.153 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.422 HG12 ' O ' ' A' ' 160' ' ' LEU . 0.4 OUTLIER -64.54 -25.2 37.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.224 -176.507 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -84.57 -10.8 57.06 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.115 0.484 . . . . 0.0 110.787 177.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -102.75 23.38 12.17 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.292 0.568 . . . . 0.0 110.364 -177.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.416 HG21 ' HA ' ' A' ' 207' ' ' ILE . 84.8 mt -84.18 129.57 57.81 Favored Pre-proline 0 C--N 1.308 -1.221 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.048 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.98 128.79 18.32 Favored 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 121.778 1.652 . . . . 0.0 110.561 177.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 113.89 -16.72 20.65 Favored Glycine 0 C--N 1.297 -1.635 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.807 179.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 77.9 t -61.69 -43.21 96.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-O 121.028 0.442 . . . . 0.0 110.87 179.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 108.35 88.53 1.98 Allowed Glycine 0 N--CA 1.44 -1.097 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.383 178.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -60.64 -33.67 73.14 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -178.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 38.3 t -83.93 -23.49 7.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.336 0.589 . . . . 0.0 109.927 -176.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.54 ' O ' ' HG ' ' A' ' 177' ' ' LEU . 31.2 mtpt -85.57 -2.17 57.88 Favored 'General case' 0 C--O 1.193 -1.911 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.826 -176.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -42.97 -52.07 12.01 Favored Pre-proline 0 CA--C 1.566 1.587 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 -176.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.72 -38.55 10.23 Favored 'Trans proline' 0 C--N 1.366 1.487 0 C-N-CA 121.653 1.569 . . . . 0.0 111.738 178.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 54.4 tp -64.05 -41.31 97.43 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.116 177.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.54 ' HG ' ' O ' ' A' ' 173' ' ' LYS . 94.5 mt -58.22 -36.79 73.68 Favored 'General case' 0 C--O 1.206 -1.198 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.424 175.21 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.431 ' HA ' ' O ' ' A' ' 181' ' ' PHE . 92.5 mt -70.81 -11.93 61.25 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.299 0.571 . . . . 0.0 112.272 178.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -88.06 -5.42 58.49 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.83 0.824 . . . . 0.0 109.41 174.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.409 ' NZ ' ' HA ' ' A' ' 180' ' ' LYS . 0.3 OUTLIER -113.82 -50.73 2.82 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.359 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' PHE . . . . . 0.537 ' CD2' ' HG ' ' A' ' 187' ' ' LEU . 34.5 m-85 -110.23 140.81 22.78 Favored Pre-proline 0 C--N 1.3 -1.549 0 CA-C-N 114.571 -1.195 . . . . 0.0 108.921 -177.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.91 -52.5 5.86 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 123.178 2.585 . . . . 0.0 112.682 178.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 50.7 m -154.64 172.83 17.24 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -179.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -54.05 -32.08 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 114.495 1.294 . . . . 0.0 114.495 -176.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -65.02 -43.06 93.7 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.901 0.381 . . . . 0.0 111.01 -177.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -79.42 -35.9 39.84 Favored 'General case' 0 C--O 1.196 -1.73 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 176.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.537 ' HG ' ' CD2' ' A' ' 181' ' ' PHE . 5.5 tt -51.82 -67.05 0.28 Allowed 'General case' 0 C--O 1.208 -1.126 0 C-N-CA 124.712 1.205 . . . . 0.0 112.208 -173.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . 0.417 ' CB ' HG22 ' A' ' 163' ' ' VAL . 24.3 m -75.83 -18.72 59.36 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-O 121.157 0.503 . . . . 0.0 112.235 -174.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -93.57 -0.06 56.4 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.131 -179.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.93 155.6 36.02 Favored 'General case' 0 CA--C 1.506 -0.721 0 C-N-CA 123.539 0.736 . . . . 0.0 110.375 176.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 20.4 m -64.95 159.51 22.76 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.035 -176.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 48.2 mm -51.72 -39.62 24.56 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.647 0 C-N-CA 123.271 0.628 . . . . 0.0 110.707 -177.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -60.16 -37.92 93.63 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-N 116.003 -0.544 . . . . 0.0 113.482 179.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -75.1 -41.25 59.08 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -177.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 96.1 mt -68.64 -34.66 76.1 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.217 179.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . 0.476 ' HG2' ' N ' ' A' ' 201' ' ' GLN . 5.0 tm-20 -65.92 -33.75 76.53 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -178.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -61.88 -30.5 70.91 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.792 -1.094 . . . . 0.0 113.113 179.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 25.9 m -100.3 -36.27 5.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 C-N-CA 119.592 -0.843 . . . . 0.0 111.411 -179.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.544 HG23 ' H ' ' A' ' 200' ' ' GLY . 2.9 m -116.19 -85.65 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 176.216 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . 0.544 ' H ' HG23 ' A' ' 199' ' ' VAL . . . -176.82 165.67 35.97 Favored Glycine 0 N--CA 1.415 -2.708 0 N-CA-C 108.274 -1.93 . . . . 0.0 108.274 -175.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' GLN . . . . . 0.476 ' N ' ' HG2' ' A' ' 196' ' ' GLU . 52.9 tt0 -67.72 -42.15 82.37 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 117.496 0.648 . . . . 0.0 112.097 -174.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -66.66 -35.78 80.97 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.186 0.517 . . . . 0.0 110.624 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.519 ' O ' ' HG2' ' A' ' 206' ' ' GLN . 2.6 t -71.64 -40.38 70.62 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.747 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -57.06 -43.84 82.44 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 114.366 -1.288 . . . . 0.0 110.098 178.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . 0.403 ' HG3' ' O ' ' A' ' 201' ' ' GLN . 53.9 mt-30 -60.93 -45.59 94.06 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 114.955 -1.021 . . . . 0.0 112.372 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' GLN . . . . . 0.519 ' HG2' ' O ' ' A' ' 203' ' ' VAL . 13.2 pt20 -69.29 -30.86 69.03 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 120.236 -0.585 . . . . 0.0 110.708 -177.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' ILE . . . . . 0.416 ' HA ' HG21 ' A' ' 166' ' ' ILE . 92.4 mt -73.44 -50.38 30.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.268 178.107 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 48.1 t-80 -69.1 -41.46 77.4 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.159 -177.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -73.44 -11.51 60.49 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 121.941 -0.474 . . . . 0.0 112.227 179.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -58.82 -51.9 68.02 Favored 'General case' 0 C--O 1.217 -0.646 0 C-N-CA 122.795 0.438 . . . . 0.0 110.743 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -80.51 -24.84 39.09 Favored 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.524 -179.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 27.5 m . . . . . 0 CA--C 1.546 0.815 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.615 175.696 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 36.6 t . . . . . 0 N--CA 1.437 -1.105 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -133.59 164.39 27.28 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -177.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -77.94 124.05 86.2 Favored Pre-proline 0 C--N 1.306 -1.296 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 170.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -58.03 108.48 0.39 Allowed 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.471 2.114 . . . . 0.0 113.283 -175.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 93.7 mt -90.1 -3.68 57.78 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.01 -0.995 . . . . 0.0 108.754 176.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 74.8 mt -81.21 105.22 12.24 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 114.777 -1.102 . . . . 0.0 108.491 178.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 127.27 160.42 10.49 Favored Glycine 0 N--CA 1.431 -1.68 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.548 178.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -88.7 127.11 35.58 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -122.21 128.86 51.69 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.425 -176.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -106.0 128.94 54.17 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 174.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -132.45 101.8 5.48 Favored 'General case' 0 C--N 1.295 -1.761 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.743 -177.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 52.1 tp -78.98 106.66 11.17 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 176.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 85.0 mt -101.18 135.13 43.15 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.277 -172.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 60.6 tp -88.35 85.53 6.9 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 176.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 28.4 m -135.63 107.26 6.96 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.314 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -77.58 115.85 53.17 Favored Pre-proline 0 C--N 1.307 -1.245 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 -179.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -81.8 21.43 0.94 Allowed 'Trans proline' 0 N--CA 1.482 0.827 0 C-N-CA 123.5 2.8 . . . . 0.0 113.536 -174.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.578 ' O ' ' HG2' ' A' ' 161' ' ' ARG . 28.0 m 62.88 59.47 1.37 Allowed 'General case' 0 N--CA 1.436 -1.175 0 CA-C-O 122.531 1.158 . . . . 0.0 109.583 -176.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -76.99 -29.75 55.64 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 114.255 -1.339 . . . . 0.0 108.929 -179.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.535 ' O ' HG12 ' A' ' 163' ' ' VAL . 2.0 pt? -58.81 -30.35 67.55 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.455 -179.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.578 ' HG2' ' O ' ' A' ' 158' ' ' SER . 12.3 ptm180 -78.78 -26.4 44.45 Favored 'General case' 0 C--N 1.309 -1.166 0 O-C-N 121.837 -0.54 . . . . 0.0 110.563 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 24.9 m -85.84 -28.59 24.34 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.574 0.702 . . . . 0.0 109.637 177.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.535 HG12 ' O ' ' A' ' 160' ' ' LEU . 0.3 OUTLIER -66.3 -25.71 36.15 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 CA-C-O 121.832 0.825 . . . . 0.0 111.072 -176.703 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . 0.4 HE21 HG21 ' A' ' 184' ' ' ILE . 3.8 pt20 -84.87 -7.44 59.17 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.37 177.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -96.3 1.86 52.33 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.027 -178.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.404 HG21 ' HA ' ' A' ' 207' ' ' ILE . 70.3 mt -73.96 131.14 81.83 Favored Pre-proline 0 C--N 1.314 -0.975 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.057 -177.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -66.68 128.23 18.62 Favored 'Trans proline' 0 C--O 1.246 0.897 0 C-N-CA 121.934 1.756 . . . . 0.0 110.235 175.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 116.02 -24.23 10.2 Favored Glycine 0 C--N 1.297 -1.59 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 -178.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 65.6 t -75.02 -58.39 4.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 177.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 90.13 107.06 1.27 Allowed Glycine 0 N--CA 1.425 -2.062 0 CA-C-N 115.431 -0.804 . . . . 0.0 113.576 177.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? -68.46 -21.24 64.65 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 121.577 0.703 . . . . 0.0 111.201 178.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 57.9 t -82.53 -30.56 9.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-O 121.712 0.768 . . . . 0.0 109.35 178.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.429 ' O ' HD13 ' A' ' 177' ' ' LEU . 60.0 mtpt -84.79 -10.25 57.38 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.955 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -51.73 -53.79 46.97 Favored Pre-proline 0 C--O 1.201 -1.472 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -178.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -62.3 -26.58 77.3 Favored 'Trans proline' 0 C--N 1.376 1.982 0 C-N-CA 121.856 1.704 . . . . 0.0 113.413 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 61.6 tp -77.38 -45.27 26.49 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 121.741 0.781 . . . . 0.0 109.103 178.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.429 HD13 ' O ' ' A' ' 173' ' ' LYS . 8.2 mp -71.84 -24.35 61.69 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.873 178.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.449 HD12 ' O ' ' A' ' 181' ' ' PHE . 42.5 tp -67.31 -11.68 58.21 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 124.091 0.956 . . . . 0.0 110.401 177.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -76.53 -20.59 56.74 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.514 175.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 7.8 mmmm -105.58 -42.13 5.29 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.918 178.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . 0.449 ' O ' HD12 ' A' ' 178' ' ' LEU . 32.5 m-85 -105.64 130.55 22.87 Favored Pre-proline 0 C--N 1.299 -1.611 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.935 -174.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -53.73 -42.4 66.52 Favored 'Trans proline' 0 C--N 1.359 1.128 0 C-N-CA 123.623 2.882 . . . . 0.0 113.7 -175.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 42.6 m -158.5 177.5 11.17 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.482 ' HA ' ' HB3' ' A' ' 187' ' ' LEU . 0.2 OUTLIER -59.52 -27.89 38.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 -175.961 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -69.1 -38.63 79.03 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 120.67 0.272 . . . . 0.0 110.94 -177.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . 0.433 HE21 ' C ' ' A' ' 186' ' ' GLN . 0.0 OUTLIER -79.9 -33.44 39.89 Favored 'General case' 0 C--O 1.195 -1.81 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 176.296 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.482 ' HB3' ' HA ' ' A' ' 184' ' ' ILE . 62.4 tp -52.63 -67.78 0.22 Allowed 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 125.104 1.362 . . . . 0.0 113.467 -176.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.438 ' HB2' HG22 ' A' ' 163' ' ' VAL . 19.4 m -74.65 -24.75 58.87 Favored 'General case' 0 C--N 1.289 -2.04 0 C-N-CA 120.24 -0.584 . . . . 0.0 111.609 -176.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.473 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 62.4 t30 -89.45 12.0 17.7 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-O 122.095 0.95 . . . . 0.0 110.025 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.51 156.62 31.95 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.606 173.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 6.6 m -63.6 154.38 32.91 Favored 'General case' 0 N--CA 1.425 -1.676 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.082 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 48.9 mm -52.02 -39.73 26.96 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.825 0 C-N-CA 123.477 0.711 . . . . 0.0 110.889 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.502 ' O ' ' HG2' ' A' ' 197' ' ' GLN . . . -59.39 -39.13 94.39 Favored Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 116.18 -0.464 . . . . 0.0 112.631 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 0.441 ' O ' ' HB2' ' A' ' 197' ' ' GLN . 41.6 mm-40 -77.72 -38.55 46.96 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.43 0.633 . . . . 0.0 109.807 -176.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 96.8 mt -69.88 -32.2 70.42 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.485 178.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -67.37 -29.72 69.32 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -178.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.502 ' HG2' ' O ' ' A' ' 193' ' ' GLY . 15.8 mm100 -59.62 -33.84 72.01 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.737 -1.12 . . . . 0.0 112.441 178.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 23.4 m -103.48 -26.83 3.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -174.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.484 HG23 ' H ' ' A' ' 200' ' ' GLY . 1.4 m -123.15 -82.82 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 175.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . 0.484 ' H ' HG23 ' A' ' 199' ' ' VAL . . . -177.0 167.87 39.42 Favored Glycine 0 N--CA 1.419 -2.449 0 N-CA-C 108.857 -1.697 . . . . 0.0 108.857 -177.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 19.5 tm0? -64.14 -47.95 77.94 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 123.254 0.622 . . . . 0.0 110.814 -175.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -71.65 -32.34 67.81 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.859 0.361 . . . . 0.0 111.066 -177.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.442 ' O ' ' HG2' ' A' ' 206' ' ' GLN . 2.9 t -69.03 -40.07 80.39 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.649 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 179.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -60.19 -43.18 96.12 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 114.294 -1.321 . . . . 0.0 109.675 177.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -59.72 -45.58 91.75 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.785 179.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . 0.442 ' HG2' ' O ' ' A' ' 203' ' ' VAL . 12.0 pt20 -66.26 -34.75 78.72 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 120.145 -0.622 . . . . 0.0 111.084 -179.041 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' ILE . . . . . 0.404 ' HA ' HG21 ' A' ' 166' ' ' ILE . 87.3 mt -69.43 -51.48 41.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.291 0.567 . . . . 0.0 109.712 178.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' HIS . . . . . 0.553 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 13.4 t60 -68.0 -36.71 80.46 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.237 -175.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -68.06 -32.79 73.37 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.694 176.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -54.62 -52.21 62.94 Favored 'General case' 0 C--O 1.215 -0.733 0 C-N-CA 124.023 0.929 . . . . 0.0 112.367 -174.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.553 ' CZ ' ' HA ' ' A' ' 208' ' ' HIS . 21.5 p90 -80.8 -23.85 38.96 Favored 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 120.36 -0.536 . . . . 0.0 112.097 -178.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 75.2 m -65.78 -51.53 58.34 Favored 'General case' 0 C--O 1.247 0.932 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -140.88 109.04 6.47 Favored Pre-proline 0 N--CA 1.423 -1.803 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 177.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -108.43 162.61 0.1 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 122.282 1.988 . . . . 0.0 113.743 177.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 13.6 tpp180 . . . . . 0 N--CA 1.422 -1.871 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 174.246 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 50.8 m . . . . . 0 N--CA 1.427 -1.623 0 N-CA-C 110.334 -0.247 . . . . 0.0 110.334 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt 61.19 83.84 0.14 Allowed 'General case' 0 C--O 1.242 0.701 0 C-N-CA 124.272 1.029 . . . . 0.0 111.995 176.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.55 HD21 ' HA ' ' A' ' 146' ' ' LEU . 27.8 p-10 -96.67 157.8 34.67 Favored Pre-proline 0 C--N 1.295 -1.795 0 CA-C-N 114.696 -1.138 . . . . 0.0 108.624 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -39.26 -54.76 1.7 Allowed 'Trans proline' 0 C--N 1.366 1.464 0 C-N-CA 124.131 3.221 . . . . 0.0 114.067 178.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 7.1 tt -156.97 114.17 3.1 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.55 ' HA ' HD21 ' A' ' 143' ' ' ASN . 57.1 tp -69.16 105.88 2.63 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.566 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 132.45 -149.35 19.46 Favored Glycine 0 N--CA 1.41 -3.087 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 178.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -106.8 101.93 11.33 Favored 'General case' 0 C--N 1.284 -2.263 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -76.75 169.09 18.94 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-O 121.104 0.478 . . . . 0.0 110.183 -178.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 9.9 tpt180 -98.96 131.39 45.06 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -74.44 100.68 3.89 Favored 'General case' 0 N--CA 1.425 -1.713 0 N-CA-C 105.085 -2.191 . . . . 0.0 105.085 171.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 62.6 tp -93.89 122.48 36.42 Favored 'General case' 0 N--CA 1.41 -2.438 0 CA-C-N 114.592 -1.186 . . . . 0.0 109.869 -172.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -77.27 83.54 3.73 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.987 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.511 ' O ' HD12 ' A' ' 154' ' ' LEU . 2.9 pp -108.03 119.03 38.3 Favored 'General case' 0 N--CA 1.404 -2.767 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 169.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 8.6 t -80.73 107.26 13.39 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -176.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -73.29 113.66 24.22 Favored Pre-proline 0 C--N 1.291 -1.958 0 CA-C-N 114.129 -1.396 . . . . 0.0 109.65 -176.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -81.15 -165.27 0.33 Allowed 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 122.464 2.11 . . . . 0.0 112.012 -178.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.414 ' O ' ' HG2' ' A' ' 161' ' ' ARG . 14.7 m -75.45 18.63 0.21 Allowed 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -176.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.483 ' O ' HD23 ' A' ' 159' ' ' LEU . 6.2 tt -60.21 -21.81 62.23 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 124.628 1.171 . . . . 0.0 110.169 -178.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -59.37 -22.36 61.24 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.045 0.45 . . . . 0.0 111.738 178.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.414 ' HG2' ' O ' ' A' ' 158' ' ' SER . 32.8 ptt180 -73.49 -35.42 65.64 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.451 ' HA ' ' OE1' ' A' ' 165' ' ' GLN . 33.3 m -87.03 -29.11 22.18 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 124.244 1.018 . . . . 0.0 112.163 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 2.8 p -64.56 -27.08 41.76 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-O 121.752 0.787 . . . . 0.0 110.757 -176.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -82.94 -8.67 59.54 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.91 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.451 ' OE1' ' HA ' ' A' ' 162' ' ' THR . 51.0 mt-30 -98.42 0.42 45.26 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.665 -177.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 96.4 mt -68.43 131.54 91.66 Favored Pre-proline 0 C--N 1.312 -1.048 0 N-CA-C 108.876 -0.786 . . . . 0.0 108.876 178.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -61.36 128.72 25.77 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 121.843 1.696 . . . . 0.0 109.632 177.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 115.52 -30.12 6.87 Favored Glycine 0 N--CA 1.429 -1.773 0 C-N-CA 120.267 -0.968 . . . . 0.0 111.279 -178.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 84.5 t -66.2 -62.91 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 103.47 105.19 2.95 Favored Glycine 0 N--CA 1.427 -1.964 0 C-N-CA 120.575 -0.822 . . . . 0.0 112.164 178.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -81.29 -17.11 50.46 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -177.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 42.4 t -85.15 -37.84 12.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 CA-C-O 121.596 0.712 . . . . 0.0 109.3 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.518 ' O ' ' HG ' ' A' ' 177' ' ' LEU . 20.8 ptmt -88.72 -4.75 58.45 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.509 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -54.72 -48.89 94.24 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -178.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.489 ' O ' ' HG2' ' A' ' 179' ' ' GLN . 11.2 Cg_endo -57.27 -35.15 98.85 Favored 'Trans proline' 0 C--N 1.38 2.237 0 C-N-CA 121.715 1.61 . . . . 0.0 112.179 177.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 59.4 tp -69.31 -42.4 75.45 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.274 0.559 . . . . 0.0 109.54 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.518 ' HG ' ' O ' ' A' ' 173' ' ' LYS . 74.5 mt -69.47 -29.85 67.6 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.795 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 50.9 tp -70.73 -12.57 61.63 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.738 179.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 0.489 ' HG2' ' O ' ' A' ' 175' ' ' PRO . 24.8 mm-40 -88.22 -13.77 40.2 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 176.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -99.33 -51.52 3.77 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 -179.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . 0.581 ' CD2' ' HG ' ' A' ' 187' ' ' LEU . 89.7 m-85 -94.24 148.85 35.8 Favored Pre-proline 0 C--N 1.307 -1.267 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.183 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -68.94 -31.29 24.66 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.053 1.835 . . . . 0.0 113.332 -175.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 66.5 m -158.56 161.84 37.32 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -62.01 -29.41 46.39 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.411 0 O-C-N 123.55 0.531 . . . . 0.0 112.024 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -62.54 -47.7 82.77 Favored 'General case' 0 C--O 1.211 -0.966 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.429 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -74.08 -31.18 62.72 Favored 'General case' 0 C--O 1.2 -1.528 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.581 ' HG ' ' CD2' ' A' ' 181' ' ' PHE . 4.5 tt -57.81 -59.91 4.5 Favored 'General case' 0 C--O 1.204 -1.301 0 C-N-CA 123.811 0.844 . . . . 0.0 109.561 -178.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 22.8 m -73.77 -24.72 59.89 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -178.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -86.98 1.99 50.95 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-O 121.516 0.674 . . . . 0.0 110.724 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.55 156.94 31.07 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 124.023 0.929 . . . . 0.0 111.373 175.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 5.0 m -64.49 159.72 20.91 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.249 -178.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 43.1 mm -52.67 -38.79 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 123.205 0.602 . . . . 0.0 111.449 -179.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.506 ' O ' ' HG2' ' A' ' 197' ' ' GLN . . . -61.48 -43.65 99.04 Favored Glycine 0 C--O 1.214 -1.142 0 C-N-CA 120.853 -0.689 . . . . 0.0 111.908 178.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -67.47 -41.23 84.95 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.635 0.731 . . . . 0.0 109.575 -176.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 94.2 mt -70.47 -31.05 68.03 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.001 -0.999 . . . . 0.0 111.121 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . 0.543 ' HG2' ' N ' ' A' ' 201' ' ' GLN . 4.2 tm-20 -73.42 -41.01 63.81 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.506 ' HG2' ' O ' ' A' ' 193' ' ' GLY . 14.6 mm100 -57.66 -25.32 60.04 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 123.8 0.84 . . . . 0.0 112.369 178.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.405 HG23 HG23 ' A' ' 199' ' ' VAL . 14.6 m -103.52 -34.84 3.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.539 HG11 HG11 ' A' ' 203' ' ' VAL . 1.2 t -122.01 -77.43 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 C-N-CA 119.259 -0.976 . . . . 0.0 111.392 178.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -177.22 160.43 27.34 Favored Glycine 0 N--CA 1.435 -1.383 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 -176.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . 0.543 ' N ' ' HG2' ' A' ' 196' ' ' GLU . 4.0 pt20 -63.36 -38.05 89.64 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 123.624 0.77 . . . . 0.0 112.34 -176.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -74.86 -34.92 62.34 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 121.837 0.827 . . . . 0.0 109.672 -178.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.539 HG11 HG11 ' A' ' 199' ' ' VAL . 24.8 t -68.53 -45.09 82.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-N 114.373 -1.285 . . . . 0.0 109.57 -179.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -53.51 -43.82 68.62 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 114.161 -1.381 . . . . 0.0 109.756 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -66.8 -44.98 79.84 Favored 'General case' 0 N--CA 1.421 -1.904 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.451 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . 0.467 ' HG2' ' O ' ' A' ' 203' ' ' VAL . 20.9 pt20 -66.09 -33.67 76.31 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.254 -0.578 . . . . 0.0 111.147 -178.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 84.7 mt -73.59 -50.19 31.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.561 177.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 28.0 t-80 -63.75 -46.99 82.81 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.997 -177.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -72.35 -9.96 59.18 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -178.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -64.13 -47.43 79.98 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 178.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -97.79 -29.44 13.36 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.647 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 33.4 m -77.97 -37.37 47.55 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -176.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -93.84 133.74 27.33 Favored Pre-proline 0 C--N 1.311 -1.08 0 C-N-CA 120.376 -0.53 . . . . 0.0 109.627 -176.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -51.16 159.97 2.41 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 123.981 3.121 . . . . 0.0 114.023 177.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 25.3 ptt180 . . . . . 0 C--N 1.296 -1.724 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.059 -176.17 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.9 m . . . . . 0 N--CA 1.422 -1.847 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -167.23 -56.44 0.03 OUTLIER 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.099 -176.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.407 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . 95.2 m-20 -79.33 131.24 66.16 Favored Pre-proline 0 C--N 1.313 -0.982 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.756 -175.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 143' ' ' ASN . 21.0 Cg_exo -65.03 109.55 1.33 Allowed 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.025 1.817 . . . . 0.0 109.711 176.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 58.2 tp -142.32 107.87 5.07 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-O 121.363 0.602 . . . . 0.0 109.952 -176.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 7.8 mp -89.06 104.8 17.32 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 115.058 -0.974 . . . . 0.0 108.47 176.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 147.76 -150.13 22.31 Favored Glycine 0 N--CA 1.424 -2.154 0 N-CA-C 108.425 -1.87 . . . . 0.0 108.425 -177.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -91.58 158.95 16.15 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 117.355 0.577 . . . . 0.0 111.147 179.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -76.03 96.3 3.78 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 121.492 0.663 . . . . 0.0 111.368 -175.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 44.7 ttm180 -125.93 103.92 8.02 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.442 178.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -86.46 101.08 12.83 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 121.286 0.565 . . . . 0.0 109.494 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 61.0 tp -129.86 121.17 26.18 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.601 ' H ' HD23 ' A' ' 153' ' ' LEU . 2.0 pt? -72.83 153.58 41.0 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.998 177.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 49.6 mt -105.74 111.72 24.5 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.6 176.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 42.3 p -80.77 101.51 9.38 Favored 'General case' 0 N--CA 1.417 -2.08 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 170.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.401 ' HB3' ' OG ' ' A' ' 158' ' ' SER . 42.0 mt-10 -107.25 129.36 24.41 Favored Pre-proline 0 C--N 1.285 -2.234 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -89.9 23.44 0.7 Allowed 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 123.044 2.496 . . . . 0.0 108.441 168.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.401 ' OG ' ' HB3' ' A' ' 156' ' ' GLU . 19.8 m -72.25 103.88 3.51 Favored 'General case' 0 N--CA 1.414 -2.265 0 CA-C-N 114.048 -1.433 . . . . 0.0 110.866 -178.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -90.37 -22.15 21.63 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.574 177.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.521 ' H ' HD23 ' A' ' 160' ' ' LEU . 1.7 pt? -60.53 -32.63 71.66 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.281 0.562 . . . . 0.0 111.232 178.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.413 ' O ' ' HG2' ' A' ' 164' ' ' GLN . 14.8 ptm180 -75.39 -30.14 60.03 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.036 177.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.601 ' O ' ' HG2' ' A' ' 165' ' ' GLN . 12.0 m -81.27 -37.99 27.58 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-O 121.457 0.646 . . . . 0.0 110.015 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.402 HG12 ' O ' ' A' ' 160' ' ' LEU . 1.7 p -63.55 -25.15 37.65 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.049 0 CA-C-O 121.479 0.657 . . . . 0.0 110.952 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . 0.516 HE21 HG13 ' A' ' 184' ' ' ILE . 3.4 pt20 -90.13 -11.64 40.64 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 122.015 -0.428 . . . . 0.0 110.9 178.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.601 ' HG2' ' O ' ' A' ' 162' ' ' THR . 18.9 pt20 -91.77 -6.02 52.54 Favored 'General case' 0 CA--C 1.505 -0.783 0 C-N-CA 119.303 -0.959 . . . . 0.0 111.168 -174.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 66.0 mt -61.19 133.51 92.84 Favored Pre-proline 0 C--N 1.298 -1.654 0 CA-C-N 114.823 -1.08 . . . . 0.0 109.481 -178.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -63.3 127.96 21.4 Favored 'Trans proline' 0 C--O 1.246 0.91 0 C-N-CA 122.022 1.815 . . . . 0.0 110.345 179.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 114.36 -32.82 5.71 Favored Glycine 0 N--CA 1.424 -2.126 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 -177.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 57.9 t -69.02 -53.01 28.27 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 177.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . 0.483 ' HA3' ' HG2' ' A' ' 173' ' ' LYS . . . 88.88 90.93 1.15 Allowed Glycine 0 N--CA 1.414 -2.779 0 CA-C-N 114.77 -1.105 . . . . 0.0 111.818 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -66.3 -23.18 66.33 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 120.776 0.322 . . . . 0.0 111.724 -178.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 47.2 t -86.53 -28.19 5.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-O 121.194 0.521 . . . . 0.0 110.281 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.564 ' O ' ' HG ' ' A' ' 177' ' ' LEU . 21.0 ptmt -91.29 9.26 32.18 Favored 'General case' 0 C--O 1.214 -0.764 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.707 178.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.464 ' O ' ' HG ' ' A' ' 178' ' ' LEU . . . -52.07 -48.66 87.88 Favored Pre-proline 0 CA--C 1.556 1.2 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 177.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -59.99 -23.22 72.22 Favored 'Trans proline' 0 C--N 1.381 2.243 0 C-N-CA 122.401 2.067 . . . . 0.0 112.867 177.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.497 ' HB3' ' O ' ' A' ' 173' ' ' LYS . 51.0 tp -79.23 -21.05 46.77 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 123.683 0.793 . . . . 0.0 109.489 178.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.564 ' HG ' ' O ' ' A' ' 173' ' ' LYS . 39.7 mt -98.32 -34.46 10.68 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -178.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 174' ' ' ALA . 95.2 mt -66.82 -5.66 13.17 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.997 0.919 . . . . 0.0 112.732 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 0.473 ' HG2' ' O ' ' A' ' 176' ' ' LEU . 16.1 pt20 -74.5 -35.02 63.2 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 172.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 48.9 mmtm -92.52 -51.43 5.13 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.138 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . 0.426 ' CD1' ' HA ' ' A' ' 187' ' ' LEU . 89.9 m-85 -90.27 144.36 30.9 Favored Pre-proline 0 C--N 1.304 -1.401 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.63 -176.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -69.78 -44.56 1.99 Allowed 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 121.851 1.701 . . . . 0.0 112.652 -175.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 45.4 m -152.38 167.84 27.4 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 178.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.516 HG13 HE21 ' A' ' 164' ' ' GLN . 0.2 OUTLIER -60.75 -31.76 50.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 N-CA-C 115.613 1.708 . . . . 0.0 115.613 -173.225 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -68.57 -45.92 70.78 Favored 'General case' 0 C--O 1.207 -1.15 0 C-N-CA 118.81 -1.156 . . . . 0.0 110.425 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -67.49 -32.8 73.87 Favored 'General case' 0 C--O 1.209 -1.059 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.426 ' HA ' ' CD1' ' A' ' 181' ' ' PHE . 3.6 tt -56.76 -62.6 1.62 Allowed 'General case' 0 C--O 1.213 -0.857 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.5 -179.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 29.5 m -70.87 -27.82 64.11 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -178.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.498 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 11.1 t-20 -81.03 -3.25 51.17 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-O 121.222 0.534 . . . . 0.0 110.511 -178.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.412 ' HB1' ' HB2' ' A' ' 194' ' ' GLU . . . -64.56 155.67 32.31 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 123.055 0.542 . . . . 0.0 110.79 177.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 20.6 t -68.09 170.65 8.08 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 121.262 0.553 . . . . 0.0 110.836 -175.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 47.7 mm -59.33 -39.61 79.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.55 -177.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.548 ' O ' ' HG3' ' A' ' 197' ' ' GLN . . . -59.86 -38.62 94.31 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.305 178.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 0.412 ' HB2' ' HB1' ' A' ' 190' ' ' ALA . 29.2 mt-10 -77.82 -43.12 31.42 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -176.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 96.2 mt -67.6 -25.32 65.7 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.712 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . 0.415 ' HG2' ' N ' ' A' ' 201' ' ' GLN . 9.7 tm-20 -73.67 -31.7 63.59 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.548 ' HG3' ' O ' ' A' ' 193' ' ' GLY . 98.4 mt-30 -68.8 -20.29 64.32 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.913 -1.04 . . . . 0.0 111.702 -178.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.434 HG23 HG23 ' A' ' 199' ' ' VAL . 16.7 m -105.19 -33.32 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.74 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.023 177.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.512 HG11 HG11 ' A' ' 203' ' ' VAL . 1.7 t -124.64 -84.48 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 C-N-CA 120.338 -0.545 . . . . 0.0 111.504 176.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -177.91 168.95 40.66 Favored Glycine 0 N--CA 1.436 -1.331 0 N-CA-C 109.851 -1.299 . . . . 0.0 109.851 -176.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . 0.415 ' N ' ' HG2' ' A' ' 196' ' ' GLU . 51.5 mt-30 -59.14 -52.86 63.9 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.911 0.884 . . . . 0.0 112.628 -175.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -68.85 -35.39 76.88 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 121.45 0.643 . . . . 0.0 111.186 -173.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.512 HG11 HG11 ' A' ' 199' ' ' VAL . 2.2 t -72.57 -38.19 58.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -178.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -57.85 -44.11 86.34 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 114.347 -1.297 . . . . 0.0 109.844 178.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -64.42 -42.78 95.86 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.886 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -74.56 -25.02 59.02 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.417 -0.513 . . . . 0.0 112.239 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 98.2 mt -76.4 -49.43 24.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 174.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 53.3 t-80 -63.44 -47.36 82.2 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.003 -178.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -65.74 -20.07 66.13 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -179.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -59.05 -44.13 91.76 Favored 'General case' 0 C--O 1.214 -0.792 0 C-N-CA 122.799 0.439 . . . . 0.0 110.613 -178.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.498 ' CZ ' ' HA ' ' A' ' 189' ' ' ASN . 31.6 p90 -99.4 -25.73 14.37 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.672 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 37.5 m -74.63 -35.77 62.9 Favored 'General case' 0 C--N 1.313 -1.022 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -178.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . 0.401 ' HA ' ' HD3' ' A' ' 214' ' ' PRO . 59.0 tp60 -108.41 119.62 49.0 Favored Pre-proline 0 N--CA 1.434 -1.26 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 -177.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 213' ' ' GLN . 23.4 Cg_exo -67.22 170.03 14.09 Favored 'Trans proline' 0 C--O 1.243 0.742 0 C-N-CA 122.604 2.202 . . . . 0.0 113.141 178.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . 0.456 ' HD2' ' N ' ' A' ' 215' ' ' ARG . 2.4 mpt_? . . . . . 0 C--O 1.26 1.609 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.147 -177.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 9.1 p . . . . . 0 N--CA 1.427 -1.614 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -96.32 148.02 23.19 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 178.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.421 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . 18.3 m120 -91.09 132.57 33.87 Favored Pre-proline 0 C--N 1.292 -1.9 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -178.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 143' ' ' ASN . 4.2 Cg_exo -74.25 93.24 0.9 Allowed 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 121.872 1.715 . . . . 0.0 112.994 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 11.1 mp -86.5 -23.72 25.83 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.244 174.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 60.7 tp -55.03 124.41 16.72 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 123.867 0.867 . . . . 0.0 111.801 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -168.85 -174.46 37.48 Favored Glycine 0 N--CA 1.428 -1.865 0 N-CA-C 108.117 -1.993 . . . . 0.0 108.117 178.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -89.28 93.28 9.49 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 118.232 1.016 . . . . 0.0 110.111 178.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -92.03 111.92 23.65 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 178.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 76.7 mtp180 -72.73 103.81 3.75 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -108.29 101.63 10.82 Favored 'General case' 0 CA--C 1.481 -1.696 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 -176.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 95.7 mt -118.5 101.12 7.91 Favored 'General case' 0 C--N 1.276 -2.628 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.473 -173.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 26.1 tp -94.12 128.99 40.84 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 178.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.545 ' O ' HD12 ' A' ' 154' ' ' LEU . 4.7 pp -84.01 106.24 15.52 Favored 'General case' 0 N--CA 1.432 -1.346 0 C-N-CA 119.083 -1.047 . . . . 0.0 111.089 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 40.0 m -114.5 133.75 55.54 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 175.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -96.99 107.03 35.04 Favored Pre-proline 0 C--N 1.303 -1.454 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -177.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -69.24 -45.04 2.04 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.431 2.087 . . . . 0.0 113.245 -175.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 48.4 t -102.32 108.46 19.82 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-O 120.796 0.331 . . . . 0.0 110.582 -176.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -93.94 -27.37 16.4 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 173.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.654 HD23 ' H ' ' A' ' 160' ' ' LEU . 1.6 pt? -60.38 -23.79 64.59 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.267 -0.879 . . . . 0.0 112.118 178.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.412 ' O ' ' HG2' ' A' ' 164' ' ' GLN . 14.3 ptm180 -65.87 -29.36 69.79 Favored 'General case' 0 C--O 1.215 -0.744 0 CA-C-O 120.92 0.39 . . . . 0.0 110.115 176.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 37.9 m -86.55 -31.75 21.06 Favored 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 123.025 0.53 . . . . 0.0 111.39 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.51 HG12 ' O ' ' A' ' 160' ' ' LEU . 2.5 p -64.52 -25.66 38.43 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.115 0 CA-C-O 121.418 0.627 . . . . 0.0 111.372 -176.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . 0.412 ' HG2' ' O ' ' A' ' 161' ' ' ARG . 29.5 pt20 -81.32 -13.01 58.87 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 121.161 0.505 . . . . 0.0 110.459 177.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -95.38 -0.05 53.0 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.545 -175.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 81.2 mt -66.14 132.42 94.53 Favored Pre-proline 0 C--N 1.317 -0.837 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.28 128.16 26.54 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.096 1.864 . . . . 0.0 111.006 178.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 112.65 -29.91 7.87 Favored Glycine 0 N--CA 1.425 -2.096 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 -178.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 59.1 t -73.25 -65.74 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 101.97 110.55 3.38 Favored Glycine 0 N--CA 1.43 -1.737 0 C-N-CA 120.314 -0.946 . . . . 0.0 112.799 177.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -82.66 -18.88 39.47 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.4 0.619 . . . . 0.0 111.597 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 62.7 t -84.13 -30.35 7.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 CA-C-O 121.819 0.819 . . . . 0.0 109.27 177.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -90.34 -4.17 57.27 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.372 178.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.507 ' O ' ' HG ' ' A' ' 178' ' ' LEU . . . -55.07 -47.16 99.19 Favored Pre-proline 0 C--O 1.202 -1.403 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -178.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.443 ' O ' ' HG3' ' A' ' 179' ' ' GLN . 36.2 Cg_exo -59.82 -36.99 89.33 Favored 'Trans proline' 0 C--N 1.381 2.243 0 CA-C-N 121.337 1.513 . . . . 0.0 111.234 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 57.2 tp -66.97 -44.64 79.96 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.665 176.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 96.3 mt -65.33 -32.25 73.79 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.027 178.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.507 ' HG ' ' O ' ' A' ' 174' ' ' ALA . 88.7 mt -72.44 -7.32 49.24 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 123.4 0.68 . . . . 0.0 111.774 178.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 0.443 ' HG3' ' O ' ' A' ' 175' ' ' PRO . 52.6 mt-30 -95.65 -9.31 32.39 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.386 0.612 . . . . 0.0 109.356 174.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -105.18 -51.42 3.03 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . 0.448 ' CD2' ' HG ' ' A' ' 187' ' ' LEU . 86.4 m-85 -99.69 149.46 35.93 Favored Pre-proline 0 C--N 1.294 -1.837 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -66.99 -46.11 3.47 Favored 'Trans proline' 0 C--O 1.24 0.601 0 C-N-CA 121.439 1.426 . . . . 0.0 112.13 -175.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 30.0 m -151.33 167.79 26.81 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.432 ' H ' HD13 ' A' ' 184' ' ' ILE . 0.2 OUTLIER -60.67 -29.86 45.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 -174.274 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 56.8 tp60 -70.82 -39.13 73.23 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 119.731 -0.788 . . . . 0.0 110.384 -176.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -76.06 -32.23 59.18 Favored 'General case' 0 C--O 1.197 -1.66 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 178.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.448 ' HG ' ' CD2' ' A' ' 181' ' ' PHE . 3.8 tt -56.53 -61.26 2.54 Favored 'General case' 0 C--O 1.212 -0.906 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.717 -178.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 19.8 m -70.26 -32.16 69.87 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 120.641 -0.423 . . . . 0.0 111.88 -178.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.405 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 7.9 t30 -83.96 4.72 28.47 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-O 121.566 0.698 . . . . 0.0 110.839 -177.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.414 ' HB1' ' HB2' ' A' ' 194' ' ' GLU . . . -65.46 156.16 33.26 Favored 'General case' 0 C--O 1.248 1.004 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.414 174.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 2.6 m -63.58 159.48 18.74 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.987 -176.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 50.8 mm -53.09 -36.25 24.45 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.963 0 C-N-CA 122.917 0.487 . . . . 0.0 111.537 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -69.47 -28.92 71.9 Favored Glycine 0 C--N 1.314 -0.66 0 C-N-CA 121.222 -0.513 . . . . 0.0 112.903 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 0.678 ' O ' ' HG2' ' A' ' 197' ' ' GLN . 26.2 mt-10 -81.29 -31.28 33.69 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -178.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 97.3 mt -79.33 -29.45 42.32 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.409 175.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . 0.549 ' HG2' ' N ' ' A' ' 201' ' ' GLN . 2.6 tm-20 -69.59 -35.61 75.48 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -178.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.678 ' HG2' ' O ' ' A' ' 194' ' ' GLU . 20.3 pt20 -67.19 -20.86 65.78 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.412 -176.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 15.7 m -104.6 -31.19 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -127.32 -83.41 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 173.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -177.21 164.07 33.14 Favored Glycine 0 CA--C 1.488 -1.602 0 N-CA-C 108.027 -2.029 . . . . 0.0 108.027 -176.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . 0.549 ' N ' ' HG2' ' A' ' 196' ' ' GLU . 12.1 pt20 -69.68 -38.59 77.08 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 118.239 1.02 . . . . 0.0 111.778 -176.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -64.25 -28.86 70.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.644 0.735 . . . . 0.0 110.561 -179.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 3.1 t -81.17 -43.09 20.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 178.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -56.44 -46.03 80.51 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.209 -1.36 . . . . 0.0 110.946 -178.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -60.74 -44.82 96.19 Favored 'General case' 0 C--O 1.199 -1.588 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.599 -178.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -73.63 -33.22 64.43 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.528 -178.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 92.5 mt -66.37 -49.56 74.64 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.241 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 175.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' HIS . . . . . 0.545 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 9.9 t60 -68.68 -39.2 80.68 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.829 -176.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -65.44 -29.12 69.77 Favored 'General case' 0 C--O 1.219 -0.523 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 177.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -54.27 -47.69 72.05 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.208 0.603 . . . . 0.0 111.912 -176.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.545 ' CZ ' ' HA ' ' A' ' 208' ' ' HIS . 19.9 p90 -93.6 -22.16 18.96 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.096 -178.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 80.6 m -75.59 -34.65 60.65 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.198 179.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -81.68 134.28 50.96 Favored Pre-proline 0 C--N 1.313 -1.01 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 174.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_exo -50.15 159.61 1.78 Allowed 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.803 3.002 . . . . 0.0 114.162 -178.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 . . . . . 0 C--N 1.289 -2.04 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.581 179.821 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 25.7 t . . . . . 0 N--CA 1.428 -1.546 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -119.37 13.14 12.66 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.542 0.687 . . . . 0.0 110.586 -179.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -140.14 121.76 9.6 Favored Pre-proline 0 C--N 1.302 -1.467 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 177.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -49.5 111.04 0.43 Allowed 'Trans proline' 0 C--O 1.245 0.854 0 C-N-CA 123.107 2.538 . . . . 0.0 113.16 178.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 61.5 tp -136.92 -53.8 0.71 Allowed 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 177.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.619 ' H ' HD13 ' A' ' 146' ' ' LEU . 0.0 OUTLIER -101.6 172.27 7.06 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.009 -0.996 . . . . 0.0 108.7 174.186 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 169.75 -151.75 17.81 Favored Glycine 0 N--CA 1.433 -1.513 0 C-N-CA 120.031 -1.081 . . . . 0.0 111.662 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -124.51 143.43 50.67 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -178.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -71.26 136.21 47.84 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 120.99 0.424 . . . . 0.0 110.559 178.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 4.1 tpm_? -82.25 94.53 7.33 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 175.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -52.74 113.39 1.06 Allowed 'General case' 0 CA--C 1.501 -0.936 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.138 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 53.5 tp -132.35 96.22 3.81 Favored 'General case' 0 N--CA 1.416 -2.169 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.481 -175.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -140.74 164.6 29.77 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 177.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -70.07 91.64 0.7 Allowed 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 177.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 15.3 m -94.77 103.06 14.96 Favored 'General case' 0 N--CA 1.415 -2.223 0 CA-C-N 114.557 -1.202 . . . . 0.0 111.764 -174.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -109.73 165.76 12.04 Favored Pre-proline 0 C--N 1.288 -2.089 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 170.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -59.25 95.43 0.09 OUTLIER 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 121.818 1.678 . . . . 0.0 109.799 174.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 47.3 t -164.32 89.69 0.54 Allowed 'General case' 0 N--CA 1.419 -2.02 0 C-N-CA 124.058 0.943 . . . . 0.0 108.816 -175.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 41.7 tp -94.08 -19.81 20.49 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 174.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.421 ' O ' HG12 ' A' ' 163' ' ' VAL . 2.4 pt? -60.75 -29.84 69.63 Favored 'General case' 0 C--O 1.225 -0.193 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.789 -178.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -63.07 -37.44 87.22 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.52 177.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 15.0 m -86.32 -31.95 21.29 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.183 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.421 HG12 ' O ' ' A' ' 160' ' ' LEU . 0.7 OUTLIER -62.96 -25.91 39.68 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.928 0 CA-C-O 121.587 0.708 . . . . 0.0 111.556 -176.597 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . 0.501 ' HG3' HE21 ' A' ' 165' ' ' GLN . 28.9 pt20 -85.99 -8.02 58.25 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.15 0.5 . . . . 0.0 110.732 178.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.501 HE21 ' HG3' ' A' ' 164' ' ' GLN . 29.0 mm-40 -97.49 -0.16 46.53 Favored 'General case' 0 C--O 1.238 0.476 0 O-C-N 122.249 -0.282 . . . . 0.0 110.873 -177.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 92.1 mt -62.1 129.68 92.23 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -62.71 127.44 20.64 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 121.603 1.535 . . . . 0.0 110.619 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 115.56 -29.95 6.95 Favored Glycine 0 N--CA 1.424 -2.138 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.646 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 93.2 t -58.15 -60.27 2.45 Favored 'Isoleucine or valine' 0 C--O 1.245 0.847 0 CA-C-O 120.954 0.407 . . . . 0.0 110.94 -179.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 93.89 85.87 1.62 Allowed Glycine 0 N--CA 1.431 -1.647 0 C-N-CA 120.331 -0.938 . . . . 0.0 110.983 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -68.62 -12.03 60.82 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.668 0.746 . . . . 0.0 111.916 -176.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 42.1 t -71.73 -28.58 31.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 176.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.62 ' O ' ' HG ' ' A' ' 177' ' ' LEU . 47.1 mtmt -87.37 0.19 55.83 Favored 'General case' 0 C--O 1.208 -1.098 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.308 -179.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.479 ' O ' ' HG ' ' A' ' 178' ' ' LEU . . . -46.73 -53.06 27.82 Favored Pre-proline 0 N--CA 1.483 1.206 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 -174.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.415 ' O ' ' HG2' ' A' ' 179' ' ' GLN . 32.2 Cg_exo -60.07 -43.41 36.31 Favored 'Trans proline' 0 C--N 1.373 1.831 0 C-N-CA 121.569 1.512 . . . . 0.0 111.379 179.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 49.2 tp -60.83 -45.55 94.02 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.918 177.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.62 ' HG ' ' O ' ' A' ' 173' ' ' LYS . 91.6 mt -61.62 -41.72 97.87 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.173 178.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 174' ' ' ALA . 90.8 mt -68.95 -8.39 44.02 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 0.415 ' HG2' ' O ' ' A' ' 175' ' ' PRO . 29.5 mm-40 -80.6 -21.14 41.86 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.374 0.607 . . . . 0.0 110.011 175.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 8.2 mmmm -106.51 -45.01 4.35 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.801 177.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . 0.45 ' O ' ' HA ' ' A' ' 178' ' ' LEU . 32.3 m-85 -103.42 132.31 21.21 Favored Pre-proline 0 N--CA 1.424 -1.769 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -176.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -62.31 -35.76 71.63 Favored 'Trans proline' 0 CA--C 1.51 -0.695 0 C-N-CA 122.839 2.359 . . . . 0.0 112.803 -172.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 59.3 m -153.46 160.21 42.51 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.473 ' O ' ' HB3' ' A' ' 187' ' ' LEU . 0.2 OUTLIER -60.02 -23.14 26.19 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.5 0 O-C-N 123.926 0.766 . . . . 0.0 112.905 -178.335 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -66.23 -47.2 74.59 Favored 'General case' 0 C--O 1.215 -0.715 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -77.33 -29.04 53.34 Favored 'General case' 0 C--O 1.19 -2.051 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -178.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.474 HD13 ' HB3' ' A' ' 177' ' ' LEU . 41.2 tp -51.57 -64.14 0.91 Allowed 'General case' 0 C--O 1.204 -1.329 0 C-N-CA 124.351 1.06 . . . . 0.0 111.63 177.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 20.0 m -69.23 -24.43 64.01 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.402 0.62 . . . . 0.0 111.454 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -85.97 1.37 50.38 Favored 'General case' 0 C--O 1.244 0.816 0 CA-C-O 122.042 0.925 . . . . 0.0 111.194 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -67.85 157.05 35.75 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.218 177.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 15.0 m -63.3 153.72 33.98 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.568 -179.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 51.1 mm -57.87 -34.32 48.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.117 -176.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.416 ' O ' ' HG3' ' A' ' 197' ' ' GLN . . . -62.19 -36.41 92.95 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 116.095 -0.502 . . . . 0.0 112.477 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 0.463 ' O ' ' HB2' ' A' ' 197' ' ' GLN . 55.4 mm-40 -77.66 -41.64 37.51 Favored 'General case' 0 CA--C 1.498 -1.043 0 CA-C-O 121.62 0.724 . . . . 0.0 109.915 -178.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.459 HD21 ' O ' ' A' ' 187' ' ' LEU . 97.5 mt -67.64 -32.24 72.79 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.131 -0.941 . . . . 0.0 111.074 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . 0.554 ' HG2' ' N ' ' A' ' 201' ' ' GLN . 4.6 tm-20 -66.44 -30.15 70.45 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -178.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.463 ' HB2' ' O ' ' A' ' 194' ' ' GLU . 69.6 mt-30 -60.16 -37.27 79.62 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.652 -1.158 . . . . 0.0 111.376 178.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 30.0 m -103.66 -31.04 2.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -175.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.6 HG23 ' H ' ' A' ' 200' ' ' GLY . 6.5 m -115.34 -85.67 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 176.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . 0.6 ' H ' HG23 ' A' ' 199' ' ' VAL . . . -178.74 166.25 35.87 Favored Glycine 0 N--CA 1.408 -3.225 0 N-CA-C 108.413 -1.875 . . . . 0.0 108.413 -177.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . 0.554 ' N ' ' HG2' ' A' ' 196' ' ' GLU . 0.4 OUTLIER -62.64 -51.38 67.49 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 123.827 0.851 . . . . 0.0 109.122 -179.344 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -72.73 -26.73 61.68 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.066 -176.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 3.4 t -76.44 -42.83 36.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -56.29 -43.54 78.98 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.241 -1.345 . . . . 0.0 109.902 179.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -54.89 -53.79 50.87 Favored 'General case' 0 N--CA 1.436 -1.16 0 C-N-CA 124.218 1.007 . . . . 0.0 111.964 177.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -69.87 -28.87 66.01 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 119.826 -0.749 . . . . 0.0 111.903 -176.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 98.6 mt -71.78 -48.73 49.84 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-N 116.22 -0.446 . . . . 0.0 109.873 177.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 10.4 t60 -70.96 -40.0 72.23 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -176.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -66.51 -25.55 66.74 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 178.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -53.65 -47.52 70.27 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.069 0.948 . . . . 0.0 112.285 -175.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -93.35 -23.59 18.4 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.694 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 62.8 m -70.58 -48.15 56.66 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.241 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -82.01 117.5 68.56 Favored Pre-proline 0 C--N 1.316 -0.886 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.304 -178.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_exo -54.38 124.34 15.83 Favored 'Trans proline' 0 C--O 1.246 0.901 0 C-N-CA 123.722 2.948 . . . . 0.0 112.89 178.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 69.9 mtp180 . . . . . 0 C--N 1.278 -2.514 0 CA-C-N 114.316 -1.311 . . . . 0.0 109.061 -178.644 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 16.8 m . . . . . 0 N--CA 1.443 -0.803 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -88.13 -17.76 30.29 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 120.661 -0.416 . . . . 0.0 111.903 -175.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -140.73 151.32 62.8 Favored Pre-proline 0 C--N 1.302 -1.481 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 177.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -80.75 79.71 3.24 Favored 'Trans proline' 0 N--CA 1.429 -2.296 0 C-N-CA 121.507 1.471 . . . . 0.0 110.434 174.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 38.2 tp -86.93 76.11 9.46 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 178.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 82.7 mt -106.99 159.01 16.6 Favored 'General case' 0 N--CA 1.418 -2.072 0 CA-C-N 113.962 -1.472 . . . . 0.0 109.266 -176.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 91.63 146.86 18.91 Favored Glycine 0 N--CA 1.423 -2.189 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -174.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -130.72 97.79 4.45 Favored 'General case' 0 C--N 1.284 -2.278 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -142.08 119.84 11.88 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 120.783 0.325 . . . . 0.0 110.161 178.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 44.9 ttp180 -98.29 104.23 16.24 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 177.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -110.76 101.5 10.12 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 -176.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 94.3 mt -128.43 97.98 4.9 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.593 -176.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -102.85 124.75 48.95 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 177.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 5.5 tt -98.36 92.75 5.84 Favored 'General case' 0 N--CA 1.422 -1.852 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 5.1 p -89.6 144.3 26.12 Favored 'General case' 0 C--N 1.285 -2.197 0 CA-C-N 114.946 -1.025 . . . . 0.0 109.028 174.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.42 ' OE2' ' HD2' ' A' ' 157' ' ' PRO . 11.1 tp10 -84.32 116.24 64.07 Favored Pre-proline 0 C--N 1.305 -1.348 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -177.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.42 ' HD2' ' OE2' ' A' ' 156' ' ' GLU . 75.4 Cg_endo -84.92 171.94 9.06 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.772 2.315 . . . . 0.0 112.983 -177.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.404 ' OG ' ' HB3' ' A' ' 161' ' ' ARG . 26.4 t 62.37 84.93 0.13 Allowed 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 124.884 1.273 . . . . 0.0 111.879 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -77.61 -31.42 52.91 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 177.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.434 ' HA ' HG12 ' A' ' 163' ' ' VAL . 3.6 pp -59.51 -27.51 66.23 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 123.944 0.898 . . . . 0.0 111.917 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.404 ' HB3' ' OG ' ' A' ' 158' ' ' SER . 11.4 ptt180 -67.57 -37.8 83.16 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -178.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 25.0 m -86.5 -31.6 21.21 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.21 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.442 HG22 ' HB2' ' A' ' 188' ' ' SER . 0.3 OUTLIER -63.36 -26.23 40.32 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 CA-C-O 121.609 0.719 . . . . 0.0 111.358 -177.231 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -86.54 -8.01 57.89 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.591 177.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -105.3 21.19 17.59 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 -176.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.456 HG21 ' HA ' ' A' ' 207' ' ' ILE . 75.0 mt -78.93 125.93 83.08 Favored Pre-proline 0 C--N 1.31 -1.116 0 CA-C-N 116.297 -0.411 . . . . 0.0 109.961 -178.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -66.6 130.84 24.47 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.208 1.939 . . . . 0.0 110.073 176.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 120.21 -35.16 3.87 Favored Glycine 0 C--N 1.292 -1.88 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 -177.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 95.5 t -60.45 -52.56 60.0 Favored 'Isoleucine or valine' 0 C--O 1.246 0.875 0 CA-C-O 121.376 0.608 . . . . 0.0 110.052 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 99.68 99.77 2.26 Favored Glycine 0 N--CA 1.425 -2.09 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -177.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -63.32 -29.81 71.06 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 120.969 0.414 . . . . 0.0 111.491 -176.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 60.9 t -83.19 -26.52 7.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-O 121.513 0.673 . . . . 0.0 110.148 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.426 ' O ' ' HB3' ' A' ' 176' ' ' LEU . 37.3 ttpt -92.45 -5.8 51.21 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 120.443 -0.503 . . . . 0.0 109.808 -178.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -53.4 -49.9 85.78 Favored Pre-proline 0 CA--C 1.553 1.085 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -177.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -57.52 -30.1 87.17 Favored 'Trans proline' 0 C--N 1.384 2.399 0 C-N-CA 121.961 1.774 . . . . 0.0 112.562 176.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.426 ' HB3' ' O ' ' A' ' 173' ' ' LYS . 54.0 tp -70.22 -39.8 74.89 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 121.469 0.652 . . . . 0.0 109.604 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.419 ' HB3' HD21 ' A' ' 187' ' ' LEU . 9.5 mp -72.52 -32.68 66.32 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.174 178.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 42.7 tp -68.93 -8.84 48.1 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.005 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -82.96 -23.27 33.49 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 174.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm -93.37 -49.67 5.83 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.497 0.665 . . . . 0.0 109.736 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . 0.548 ' CD2' HD22 ' A' ' 187' ' ' LEU . 64.5 m-85 -95.14 143.0 25.38 Favored Pre-proline 0 C--N 1.304 -1.37 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.642 -176.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -66.36 -39.19 17.9 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.37 2.047 . . . . 0.0 113.867 -174.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 58.8 m -157.0 164.51 37.93 Favored 'General case' 0 C--O 1.247 0.938 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.409 ' HA ' ' HB2' ' A' ' 187' ' ' LEU . 0.2 OUTLIER -56.36 -29.66 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 -176.194 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -62.66 -45.83 91.02 Favored 'General case' 0 C--O 1.217 -0.636 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.328 178.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -78.78 -28.84 44.76 Favored 'General case' 0 C--O 1.201 -1.462 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -177.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.548 HD22 ' CD2' ' A' ' 181' ' ' PHE . 0.3 OUTLIER -51.71 -67.65 0.23 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.263 1.425 . . . . 0.0 109.541 -179.629 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.442 ' HB2' HG22 ' A' ' 163' ' ' VAL . 17.0 m -73.09 -27.17 61.55 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.048 -176.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -81.59 1.31 34.39 Favored 'General case' 0 C--O 1.253 1.241 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.521 ' HB1' ' HB2' ' A' ' 194' ' ' GLU . . . -65.32 154.98 36.7 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 121.601 0.715 . . . . 0.0 110.684 174.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 3.5 m -68.95 163.11 25.25 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.702 -177.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.4 mm -53.56 -41.2 45.05 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.184 0 C-N-CA 123.105 0.562 . . . . 0.0 111.056 -178.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.494 ' O ' ' HG3' ' A' ' 197' ' ' GLN . . . -63.84 -38.94 96.86 Favored Glycine 0 CA--C 1.522 0.497 0 O-C-N 123.395 0.434 . . . . 0.0 112.675 179.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 0.521 ' HB2' ' HB1' ' A' ' 190' ' ' ALA . 29.7 mt-10 -73.11 -38.21 66.42 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -177.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 95.8 mt -72.93 -30.4 63.86 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.539 177.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . 0.495 ' HG2' ' N ' ' A' ' 201' ' ' GLN . 5.6 tm-20 -63.88 -37.5 87.63 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.494 ' HG3' ' O ' ' A' ' 193' ' ' GLY . 29.2 mt-30 -54.82 -35.02 63.49 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.571 -1.195 . . . . 0.0 112.123 177.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 10.0 m -102.11 -35.08 3.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -175.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.614 HG23 ' H ' ' A' ' 200' ' ' GLY . 5.1 m -116.14 -83.2 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 176.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . 0.614 ' H ' HG23 ' A' ' 199' ' ' VAL . . . -178.86 162.55 29.66 Favored Glycine 0 N--CA 1.417 -2.593 0 N-CA-C 107.364 -2.295 . . . . 0.0 107.364 -177.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . 0.495 ' N ' ' HG2' ' A' ' 196' ' ' GLU . 9.6 pt20 -66.93 -36.29 81.91 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 118.834 1.317 . . . . 0.0 111.587 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -67.31 -41.07 85.93 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.403 0.62 . . . . 0.0 110.52 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 2.7 t -72.56 -39.17 61.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-O 121.864 0.84 . . . . 0.0 109.015 -177.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -54.64 -40.57 69.11 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 113.856 -1.52 . . . . 0.0 110.751 -178.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . 0.43 ' HG3' ' O ' ' A' ' 201' ' ' GLN . 26.6 mt-30 -61.92 -48.46 80.33 Favored 'General case' 0 N--CA 1.422 -1.84 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.674 -179.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 23.1 pt20 -70.6 -32.71 70.16 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 119.112 -1.035 . . . . 0.0 111.224 -178.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' ILE . . . . . 0.456 ' HA ' HG21 ' A' ' 166' ' ' ILE . 91.6 mt -66.44 -50.78 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 O-C-N 123.531 0.519 . . . . 0.0 110.091 178.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 11.7 t60 -69.42 -39.87 77.63 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.787 -177.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -66.28 -25.67 66.97 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 178.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . 0.433 ' CD1' HG12 ' A' ' 166' ' ' ILE . 57.4 t80 -52.33 -57.44 9.77 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.447 0.699 . . . . 0.0 112.282 -176.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -79.66 -24.66 41.67 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.508 -177.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 77.3 m -64.49 -38.45 91.05 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.046 178.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -76.85 125.64 86.78 Favored Pre-proline 0 C--N 1.309 -1.193 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 176.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -74.08 157.11 46.94 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 122.192 1.928 . . . . 0.0 110.063 178.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 7.5 tpt180 . . . . . 0 C--N 1.292 -1.893 0 C-N-CA 119.956 -0.697 . . . . 0.0 109.421 -176.62 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 18.5 p . . . . . 0 N--CA 1.429 -1.484 0 CA-C-O 120.548 0.213 . . . . 0.0 110.573 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -97.78 155.14 17.17 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 174.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -82.2 150.9 65.42 Favored Pre-proline 0 C--N 1.308 -1.21 0 CA-C-O 121.015 0.436 . . . . 0.0 112.064 -173.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -75.99 110.8 3.15 Favored 'Trans proline' 0 N--CA 1.445 -1.348 0 C-N-CA 122.687 2.258 . . . . 0.0 111.265 174.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 96.6 mt -77.63 -39.14 46.22 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 115.3 -0.863 . . . . 0.0 108.696 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 7.4 mp -82.96 105.11 13.69 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 115.193 -0.912 . . . . 0.0 108.985 177.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -163.41 167.53 37.68 Favored Glycine 0 N--CA 1.42 -2.415 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -83.22 96.42 8.44 Favored 'General case' 0 C--N 1.289 -2.023 0 C-N-CA 122.71 0.404 . . . . 0.0 111.41 -176.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 43.7 mmtm -88.87 100.51 13.23 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 174.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 10.6 tpp180 -75.46 98.81 4.01 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 121.167 0.508 . . . . 0.0 110.139 -175.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -136.16 102.38 4.99 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 86.4 mt -123.39 125.04 44.25 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.55 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 6.5 tt -132.87 124.53 28.09 Favored 'General case' 0 C--N 1.287 -2.124 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.72 77.13 0.3 Allowed 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 122.567 1.175 . . . . 0.0 112.701 178.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 11.2 p -80.19 124.61 28.95 Favored 'General case' 0 N--CA 1.417 -2.114 0 CA-C-N 114.823 -1.08 . . . . 0.0 111.992 -173.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.426 ' HA ' ' HD3' ' A' ' 157' ' ' PRO . 28.5 mm-40 -73.38 142.25 81.32 Favored Pre-proline 0 N--CA 1.424 -1.734 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 173.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 156' ' ' GLU . 8.0 Cg_exo -75.22 45.05 1.31 Allowed 'Trans proline' 0 CA--C 1.532 0.398 0 C-N-CA 123.237 2.625 . . . . 0.0 113.294 -176.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.51 ' O ' ' HG2' ' A' ' 161' ' ' ARG . 6.2 p -103.02 35.14 2.62 Favored 'General case' 0 C--N 1.295 -1.774 0 C-N-CA 123.524 0.73 . . . . 0.0 110.637 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -89.63 -37.28 14.76 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.465 ' O ' HG12 ' A' ' 163' ' ' VAL . 1.6 pt? -60.79 -28.68 68.94 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.357 -177.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.51 ' HG2' ' O ' ' A' ' 158' ' ' SER . 35.9 ptt180 -65.07 -34.45 78.45 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-O 121.327 0.584 . . . . 0.0 109.488 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 24.7 m -86.69 -33.45 20.04 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.183 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.465 HG12 ' O ' ' A' ' 160' ' ' LEU . 0.9 OUTLIER -62.22 -26.18 39.55 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 CA-C-O 121.701 0.762 . . . . 0.0 111.68 -174.908 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -81.08 -10.6 59.65 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.805 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -104.74 12.4 32.82 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.265 0.555 . . . . 0.0 110.942 -174.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.436 HG21 ' HA ' ' A' ' 207' ' ' ILE . 83.7 mt -78.51 142.68 62.49 Favored Pre-proline 0 C--N 1.31 -1.145 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.137 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.28 128.39 26.12 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.225 1.95 . . . . 0.0 110.935 174.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 113.71 -31.02 6.82 Favored Glycine 0 N--CA 1.435 -1.43 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 -178.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 60.9 t -72.68 -64.36 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 178.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 98.95 133.23 7.99 Favored Glycine 0 N--CA 1.438 -1.177 0 C-N-CA 120.299 -0.953 . . . . 0.0 113.443 175.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 54.9 pttt -89.07 -25.53 21.87 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.348 0.594 . . . . 0.0 110.926 177.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 61.7 t -84.8 -32.11 7.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 178.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -81.09 -14.26 57.94 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 114.331 -1.304 . . . . 0.0 109.079 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -52.03 -53.93 46.49 Favored Pre-proline 0 N--CA 1.476 0.841 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 -174.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.516 ' O ' ' HG2' ' A' ' 179' ' ' GLN . 19.1 Cg_endo -60.33 -33.75 94.15 Favored 'Trans proline' 0 C--N 1.377 2.077 0 C-N-CA 121.198 1.266 . . . . 0.0 112.232 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 60.9 tp -70.87 -39.32 72.95 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.574 178.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.515 ' CD2' HG11 ' A' ' 198' ' ' VAL . 93.9 mt -64.18 -36.91 85.61 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.085 177.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 97.7 mt -72.35 -9.56 58.66 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.63 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 0.516 ' HG2' ' O ' ' A' ' 175' ' ' PRO . 11.8 mm-40 -82.57 -19.25 38.86 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 176.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm -104.75 -51.21 3.11 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.687 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -102.68 142.98 25.67 Favored Pre-proline 0 C--N 1.303 -1.449 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -175.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -60.99 -41.81 41.62 Favored 'Trans proline' 0 C--N 1.356 0.959 0 C-N-CA 122.663 2.242 . . . . 0.0 112.321 -172.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 59.6 m -154.45 169.4 23.85 Favored 'General case' 0 N--CA 1.421 -1.92 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 177.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.502 ' HA ' ' HB3' ' A' ' 187' ' ' LEU . 0.2 OUTLIER -63.15 -20.5 26.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 -174.931 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -73.91 -44.31 55.61 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.172 -177.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -78.9 -26.53 43.81 Favored 'General case' 0 C--O 1.2 -1.529 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 178.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.502 ' HB3' ' HA ' ' A' ' 184' ' ' ILE . 54.6 tp -56.21 -56.41 21.34 Favored 'General case' 0 C--O 1.207 -1.156 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.726 177.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 23.2 p -72.76 -31.21 64.74 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.929 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -84.11 6.39 22.51 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 121.521 0.677 . . . . 0.0 111.317 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.425 ' HB1' ' HB2' ' A' ' 194' ' ' GLU . . . -65.3 155.58 34.79 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.029 173.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . 0.421 ' OG ' ' HG3' ' A' ' 194' ' ' GLU . 10.2 p -63.95 156.83 26.62 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.811 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 48.7 mm -52.29 -36.2 20.84 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.948 0 C-N-CA 123.244 0.618 . . . . 0.0 110.374 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -59.33 -41.33 96.85 Favored Glycine 0 N--CA 1.442 -0.904 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.629 177.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 0.516 ' O ' ' HG2' ' A' ' 197' ' ' GLN . 30.1 mt-10 -77.62 -35.72 52.38 Favored 'General case' 0 C--O 1.206 -1.217 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -177.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 96.1 mt -74.37 -24.56 59.17 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.803 0.811 . . . . 0.0 110.291 178.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -74.07 -24.15 59.46 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.847 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.516 ' HG2' ' O ' ' A' ' 194' ' ' GLU . 4.9 pt20 -67.03 -29.91 69.85 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -177.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.515 HG11 ' CD2' ' A' ' 177' ' ' LEU . 13.4 m -99.1 -21.2 5.22 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.947 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.687 -174.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.402 HG23 ' H ' ' A' ' 200' ' ' GLY . 0.2 OUTLIER -139.23 -84.22 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 173.214 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . 0.402 ' H ' HG23 ' A' ' 199' ' ' VAL . . . -178.29 171.94 44.35 Favored Glycine 0 N--CA 1.431 -1.643 0 N-CA-C 108.514 -1.834 . . . . 0.0 108.514 -173.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -69.06 -42.41 76.29 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 117.886 0.843 . . . . 0.0 112.024 -177.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -68.26 -31.54 71.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.629 0.728 . . . . 0.0 110.69 -177.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 2.1 t -77.75 -40.08 27.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -179.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -57.45 -39.72 76.91 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 114.616 -1.175 . . . . 0.0 109.844 177.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -59.69 -46.71 88.24 Favored 'General case' 0 C--O 1.209 -1.049 0 CA-C-N 115.075 -0.966 . . . . 0.0 112.322 177.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . 0.406 ' O ' ' HB2' ' A' ' 210' ' ' PHE . 4.3 pt20 -68.52 -28.48 67.03 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 119.901 -0.72 . . . . 0.0 111.477 -178.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' ILE . . . . . 0.436 ' HA ' HG21 ' A' ' 166' ' ' ILE . 76.2 mt -73.96 -52.55 20.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.117 176.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -70.3 -40.78 74.04 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 120.958 0.408 . . . . 0.0 110.981 -175.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -73.84 -10.55 59.78 Favored 'General case' 0 C--N 1.323 -0.587 0 O-C-N 122.106 -0.371 . . . . 0.0 111.875 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . 0.406 ' HB2' ' O ' ' A' ' 206' ' ' GLN . 40.8 t80 -60.07 -47.78 84.45 Favored 'General case' 0 C--O 1.218 -0.563 0 CA-C-O 121.084 0.469 . . . . 0.0 110.257 179.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -96.39 -26.59 15.28 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.207 -178.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 32.7 m -74.17 -33.18 63.38 Favored 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -178.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -93.75 135.93 24.49 Favored Pre-proline 0 C--N 1.312 -1.025 0 O-C-N 121.964 -0.46 . . . . 0.0 109.802 -178.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -66.77 157.91 58.86 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 122.782 2.322 . . . . 0.0 112.246 179.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 30.8 ttp-105 . . . . . 0 C--N 1.303 -1.454 0 CA-C-N 115.2 -0.909 . . . . 0.0 108.854 -177.217 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 20.0 m . . . . . 0 N--CA 1.417 -2.123 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -134.29 148.09 50.73 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 108.606 -0.886 . . . . 0.0 108.606 -177.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -133.18 140.93 38.91 Favored Pre-proline 0 C--N 1.294 -1.843 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -82.1 68.16 7.94 Favored 'Trans proline' 0 N--CA 1.439 -1.714 0 C-N-CA 121.833 1.689 . . . . 0.0 111.257 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 5.8 tt -89.95 -68.35 0.79 Allowed 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 178.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -128.14 105.23 8.23 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 176.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -174.42 161.44 31.35 Favored Glycine 0 N--CA 1.421 -2.338 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -112.41 169.09 9.12 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 10.3 mtmp? -86.99 151.58 23.14 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 172.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 37.4 mmt180 -74.28 97.83 3.08 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.557 0.694 . . . . 0.0 111.934 -176.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -160.98 103.17 1.3 Allowed 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 114.372 -1.285 . . . . 0.0 108.202 177.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 60.0 tp -106.15 119.55 39.5 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -93.7 154.66 17.68 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -81.67 76.79 8.57 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 177.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 13.7 m -85.45 103.79 14.66 Favored 'General case' 0 N--CA 1.415 -2.217 0 CA-C-N 114.766 -1.106 . . . . 0.0 108.058 178.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -84.85 143.64 40.72 Favored Pre-proline 0 C--N 1.293 -1.878 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -83.86 19.38 1.36 Allowed 'Trans proline' 0 C--O 1.243 0.754 0 C-N-CA 122.865 2.377 . . . . 0.0 111.704 -177.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.439 ' O ' ' HG2' ' A' ' 161' ' ' ARG . 5.3 m -74.24 91.98 2.2 Favored 'General case' 0 N--CA 1.42 -1.965 0 CA-C-N 115.381 -0.827 . . . . 0.0 108.992 178.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 37.8 mt -93.56 -18.87 21.75 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.461 HD23 ' H ' ' A' ' 160' ' ' LEU . 2.2 pt? -59.13 -30.6 68.25 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.385 0.612 . . . . 0.0 110.67 176.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.439 ' HG2' ' O ' ' A' ' 158' ' ' SER . 16.0 ptm180 -76.33 -33.5 58.99 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.987 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 24.7 m -85.28 -37.14 20.35 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 120.959 0.409 . . . . 0.0 111.15 -178.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.423 HG22 ' CB ' ' A' ' 188' ' ' SER . 4.1 p -59.68 -25.92 33.37 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.404 0 CA-C-O 121.266 0.555 . . . . 0.0 112.428 -178.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -87.82 -10.26 51.4 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-O 121.592 0.711 . . . . 0.0 110.368 177.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -101.65 3.01 39.41 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.311 -176.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.414 ' HB ' ' CG2' ' A' ' 169' ' ' VAL . 88.9 mt -60.91 133.65 92.37 Favored Pre-proline 0 C--O 1.248 1.017 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.268 178.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -60.88 127.91 23.87 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 121.991 1.794 . . . . 0.0 109.92 176.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 113.65 -36.55 3.98 Favored Glycine 0 N--CA 1.428 -1.885 0 C-N-CA 120.012 -1.09 . . . . 0.0 112.019 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.414 ' CG2' ' HB ' ' A' ' 166' ' ' ILE . 57.5 t -58.83 -44.2 89.95 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 CA-C-O 121.498 0.666 . . . . 0.0 110.757 -178.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 91.45 80.76 1.41 Allowed Glycine 0 N--CA 1.408 -3.179 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -177.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 55.2 pttt -63.59 -13.87 45.99 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.515 0.674 . . . . 0.0 112.623 -178.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 43.3 t -71.12 -32.11 46.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-O 122.158 0.98 . . . . 0.0 108.421 175.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.533 ' HB3' HD13 ' A' ' 177' ' ' LEU . 89.9 mttt -88.26 -6.21 57.92 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 114.578 -1.192 . . . . 0.0 111.472 -177.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -54.23 -52.99 64.01 Favored Pre-proline 0 CA--C 1.558 1.254 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -177.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -67.4 -31.26 35.04 Favored 'Trans proline' 0 C--N 1.375 1.931 0 C-N-CA 121.584 1.523 . . . . 0.0 112.325 179.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 55.4 tp -69.96 -44.7 68.98 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.684 0.754 . . . . 0.0 109.601 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.533 HD13 ' HB3' ' A' ' 173' ' ' LYS . 5.4 mp -75.35 -22.28 57.7 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.081 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 44.1 tp -70.55 -11.25 60.81 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 121.637 0.732 . . . . 0.0 109.803 175.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -88.62 -14.35 37.69 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 174.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -105.07 -51.17 3.08 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 122.014 0.911 . . . . 0.0 110.325 -176.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . 0.465 ' CD2' ' HA ' ' A' ' 187' ' ' LEU . 90.0 m-85 -88.72 148.92 42.84 Favored Pre-proline 0 N--CA 1.417 -2.116 0 CA-C-N 114.423 -1.262 . . . . 0.0 107.753 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -59.07 -47.5 17.51 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.479 2.119 . . . . 0.0 111.883 -179.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 23.9 m -153.21 165.0 37.05 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.554 ' H ' HD13 ' A' ' 184' ' ' ILE . 0.2 OUTLIER -62.36 -27.25 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -178.202 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 24.8 tp60 -61.57 -41.15 96.97 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 110.348 -0.242 . . . . 0.0 110.348 177.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . 0.422 ' NE2' ' HD2' ' A' ' 181' ' ' PHE . 0.7 OUTLIER -79.06 -32.91 45.0 Favored 'General case' 0 C--O 1.196 -1.733 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -179.736 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.465 ' HA ' ' CD2' ' A' ' 181' ' ' PHE . 5.3 tt -53.72 -62.01 1.93 Allowed 'General case' 0 C--O 1.21 -0.991 0 C-N-CA 123.893 0.877 . . . . 0.0 110.471 -176.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.423 ' CB ' HG22 ' A' ' 163' ' ' VAL . 25.4 m -73.99 -23.23 59.43 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -177.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -89.75 4.33 50.01 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.467 0.651 . . . . 0.0 109.372 -179.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.401 ' HB1' ' HB2' ' A' ' 194' ' ' GLU . . . -65.2 154.98 36.47 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-O 121.301 0.572 . . . . 0.0 110.123 175.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 3.0 m -64.26 158.05 24.3 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.48 -176.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 48.8 mm -53.44 -37.86 31.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 C-N-CA 123.279 0.631 . . . . 0.0 111.191 -177.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -63.4 -38.32 96.19 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.642 178.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 0.401 ' HB2' ' HB1' ' A' ' 190' ' ' ALA . 26.7 mt-10 -74.22 -37.27 63.89 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -176.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 96.2 mt -74.02 -31.36 62.89 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.832 -1.076 . . . . 0.0 110.71 178.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -64.87 -35.54 81.47 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -60.55 -26.36 66.84 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 114.438 -1.255 . . . . 0.0 112.834 178.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 13.1 m -103.59 -37.35 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.305 0 C-N-CA 120.04 -0.664 . . . . 0.0 112.437 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.519 HG23 ' H ' ' A' ' 200' ' ' GLY . 2.5 m -117.87 -80.97 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 177.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . 0.519 ' H ' HG23 ' A' ' 199' ' ' VAL . . . -178.05 166.88 37.28 Favored Glycine 0 N--CA 1.424 -2.16 0 N-CA-C 108.536 -1.826 . . . . 0.0 108.536 -178.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -69.23 -41.94 76.34 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 118.218 1.009 . . . . 0.0 110.296 -178.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -65.55 -35.98 82.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.414 0.626 . . . . 0.0 110.197 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.412 ' O ' HG13 ' A' ' 207' ' ' ILE . 2.7 t -72.66 -43.5 61.65 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.829 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -55.2 -42.47 73.31 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.3 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -58.74 -52.39 65.9 Favored 'General case' 0 N--CA 1.433 -1.315 0 C-N-CA 124.263 1.025 . . . . 0.0 111.507 177.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -69.01 -27.39 65.64 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 -178.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' ILE . . . . . 0.412 HG13 ' O ' ' A' ' 203' ' ' VAL . 98.3 mt -73.45 -51.36 25.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-O 121.311 0.577 . . . . 0.0 109.723 176.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -71.33 -37.94 71.69 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.783 -173.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -75.64 -10.08 59.14 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 178.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -66.12 -46.66 76.78 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.103 0.478 . . . . 0.0 110.86 -179.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -93.11 -25.7 17.77 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.883 -177.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 25.6 m -74.65 -25.8 59.44 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-O 121.387 0.613 . . . . 0.0 111.569 -178.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -110.87 153.56 43.7 Favored Pre-proline 0 C--N 1.314 -0.956 0 O-C-N 121.989 -0.444 . . . . 0.0 110.145 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -84.99 154.91 11.28 Favored 'Trans proline' 0 N--CA 1.443 -1.462 0 C-N-CA 121.918 1.745 . . . . 0.0 111.625 178.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 69.7 mtp180 . . . . . 0 C--N 1.299 -1.629 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 177.471 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 18.1 m . . . . . 0 C--O 1.242 0.682 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -89.89 -23.46 21.61 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.479 0.657 . . . . 0.0 110.428 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -123.15 167.12 15.47 Favored Pre-proline 0 C--N 1.296 -1.742 0 N-CA-C 105.464 -2.05 . . . . 0.0 105.464 177.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -60.59 97.32 0.12 Allowed 'Trans proline' 0 C--O 1.248 0.999 0 C-N-CA 121.831 1.687 . . . . 0.0 110.576 175.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 58.6 tp -83.12 -40.2 20.1 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.491 -177.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.449 HD23 ' H ' ' A' ' 146' ' ' LEU . 2.5 pt? -82.19 174.4 11.22 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 168.26 -158.59 31.41 Favored Glycine 0 N--CA 1.412 -2.928 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -89.84 104.0 16.6 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 121.825 0.821 . . . . 0.0 112.382 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -98.12 152.55 19.22 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 174.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 54.0 ttp180 -83.36 93.74 7.81 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 176.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -168.87 101.29 0.39 Allowed 'General case' 0 N--CA 1.426 -1.65 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -85.45 96.41 9.58 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 177.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 61.5 tp -135.76 129.32 32.37 Favored 'General case' 0 N--CA 1.421 -1.894 0 CA-C-N 114.488 -1.233 . . . . 0.0 108.952 -176.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 5.5 tt -77.05 99.74 5.43 Favored 'General case' 0 N--CA 1.421 -1.918 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 175.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 64.0 m -131.02 101.74 5.73 Favored 'General case' 0 N--CA 1.424 -1.734 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 173.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -144.33 119.12 5.95 Favored Pre-proline 0 C--N 1.299 -1.605 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 -176.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.67 -32.43 96.82 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 122.739 2.293 . . . . 0.0 114.138 -176.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.565 ' O ' ' HG2' ' A' ' 161' ' ' ARG . 31.9 m 57.73 32.87 22.51 Favored 'General case' 0 C--O 1.22 -0.452 0 C-N-CA 123.423 0.689 . . . . 0.0 111.168 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.49 ' O ' HD23 ' A' ' 159' ' ' LEU . 6.4 tt -60.44 -22.83 63.88 Favored 'General case' 0 C--O 1.211 -0.948 0 C-N-CA 123.744 0.818 . . . . 0.0 110.322 -175.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.48 ' O ' HG12 ' A' ' 163' ' ' VAL . 3.4 pp -53.85 -31.42 49.46 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.98 0.912 . . . . 0.0 111.595 176.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.565 ' HG2' ' O ' ' A' ' 158' ' ' SER . 13.6 ptm180 -71.5 -29.38 64.73 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.844 0.831 . . . . 0.0 109.397 -178.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 21.1 m -86.69 -29.56 22.37 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.157 177.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 160' ' ' LEU . 0.3 OUTLIER -65.24 -26.46 39.71 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.643 0 CA-C-O 121.583 0.706 . . . . 0.0 110.916 -176.124 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -82.64 -6.71 59.51 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.481 0.657 . . . . 0.0 110.865 177.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 78.9 mm-40 -101.64 13.26 35.45 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.098 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 80.9 mt -84.35 131.75 49.5 Favored Pre-proline 0 C--N 1.306 -1.297 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -62.89 127.14 19.66 Favored 'Trans proline' 0 C--O 1.245 0.86 0 C-N-CA 121.642 1.561 . . . . 0.0 110.633 177.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 112.33 -18.51 23.12 Favored Glycine 0 N--CA 1.43 -1.765 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.62 -177.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 84.0 t -71.67 -50.41 39.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 178.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 96.58 102.09 2.02 Favored Glycine 0 N--CA 1.43 -1.743 0 C-N-CA 120.236 -0.983 . . . . 0.0 113.159 178.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -67.76 -32.4 72.98 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.219 0.533 . . . . 0.0 110.678 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 48.7 t -85.1 -30.76 6.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-O 121.801 0.81 . . . . 0.0 109.342 -178.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -79.89 -12.74 59.72 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.875 -178.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -50.72 -55.03 29.97 Favored Pre-proline 0 CA--C 1.55 0.974 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -177.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.494 ' O ' ' HG3' ' A' ' 179' ' ' GLN . 21.1 Cg_endo -62.25 -28.68 79.37 Favored 'Trans proline' 0 C--N 1.369 1.642 0 CA-C-N 121.045 1.409 . . . . 0.0 112.899 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 51.7 tp -73.02 -47.98 40.31 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 176.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.456 ' HB3' HD13 ' A' ' 187' ' ' LEU . 97.2 mt -59.27 -39.77 83.92 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.686 177.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.438 ' HA ' ' O ' ' A' ' 181' ' ' PHE . 10.2 mp -68.99 -6.81 30.12 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 179.013 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 0.494 ' HG3' ' O ' ' A' ' 175' ' ' PRO . 76.7 mt-30 -83.19 -17.35 43.13 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 174.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 7.7 mmmm -103.94 -44.92 4.9 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.09 177.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . 0.438 ' O ' ' HA ' ' A' ' 178' ' ' LEU . 27.9 m-85 -111.35 131.51 22.23 Favored Pre-proline 0 N--CA 1.424 -1.753 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 -176.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 181' ' ' PHE . 78.4 Cg_exo -48.33 -38.57 34.41 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 124.152 3.235 . . . . 0.0 113.801 -175.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 73.6 p -154.06 173.69 15.69 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -177.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.521 ' H ' HD13 ' A' ' 184' ' ' ILE . 0.2 OUTLIER -66.59 -21.24 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 O-C-N 123.664 0.602 . . . . 0.0 110.78 175.275 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -67.07 -48.49 68.08 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -77.76 -32.73 52.79 Favored 'General case' 0 C--O 1.201 -1.449 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -178.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.498 ' HB3' ' HA ' ' A' ' 184' ' ' ILE . 61.5 tp -52.78 -57.72 9.22 Favored 'General case' 0 C--O 1.207 -1.156 0 C-N-CA 124.589 1.156 . . . . 0.0 111.691 178.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 24.5 p -68.73 -32.79 72.82 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.617 0.723 . . . . 0.0 111.353 -179.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -80.97 -2.67 48.76 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.259 -178.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -66.35 156.51 34.27 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 123.465 0.706 . . . . 0.0 111.015 177.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 5.4 m -63.26 152.31 38.08 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.115 -175.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 50.3 mm -54.21 -35.86 31.05 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.839 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.865 -177.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.422 ' O ' ' HG2' ' A' ' 197' ' ' GLN . . . -61.63 -39.09 96.92 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.322 -0.466 . . . . 0.0 112.56 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -71.42 -45.11 63.54 Favored 'General case' 0 CA--C 1.489 -1.392 0 CA-C-O 121.548 0.69 . . . . 0.0 110.214 -178.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 95.8 mt -66.65 -29.59 69.64 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 114.279 -1.328 . . . . 0.0 110.804 178.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -70.49 -33.11 70.86 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.441 ' HA ' ' OE1' ' A' ' 197' ' ' GLN . 13.6 mm-40 -66.65 -21.51 66.11 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 114.987 -1.006 . . . . 0.0 113.1 -179.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 18.8 m -104.11 -32.85 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.757 177.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.424 HG23 ' H ' ' A' ' 200' ' ' GLY . 0.7 OUTLIER -125.17 -85.38 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 173.76 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . 0.424 ' H ' HG23 ' A' ' 199' ' ' VAL . . . -177.22 165.35 35.23 Favored Glycine 0 N--CA 1.43 -1.742 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -176.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -58.39 -49.32 77.69 Favored 'General case' 0 C--O 1.21 -0.996 0 CA-C-N 117.487 0.643 . . . . 0.0 111.626 -177.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -65.01 -32.57 74.35 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.314 0.578 . . . . 0.0 111.095 -175.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.412 ' O ' HG13 ' A' ' 207' ' ' ILE . 3.8 t -75.76 -44.56 39.43 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 -179.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -57.06 -43.75 82.36 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 114.009 -1.45 . . . . 0.0 109.912 179.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -62.94 -44.97 94.61 Favored 'General case' 0 N--CA 1.424 -1.752 0 CA-C-N 114.982 -1.008 . . . . 0.0 112.579 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -69.43 -29.16 66.82 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 119.442 -0.903 . . . . 0.0 111.169 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' ILE . . . . . 0.412 HG13 ' O ' ' A' ' 203' ' ' VAL . 87.4 mt -72.04 -52.15 26.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 176.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 12.2 t60 -69.7 -37.03 76.45 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.614 -174.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -73.36 -22.32 60.32 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 179.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -50.94 -56.74 10.92 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.843 0.857 . . . . 0.0 111.475 -177.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -83.57 -27.64 29.12 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.235 -176.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 38.8 m -69.83 -48.03 60.5 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.472 -178.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -87.27 146.8 40.83 Favored Pre-proline 0 C--N 1.309 -1.188 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 -177.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -85.77 164.93 10.44 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.189 1.926 . . . . 0.0 110.293 173.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . 0.627 ' HD3' ' O ' ' A' ' 215' ' ' ARG 0.262 0.0 OUTLIER . . . . . 0 C--N 1.303 -1.421 0 O-C-N 121.948 -0.47 . . . . 0.0 110.745 177.487 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 37.0 t . . . . . 0 N--CA 1.428 -1.549 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -136.28 147.36 47.46 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 174.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -86.29 151.9 54.53 Favored Pre-proline 0 C--N 1.288 -2.085 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -60.0 159.99 23.74 Favored 'Trans proline' 0 C--O 1.256 1.403 0 C-N-CA 122.471 2.114 . . . . 0.0 111.606 178.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 67.4 tp -56.57 -46.52 80.72 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 6.0 tt -105.45 115.92 31.06 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 175.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -150.7 152.58 24.41 Favored Glycine 0 N--CA 1.423 -2.204 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -115.01 132.05 56.73 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -80.47 96.49 6.77 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-O 121.237 0.541 . . . . 0.0 110.056 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -157.12 108.87 2.39 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 177.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -153.27 160.91 42.84 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -178.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 59.5 tp -134.17 96.93 3.72 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 175.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 7.5 mp -72.17 137.22 46.79 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.363 -176.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -93.15 75.11 4.67 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 -178.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 62.1 m -146.8 102.45 3.54 Favored 'General case' 0 N--CA 1.425 -1.703 0 CA-C-N 114.284 -1.326 . . . . 0.0 108.812 173.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -105.65 160.88 24.56 Favored Pre-proline 0 C--N 1.295 -1.79 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.448 ' O ' ' HD2' ' A' ' 161' ' ' ARG . 33.0 Cg_exo -62.71 111.84 1.46 Allowed 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.181 1.921 . . . . 0.0 110.273 177.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 48.5 m 77.59 84.59 0.08 Allowed 'General case' 0 C--O 1.207 -1.184 0 C-N-CA 125.191 1.396 . . . . 0.0 110.589 -174.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.479 ' O ' HD23 ' A' ' 159' ' ' LEU . 5.5 tt -57.95 -28.63 64.49 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.779 0.831 . . . . 0.0 111.243 -174.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.492 ' H ' HD23 ' A' ' 160' ' ' LEU . 2.1 pt? -57.99 -22.28 48.69 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 177.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.448 ' HD2' ' O ' ' A' ' 157' ' ' PRO . 11.1 ptm180 -68.86 -32.1 71.52 Favored 'General case' 0 C--O 1.218 -0.555 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 177.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 28.4 m -86.51 -34.04 20.13 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.442 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -63.87 -26.53 40.8 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.968 0 CA-C-O 121.516 0.674 . . . . 0.0 110.644 -176.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -82.84 -7.74 59.63 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.371 177.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.592 ' HA ' HE21 ' A' ' 165' ' ' GLN . 0.0 OUTLIER -108.47 13.59 25.32 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.89 0.376 . . . . 0.0 110.605 -176.417 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.477 HG21 ' HA ' ' A' ' 207' ' ' ILE . 81.2 mt -71.82 138.71 82.74 Favored Pre-proline 0 C--N 1.31 -1.12 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.876 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -61.73 128.85 25.69 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.132 1.888 . . . . 0.0 110.637 175.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 114.46 -33.46 5.38 Favored Glycine 0 C--N 1.308 -0.978 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -178.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.498 ' O ' ' HE3' ' A' ' 173' ' ' LYS . 89.1 t -63.14 -57.48 11.78 Favored 'Isoleucine or valine' 0 C--N 1.338 0.109 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 178.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 99.24 126.82 5.76 Favored Glycine 0 N--CA 1.43 -1.748 0 C-N-CA 120.588 -0.815 . . . . 0.0 113.552 175.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -85.51 -25.07 27.05 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 121.313 0.578 . . . . 0.0 111.145 178.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 40.8 t -83.96 -28.26 7.31 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-O 122.082 0.944 . . . . 0.0 108.897 -178.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.498 ' HE3' ' O ' ' A' ' 169' ' ' VAL . 46.6 mtmt -87.28 -1.03 57.62 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.593 178.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -51.77 -49.01 85.79 Favored Pre-proline 0 CA--C 1.546 0.811 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 -178.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.516 ' O ' ' HG2' ' A' ' 179' ' ' GLN . 26.1 Cg_exo -62.86 -42.6 23.91 Favored 'Trans proline' 0 C--N 1.378 2.097 0 CA-C-N 120.69 1.282 . . . . 0.0 111.022 178.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 39.6 tp -58.42 -48.94 79.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.184 177.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.456 ' HB3' HD11 ' A' ' 187' ' ' LEU . 87.5 mt -60.68 -40.48 92.32 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.173 178.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 94.3 mt -71.15 -13.53 61.97 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 0.516 ' HG2' ' O ' ' A' ' 175' ' ' PRO . 28.6 mm-40 -93.83 -12.38 29.13 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.289 0.566 . . . . 0.0 110.055 174.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -97.74 -50.59 4.4 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 121.792 0.805 . . . . 0.0 109.515 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . 0.518 ' CD2' ' HG ' ' A' ' 187' ' ' LEU . 79.9 m-85 -100.26 146.64 32.32 Favored Pre-proline 0 C--N 1.294 -1.846 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.871 -178.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -70.93 -29.45 18.3 Favored 'Trans proline' 0 C--O 1.235 0.366 0 C-N-CA 122.551 2.167 . . . . 0.0 112.594 -178.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . 0.431 ' O ' ' HB2' ' A' ' 187' ' ' LEU . 64.3 p -153.84 166.58 32.46 Favored 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -178.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.436 HD13 ' H ' ' A' ' 184' ' ' ILE . 0.2 OUTLIER -71.05 -22.51 22.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 O-C-N 123.479 0.487 . . . . 0.0 110.138 176.574 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -61.81 -52.84 62.52 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 114.944 -1.025 . . . . 0.0 108.914 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -76.95 -28.03 55.04 Favored 'General case' 0 C--O 1.207 -1.15 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -179.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.518 ' HG ' ' CD2' ' A' ' 181' ' ' PHE . 3.7 tt -54.78 -64.56 0.8 Allowed 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 124.081 0.952 . . . . 0.0 110.24 -178.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 24.0 m -75.94 -22.93 55.49 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.773 -175.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -84.87 -3.87 58.86 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.32 0.581 . . . . 0.0 110.18 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.7 154.58 38.53 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.687 178.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 1.9 t -73.59 169.23 17.69 Favored 'General case' 0 N--CA 1.423 -1.812 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.984 -176.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 50.1 mm -51.8 -39.37 24.48 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.973 0 C-N-CA 123.99 0.916 . . . . 0.0 111.138 -176.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.433 ' O ' ' HG3' ' A' ' 197' ' ' GLN . . . -59.26 -31.88 70.68 Favored Glycine 0 CA--C 1.527 0.817 0 O-C-N 123.431 0.457 . . . . 0.0 113.899 -179.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 0.47 ' O ' ' HB2' ' A' ' 197' ' ' GLN . 29.2 mm-40 -83.61 -40.13 19.42 Favored 'General case' 0 C--O 1.215 -0.746 0 CA-C-O 121.696 0.76 . . . . 0.0 109.638 -178.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.414 ' HB2' ' HB1' ' A' ' 204' ' ' ALA . 77.7 mt -73.39 -23.99 60.24 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-O 121.744 0.783 . . . . 0.0 110.696 -178.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -71.83 -26.54 62.42 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 178.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.47 ' HB2' ' O ' ' A' ' 194' ' ' GLU . 74.6 mt-30 -61.17 -29.67 69.94 Favored 'General case' 0 C--O 1.242 0.71 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.719 178.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.402 HG11 ' CD2' ' A' ' 177' ' ' LEU . 12.0 m -103.27 -37.18 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.295 0 C-N-CA 120.709 -0.397 . . . . 0.0 111.888 -178.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.459 HG23 ' H ' ' A' ' 200' ' ' GLY . 1.7 m -122.47 -83.75 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . 0.459 ' H ' HG23 ' A' ' 199' ' ' VAL . . . -177.6 172.53 45.26 Favored Glycine 0 N--CA 1.429 -1.789 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -175.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -64.55 -46.78 81.31 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 117.421 0.611 . . . . 0.0 111.816 -176.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -70.6 -30.21 66.82 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.311 0.577 . . . . 0.0 110.997 -176.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.62 ' O ' ' HG2' ' A' ' 206' ' ' GLN . 2.2 t -78.62 -33.91 17.28 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.051 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . 0.414 ' HB1' ' HB2' ' A' ' 195' ' ' LEU . . . -63.25 -38.45 91.22 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.41 175.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . 0.562 ' HA ' HE21 ' A' ' 205' ' ' GLN . 0.0 OUTLIER -60.24 -42.69 95.81 Favored 'General case' 0 C--O 1.207 -1.134 0 CA-C-N 115.32 -0.855 . . . . 0.0 112.522 179.434 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . 0.62 ' HG2' ' O ' ' A' ' 203' ' ' VAL . 20.6 pt20 -66.79 -30.22 70.37 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.894 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' ILE . . . . . 0.477 ' HA ' HG21 ' A' ' 166' ' ' ILE . 71.6 mt -78.19 -52.91 15.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-O 121.47 0.652 . . . . 0.0 109.982 178.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 40.0 t-80 -65.04 -39.56 93.51 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.839 -175.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -80.97 -14.04 58.33 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 120.728 -0.389 . . . . 0.0 112.023 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -55.11 -53.84 50.82 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.323 0.649 . . . . 0.0 111.318 -176.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -84.28 -27.82 27.58 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.896 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 25.5 m -71.54 -27.29 63.08 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-O 121.204 0.526 . . . . 0.0 111.392 -179.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -88.28 116.18 65.46 Favored Pre-proline 0 C--N 1.305 -1.341 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.85 158.32 42.85 Favored 'Trans proline' 0 N--CA 1.44 -1.656 0 C-N-CA 121.465 1.443 . . . . 0.0 109.143 176.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 35.8 ttm180 . . . . . 0 C--N 1.285 -2.232 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -174.399 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 19.8 m . . . . . 0 N--CA 1.433 -1.299 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 66.3 tttm -145.08 145.53 31.48 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -175.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -78.82 118.71 74.0 Favored Pre-proline 0 C--N 1.304 -1.39 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -179.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_exo -71.12 132.09 20.51 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.075 1.85 . . . . 0.0 110.899 179.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 92.5 mt -98.99 83.2 2.86 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-O 121.555 0.693 . . . . 0.0 109.336 179.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 50.7 tp -123.3 105.32 9.75 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.159 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -148.75 -156.58 7.19 Favored Glycine 0 N--CA 1.414 -2.767 0 C-N-CA 120.366 -0.921 . . . . 0.0 112.155 -178.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 55.9 mttp -87.38 101.58 13.71 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-O 121.266 0.555 . . . . 0.0 110.144 -176.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -111.7 105.61 14.17 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 175.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 60.5 ttt180 -120.22 111.9 18.4 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.946 -177.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -87.9 103.47 15.7 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 178.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 53.9 tp -96.01 93.26 6.89 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-O 121.972 0.891 . . . . 0.0 110.685 -175.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 7.0 tt -111.18 135.55 51.54 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 179.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.11 93.98 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 122.706 1.241 . . . . 0.0 111.908 178.267 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 16.1 m -98.86 109.48 22.23 Favored 'General case' 0 N--CA 1.421 -1.899 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.726 -173.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -105.8 98.2 17.3 Favored Pre-proline 0 C--N 1.295 -1.762 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 171.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -77.76 83.24 2.22 Favored 'Trans proline' 0 N--CA 1.429 -2.302 0 C-N-CA 121.876 1.718 . . . . 0.0 110.777 178.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 2.4 m -87.39 -6.4 58.47 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 175.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 39.5 tp -55.58 -17.83 6.35 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 125.482 1.513 . . . . 0.0 111.608 178.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -62.57 -26.55 68.64 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.074 0.464 . . . . 0.0 110.24 177.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 23.9 ptt180 -67.35 -35.58 79.67 Favored 'General case' 0 C--O 1.215 -0.731 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 8.4 m -86.14 -33.28 20.91 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.618 -178.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -64.95 -26.09 39.25 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-O 121.515 0.674 . . . . 0.0 110.835 -175.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 30.3 pt20 -85.27 -7.3 59.08 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.307 177.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -99.26 4.7 46.67 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -178.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.442 HG21 ' HA ' ' A' ' 207' ' ' ILE . 85.7 mt -72.18 131.58 85.08 Favored Pre-proline 0 C--N 1.309 -1.162 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -179.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -62.13 131.73 35.89 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.485 2.123 . . . . 0.0 110.586 176.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 113.83 -36.42 4.03 Favored Glycine 0 N--CA 1.424 -2.134 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 -178.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 91.9 t -55.72 -48.09 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-O 120.96 0.409 . . . . 0.0 110.593 -178.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 85.63 95.26 0.77 Allowed Glycine 0 N--CA 1.429 -1.794 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 -179.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -70.24 -18.71 63.16 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -175.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 62.0 t -83.24 -30.75 8.32 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 CA-C-O 121.396 0.617 . . . . 0.0 109.831 179.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.604 ' O ' ' HG ' ' A' ' 177' ' ' LEU . 21.2 ptmt -93.93 -4.0 50.61 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.415 0.626 . . . . 0.0 110.035 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.443 ' N ' ' HD2' ' A' ' 175' ' ' PRO . . . -59.72 -45.99 98.49 Favored Pre-proline 0 CA--C 1.548 0.9 0 CA-C-N 114.906 -1.043 . . . . 0.0 113.417 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.443 ' HD2' ' N ' ' A' ' 174' ' ' ALA . 9.3 Cg_endo -54.88 -35.94 90.27 Favored 'Trans proline' 0 C--N 1.385 2.449 0 C-N-CA 122.176 1.917 . . . . 0.0 112.193 176.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 53.3 tp -68.14 -42.3 80.34 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.437 0.637 . . . . 0.0 109.699 178.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.604 ' HG ' ' O ' ' A' ' 173' ' ' LYS . 59.8 mt -70.1 -31.06 68.43 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.75 -179.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 35.5 tp -72.91 -10.83 60.23 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.528 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 0.438 ' HG2' ' O ' ' A' ' 175' ' ' PRO . 13.8 mm100 -83.72 -20.17 33.91 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 174.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -103.65 -51.81 3.11 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-O 121.31 0.576 . . . . 0.0 110.354 -174.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -90.73 140.55 26.47 Favored Pre-proline 0 C--N 1.296 -1.751 0 CA-C-N 115.346 -0.843 . . . . 0.0 108.752 178.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -47.0 -47.5 16.51 Favored 'Trans proline' 0 C--N 1.361 1.217 0 C-N-CA 123.96 3.107 . . . . 0.0 112.545 -176.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . 0.435 ' OG ' HD13 ' A' ' 184' ' ' ILE . 25.8 t -153.71 169.48 23.21 Favored 'General case' 0 N--CA 1.41 -2.437 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.589 ' H ' HD13 ' A' ' 184' ' ' ILE . 0.2 OUTLIER -60.03 -27.93 40.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 O-C-N 124.013 0.821 . . . . 0.0 110.151 177.114 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -56.86 -50.21 73.16 Favored 'General case' 0 C--O 1.212 -0.889 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.033 176.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.1 -34.04 43.85 Favored 'General case' 0 C--O 1.206 -1.217 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -177.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.451 ' HB3' ' HA ' ' A' ' 184' ' ' ILE . 57.8 tp -50.8 -62.55 1.53 Allowed 'General case' 0 C--O 1.21 -0.976 0 C-N-CA 124.408 1.083 . . . . 0.0 111.278 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 25.3 m -72.07 -22.66 61.33 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.012 0.434 . . . . 0.0 112.07 -178.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -83.59 -4.04 58.21 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 121.488 0.661 . . . . 0.0 110.845 -178.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.513 ' HB1' ' HB2' ' A' ' 194' ' ' GLU . . . -65.74 155.48 35.97 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.019 175.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 4.0 m -65.33 162.27 17.88 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.994 -176.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.2 mm -53.66 -39.98 40.54 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.622 0 C-N-CA 122.751 0.42 . . . . 0.0 111.113 -178.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -62.77 -35.14 91.52 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 121.515 -0.374 . . . . 0.0 112.471 179.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 0.644 ' O ' ' HG2' ' A' ' 197' ' ' GLN . 25.2 mt-10 -80.7 -29.72 36.46 Favored 'General case' 0 C--O 1.215 -0.76 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -177.135 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 97.4 mt -78.76 -33.33 46.57 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.983 176.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . 0.422 ' HG2' ' N ' ' A' ' 201' ' ' GLN . 6.5 tm-20 -67.46 -31.71 72.07 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 -177.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.644 ' HG2' ' O ' ' A' ' 194' ' ' GLU . 16.5 pt20 -67.92 -28.39 67.45 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.529 -177.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 14.1 m -99.52 -34.58 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.969 -177.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.481 HG23 ' H ' ' A' ' 200' ' ' GLY . 2.5 m -119.81 -82.84 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 175.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . 0.481 ' H ' HG23 ' A' ' 199' ' ' VAL . . . -177.84 166.0 35.96 Favored Glycine 0 N--CA 1.429 -1.794 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 -176.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . 0.422 ' N ' ' HG2' ' A' ' 196' ' ' GLU . 8.8 tm0? -62.51 -47.03 85.73 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 117.565 0.682 . . . . 0.0 110.303 -177.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -71.63 -28.8 64.02 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.248 -176.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 3.0 t -76.06 -41.2 38.08 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.706 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -55.94 -45.11 78.88 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 114.224 -1.353 . . . . 0.0 109.651 179.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -59.26 -46.65 87.95 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 114.973 -1.012 . . . . 0.0 112.437 179.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -67.87 -33.09 74.06 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 120.366 -0.533 . . . . 0.0 111.357 -179.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' ILE . . . . . 0.442 ' HA ' HG21 ' A' ' 166' ' ' ILE . 85.8 mt -74.72 -50.44 25.87 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-O 121.141 0.496 . . . . 0.0 110.577 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 15.1 t60 -68.99 -43.88 73.98 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.106 -175.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -72.58 -10.77 60.2 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -62.46 -47.42 84.12 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.169 0.509 . . . . 0.0 110.223 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -98.07 -25.17 15.03 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.857 -178.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 24.1 m -77.13 -38.84 51.26 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -178.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -108.11 115.54 58.29 Favored Pre-proline 0 N--CA 1.435 -1.218 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -176.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.9 167.53 26.38 Favored 'Trans proline' 0 C--O 1.243 0.759 0 C-N-CA 122.406 2.071 . . . . 0.0 112.275 -179.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 48.4 mtm180 . . . . . 0 C--N 1.298 -1.671 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.365 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 13.2 t . . . . . 0 N--CA 1.424 -1.746 0 N-CA-C 106.387 -1.709 . . . . 0.0 106.387 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 51.9 pttt -115.41 -31.17 6.01 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -173.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.407 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . 11.3 m120 -139.67 130.95 14.63 Favored Pre-proline 0 C--N 1.31 -1.149 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.104 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 143' ' ' ASN . 5.9 Cg_exo -77.39 85.99 1.7 Allowed 'Trans proline' 0 N--CA 1.445 -1.344 0 C-N-CA 121.991 1.794 . . . . 0.0 109.894 173.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 61.5 tp -98.72 -35.16 10.26 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.483 -178.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.6 mp -98.79 114.48 27.05 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -179.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -148.43 -161.55 9.67 Favored Glycine 0 N--CA 1.425 -2.085 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 -177.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -123.21 137.58 54.85 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 178.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.77 142.3 37.1 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 177.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -81.28 149.94 28.75 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 176.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -83.91 101.67 11.85 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.6 tt -113.32 112.74 24.2 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 -179.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 45.2 tp -94.07 137.58 33.11 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.363 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -65.1 108.04 1.72 Allowed 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.626 0.727 . . . . 0.0 109.192 176.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 15.2 m -105.96 110.72 23.1 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.457 179.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -78.14 140.82 61.85 Favored Pre-proline 0 C--N 1.317 -0.834 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 176.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -85.45 66.86 5.79 Favored 'Trans proline' 0 N--CA 1.443 -1.451 0 C-N-CA 122.285 1.99 . . . . 0.0 109.477 172.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.408 ' O ' ' HG2' ' A' ' 161' ' ' ARG . 34.6 m -84.92 110.53 18.94 Favored 'General case' 0 N--CA 1.427 -1.595 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.619 -178.161 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 42.8 tp -93.61 -29.47 15.45 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.667 -178.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -60.26 -25.67 65.87 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.246 0.546 . . . . 0.0 112.038 -179.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.408 ' HG2' ' O ' ' A' ' 158' ' ' SER . 40.1 ptt180 -73.62 -33.58 64.62 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.207 0.527 . . . . 0.0 110.114 177.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 16.9 m -85.76 -33.99 21.28 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 121.243 0.544 . . . . 0.0 110.591 -178.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.438 HG22 ' CB ' ' A' ' 188' ' ' SER . 0.8 OUTLIER -64.17 -25.61 38.46 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.131 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.049 -176.555 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . 0.422 ' NE2' HG13 ' A' ' 184' ' ' ILE . 11.5 pt20 -87.69 -7.59 57.2 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.755 177.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -103.56 12.15 35.36 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.17 0.51 . . . . 0.0 109.996 -178.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 77.7 mt -72.8 125.97 90.88 Favored Pre-proline 0 C--N 1.314 -0.961 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.24 128.5 20.6 Favored 'Trans proline' 0 N--CA 1.445 -1.331 0 C-N-CA 121.562 1.508 . . . . 0.0 109.183 176.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 116.16 -29.24 7.17 Favored Glycine 0 N--CA 1.428 -1.872 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 -177.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 93.1 t -65.32 -52.23 54.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 121.313 0.578 . . . . 0.0 110.426 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 102.33 75.31 1.09 Allowed Glycine 0 N--CA 1.424 -2.102 0 C-N-CA 120.365 -0.921 . . . . 0.0 111.234 -179.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -73.64 -15.63 61.25 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.279 0.562 . . . . 0.0 111.656 -177.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 45.1 t -86.86 -22.86 6.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 CA-C-O 121.96 0.886 . . . . 0.0 108.637 176.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.464 ' O ' ' HG ' ' A' ' 177' ' ' LEU . 38.0 ttpt -96.12 8.36 43.98 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.309 -1.314 . . . . 0.0 108.226 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -56.67 -46.3 99.85 Favored Pre-proline 0 C--O 1.212 -0.901 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 -177.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.567 ' O ' ' HG2' ' A' ' 179' ' ' GLN . 51.7 Cg_exo -56.97 -41.08 79.04 Favored 'Trans proline' 0 C--N 1.377 2.036 0 CA-C-N 121.204 1.466 . . . . 0.0 111.345 178.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 48.5 tp -64.7 -43.36 93.74 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.435 176.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 173' ' ' LYS . 96.3 mt -63.34 -40.27 96.83 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.533 178.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -68.63 -6.91 28.57 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 178.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 0.567 ' HG2' ' O ' ' A' ' 175' ' ' PRO . 86.9 mm-40 -84.46 -15.64 45.38 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.06 0.457 . . . . 0.0 110.102 174.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -112.17 -51.01 2.87 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 121.434 0.635 . . . . 0.0 110.047 179.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . 0.485 ' CD1' ' HA ' ' A' ' 187' ' ' LEU . 80.6 m-85 -88.58 139.05 29.68 Favored Pre-proline 0 C--N 1.299 -1.622 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.433 -177.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -64.07 -48.94 4.31 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.511 2.141 . . . . 0.0 112.289 -177.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 25.2 m -148.11 167.38 25.16 Favored 'General case' 0 N--CA 1.426 -1.646 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 178.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.422 HG13 ' NE2' ' A' ' 164' ' ' GLN . 0.2 OUTLIER -60.66 -25.45 35.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -179.085 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 24.0 tp60 -60.87 -51.91 67.27 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.52 -178.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -79.24 -27.18 42.41 Favored 'General case' 0 C--O 1.189 -2.103 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.485 ' HA ' ' CD1' ' A' ' 181' ' ' PHE . 5.1 tt -52.32 -61.55 2.2 Favored 'General case' 0 C--O 1.214 -0.804 0 C-N-CA 123.332 0.653 . . . . 0.0 110.304 -177.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.438 ' CB ' HG22 ' A' ' 163' ' ' VAL . 19.5 m -73.72 -22.97 59.72 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 121.165 0.507 . . . . 0.0 112.035 -177.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -91.0 7.44 40.32 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.858 178.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -66.21 156.89 32.87 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 123.22 0.608 . . . . 0.0 111.533 176.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 4.6 m -62.9 158.27 19.52 Favored 'General case' 0 N--CA 1.427 -1.61 0 CA-C-N 115.153 -0.931 . . . . 0.0 109.761 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 47.9 mm -55.54 -36.06 40.38 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.355 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.491 -177.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -62.58 -36.15 92.81 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 121.045 -0.598 . . . . 0.0 112.434 178.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 0.463 ' O ' ' HG2' ' A' ' 197' ' ' GLN . 13.1 mm-40 -76.84 -35.88 57.21 Favored 'General case' 0 C--O 1.215 -0.727 0 CA-C-O 121.475 0.655 . . . . 0.0 109.36 -177.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 92.0 mt -77.94 -23.33 48.59 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-O 121.616 0.722 . . . . 0.0 110.793 178.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . 0.477 ' HG2' ' N ' ' A' ' 201' ' ' GLN . 4.0 tm-20 -81.95 -37.76 26.22 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -178.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.463 ' HG2' ' O ' ' A' ' 194' ' ' GLU . 9.9 pt20 -66.37 -22.79 66.26 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.736 -178.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.429 HG22 ' O ' ' A' ' 194' ' ' GLU . 12.6 m -99.19 -28.83 3.44 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.422 HG23 HG23 ' A' ' 198' ' ' VAL . 1.5 t -130.64 -79.74 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.613 176.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -177.51 164.63 33.88 Favored Glycine 0 N--CA 1.438 -1.181 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 -177.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . 0.477 ' N ' ' HG2' ' A' ' 196' ' ' GLU . 11.1 pt20 -66.23 -40.13 90.04 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -177.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -68.2 -24.71 64.97 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 122.188 0.994 . . . . 0.0 109.827 -178.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.416 HG11 HG11 ' A' ' 199' ' ' VAL . 6.9 t -83.32 -47.56 18.1 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 CA-C-N 114.435 -1.257 . . . . 0.0 108.324 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -52.89 -44.96 67.28 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 114.473 -1.239 . . . . 0.0 110.846 -178.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -63.33 -48.03 79.73 Favored 'General case' 0 N--CA 1.423 -1.783 0 CA-C-N 114.922 -1.035 . . . . 0.0 111.574 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -70.96 -29.82 65.93 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.48 -177.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 90.6 mt -69.53 -51.91 37.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 175.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 7.0 t60 -69.6 -31.15 69.13 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.472 0.653 . . . . 0.0 109.374 -176.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -80.18 -13.69 59.05 Favored 'General case' 0 C--O 1.207 -1.142 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 176.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -62.24 -43.37 98.98 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-O 121.022 0.439 . . . . 0.0 111.782 -176.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -90.91 -23.38 20.51 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.261 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 28.4 m -76.2 -40.9 51.17 Favored 'General case' 0 CA--C 1.555 1.152 0 CA-C-O 121.059 0.457 . . . . 0.0 111.277 178.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -91.51 126.55 53.94 Favored Pre-proline 0 C--N 1.31 -1.146 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 178.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -48.64 141.66 19.92 Favored 'Trans proline' 0 C--O 1.243 0.751 0 C-N-CA 123.278 2.652 . . . . 0.0 112.995 176.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 . . . . . 0 N--CA 1.415 -2.177 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -177.108 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 43.4 m . . . . . 0 N--CA 1.426 -1.667 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -142.03 -28.24 0.62 Allowed 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.697 -175.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.41 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . 3.7 p-10 -140.96 148.56 52.67 Favored Pre-proline 0 C--N 1.317 -0.836 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 -176.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 143' ' ' ASN . 7.0 Cg_endo -88.35 -174.21 1.06 Allowed 'Trans proline' 0 N--CA 1.439 -1.7 0 C-N-CA 122.137 1.891 . . . . 0.0 109.301 172.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 3.3 tt -98.58 -67.29 0.85 Allowed 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 179.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -128.72 174.8 9.12 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.12 176.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -177.67 174.28 46.77 Favored Glycine 0 N--CA 1.417 -2.593 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 178.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -81.47 109.19 15.7 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 177.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -88.77 145.05 25.84 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -178.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.407 ' HA ' ' HD3' ' A' ' 150' ' ' ARG . 37.3 mmt180 -87.32 116.88 25.71 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 178.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -148.16 105.82 3.68 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.648 179.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 64.4 tp -125.71 109.04 12.12 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 -178.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -105.71 144.38 32.53 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 2.9 tt -89.39 77.38 7.37 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -178.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 20.0 m -82.24 103.46 11.85 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.497 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.412 ' HA ' ' HD3' ' A' ' 157' ' ' PRO . 36.5 mt-10 -79.21 139.82 56.56 Favored Pre-proline 0 C--N 1.309 -1.179 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.159 -177.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 156' ' ' GLU . 37.7 Cg_exo -60.47 101.97 0.18 Allowed 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.96 2.44 . . . . 0.0 111.152 176.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.447 ' HB2' ' HD2' ' A' ' 161' ' ' ARG . 16.8 m -97.89 89.06 4.45 Favored 'General case' 0 N--CA 1.416 -2.149 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.443 ' O ' HD23 ' A' ' 159' ' ' LEU . 6.4 tt -64.83 -28.88 69.86 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.972 -173.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.423 ' O ' HG12 ' A' ' 163' ' ' VAL . 2.4 pt? -59.22 -25.19 63.79 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.821 0.344 . . . . 0.0 111.834 179.122 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.447 ' HD2' ' HB2' ' A' ' 158' ' ' SER . 5.5 ptm180 -77.98 -26.05 48.47 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 120.077 -0.649 . . . . 0.0 109.522 -179.099 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 97.0 m -86.7 -32.1 20.67 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.253 176.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.423 HG12 ' O ' ' A' ' 160' ' ' LEU . 0.8 OUTLIER -65.47 -26.09 38.46 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 CA-C-O 121.654 0.74 . . . . 0.0 110.9 -177.07 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -83.61 -14.62 51.56 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.532 0.682 . . . . 0.0 109.768 176.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -99.52 20.39 13.95 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.455 -176.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 98.4 mt -80.09 129.16 71.06 Favored Pre-proline 0 C--N 1.293 -1.87 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 175.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.65 128.79 23.14 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 122.036 1.824 . . . . 0.0 109.96 177.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 116.21 -29.4 7.07 Favored Glycine 0 N--CA 1.426 -1.975 0 C-N-CA 120.146 -1.026 . . . . 0.0 111.508 -179.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 63.6 t -63.6 -64.85 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.592 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 177.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 113.62 98.95 2.33 Favored Glycine 0 N--CA 1.422 -2.255 0 C-N-CA 120.066 -1.064 . . . . 0.0 112.18 178.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -68.77 -27.39 65.85 Favored 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 122.926 0.49 . . . . 0.0 111.32 -178.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 22.5 t -83.88 -30.9 7.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-O 121.299 0.571 . . . . 0.0 109.748 -175.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.536 ' O ' ' HG ' ' A' ' 177' ' ' LEU . 20.4 ptmt -91.72 1.41 57.18 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.36 178.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -56.99 -50.35 88.71 Favored Pre-proline 0 CA--C 1.545 0.785 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.523 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.412 ' O ' ' HG2' ' A' ' 179' ' ' GLN . 15.9 Cg_endo -58.91 -24.05 70.74 Favored 'Trans proline' 0 C--N 1.376 2.021 0 C-N-CA 121.801 1.667 . . . . 0.0 112.764 178.163 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.409 ' HB3' ' O ' ' A' ' 173' ' ' LYS . 54.5 tp -77.58 -40.05 43.59 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 177.001 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.536 ' HG ' ' O ' ' A' ' 173' ' ' LYS . 84.3 mt -71.53 -33.59 69.31 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.869 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -69.12 -5.87 24.98 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 177.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 0.412 ' HG2' ' O ' ' A' ' 175' ' ' PRO . 29.8 mm-40 -93.17 -3.74 53.37 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.266 0.555 . . . . 0.0 109.869 174.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -113.0 -50.53 2.88 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.47 176.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . 0.579 ' CD2' ' HG ' ' A' ' 187' ' ' LEU . 66.8 m-85 -96.76 141.16 22.67 Favored Pre-proline 0 C--N 1.309 -1.173 0 CA-C-N 114.769 -1.105 . . . . 0.0 108.55 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -67.76 -35.73 20.8 Favored 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 122.096 1.864 . . . . 0.0 112.82 -177.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 67.7 p -149.3 165.54 31.66 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -178.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -65.67 -26.13 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 O-C-N 123.403 0.439 . . . . 0.0 110.559 177.164 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -63.98 -43.57 95.34 Favored 'General case' 0 C--O 1.202 -1.416 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.977 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . 0.415 ' NE2' ' HD1' ' A' ' 181' ' ' PHE . 0.6 OUTLIER -78.84 -34.56 45.05 Favored 'General case' 0 C--O 1.197 -1.703 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.944 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.579 ' HG ' ' CD2' ' A' ' 181' ' ' PHE . 4.8 tt -52.88 -66.61 0.35 Allowed 'General case' 0 C--O 1.21 -1.022 0 C-N-CA 124.205 1.002 . . . . 0.0 111.296 -175.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 23.1 m -75.2 -21.73 58.47 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.243 0.544 . . . . 0.0 112.062 -175.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -86.6 -4.33 59.16 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.032 -178.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.38 155.43 35.42 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 121.498 0.666 . . . . 0.0 111.167 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 12.4 m -65.32 162.17 18.06 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.365 -177.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 41.4 mm -53.57 -40.3 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 123.073 0.549 . . . . 0.0 110.892 -178.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -62.55 -29.03 72.36 Favored Glycine 0 C--O 1.214 -1.133 0 CA-C-N 115.974 -0.557 . . . . 0.0 113.135 -179.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -83.6 -41.88 17.35 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 121.467 0.651 . . . . 0.0 109.275 -178.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 97.4 mt -69.54 -38.42 77.49 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 114.706 -1.134 . . . . 0.0 111.345 -178.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.32 -33.9 77.05 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.311 0.577 . . . . 0.0 109.522 -176.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -60.94 -30.29 70.13 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.619 -1.173 . . . . 0.0 112.923 177.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 16.9 m -103.75 -39.29 5.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -176.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.555 HG23 ' H ' ' A' ' 200' ' ' GLY . 3.5 m -108.09 -84.64 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 177.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . 0.555 ' H ' HG23 ' A' ' 199' ' ' VAL . . . -178.0 167.46 38.24 Favored Glycine 0 N--CA 1.414 -2.819 0 N-CA-C 108.574 -1.81 . . . . 0.0 108.574 -178.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -57.69 -52.7 64.35 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 117.535 0.667 . . . . 0.0 112.357 179.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -67.37 -34.58 77.59 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.313 0.578 . . . . 0.0 110.809 -176.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.463 ' O ' ' HG2' ' A' ' 206' ' ' GLN . 2.6 t -70.57 -42.3 78.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 -179.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -56.36 -46.24 80.11 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.61 178.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -61.68 -47.02 87.23 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 114.972 -1.013 . . . . 0.0 112.615 179.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . 0.463 ' HG2' ' O ' ' A' ' 203' ' ' VAL . 3.4 pt20 -65.28 -34.98 79.62 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 118.373 0.533 . . . . 0.0 111.364 -178.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 88.4 mt -72.92 -50.52 32.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.972 178.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -65.01 -45.31 86.07 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.821 -177.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -70.07 -15.79 63.04 Favored 'General case' 0 C--O 1.217 -0.624 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -59.24 -45.54 90.9 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.129 0.572 . . . . 0.0 110.44 -179.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -95.91 -31.18 13.25 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.091 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 52.0 m -67.98 -40.07 83.19 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.518 -177.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -93.76 112.16 55.72 Favored Pre-proline 0 N--CA 1.44 -0.93 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -92.37 167.97 2.83 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 122.879 2.386 . . . . 0.0 112.659 -178.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? . . . . . 0 N--CA 1.404 -2.762 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 176.626 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.4 p . . . . . 0 N--CA 1.42 -1.955 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -161.19 135.92 7.34 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 -177.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -140.44 137.69 17.98 Favored Pre-proline 0 C--N 1.306 -1.314 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 173.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.47 -50.81 10.77 Favored 'Trans proline' 0 C--O 1.243 0.749 0 C-N-CA 122.695 2.264 . . . . 0.0 112.665 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 55.9 tp 67.23 -71.23 0.1 Allowed 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 125.114 1.365 . . . . 0.0 111.995 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.469 HD23 ' H ' ' A' ' 146' ' ' LEU . 2.4 pt? -128.41 159.41 35.46 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -178.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 153.0 147.92 4.74 Favored Glycine 0 N--CA 1.429 -1.833 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.658 177.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.517 ' H ' ' HD3' ' A' ' 148' ' ' LYS . 0.1 OUTLIER -130.13 146.86 51.81 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 179.646 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -159.54 99.63 1.44 Allowed 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.161 0.505 . . . . 0.0 111.41 178.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 42.2 ttt180 -141.01 93.78 2.63 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 173.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -95.77 101.66 13.37 Favored 'General case' 0 N--CA 1.427 -1.618 0 CA-C-N 115.393 -0.822 . . . . 0.0 109.209 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -132.35 159.45 39.18 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 70.0 mt -124.39 118.27 26.32 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 172.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 5.9 tt -106.91 90.2 3.24 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 -177.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 47.3 m -144.47 103.63 3.98 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -93.86 154.81 40.8 Favored Pre-proline 0 C--N 1.287 -2.114 0 CA-C-N 115.129 -0.942 . . . . 0.0 109.283 -178.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -60.26 -30.63 91.58 Favored 'Trans proline' 0 C--O 1.242 0.682 0 C-N-CA 122.325 2.017 . . . . 0.0 111.577 178.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -75.78 83.86 2.75 Favored 'General case' 0 N--CA 1.415 -2.176 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.222 177.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 43.0 tp -94.06 -25.39 17.21 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.118 178.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.468 ' O ' HG12 ' A' ' 163' ' ' VAL . 2.3 pt? -55.44 -34.54 64.55 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-O 121.223 0.535 . . . . 0.0 111.695 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -66.0 -31.9 73.07 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.198 177.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 15.9 m -86.72 -31.45 20.98 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 120.956 0.408 . . . . 0.0 110.76 178.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.468 HG12 ' O ' ' A' ' 160' ' ' LEU . 0.3 OUTLIER -64.79 -25.85 38.75 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.069 0 CA-C-O 121.719 0.771 . . . . 0.0 110.647 -177.271 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . 0.438 ' OE1' HG21 ' A' ' 184' ' ' ILE . 9.8 pt20 -83.44 -6.69 59.53 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.412 175.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -100.2 7.96 44.15 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.062 0.458 . . . . 0.0 110.307 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 84.5 mt -75.38 128.72 83.8 Favored Pre-proline 0 C--N 1.317 -0.829 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -65.75 128.67 20.42 Favored 'Trans proline' 0 C--O 1.238 0.478 0 C-N-CA 122.145 1.896 . . . . 0.0 111.353 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 117.35 -27.99 7.41 Favored Glycine 0 C--N 1.306 -1.084 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 -179.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 97.7 t -61.86 -62.01 1.34 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.689 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 177.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 110.89 100.81 2.6 Favored Glycine 0 N--CA 1.424 -2.12 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.323 176.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -73.66 -26.51 60.78 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.261 0.553 . . . . 0.0 109.935 177.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 62.1 t -82.88 -24.46 8.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-O 122.08 0.943 . . . . 0.0 108.896 178.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.438 ' O ' ' HG ' ' A' ' 177' ' ' LEU . 44.9 mtpt -86.01 -0.82 56.47 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.497 -1.229 . . . . 0.0 110.305 178.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -47.98 -51.04 50.76 Favored Pre-proline 0 C--O 1.203 -1.377 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -178.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.585 ' O ' ' HG2' ' A' ' 179' ' ' GLN . 12.9 Cg_endo -58.24 -42.57 55.24 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 121.684 1.589 . . . . 0.0 112.132 177.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 55.6 tp -64.46 -45.56 86.89 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.729 0.776 . . . . 0.0 109.639 179.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' A' ' 173' ' ' LYS . 93.2 mt -69.16 -26.41 64.85 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.973 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 57.4 tp -74.06 -30.75 62.54 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 121.132 0.492 . . . . 0.0 109.831 178.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 0.585 ' HG2' ' O ' ' A' ' 175' ' ' PRO . 12.7 mm-40 -76.09 -30.97 58.5 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 121.167 0.508 . . . . 0.0 109.965 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 22.9 mmmt -83.28 -50.62 8.21 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.979 179.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . 0.427 ' HA ' ' HD3' ' A' ' 182' ' ' PRO . 28.8 m-85 -111.75 135.66 21.16 Favored Pre-proline 0 N--CA 1.436 -1.134 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.795 -172.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 181' ' ' PHE . 51.2 Cg_exo -53.42 -38.51 82.87 Favored 'Trans proline' 0 N--CA 1.487 1.118 0 C-N-CA 124.367 3.378 . . . . 0.0 114.184 -176.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 24.4 t -158.66 167.83 28.49 Favored 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 179.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.514 ' HA ' ' HB3' ' A' ' 187' ' ' LEU . 0.2 OUTLIER -61.37 -26.98 40.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 O-C-N 124.277 0.985 . . . . 0.0 110.995 178.214 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -64.39 -40.73 96.39 Favored 'General case' 0 C--O 1.21 -1.022 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.692 179.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -80.2 -37.87 32.34 Favored 'General case' 0 C--O 1.191 -2.017 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 177.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.514 ' HB3' ' HA ' ' A' ' 184' ' ' ILE . 66.8 tp -46.67 -65.59 0.54 Allowed 'General case' 0 C--O 1.212 -0.873 0 C-N-CA 126.07 1.748 . . . . 0.0 113.202 -177.045 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 36.9 m -72.96 -20.94 60.95 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -177.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -91.89 3.88 54.19 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.461 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.96 158.23 28.71 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 124.816 1.247 . . . . 0.0 112.737 178.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 14.6 m -62.99 152.06 37.9 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.848 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 48.2 mm -55.15 -35.57 36.09 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.137 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.878 -177.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -61.9 -30.2 74.57 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 121.313 -0.47 . . . . 0.0 112.842 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 0.461 ' O ' ' HG2' ' A' ' 197' ' ' GLN . 59.4 mm-40 -84.24 -36.99 22.33 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-O 121.529 0.681 . . . . 0.0 109.752 -179.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.404 HD21 ' O ' ' A' ' 187' ' ' LEU . 96.0 mt -75.97 -24.38 55.4 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.385 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . 0.442 ' HG2' ' N ' ' A' ' 201' ' ' GLN . 3.9 tm-20 -78.91 -37.95 38.64 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -178.041 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.461 ' HG2' ' O ' ' A' ' 194' ' ' GLU . 10.3 pt20 -69.75 -19.6 63.53 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 114.999 -1.0 . . . . 0.0 112.328 -175.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 17.1 m -102.54 -26.33 3.52 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 C-N-CA 120.587 -0.445 . . . . 0.0 111.842 178.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.531 HG11 HG11 ' A' ' 203' ' ' VAL . 0.2 OUTLIER -128.24 -81.8 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 C-N-CA 120.721 -0.392 . . . . 0.0 111.129 175.897 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -176.95 162.78 31.24 Favored Glycine 0 N--CA 1.442 -0.914 0 N-CA-C 108.791 -1.723 . . . . 0.0 108.791 -176.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . 0.442 ' N ' ' HG2' ' A' ' 196' ' ' GLU . 8.8 tt0 -67.01 -40.69 87.36 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 117.996 0.898 . . . . 0.0 112.065 -176.117 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -65.7 -37.64 87.01 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.399 0.619 . . . . 0.0 109.936 -179.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.531 HG11 HG11 ' A' ' 199' ' ' VAL . 3.9 t -69.91 -44.05 79.04 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.864 0 CA-C-N 114.986 -1.007 . . . . 0.0 108.755 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -55.31 -46.43 76.27 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 114.356 -1.293 . . . . 0.0 110.2 -179.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -71.12 -31.62 67.99 Favored 'General case' 0 N--CA 1.417 -2.124 0 CA-C-N 114.735 -1.12 . . . . 0.0 112.494 -177.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . 0.42 ' HG2' ' O ' ' A' ' 203' ' ' VAL . 3.4 pt20 -78.08 -34.1 50.45 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 119.742 -0.783 . . . . 0.0 110.765 178.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 93.7 mt -66.38 -45.61 88.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 174.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 28.4 t-80 -68.95 -35.77 77.15 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.007 -178.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -72.56 -25.6 61.42 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 121.743 -0.598 . . . . 0.0 112.507 177.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -50.84 -54.13 26.37 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.532 1.133 . . . . 0.0 112.667 -175.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 20.3 p90 -81.76 -24.16 36.21 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -177.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 30.6 m -76.53 -38.27 55.36 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 120.975 0.417 . . . . 0.0 111.225 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -96.47 117.71 65.87 Favored Pre-proline 0 C--N 1.312 -1.031 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -178.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -74.38 177.87 7.76 Favored 'Trans proline' 0 C--O 1.245 0.859 0 C-N-CA 122.711 2.274 . . . . 0.0 112.137 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 58.2 mtt85 . . . . . 0 C--N 1.298 -1.672 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -179.199 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 35.9 m . . . . . 0 N--CA 1.436 -1.164 0 CA-C-O 121.267 0.556 . . . . 0.0 110.96 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -112.59 -26.9 8.42 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 176.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -104.12 111.29 65.12 Favored Pre-proline 0 C--N 1.305 -1.342 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 171.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.42 ' HB2' ' O ' ' A' ' 146' ' ' LEU . 50.6 Cg_endo -71.28 128.29 14.47 Favored 'Trans proline' 0 N--CA 1.445 -1.342 0 C-N-CA 121.505 1.47 . . . . 0.0 111.799 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 92.0 mt -64.37 -40.88 96.7 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.697 177.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.42 ' O ' ' HB2' ' A' ' 144' ' ' PRO . 7.2 mp -107.18 148.06 29.34 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.044 177.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 137.18 -149.81 20.42 Favored Glycine 0 N--CA 1.417 -2.617 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 -178.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -69.25 168.9 13.21 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 123.493 0.717 . . . . 0.0 110.429 -178.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -61.68 101.76 0.21 Allowed 'General case' 0 C--O 1.24 0.603 0 O-C-N 123.737 0.648 . . . . 0.0 109.849 174.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.436 ' HD2' ' O ' ' A' ' 150' ' ' ARG . 3.4 ppt_? -102.72 100.19 10.21 Favored 'General case' 0 N--CA 1.425 -1.704 0 CA-C-O 122.24 1.019 . . . . 0.0 112.535 -178.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -77.54 108.65 10.87 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.946 178.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 62.9 tp -146.97 142.32 27.4 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 106.201 -1.778 . . . . 0.0 106.201 176.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.448 ' H ' HD23 ' A' ' 153' ' ' LEU . 2.7 pt? -70.11 132.38 45.74 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.442 0.639 . . . . 0.0 109.55 178.174 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.577 HD13 ' H ' ' A' ' 154' ' ' LEU 0.382 0.0 OUTLIER -85.0 81.18 9.01 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-O 123.501 1.62 . . . . 0.0 111.292 179.589 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 66.3 m -133.16 102.28 5.52 Favored 'General case' 0 N--CA 1.395 -3.21 0 CA-C-N 113.913 -1.494 . . . . 0.0 108.821 178.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.453 ' OE1' ' HD2' ' A' ' 157' ' ' PRO . 7.0 tp10 -95.66 138.42 21.79 Favored Pre-proline 0 C--N 1.291 -1.956 0 N-CA-C 104.521 -2.4 . . . . 0.0 104.521 174.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.453 ' HD2' ' OE1' ' A' ' 156' ' ' GLU . 6.2 Cg_endo -49.72 128.54 21.55 Favored 'Trans proline' 0 C--O 1.246 0.922 0 C-N-CA 122.617 2.211 . . . . 0.0 110.832 177.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.498 ' O ' ' HG2' ' A' ' 161' ' ' ARG . 3.3 p -66.35 33.4 0.02 OUTLIER 'General case' 0 C--O 1.207 -1.132 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 -176.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.418 ' H ' ' C ' ' A' ' 157' ' ' PRO . 3.0 tm? -90.8 -23.77 20.51 Favored 'General case' 0 C--N 1.277 -2.551 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 175.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.405 ' HA ' HG12 ' A' ' 163' ' ' VAL . 2.4 pt? -61.82 -23.52 66.28 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 115.316 -0.856 . . . . 0.0 112.035 -177.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.498 ' HG2' ' O ' ' A' ' 158' ' ' SER . 34.6 ptt180 -70.0 -39.32 75.96 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.345 0.593 . . . . 0.0 110.104 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 74.8 m -86.75 -32.57 20.33 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.937 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.436 HG22 ' CB ' ' A' ' 188' ' ' SER . 0.4 OUTLIER -62.49 -26.2 39.87 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.126 -174.568 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -80.47 -10.22 59.75 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.995 179.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -103.8 11.45 35.75 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 121.143 0.497 . . . . 0.0 110.978 -176.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.444 HG21 ' HA ' ' A' ' 207' ' ' ILE . 73.6 mt -78.74 133.86 61.81 Favored Pre-proline 0 C--N 1.304 -1.404 0 CA-C-N 116.059 -0.518 . . . . 0.0 109.71 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -62.12 128.76 24.94 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.106 1.871 . . . . 0.0 109.869 175.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 116.07 -40.95 2.25 Favored Glycine 0 N--CA 1.429 -1.805 0 N-CA-C 108.668 -1.773 . . . . 0.0 108.668 -176.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.455 ' O ' HD11 ' A' ' 177' ' ' LEU . 57.7 t -70.89 -56.34 11.03 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.174 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 174.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 91.77 147.08 19.58 Favored Glycine 0 N--CA 1.417 -2.596 0 C-N-CA 120.201 -1.0 . . . . 0.0 114.893 172.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.449 ' HG3' HG23 ' A' ' 172' ' ' VAL . 56.7 pttt -89.37 -35.93 15.79 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 114.401 -0.899 . . . . 0.0 110.556 177.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.449 HG23 ' HG3' ' A' ' 171' ' ' LYS . 43.3 t -86.14 -39.03 13.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-O 121.204 0.526 . . . . 0.0 110.729 -175.008 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.652 ' O ' ' HG ' ' A' ' 177' ' ' LEU . 21.6 ptmt -84.25 2.07 41.73 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.765 -178.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.412 ' O ' ' HG ' ' A' ' 178' ' ' LEU . . . -54.59 -52.75 67.17 Favored Pre-proline 0 CA--C 1.563 1.443 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -61.74 -23.16 75.85 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 122.137 1.891 . . . . 0.0 112.22 177.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.509 ' HB3' ' O ' ' A' ' 173' ' ' LYS . 53.5 tp -74.54 -34.86 63.08 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.252 176.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.652 ' HG ' ' O ' ' A' ' 173' ' ' LYS . 61.5 mt -78.69 -29.29 45.48 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.073 -179.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 174' ' ' ALA . 87.3 mt -68.69 -5.58 21.13 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.615 177.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -85.3 -21.42 28.99 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 121.838 0.828 . . . . 0.0 108.941 174.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -101.05 -47.41 4.77 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.567 -178.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . 0.588 ' CD2' ' HG ' ' A' ' 187' ' ' LEU . 85.4 m-85 -107.32 149.06 38.27 Favored Pre-proline 0 N--CA 1.427 -1.609 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.623 -175.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 181' ' ' PHE . 2.8 Cg_exo -67.46 -50.47 0.94 Allowed 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.774 2.316 . . . . 0.0 112.566 -178.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 66.6 m -150.19 164.48 35.57 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -57.33 -30.49 35.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 115.671 1.73 . . . . 0.0 115.671 -173.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -68.55 -46.9 68.25 Favored 'General case' 0 C--O 1.206 -1.223 0 C-N-CA 119.439 -0.905 . . . . 0.0 108.995 -176.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -73.04 -29.89 63.32 Favored 'General case' 0 C--O 1.194 -1.846 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -179.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.588 ' HG ' ' CD2' ' A' ' 181' ' ' PHE . 5.1 tt -56.03 -64.12 0.96 Allowed 'General case' 0 C--O 1.217 -0.607 0 C-N-CA 123.666 0.786 . . . . 0.0 110.27 -178.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.436 ' CB ' HG22 ' A' ' 163' ' ' VAL . 17.6 m -74.29 -26.44 60.19 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 123.29 0.369 . . . . 0.0 111.831 -176.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.416 ' HA ' ' CZ ' ' A' ' 211' ' ' PHE . 8.6 t30 -85.36 -0.03 53.55 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.138 0.494 . . . . 0.0 111.014 -178.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -66.62 155.47 37.77 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.035 0.445 . . . . 0.0 110.704 175.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 12.5 m -63.94 159.72 19.27 Favored 'General case' 0 C--O 1.251 1.14 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.089 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.1 mm -49.09 -39.17 12.06 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.851 0 C-N-CA 123.772 0.829 . . . . 0.0 111.619 -179.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.462 ' O ' ' HG3' ' A' ' 197' ' ' GLN . . . -57.22 -39.05 89.45 Favored Glycine 0 CA--C 1.526 0.767 0 O-C-N 123.129 0.268 . . . . 0.0 113.453 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -77.56 -41.46 38.86 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.551 0.691 . . . . 0.0 109.231 -177.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 96.0 mt -69.72 -26.44 64.33 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.268 -179.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . 0.624 ' HG2' ' N ' ' A' ' 201' ' ' GLN . 1.5 tm-20 -73.39 -34.43 65.54 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 -179.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.462 ' HG3' ' O ' ' A' ' 193' ' ' GLY . 89.9 mt-30 -62.52 -29.92 70.91 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.999 178.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.416 HG23 HG23 ' A' ' 199' ' ' VAL . 12.8 m -103.84 -24.44 4.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -176.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.436 HG11 HG11 ' A' ' 203' ' ' VAL . 1.0 OUTLIER -128.4 -85.75 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.779 176.58 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -178.36 158.3 22.86 Favored Glycine 0 CA--C 1.494 -1.223 0 N-CA-C 108.669 -1.772 . . . . 0.0 108.669 -176.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . 0.624 ' N ' ' HG2' ' A' ' 196' ' ' GLU . 10.7 pt20 -57.19 -46.39 82.89 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -177.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -69.93 -34.69 73.8 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.395 0.616 . . . . 0.0 110.55 -175.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.445 ' O ' HG13 ' A' ' 207' ' ' ILE . 2.0 t -75.2 -39.28 42.78 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-N 114.945 -1.025 . . . . 0.0 108.241 -178.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -57.48 -41.59 80.97 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.587 -1.188 . . . . 0.0 109.903 179.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -64.56 -39.79 94.38 Favored 'General case' 0 N--CA 1.422 -1.85 0 CA-C-N 114.966 -1.015 . . . . 0.0 112.047 -179.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . 0.436 HE21 HG13 ' A' ' 203' ' ' VAL . 27.1 pt20 -73.4 -30.09 63.02 Favored 'General case' 0 C--O 1.218 -0.554 0 C-N-CA 119.367 -0.933 . . . . 0.0 110.438 179.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' ILE . . . . . 0.445 HG13 ' O ' ' A' ' 203' ' ' VAL . 82.8 mt -68.03 -53.07 32.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 176.178 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 53.3 t-80 -62.57 -43.73 98.08 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 114.668 -1.151 . . . . 0.0 110.531 -177.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -70.7 -25.3 62.9 Favored 'General case' 0 C--O 1.202 -1.396 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -54.56 -47.84 72.76 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.083 0.553 . . . . 0.0 111.742 -176.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . 0.416 ' CZ ' ' HA ' ' A' ' 189' ' ' ASN . 34.1 p90 -93.69 -26.34 17.07 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.172 -178.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 46.4 m -75.67 -37.89 59.19 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-O 120.895 0.379 . . . . 0.0 111.061 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -94.0 120.53 65.63 Favored Pre-proline 0 C--N 1.31 -1.144 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 177.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.07 159.01 51.14 Favored 'Trans proline' 0 C--O 1.244 0.798 0 C-N-CA 122.464 2.109 . . . . 0.0 112.854 -177.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 29.0 ttp180 . . . . . 0 C--N 1.3 -1.555 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 177.865 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.6 t . . . . . 0 N--CA 1.43 -1.471 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -112.05 -59.72 1.96 Allowed 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.35 0.595 . . . . 0.0 110.338 -179.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.412 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . 38.3 m-80 -72.75 127.71 89.33 Favored Pre-proline 0 C--N 1.305 -1.366 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.742 -175.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 143' ' ' ASN . 6.6 Cg_exo -73.29 97.85 0.97 Allowed 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 121.975 1.784 . . . . 0.0 109.068 173.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 40.7 tp -121.66 -17.92 7.31 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.396 -176.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 93.4 mt -117.29 156.06 28.44 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 115.59 -150.26 18.7 Favored Glycine 0 N--CA 1.412 -2.935 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 178.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -110.63 147.45 34.24 Favored 'General case' 0 C--N 1.276 -2.595 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -115.4 126.14 54.02 Favored 'General case' 0 C--N 1.287 -2.12 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 174.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 17.9 tpt180 -47.6 105.37 0.07 Allowed 'General case' 0 C--O 1.245 0.84 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 -167.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -154.84 156.68 36.63 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 105.722 -1.955 . . . . 0.0 105.722 177.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.498 ' H ' HD23 ' A' ' 152' ' ' LEU . 1.8 pt? -116.21 143.93 44.87 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.293 -177.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 68.1 tp -148.16 132.12 17.17 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 179.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 62.3 tp -80.76 105.66 12.16 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 177.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 12.9 t -86.47 115.73 24.16 Favored 'General case' 0 N--CA 1.411 -2.401 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -109.44 137.18 20.22 Favored Pre-proline 0 C--N 1.284 -2.258 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 -175.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.84 9.98 0.55 Allowed 'Trans proline' 0 N--CA 1.49 1.271 0 C-N-CA 123.725 2.95 . . . . 0.0 114.799 -177.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.421 ' O ' ' HG2' ' A' ' 161' ' ' ARG . 18.9 m 63.72 34.73 11.89 Favored 'General case' 0 C--O 1.216 -0.696 0 C-N-CA 124.553 1.141 . . . . 0.0 109.94 178.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 44.6 tp -57.26 -26.87 61.47 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 124.701 1.2 . . . . 0.0 112.641 -174.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -63.36 -23.94 67.63 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.666 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.421 ' HG2' ' O ' ' A' ' 158' ' ' SER . 30.4 ptt180 -72.13 -32.5 66.99 Favored 'General case' 0 C--O 1.22 -0.497 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 10.2 m -86.37 -35.59 19.7 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.937 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.435 HG22 ' HB2' ' A' ' 188' ' ' SER . 0.4 OUTLIER -61.66 -25.68 37.57 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 C-N-CA 123.835 0.854 . . . . 0.0 111.571 -177.259 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -86.11 -8.01 58.18 Favored 'General case' 0 C--N 1.311 -1.103 0 O-C-N 121.941 -0.474 . . . . 0.0 111.561 178.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -97.46 17.99 16.33 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-O 120.606 0.241 . . . . 0.0 110.638 -176.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.438 HG21 ' HA ' ' A' ' 207' ' ' ILE . 65.2 mt -83.09 120.33 75.79 Favored Pre-proline 0 C--N 1.302 -1.463 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.364 -176.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.23 129.12 15.58 Favored 'Trans proline' 0 N--CA 1.445 -1.364 0 C-N-CA 121.82 1.68 . . . . 0.0 108.349 175.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 124.45 -33.14 3.88 Favored Glycine 0 C--N 1.288 -2.126 0 N-CA-C 108.47 -1.852 . . . . 0.0 108.47 -171.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 81.3 t -68.48 -43.5 83.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 174.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 107.55 140.27 9.43 Favored Glycine 0 N--CA 1.424 -2.12 0 CA-C-N 115.267 -0.879 . . . . 0.0 112.492 175.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 58.6 pttt -89.27 -36.27 15.68 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 121.131 0.491 . . . . 0.0 110.193 178.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 44.0 t -89.19 -31.98 5.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-O 121.735 0.778 . . . . 0.0 109.643 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.45 ' HG2' ' HG ' ' A' ' 177' ' ' LEU . 39.3 ttmt -77.36 -14.39 59.73 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.376 -179.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -52.36 -53.86 48.34 Favored Pre-proline 0 CA--C 1.557 1.222 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -176.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.444 ' O ' ' HG3' ' A' ' 179' ' ' GLN . 18.9 Cg_endo -61.19 -32.36 90.75 Favored 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 121.575 1.517 . . . . 0.0 112.8 178.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 57.4 tp -69.84 -40.59 75.75 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.543 0.687 . . . . 0.0 109.804 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.45 ' HG ' ' HG2' ' A' ' 173' ' ' LYS . 87.6 mt -68.51 -27.99 66.61 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.259 178.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 43.4 tp -74.91 -9.49 58.59 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.179 177.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 0.444 ' HG3' ' O ' ' A' ' 175' ' ' PRO . 24.6 mt-30 -91.02 -29.74 17.19 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 175.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -84.27 -50.64 7.67 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.825 -179.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . 0.421 ' CD2' ' HG ' ' A' ' 187' ' ' LEU . 71.9 m-85 -97.7 149.12 35.38 Favored Pre-proline 0 C--N 1.293 -1.857 0 CA-C-N 115.056 -0.974 . . . . 0.0 109.204 -177.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -68.78 -42.21 4.89 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 121.994 1.796 . . . . 0.0 112.705 -177.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 78.2 p -147.72 166.77 26.48 Favored 'General case' 0 N--CA 1.427 -1.58 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -177.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.451 ' H ' HD13 ' A' ' 184' ' ' ILE . 0.2 OUTLIER -62.42 -29.28 46.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 O-C-N 123.772 0.67 . . . . 0.0 111.569 177.971 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -63.23 -45.95 89.25 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.735 -179.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . 0.543 HE21 ' C ' ' A' ' 186' ' ' GLN . 0.0 OUTLIER -79.2 -32.59 44.11 Favored 'General case' 0 C--O 1.202 -1.419 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.54 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.421 ' HG ' ' CD2' ' A' ' 181' ' ' PHE . 4.1 tt -53.81 -64.09 0.94 Allowed 'General case' 0 C--O 1.218 -0.567 0 C-N-CA 124.141 0.976 . . . . 0.0 110.285 -176.228 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.435 ' HB2' HG22 ' A' ' 163' ' ' VAL . 19.9 m -70.42 -20.71 62.9 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 121.322 0.582 . . . . 0.0 111.793 -178.073 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -90.34 4.9 49.46 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.408 0.623 . . . . 0.0 111.009 -178.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.49 155.3 36.02 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.781 173.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 5.4 t -72.89 168.69 18.4 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.553 -175.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 50.8 mm -59.62 -37.73 72.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.751 -175.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -60.34 -31.92 75.44 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 116.448 -0.342 . . . . 0.0 112.803 178.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 0.495 ' O ' ' HG2' ' A' ' 197' ' ' GLN . 24.3 mt-10 -83.77 -36.73 23.38 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 121.556 0.693 . . . . 0.0 109.269 -177.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 88.6 mt -78.44 -23.27 46.69 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-O 121.306 0.574 . . . . 0.0 111.72 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . 0.572 ' HG2' ' N ' ' A' ' 201' ' ' GLN . 2.5 tm-20 -80.49 -37.44 31.72 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.495 ' HG2' ' O ' ' A' ' 194' ' ' GLU . 9.5 pt20 -68.01 -14.69 63.16 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.708 -177.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 4.1 m -103.46 -34.66 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 N-CA-C 111.621 0.23 . . . . 0.0 111.621 174.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 1.3 t -128.76 -80.31 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 C-N-CA 119.909 -0.716 . . . . 0.0 111.25 177.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -177.61 166.27 36.52 Favored Glycine 0 N--CA 1.434 -1.458 0 N-CA-C 111.46 -0.656 . . . . 0.0 111.46 -176.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . 0.572 ' N ' ' HG2' ' A' ' 196' ' ' GLU . 78.7 mt-30 -56.51 -50.39 71.95 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 124.756 1.222 . . . . 0.0 111.82 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -64.81 -27.87 69.17 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.681 0.753 . . . . 0.0 111.205 -175.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 90.3 t -80.14 -49.44 18.99 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.581 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -52.31 -46.64 66.07 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 124.763 1.225 . . . . 0.0 110.891 -179.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -61.74 -45.75 92.6 Favored 'General case' 0 N--CA 1.419 -2.011 0 CA-C-N 114.433 -1.258 . . . . 0.0 111.529 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -73.86 -28.61 61.67 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.348 -0.541 . . . . 0.0 111.877 -179.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' ILE . . . . . 0.438 ' HA ' HG21 ' A' ' 166' ' ' ILE . 81.9 mt -70.04 -50.34 48.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.182 0.515 . . . . 0.0 109.945 175.189 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 9.7 t60 -72.63 -37.02 68.15 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.248 -175.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -73.85 -16.38 61.13 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 120.22 -0.592 . . . . 0.0 112.164 178.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -54.37 -56.72 15.75 Favored 'General case' 0 C--O 1.215 -0.716 0 C-N-CA 123.386 0.674 . . . . 0.0 111.68 -177.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -81.04 -26.35 36.44 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.59 -178.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 32.3 m -64.73 -38.5 91.2 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.585 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -108.89 110.26 61.01 Favored Pre-proline 0 C--N 1.315 -0.909 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 175.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -89.94 156.67 4.93 Favored 'Trans proline' 0 N--CA 1.44 -1.623 0 C-N-CA 122.243 1.962 . . . . 0.0 112.888 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 62.8 ttp180 . . . . . 0 C--N 1.301 -1.535 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 179.271 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 49.1 m . . . . . 0 N--CA 1.433 -1.299 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 20.7 pttm -119.63 13.93 12.57 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -175.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -127.32 150.64 73.06 Favored Pre-proline 0 C--N 1.301 -1.52 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 178.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -63.74 115.43 3.06 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.085 1.856 . . . . 0.0 109.854 176.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.706 ' H ' HD23 ' A' ' 145' ' ' LEU . 2.0 pt? -75.39 -6.86 52.14 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.511 -1.222 . . . . 0.0 113.144 -173.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 62.0 tp -82.96 104.02 12.86 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 170.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 89.22 -172.82 40.27 Favored Glycine 0 N--CA 1.401 -3.644 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 -173.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 59.2 mttm -112.22 168.01 9.96 Favored 'General case' 0 C--N 1.27 -2.876 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 178.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -74.33 113.2 11.27 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 176.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 8.4 tpm_? -77.03 93.34 3.83 Favored 'General case' 0 N--CA 1.427 -1.59 0 CA-C-O 121.71 0.767 . . . . 0.0 110.657 -178.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -93.65 108.23 19.99 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 171.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 59.8 tp -128.06 121.14 28.97 Favored 'General case' 0 C--N 1.292 -1.894 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.8 -174.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.473 ' H ' HD13 ' A' ' 153' ' ' LEU . 0.0 OUTLIER -113.76 129.01 56.64 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 175.651 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -120.7 96.59 5.18 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.452 ' O ' ' HD3' ' A' ' 157' ' ' PRO . 8.1 p -101.16 103.56 14.61 Favored 'General case' 0 N--CA 1.423 -1.807 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.345 -175.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.407 ' HB3' ' HA ' ' A' ' 159' ' ' LEU . 33.2 mm-40 -104.54 96.54 10.42 Favored Pre-proline 0 C--N 1.308 -1.212 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.647 174.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.452 ' HD3' ' O ' ' A' ' 155' ' ' SER . 9.2 Cg_exo -75.88 -24.93 11.03 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 121.903 1.735 . . . . 0.0 109.65 175.411 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.476 ' O ' ' HG2' ' A' ' 161' ' ' ARG . 3.4 p -105.92 33.94 3.55 Favored 'General case' 0 N--CA 1.425 -1.68 0 C-N-CA 125.312 1.445 . . . . 0.0 109.441 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.407 ' HA ' ' HB3' ' A' ' 156' ' ' GLU . 2.6 tt -43.22 -35.36 1.39 Allowed 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 126.387 1.875 . . . . 0.0 113.246 -173.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.5 ' HA ' HG12 ' A' ' 163' ' ' VAL . 2.3 pt? -58.18 -22.43 51.51 Favored 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 179.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.476 ' HG2' ' O ' ' A' ' 158' ' ' SER . 37.7 ptt180 -68.04 -39.17 83.11 Favored 'General case' 0 C--O 1.223 -0.34 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 176.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 93.7 m -86.51 -31.64 21.18 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.731 -177.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.5 HG12 ' HA ' ' A' ' 160' ' ' LEU . 0.5 OUTLIER -65.32 -26.19 38.94 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 CA-C-O 121.664 0.745 . . . . 0.0 111.083 -177.416 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -86.44 -8.01 57.97 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.597 178.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -104.41 16.41 26.2 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.441 -178.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 84.5 mt -77.72 127.01 83.43 Favored Pre-proline 0 C--N 1.302 -1.46 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -66.31 128.55 19.6 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 121.778 1.652 . . . . 0.0 109.522 177.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 120.66 -33.87 4.29 Favored Glycine 0 N--CA 1.427 -1.953 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 -177.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 93.3 t -59.33 -60.27 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 CA-C-O 121.294 0.568 . . . . 0.0 110.447 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 113.87 95.04 2.1 Favored Glycine 0 N--CA 1.428 -1.833 0 C-N-CA 119.965 -1.112 . . . . 0.0 112.248 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -76.68 -20.57 56.47 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 121.274 0.559 . . . . 0.0 110.863 -178.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 57.5 t -83.11 -29.87 8.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-O 121.672 0.749 . . . . 0.0 109.362 178.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -83.44 -7.18 59.6 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.432 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -49.14 -50.12 65.5 Favored Pre-proline 0 CA--C 1.551 0.99 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 -176.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.512 ' O ' ' HG3' ' A' ' 179' ' ' GLN . 10.9 Cg_endo -57.28 -36.84 99.01 Favored 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 121.583 1.522 . . . . 0.0 112.862 177.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 60.4 tp -71.83 -40.47 69.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.419 ' HB3' HD11 ' A' ' 187' ' ' LEU . 97.0 mt -66.05 -34.03 77.16 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.705 179.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 47.9 tp -70.72 -13.94 62.25 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.441 0.639 . . . . 0.0 110.834 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 0.512 ' HG3' ' O ' ' A' ' 175' ' ' PRO . 21.0 mt-30 -89.43 -35.99 15.7 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 176.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 40.9 mmtm -80.83 -47.43 13.84 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.212 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . 0.531 ' CD2' ' HA ' ' A' ' 187' ' ' LEU . 80.1 m-85 -101.78 145.54 30.65 Favored Pre-proline 0 C--N 1.296 -1.753 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -177.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -56.8 -47.57 22.76 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 122.919 2.412 . . . . 0.0 111.673 177.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . 0.411 ' O ' ' HB2' ' A' ' 187' ' ' LEU . 78.2 p -153.24 171.58 18.31 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 -178.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -63.32 -25.14 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 121.333 0.587 . . . . 0.0 110.401 176.003 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -65.51 -45.12 84.77 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 114.741 -1.118 . . . . 0.0 110.359 -178.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -79.49 -36.2 39.01 Favored 'General case' 0 C--O 1.203 -1.381 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 176.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.531 ' HA ' ' CD2' ' A' ' 181' ' ' PHE . 4.7 tt -49.1 -66.29 0.42 Allowed 'General case' 0 C--O 1.213 -0.844 0 C-N-CA 125.482 1.513 . . . . 0.0 111.503 -175.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 35.1 m -70.95 -20.78 62.41 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -175.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -90.89 0.59 57.45 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.472 ' HB1' ' HB2' ' A' ' 194' ' ' GLU . . . -65.58 155.46 35.71 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 122.902 0.481 . . . . 0.0 110.445 175.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 27.9 p -66.98 165.24 15.99 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.125 -178.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 50.7 mm -55.91 -37.64 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -58.58 -37.08 88.12 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-N 115.309 -0.86 . . . . 0.0 113.514 178.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 0.472 ' HB2' ' HB1' ' A' ' 190' ' ' ALA . 30.1 mt-10 -83.4 -37.88 22.69 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.336 0.589 . . . . 0.0 109.503 -177.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 95.0 mt -71.65 -31.76 67.19 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.866 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -67.1 -31.37 71.79 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.35 0.595 . . . . 0.0 109.743 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -63.81 -26.27 68.55 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 114.865 -1.061 . . . . 0.0 112.723 179.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 12.2 m -103.88 -38.35 5.02 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.517 HG23 ' H ' ' A' ' 200' ' ' GLY . 2.5 m -117.05 -80.55 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 178.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . 0.517 ' H ' HG23 ' A' ' 199' ' ' VAL . . . -177.99 166.41 36.54 Favored Glycine 0 N--CA 1.418 -2.525 0 N-CA-C 108.434 -1.866 . . . . 0.0 108.434 -178.082 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . 0.519 ' O ' ' HG3' ' A' ' 205' ' ' GLN . 63.4 tt0 -68.54 -43.37 76.84 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 118.038 0.919 . . . . 0.0 110.837 -178.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -65.46 -32.99 74.9 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.122 0.487 . . . . 0.0 110.866 -179.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 2.4 t -75.53 -40.89 41.74 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.738 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -179.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -57.94 -43.85 86.56 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.355 -179.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . 0.519 ' HG3' ' O ' ' A' ' 201' ' ' GLN . 26.7 mt-30 -61.89 -47.12 86.4 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.684 -178.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -69.53 -33.05 72.24 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.437 -0.505 . . . . 0.0 111.54 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 99.2 mt -69.24 -50.39 52.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.13 0.49 . . . . 0.0 109.82 176.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 59.5 t-80 -67.59 -39.88 84.81 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.253 -177.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -72.01 -18.39 61.97 Favored 'General case' 0 C--O 1.213 -0.826 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -55.12 -51.45 66.4 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.396 0.617 . . . . 0.0 110.459 -178.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -89.37 -27.67 20.31 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.994 -179.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 60.4 m -73.97 -46.81 41.63 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -177.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -84.16 136.56 40.67 Favored Pre-proline 0 C--N 1.304 -1.377 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -176.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo -51.6 144.06 34.51 Favored 'Trans proline' 0 C--O 1.249 1.035 0 C-N-CA 123.218 2.612 . . . . 0.0 112.586 176.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 28.4 mmm180 . . . . . 0 C--N 1.289 -2.024 0 CA-C-N 114.825 -1.08 . . . . 0.0 108.482 -175.993 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 2.9 p . . . . . 0 N--CA 1.427 -1.588 0 CA-C-O 121.391 0.615 . . . . 0.0 110.893 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -104.78 160.02 15.32 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 115.401 -0.818 . . . . 0.0 108.988 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -115.93 167.44 10.24 Favored Pre-proline 0 C--N 1.286 -2.194 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -66.62 96.08 0.35 Allowed 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 121.459 1.439 . . . . 0.0 109.839 172.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 45.2 tp -68.97 -38.29 79.28 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 92.3 mt -94.42 111.73 23.48 Favored 'General case' 0 N--CA 1.424 -1.731 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 174.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 165.97 -149.66 16.07 Favored Glycine 0 N--CA 1.428 -1.892 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -176.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 15.3 ptmm? -119.48 114.2 21.92 Favored 'General case' 0 C--N 1.293 -1.853 0 C-N-CA 119.363 -0.935 . . . . 0.0 111.965 179.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.53 96.32 2.89 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 106.071 -1.825 . . . . 0.0 106.071 173.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 2.3 tpp180 -92.35 109.42 20.81 Favored 'General case' 0 C--N 1.285 -2.207 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.412 -174.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -89.58 102.7 15.38 Favored 'General case' 0 N--CA 1.426 -1.639 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 175.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 55.8 tp -100.11 118.65 36.91 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.499 -176.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.58 HD13 ' H ' ' A' ' 154' ' ' LEU . 0.2 OUTLIER -151.99 166.84 30.32 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 103.955 -2.609 . . . . 0.0 103.955 -177.964 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.58 ' H ' HD13 ' A' ' 153' ' ' LEU . 2.5 pp -61.55 99.17 0.1 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 122.572 1.177 . . . . 0.0 112.726 179.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 19.2 m -84.77 107.88 17.18 Favored 'General case' 0 N--CA 1.417 -2.089 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.616 178.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -113.83 134.21 22.14 Favored Pre-proline 0 N--CA 1.413 -2.288 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 177.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -66.68 -14.99 46.12 Favored 'Trans proline' 0 C--O 1.235 0.366 0 C-N-CA 122.382 2.054 . . . . 0.0 110.995 177.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 3.8 m -77.08 79.89 3.61 Favored 'General case' 0 N--CA 1.415 -2.178 0 CA-C-N 115.354 -0.839 . . . . 0.0 108.967 177.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 48.8 tp -90.62 -33.63 15.78 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.579 -178.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.413 ' HA ' HG12 ' A' ' 163' ' ' VAL . 2.0 pt? -49.59 -40.9 40.4 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.159 0.984 . . . . 0.0 112.542 -178.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.434 HH11 ' HD3' ' A' ' 161' ' ' ARG . 1.7 ptm180 -59.89 -47.05 87.32 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.35 178.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 38.0 m -86.18 -29.72 23.0 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 120.988 0.423 . . . . 0.0 112.083 -175.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.413 HG12 ' HA ' ' A' ' 160' ' ' LEU . 0.6 OUTLIER -67.0 -25.38 34.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 121.701 0.762 . . . . 0.0 111.239 -175.771 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 24.6 pt20 -82.59 -7.6 59.64 Favored 'General case' 0 C--N 1.315 -0.921 0 O-C-N 121.897 -0.502 . . . . 0.0 111.847 177.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -101.77 21.92 13.74 Favored 'General case' 0 C--O 1.239 0.553 0 CA-C-O 121.459 0.647 . . . . 0.0 110.671 -178.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.496 HG21 ' HA ' ' A' ' 207' ' ' ILE . 74.5 mt -88.51 133.15 36.93 Favored Pre-proline 0 C--N 1.303 -1.425 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.395 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -64.18 128.58 21.98 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 121.708 1.606 . . . . 0.0 109.745 175.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 118.76 -30.97 5.71 Favored Glycine 0 N--CA 1.43 -1.715 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -174.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 97.8 t -74.22 -59.58 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 176.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 104.69 147.16 16.19 Favored Glycine 0 N--CA 1.44 -1.074 0 C-N-CA 120.931 -0.652 . . . . 0.0 113.923 174.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.541 ' HG3' HG23 ' A' ' 172' ' ' VAL . 57.2 pttt -89.64 -43.36 10.8 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.11 0.481 . . . . 0.0 110.883 176.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.541 HG23 ' HG3' ' A' ' 171' ' ' LYS . 40.4 t -81.32 -33.17 12.47 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.69 0 CA-C-O 121.679 0.752 . . . . 0.0 109.933 -174.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.501 ' O ' ' HG ' ' A' ' 177' ' ' LEU . 14.4 ptmm? -90.94 5.94 46.66 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.931 -179.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -66.11 -47.39 62.18 Favored Pre-proline 0 CA--C 1.55 0.972 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.488 ' O ' ' HG2' ' A' ' 179' ' ' GLN . 37.0 Cg_exo -61.25 -36.88 77.56 Favored 'Trans proline' 0 C--N 1.384 2.438 0 C-N-CA 121.555 1.503 . . . . 0.0 110.724 178.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 58.9 tp -61.71 -46.79 88.15 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.3 175.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.501 ' HG ' ' O ' ' A' ' 173' ' ' LYS . 94.1 mt -61.38 -37.69 84.32 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.938 178.307 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 95.7 mt -65.75 -17.92 64.96 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.337 177.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 0.488 ' HG2' ' O ' ' A' ' 175' ' ' PRO . 15.3 mm100 -92.47 -7.81 46.42 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 120.899 0.381 . . . . 0.0 110.488 177.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.462 ' NZ ' ' HA ' ' A' ' 180' ' ' LYS . 0.3 OUTLIER -102.87 -51.68 3.23 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.644 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . 0.496 ' CD2' ' HG ' ' A' ' 187' ' ' LEU . 88.3 m-85 -98.08 149.91 36.21 Favored Pre-proline 0 C--N 1.294 -1.843 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -63.89 -43.42 16.08 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 121.737 1.625 . . . . 0.0 112.063 -175.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 43.1 m -155.05 171.8 19.17 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.506 ' H ' HD13 ' A' ' 184' ' ' ILE . 0.2 OUTLIER -65.99 -28.94 45.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -175.015 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 22.4 tp60 -66.88 -35.8 80.85 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.973 -177.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -79.66 -37.44 35.89 Favored 'General case' 0 C--O 1.203 -1.349 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 176.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.496 ' HG ' ' CD2' ' A' ' 181' ' ' PHE . 4.3 tt -49.71 -68.07 0.21 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.065 1.346 . . . . 0.0 112.344 -173.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 20.1 m -72.65 -24.29 61.02 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 121.169 0.509 . . . . 0.0 111.818 -174.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -87.47 1.27 53.95 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.995 -179.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.2 155.76 33.98 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 121.085 0.469 . . . . 0.0 110.582 176.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 4.7 m -63.34 160.96 14.89 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.297 -177.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 46.4 mm -50.16 -41.06 18.13 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.865 0 C-N-CA 123.278 0.631 . . . . 0.0 110.927 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -61.82 -30.05 74.01 Favored Glycine 0 CA--C 1.523 0.549 0 CA-C-N 116.216 -0.447 . . . . 0.0 113.243 -179.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -83.44 -44.67 14.51 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 98.4 mt -65.69 -28.29 68.96 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.857 -179.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -70.43 -35.41 73.37 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -63.5 -24.72 67.94 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.221 -0.9 . . . . 0.0 113.221 -178.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 13.4 m -101.47 -26.42 3.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -178.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.478 HG23 ' H ' ' A' ' 200' ' ' GLY . 2.2 m -131.77 -82.33 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 112.902 0.705 . . . . 0.0 112.902 174.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . 0.478 ' H ' HG23 ' A' ' 199' ' ' VAL . . . -177.37 165.36 35.16 Favored Glycine 0 N--CA 1.422 -2.249 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 -177.023 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -65.3 -39.07 92.05 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 117.596 0.698 . . . . 0.0 112.507 -177.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -66.91 -35.92 81.08 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.164 0.507 . . . . 0.0 110.306 -178.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.435 ' O ' ' HG2' ' A' ' 206' ' ' GLN . 2.0 t -76.62 -39.46 32.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 -179.165 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -57.22 -41.5 79.58 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.033 178.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . 0.548 HE21 ' HA ' ' A' ' 205' ' ' GLN . 0.0 OUTLIER -62.42 -40.82 97.79 Favored 'General case' 0 N--CA 1.424 -1.737 0 CA-C-N 115.133 -0.939 . . . . 0.0 112.341 179.689 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . 0.435 ' HG2' ' O ' ' A' ' 203' ' ' VAL . 20.8 pt20 -72.42 -34.59 67.96 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.895 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' ILE . . . . . 0.496 ' HA ' HG21 ' A' ' 166' ' ' ILE . 73.5 mt -65.67 -48.55 82.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.559 0.695 . . . . 0.0 109.417 175.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 46.9 t-80 -67.22 -40.38 86.37 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.071 -178.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -64.29 -25.93 68.26 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 178.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -56.62 -43.73 80.48 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.533 0.733 . . . . 0.0 110.894 -177.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -95.88 -28.46 14.7 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 120.108 -0.637 . . . . 0.0 111.838 178.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 86.7 m -64.24 -41.12 97.13 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -103.98 125.8 33.53 Favored Pre-proline 0 C--N 1.306 -1.311 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -81.69 157.46 18.75 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 121.957 1.771 . . . . 0.0 110.184 174.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 40.7 mtm180 . . . . . 0 C--N 1.294 -1.823 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.018 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 14.0 m . . . . . 0 N--CA 1.437 -1.116 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -103.91 124.71 49.48 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 178.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -91.77 124.98 58.94 Favored Pre-proline 0 C--N 1.306 -1.312 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -174.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -88.78 28.99 0.45 Allowed 'Trans proline' 0 CA--C 1.505 -0.966 0 C-N-CA 123.98 3.12 . . . . 0.0 112.09 179.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 61.4 tp -150.31 102.96 3.11 Favored 'General case' 0 N--CA 1.409 -2.482 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.93 -176.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 74.9 mt -106.63 109.04 20.84 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -160.41 145.67 11.48 Favored Glycine 0 N--CA 1.422 -2.261 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.286 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -99.47 168.67 9.83 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.76 150.38 49.48 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 177.201 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 23.3 ttt180 -111.99 97.41 6.65 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -96.62 101.25 12.83 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 45.6 tp -100.16 108.72 20.91 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 178.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -79.56 158.81 27.07 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.134 -175.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.526 HD22 ' O ' ' A' ' 154' ' ' LEU 0.303 0.0 OUTLIER -76.72 84.06 3.35 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 122.552 1.168 . . . . 0.0 112.104 178.75 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 19.6 m -86.88 106.33 17.68 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 173.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.424 ' HA ' ' HD3' ' A' ' 157' ' ' PRO . 6.5 mm-40 -73.3 112.59 16.42 Favored Pre-proline 0 C--N 1.297 -1.697 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.206 -175.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 156' ' ' GLU . 4.6 Cg_exo -76.06 103.61 1.77 Allowed 'Trans proline' 0 N--CA 1.427 -2.412 0 C-N-CA 121.76 1.64 . . . . 0.0 108.522 176.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.574 ' O ' ' HG2' ' A' ' 161' ' ' ARG . 28.0 m -74.85 77.12 2.12 Favored 'General case' 0 N--CA 1.419 -2.008 0 CA-C-O 121.841 0.829 . . . . 0.0 109.099 178.237 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 42.4 mt -62.67 -21.82 66.01 Favored 'General case' 0 CA--C 1.487 -1.458 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -175.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.538 HD23 ' H ' ' A' ' 160' ' ' LEU . 2.0 pt? -61.31 -29.58 69.96 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.66 176.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.574 ' HG2' ' O ' ' A' ' 158' ' ' SER . 27.0 ptt180 -78.86 -24.78 44.09 Favored 'General case' 0 C--O 1.216 -0.69 0 C-N-CA 120.485 -0.486 . . . . 0.0 109.703 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 26.5 m -86.19 -41.53 14.59 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-O 121.377 0.608 . . . . 0.0 110.379 178.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -59.78 -26.5 35.48 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 C-N-CA 124.216 1.007 . . . . 0.0 111.553 -177.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -83.29 -15.1 51.47 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.81 177.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 10.3 mm-40 -106.28 14.2 27.78 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-O 121.329 0.585 . . . . 0.0 110.129 -175.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 94.8 mt -71.56 132.05 85.82 Favored Pre-proline 0 C--O 1.249 1.04 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 176.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -63.15 128.44 22.81 Favored 'Trans proline' 0 C--O 1.246 0.924 0 C-N-CA 122.007 1.805 . . . . 0.0 109.768 176.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 117.1 -32.82 5.29 Favored Glycine 0 N--CA 1.431 -1.65 0 C-N-CA 120.789 -0.72 . . . . 0.0 111.391 -177.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 59.6 t -66.95 -71.43 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.773 0 CA-C-O 121.231 0.538 . . . . 0.0 109.674 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 113.66 109.42 2.88 Favored Glycine 0 N--CA 1.421 -2.302 0 C-N-CA 119.975 -1.107 . . . . 0.0 112.91 177.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt -78.74 -15.05 58.91 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 121.718 0.771 . . . . 0.0 109.69 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 91.0 t -79.81 -36.64 17.38 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.895 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.538 ' O ' ' HG ' ' A' ' 177' ' ' LEU . 9.3 ptpp? -90.43 -5.89 55.56 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.073 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -52.81 -49.67 85.45 Favored Pre-proline 0 CA--C 1.552 1.03 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -177.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -62.56 -23.94 74.99 Favored 'Trans proline' 0 C--N 1.371 1.714 0 C-N-CA 121.283 1.322 . . . . 0.0 112.824 176.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.52 ' HA ' HE21 ' A' ' 179' ' ' GLN . 59.6 tp -77.63 -39.34 45.58 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 175.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 173' ' ' LYS . 87.4 mt -69.17 -33.05 72.79 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.837 -179.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 41.1 tp -68.24 -12.73 61.47 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-O 121.824 0.821 . . . . 0.0 110.76 178.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 0.52 HE21 ' HA ' ' A' ' 176' ' ' LEU . 51.3 mt-30 -94.13 -3.34 51.22 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.829 177.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 37.2 mmtm -117.51 -45.91 2.69 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 121.284 0.564 . . . . 0.0 110.94 177.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -102.4 145.03 29.79 Favored Pre-proline 0 C--N 1.303 -1.451 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 -179.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -67.0 -34.45 29.04 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 121.723 1.615 . . . . 0.0 112.411 -176.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 84.5 p -151.29 166.49 30.79 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -178.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.467 ' H ' HD13 ' A' ' 184' ' ' ILE . 0.2 OUTLIER -66.91 -25.02 33.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 O-C-N 123.384 0.428 . . . . 0.0 110.885 175.025 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -64.71 -47.46 78.24 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.45 178.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -73.37 -35.93 66.0 Favored 'General case' 0 C--O 1.195 -1.775 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.466 HD21 HD13 ' A' ' 177' ' ' LEU . 4.4 tt -49.04 -65.96 0.48 Allowed 'General case' 0 C--O 1.217 -0.631 0 C-N-CA 124.697 1.199 . . . . 0.0 110.398 -177.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 19.8 m -68.79 -23.75 64.33 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -177.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 26.6 m-80 -85.11 -2.76 58.37 Favored 'General case' 0 C--O 1.242 0.699 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 178.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -66.34 156.3 34.87 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 122.978 0.511 . . . . 0.0 110.965 178.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 15.8 m -63.05 153.3 34.44 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.832 -178.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 48.9 mm -51.21 -36.67 16.95 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.927 0 C-N-CA 123.84 0.856 . . . . 0.0 111.274 -176.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.57 ' O ' ' HG2' ' A' ' 197' ' ' GLN . . . -58.42 -45.89 93.78 Favored Glycine 0 N--CA 1.443 -0.843 0 O-C-N 123.385 0.428 . . . . 0.0 112.547 178.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 0.447 ' O ' ' HB2' ' A' ' 197' ' ' GLN . 11.1 mm-40 -67.96 -40.77 83.13 Favored 'General case' 0 CA--C 1.494 -1.208 0 CA-C-O 121.772 0.796 . . . . 0.0 109.705 -177.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 94.3 mt -70.82 -31.09 67.71 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.76 178.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -68.95 -35.71 77.1 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.57 ' HG2' ' O ' ' A' ' 193' ' ' GLY . 15.5 mm100 -57.89 -33.31 68.6 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.638 -1.164 . . . . 0.0 111.465 177.172 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 14.2 m -103.33 -35.04 3.62 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -176.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.467 HG23 ' H ' ' A' ' 200' ' ' GLY . 2.4 m -118.89 -77.66 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 176.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . 0.467 ' H ' HG23 ' A' ' 199' ' ' VAL . . . -178.69 165.33 34.39 Favored Glycine 0 N--CA 1.419 -2.443 0 N-CA-C 107.963 -2.055 . . . . 0.0 107.963 -177.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -66.07 -45.65 80.52 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 117.762 0.781 . . . . 0.0 109.855 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -67.76 -33.59 75.14 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-O 121.161 0.505 . . . . 0.0 110.983 -179.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.412 HG23 ' H ' ' A' ' 203' ' ' VAL . 2.6 t -73.81 -40.52 53.53 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.686 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 -178.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -56.04 -44.97 79.3 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.545 -1.207 . . . . 0.0 109.882 177.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -59.32 -50.9 72.19 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.582 178.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -66.97 -30.63 70.81 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 121.046 -0.261 . . . . 0.0 111.559 -176.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' ILE . . . . . . . . . . . . . 97.4 mt -75.11 -51.4 21.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.373 177.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 9.7 t60 -69.86 -38.4 76.43 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.368 0.604 . . . . 0.0 110.202 -175.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -77.95 -9.94 59.34 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -60.1 -51.29 70.23 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-O 121.514 0.673 . . . . 0.0 110.395 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -86.82 -26.97 23.79 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.394 -179.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 37.6 m -72.77 -43.97 62.18 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.595 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -114.21 119.16 40.98 Favored Pre-proline 0 C--N 1.303 -1.443 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -44.84 128.38 8.89 Favored 'Trans proline' 0 C--O 1.251 1.146 0 C-N-CA 123.93 3.087 . . . . 0.0 113.981 177.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 35.8 ttm180 . . . . . 0 C--N 1.295 -1.799 0 CA-C-N 113.955 -1.475 . . . . 0.0 108.773 -178.5 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 61.0 m . . . . . 0 C--O 1.243 0.75 0 N-CA-C 111.509 0.189 . . . . 0.0 111.509 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp 70.12 -62.11 0.44 Allowed 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 125.095 1.358 . . . . 0.0 112.168 177.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -98.64 148.68 34.88 Favored Pre-proline 0 C--N 1.299 -1.622 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -179.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -79.95 3.8 7.29 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.355 2.037 . . . . 0.0 112.04 178.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 55.1 tp 62.06 102.45 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 125.398 1.479 . . . . 0.0 111.272 -177.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 83.7 mt -77.79 109.52 11.88 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.557 0.694 . . . . 0.0 110.288 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -153.56 -150.18 5.38 Favored Glycine 0 N--CA 1.431 -1.673 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 -178.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.46 145.19 27.55 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.601 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 66.1 pttt -150.03 153.97 37.39 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 177.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 17.9 ptt180 -120.62 104.4 9.9 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 121.872 0.844 . . . . 0.0 111.934 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -137.16 148.54 46.67 Favored 'General case' 0 N--CA 1.431 -1.388 0 CA-C-N 114.293 -1.322 . . . . 0.0 107.669 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 58.4 tp -121.01 116.76 25.69 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 91.7 mt -88.58 157.76 18.5 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 178.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 53.4 tp -86.71 77.24 9.37 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 121.585 0.707 . . . . 0.0 109.72 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 20.5 m -96.03 115.9 28.13 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.203 178.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -131.28 156.64 79.85 Favored Pre-proline 0 C--N 1.304 -1.403 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -49.33 -61.92 0.5 Allowed 'Trans proline' 0 CA--C 1.553 1.453 0 C-N-CA 124.077 3.184 . . . . 0.0 116.885 -176.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.534 ' O ' ' HG2' ' A' ' 161' ' ' ARG . 13.7 p -173.26 27.94 0.01 OUTLIER 'General case' 0 C--O 1.245 0.861 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -170.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -73.42 -43.75 59.79 Favored 'General case' 0 C--N 1.291 -1.963 0 O-C-N 121.546 -0.721 . . . . 0.0 109.166 -177.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.422 ' O ' HG12 ' A' ' 163' ' ' VAL . 2.1 pt? -60.21 -33.08 71.75 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -178.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.534 ' HG2' ' O ' ' A' ' 158' ' ' SER . 4.1 ptm180 -75.79 -26.26 57.15 Favored 'General case' 0 C--O 1.219 -0.536 0 CA-C-O 121.768 0.794 . . . . 0.0 109.75 -178.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 21.5 m -86.24 -35.43 20.01 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-O 121.537 0.685 . . . . 0.0 110.153 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.422 HG12 ' O ' ' A' ' 160' ' ' LEU . 0.4 OUTLIER -64.54 -25.2 37.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.224 -176.507 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -84.57 -10.8 57.06 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.115 0.484 . . . . 0.0 110.787 177.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -102.75 23.38 12.17 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.292 0.568 . . . . 0.0 110.364 -177.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.416 HG21 ' HA ' ' A' ' 207' ' ' ILE . 84.8 mt -84.18 129.57 57.81 Favored Pre-proline 0 C--N 1.308 -1.221 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.048 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.98 128.79 18.32 Favored 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 121.778 1.652 . . . . 0.0 110.561 177.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 113.89 -16.72 20.65 Favored Glycine 0 C--N 1.297 -1.635 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.807 179.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 77.9 t -61.69 -43.21 96.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-O 121.028 0.442 . . . . 0.0 110.87 179.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 108.35 88.53 1.98 Allowed Glycine 0 N--CA 1.44 -1.097 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.383 178.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -60.64 -33.67 73.14 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -178.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 38.3 t -83.93 -23.49 7.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.336 0.589 . . . . 0.0 109.927 -176.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.54 ' O ' ' HG ' ' A' ' 177' ' ' LEU . 31.2 mtpt -85.57 -2.17 57.88 Favored 'General case' 0 C--O 1.193 -1.911 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.826 -176.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -42.97 -52.07 12.01 Favored Pre-proline 0 CA--C 1.566 1.587 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 -176.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.72 -38.55 10.23 Favored 'Trans proline' 0 C--N 1.366 1.487 0 C-N-CA 121.653 1.569 . . . . 0.0 111.738 178.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 54.4 tp -64.05 -41.31 97.43 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.116 177.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.54 ' HG ' ' O ' ' A' ' 173' ' ' LYS . 94.5 mt -58.22 -36.79 73.68 Favored 'General case' 0 C--O 1.206 -1.198 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.424 175.21 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.431 ' HA ' ' O ' ' A' ' 181' ' ' PHE . 92.5 mt -70.81 -11.93 61.25 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.299 0.571 . . . . 0.0 112.272 178.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -88.06 -5.42 58.49 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.83 0.824 . . . . 0.0 109.41 174.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.409 ' NZ ' ' HA ' ' A' ' 180' ' ' LYS . 0.3 OUTLIER -113.82 -50.73 2.82 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.359 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . 0.537 ' CD2' ' HG ' ' A' ' 187' ' ' LEU . 34.5 m-85 -110.23 140.81 22.78 Favored Pre-proline 0 C--N 1.3 -1.549 0 CA-C-N 114.571 -1.195 . . . . 0.0 108.921 -177.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.91 -52.5 5.86 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 123.178 2.585 . . . . 0.0 112.682 178.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 50.7 m -154.64 172.83 17.24 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -179.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -54.05 -32.08 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 114.495 1.294 . . . . 0.0 114.495 -176.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -65.02 -43.06 93.7 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.901 0.381 . . . . 0.0 111.01 -177.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -79.42 -35.9 39.84 Favored 'General case' 0 C--O 1.196 -1.73 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 176.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.537 ' HG ' ' CD2' ' A' ' 181' ' ' PHE . 5.5 tt -51.82 -67.05 0.28 Allowed 'General case' 0 C--O 1.208 -1.126 0 C-N-CA 124.712 1.205 . . . . 0.0 112.208 -173.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.417 ' CB ' HG22 ' A' ' 163' ' ' VAL . 24.3 m -75.83 -18.72 59.36 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-O 121.157 0.503 . . . . 0.0 112.235 -174.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -93.57 -0.06 56.4 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.131 -179.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.93 155.6 36.02 Favored 'General case' 0 CA--C 1.506 -0.721 0 C-N-CA 123.539 0.736 . . . . 0.0 110.375 176.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 20.4 m -64.95 159.51 22.76 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.035 -176.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 48.2 mm -51.72 -39.62 24.56 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.647 0 C-N-CA 123.271 0.628 . . . . 0.0 110.707 -177.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -60.16 -37.92 93.63 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-N 116.003 -0.544 . . . . 0.0 113.482 179.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -75.1 -41.25 59.08 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -177.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 96.1 mt -68.64 -34.66 76.1 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.217 179.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . 0.476 ' HG2' ' N ' ' A' ' 201' ' ' GLN . 5.0 tm-20 -65.92 -33.75 76.53 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -178.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -61.88 -30.5 70.91 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.792 -1.094 . . . . 0.0 113.113 179.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 25.9 m -100.3 -36.27 5.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 C-N-CA 119.592 -0.843 . . . . 0.0 111.411 -179.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.544 HG23 ' H ' ' A' ' 200' ' ' GLY . 2.9 m -116.19 -85.65 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 176.216 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . 0.544 ' H ' HG23 ' A' ' 199' ' ' VAL . . . -176.82 165.67 35.97 Favored Glycine 0 N--CA 1.415 -2.708 0 N-CA-C 108.274 -1.93 . . . . 0.0 108.274 -175.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . 0.476 ' N ' ' HG2' ' A' ' 196' ' ' GLU . 52.9 tt0 -67.72 -42.15 82.37 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 117.496 0.648 . . . . 0.0 112.097 -174.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -66.66 -35.78 80.97 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.186 0.517 . . . . 0.0 110.624 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.519 ' O ' ' HG2' ' A' ' 206' ' ' GLN . 2.6 t -71.64 -40.38 70.62 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.747 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -57.06 -43.84 82.44 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 114.366 -1.288 . . . . 0.0 110.098 178.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . 0.403 ' HG3' ' O ' ' A' ' 201' ' ' GLN . 53.9 mt-30 -60.93 -45.59 94.06 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 114.955 -1.021 . . . . 0.0 112.372 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' GLN . . . . . 0.519 ' HG2' ' O ' ' A' ' 203' ' ' VAL . 13.2 pt20 -69.29 -30.86 69.03 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 120.236 -0.585 . . . . 0.0 110.708 -177.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' ILE . . . . . 0.416 ' HA ' HG21 ' A' ' 166' ' ' ILE . 92.4 mt -73.44 -50.38 30.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.268 178.107 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' HIS . . . . . . . . . . . . . 48.1 t-80 -69.1 -41.46 77.4 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.159 -177.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -73.44 -11.51 60.49 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 121.941 -0.474 . . . . 0.0 112.227 179.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -58.82 -51.9 68.02 Favored 'General case' 0 C--O 1.217 -0.646 0 C-N-CA 122.795 0.438 . . . . 0.0 110.743 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -80.51 -24.84 39.09 Favored 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.524 -179.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 27.5 m -61.84 -47.7 83.91 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.615 175.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -74.17 121.33 84.94 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.484 -178.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -80.48 147.59 17.91 Favored 'Trans proline' 0 C--O 1.253 1.256 0 C-N-CA 122.199 1.932 . . . . 0.0 112.181 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? . . . . . 0 N--CA 1.414 -2.242 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 179.806 . . . . . . . . 0 0 . 1 stop_ save_